Pr\xc3\xa4eklampsie/RB/B-VP/O ist/VB/I-VP/O verheerend/JJ/B-ADJP/O f\xc3\xbcr/IN/B-PP/B-PNP Mutter/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Kind/NN/I-NP/I-PNP ././O/O

Der/DT/B-NP/O Ursprung/NN/I-NP/O der/DT/B-NP/O Krankheit/NN/I-NP/O liegt/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP utero-plazent\xc3\xa4ren/JJ/I-NP/I-PNP Einheit/NN/I-NP/I-PNP (/(/O/O upE/NN/B-NP/O )/)/O/O ././O/O

Auswirkungen/RB/B-VP/O sind/VB/I-VP/O bis/IN/B-PP/B-PNP in/IN/I-PP/I-PNP die/DT/B-NP/I-PNP Zirkulation/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Mutter/NN/I-NP/I-PNP messbar/JJ/B-ADJP/O ././O/O

Das/DT/B-NP/O Renin-Angiotensin/JJ/I-NP/O System/NN/I-NP/O (/(/O/O RAS/NNP/B-NP/O )/)/O/O ist/NN/B-NP/O in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Pr\xc3\xa4eklampsie/NN/I-NP/I-PNP involviert/NN/I-NP/I-PNP ,/,/O/O obwohl/CC/O/O nicht/RB/B-VP/O gekl\xc3\xa4rt/VBN/I-VP/O ist/VB/I-VP/O ,/,/O/O wie/IN/B-PP/O das/DT/O/O zirkulatorische/JJ/B-ADJP/O und/CC/O/O das/DT/B-NP/O gewebespezifische/JJ/I-NP/O utero-plazent\xc3\xa4re/JJ/I-NP/O RAS/NNP/I-NP/O miteinander/RB/B-VP/O interagieren/VB/I-VP/O ././O/O

Diese/DT/B-NP/O Arbeit/NN/I-NP/O sollte/MD/B-VP/O die/DT/B-NP/O Dysregulation/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP upE/NN/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O maternalen/JJ/I-NP/O und/CC/I-NP/O fetalen/JJ/I-NP/O Zirkulation/NN/I-NP/O ,/,/O/O insbesondere/RB/B-ADVP/O des/DT/B-NP/O RAS/NNP/I-NP/O ,/,/O/O zeigen/VB/B-VP/O ././O/O

Es/PRP/B-NP/O wurden/VB/B-VP/O Expressionsanalysen/NN/B-NP/O der/DT/I-NP/O Decidua/NN/I-NP/O ,/,/O/O Plazenta/NN/B-NP/O (/(/O/O als/IN/B-PP/B-PNP upE/NN/B-NP/I-PNP )/)/O/O ,/,/O/O Fett/NN/B-NP/O -/-/O/O und/CC/O/O Muskelgewebe/NN/B-NP/O von/IN/B-PP/B-PNP 10/CD/B-NP/I-PNP Kontroll-Schwangeren/NN/I-NP/I-PNP und/CC/O/O 10/CD/B-NP/O pr\xc3\xa4eklamptischen/JJ/I-NP/O Schwangeren/NN/I-NP/O durchgef\xc3\xbchrt/VBN/B-VP/O und/CC/O/O auf/IN/B-PP/B-PNP Proteinebene/JJ/B-NP/I-PNP verifiziert/NN/I-NP/I-PNP ././O/O

Au\xc3\x9ferdem/RB/B-VP/O wurden/VB/I-VP/O die/DT/B-NP/O Plasma-Renin/JJ/I-NP/O Aktivit\xc3\xa4t/NN/I-NP/O (/(/O/O PRA/NNP/B-NP/O )/)/O/O und/CC/O/O der/DT/B-NP/O Angiotensin/NN/I-NP/O II-Rezeptor/NN/I-NP/O Typ/JJ/B-NP/O 1-Autoantik\xc3\xb6rper/NN/I-NP/O (/(/O/O AT1-AA/NNP/B-NP/O )/)/O/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Zirkulation/NN/I-NP/I-PNP untersucht/VBN/B-VP/I-PNP und/CC/O/O die/DT/B-NP/O Aktivit\xc3\xa4t/NN/I-NP/O des/DT/B-NP/O AT1-AA/NNP/I-NP/O charakterisiert/NNP/I-NP/O ././O/O

Die/DT/B-NP/O meisten/DT/I-NP/O Gene/NN/I-NP/O waren/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Decidua/JJ/I-NP/I-PNP dysreguliert/NN/I-NP/I-PNP ././O/O

Der/DT/B-NP/O Angiotensin/NN/I-NP/O II-Rezeptor/NN/I-NP/O Typ/NN/I-NP/O 1/CD/O/O (/(/O/O AT1-R/NN/B-NP/O )/)/O/O war/NN/B-NP/O um/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Faktor/NN/I-NP/I-PNP 5,0/CD/O/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP pr\xc3\xa4eklamptischen/JJ/I-NP/I-PNP Decidua/NN/I-NP/I-PNP hochreguliert/NN/I-NP/I-PNP ,/,/O/O der/DT/B-NP/O AT2-R/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP pr\xc3\xa4eklamptischen/JJ/I-NP/I-PNP Plazenta/JJ/I-NP/I-PNP runterreguliert/NN/I-NP/I-PNP ././O/O

Der/DT/B-NP/O AT1-AA/NNP/I-NP/O wurde/VB/B-VP/O in/IN/B-PP/B-PNP maternalem/NN/B-NP/I-PNP Serum/NN/I-NP/I-PNP und/CC/O/O im/IN/B-PP/B-PNP transplazentaren/NN/B-NP/I-PNP Transfer/NN/I-NP/I-PNP detektiert/NN/I-NP/I-PNP und/CC/O/O zeigte/VB/B-VP/O sich/PRP/B-NP/O bef\xc3\xa4higt/VB/B-VP/O den/DT/B-NP/O MAPK-Weg/NN/I-NP/O spezifisch/JJ/B-ADJP/O zu/TO/B-VP/O aktivieren/VB/I-VP/O ././O/O

Die/DT/B-NP/O PRA/NNP/I-NP/O war/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Pr\xc3\xa4eklampsie/NN/I-NP/I-PNP um/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Faktor/NN/I-NP/I-PNP 3/CD/O/O reduziert/RP/O/O ././O/O

Die/DT/B-NP/O RAS-Komponenten/JJ/I-NP/O Renin/NN/I-NP/O (/(/O/O 35-fach/NN/B-NP/O )/)/O/O ,/,/O/O Angiotensin/FW/O/O converting/NN/B-NP/O enzyme/NN/I-NP/O (/(/O/O 2,8-fach/NN/B-NP/O )/)/O/O und/CC/O/O Angiotensinogen/NN/B-NP/O (/(/O/O 9-fach/NN/B-NP/O )/)/O/O waren/NN/B-NP/O unabh\xc3\xa4ngig/JJ/B-ADJP/O der/DT/B-NP/O Pr\xc3\xa4eklampsie/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Decidua/NN/I-NP/I-PNP h\xc3\xb6her/JJ/B-NP/I-PNP expremiert/NN/I-NP/I-PNP als/IN/B-PP/B-PNP in/IN/I-PP/I-PNP der/DT/B-NP/I-PNP Plazenta/NN/I-NP/I-PNP ,/,/O/O wohingegen/IN/B-PP/B-PNP der/DT/B-NP/I-PNP AT1-R/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Plazenta/NN/I-NP/I-PNP h\xc3\xb6her/JJ/B-NP/I-PNP expremiert/NN/I-NP/I-PNP wurde/VB/B-VP/O ././O/O

Diese/DT/B-NP/O Ergebnisse/NN/I-NP/O verdeutlichen/VB/B-VP/O die/DT/B-NP/O Dysregulation/NN/I-NP/O des/DT/O/O lokalen/JJ/B-ADJP/O und/CC/O/O zirkulierenden/NN/B-NP/O RAS/NNP/I-NP/O w\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Pr\xc3\xa4eklampsie/NN/I-NP/I-PNP und/CC/O/O beschreiben/VB/B-VP/O das/DT/B-NP/O RAS/NNP/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP upE/NN/I-NP/I-PNP ././O/O

Diese/DT/B-NP/O neuen/JJ/I-NP/O Faktoren/NN/I-NP/O k\xc3\xb6nnten/VB/B-VP/O zum/IN/B-PP/B-PNP besseren/JJ/B-NP/I-PNP Verst\xc3\xa4ndnis/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Pathologie/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Pr\xc3\xa4eklampsie/NN/B-NP/I-PNP beitragen.Die/NN/I-NP/I-PNP systemische/JJ/I-NP/I-PNP Sklerose/NN/I-NP/I-PNP ist/VB/B-VP/O eine/DT/B-NP/O seltene/NN/I-NP/O und/CC/O/O komplexe/JJ/B-NP/O Multisystemerkrankung/NN/I-NP/O ,/,/O/O charakterisiert/NN/B-NP/O durch/IN/B-PP/B-PNP Vaskulopathie/NN/B-NP/I-PNP (/(/O/O Gef\xc3\xa4\xc3\x9fver\xc3\xa4nderungen/NN/B-NP/O )/)/O/O ,/,/O/O Gewebefibrose/NN/B-NP/O und/CC/I-NP/O der/DT/I-NP/O Bildung/NN/I-NP/O von/IN/B-PP/B-PNP Autoantik\xc3\xb6rpern/NN/B-NP/I-PNP gegen/IN/B-PP/B-PNP verschiedene/JJ/B-NP/I-PNP Antigene/NN/I-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP fortschreitenden/NN/B-NP/I-PNP Verlauf/NN/I-NP/I-PNP der/DT/I-NP/I-PNP Erkrankung/NN/I-NP/I-PNP k\xc3\xb6nnen/PRP$/I-NP/I-PNP Dysfunktionen/NN/I-NP/I-PNP und/CC/O/O Ausf\xc3\xa4lle/NN/B-NP/O verschiedener/JJ/B-NP/O Organe/NN/I-NP/O auftreten/VB/B-VP/O ././O/O

Pathogenetisch/JJ/B-ADJP/O stehen/VB/B-VP/O funktionelle/NN/B-NP/O Ver\xc3\xa4nderungen/NN/I-NP/O der/DT/I-NP/O Endothelzellen/NN/I-NP/O im/IN/B-PP/B-PNP Vordergrund/NN/B-NP/I-PNP ././O/O

Durch/IN/B-PP/B-PNP gest\xc3\xb6rte/JJ/B-NP/I-PNP Vasodilatation/NN/I-NP/I-PNP (/(/O/O verminderte/NN/B-NP/O NO-Produktion/NN/I-NP/O )/)/O/O und/CC/O/O gesteigerte/JJ/B-NP/O Vasokonstriktion/NN/I-NP/O (/(/O/O vermehrte/JJ/B-NP/O Bildung/NN/I-NP/O von/IN/B-PP/B-PNP Endothelin-1/NN/B-NP/I-PNP (/(/O/O ET-1/NN/B-NP/O )/)/O/O und/CC/O/O Angiotensin/NN/B-NP/O II/CD/O/O (/(/O/O Ang/NN/B-NP/O II/CD/O/O )/)/O/O kommt/VB/B-VP/O es/PRP/B-NP/O zu/IN/B-PP/B-PNP St\xc3\xb6rungen/NN/B-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Gewebeperfusion/NN/I-NP/I-PNP ././O/O

Ang/NN/B-NP/O II/CD/I-NP/O und/CC/I-NP/O ET-1/NN/I-NP/O vermitteln/VB/B-VP/O ihre/PRP$/B-NP/O physiologischen/JJ/I-NP/O und/CC/I-NP/O pathophysiologischen/JJ/I-NP/O Wirkungen/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP vier/CD/B-NP/I-PNP Rezeptoren/NN/I-NP/I-PNP (/(/O/O AT1,-AT2,-ETA-und/NN/B-NP/O ETB-Rezeptor/NN/I-NP/O )/)/O/O ././O/O

Die/DT/B-NP/O direkte/JJ/I-NP/O pharmakologische/JJ/I-NP/O Blockade/NN/I-NP/O der/DT/B-NP/O Rezeptoren/NN/I-NP/O mit/IN/B-PP/B-PNP spezifischen/JJ/B-NP/I-PNP Antagonisten/NN/I-NP/I-PNP wird/VB/B-VP/O teilweise/RB/B-ADJP/O erfolgreich/JJ/I-ADJP/O bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Behandlung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP systemischen/JJ/I-NP/I-PNP Sklerose/NN/I-NP/I-PNP eingesetzt/RP/O/O ././O/O

Ziel/NN/B-NP/O dieser/DT/I-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O es/PRP/B-NP/O autoimmun-vermittelte/JJ/I-NP/O \xc3\x84nderungen/NN/I-NP/O an/IN/B-PP/B-PNP Rezeptoren/NN/B-NP/I-PNP \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Signaltransduktion/NN/I-NP/I-PNP an/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP mikrovaskul\xc3\xa4ren/NN/I-NP/I-PNP endothelialen/JJ/B-NP/I-PNP Zelllinie/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Haut/NN/I-NP/I-PNP (/(/O/O HMEC-1/NN/B-NP/O )/)/O/O zu/TO/B-VP/O untersuchen/VB/I-VP/O ././O/O

Es/PRP/B-NP/O wurden/VB/B-VP/O die/DT/B-NP/O Effekte/NNS/I-NP/O der/DT/O/O nat\xc3\xbcrlichen/IN/B-PP/B-PNP Liganden/NN/B-NP/I-PNP Ang/NN/I-NP/I-PNP II/CD/I-NP/I-PNP und/CC/I-NP/I-PNP ET-1/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP immunologisch/JJ/B-NP/I-PNP bedingten/JJ/I-NP/I-PNP Mechanismen/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP isoliertes/JJ/B-NP/I-PNP IgG/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Patienten/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP systemischer/JJ/B-NP/I-PNP Sklerose/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Aktivierung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Signaltransduktionsweges/NN/I-NP/I-PNP ERK1&slash;2&slash;Ets-1/NN/I-NP/I-PNP verglichen/RP/O/O ././O/O

owohl/CC/O/O die/DT/B-NP/O Liganden/NN/I-NP/O als/CC/O/O auch/IN/B-PP/B-PNP IgG/NN/B-NP/I-PNP von/IN/B-PP/B-PNP erkrankten/NN/B-NP/I-PNP Patienten/NN/I-NP/I-PNP f\xc3\xbchrten/VB/B-VP/O zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP gesteigerten/JJ/I-NP/I-PNP Phosphorylierung/NN/I-NP/I-PNP ././O/O

Dar\xc3\xbcber/RB/B-ADVP/O hinaus/IN/B-PP/O wurde/VB/B-VP/O ausschlie\xc3\x9flich/RB/B-ADVP/O durch/IN/B-PP/B-PNP Stimulation/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP Patienten-IgG/NN/B-NP/I-PNP eine/DT/I-NP/I-PNP Zunahme/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Endothelzellproliferation/NN/I-NP/I-PNP beobachtet/RP/O/O ././O/O

pezifische/JJ/B-NP/O Blockade/NN/I-NP/O von/IN/B-PP/B-PNP AT1R/NN/B-NP/I-PNP und/CC/I-NP/I-PNP ETAR/NN/I-NP/I-PNP reduzierte/VB/B-VP/O die/DT/B-NP/O ERK1&slash;2&slash;Ets-1/NN/I-NP/O Aktivierung/NN/I-NP/O deutlich/JJ/B-ADJP/O ././O/O

AT2R/NN/B-NP/O -/-/O/O und/CC/O/O ETBR-Antagonisten/NN/B-NP/O zeigten/VB/B-VP/O dagegen/RB/B-NP/O keinen/JJ/I-NP/O inhibierbaren/JJ/I-NP/O Effekt/NN/I-NP/O ././O/O

In/IN/B-PP/B-PNP weiteren/JJ/B-NP/I-PNP Experimenten/NN/I-NP/I-PNP konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP durch/IN/I-PP/I-PNP Inhibition/NN/B-NP/I-PNP der/DT/I-NP/I-PNP ERK1&slash;2-Vorl\xc3\xa4uferkinasen/NN/I-NP/I-PNP Raf/NN/I-NP/I-PNP und/CC/O/O MEK1&slash;2/NN/B-NP/O die/DT/B-NP/O aktivierenden/NN/I-NP/O Effekte/NNS/I-NP/O durch/IN/B-PP/B-PNP Patienten-IgG/NN/B-NP/I-PNP sowie/RB/B-ADVP/O die/DT/O/O nat\xc3\xbcrlichen/IN/B-PP/B-PNP Liganden/NN/B-NP/I-PNP verhindert/VBN/B-VP/I-PNP wurden/VB/I-VP/O ././O/O

Ein/DT/B-NP/O h\xc3\xa4ufiges/NN/I-NP/O pathomorphologisches/JJ/B-NP/O Korrelat/NN/I-NP/O der/DT/B-NP/O Gef\xc3\xa4\xc3\x9fver\xc3\xa4nderungen/NN/I-NP/O bei/IN/B-PP/B-PNP Patienten/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP systemischer/NN/B-NP/I-PNP Sklerose/NN/I-NP/I-PNP sind/VB/B-VP/O Mikrothrombosen/NN/B-NP/O ././O/O

Deshalb/RB/B-VP/O wurden/VB/I-VP/O Unterschiede/NN/B-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Regulation/NN/I-NP/I-PNP und/CC/O/O Expression/NN/B-NP/O des/DT/B-NP/O prokoagulatorischen/JJ/I-NP/O und/CC/I-NP/O prothrombotischen/JJ/I-NP/O Proteins/NN/I-NP/O Tissue/NN/I-NP/O Factor/NN/I-NP/O untersucht/RP/O/O ././O/O

Auf/IN/B-PP/B-PNP Ebene/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Gen/NN/I-NP/I-PNP -/-/O/O und/CC/O/O der/DT/B-NP/O Proteinexpression/NN/I-NP/O konnte/VB/B-VP/O eine/DT/B-NP/O gesteigerte/JJ/I-NP/O Aktivierung/NN/I-NP/O von/IN/B-PP/B-PNP Tissue/JJ/B-NP/I-PNP Factor/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP Stimulation/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP Patienten-IgG/NN/B-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Zudem/RB/B-VP/O wurde/VB/I-VP/O eine/DT/B-NP/O Bindung/NN/I-NP/O zwischen/IN/B-PP/B-PNP Ets-1/NN/B-NP/I-PNP und/CC/I-NP/I-PNP dem/DT/I-NP/I-PNP Tissue/NN/I-NP/I-PNP Factor/NN/I-NP/I-PNP Promotor/JJ/B-NP/I-PNP observiert/NN/I-NP/I-PNP ././O/O

Zusammenfassend/JJ/B-ADJP/O konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP das/DT/B-NP/I-PNP IgG/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Patienten/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP systemischer/NN/B-NP/I-PNP Sklerose/NN/I-NP/I-PNP proliferationssteigernde/JJ/I-NP/I-PNP Signalwege/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Endothelzellen/JJ/B-NP/I-PNP aktiviert/NN/I-NP/I-PNP ././O/O

Damit/RB/B-VP/O konnte/VB/I-VP/O eine/DT/B-NP/O immunologisch/JJ/I-NP/O bedingte/NN/I-NP/O Rezeptoraktivierung/NN/I-NP/O als/IN/B-PP/B-PNP m\xc3\xb6glicher/JJ/B-NP/I-PNP Pathomechanismus/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Hieraus/RB/B-VP/O ergeben/VB/I-VP/O sich/PRP/B-NP/O neue/RB/I-NP/O therapeutische/JJ/I-NP/O Optionen/NN/I-NP/O durch/IN/B-PP/B-PNP Immunmodulation/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Rezeptorblockade/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Behandlung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Patienten/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP systemischer/NN/B-NP/I-PNP Sklerose.Legionella/NN/I-NP/I-PNP pneumophila/NN/I-NP/I-PNP ist/VB/B-VP/O ein/DT/B-NP/O opportunistisch/JJ/I-NP/O humanpathogenes/NN/I-NP/O Bakterium/NN/I-NP/O und/CC/O/O Verursacher/NN/B-NP/O einer/DT/B-NP/O schweren/JJ/I-NP/O Lungenentz\xc3\xbcndung/NN/I-NP/O ,/,/O/O der/DT/B-NP/O Legion\xc3\xa4rskrankheit/NN/I-NP/O ././O/O

Das/DT/B-NP/O Bakterium/NN/I-NP/O vermehrt/JJ/B-NP/O sich/PRP/I-NP/O intrazellul\xc3\xa4r/NN/I-NP/O in/IN/B-PP/B-PNP Protozoen/NN/B-NP/I-PNP ,/,/O/O wie/IN/B-PP/B-PNP z./IN/I-PP/I-PNP B./JJ/B-NP/I-PNP Acanthamoeba/NN/I-NP/I-PNP castellanii/NN/I-NP/I-PNP ,/,/O/O sowie/CC/O/O in/IN/B-PP/B-PNP alveolaren/JJ/B-NP/I-PNP Makrophagen/NN/I-NP/I-PNP ././O/O

Neben/IN/B-PP/O bereits/RB/B-VP/O bekannten/VB/I-VP/O und/CC/O/O gut/JJ/B-NP/O charakterisierten/NN/I-NP/O Virulenzfaktoren/NN/I-NP/O ,/,/O/O wie/IN/B-PP/O z.B./RB/B-ADVP/O dem/DT/B-NP/O Typ/NN/I-NP/O IVB/NN/I-NP/O Sekretionssystem/NN/I-NP/O Dot&slash;Icm/NN/I-NP/O ,/,/O/O sind/VB/B-VP/O im/IN/B-PP/B-PNP Genom/NN/B-NP/I-PNP von/IN/B-PP/B-PNP L./JJ/B-NP/I-PNP pneumophila/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP Vielzahl/NN/I-NP/I-PNP potentieller/NN/I-NP/I-PNP Virulenzfaktoren/JJ/B-NP/I-PNP kodiert/NN/I-NP/I-PNP ././O/O

Zu/IN/B-PP/O diesen/DT/O/O z\xc3\xa4hlen/VB/B-VP/O auch/IN/B-PP/B-PNP Gene/NN/B-NP/I-PNP ,/,/O/O die/WDT/O/O f\xc3\xbcr/IN/B-PP/B-PNP putative/NN/B-NP/I-PNP hydrolytische/JJ/I-NP/I-PNP Proteine/NN/I-NP/I-PNP kodieren/VB/B-VP/O ,/,/O/O wie/IN/B-PP/B-PNP z.B./IN/I-PP/I-PNP Proteasen/NN/B-NP/I-PNP ,/,/O/O Lipasen/NN/B-NP/O und/CC/I-NP/O H\xc3\xa4molysine/NN/I-NP/O ././O/O

Um/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Einfluss/NN/I-NP/I-PNP solcher/DT/B-NP/I-PNP Proteine/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Pathogenit\xc3\xa4t/NN/I-NP/I-PNP von/IN/B-PP/B-PNP L./JJ/B-NP/I-PNP pneumophila/NN/I-NP/I-PNP zu/IN/B-PP/O untersuchen/VB/B-VP/O ,/,/O/O sollten/NN/B-NP/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP eines/DT/I-NP/I-PNP entwickelten/NN/I-NP/I-PNP Screeningsystems/NN/I-NP/I-PNP Gene/NN/I-NP/I-PNP die/DT/O/O f\xc3\xbcr/IN/B-PP/B-PNP proteo/NN/B-NP/I-PNP -/-/O/O ,/,/O/O lipo/NN/B-NP/O -/-/O/O ,/,/O/O sowie/CC/O/O h\xc3\xa4molytische/JJ/B-NP/O Proteine/NN/I-NP/O kodieren/VB/B-VP/O bzw./CC/O/O Faktoren/NN/B-NP/O ,/,/O/O die/DT/O/O diese/WDT/B-NP/O Aktivit\xc3\xa4ten/NN/I-NP/O beeinflussen/VB/B-VP/O ,/,/O/O identifiziert/NN/B-NP/O werden/VB/B-VP/O ././O/O

Zus\xc3\xa4tzlich/JJ/B-ADJP/O sollte/MD/B-VP/O deren/DT/B-NP/O Einfluss/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP intrazellul\xc3\xa4re/JJ/I-NP/I-PNP Vermehrung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Pathogens/NN/I-NP/I-PNP gepr\xc3\xbcft/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O welche/WDT/B-NP/O einen/DT/I-NP/O Hinweis/NN/I-NP/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Virulenzeigenschaft/NN/I-NP/I-PNP des/DT/B-NP/I-PNP entsprechenden/JJ/I-NP/I-PNP Faktors/NN/I-NP/I-PNP darstellt/VB/B-VP/O ././O/O

Drei/CD/O/O der/DT/O/O im/IN/B-PP/O Screening/FW/O/O identifizierten/FW/O/O Gene/FW/O/O ,/,/O/O bzw./CC/O/O deren/WDT/B-NP/O Mutanten/NN/I-NP/O wurden/VB/B-VP/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP n\xc3\xa4her/JJ/B-NP/I-PNP charakterisiert/NN/I-NP/I-PNP ././O/O

Dazu/RB/B-VP/O z\xc3\xa4hlt/VB/I-VP/O das/DT/B-NP/O Gen/NN/I-NP/O lpg2166/NN/I-NP/O ,/,/O/O dessen/WDT/B-NP/O Genprodukt/NN/I-NP/O k\xc3\xbcrzlich/RB/B-ADVP/O als/IN/B-PP/B-PNP Typ/NN/B-NP/I-PNP IVB/NN/I-NP/I-PNP -/-/O/O Effektor/NN/B-NP/O identifiziert/NN/I-NP/O wurde/VB/B-VP/O ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP weisen/VB/B-VP/O darauf/RB/B-ADVP/O hin/IN/B-PP/O ,/,/O/O dass/IN/B-PP/B-PNP Lpg2166/NN/B-NP/I-PNP als/IN/B-PP/B-PNP Regulator/NN/B-NP/I-PNP eines/DT/I-NP/I-PNP h\xc3\xa4molytischen/JJ/I-NP/I-PNP Faktors/NN/I-NP/I-PNP agiert/NN/I-NP/I-PNP und/CC/O/O dar\xc3\xbcber/RB/B-ADVP/O hinaus/IN/B-PP/B-PNP die/DT/B-NP/I-PNP intrazellul\xc3\xa4re/JJ/I-NP/I-PNP Vermehrungsf\xc3\xa4higkeit/NN/I-NP/I-PNP von/IN/B-PP/B-PNP L./JJ/B-NP/I-PNP pneumophila/NN/I-NP/I-PNP stammspezifisch/JJ/B-ADJP/O beeinflusst/VB/B-VP/O ././O/O

Als/IN/B-PP/O ebenfalls/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP h\xc3\xa4molytische/JJ/I-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP essentieller/NN/I-NP/I-PNP regulatori-scher/NN/I-NP/I-PNP Faktor/NN/I-NP/I-PNP stellte/VB/B-VP/O sich/PRP/B-NP/O HtpG/NN/I-NP/O ,/,/O/O ein/DT/B-NP/O Hitzeschockprotein/NN/I-NP/O ,/,/O/O welches/WDT/O/O vermutlich/JJ/B-ADJP/O als/IN/B-PP/B-PNP Chaperon/NN/B-NP/I-PNP fungiert/JJ/B-ADJP/O ,/,/O/O heraus/RP/O/O ././O/O

Dar\xc3\xbcber/RB/B-ADVP/O hinaus/IN/B-PP/O beeinflusst/VB/B-VP/O HtpG/NN/B-NP/O die/DT/I-NP/O intrazellul\xc3\xa4re/JJ/I-NP/O Vermehrung/NN/I-NP/O in/IN/B-PP/B-PNP A./NNP/B-NP/I-PNP castellanii/NNP/I-NP/I-PNP und/CC/I-NP/I-PNP humanen/NNP/I-NP/I-PNP Makrophagen/NNP/I-NP/I-PNP ././O/O

Als/IN/B-PP/O weiterer/VB/B-VP/O die/DT/B-NP/O H\xc3\xa4molyse/NN/I-NP/O f\xc3\xb6rdernder/JJ/B-NP/O Faktor/NN/I-NP/O mit/IN/B-PP/B-PNP stammspezifischem/JJ/B-NP/I-PNP Einfluss/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP intrazellul\xc3\xa4re/JJ/I-NP/I-PNP Replikationsf\xc3\xa4higkeit/NN/I-NP/I-PNP konnte/VB/B-VP/O lpg0721/NN/B-NP/O identifiziert/NN/I-NP/O werden/VB/B-VP/O ,/,/O/O dessen/WDT/B-NP/O Expressionsprodukt/NN/I-NP/O das/DT/B-NP/O Membranfusionprotein/NNP/I-NP/O eines/DT/B-NP/O RND-Effluxsystems/NN/I-NP/O darstellt/VB/B-VP/O ././O/O

Der/DT/B-NP/O zweite/JJ/I-NP/O Teil/NN/I-NP/O dieser/DT/B-NP/O Arbeit/NN/I-NP/O besch\xc3\xa4ftigt/VBN/B-VP/O sich/PRP/B-NP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Zinkmetalloprotease/NN/I-NP/I-PNP ProA/NNP/I-NP/I-PNP ././O/O

Durch/IN/B-PP/B-PNP Analysen/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Substratspezifit\xc3\xa4t/NN/I-NP/I-PNP konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP ProA/NNP/B-NP/I-PNP sowohl/CC/I-NP/I-PNP Wirts/NNP/I-NP/I-PNP -/-/O/O als/CC/O/O auch/IN/B-PP/B-PNP Legionella-eigene/NN/B-NP/I-PNP Proteine/NN/I-NP/I-PNP proteolytisch/JJ/I-NP/I-PNP prozessiert/NN/I-NP/I-PNP ././O/O

Eines/DT/B-NP/O dieser/DT/I-NP/O Legionella/NN/I-NP/O Proteine/NN/I-NP/O ist/VB/B-VP/O die/DT/B-NP/O sekretierte/NN/I-NP/O Phospholipase/NN/I-NP/O PlaC/NN/I-NP/O ,/,/O/O welche/WDT/O/O nach/IN/B-PP/B-PNP Prozessierung/NN/B-NP/I-PNP durch/IN/B-PP/B-PNP ProA/NNP/B-NP/I-PNP eine/DT/I-NP/I-PNP Glyzerophospholipid-Cholesterol/NN/I-NP/I-PNP Azyltransferase-Aktivit\xc3\xa4t/JJ/B-NP/I-PNP aufweist/NN/I-NP/I-PNP ././O/O

Durch/IN/B-PP/B-PNP Peptidchip-basierte/NN/B-NP/I-PNP Analysen/NN/I-NP/I-PNP konnten/VB/B-VP/O die/DT/B-NP/O putativen/NN/I-NP/O Schnittstellen/NNP/I-NP/O von/IN/B-PP/B-PNP ProA/NNP/B-NP/I-PNP in/IN/B-PP/B-PNP PlaC/NN/B-NP/I-PNP weiter/IN/B-PP/B-PNP spezifiziert/NN/B-NP/I-PNP werden/VB/B-VP/O ,/,/O/O was/WDT/O/O zur/IN/B-PP/B-PNP Aufkl\xc3\xa4rung/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Mechanismus/NN/I-NP/I-PNP ,/,/O/O der/WDT/O/O zur/IN/B-PP/B-PNP Aktivierung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP GCAT/NNP/I-NP/I-PNP f\xc3\xbchrt/VB/B-VP/O ,/,/O/O beitr\xc3\xa4gt.Bei/NN/B-NP/O vielen/DT/I-NP/O Interaktionen/NN/I-NP/O pathogener/NNP/I-NP/O Bakterien/NNP/I-NP/O und/CC/O/O ihrer/PRP$/B-NP/O Wirte/NNS/I-NP/O spielen/JJ/B-NP/O kapsul\xc3\xa4re/JJ/I-NP/O Polysaccharide/NN/I-NP/O (/(/O/O KPS/NNP/B-NP/O )/)/O/O eine/DT/B-NP/O wichtige/JJ/I-NP/O Rolle/NN/I-NP/O ././O/O

Bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Ausbildung/NN/I-NP/I-PNP einer/DT/B-NP/I-PNP funktionellen/NN/I-NP/I-PNP Symbiose/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Bakteriums/NN/I-NP/I-PNP Sinorhizobium/NN/I-NP/I-PNP meliloti/NN/I-NP/I-PNP Stamm/NN/I-NP/I-PNP 41/CD/B-NP/I-PNP und/CC/I-NP/I-PNP der/DT/I-NP/I-PNP Wirtspflanze/NN/I-NP/I-PNP Medicago/NN/I-NP/I-PNP sativa/NN/I-NP/I-PNP sind/JJ/B-NP/I-PNP kapsul\xc3\xa4re/JJ/I-NP/I-PNP Polysaccharide/JJ/I-NP/I-PNP essentiell/NN/I-NP/I-PNP ././O/O

Mutationen/NN/B-NP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Genen/NN/I-NP/I-PNP rkpABCDEFGHIJ/NN/I-NP/I-PNP verhindern/VB/B-VP/O die/DT/B-NP/O Synthese/NN/I-NP/O der/DT/B-NP/O Polysaccharide/NN/I-NP/O ././O/O

olche/DT/B-NP/O Mutanten/NN/I-NP/O sind/VB/B-VP/O nicht/RB/B-ADVP/O mehr/RB/I-ADVP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Lage/NN/I-NP/I-PNP Stickstoff-fixierende/NN/I-NP/I-PNP Wurzelkn\xc3\xb6llchen/VB/B-VP/O zu/TO/I-VP/O bilden/VB/I-VP/O ././O/O

Die/DT/B-NP/O Gene/NN/I-NP/O rkpABCDEF/NN/I-NP/O zeigen/JJ/B-NP/O starke/JJ/I-NP/O \xc3\x84hnlichkeiten/NN/I-NP/O zu/IN/B-PP/B-PNP Genen/NN/B-NP/I-PNP von/IN/B-PP/B-PNP modularen/NN/B-NP/I-PNP Polyketidsynthasen/NN/I-NP/I-PNP und/CC/I-NP/I-PNP eukaryotischen/JJ/I-NP/I-PNP Fetts\xc3\xa4uresynthethasen/NN/I-NP/I-PNP ././O/O

Bisher/RB/B-VP/O konnte/VB/I-VP/O jedoch/RB/B-ADVP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP KPS/NNP/I-NP/I-PNP weder/CC/O/O ein/DT/B-NP/O \xc3\x9f-Ketid/NN/I-NP/O noch/RB/B-ADVP/O ein/DT/B-NP/O Fetts\xc3\xa4urerest/NN/I-NP/O entdeckt/NN/I-NP/O werden/VB/B-VP/O ././O/O

Im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP es/JJ/B-NP/I-PNP sich/PRP/I-NP/I-PNP beim/IN/B-PP/B-PNP Protein/NN/B-NP/I-PNP RkpF/NN/I-NP/I-PNP tats\xc3\xa4chlich/JJ/B-ADJP/O um/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP Acyl-Carrier-Protein/NN/I-NP/I-PNP handelt/VB/B-VP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP heterologe/NN/I-NP/I-PNP \xc3\x9cberexpression/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Gene/JJ/I-NP/I-PNP rkpABCDEF/NN/I-NP/I-PNP in/IN/B-PP/B-PNP E./JJ/B-NP/I-PNP coli/NN/I-NP/I-PNP wurden/VB/B-VP/O diese/DT/O/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP pET9a-Vektor/JJ/I-NP/I-PNP kloniert/NN/I-NP/I-PNP ././O/O

Um/IN/B-PP/B-PNP die/DT/B-NP/I-PNP korrekte/NN/I-NP/I-PNP Klonierung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Gene/NN/I-NP/I-PNP rkpABCDEF/NN/I-NP/I-PNP zu/TO/B-VP/O \xc3\xbcberpr\xc3\xbcfen/VB/I-VP/O ,/,/O/O sollte/MD/B-VP/O die/DT/B-NP/O rhizobielle/NN/I-NP/O rkpC-Mutante/NN/I-NP/O 644/CD/B-NP/O komplementiert/NN/I-NP/O werden/VB/B-VP/O ././O/O

Diese/DT/B-NP/O Komplementation/NN/I-NP/O war/VBN/B-VP/O jedoch/RB/B-ADVP/O mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Genen/NN/I-NP/I-PNP rkpABCDEF/NN/I-NP/I-PNP nicht/RB/B-ADJP/O m\xc3\xb6glich/JJ/I-ADJP/O ././O/O

Anschliessende/JJ/B-NP/O Untersuchungen/NN/I-NP/O ergaben/VB/B-VP/O ,/,/O/O dass/RB/B-VP/O weitere/VB/I-VP/O bisher/IN/B-PP/B-PNP unbekannte/NN/B-NP/I-PNP Gene/NN/I-NP/I-PNP ,/,/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP KPS-Bildung/NN/I-NP/I-PNP ben\xc3\xb6tigt/VBN/B-VP/I-PNP werden/VB/I-VP/O und/CC/O/O auf/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP komplementierenden/NN/I-NP/I-PNP Kosmid/NN/I-NP/I-PNP pPP428/NN/I-NP/I-PNP lokalisiert/NN/I-NP/I-PNP sein/VB/B-VP/O mussten/VB/I-VP/O ././O/O

Die/DT/B-NP/O Sequenzierung/NN/I-NP/O der/DT/B-NP/O verbleibenden/NN/I-NP/O 17/CD/B-NP/O kb/NN/I-NP/O des/DT/B-NP/O Kosmides/NN/I-NP/O f\xc3\xbchrte/VB/B-VP/O zur/IN/B-PP/B-PNP Entdeckung/NN/B-NP/I-PNP zweier/DT/I-NP/I-PNP neuer/JJ/I-NP/I-PNP Gene/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Biosynthese/NN/I-NP/I-PNP bzw./RB/B-ADVP/O dem/DT/B-NP/O Transport/NN/I-NP/O der/DT/B-NP/O kapsul\xc3\xa4ren/NN/I-NP/O Polysaccharide/NN/I-NP/O beteiligt/VBN/B-VP/O sind/VB/I-VP/O ././O/O

Zus\xc3\xa4tzlich/VBN/B-VP/O wurden/VB/I-VP/O die/DT/B-NP/O Komplementationsgruppen/NN/I-NP/O der/DT/B-NP/O rkp-1-Region/NN/I-NP/O neu/JJ/B-ADJP/O bestimmt/RP/O/O ././O/O

Eines/DT/B-NP/O der/DT/I-NP/O neuen/JJ/I-NP/O Gene/NN/I-NP/O zeigt/VB/B-VP/O Homologien/NN/B-NP/O zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Familie/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Lipoproteinen/NN/B-NP/I-PNP ,/,/O/O die/WDT/O/O am/IN/B-PP/B-PNP Export/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Polysacchariden/NN/B-NP/I-PNP beteiligt/VBN/B-VP/I-PNP sind/VB/I-VP/O ././O/O

Dieses/DT/B-NP/O Lipoprotein/NNP/I-NP/O k\xc3\xb6nnte/VB/B-VP/O einen/DT/B-NP/O m\xc3\xb6glichen/NN/I-NP/O Akzeptor/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP \xc3\x9f-Ketid/NN/I-NP/I-PNP darstellen/VB/B-VP/O ,/,/O/O welches/WDT/O/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Proteine/NN/I-NP/I-PNP RkpABCDEF/NN/I-NP/I-PNP synthetisiert/NN/I-NP/I-PNP wird/VB/B-VP/O ././O/O

Das/DT/B-NP/O zweite/JJ/I-NP/O neue/JJ/I-NP/O Gen/NN/I-NP/O zeigt/VB/B-VP/O Homologien/NN/B-NP/O zum/IN/B-PP/B-PNP kpsF-Gen/NN/B-NP/I-PNP aus/IN/B-PP/B-PNP E./JJ/B-NP/I-PNP coli/NN/I-NP/I-PNP ,/,/O/O dessen/WDT/B-NP/O genaue/JJ/I-NP/O Rolle/NN/I-NP/O beim/IN/B-PP/B-PNP Transport/NN/B-NP/I-PNP der/DT/I-NP/I-PNP kapsul\xc3\xa4ren/NN/I-NP/I-PNP Polysaccharide/NN/I-NP/I-PNP noch/VB/B-VP/O nicht/RB/I-VP/O gekl\xc3\xa4rt/VBN/I-VP/O ist/VB/I-VP/O ././O/O

Die/DT/B-NP/O heterologe/NN/I-NP/O Expression/NN/I-NP/O der/DT/B-NP/O Gene/JJ/I-NP/O rkpABCDEF/NN/I-NP/O in/IN/B-PP/B-PNP E./JJ/B-NP/I-PNP coli/NN/I-NP/I-PNP f\xc3\xbchrte/VB/B-VP/O zur/IN/B-PP/B-PNP Bildung/NN/B-NP/I-PNP eines/DT/I-NP/I-PNP stabilen/JJ/I-NP/I-PNP Proteinkomplexes/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Masse/NN/I-NP/I-PNP von/IN/B-PP/B-PNP ca/NN/B-NP/I-PNP ././O/O

250/CD/B-NP/O kDa/NN/I-NP/O ././O/O

\xc3\x9cberraschenderweise/RB/B-VP/O ist/VB/I-VP/O dieser/DT/B-NP/O Proteinkomplex/NN/I-NP/O auch/RB/B-ADVP/O in/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP denaturierenden/NN/I-NP/I-PNP SDS-Gel/NN/I-NP/I-PNP stabil/JJ/B-ADJP/O ././O/O

Mit/IN/B-PP/B-PNP Western-Blots/NN/B-NP/I-PNP konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP RkpF/NN/B-NP/I-PNP ein/DT/I-NP/I-PNP Bestandteil/NN/I-NP/I-PNP dieses/DT/B-NP/I-PNP Komplexes/NN/I-NP/I-PNP ist/VB/B-VP/O ././O/O

Der/DT/B-NP/O Komplex/NN/I-NP/O konnte/VBN/B-VP/O auch/RB/B-ADVP/O mit/IN/B-PP/B-PNP [/NN/B-NP/I-PNP 3H]-\xc3\x9f-Alanin/NN/I-NP/I-PNP markiert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Dies/DT/O/O ist/VB/B-VP/O ein/DT/B-NP/O Hinweis/NN/I-NP/O darauf/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O RkpF/NN/B-NP/O zumindest/RB/B-ADVP/O teilweise/RB/I-ADVP/O mit/IN/B-PP/B-PNP 4\xc2\xb4-Phosphopantethein/NN/B-NP/I-PNP substituiert/NN/I-NP/I-PNP ist/VB/B-VP/O und/CC/O/O entsprechend/JJ/B-ADJP/O in/IN/B-PP/B-PNP seiner/PRP$/B-NP/I-PNP Holoform/NN/I-NP/I-PNP vorliegt/RP/O/O ././O/O

Der/DT/B-NP/O ungew\xc3\xb6hnliche/JJ/I-NP/O Proteinkomplex/NN/I-NP/O konnte/VB/B-VP/O ausserdem/RB/B-ADVP/O in/IN/B-PP/O S./VB/B-VP/O meliloti/NN/B-NP/O Stamm/NN/I-NP/O 41/CD/O/O nachgewiesen/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Wenn/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Gene/JJ/I-NP/I-PNP rkpABCDEF/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Anwesenheit/NN/B-NP/I-PNP von/IN/B-PP/B-PNP 14C-markiertem/JJ/B-NP/I-PNP Acetat/NN/I-NP/I-PNP in/IN/B-PP/B-PNP E./JJ/B-NP/I-PNP coli/NN/I-NP/I-PNP \xc3\xbcberexprimiert/NN/I-NP/I-PNP wurden/VB/B-VP/O ,/,/O/O erfolgte/VBN/B-VP/O die/DT/B-NP/O Bildung/NN/I-NP/O einer/DT/B-NP/O neuen/JJ/I-NP/O Substanz/NN/I-NP/O ././O/O

Diese/DT/B-NP/O neue/JJ/I-NP/O Substanz/NN/I-NP/O konnte/VB/B-VP/O mittels/IN/B-PP/B-PNP D\xc3\xbcnnschichtchromatografie/NN/B-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Das/DT/B-NP/O Auftreten/NN/I-NP/O dieser/DT/B-NP/O neuen/JJ/I-NP/O Substanz/NN/I-NP/O ist/VBN/B-VP/O von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Induktion/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Gene/NN/I-NP/I-PNP rkpABCDEF/NN/I-NP/I-PNP abh\xc3\xa4ngig.In/NN/I-NP/I-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurde/VB/B-VP/O das/DT/B-NP/O gustatorische/JJ/I-NP/O System/NN/I-NP/O der/DT/B-NP/O Biene/NN/I-NP/O mit/IN/B-PP/O elektrophysiologischen/VB/B-VP/O ,/,/O/O verhaltensphysiologischen/JJ/B-NP/O und/CC/I-NP/O anatomischen/JJ/I-NP/O Methoden/NN/I-NP/O analysiert/VB/B-VP/O ././O/O

Hierbei/RB/B-VP/O stand/VB/I-VP/O vor/IN/B-PP/B-PNP allem/DT/B-NP/I-PNP das/DT/I-NP/I-PNP Verst\xc3\xa4ndnis/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Verarbeitung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Zuckerstimulus/NN/I-NP/I-PNP ,/,/O/O der/WDT/O/O in/IN/B-PP/B-PNP Lernexperimenten/NN/B-NP/I-PNP als/IN/B-PP/B-PNP unkonditionierter/NN/B-NP/I-PNP Stimulus/NN/I-NP/I-PNP und/CC/I-NP/I-PNP Belohnung/NN/I-NP/I-PNP eingesetzt/VBN/B-VP/I-PNP wird/VB/I-VP/O ,/,/O/O im/IN/B-PP/B-PNP Vordergrund/NN/B-NP/I-PNP ././O/O

Diese/DT/B-NP/O Ergebnisse/NN/I-NP/O wurden/VB/B-VP/O verwendet/VBN/I-VP/O ,/,/O/O um/IN/B-PP/B-PNP Lernvorg\xc3\xa4nge/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Antennenmuskelsystem/NN/B-NP/I-PNP zu/TO/B-VP/O untersuchen/VB/I-VP/O ././O/O

Auf/IN/B-PP/B-PNP Zuckerwasserstimulation/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Antenne/NN/I-NP/I-PNP wurden/VB/B-VP/O nach/IN/B-PP/O etwa/RB/B-ADVP/O 200/CD/B-NP/O ms/NN/I-NP/O erste/JJ/B-ADJP/O Aktionspotentiale/VB/B-VP/O im/IN/B-PP/B-PNP Labiummuskel/NN/B-NP/I-PNP M17/NN/I-NP/I-PNP registriert/VBN/B-VP/I-PNP ,/,/O/O die/DT/B-NP/O resultierende/NN/I-NP/O Proboscisreaktion/NN/I-NP/O erfolgte/VB/B-VP/O 100/CD/B-NP/O ms/NN/I-NP/O sp\xc3\xa4ter/RP/O/O ././O/O

Die/DT/B-NP/O Latenz/NN/I-NP/O der/DT/B-NP/O Proboscisreaktion/NN/I-NP/O war/VB/B-VP/O weitgehend/JJ/B-ADJP/O unabh\xc3\xa4ngig/JJ/I-ADJP/O von/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Stimulationsbedingungen/NN/I-NP/I-PNP ././O/O

Gustatorische/JJ/B-NP/O Stimuli/NN/I-NP/O wurden/VB/B-VP/O von/IN/B-PP/B-PNP Bienen/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP ihren/PRP$/B-NP/I-PNP Antennen/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP kurze/JJ/B-NP/I-PNP Kontakte/NN/I-NP/I-PNP (/(/O/O 10-20/CD/B-NP/O ms/NN/I-NP/O )/)/O/O in/IN/B-PP/B-PNP kurzen/JJ/B-NP/I-PNP Abst\xc3\xa4nden/NN/I-NP/I-PNP (/(/O/O ca/NN/B-NP/O ././O/O

40/CD/B-NP/O ms/NN/I-NP/O )/)/O/O repetitiv/JJ/B-NP/O abgetastet/NN/I-NP/O ././O/O

Unattraktive/JJ/B-NP/O Stimuli/NN/I-NP/O wurden/VB/B-VP/O nach/IN/B-PP/B-PNP wenigen/JJ/B-NP/I-PNP Ber\xc3\xbchrungen/NN/I-NP/I-PNP nicht/RB/B-ADVP/O weiter/IN/B-PP/B-PNP abgetastet/NN/B-NP/I-PNP ././O/O

Antennale/JJ/B-NP/O Geschmackshaare/NN/I-NP/O zeigten/VB/B-VP/O eine/DT/B-NP/O hohe/JJ/I-NP/O Empfindlichkeit/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP Saccharose/NN/B-NP/I-PNP und/CC/I-NP/I-PNP eine/DT/I-NP/I-PNP geringe/JJ/I-NP/I-PNP Empfindlichkeit/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP KCl/NN/B-NP/I-PNP ././O/O

Wasserantworten/RB/B-VP/O traten/VB/I-VP/O nicht/RB/B-ADVP/O auf/RP/O/O ././O/O

Die/DT/B-NP/O Antworteigenschaften/NN/I-NP/O waren/VB/B-VP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP nat\xc3\xbcrlich/RB/I-NP/I-PNP auftretende/JJ/I-NP/I-PNP Stimulation/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP kurze/JJ/B-NP/I-PNP Kontakte/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Stimuli/JJ/B-NP/I-PNP abgestimmt/NN/I-NP/I-PNP ././O/O

Anhaltende/JJ/B-NP/O Adaptation/NN/I-NP/O der/DT/B-NP/O Antworten/NN/I-NP/O bei/IN/B-PP/B-PNP repetitiver/NN/B-NP/I-PNP Stimulation/NN/I-NP/I-PNP trat/VB/B-VP/O nicht/RB/B-ADVP/O auf/RP/O/O ././O/O

Antwortvariabilit\xc3\xa4t/NN/B-NP/O betr\xc3\xa4chtlichen/JJ/I-NP/O Ausma\xc3\x9fes/NN/I-NP/O wurde/VB/B-VP/O auf/IN/B-PP/B-PNP zwei/CD/B-NP/I-PNP Ebenen/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP :/:/O/O zwischen/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Sensillen/NN/I-NP/I-PNP einer/DT/B-NP/I-PNP Antenne/NN/I-NP/I-PNP und/CC/O/O im/IN/B-PP/B-PNP einzelnen/JJ/B-NP/I-PNP Sensillum/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP aufeinanderfolgenden/JJ/B-NP/I-PNP Stimuli/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Antworten/NN/I-NP/O konnten/VB/B-VP/O durch/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Oktopamin-Antagonisten/NN/I-NP/I-PNP Epinastin/NN/I-NP/I-PNP stark/JJ/B-ADJP/O erniedrigt/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Oktopamin/RB/B-VP/O erh\xc3\xb6hte/VB/I-VP/O das/DT/B-NP/O transepitheliale/JJ/I-NP/O Potential/NN/I-NP/O ././O/O

Als/IN/B-PP/B-PNP putative/NN/B-NP/I-PNP modulatorische/JJ/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP wurden/VB/B-VP/O zwei/CD/O/O ins/IN/B-PP/B-PNP Flagellum/NN/B-NP/I-PNP projizierende/NN/I-NP/I-PNP VUM-Neurone/NN/I-NP/I-PNP des/DT/I-NP/I-PNP suboesophagealen/JJ/I-NP/I-PNP Ganglions/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP ././O/O

pikeantworten/NN/B-NP/O von/IN/B-PP/B-PNP Mechanorezeptoren/NN/B-NP/I-PNP gustatorischer/NN/I-NP/I-PNP und/CC/I-NP/I-PNP taktiler/NN/I-NP/I-PNP Haare/NNS/I-NP/I-PNP der/DT/B-NP/I-PNP Antenne/NN/I-NP/I-PNP traten/VB/B-VP/O nur/RB/B-ADVP/O bei/IN/B-PP/B-PNP Bewegung/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Haarschaftes/NN/I-NP/I-PNP auf/RP/O/O ././O/O

Projektionen/JJ/B-NP/O gustatorischer/NN/I-NP/O Sensillen/NN/I-NP/O der/DT/B-NP/O Antenne/NN/I-NP/O wurden/VB/B-VP/O im/IN/B-PP/B-PNP Dorsallobus/JJ/B-NP/I-PNP identifiziert/NN/I-NP/I-PNP ././O/O

Putative/JJ/B-NP/O Chemorezeptoren/JJ/I-NP/O projizierten/NN/I-NP/O in/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP medialen/JJ/I-NP/I-PNP Bereich/NN/I-NP/I-PNP und/CC/O/O putative/NN/B-NP/O Mechanorezeptoren/JJ/B-NP/O projizierten/NN/I-NP/O in/IN/B-PP/O einen/DT/O/O weiter/IN/B-PP/B-PNP lateral/NN/B-NP/I-PNP gelegenen/JJ/I-NP/I-PNP Bereich/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Projektionen/NN/I-NP/O gustatorischer/NN/I-NP/O Sensillen/NN/I-NP/O der/DT/B-NP/O Proboscis/NN/I-NP/O lagen/VB/B-VP/O im/IN/B-PP/B-PNP ventralen/JJ/B-NP/I-PNP Bereich/NN/I-NP/I-PNP des/DT/B-NP/I-PNP suboesophagealen/JJ/I-NP/I-PNP Ganglions/NN/I-NP/I-PNP und/CC/O/O verliefen/NN/B-NP/O bis/IN/B-PP/B-PNP ins/IN/I-PP/I-PNP Tritocerebrum/NN/B-NP/I-PNP ././O/O

Projektionen/NN/B-NP/O des/DT/I-NP/O Tarsus/NN/I-NP/O des/DT/B-NP/O Vorderbeins/NN/I-NP/O lagen/VB/B-VP/O im/IN/B-PP/B-PNP ipsilateralen/JJ/B-NP/I-PNP ventralen/JJ/I-NP/I-PNP Bereich/NN/I-NP/I-PNP des/DT/O/O Prothorakalganglions/FW/O/O ././O/O

Die/DT/B-NP/O gustatorischen/JJ/I-NP/O und/CC/I-NP/O mechanosensorischen/JJ/I-NP/O Projektionen/NN/I-NP/O der/DT/B-NP/O Antenne/JJ/I-NP/O \xc3\xbcberlappten/NN/I-NP/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP dendritischen/JJ/I-NP/I-PNP Areal/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Motoneurons/NN/I-NP/I-PNP des/DT/B-NP/I-PNP schnellen/PRP$/I-NP/I-PNP Flagellum/NN/I-NP/I-PNP Flexor/NN/I-NP/I-PNP Muskels/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Antenne/NN/I-NP/I-PNP ,/,/O/O dessen/WDT/O/O Aktionspotentiale/JJ/B-ADJP/O mit/IN/B-PP/B-PNP denen/WDT/B-NP/I-PNP des/DT/I-NP/I-PNP Muskels/NN/I-NP/I-PNP 1:1/CD/B-NP/I-PNP korreliert/NN/I-NP/I-PNP sind/VB/B-VP/O ././O/O

Der/DT/B-NP/O Muskel/NN/I-NP/O zeigte/VB/B-VP/O sensorisch/JJ/B-NP/O induzierte/NN/I-NP/O Antworten/NN/I-NP/O kurzer/JJ/B-NP/O Latenz/NN/I-NP/O auf/IN/B-PP/B-PNP ipsilaterale/NN/B-NP/I-PNP mechanische/VB/B-VP/O und/CC/O/O gustatorische/JJ/B-NP/O Stimulation/NN/I-NP/O ././O/O

Antworten/NN/B-NP/O auf/IN/B-PP/B-PNP kontralaterale/NN/B-NP/I-PNP gustatorische/JJ/I-NP/I-PNP Stimulation/NN/I-NP/I-PNP waren/VB/B-VP/O schwach/JJ/B-ADJP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP operante/NN/I-NP/I-PNP Konditionierung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Spontanaktivit\xc3\xa4t/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Muskels/NN/I-NP/I-PNP war/VB/B-VP/O nur/RB/B-ADVP/O eine/DT/B-NP/O Paarung/NN/I-NP/O hoher/JJ/B-NP/O Muskelaktivit\xc3\xa4t/NN/I-NP/O mit/IN/B-PP/B-PNP ipsilateraler/NN/B-NP/I-PNP Zuckerwasserstimulation/NN/I-NP/I-PNP der/DT/I-NP/I-PNP Antenne/NN/I-NP/I-PNP notwendig/JJ/B-ADJP/O ././O/O

Konditionierung/NN/B-NP/O mit/IN/B-PP/B-PNP kontralateraler/NN/B-NP/I-PNP Stimulation/NN/I-NP/I-PNP war/VB/B-VP/O nicht/RB/B-ADJP/O erfolgreich/JJ/I-ADJP/O ././O/O

Das/DT/B-NP/O entwickelte/JJ/I-NP/O modifizierte/JJ/I-NP/O Lernparadigma/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP operante/NN/I-NP/I-PNP Konditionierung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP schnellen/PRP$/I-NP/I-PNP Flagellum/NN/I-NP/I-PNP Flexors/NN/I-NP/I-PNP bzw./RB/B-ADVP/O Seines/PRP$/B-NP/O Motoneurons/NN/I-NP/O hat/VB/B-VP/O den/DT/B-NP/O Vorteil/NN/I-NP/O ,/,/O/O da\xc3\x9f/IN/B-PP/B-PNP im/IN/I-PP/I-PNP Vergleich/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP anderen/JJ/B-NP/I-PNP Lernpr\xc3\xa4paraten/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Zahl/NN/I-NP/I-PNP der/DT/O/O im/IN/B-PP/B-PNP Lernvorgang/NN/B-NP/I-PNP involvierten/NN/I-NP/I-PNP Elemente/NN/I-NP/I-PNP stark/JJ/B-ADJP/O reduziert/VBN/B-VP/O ist/VB/I-VP/O ,/,/O/O was/WP/O/O weitergehende/NN/B-NP/O Analysen/NN/I-NP/O des/DT/I-NP/O Lernvorgangs/NN/I-NP/O auf/IN/B-PP/B-PNP zellul\xc3\xa4rer/NN/B-NP/I-PNP Ebene/NN/I-NP/I-PNP vereinfachen/JJ/I-NP/I-PNP wird.Nur/JJ/I-NP/I-PNP Mehle/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP Getreiden/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Familie/NN/I-NP/I-PNP Triticeae/NN/I-NP/I-PNP bilden/VB/B-VP/O beim/IN/B-PP/B-PNP Anteigen/NN/B-NP/I-PNP ein/DT/I-NP/I-PNP Netzwerk/NN/I-NP/I-PNP mit/IN/B-PP/O viskoelastischen/JJ/B-ADJP/O und/CC/O/O koh\xc3\xa4siven/NN/B-NP/O Eigenschaften/NNS/I-NP/O aus/RP/O/O ,/,/O/O wodurch/RB/B-ADVP/O nach/IN/B-PP/B-PNP G\xc3\xa4r/NN/B-NP/I-PNP -/-/O/O und/CC/O/O Backproze\xc3\x9f/NN/B-NP/O ein/DT/B-NP/O Geb\xc3\xa4ck/NN/I-NP/O mit/IN/B-PP/B-PNP elastischer/NN/B-NP/I-PNP Krume/NN/I-NP/I-PNP entsteht/VB/B-VP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Ausbildung/NN/I-NP/I-PNP derartiger/JJ/B-NP/I-PNP Netzwerke/NN/I-NP/I-PNP sind/VB/B-VP/O die/DT/B-NP/O Speicher/NN/I-NP/O -/-/O/O bzw./CC/O/O Glutenproteine/NN/B-NP/O verantwortlich/JJ/B-ADJP/O ././O/O

Backwaren/NN/B-NP/O aus/IN/B-PP/B-PNP Mehlen/NN/B-NP/I-PNP anderer/JJ/I-NP/I-PNP Getreide/NN/I-NP/I-PNP (/(/O/O z.B./IN/B-PP/B-PNP Mais/NN/B-NP/I-PNP )/)/O/O bilden/VB/B-VP/O hingegen/RB/B-NP/O kein/JJ/I-NP/O Glutennetzwerk/NN/I-NP/O aus/RP/O/O und/CC/O/O daher/RB/B-ADVP/O auch/RB/I-ADVP/O keine/DT/B-NP/O elastische/JJ/I-NP/O Krume/NN/I-NP/O ././O/O

Um/IN/B-PP/B-PNP Mehle/NN/B-NP/I-PNP nicht/RB/I-NP/I-PNP backf\xc3\xa4higer/NNP/I-NP/I-PNP Getreide/NNP/I-NP/I-PNP durch/IN/B-PP/B-PNP Anreicherung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Glutenproteinen/NN/B-NP/I-PNP backf\xc3\xa4hig/JJ/B-ADJP/O zu/TO/B-VP/O machen/VB/I-VP/O ,/,/O/O wurde/VB/B-VP/O in/IN/B-PP/B-PNP Hefe/NN/B-NP/I-PNP (/(/O/O S./VB/B-VP/O cerevisiae/NN/B-NP/O )/)/O/O ein/DT/B-NP/O System/NN/I-NP/O entwickelt/VB/B-VP/O ,/,/O/O verschiedene/JJ/B-NP/O Glutenproteine/NN/I-NP/O aus/IN/B-PP/B-PNP Weizen/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Kombination/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP exprimieren/NN/B-NP/I-PNP ,/,/O/O um/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP gluten\xc3\xa4hnliches-Netzwerk/NN/I-NP/I-PNP zu/TO/B-VP/O produzieren/VB/I-VP/O ././O/O

Hierzu/VBN/B-VP/O wurde/VB/I-VP/O ein/DT/B-NP/O Set/NN/I-NP/O integrativer/NN/I-NP/O Vektoren/NN/I-NP/O konstruiert/NN/I-NP/O ,/,/O/O mit/IN/B-PP/O dem/DT/O/O vier/CD/O/O zur/IN/B-PP/B-PNP Netzwerkbildung/NN/B-NP/I-PNP notwendige/VB/B-VP/O aus/IN/B-PP/B-PNP Weizen/NN/B-NP/I-PNP isolierte/JJ/I-NP/I-PNP Glutenproteingene/NN/I-NP/I-PNP (/(/O/O LMW6/NN/B-NP/O ,/,/O/O ein/DT/B-NP/O modifiziertes/NN/I-NP/O LMWa3/NN/I-NP/O als/IN/B-PP/B-PNP Gliadinersatz/NN/B-NP/I-PNP ,/,/O/O sowie/CC/O/O die/DT/B-NP/O Gene/NN/I-NP/O HMW/NNP/I-NP/O 1Dx5/NNP/I-NP/O und/CC/O/O HMW/NNP/B-NP/O 1Dy10/NNP/I-NP/O )/)/O/O stabil/JJ/B-ADJP/O in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP \xc3\xaf?\xe2\x80\x9e-Sequenzen/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Genoms/NN/I-NP/I-PNP von/IN/B-PP/O S./VB/B-VP/O cerevisiae/NN/B-NP/O integriert/VBN/B-VP/O wurden/VB/I-VP/O ././O/O

Durch/IN/B-PP/B-PNP anschlie\xc3\x9fende/NN/B-NP/I-PNP Kreuzung/NN/I-NP/I-PNP der/DT/I-NP/I-PNP rekombinanten/NN/I-NP/I-PNP Hefen/NN/I-NP/I-PNP ,/,/O/O gelang/NN/B-NP/O es/PRP/I-NP/O erstmals/RP/O/O ,/,/O/O vier/CD/O/O verschiedene/VB/B-VP/O zur/IN/B-PP/B-PNP Bildung/NN/B-NP/I-PNP eines/DT/I-NP/I-PNP Gluten-Netzwerkes/NN/I-NP/I-PNP notwendige/JJ/B-NP/I-PNP Proteine/NN/I-NP/I-PNP in/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Organismus/NN/I-NP/I-PNP zeitlich/RB/B-NP/I-PNP parallel/JJ/I-NP/I-PNP heterolog/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP exprimieren/NN/B-NP/I-PNP ././O/O

Es/PRP/B-NP/O konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP heterolog/NN/I-NP/I-PNP exprimierten/JJ/B-NP/I-PNP Speicherproteine/NN/I-NP/I-PNP in/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Netzwerk/NN/I-NP/I-PNP vorliegen/VB/B-VP/O ././O/O

Die/DT/O/O hier/RB/B-VP/O entwickelten/VB/I-VP/O rekombinanten/NN/B-NP/O Hefen/NN/I-NP/O stellen/VB/B-VP/O daher/RB/B-ADVP/O einen/DT/B-NP/O leistungsf\xc3\xa4higen/JJ/I-NP/O Ansatz/NN/I-NP/O zur/IN/B-PP/B-PNP industriellen/JJ/B-NP/I-PNP Produktion/NN/I-NP/I-PNP dar.Die/JJ/B-NP/I-PNP Bedeutung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP klinischen/JJ/I-NP/I-PNP Forschung/NN/I-NP/I-PNP an/IN/B-PP/B-PNP Stamm/NN/B-NP/I-PNP -/-/O/O und/CC/O/O Vorl\xc3\xa4uferzellen/NN/B-NP/O besonders/RB/B-ADVP/O im/IN/B-PP/B-PNP Bereich/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Geweberegeneration/NN/I-NP/I-PNP hat/VB/B-VP/O im/IN/B-PP/B-PNP Laufe/NN/B-NP/I-PNP der/DT/I-NP/I-PNP letzten/JJ/I-NP/I-PNP Jahre/NN/I-NP/I-PNP deutlich/JJ/B-ADJP/O zugenommen/RP/O/O ././O/O

ammzellen/NN/B-NP/O aus/IN/B-PP/B-PNP adulten/NN/B-NP/I-PNP Organismen/NN/I-NP/I-PNP werden/VB/B-VP/O in/IN/B-PP/B-PNP endodermale/NN/B-NP/I-PNP ,/,/O/O ectodermale/NN/B-NP/O und/CC/I-NP/O mesodermale/NN/I-NP/O Stammzellen/NN/I-NP/O ,/,/O/O welche/WDT/B-NP/O endotheliale/JJ/I-NP/O Vorl\xc3\xa4uferzellen/NN/I-NP/O bilden/VB/B-VP/O ,/,/O/O unterschieden/RP/O/O ././O/O

Diese/DT/B-NP/O Vorl\xc3\xa4uferzellen/NN/I-NP/O wurden/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP auf/IN/B-PP/O Transkriptions/FW/O/O -/-/O/O und/CC/O/O Translationsebene/JJ/B-NP/O charakterisiert/NN/I-NP/O ././O/O

Ihre/PRP$/B-NP/O Funktion/NN/I-NP/O bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Angiogenese/NN/I-NP/I-PNP ,/,/O/O speziell/JJ/B-ADJP/O der/DT/B-NP/O Tumorangiogenese/NN/I-NP/O war/VBN/B-VP/O von/IN/B-PP/B-PNP besonderem/JJ/B-NP/I-PNP Interesse/NN/I-NP/I-PNP ././O/O

Ein/DT/B-NP/O weiterer/JJ/I-NP/O Aspekt/NN/I-NP/O dieser/DT/B-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O die/DT/B-NP/O Kl\xc3\xa4rung/NN/I-NP/O ,/,/O/O ob/IN/B-PP/B-PNP sich/PRP/B-NP/I-PNP endotheliale/RB/I-NP/I-PNP Vorl\xc3\xa4uferzellen/NN/I-NP/I-PNP als/IN/B-PP/B-PNP Surrogatmarker/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP antiangiogene/NN/B-NP/I-PNP Therapien/NN/I-NP/I-PNP verwenden/VB/B-VP/O lassen/VB/I-VP/O ././O/O

Die/DT/B-NP/O Endothelvorl\xc3\xa4uferzellen/NN/I-NP/O wurden/VB/B-VP/O aus/IN/B-PP/B-PNP humanem/NN/B-NP/I-PNP peripherem/NN/I-NP/I-PNP Blut/NN/I-NP/I-PNP sowie/RB/I-NP/I-PNP Nabelschnurblut/NN/I-NP/I-PNP mittels/IN/B-PP/B-PNP des/DT/B-NP/I-PNP Oberfl\xc3\xa4chenproteins/NN/I-NP/I-PNP AC133/NN/I-NP/I-PNP ,/,/O/O welches/WP/O/O Stamm/NN/B-NP/O -/-/O/O und/CC/O/O Vorl\xc3\xa4uferzellen/NN/B-NP/O charakterisiert/NN/I-NP/O ,/,/O/O isoliert/NN/B-NP/O und/CC/O/O als/IN/B-PP/B-PNP AC133/NN/B-NP/I-PNP positive/JJ/I-NP/I-PNP Vorl\xc3\xa4uferzellen/NN/I-NP/I-PNP bezeichnet/RP/O/O ././O/O

Die/DT/B-NP/O Expression/NN/I-NP/O spezifischer/JJ/B-NP/O Proteine/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP Stamm/NN/B-NP/I-PNP -/-/O/O und/CC/O/O Vorl\xc3\xa4uferzellen/NN/B-NP/O (/(/O/O AC133/NN/B-NP/O ,/,/O/O CD34/NN/B-NP/O und/CC/I-NP/O cKit/NN/I-NP/O )/)/O/O und/CC/O/O f\xc3\xbcr/IN/B-PP/B-PNP bestimmte/JJ/B-NP/I-PNP Blutzellarten/NN/I-NP/I-PNP (/(/O/O CD45/NN/B-NP/O und/CC/I-NP/O CD13/NNP/I-NP/O )/)/O/O wurde/VB/B-VP/O mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP der/DT/I-NP/I-PNP semiquantitativen/NN/I-NP/I-PNP RT-PCR/NN/I-NP/I-PNP sowie/RB/B-ADVP/O der/DT/B-NP/O FACS/NNP/I-NP/O Analyse/NNP/I-NP/O nachgewiesen/RP/O/O ././O/O

Endothelzell-spezifische/JJ/B-ADJP/O Marker/JJ/I-ADJP/O (/(/O/O VEGFR-2/NN/B-NP/O und/CC/I-NP/O vWF/NN/I-NP/O )/)/O/O konnten/VB/B-VP/O nur/RB/B-ADVP/O zum/IN/B-PP/B-PNP Teil/NN/B-NP/I-PNP detektiert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Die/DT/B-NP/O Kokultur/NN/I-NP/O der/DT/B-NP/O AC133/NN/I-NP/O positive/JJ/B-NP/O Vorl\xc3\xa4uferzellen/NN/I-NP/O mit/IN/B-PP/B-PNP anderen/JJ/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP (/(/O/O Endothelzellen/NN/B-NP/O ,/,/O/O mononukle\xc3\xa4re/JJ/B-NP/O Blutzellen/NN/I-NP/O und/CC/O/O Promyeloblasten/NN/B-NP/O )/)/O/O f\xc3\xbchrte/VB/B-VP/O zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP \xc3\x84nderung/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Expressionsst\xc3\xa4rke/NN/I-NP/I-PNP dieser/DT/B-NP/I-PNP Marker/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Affymetrix/NN/I-NP/O Chip/NN/I-NP/O Analyse/NN/I-NP/O zeigte/VB/B-VP/O eine/DT/B-NP/O \xc3\x9cberexpression/NN/I-NP/O h\xc3\xa4matopoetischer/JJ/B-NP/O Proteine/NN/I-NP/O in/IN/B-PP/B-PNP AC133/NN/B-NP/I-PNP positive/JJ/I-NP/I-PNP Vorl\xc3\xa4uferzellen/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Rolle/NN/I-NP/O dieser/DT/B-NP/O Zellen/NNS/I-NP/O bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Tumorangiogenese/NN/I-NP/I-PNP wurde/RB/B-ADVP/O im/IN/B-PP/B-PNP Mausmodell/NN/B-NP/I-PNP untersucht/RP/O/O ././O/O

Histologisch/VBN/B-VP/O wurde/VB/I-VP/O ein/DT/B-NP/O irregul\xc3\xa4rer/NN/I-NP/O Einbau/NN/I-NP/O der/DT/B-NP/O AC133/NN/I-NP/O positive/JJ/B-NP/O Vorl\xc3\xa4uferzellen/NN/I-NP/O im/IN/B-PP/B-PNP Stroma/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Tumorgewebes/NN/I-NP/I-PNP nachgewiesen/RP/O/O ././O/O

Endothelzellen/NN/B-NP/O (/(/O/O MVEC/NN/B-NP/O )/)/O/O ,/,/O/O welche/WDT/O/O in/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Parallelversuch/NN/I-NP/I-PNP injiziert/NN/I-NP/I-PNP wurden/VB/B-VP/O ,/,/O/O fanden/VBN/B-VP/O sich/PRP/B-NP/O teilweise/RB/B-ADVP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Gef\xc3\xa4\xc3\x9fen/NN/I-NP/I-PNP ././O/O

Zur/IN/B-PP/B-PNP weiteren/JJ/B-NP/I-PNP Kl\xc3\xa4rung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Rolle/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Vorl\xc3\xa4uferzellen/NN/B-NP/I-PNP wurden/VB/B-VP/O murine/NN/B-NP/O GFP/NNP/I-NP/O positive/JJ/I-NP/O transfizierte/JJ/I-NP/O Vorl\xc3\xa4uferzellen/NN/I-NP/O aus/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Knochenmark/NN/I-NP/I-PNP in/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP syngenen/NN/I-NP/I-PNP Modell/NN/I-NP/I-PNP eingesetzt/RP/O/O ././O/O

ie/PRP/B-NP/O wurden/VB/B-VP/O im/IN/B-PP/B-PNP Stroma/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Tumorgewebes/NN/I-NP/I-PNP sowie/RB/B-ADVP/O im/IN/B-PP/B-PNP Thymus/JJ/B-NP/I-PNP detektiert/NN/I-NP/I-PNP ././O/O

Entgegen/IN/B-PP/B-PNP der/DT/B-NP/I-PNP urspr\xc3\xbcnglichen/JJ/I-NP/I-PNP Annahme/NN/I-NP/I-PNP ,/,/O/O dass/IN/B-PP/B-PNP es/JJ/B-NP/I-PNP sich/PRP/I-NP/I-PNP bei/IN/B-PP/B-PNP den/DT/B-NP/I-PNP AC133/NN/I-NP/I-PNP positive/JJ/B-NP/I-PNP Vorl\xc3\xa4uferzellen/NN/I-NP/I-PNP um/IN/B-PP/B-PNP endotheliale/JJ/B-NP/I-PNP Vorl\xc3\xa4uferzellen/NN/I-NP/I-PNP handelt/VB/B-VP/O ,/,/O/O konnte/RB/B-ADVP/O im/IN/B-PP/B-PNP Laufe/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP gezeigt/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP diese/WDT/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP eher/RB/B-NP/I-PNP h\xc3\xa4matopoetische/JJ/I-NP/I-PNP Vorl\xc3\xa4uferzellen/NN/I-NP/I-PNP sind/VB/B-VP/O ././O/O

Es/PRP/B-NP/O lie\xc3\x9f/VB/B-VP/O sich/PRP/B-NP/O kein/DT/I-NP/O direkter/JJ/I-NP/O Einfluss/NN/I-NP/O bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Tumorangiogenese/NN/I-NP/I-PNP nachweisen/VB/B-VP/O ././O/O

Ein/DT/B-NP/O Einsatz/NN/I-NP/O der/DT/B-NP/O Vorl\xc3\xa4uferzellen/NN/I-NP/O als/IN/B-PP/B-PNP Surrogatmarker/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP antiangiogene/NN/B-NP/I-PNP Therapien/NN/I-NP/I-PNP ist/VB/B-VP/O somit/RB/B-ADVP/O eher/IN/B-PP/B-PNP unwahrscheinlich.Im/NN/B-NP/I-PNP Rahmen/NN/I-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurden/VB/B-VP/O zwei/CD/B-NP/O Real-Time/NN/I-NP/O PCR-Systeme/NN/I-NP/O zum/IN/B-PP/B-PNP Nachweis/NN/B-NP/I-PNP von/IN/B-PP/B-PNP getr\xc3\xa4nkerelevanten/JJ/B-NP/I-PNP Hefen/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP Basis/NN/B-NP/I-PNP der/DT/I-NP/I-PNP LightCycler\xc2\xae/JJ/I-NP/I-PNP Technologie/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Hybridisierungssonden/NN/B-NP/I-PNP entwickelt/VB/B-VP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP beide/JJ/B-NP/I-PNP Systeme/NN/I-NP/I-PNP wurden/VB/B-VP/O interne/JJ/B-NP/O Amplifikationskontrollen/NN/I-NP/O und/CC/O/O Positivkontrollen/NN/B-NP/O hergestellt/VBN/B-VP/O und/CC/O/O zwei/CD/B-NP/O DNA-Extraktionssysteme/NN/I-NP/O bereitgestellt/RP/O/O ././O/O

Ein/DT/B-NP/O hoch/JJ/I-NP/O spezifischer/JJ/I-NP/O und/CC/I-NP/O sensitiver/JJ/I-NP/O Einzelnachweis/NN/I-NP/O f\xc3\xbcr/IN/B-PP/O die/DT/O/O wichtigste/VB/B-VP/O ,/,/O/O biersch\xc3\xa4dliche/JJ/B-NP/O Saccharomyces/NN/I-NP/O Fremdhefe/NN/I-NP/O ,/,/O/O S./VB/B-VP/O cerevisiae/JJ/B-NP/O var/NN/I-NP/O ././O/O

diastaticus/FW/O/O ,/,/O/O wurde/VB/B-VP/O entwickelt/VBN/I-VP/O ,/,/O/O indem/IN/B-PP/B-PNP die/DT/B-NP/I-PNP sequenziellen/JJ/I-NP/I-PNP Unterschiede/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Glucoamylase/NN/I-NP/I-PNP kodierenden/JJ/B-NP/I-PNP Genen/NN/I-NP/I-PNP von/IN/B-PP/O S./VB/B-VP/O cerevisiae/JJ/B-NP/O var/NN/I-NP/O ././O/O

diastaticus/FW/O/O (/(/O/O STA1-3/NN/B-NP/O )/)/O/O und/CC/O/O S./VB/B-VP/O cerevisiae/NN/B-NP/O (/(/O/O SGA1/NN/B-NP/O )/)/O/O ausgenutzt/NN/B-NP/O wurden/VB/B-VP/O ././O/O

Die/DT/B-NP/O hohe/JJ/I-NP/O Nachweisempfindlichkeit/NN/I-NP/O des/DT/B-NP/O PCR-Systems/NN/I-NP/O von/IN/B-PP/O 5/CD/O/O bis/IN/B-PP/B-PNP 10/CD/B-NP/I-PNP Genom\xc3\xa4quivalenten/NN/I-NP/I-PNP pro/IN/B-PP/B-PNP Reaktion/NN/B-NP/I-PNP erm\xc3\xb6glichte/VB/B-VP/O in/IN/B-PP/B-PNP Kombination/NN/B-NP/I-PNP mit/IN/B-PP/O einer/DT/O/O schnellen/VB/B-VP/O ,/,/O/O mechanisch&slash;thermischen/JJ/B-NP/O Probenaufarbeitung/NN/I-NP/O den/DT/B-NP/O Nachweis/NN/I-NP/O von/IN/B-PP/B-PNP 1,0E+02/NN/B-NP/I-PNP bis/IN/B-PP/B-PNP 1,0E+03/NN/B-NP/I-PNP S./VB/B-VP/O cerevisiae/JJ/B-NP/O var/NN/I-NP/O ././O/O

diastaticus/FW/O/O Zellen&slash;ml/FW/O/O bei/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Hintergrundpopulation/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 1,0E+08/NN/B-NP/I-PNP Zellen&slash;ml/NN/I-NP/I-PNP S./VB/B-VP/O cerevisiae/NN/B-NP/O ././O/O

Die/DT/B-NP/O Robustheit/NN/I-NP/O des/DT/B-NP/O Systems/NN/I-NP/O wurde/VB/B-VP/O durch/IN/B-PP/B-PNP Testung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP 66/CD/B-NP/I-PNP unterschiedlichen/JJ/I-NP/I-PNP Probenmatrices/NN/I-NP/I-PNP ,/,/O/O von/IN/B-PP/B-PNP denen/WDT/B-NP/I-PNP sich/PRP/I-NP/I-PNP nur/RB/B-ADVP/O eine/RP/O/O als/IN/B-PP/B-PNP ungeeignet/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Real-Time/NN/I-NP/I-PNP PCR-System/NN/I-NP/I-PNP herausstellte/NN/I-NP/I-PNP ,/,/O/O gezeigt/VBN/B-VP/O und/CC/O/O die/DT/B-NP/O Praxistauglichkeit/NN/I-NP/O wurde/VB/B-VP/O direkt/RB/B-ADVP/O bei/IN/B-PP/B-PNP vier/CD/B-NP/I-PNP Brauereien/JJ/I-NP/I-PNP verifiziert/NN/I-NP/I-PNP ././O/O

Der/DT/B-NP/O gesamte/JJ/I-NP/O Assay/NNP/I-NP/O mit/IN/B-PP/B-PNP Probenaufarbeitung/NN/B-NP/I-PNP und/CC/I-NP/I-PNP PCR/NN/I-NP/I-PNP ist/VB/B-VP/O innerhalb/IN/B-PP/B-PNP von/IN/I-PP/I-PNP 2,5/CD/B-NP/I-PNP Stunden/NN/I-NP/I-PNP durchf\xc3\xbchrbar/JJ/B-ADJP/O und/CC/O/O damit/RB/B-ADJP/O signifikant/JJ/I-ADJP/O schneller/JJ/I-ADJP/O als/IN/B-PP/B-PNP kultivierungsabh\xc3\xa4ngige/JJ/B-NP/I-PNP Methoden/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Sequenzierung/NN/I-NP/O eines/DT/B-NP/O Abschnitts/NN/I-NP/O des/DT/B-NP/O Gens/NN/I-NP/O des/DT/B-NP/O Elongationsfaktors/NN/I-NP/O 3/CD/O/O (/(/O/O EF-3/NN/B-NP/O )/)/O/O von/IN/B-PP/B-PNP 93/CD/B-NP/I-PNP Hefest\xc3\xa4mmen/NN/I-NP/I-PNP lieferte/VB/B-VP/O die/DT/B-NP/O Grundlage/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Entwicklung/NN/I-NP/I-PNP einer/DT/B-NP/I-PNP Real-Time/NN/I-NP/I-PNP Consensus-PCR/NN/I-NP/I-PNP zum/IN/B-PP/B-PNP Nachweis/NN/B-NP/I-PNP von/IN/B-PP/B-PNP getr\xc3\xa4nkerelevanten/JJ/B-NP/I-PNP Hefen/NN/I-NP/I-PNP ././O/O

Der/DT/B-NP/O Nachweis/NN/I-NP/O von/IN/B-PP/B-PNP allen/DT/B-NP/I-PNP 252/CD/I-NP/I-PNP getesteten/NN/I-NP/I-PNP Hefest\xc3\xa4mmen/NN/I-NP/I-PNP wurde/VB/B-VP/O bei/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Assay/NNP/I-NP/I-PNP durch/IN/B-PP/B-PNP degenerierte/NN/B-NP/I-PNP Primer/NN/I-NP/I-PNP und/CC/I-NP/I-PNP Hybridisierungssonden/NN/I-NP/I-PNP erm\xc3\xb6glicht/VBN/B-VP/I-PNP ,/,/O/O ohne/IN/B-PP/O dass/RB/B-ADVP/O mit/IN/B-PP/B-PNP DNA/NN/B-NP/I-PNP von/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP der/DT/I-NP/I-PNP 71/CD/I-NP/I-PNP getesteten/NN/I-NP/I-PNP Bakterien/NN/I-NP/I-PNP falsch-positive/NN/I-NP/I-PNP Ergebnisse/JJ/B-NP/I-PNP auftraten/NN/I-NP/I-PNP ././O/O

Der/DT/B-NP/O Nachweis/NN/I-NP/O konnte/VB/B-VP/O nicht/RB/B-ADVP/O zur/IN/B-PP/B-PNP Identifizierung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Hefearten/NN/I-NP/I-PNP oder/RB/B-ADVP/O -/-/O/O gattungen/NN/B-NP/O eingesetzt/VBN/B-VP/O werden/VB/I-VP/O und/CC/O/O die/DT/B-NP/O Abgrenzung/NN/I-NP/O zu/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Schimmelpilzen/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O ebenfalls/RB/B-ADVP/O das/DT/B-NP/O EF-3/NN/I-NP/O Gen/NN/I-NP/O enthalten/VB/B-VP/O ,/,/O/O lie\xc3\x9f/RB/B-ADVP/O sich/PRP/B-NP/O nicht/RB/B-ADVP/O zu/IN/B-PP/B-PNP 100/CD/B-NP/I-PNP %/NN/I-NP/I-PNP erreichen/VB/B-VP/O ././O/O

Die/DT/B-NP/O Sensitivit\xc3\xa4t/NN/I-NP/O des/DT/B-NP/O Systems/NN/I-NP/O lag/VB/B-VP/O in/IN/B-PP/B-PNP Abh\xc3\xa4ngigkeit/NN/B-NP/I-PNP von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Hefeart/NNP/I-NP/I-PNP zwischen/IN/B-PP/B-PNP 10/CD/B-NP/I-PNP und/CC/I-NP/I-PNP 250/CD/I-NP/I-PNP G\xc3\x84/NN/I-NP/I-PNP pro/IN/B-PP/B-PNP Reaktion/NN/B-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP Kombination/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Erweiterung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP mechanisch&slash;thermischen/JJ/I-NP/I-PNP Probenaufarbeitung/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP 1,0E+03/NN/B-NP/I-PNP bis/IN/B-PP/B-PNP 1,0E+04/JJ/B-NP/I-PNP Zellen&slash;ml/NN/I-NP/I-PNP ././O/O

Ein/DT/B-NP/O Nachweis/NN/I-NP/O von/IN/B-PP/O 1/CD/O/O bis/IN/B-PP/B-PNP 100/CD/B-NP/I-PNP Zellen&slash;ml/NN/I-NP/I-PNP war/VB/B-VP/O nach/IN/B-PP/O zwei/CD/O/O bis/IN/B-PP/B-PNP drei/CD/B-NP/I-PNP Tagen/JJ/I-NP/I-PNP Fl\xc3\xbcssiganreicherung/NN/I-NP/I-PNP in/IN/B-PP/B-PNP YM-Medium/NN/B-NP/I-PNP m\xc3\xb6glich.Verschiedene/NN/I-NP/I-PNP Studien/NN/I-NP/I-PNP weisen/VB/B-VP/O darauf/RB/B-ADVP/O hin/IN/B-PP/O ,/,/O/O dass/IN/B-PP/B-PNP im/IN/I-PP/I-PNP Falle/NN/B-NP/I-PNP akuter/NN/I-NP/I-PNP Erkrankungen/NNS/I-NP/I-PNP wie/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Herzinfarkt/NN/I-NP/I-PNP oder/RB/B-ADVP/O dem/DT/B-NP/O Schlaganfall/NN/I-NP/O ,/,/O/O mesenchymale/JJ/B-NP/O Stammzellen/NN/I-NP/O (/(/O/O MSC/NN/B-NP/O )/)/O/O zu/IN/B-PP/B-PNP den/DT/B-NP/I-PNP betroffenen/JJ/I-NP/I-PNP Geweben/NN/I-NP/I-PNP migrieren/VB/B-VP/O und/CC/O/O an/IN/B-PP/B-PNP deren/DT/B-NP/I-PNP Regeneration/NN/I-NP/I-PNP beteiligt/VBN/B-VP/I-PNP sind/VB/I-VP/O ././O/O

olche/DT/B-NP/O Beobachtungen/NN/I-NP/O sind/VB/B-VP/O die/DT/B-NP/O Grundlage/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Entwicklung/NN/I-NP/I-PNP des/DT/O/O in/IN/B-PP/B-PNP situ/NN/B-NP/I-PNP Tissue/FW/O/O Engineering/FW/O/O (/(/O/O TE/NN/B-NP/O )/)/O/O ././O/O

Hier/VBN/B-VP/O werden/VB/I-VP/O zellfreie/JJ/B-NP/O Biomaterialien/NN/I-NP/O mit/IN/B-PP/B-PNP chemotaktisch/JJ/B-NP/I-PNP aktiven/JJ/I-NP/I-PNP Faktoren/NN/I-NP/I-PNP wie/IN/B-PP/B-PNP Chemokinen/NN/B-NP/I-PNP sowie/RB/I-NP/I-PNP Differenzierungs-faktoren/NN/I-NP/I-PNP kombiniert/JJ/B-ADJP/O und/CC/O/O in/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP Gewebedefekt/JJ/I-NP/I-PNP implantiert/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Faktoren/NN/I-NP/O erm\xc3\xb6glichen/VB/B-VP/O eine/DT/B-NP/O Rekrutierung/NN/I-NP/O geeigneter/JJ/B-NP/O Zellen/NNS/I-NP/O und/CC/O/O deren/DT/B-NP/O Entwicklung/NN/I-NP/O zum/IN/B-PP/B-PNP Ersatzgewebe/NN/B-NP/I-PNP ././O/O

In/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Dissertation/NN/I-NP/I-PNP wurden/RB/B-ADVP/O Fragestellungen/NN/B-NP/O untersucht/VBN/B-VP/O ,/,/O/O die/WDT/O/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP vor/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Durchf\xc3\xbchrung/JJ/I-NP/I-PNP pr\xc3\xa4klinischer/NN/I-NP/I-PNP in/IN/B-PP/B-PNP situ/NN/B-NP/I-PNP Knorpel/NN/I-NP/I-PNP TE/NN/I-NP/I-PNP Studien/NN/I-NP/I-PNP beantwortet/VBN/B-VP/I-PNP werden/VB/I-VP/O m\xc3\xbcssen/VB/I-VP/O ././O/O

Aus/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Knochen-mark/NN/I-NP/I-PNP isolierte/NN/I-NP/I-PNP und/CC/O/O expandierte/NN/B-NP/O humane/NN/I-NP/O MSC/NN/I-NP/O pr\xc3\xa4sentierten/NN/I-NP/O das/DT/O/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Literatur/NN/I-NP/I-PNP beschriebene/JJ/B-NP/I-PNP Profil/NN/I-NP/I-PNP an/IN/B-PP/B-PNP Oberfl\xc3\xa4chenmarkern/NN/B-NP/I-PNP (/(/O/O SH2/NN/B-NP/O +/NN/I-NP/O ,/,/O/O SH3/NN/B-NP/O +/NNP/I-NP/O ,/,/O/O CD34/NN/B-NP/O -/-/O/O )/)/O/O ././O/O

In/IN/B-PP/B-PNP hochdichten/NN/B-NP/I-PNP Zellaggregaten/NN/I-NP/I-PNP konnte/VB/B-VP/O histologisch/JJ/B-ADJP/O ,/,/I-ADJP/O immunhistochemisch/JJ/I-ADJP/O und/CC/O/O mittels/IN/B-PP/B-PNP PCR/NN/B-NP/I-PNP erstmals/RB/B-ADVP/O eine/DT/B-NP/O chondrogene/NN/I-NP/O Induktion/NN/I-NP/O dieser/DT/B-NP/O Zellen/NNS/I-NP/O durch/IN/B-PP/B-PNP BMP2/NN/B-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Eine/DT/B-NP/O BMP2/NN/I-NP/O induzierte/NN/I-NP/O Weiterentwicklung/NN/I-NP/O zu/IN/B-PP/B-PNP hypertrophem/NN/B-NP/I-PNP Knorpel/NN/I-NP/I-PNP oder/RB/B-ADVP/O eine/DT/B-NP/O Differenzierung/NN/I-NP/O in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP osteo/NN/I-NP/I-PNP -/-/O/O bzw./CC/O/O adipogene/NN/B-NP/O Richtung/NN/I-NP/O wurde/RB/B-ADVP/O nicht/RB/I-ADVP/O beobachtet/RP/O/O ././O/O

Zus\xc3\xa4tzlich/JJ/B-ADJP/O konnte/VB/B-VP/O auf/IN/B-PP/B-PNP der/DT/B-NP/I-PNP mRNA/NNP/I-NP/I-PNP -/-/O/O und/CC/O/O der/DT/B-NP/O Proteinebene/NN/I-NP/O erstmals/RB/B-ADVP/O das/DT/B-NP/O komplette/JJ/I-NP/O Chemokinrezeptor/NN/I-NP/O Expressionsprofil/NN/I-NP/O humaner/NN/I-NP/O MSC/NN/I-NP/O bestimmt/VBN/B-VP/O werden/VB/I-VP/O und/CC/O/O im/IN/B-PP/B-PNP 96-Well/NN/B-NP/I-PNP Chemotaxis/NN/I-NP/I-PNP Assay/NNP/I-NP/I-PNP ein/DT/I-NP/I-PNP dosisabh\xc3\xa4ngiger/NN/I-NP/I-PNP migratorischer/NN/I-NP/I-PNP Effekt/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Chemokine/NN/I-NP/I-PNP IL8/NN/I-NP/I-PNP und/CC/O/O SDF1\xce\xb1/NN/B-NP/O gemessen/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Insgesamt/VBN/B-VP/O wurde/VB/I-VP/O das/DT/O/O Proof/FW/O/O of/FW/O/O Principal/FW/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Eignung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Chemokinen/NN/B-NP/I-PNP als/IN/B-PP/B-PNP Chemoattraktanten/NN/B-NP/I-PNP humaner/NN/I-NP/I-PNP MSC/NN/I-NP/I-PNP erbracht/NN/I-NP/I-PNP und/CC/O/O gezeigt/VBN/B-VP/O ,/,/O/O dass/IN/B-PP/B-PNP BMP2/NN/B-NP/I-PNP ,/,/O/O IL8/NN/B-NP/O und/CC/I-NP/O SDF1\xce\xb1/NN/I-NP/O interessante/JJ/B-NP/O Kandidaten/NN/I-NP/O f\xc3\xbcr/IN/B-PP/O pr\xc3\xa4klinische/RB/B-ADVP/O in/IN/B-PP/B-PNP situ/NN/B-NP/I-PNP Knorpel/NN/I-NP/I-PNP TE/NN/I-NP/I-PNP Studien/NN/I-NP/I-PNP sind/VB/B-VP/O ././O/O

Hinsichtlich/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Etablierung/NN/I-NP/I-PNP eines/DT/O/O Gro\xc3\x9ftiermodells/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/O das/DT/O/O in/IN/B-PP/B-PNP situ/NN/B-NP/I-PNP TE/NN/I-NP/I-PNP wurden/VB/B-VP/O aus/IN/B-PP/B-PNP porcinem/NN/B-NP/I-PNP und/CC/I-NP/I-PNP equinem/NN/I-NP/I-PNP Knochenmark/NN/I-NP/I-PNP MSC/NN/I-NP/I-PNP isoliert/NN/I-NP/I-PNP und/CC/O/O charakterisiert/NN/B-NP/O ././O/O

Porcine/NN/B-NP/O und/CC/I-NP/O humane/NN/I-NP/O MSC/NN/I-NP/O verhielten/VB/B-VP/O sich/PRP/B-NP/O sehr/RB/B-ADJP/O \xc3\xa4hnlich/JJ/I-ADJP/O ,/,/O/O w\xc3\xa4hrend/IN/B-PP/B-PNP equine/NN/B-NP/I-PNP MSC/NN/I-NP/I-PNP nicht/RB/B-ADVP/O in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP adipogene/NN/I-NP/I-PNP Entwicklungslinie/NN/I-NP/I-PNP gelenkt/VBN/B-VP/I-PNP werden/VB/I-VP/O konnten/VBN/I-VP/O ././O/O

Dennoch/VBN/B-VP/O wurden/VB/I-VP/O die/DT/B-NP/O equinen/NN/I-NP/O MSC/NN/I-NP/O dazu/VB/B-VP/O verwendet/RB/B-ADVP/O ,/,/O/O um/IN/B-PP/O erstmals/RB/B-ADVP/O einen/DT/B-NP/O chondrogenen/NN/I-NP/O Effekt/NN/I-NP/O der/DT/B-NP/O gelenkrelevanten/NN/I-NP/O Faktoren/NN/I-NP/O Hyalurons\xc3\xa4ure/NN/I-NP/O und/CC/O/O autologe/JJ/B-NP/O Synovialfl\xc3\xbcssigkeit/NN/I-NP/O auf/IN/B-PP/B-PNP MSC/NN/B-NP/I-PNP zu/TO/B-VP/O demonstrieren/VB/I-VP/O ././O/O

Zusammengefasst/VBN/B-VP/O sind/VB/I-VP/O beide/JJ/B-NP/O Faktoren/NN/I-NP/O interessante/JJ/B-NP/O Kandidaten/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP pr\xc3\xa4klinische/JJ/I-NP/I-PNP Testung/NN/I-NP/I-PNP ././O/O

Das/DT/B-NP/O Schwein/NN/I-NP/O und/CC/O/O auch/RB/B-ADVP/O das/DT/B-NP/O Pferd/NN/I-NP/O repr\xc3\xa4sentieren/VB/B-VP/O hierf\xc3\xbcr/RB/B-NP/O geeignete/JJ/I-NP/O Gro\xc3\x9ftiermodelle/NN/I-NP/O ././O/O

In/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP weiteren/JJ/I-NP/I-PNP Teil/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP konnte/VB/B-VP/O erstmals/RB/I-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Periostzellen/NN/I-NP/I-PNP des/DT/B-NP/I-PNP humanen/NN/I-NP/I-PNP Mastoids/NN/I-NP/I-PNP ein/DT/B-NP/I-PNP adipogenes/NN/I-NP/I-PNP Potential/NN/I-NP/I-PNP haben/VB/B-VP/O ,/,/O/O sie/PRP/B-NP/O basierend/JJ/B-ADJP/O auf/IN/B-PP/B-PNP FACS/NNP/B-NP/I-PNP und/CC/I-NP/I-PNP genomweiten/NNP/I-NP/I-PNP Mikroarray/NNP/I-NP/I-PNP Analysen/NNP/I-NP/I-PNP zahlreiche/JJ/B-NP/I-PNP MSC/NN/I-NP/I-PNP Marker/JJ/B-ADJP/O pr\xc3\xa4sentieren/VB/B-VP/O ,/,/O/O sie/PRP/B-NP/O ein/DT/I-NP/O MSC-\xc3\xa4hnliches/JJ/I-NP/O Chemokinrezeptor/NN/I-NP/O Profil/NN/I-NP/O aufweisen/VB/B-VP/O und/CC/O/O dass/RB/B-ADVP/O sie/PRP/B-NP/O nach/IN/B-PP/B-PNP Stimulation/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP SDF1\xce\xb1/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Chemotaxis/NN/B-NP/I-PNP Assay/NNP/I-NP/I-PNP migrieren/VB/B-VP/O ././O/O

Die/DT/B-NP/O Periostzellen/NN/I-NP/O zeigen/VB/B-VP/O somit/RB/B-ADVP/O einen/DT/B-NP/O MSC-\xc3\xa4hnlichen/JJ/I-NP/O Charakter/NN/I-NP/O und/CC/O/O sind/VB/B-VP/O f\xc3\xbcr/IN/B-PP/O das/DT/O/O in/IN/B-PP/B-PNP situ/JJ/B-NP/I-PNP TE/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Interesse/NN/B-NP/I-PNP ././O/O

Periostzellen/VBN/B-VP/O wurden/VB/I-VP/O oftmals/RB/B-ADVP/O als/IN/B-PP/B-PNP multipotente/NN/B-NP/I-PNP MSC/NN/I-NP/I-PNP bezeichnet/VBN/B-VP/I-PNP ,/,/O/O ohne/IN/B-PP/O das/DT/O/O bisher/RB/B-ADVP/O ein/DT/O/O mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP MSC/NN/I-NP/I-PNP vergleichbares/NN/I-NP/I-PNP Potential/NN/I-NP/I-PNP aufgezeigt/VBN/B-VP/I-PNP wurde/VB/I-VP/O ././O/O

Insgesamt/RB/B-VP/O sind/VB/I-VP/O die/DT/B-NP/O Ergebnisse/NN/I-NP/O zum/IN/B-PP/B-PNP Differenzierungspotential/NN/B-NP/I-PNP der/DT/O/O f\xc3\xbcr/IN/B-PP/B-PNP klinische/JJ/B-NP/I-PNP Anwendungen/NN/I-NP/I-PNP zugelassenen/NN/I-NP/I-PNP Faktoren/NN/I-NP/I-PNP BMP2/NN/I-NP/I-PNP ,/,/O/O Hyalurons\xc3\xa4ure/NN/B-NP/O und/CC/I-NP/O Synovialfl\xc3\xbcssigkeit/NN/I-NP/O f\xc3\xbcr/IN/B-PP/O die/DT/O/O in/IN/B-PP/B-PNP situ/NN/B-NP/I-PNP Knorpelregeneration/NN/I-NP/I-PNP viel/VB/B-VP/O versprechend/JJ/B-ADJP/O ././O/O

Die/DT/B-NP/O Wirkung/NN/I-NP/O dieser/DT/B-NP/O Faktoren/NN/I-NP/O und/CC/O/O auch/RB/B-ADVP/O die/WDT/B-NP/O der/DT/I-NP/O Chemokine/NN/I-NP/O sollte/MD/B-VP/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP best\xc3\xa4tigt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Hierf\xc3\xbcr/RB/B-VP/O stehen/VBN/I-VP/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Pferd/NN/I-NP/I-PNP und/CC/O/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Schwein/NN/I-NP/I-PNP zwei/CD/B-NP/I-PNP Gro\xc3\x9ftiermodelle/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP Verf\xc3\xbcgung.In/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Doktorarbeit/NN/I-NP/I-PNP wurde/VB/B-VP/O ein/DT/B-NP/O neues/JJ/I-NP/O Testverfahren/NN/I-NP/O zum/IN/B-PP/B-PNP Nachweis/NN/B-NP/I-PNP von/IN/B-PP/B-PNP HLA/NNP/B-NP/I-PNP -/-/O/O Antigen/NN/B-NP/O bzw./RB/I-NP/O \xe2\x80\x93Antik\xc3\xb6rper/NN/I-NP/O entwickelt/VB/B-VP/O ././O/O

Grundlage/NN/B-NP/O des/DT/O/O entwickelten/VB/B-VP/O Verfahrens/NN/B-NP/O ist/RB/B-ADVP/O der/DT/B-NP/O Partikel-Gel/NN/I-NP/O -/-/O/O Agglutinationstest/NN/B-NP/O (/(/O/O PaGIA/NNP/B-NP/O )/)/O/O ././O/O

Durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Verwendung/NN/I-NP/I-PNP superparamagnetischer/NN/I-NP/I-PNP Polystyrenpartikel/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O mit/IN/B-PP/B-PNP monoklonalen/JJ/B-NP/I-PNP Antik\xc3\xb6rpern/NN/I-NP/I-PNP gegen/IN/B-PP/B-PNP das/DT/B-NP/I-PNP HLA-B27-Merkmal/NN/I-NP/I-PNP beladen/VB/B-VP/O sind/VB/I-VP/O ,/,/O/O gelang/NN/B-NP/O es/PRP/I-NP/O ,/,/O/O HLA-B27/NN/B-NP/O positive/JJ/I-NP/O Lymphozyten/NN/I-NP/O mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP eines/DT/I-NP/I-PNP Magneten/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP Vollblut/NN/B-NP/I-PNP zu/TO/B-VP/O isolieren/VB/I-VP/O ././O/O

Wurden/VB/B-VP/O diese/DT/B-NP/O Lymphozyten/NN/I-NP/O dann/RB/B-ADVP/O gemeinsam/RB/I-ADVP/O mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Polystyrenpartikeln/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Gelkarte/NN/I-NP/I-PNP gegeben/VB/B-VP/O und/CC/O/O zentrifugiert/NN/B-NP/O ,/,/O/O so/RB/B-VP/O konnte/VB/I-VP/O anhand/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Agglutination/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Partikeln/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Lymphozyten/NN/I-NP/I-PNP sehr/RB/B-ADVP/O einfach/RB/I-ADVP/O das/DT/B-NP/O HLA-B27-Merkmal/NN/I-NP/O bestimmt/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Dieser/DT/B-NP/O Test/NN/I-NP/O erlaubt/VB/B-VP/O es/PRP/B-NP/O ,/,/O/O sehr/RB/B-ADVP/O viel/IN/B-PP/B-PNP einfacher/NN/B-NP/I-PNP Krankheitsassoziationen/NN/I-NP/I-PNP des/DT/O/O HLA-B27-Merkmals/RB/B-VP/O zu/TO/I-VP/O diagnostizieren/VB/I-VP/O F\xc3\xbcr/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Nachweis/NN/I-NP/I-PNP von/IN/B-PP/B-PNP HLA-Antik\xc3\xb6rpern/NN/B-NP/I-PNP wurden/VB/B-VP/O Polystyrenpartikel/NN/B-NP/O ,/,/O/O die/WDT/O/O mit/IN/B-PP/B-PNP monoklonalen/JJ/B-NP/I-PNP Antik\xc3\xb6rpern/NN/I-NP/I-PNP gegen/IN/B-PP/B-PNP HLA-Klasse/NNP/B-NP/I-PNP I/CD/O/O -/-/O/O bzw./CC/O/O gegen/IN/B-PP/B-PNP HLA-Klasse/NNP/B-NP/I-PNP II-Merkmale/NNP/I-NP/I-PNP beschichtet/NNP/I-NP/I-PNP waren/VB/B-VP/O ,/,/O/O verwendet/RB/B-ADVP/O ././O/O

Diese/DT/B-NP/O Partikel/NN/I-NP/O wurden/VB/B-VP/O mit/IN/B-PP/B-PNP Lymphozytensolubilisaten/NN/B-NP/I-PNP und/CC/O/O dem/DT/O/O zu/IN/B-PP/B-PNP untersuchenden/JJ/B-NP/I-PNP Serum/NN/I-NP/I-PNP inkubiert/RP/O/O ,/,/O/O so/RB/B-ADVP/O dass/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP glykoproteinspezifischer/JJ/I-NP/I-PNP Nachweis/NN/I-NP/I-PNP von/IN/B-PP/B-PNP HLAAntik\xc3\xb6rpern/NN/B-NP/I-PNP m\xc3\xb6glich/JJ/B-ADJP/O war/VB/B-VP/O ././O/O

Durch/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Einsatz/NN/I-NP/I-PNP des/DT/B-NP/I-PNP PaGIA/NNP/I-NP/I-PNP konnten/VB/B-VP/O die/DT/B-NP/O Nachteile/NNS/I-NP/O der/DT/O/O bisher/IN/B-PP/B-PNP genutzten/NN/B-NP/I-PNP Testsysteme/NN/I-NP/I-PNP zum/IN/B-PP/B-PNP Nachweis/NN/B-NP/I-PNP von/IN/B-PP/B-PNP HLA/NNP/B-NP/I-PNP -/-/O/O Antigenen/NN/B-NP/O bzw./RB/I-NP/O Antik\xc3\xb6rpern/NN/I-NP/O (/(/O/O LCT/NNP/B-NP/O ,/,/O/O FACS/NNP/B-NP/O ,/,/O/O PCR/NN/B-NP/O )/)/O/O ,/,/O/O wie/IN/B-PP/B-PNP z.B./IN/I-PP/I-PNP Arbeits/NN/B-NP/I-PNP -/-/O/O ,/,/O/O Zeitaufwand/NN/B-NP/O und/CC/I-NP/O Komplexit\xc3\xa4t/NN/I-NP/O ,/,/O/O unter/IN/B-PP/B-PNP Beibehaltung/NN/B-NP/I-PNP einer/DT/I-NP/I-PNP vergleichbaren/NN/I-NP/I-PNP Sensitivit\xc3\xa4t/NN/I-NP/I-PNP und/CC/O/O Spezifit\xc3\xa4t/NN/B-NP/O \xc3\xbcberwunden/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Das/DT/B-NP/O Testsystem/NN/I-NP/O ist/VB/B-VP/O einfach/NNP/B-NP/O und/CC/O/O schnell/JJ/B-ADJP/O durchf\xc3\xbchrbar/JJ/I-ADJP/O ,/,/O/O so/RB/B-ADVP/O dass/IN/B-PP/O es/JJ/B-ADJP/O ohne/IN/B-PP/B-PNP gro\xc3\x9fen/JJ/B-NP/I-PNP personellen/JJ/I-NP/I-PNP und/CC/I-NP/I-PNP technischen/JJ/I-NP/I-PNP Aufwand/NN/I-NP/I-PNP in/IN/B-PP/B-PNP praktisch/JJ/B-NP/I-PNP jedem/JJ/I-NP/I-PNP Labor/NN/I-NP/I-PNP durchgef\xc3\xbchrt/VBN/B-VP/I-PNP werden/VB/I-VP/O kann/VBN/I-VP/O ././O/O

Das/DT/B-NP/O entwickelte/JJ/I-NP/O Testverfahren/NN/I-NP/O stellt/VB/B-VP/O eine/DT/B-NP/O Grundlage/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Weiterentwicklung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP diagnostischen/JJ/B-NP/I-PNP Tests/NN/I-NP/I-PNP dar/RB/B-ADVP/O ,/,/O/O die/WDT/O/O auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP gleichen/JJ/I-NP/I-PNP Prinzipien/NN/I-NP/I-PNP beruhen.Der/NN/I-NP/I-PNP Haupthistokompatibilit\xc3\xa4tskomplex/NN/I-NP/I-PNP ist/VB/B-VP/O durch/IN/B-PP/B-PNP seine/PRP$/B-NP/I-PNP biologische/JJ/I-NP/I-PNP Funktion/NN/I-NP/I-PNP eine/DT/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Diagnostik/NN/I-NP/I-PNP und/CC/O/O Forschung/NN/B-NP/O \xc3\xa4u\xc3\x9ferst/JJ/B-NP/O wichtige/JJ/I-NP/O Region/NN/I-NP/O im/IN/B-PP/B-PNP humanen/JJ/B-NP/I-PNP Genom/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Untersuchung/NN/I-NP/O von/IN/B-PP/B-PNP HLA-Genorten/NN/B-NP/I-PNP stellt/VB/B-VP/O ein/DT/B-NP/O wichtiges/JJ/I-NP/O Instrument/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP molekulargenetischen/JJ/I-NP/I-PNP Praxis/NN/I-NP/I-PNP dar/RP/O/O ././O/O

Die/DT/B-NP/O Pyrosequencing-Technik/NN/I-NP/O ist/VB/B-VP/O gut/JJ/B-ADJP/O geeignet/JJ/I-ADJP/O ,/,/O/O um/IN/B-PP/B-PNP kurze/JJ/B-NP/I-PNP DNA-Abschnitte/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP weitgehend/JJ/B-NP/I-PNP bekannter/JJ/I-NP/I-PNP Sequenz/NN/I-NP/I-PNP schnell/JJ/B-ADJP/O und/CC/I-ADJP/O effizient/JJ/I-ADJP/O zu/TO/B-VP/O untersuchen/VB/I-VP/O ././O/O

Ziel/NN/B-NP/O dieser/DT/I-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O die/DT/B-NP/O Entwicklung/NN/I-NP/O von/IN/B-PP/B-PNP Pyrosequencing-basierten/NN/B-NP/I-PNP Methoden/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP HLA-Typisierung/NN/B-NP/I-PNP ././O/O

Exemplarisch/VBN/B-VP/O wurden/VB/I-VP/O f\xc3\xbcr/IN/B-PP/B-PNP drei/CD/B-NP/I-PNP wichtige/JJ/I-NP/I-PNP HLA-Genorte/NN/I-NP/I-PNP ,/,/O/O HLA-DQB1/NN/B-NP/O ,/,/O/O HLA-DRB1/NN/B-NP/O und/CC/I-NP/O HLA-B/NN/I-NP/O Untersuchungsstrategien/NN/I-NP/O entwickelt/VB/B-VP/O ././O/O

Die/DT/B-NP/O Vorgehensweise/NN/I-NP/O wurde/VB/B-VP/O jeweils/RB/B-ADVP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Besonderheiten/NN/I-NP/I-PNP der/DT/B-NP/I-PNP unterschiedlichen/JJ/I-NP/I-PNP Genorte/NN/I-NP/I-PNP angepasst/RP/O/O ././O/O

Die/DT/B-NP/O Strategien/NN/I-NP/O wurden/VB/B-VP/O an/IN/B-PP/B-PNP Standardproben/NN/B-NP/I-PNP validiert/NN/I-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP Kleinstudien/JJ/B-NP/I-PNP angewendet/NN/I-NP/I-PNP ././O/O

o/VBN/B-VP/O wurde/VB/I-VP/O eine/DT/B-NP/O Fall-Kontroll-Studie/NN/I-NP/O zur/IN/B-PP/B-PNP Untersuchung/NN/B-NP/I-PNP einer/DT/I-NP/I-PNP m\xc3\xb6glichen/NN/I-NP/I-PNP Assoziation/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP HLA-DRB1/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Alopecia/JJ/I-NP/I-PNP areata/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP der/DT/O/O entwickelten/VB/B-VP/O Typisierungsstrategie/NN/B-NP/O durchgef\xc3\xbchrt/RP/O/O ././O/O

Neben/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP populationsgenetischen/JJ/I-NP/I-PNP Untersuchung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP HLA-B/JJ/I-NP/I-PNP Genortes/NN/I-NP/I-PNP an/IN/B-PP/B-PNP Proben/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Individuen/NN/B-NP/I-PNP aus/IN/B-PP/B-PNP Papua/NN/B-NP/I-PNP Neuguinea/NN/I-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O Pyrosequencing-Methode/NN/I-NP/O daf\xc3\xbcr/VB/B-VP/O eingesetzt/VBN/I-VP/O ,/,/O/O die/DT/B-NP/O Alleltrennung/NN/I-NP/O durch/IN/B-PP/B-PNP Haplotyp-spezifische/JJ/B-NP/I-PNP Extraktion/NN/I-NP/I-PNP schnell/JJ/B-ADJP/O und/CC/I-ADJP/O g\xc3\xbcnstig/JJ/I-ADJP/O zu/TO/B-VP/O \xc3\xbcberpr\xc3\xbcfen/VB/I-VP/O ././O/O

Die/DT/O/O Pyrosequencing/FW/O/O Protokolle/NNS/B-NP/O bieten/VB/B-VP/O eine/DT/B-NP/O sehr/RB/I-NP/O effiziente/JJ/I-NP/O Alternative/NN/I-NP/O und/CC/O/O Erg\xc3\xa4nzung/NN/B-NP/O zu/IN/B-PP/B-PNP den/DT/B-NP/I-PNP bestehenden/JJ/I-NP/I-PNP HLA-Typisierungsmethoden.In/NN/I-NP/I-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP sollte/MD/B-VP/O untersucht/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O ob/IN/B-PP/B-PNP sich/PRP/B-NP/I-PNP der/DT/I-NP/I-PNP klinische/JJ/I-NP/I-PNP Verlauf/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Dickdarmkrebspatienten/NN/B-NP/I-PNP anhand/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Genexpression/NN/I-NP/I-PNP genauer/RB/B-VP/O prognostizieren/VB/I-VP/O l\xc3\xa4sst/VB/I-VP/O ,/,/O/O als/IN/B-PP/O dies/DT/O/O \xc3\xbcber/IN/B-PP/B-PNP konventionelle/JJ/B-NP/I-PNP histopathologische/JJ/I-NP/I-PNP Methoden/NN/I-NP/I-PNP derzeit/RB/B-ADJP/O m\xc3\xb6glich/JJ/I-ADJP/O ist/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP Microarray-Experimenten/NN/B-NP/I-PNP wurden/VB/B-VP/O insgesamt/RB/B-ADVP/O 516/CD/B-NP/O prognostisch/JJ/I-NP/O relevante/NN/I-NP/O Transkripte/JJ/B-NP/O identifiziert/NN/I-NP/O ././O/O

ie/PRP/B-NP/O erlaubten/VB/B-VP/O in/IN/B-PP/B-PNP silico/NN/B-NP/I-PNP die/DT/I-NP/I-PNP ordnungsgem\xc3\xa4\xc3\x9fe/JJ/I-NP/I-PNP Diskriminierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP histo\xc2\xacpatho\xc2\xaclogisch/JJ/B-NP/I-PNP \xc3\xa4hnlichen/JJ/I-NP/I-PNP Kolonkarzinompatienten/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP unterschiedlichem/NN/B-NP/I-PNP klinischen/JJ/I-NP/I-PNP Verlauf/NN/I-NP/I-PNP ././O/O

Zehn/NN/B-NP/O ausgew\xc3\xa4hlte/JJ/I-NP/O Transkripte/NN/I-NP/O wurden/VB/B-VP/O \xc3\xbcber/IN/B-PP/B-PNP quantitative/NN/B-NP/I-PNP Real-Time/JJ/I-NP/I-PNP PCR/NN/I-NP/I-PNP an/IN/B-PP/B-PNP bis/IN/I-PP/I-PNP zu/IN/I-PP/I-PNP 75/CD/B-NP/I-PNP kolo\xc2\xacrektalen/JJ/I-NP/I-PNP Karzinompatienten/JJ/I-NP/I-PNP validiert/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O beiden/DT/I-NP/O Gene/NN/I-NP/O Claudin/NN/I-NP/O 8/CD/B-NP/O und/CC/I-NP/O REG1A/NNP/I-NP/O wurden/RB/B-ADJP/O eingehender/JJ/I-ADJP/O untersucht/RP/O/O ././O/O

Claudin/NN/B-NP/O 8/CD/O/O ,/,/O/O dem/DT/B-NP/O eine/DT/I-NP/O Rolle/NN/I-NP/O bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Abdichtung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP interzellul\xc3\xa4ren/NN/I-NP/I-PNP Raumes/NN/I-NP/I-PNP zugeschrieben/VBN/B-VP/I-PNP wird/VB/I-VP/O ,/,/O/O zeigte/VBN/B-VP/O eine/DT/B-NP/O \xc3\xa4u\xc3\x9ferst/NN/I-NP/O prominente/JJ/B-NP/O Minderexpression/NN/I-NP/O in/IN/B-PP/B-PNP kolorektalen/JJ/B-NP/I-PNP Karzinomen/NN/I-NP/I-PNP ././O/O

lbst/RB/B-ADVP/O im/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Tumor/NN/I-NP/I-PNP umgebenden/NN/I-NP/I-PNP Normalgewebe/NN/I-NP/I-PNP lag/VB/B-VP/O Claudin/NN/B-NP/O 8/CD/O/O im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP gesunder/JJ/B-NP/I-PNP Mukosa/NN/I-NP/I-PNP signifikant/JJ/B-ADJP/O erniedrigt/JJ/I-ADJP/O vor/RP/O/O ././O/O

Es/PRP/B-NP/O konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP Claudin/NN/B-NP/I-PNP 8/CD/O/O im/IN/B-PP/B-PNP Tumor/NN/B-NP/I-PNP nicht/RB/B-ADVP/O durch/IN/B-PP/B-PNP DNA-Methylierung/NN/B-NP/I-PNP reprimiert/NN/I-NP/I-PNP wird/VB/B-VP/O und/CC/O/O keinen/DT/B-NP/O wesentlichen/JJ/I-NP/O Einfluss/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Zell-Adh\xc3\xa4sion/NN/I-NP/I-PNP sowie/RB/B-ADVP/O das/DT/B-NP/O Migrationsverhalten/JJ/I-NP/O besitzt/NN/I-NP/O ././O/O

REG1A/NNP/B-NP/O lag/VB/B-VP/O in/IN/B-PP/B-PNP kolorektalen/JJ/B-NP/I-PNP Karzinomen/NN/I-NP/I-PNP stark/JJ/B-NP/I-PNP \xc3\xbcberexprimiert/NN/I-NP/I-PNP vor/RP/O/O ,/,/O/O zeigte/VB/B-VP/O aber/RB/B-ADVP/O bereits/RB/B-NP/O signifikant/JJ/I-NP/O erh\xc3\xb6hte/JJ/I-NP/O Expressionslevel/NN/I-NP/O in/IN/B-PP/B-PNP Adenomen/NN/B-NP/I-PNP sowie/RB/B-ADVP/O im/IN/B-PP/B-PNP peritumoralen/JJ/B-NP/I-PNP Normalgewebe/NN/I-NP/I-PNP verglichen/JJ/B-ADJP/O mit/IN/B-PP/B-PNP gesundem/JJ/B-NP/I-PNP Darmepithel/NN/I-NP/I-PNP ././O/O

Deshalb/RB/B-VP/O handelt/VB/I-VP/O es/PRP/B-NP/O sich/PRP/I-NP/O bei/IN/B-PP/B-PNP REG1A/NN/B-NP/I-PNP m\xc3\xb6glicherweise/RB/B-ADVP/O sogar/RB/I-ADVP/O um/IN/B-PP/O einen/DT/O/O Marker/JJ/B-ADJP/O von/IN/B-PP/B-PNP pr\xc3\xa4malignem/JJ/B-NP/I-PNP Risikoepithel/NN/I-NP/I-PNP ././O/O

REG1A-mRNA/NNP/B-NP/O wurde/VB/B-VP/O \xc3\xbcber/IN/B-PP/B-PNP Tissue/JJ/B-NP/I-PNP Microarray-basierte/NN/I-NP/I-PNP in/IN/B-PP/B-PNP situ-Hybridisierung/NN/B-NP/I-PNP nur/RB/B-ADVP/O in/IN/B-PP/B-PNP Epithel/NN/B-NP/I-PNP -/-/O/O bzw./CC/O/O Tumorzellen/NN/B-NP/O und/CC/O/O nie/RB/B-ADVP/O im/IN/B-PP/B-PNP Stroma/JJ/B-NP/I-PNP detektiert/NN/I-NP/I-PNP ././O/O

REG1A/NNP/B-NP/O fungierte/NNP/I-NP/O als/IN/B-PP/B-PNP signifikanter/JJ/B-NP/I-PNP Pr\xc3\xa4diktor/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Tumor-abh\xc3\xa4ngige/NN/I-NP/I-PNP sowie/RB/B-NP/I-PNP progressionsfreie/JJ/I-NP/I-PNP Patienten\xc3\xbcberleben/NN/I-NP/I-PNP ././O/O

\xc3\x9cberdies/RB/B-VP/O zeigte/VB/I-VP/O REG1A/NNP/B-NP/O zusammen/RB/B-ADVP/O mit/IN/B-PP/B-PNP seinem/PRP$/B-NP/I-PNP Rezeptor/NN/I-NP/I-PNP EXTL3/NN/I-NP/I-PNP eine/DT/I-NP/I-PNP positive/JJ/I-NP/I-PNP Korrelation/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Auftreten/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Peritonealmetastasen/NN/B-NP/I-PNP ,/,/O/O welche/WDT/B-NP/O das/DT/I-NP/O \xc3\x9cberleben/NN/I-NP/O in/IN/B-PP/B-PNP besonderem/NN/B-NP/I-PNP Ma\xc3\x9f/NN/I-NP/I-PNP verk\xc3\xbcrzen.Die/NN/I-NP/I-PNP vorgestellte/NN/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP liefert/NN/I-NP/I-PNP neue/JJ/I-NP/I-PNP Erkenntnisse/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP mikrotr\xc3\xa4gerbasierten/JJ/B-NP/I-PNP Expansion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP prim\xc3\xa4ren/NN/B-NP/I-PNP mesenchymalen/JJ/I-NP/I-PNP Stammzellen/NN/I-NP/I-PNP (/(/O/O MSC/NN/B-NP/O )/)/O/O und/CC/O/O Chondrozyten/NN/B-NP/O im/IN/B-PP/B-PNP Spinnerflaschen-Bioreaktor/NN/B-NP/I-PNP ././O/O

Diese/DT/B-NP/O Expansionsmethode/NN/I-NP/O stellt/VB/B-VP/O eine/DT/O/O viel/IN/B-PP/B-PNP versprechende/NN/B-NP/I-PNP Alternative/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP herk\xc3\xb6mmlichen/JJ/B-NP/I-PNP 2-dimensionalen/JJ/I-NP/I-PNP Monolayerkultur/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Prim\xc3\xa4rzellen/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP des/DT/O/O Tissue/FW/O/O Engineering/FW/O/O dar/RP/O/O ././O/O

Zus\xc3\xa4tzliche/JJ/B-NP/O Vorteile/NN/I-NP/O verspricht/VB/B-VP/O die/DT/B-NP/O Verwendung/NN/I-NP/O von/IN/B-PP/B-PNP bioresorbierbaren/NN/B-NP/I-PNP Mikrotr\xc3\xa4gern/NN/I-NP/I-PNP ,/,/O/O welche/WDT/O/O zusammen/RB/B-ADVP/O mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP expandierten/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Transplantatherstellung/NN/I-NP/I-PNP eingehen/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ././O/O

Hierzu/RB/B-VP/O war/VB/I-VP/O es/PRP/B-NP/O notwendig/JJ/B-ADJP/O ,/,/O/O Mikrotr\xc3\xa4ger/NN/B-NP/O aus/IN/B-PP/B-PNP PLGA/NNP/B-NP/I-PNP selbst/JJ/I-NP/I-PNP herzustellen/NN/I-NP/I-PNP und/CC/O/O entsprechend/JJ/B-NP/O ihrer/PRP$/I-NP/O Form/NN/I-NP/O und/CC/O/O Oberfl\xc3\xa4chenbeschaffenheit/NN/B-NP/O ,/,/O/O Gr\xc3\xb6\xc3\x9fe/NN/B-NP/O und/CC/I-NP/O Gr\xc3\xb6\xc3\x9fenverteilung/NN/I-NP/O ,/,/O/O sowie/CC/O/O anhand/IN/B-PP/B-PNP ihres/PRP$/B-NP/I-PNP Degradationsverhaltens/NN/I-NP/I-PNP zu/TO/B-VP/O charakterisieren/VB/I-VP/O ././O/O

Zur/IN/B-PP/B-PNP Etablierung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Methode/NN/I-NP/I-PNP wurden/VB/B-VP/O auch/IN/B-PP/B-PNP kommerzielle/NN/B-NP/I-PNP Cytodex/NN/I-NP/I-PNP Mikrotr\xc3\xa4ger/NN/I-NP/I-PNP verwendet/VB/B-VP/O ././O/O

Neben/IN/B-PP/B-PNP der/DT/B-NP/I-PNP erstmaligen/JJ/I-NP/I-PNP Isolierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP MSC/NN/B-NP/I-PNP mittels/IN/B-PP/B-PNP Mikrotr\xc3\xa4gern/NN/B-NP/I-PNP sollte/MD/B-VP/O die/DT/B-NP/O Adh\xc3\xa4renz/NN/I-NP/O und/CC/O/O Proliferation/NN/B-NP/O der/DT/B-NP/O Zellen/NNS/I-NP/O auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Tr\xc3\xa4gern/NN/I-NP/I-PNP gezeigt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Anschlie\xc3\x9fend/VBN/B-VP/O wurde/VB/I-VP/O das/DT/B-NP/O Differenzierungspotential/NN/I-NP/O der/DT/B-NP/O 3-dimensional/NN/I-NP/O expandierten/NN/I-NP/O Zellen/NNS/I-NP/O in/IN/B-PP/B-PNP osteogene/NN/B-NP/I-PNP und/CC/I-NP/I-PNP chondrogene/NN/I-NP/I-PNP Richtung/NN/I-NP/I-PNP \xc3\xbcberpr\xc3\xbcft/RP/O/O ././O/O

Die/DT/B-NP/O PLGA/NNP/I-NP/O Mikrotr\xc3\xa4ger/NNP/I-NP/O konnten/VB/B-VP/O erfolgreich/JJ/B-ADJP/O als/IN/B-PP/B-PNP Kugeln/NNS/B-NP/I-PNP mit/IN/B-PP/B-PNP glatter/JJ/B-NP/I-PNP Oberfl\xc3\xa4che/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP gew\xc3\xbcnschten/JJ/I-NP/I-PNP Gr\xc3\xb6\xc3\x9fe/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 100-200\xc2\xb5m/NN/B-NP/I-PNP hergestellt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Das/DT/B-NP/O Degradationsverhalten/NN/I-NP/O entsprach/VB/B-VP/O insbesondere/RB/B-ADVP/O beim/IN/B-PP/B-PNP PLGA/NNP/B-NP/I-PNP 0500/CD/I-NP/I-PNP Material/NN/I-NP/I-PNP ,/,/O/O welches/WDT/O/O aus/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP 85:15/CD/I-NP/I-PNP Verh\xc3\xa4ltnis/NN/I-NP/I-PNP an/IN/B-PP/B-PNP PLA/NNP/B-NP/I-PNP zu/TO/O/O PGA/NNP/B-NP/O besteht/VB/B-VP/O ,/,/O/O den/DT/B-NP/O gew\xc3\xbcnschten/JJ/I-NP/O Kriterien/NN/I-NP/O ././O/O

Eine/DT/B-NP/O sehr/RB/I-NP/O gute/JJ/I-NP/O Adh\xc3\xa4renz/NN/I-NP/O der/DT/B-NP/O Zellen/NNS/I-NP/O konnte/VB/B-VP/O bereits/RB/B-ADVP/O nach/IN/B-PP/B-PNP 3h/NN/B-NP/I-PNP auf/IN/B-PP/B-PNP allen/JJ/B-NP/I-PNP Mikrotr\xc3\xa4gern/NN/I-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O wobei/WRB/O/O Cytodex/NN/B-NP/O 1/CD/I-NP/O die/DT/I-NP/O h\xc3\xb6chsten/JJ/I-NP/O Werte/NN/I-NP/O erreichte/VB/B-VP/O ././O/O

Die/DT/B-NP/O direkte/JJ/I-NP/O Isolierung/NN/I-NP/O der/DT/O/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Zellzahl/NN/I-NP/I-PNP limitierten/JJ/B-NP/I-PNP MSC/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Mikrotr\xc3\xa4gern/NN/B-NP/I-PNP konnte/VB/B-VP/O erstmals/RB/I-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ././O/O

Die/DT/O/O Zellspezies/VBN/B-VP/O hatte/VB/I-VP/O wenig/IN/B-PP/B-PNP Einfluss/NN/B-NP/I-PNP auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Adh\xc3\xa4renz/NN/I-NP/I-PNP ,/,/O/O w\xc3\xa4hrend/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Adaption/NN/I-NP/I-PNP an/IN/B-PP/B-PNP Monolayerbedingungen/NN/B-NP/I-PNP eine/DT/I-NP/I-PNP Steigerung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP adh\xc3\xa4renten/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP bewirkte/NN/I-NP/I-PNP ././O/O

Eine/DT/B-NP/O Proliferation/NN/I-NP/O war/VB/B-VP/O f\xc3\xbcr/IN/B-PP/B-PNP alle/JJ/B-NP/I-PNP untersuchten/NN/I-NP/I-PNP Zelltypen/NN/I-NP/I-PNP nachweisbar/JJ/B-ADJP/O ,/,/O/O blieb/NN/B-NP/O jedoch/RB/B-ADVP/O hinter/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Monolayerkultur/NN/I-NP/I-PNP zur\xc3\xbcck/RP/O/O ././O/O

Eine/DT/B-NP/O Optimierung/NN/I-NP/O der/DT/B-NP/O mikrotr\xc3\xa4gerbasierten/NN/I-NP/O Methode/NN/I-NP/O k\xc3\xb6nnte/VB/B-VP/O die/DT/B-NP/O Wachstumsraten/NN/I-NP/O entsprechend/JJ/B-ADJP/O verbessern/VB/B-VP/O ././O/O

Das/DT/B-NP/O Expansionspotential/NN/I-NP/O der/DT/B-NP/O mikrotr\xc3\xa4gerbasierten/NN/I-NP/O Kultur/NN/I-NP/O war/VB/B-VP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP gezeigte/NN/I-NP/I-PNP Rekolonisation/NN/I-NP/I-PNP frischer/JJ/B-NP/I-PNP Carrier/NN/I-NP/I-PNP ohne/IN/B-PP/B-PNP Limitierung/NN/B-NP/I-PNP und/CC/O/O stellt/VB/B-VP/O somit/RB/B-ADVP/O einen/DT/B-NP/O entscheidenden/NN/I-NP/O Vorteil/NN/I-NP/O dieser/DT/B-NP/O Methode/NN/I-NP/O dar/RP/O/O ././O/O

Das/DT/B-NP/O Differenzierungspotential/NN/I-NP/O der/DT/B-NP/O Zellen/NNS/I-NP/O blieb/NN/I-NP/O w\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP 3D-Expansion/NN/I-NP/I-PNP erhalten/VB/B-VP/O ././O/O

Die/DT/B-NP/O grunds\xc3\xa4tzliche/JJ/I-NP/O Verwendbarkeit/NN/I-NP/O von/IN/B-PP/B-PNP resorbierbaren/NNP/B-NP/I-PNP PLGA/NNP/I-NP/I-PNP Mikrotr\xc3\xa4gern/NNP/I-NP/I-PNP konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ././O/O

Insgesamt/RB/B-VP/O ist/VB/I-VP/O die/DT/B-NP/O mikrotr\xc3\xa4gerbasierte/JJ/I-NP/O Expansion/NN/I-NP/O von/IN/B-PP/B-PNP Zellen/NNS/B-NP/I-PNP im/IN/B-PP/B-PNP Spinnerflaschen-Bioreaktor/NN/B-NP/I-PNP eine/DT/I-NP/I-PNP Erfolg/NN/I-NP/I-PNP versprechende/NN/I-NP/I-PNP Methode/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP in/IN/I-PP/I-PNP vitro/JJ/B-NP/I-PNP Vermehrung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP prim\xc3\xa4ren/NN/B-NP/I-PNP Zellen.Das/NN/I-NP/I-PNP Endothel/NN/I-NP/I-PNP gilt/VB/B-VP/O als/IN/B-PP/B-PNP hochspezialisiertes/NN/B-NP/I-PNP Zellsystem/NN/I-NP/I-PNP ,/,/O/O welches/WDT/O/O \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Ca2+-abh\xc3\xa4ngige/NN/I-NP/I-PNP Freisetzung/NN/I-NP/I-PNP vasokonstriktiv/NN/I-NP/I-PNP bzw./RB/B-NP/I-PNP vasodilatatorisch/JJ/I-NP/I-PNP wirksamer/JJ/I-NP/I-PNP Autakoide/NN/I-NP/I-PNP den/DT/B-NP/I-PNP Gef\xc3\xa4\xc3\x9ftonus/NN/I-NP/I-PNP an/IN/B-PP/B-PNP die/DT/B-NP/I-PNP jeweiligen/JJ/I-NP/I-PNP h\xc3\xa4modynamischen/JJ/I-NP/I-PNP Gegebenheiten/NNS/I-NP/I-PNP anpasst/NN/I-NP/I-PNP und/CC/O/O eine/DT/B-NP/O ad\xc3\xa4quaten/JJ/I-NP/O Blutversorgung/NN/I-NP/O von/IN/B-PP/B-PNP Organen/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Geweben/JJ/I-NP/I-PNP aufrechterh\xc3\xa4lt/NN/I-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP Endothel/NN/B-NP/I-PNP erfolgt/VB/B-VP/O die/DT/B-NP/O Regulation/NN/I-NP/O der/DT/B-NP/O intrazellul\xc3\xa4ren/NN/I-NP/O Ca2+-Mobilisierung/NN/I-NP/O u.a./VB/B-VP/O \xc3\xbcber/IN/B-PP/B-PNP Ca2+-permeable/NN/B-NP/I-PNP Kationenkan\xc3\xa4le/NN/I-NP/I-PNP ,/,/O/O die/DT/B-NP/O einen/DT/I-NP/O Ca2+-Einstrom/NN/I-NP/O aus/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Extrazellul\xc3\xa4rraum/NN/I-NP/I-PNP erm\xc3\xb6glichen/VB/B-VP/O ././O/O

Eine/DT/B-NP/O molekularbiologische/JJ/I-NP/O Charakterisierung/NN/I-NP/O der/WDT/B-NP/O den/DT/I-NP/O Ca2+-Einstrom/NN/I-NP/O mediierenden/NN/I-NP/O Kan\xc3\xa4le/NN/I-NP/O im/IN/B-PP/B-PNP Endothel/NN/B-NP/I-PNP ist/VB/B-VP/O bislang/RB/B-ADJP/O nur/RB/I-ADJP/O unzureichend/JJ/I-ADJP/O ././O/O

Im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP gelang/NN/I-NP/I-PNP es/PRP/I-NP/I-PNP ,/,/O/O die/DT/B-NP/O funktionale/NN/I-NP/O Bedeutung/NN/I-NP/O des/DT/B-NP/O nicht-selektiven/NN/I-NP/O ,/,/O/O kalziumpermeablen/NN/B-NP/O Kationenkanals/NNP/I-NP/O TRPV4/NNP/I-NP/O unter/IN/B-PP/B-PNP Verwendung/NN/B-NP/I-PNP vaskul\xc3\xa4r-biologischer/NN/I-NP/I-PNP ,/,/O/O elektrophysiologischer/NN/B-NP/O und/CC/I-NP/O molekularbiologischer/JJ/I-NP/O Untersuchungsmethoden/NN/I-NP/O im/IN/B-PP/B-PNP Endothel/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Ratte/JJ/I-NP/I-PNP aufzukl\xc3\xa4ren/NN/I-NP/I-PNP ././O/O

Mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP in-situ/NN/I-NP/I-PNP Patch-Clamp-Methode/NN/I-NP/I-PNP ,/,/O/O multiplex-Einzelzell-RT-PCR/NN/B-NP/O und/CC/I-NP/O Ca2+-sensitiver/NN/I-NP/O Floureszenzmikroskopie/NN/I-NP/O konnten/JJ/B-NP/O endotheliale/JJ/I-NP/O TRPV4/NN/I-NP/O im/IN/B-PP/B-PNP nativen/NN/B-NP/I-PNP Endothel/NN/I-NP/I-PNP der/DT/I-NP/I-PNP Ratte/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP und/CC/O/O charakterisiert/NN/B-NP/O werden/VB/B-VP/O ././O/O

Pharmakologische/JJ/B-NP/O Stimulation/NN/I-NP/O von/IN/B-PP/B-PNP TRPV4/NN/B-NP/I-PNP mittels/IN/B-PP/B-PNP des/DT/B-NP/I-PNP selektiven/JJ/I-NP/I-PNP Agonisten/NN/I-NP/I-PNP 4aPDD/NN/I-NP/I-PNP f\xc3\xbchrte/VB/B-VP/O an/IN/B-PP/B-PNP nativen/NN/B-NP/I-PNP Endothelzellen/NN/I-NP/I-PNP der/DT/I-NP/I-PNP Ratte/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP signifikanten/NN/I-NP/I-PNP Kalziumeinstrom/NN/I-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP Experimente/NN/B-NP/I-PNP an/IN/B-PP/B-PNP isoliert/NN/B-NP/I-PNP perfundierten/NN/I-NP/I-PNP Arterien/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Endothel-abh\xc3\xa4ngigen/NN/I-NP/I-PNP Vasodilatation/NN/I-NP/I-PNP ,/,/O/O welche/WDT/O/O durch/IN/B-PP/B-PNP den/DT/B-NP/I-PNP selektiven/JJ/I-NP/I-PNP TRPV-Blocker/NN/I-NP/I-PNP Ruthenium/JJ/B-NP/I-PNP Red/NN/I-NP/I-PNP (/(/O/O RuR/NN/B-NP/O )/)/O/O inhibiert/NN/B-NP/O werden/VB/B-VP/O konnte/VBN/I-VP/O ././O/O

Weiterhin/RB/B-VP/O konnte/VB/I-VP/O eine/DT/B-NP/O Aktivierung/NN/I-NP/O von/IN/B-PP/B-PNP TRPV4/NN/B-NP/I-PNP durch/IN/B-PP/B-PNP verschiedene/JJ/B-NP/I-PNP chemische/JJ/I-NP/I-PNP und/CC/I-NP/I-PNP physikalische/JJ/I-NP/I-PNP Stimuli/NN/I-NP/I-PNP ,/,/O/O wie/IN/B-PP/O niedrigen/VB/B-VP/O pH-Wert/NN/B-NP/O ,/,/O/O moderate/NN/B-NP/O Hitze/NNP/I-NP/O und/CC/I-NP/O hypoosmotische/JJ/I-NP/O Zellschwellung/NN/I-NP/O ,/,/O/O ausgel\xc3\xb6st/NN/B-NP/O werden/VB/B-VP/O ././O/O

Erh\xc3\xb6hung/NN/B-NP/O der/DT/I-NP/O Wandschubspannung/NN/I-NP/O f\xc3\xbchrte/VB/B-VP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP untersuchten/NN/I-NP/I-PNP Gef\xc3\xa4\xc3\x9fen/NN/I-NP/I-PNP ebenfalls/VB/B-VP/O zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP TRPV4-vermittelten/NN/I-NP/I-PNP Vasodilatation/NN/I-NP/I-PNP ,/,/O/O was/WDT/O/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP mechanosensitive/NN/I-NP/I-PNP Funktion/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Kanals/NN/I-NP/I-PNP im/IN/B-PP/B-PNP vaskul\xc3\xa4ren/NN/B-NP/I-PNP System/JJ/I-NP/I-PNP hinweist/NN/I-NP/I-PNP ././O/O

Weiterf\xc3\xbchrenden/JJ/B-NP/O Untersuchungen/NN/I-NP/O am/IN/B-PP/B-PNP Hypertoniemodell/NN/B-NP/I-PNP zeigten/VB/B-VP/O eine/DT/B-NP/O verminderte/NN/I-NP/O TRPV4-Funktion/NN/I-NP/O und/CC/O/O Expression/NN/B-NP/O unter/IN/B-PP/B-PNP pathophysiologischen/JJ/B-NP/I-PNP Bedingungen/NN/I-NP/I-PNP ././O/O

Insgesamt/RB/B-VP/O konnte/VB/I-VP/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Studie/NN/I-NP/I-PNP gezeigt/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Ionenkanal/NN/I-NP/I-PNP TRPV4/NN/I-NP/I-PNP den/DT/O/O bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP endothelialen/JJ/I-NP/I-PNP Mechanotransduktion/NN/I-NP/I-PNP wichtigen/JJ/B-NP/I-PNP intrazellul\xc3\xa4ren/NN/I-NP/I-PNP Kalziumeinstrom/NN/I-NP/I-PNP erm\xc3\xb6glicht/VBN/B-VP/I-PNP und/CC/O/O somit/RB/B-ADVP/O die/DT/B-NP/O Vasoreaktion/NN/I-NP/O auf/IN/B-PP/B-PNP h\xc3\xa4modynamische/JJ/B-NP/I-PNP Ver\xc3\xa4nderungen/NN/I-NP/I-PNP regulieren/VB/B-VP/O kann/VB/I-VP/O ././O/O

Anhand/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Untersuchungen/NN/I-NP/I-PNP am/IN/B-PP/B-PNP Hypertoniemodell/NN/B-NP/I-PNP kann/VB/B-VP/O davon/RB/B-ADVP/O ausgegangen/NN/B-NP/O werden/VB/B-VP/O ,/,/O/O dass/IN/B-PP/B-PNP TRPV4/NN/B-NP/I-PNP eine/DT/I-NP/I-PNP Bedeutung/NN/I-NP/I-PNP in/IN/B-PP/O der/DT/O/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Krankheitsbild/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Hypertonie/NN/I-NP/I-PNP einhergehenden/NN/I-NP/I-PNP endothelialen/JJ/B-NP/I-PNP Dysfunktion/NN/I-NP/I-PNP zukommt.Mikroglia/NN/I-NP/I-PNP und/CC/O/O Astrozyten/NN/B-NP/O spielen/VB/B-VP/O als/IN/B-PP/B-PNP gliale/JJ/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP neben/IN/B-PP/B-PNP Neuronen/NN/B-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Pathogenese/NN/I-NP/I-PNP neurodegenerativer/NN/I-NP/I-PNP Krankheiten/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP bedeutende/JJ/I-NP/I-PNP Rolle/NN/I-NP/I-PNP und/CC/O/O gelten/VB/B-VP/O daher/RB/B-ADVP/O als/IN/B-PP/B-PNP therapeutische/JJ/B-NP/I-PNP Targets/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Untersuchung/NN/I-NP/O dieser/DT/B-NP/O Zellen/NNS/I-NP/O auf/IN/B-PP/B-PNP oxidativen/NN/B-NP/I-PNP Stress/NN/I-NP/I-PNP ,/,/O/O dessen/WDT/B-NP/O intrazellul\xc3\xa4re/JJ/I-NP/O Lokalisation/NN/I-NP/O und/CC/O/O die/DT/B-NP/O potentielle/NN/I-NP/O protektive/NN/I-NP/O Wirkung/NN/I-NP/O diverser/NN/I-NP/O Enzymhemmstoffe/NN/I-NP/O und/CC/O/O Antioxidantien/NN/B-NP/O auf/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP pathophysiologischen/JJ/I-NP/I-PNP Hintergrund/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Anoxie&slash;Reoxygenierung/NN/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O hepatischen/JJ/I-NP/O Enzephalopathie/NN/I-NP/O war/VB/B-VP/O Gegenstand/NN/B-NP/O der/DT/I-NP/O vorliegenden/JJ/I-NP/O Arbeit/NN/I-NP/O ././O/O

Die/DT/B-NP/O Anoxie/JJ/I-NP/O bewirkte/NN/I-NP/O bei/IN/B-PP/B-PNP Mikroglia/NN/B-NP/I-PNP ein/DT/I-NP/I-PNP Absinken/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Vitalit\xc3\xa4t/NN/I-NP/I-PNP ,/,/O/O der/DT/B-NP/O ATP-Produktion/NN/I-NP/O und/CC/O/O der/DT/B-NP/O Apoptose/NN/I-NP/O ././O/O

Die/DT/B-NP/O Reoxygenierung/NN/I-NP/O lie\xc3\x9f/VB/B-VP/O die/DT/B-NP/O Vitalit\xc3\xa4t/NN/I-NP/O und/CC/O/O die/DT/B-NP/O ATP-Produktion/NN/I-NP/O ansteigen/VB/B-VP/O ,/,/O/O wobei/WRB/O/O die/DT/B-NP/O Apoptose/NN/I-NP/O nur/RB/B-ADJP/O kurzfristig/JJ/I-ADJP/O erh\xc3\xb6ht/VBN/B-VP/O war/VB/I-VP/O ././O/O

Die/DT/B-NP/O Anoxie&slash;Reoxygenierungs-Inkubation/JJ/I-NP/O erzeugte/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Reoxygenierung/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP Produktion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP reaktiven/NN/B-NP/I-PNP Sauerstoff/NN/I-NP/I-PNP -/-/O/O und/CC/O/O Stickstoffspezies/RP/O/O ,/,/O/O die/DT/B-NP/O einen/DT/I-NP/O oxidativen/JJ/I-NP/O Schaden/NN/I-NP/O vor/IN/B-PP/O allem/DT/O/O an/IN/B-PP/B-PNP Proteinen/JJ/B-NP/I-PNP verursachten/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Hemmstoffe/NN/I-NP/O Oxypurinol/NN/I-NP/O ,/,/O/O Indomethacin/NN/B-NP/O ,/,/O/O L-NAME/NN/B-NP/O und/CC/I-NP/O Diphenyleniodoniumchlorid/NN/I-NP/O ,/,/O/O die/WDT/O/O jeweils/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Hemmung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Xanthinoxidase/NN/I-NP/I-PNP ,/,/O/O Cyclooxygenasen/NN/B-NP/O ,/,/O/O NO-Synthase/NN/B-NP/O ,/,/O/O und/CC/O/O NAD(P)H-Oxidase/LS/O/O eingesetzt/VBN/B-VP/O wurden/VB/I-VP/O ,/,/O/O und/CC/O/O die/DT/B-NP/O Antioxidantien/NN/I-NP/O MitoQ/NN/I-NP/O und/CC/O/O Trolox\xc2\xae/NN/B-NP/O konnten/VB/B-VP/O die/DT/B-NP/O Proteinoxidation/NN/I-NP/O deutlich/JJ/B-ADJP/O vermindern/VB/B-VP/O ././O/O

Die/DT/B-NP/O Lipidperoxidation/NN/I-NP/O ,/,/O/O obwohl/CC/O/O nicht/RB/B-ADJP/O bedeutend/JJ/I-ADJP/O erh\xc3\xb6ht/VBN/B-VP/O ,/,/O/O wurde/VB/B-VP/O durch/IN/B-PP/B-PNP Oxypurinol/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Indomethacin/NN/I-NP/I-PNP gesenkt/RP/O/O ././O/O

Die/DT/B-NP/O Vitalit\xc3\xa4t/NN/I-NP/O wurde/VB/B-VP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP beiden/DT/I-NP/I-PNP Inhibitioren/NN/I-NP/I-PNP gesteigert/VBN/B-VP/I-PNP ,/,/O/O wobei/WRB/O/O die/DT/B-NP/O Apoptose/NN/I-NP/O lediglich/RB/B-ADVP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Antioxidantien/NN/I-NP/I-PNP gemindert/NN/I-NP/I-PNP werden/VB/B-VP/O konnte/VBN/I-VP/O ././O/O

Protektive/JJ/B-NP/O Wirkungen/NN/I-NP/O der/DT/B-NP/O Enzymhemmstoffe/NN/I-NP/O und/CC/O/O der/DT/B-NP/O Antioxidantien/NN/I-NP/O wurden/RB/B-ADVP/O nachgewiesen/RP/O/O ././O/O

Die/DT/B-NP/O Xanthinoxidase/NN/I-NP/O und/CC/O/O die/DT/B-NP/O Cyclooxygenasen/NN/I-NP/O konnten/VB/B-VP/O als/IN/B-PP/B-PNP dominierende/NN/B-NP/I-PNP Produzenten/NNS/I-NP/I-PNP des/DT/I-NP/I-PNP oxidativen/NN/I-NP/I-PNP Stresses/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Pathologische/JJ/B-NP/O Ammoniakkonzentrationen/NN/I-NP/O verminderten/NN/I-NP/O geringf\xc3\xbcgig/JJ/B-ADJP/O die/DT/B-NP/O Vitalit\xc3\xa4t/NN/I-NP/O von/IN/B-PP/B-PNP Astrozyten/NN/B-NP/I-PNP und/CC/I-NP/I-PNP verursachten/NN/I-NP/I-PNP gleichzeitig/RB/B-ADVP/O ein/DT/B-NP/O Anschwellen/NN/I-NP/O der/DT/B-NP/O Zellen/NNS/I-NP/O und/CC/O/O eine/DT/B-NP/O Induktion/NN/I-NP/O der/DT/B-NP/O Apoptose/NN/I-NP/O ././O/O

Die/DT/B-NP/O Produktion/NN/I-NP/O reaktiver/NN/I-NP/O Oxidantien/NN/I-NP/O ,/,/O/O die/DT/B-NP/O Proteinoxidation/NN/I-NP/O und/CC/O/O die/DT/B-NP/O proteasomale/NN/I-NP/O Proteolyse/NN/I-NP/O wurden/VB/B-VP/O ebenfalls/RB/B-ADVP/O durch/IN/B-PP/O erh\xc3\xb6hte/VB/B-VP/O Ammoniakkonzentrationen/JJ/B-NP/O induziert/NN/I-NP/O ././O/O

Alle/DT/B-NP/O drei/CD/I-NP/O Parameter/NN/I-NP/O wurden/VB/B-VP/O sowohl/CC/O/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Hemmstoffe/NN/I-NP/I-PNP L-Methionin-Sulfoximin/NN/I-NP/I-PNP und/CC/O/O 6-Diazo-5-Oxo-L-Norleucin/NN/B-NP/O jeweils/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Glutamin-Synthetase/NN/I-NP/I-PNP und/CC/O/O die/DT/B-NP/O Glutaminase/NN/I-NP/O I/CD/O/O als/CC/O/O auch/RB/B-ADVP/O durch/IN/B-PP/B-PNP Trolox\xc2\xae/NN/B-NP/I-PNP und/CC/I-NP/I-PNP L-Ascorbins\xc3\xa4ure/NN/I-NP/I-PNP gesenkt/RP/O/O ././O/O

Die/DT/B-NP/O Wirkstoffe/NN/I-NP/O konnten/VB/B-VP/O folglich/RB/B-ADVP/O als/IN/B-PP/B-PNP protektive/NN/B-NP/I-PNP Enzymhemmstoffe/NN/I-NP/I-PNP und/CC/I-NP/I-PNP Antioxidantien/NN/I-NP/I-PNP ermittelt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Durch/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Einsatz/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Inhibitoren/NN/I-NP/I-PNP wurde/VB/B-VP/O der/DT/B-NP/O Ammoniakmetabolismus/NN/I-NP/O als/IN/B-PP/B-PNP Ursache/NN/B-NP/I-PNP des/DT/I-NP/I-PNP oxidativen/NN/I-NP/I-PNP Stresses/JJ/B-NP/I-PNP identifiziert/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Produktion/NN/I-NP/O reaktiver/NN/I-NP/O Oxidantien/NN/I-NP/O konnte/VB/B-VP/O durch/IN/B-PP/B-PNP Ammoniakbelastung/NN/B-NP/I-PNP in/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Mitochondrien-defizienten/NN/I-NP/I-PNP Zelllinie/NN/I-NP/I-PNP nicht/RB/B-ADVP/O induziert/NN/B-NP/O werden/VB/B-VP/O ././O/O

Der/DT/B-NP/O Ammoniakbelastung/NN/I-NP/O isolierter/NN/I-NP/O Mitochondrien/NN/I-NP/O folgte/VB/B-VP/O eine/DT/B-NP/O Produktion/NN/I-NP/O reaktiver/JJ/B-NP/O Oxidantien/NN/I-NP/O ././O/O

Mitochondrien/VBN/B-VP/O wurden/VB/I-VP/O daher/RB/B-ADVP/O als/IN/B-PP/B-PNP Quelle/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Ammoniak-induzierten/NN/I-NP/I-PNP ,/,/O/O oxidativen/NN/B-NP/O Stresses/NNP/I-NP/O identifiziert.Die/NNP/I-NP/O selektive/NNP/I-NP/O Darmdekontamination/NNP/I-NP/O stellt/VB/B-VP/O eine/DT/B-NP/O M\xc3\xb6glichkeit/NN/I-NP/O der/DT/B-NP/O Pr\xc3\xa4vention/NN/I-NP/O gegen\xc3\xbcber/IN/B-PP/B-PNP endogenen/NN/B-NP/I-PNP Infektionen/NN/I-NP/I-PNP dar/RP/O/O ,/,/O/O wohingegen/IN/B-PP/B-PNP bei/IN/I-PP/I-PNP einer/DT/B-NP/I-PNP akuten/JJ/I-NP/I-PNP Infektion/NN/I-NP/I-PNP Breitspektrum-Antibiotika/NN/I-NP/I-PNP eingesetzt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Studie/NN/I-NP/I-PNP wurden/VB/B-VP/O Stuhlproben/NN/B-NP/O von/IN/B-PP/B-PNP allogen/NN/B-NP/I-PNP und/CC/I-NP/I-PNP autolog/NN/I-NP/I-PNP transplantierten/NN/I-NP/I-PNP ,/,/O/O sowie/CC/O/O chemotherapierten/JJ/B-NP/O Patienten/NN/I-NP/O auf/IN/B-PP/B-PNP ihre/PRP$/B-NP/I-PNP mikrobielle/NN/I-NP/I-PNP Zusammensetzung/NN/I-NP/I-PNP analysiert/VB/B-VP/O ././O/O

Die/DT/B-NP/O Untersuchungen/NN/I-NP/O wurden/VB/B-VP/O gr\xc3\xb6\xc3\x9ftenteils/NN/B-NP/O mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP molekularer/NN/I-NP/I-PNP Methoden/NN/I-NP/I-PNP durchgef\xc3\xbchrt/VBN/B-VP/I-PNP ,/,/O/O welche/WDT/O/O auf/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Amplifikation/NN/I-NP/I-PNP ribosomaler/NN/I-NP/I-PNP Gene/JJ/B-NP/I-PNP basierten/NN/I-NP/I-PNP ././O/O

Neben/IN/B-PP/B-PNP bereits/RB/B-NP/I-PNP etablierten/JJ/I-NP/I-PNP Verfahren/NN/I-NP/I-PNP wie/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Denaturierenden/JJ/I-NP/I-PNP Gradientengelelektrophorese/NN/I-NP/I-PNP (/(/O/O DGGE/NN/B-NP/O )/)/O/O ,/,/O/O konnten/JJ/B-NP/O neue/JJ/I-NP/O Methoden/NN/I-NP/O auf/IN/B-PP/B-PNP Basis/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Denaturierenden/NN/I-NP/I-PNP High/NN/I-NP/I-PNP Performance/NN/I-NP/I-PNP Liquid/NN/I-NP/I-PNP Chromatography/NNP/I-NP/I-PNP (/(/O/O DHPLC/NN/B-NP/O )/)/O/O und/CC/O/O der/DT/B-NP/O Echtzeit-PCR/NN/I-NP/O entwickelt/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O zeigen/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O die/DT/O/O neu/JJ/B-ADJP/O entwickelten/VB/B-VP/O Methoden/NN/B-NP/O eine/DT/I-NP/O Verschiebung/NN/I-NP/O der/DT/B-NP/O Darmflora/NN/I-NP/O in/IN/B-PP/B-PNP Folge/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Antibiotikabehandlung/NN/I-NP/I-PNP zuverl\xc3\xa4ssig/JJ/B-ADJP/O anzeigen/VB/B-VP/O ././O/O

Weiterhin/RB/B-VP/O konnte/VBN/I-VP/O mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP der/DT/I-NP/I-PNP neuen/JJ/I-NP/I-PNP Verfahren/NN/I-NP/I-PNP die/DT/B-NP/I-PNP drastische/JJ/I-NP/I-PNP Reduktion/NN/I-NP/I-PNP der/DT/B-NP/I-PNP bakteriellen/JJ/I-NP/I-PNP Diversit\xc3\xa4t/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP Behandlung/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP Breitspektrum-Antibiotika/NN/B-NP/I-PNP detektiert/NN/I-NP/I-PNP und/CC/I-NP/I-PNP die/DT/I-NP/I-PNP Rekonstitution/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Darmflora/NN/I-NP/I-PNP ,/,/O/O welche/WDT/O/O durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP parenterale/NN/I-NP/I-PNP Ern\xc3\xa4hrung/NN/I-NP/I-PNP verz\xc3\xb6gert/NN/I-NP/I-PNP wurde/RB/B-ADVP/O ,/,/O/O reproduzierbar/JJ/B-ADJP/O dargestellt/VBN/B-VP/O werden/VB/I-VP/O ././O/O

In/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Proben/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP reduzierter/JJ/B-NP/I-PNP Artendiversit\xc3\xa4t/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Darmflora/NN/I-NP/I-PNP konnten/VB/B-VP/O gr\xc3\xb6\xc3\x9ftenteils/NN/B-NP/O Gram/NN/I-NP/O -/-/O/O (/(/O/O +/NN/B-NP/O )/)/O/O Bakterien/NN/B-NP/O identifiziert/NN/I-NP/O werden/VB/B-VP/O ,/,/O/O wobei/WRB/O/O die/DT/B-NP/O Anreicherung/NN/I-NP/O der/DT/O/O Spezies/RB/B-ADVP/O auf/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Resistenzspektrum/NN/I-NP/I-PNP gegen\xc3\xbcber/IN/B-PP/B-PNP den/DT/B-NP/I-PNP verwendeten/JJ/I-NP/I-PNP Antibiotika/NN/I-NP/I-PNP zur\xc3\xbcckzuf\xc3\xbchren/VB/B-VP/O war/VB/I-VP/O ././O/O

Bei/IN/B-PP/B-PNP allogen/NN/B-NP/I-PNP transplantierten/JJ/I-NP/I-PNP Patienten/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP reduzierter/JJ/B-NP/I-PNP Diversit\xc3\xa4t/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Darmflora/NN/I-NP/I-PNP konnte/VB/B-VP/O zudem/RB/B-ADVP/O eine/DT/B-NP/O erh\xc3\xb6hte/NN/I-NP/O Fallzahl/NN/I-NP/O von/IN/B-PP/B-PNP akuter/NN/B-NP/I-PNP Graft-versus-Host/JJ/I-NP/I-PNP Disease/NN/I-NP/I-PNP (/(/O/O GvHD/NN/B-NP/O )/)/O/O beobachtet/VBN/B-VP/O werden/VB/I-VP/O ,/,/O/O was/WDT/O/O auf/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP m\xc3\xb6glichen/NN/I-NP/I-PNP Einfluss/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Darmflora/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Entstehung/NN/I-NP/I-PNP dieser/DT/B-NP/I-PNP transplantationsassoziierten/NN/I-NP/I-PNP Folgeerkrankung/NN/I-NP/I-PNP hinweist.Die/NN/I-NP/I-PNP biologische/JJ/B-NP/I-PNP Forschung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP vergangenen/JJ/I-NP/I-PNP Jahre/NN/I-NP/I-PNP konzentrierte/VB/B-VP/O sich/PRP/B-NP/O im/IN/B-PP/O Wesentlichen/JJ/B-ADJP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP detaillierte/NN/I-NP/I-PNP qualitative/JJ/B-NP/I-PNP Beschreibung/NN/I-NP/I-PNP ausgew\xc3\xa4hlter/JJ/B-NP/I-PNP molekularer/JJ/I-NP/I-PNP Teilprozesse/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O technische/JJ/I-NP/O und&slash;oder/NN/I-NP/O medizinische/JJ/B-NP/O Nutzung/NN/I-NP/O dieser/DT/B-NP/O Erkenntnisse/NN/I-NP/O setzt/VB/B-VP/O jedoch/RB/B-ADVP/O ein/DT/B-NP/O ganzheitliches/JJ/I-NP/O Verst\xc3\xa4ndnis/NN/I-NP/O der/DT/B-NP/O Funktionszusammenh\xc3\xa4nge/NN/I-NP/O biologischer/JJ/B-NP/O Systeme/NN/I-NP/O voraus/RP/O/O ././O/O

Da/IN/B-PP/O dieses/DT/O/O bis/IN/B-PP/O heute/VB/B-VP/O bestenfalls/RB/B-ADVP/O im/IN/B-PP/B-PNP Ansatz/NN/B-NP/I-PNP gegeben/VBN/B-VP/I-PNP ist/VB/I-VP/O ,/,/O/O lag/VBN/B-VP/O der/DT/B-NP/O Schwerpunkt/NN/I-NP/O der/DT/B-NP/O vorliegenden/JJ/I-NP/O Arbeit/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Entwicklung/NN/I-NP/I-PNP und/CC/O/O Validierung/NN/B-NP/O von/IN/B-PP/B-PNP Analysemethoden/NN/B-NP/I-PNP zur/IN/B-PP/B-PNP quantitativen/JJ/B-NP/I-PNP und/CC/I-NP/I-PNP ganzheitlichen/JJ/I-NP/I-PNP Beschreibung/NN/I-NP/I-PNP zellul\xc3\xa4rer/JJ/B-NP/I-PNP Prozesse/NN/I-NP/I-PNP \xc3\xbcber/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP interdisziplin\xc3\xa4ren/JJ/I-NP/I-PNP Ansatz/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Methoden/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Konzepten/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Statistik/NN/I-NP/I-PNP und/CC/O/O Bioinformatik/NN/B-NP/O ././O/O

Zur/IN/B-PP/B-PNP Methodenvalidierung/NN/B-NP/I-PNP wurden/VB/B-VP/O komplexe/JJ/B-NP/O Extrakte/NN/I-NP/O pflanzlichen/JJ/B-NP/O Blattgewebes/NN/I-NP/O mittels/IN/B-PP/B-PNP GC-TOF-MS/NNP/B-NP/I-PNP und/CC/I-NP/I-PNP nano-HPLC-MS/NNP/I-NP/I-PNP in/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Vielzahl/NN/I-NP/I-PNP technischer/VB/B-VP/O und/CC/O/O biologischer/JJ/B-NP/O Replikate/NN/I-NP/O analysiert/VB/B-VP/O ,/,/O/O wobei/WRB/O/O insgesamt/RB/B-ADVP/O 80/CD/B-NP/O polare/NN/I-NP/O Metabolite/NN/I-NP/O sowie/RB/B-ADVP/O 179/CD/B-NP/O l\xc3\xb6sliche/JJ/I-NP/O Proteine/NN/I-NP/O eindeutig/JJ/B-NP/O identifiziert/NN/I-NP/O und/CC/O/O relativ/IN/B-PP/B-PNP quantifiziert/NN/B-NP/I-PNP werden/VB/B-VP/O konnten/VBN/I-VP/O ././O/O

Des/JJ/B-NP/O Weiteren/NN/I-NP/O wurden/VB/B-VP/O die/DT/O/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP diurnalen/JJ/I-NP/I-PNP Rhythmus/NN/I-NP/I-PNP verbundenen/JJ/B-NP/I-PNP \xc3\x84nderungen/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Stoffwechsels/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Arabidopsis/NN/B-NP/I-PNP thaliana/NN/I-NP/I-PNP sowie/RB/B-ADVP/O die/DT/B-NP/O Auswirkungen/NN/I-NP/O von/IN/B-PP/B-PNP Temperaturstress/NN/B-NP/I-PNP auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP pflanzlichen/JJ/I-NP/I-PNP Metabolismus/NN/I-NP/I-PNP erstmals/IN/B-PP/B-PNP integrativ/NN/B-NP/I-PNP analysiert/VB/B-VP/O ././O/O

Die/DT/B-NP/O Auswertung/NN/I-NP/O und/CC/O/O Interpretation/NN/B-NP/O der/DT/B-NP/O gewonnenen/NN/I-NP/O Metabolit/NN/I-NP/O -/-/O/O und/CC/O/O Proteindaten/NN/B-NP/O erfolgte/VBN/B-VP/O mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP bioinformatorischer/NN/I-NP/I-PNP Ans\xc3\xa4tze/NNS/I-NP/I-PNP wie/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Hauptkomponentenanalyse/NN/I-NP/I-PNP ,/,/O/O der/DT/B-NP/O unabh\xc3\xa4ngigen/NN/I-NP/O Komponentenanalyse/NN/I-NP/O oder/RB/B-ADVP/O der/DT/B-NP/O Analyse/NN/I-NP/O von/IN/B-PP/B-PNP Korrelationsnetzwerken/NN/B-NP/I-PNP ././O/O

Als/IN/B-PP/B-PNP Ergebnis/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Untersuchungen/NN/I-NP/I-PNP konnten/JJ/B-NP/I-PNP zahlreiche/JJ/I-NP/I-PNP metabolische/JJ/I-NP/I-PNP und/CC/I-NP/I-PNP proteomische/JJ/I-NP/I-PNP Marker/JJ/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP werden/VB/B-VP/O ,/,/O/O anhand/IN/B-PP/O welcher/WP/O/O der/DT/B-NP/O genetische/JJ/I-NP/O Hintergrund/NN/I-NP/O bzw./RB/B-ADVP/O ein/DT/O/O durch/IN/B-PP/B-PNP Temperaturstress/NN/B-NP/I-PNP ver\xc3\xa4nderter/JJ/I-NP/I-PNP Metabolismus/NN/I-NP/I-PNP angezeigt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Zudem/RB/B-ADVP/O erbrachte/NN/B-NP/O die/DT/B-NP/O Netzwerkanalyse/NN/I-NP/O einige/DT/B-NP/O gezielte/JJ/I-NP/O Hinweise/NN/I-NP/O auf/IN/B-PP/B-PNP in/IN/I-PP/I-PNP verschiedenen/JJ/B-ADJP/O pflanzlichen/VB/B-VP/O Spezies/IN/B-PP/B-PNP konservierte/NN/B-NP/I-PNP ,/,/O/O oder/CC/O/O infolge/IN/B-PP/B-PNP von/IN/I-PP/I-PNP Mutation/NN/B-NP/I-PNP oder/RB/B-VP/O ver\xc3\xa4nderten/VB/I-VP/O Umweltbedingungen/NN/B-NP/O deflektierte/NN/I-NP/O regulatorische/JJ/I-NP/O Mechanismen.Heterotrophe/NN/I-NP/O Bakterien/NN/I-NP/O sind/VB/B-VP/O sowohl/CC/O/O in/IN/B-PP/O nat\xc3\xbcrlichen/RB/B-ADVP/O wie/IN/B-PP/B-PNP in/IN/I-PP/I-PNP technischen/JJ/B-NP/I-PNP Systemen/NN/I-NP/I-PNP vielfach/JJ/B-NP/I-PNP oligotrophen/NN/I-NP/I-PNP Bedingungen/NN/I-NP/I-PNP ausgesetzt/VBN/B-VP/I-PNP ,/,/O/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP sie/PRP$/I-NP/I-PNP speziesspezifisch/JJ/B-ADJP/O mit/IN/B-PP/B-PNP unterschiedlichen/JJ/B-NP/I-PNP \xc3\x9cberlebensstrategien/NN/I-NP/I-PNP reagieren/VB/B-VP/O ././O/O

Eine/DT/B-NP/O m\xc3\xb6gliche/JJ/I-NP/O Reaktion/NN/I-NP/O auf/IN/B-PP/B-PNP n\xc3\xa4hrstofflimitierende/NN/B-NP/I-PNP Bedingungen/NN/I-NP/I-PNP ist/VB/B-VP/O das/DT/B-NP/O Einstellen/NN/I-NP/O der/DT/B-NP/O Zellteilung/NN/I-NP/O ,/,/O/O so/RB/B-ADVP/O dass/IN/B-PP/O die/DT/O/O zur/IN/B-PP/B-PNP Verf\xc3\xbcgung/NN/B-NP/I-PNP stehenden/JJ/I-NP/I-PNP Substrate/NN/I-NP/I-PNP haupts\xc3\xa4chlich/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Erhalt/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Zelle/NN/I-NP/I-PNP genutzt/VBN/B-VP/I-PNP werden/VB/I-VP/O (/(/O/O Erhaltungsstoffwechsel/NN/B-NP/O )/)/O/O ././O/O

Unser/PRP$/B-NP/O derzeitiges/JJ/I-NP/O Verst\xc3\xa4ndnis/NN/I-NP/O der/DT/B-NP/O Anpassungsstrategien/NN/I-NP/O entstammt/NN/I-NP/O zumeist/JJ/B-NP/O Untersuchungen/NN/I-NP/O an/IN/B-PP/B-PNP relativ/IN/I-PP/I-PNP kurzzeitigen/JJ/B-NP/I-PNP Kultivierungen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Batch/NN/B-NP/I-PNP -/-/O/O oder/CC/O/O Chemostatkulturen/NN/B-NP/O ././O/O

Diese/DT/O/O eignen/VB/B-VP/O sich/PRP/B-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Analyse/NN/I-NP/I-PNP kurzfristiger/JJ/B-NP/I-PNP Stressantworten/NN/I-NP/I-PNP und/CC/O/O deren/DT/B-NP/O Regulation/NN/I-NP/O ,/,/O/O spiegeln/VB/B-VP/O jedoch/RB/B-ADVP/O nicht/RB/I-ADVP/O die/DT/B-NP/O langfristig/JJ/I-NP/O n\xc3\xa4hrstofflimitierenden/JJ/I-NP/O Bedingungen/NN/I-NP/O wider/RP/O/O ,/,/O/O denen/WP/O/O Bakterien/NN/B-NP/O in/IN/B-PP/B-PNP ihren/PRP$/B-NP/I-PNP nat\xc3\xbcrlichen/IN/B-PP/B-PNP Habitaten/NN/B-NP/I-PNP und/CC/I-NP/I-PNP artifiziellen/NN/I-NP/I-PNP Systemen/NN/I-NP/I-PNP wie/IN/B-PP/B-PNP in/IN/I-PP/I-PNP der/DT/B-NP/I-PNP Abwasserreinigung/NN/I-NP/I-PNP ausgesetzt/VBN/B-VP/I-PNP sind/VB/I-VP/O ././O/O

In/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurden/VB/B-VP/O die/DT/B-NP/O verfahrenstechnischen/JJ/I-NP/O Voraussetzungen/NN/I-NP/O zur/IN/B-PP/B-PNP langfristigen/JJ/B-NP/I-PNP Untersuchung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP substratlimitierten/NN/B-NP/I-PNP ,/,/O/O nicht-wachsenden/NN/B-NP/O Bakterien/NNP/I-NP/O im/IN/B-PP/B-PNP Erhaltungsstoffwechsel/NN/B-NP/I-PNP geschaffen/VBN/B-VP/I-PNP und/CC/O/O das/DT/B-NP/O Wachstumsverhalten/NN/I-NP/O einer/DT/B-NP/O Reinkultur/NN/I-NP/O eines/DT/B-NP/O Escherichia/NN/I-NP/O coli/NN/I-NP/O Umweltisolates/NN/I-NP/O erstmals/VB/B-VP/O unter/IN/B-PP/B-PNP diesen/DT/B-NP/I-PNP Bedingungen/NN/I-NP/I-PNP detailliert/JJ/B-NP/I-PNP beschrieben/NN/I-NP/I-PNP und/CC/O/O dem/DT/O/O von/IN/B-PP/B-PNP langfristig/JJ/B-NP/I-PNP hungernden/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP in/IN/B-PP/B-PNP Batch-Kulturen/JJ/B-NP/I-PNP gegen\xc3\xbcbergestellt/NN/I-NP/I-PNP ././O/O

Dazu/RB/B-VP/O wurde/VB/I-VP/O ein/DT/B-NP/O Membranbioreaktorsystem/NN/I-NP/O (/(/O/O MBR/NN/B-NP/O )/)/O/O etabliert/NN/B-NP/O ,/,/O/O das/WDT/B-NP/O die/DT/I-NP/O langfristige/JJ/I-NP/O Kultivierung/NN/I-NP/O der/DT/B-NP/O Bakterien/NN/I-NP/O bei/IN/B-PP/B-PNP kontinuierlicher/JJ/B-NP/I-PNP Versorgung/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP gering/JJ/B-NP/I-PNP konzentrierten/JJ/I-NP/I-PNP N\xc3\xa4hrstoffen/NN/I-NP/I-PNP unter/IN/B-PP/B-PNP vollst\xc3\xa4ndigem/NN/B-NP/I-PNP Bakterienr\xc3\xbcckhalt/NN/I-NP/I-PNP erm\xc3\xb6glichte/VB/B-VP/O ././O/O

Die/DT/B-NP/O Bakterienpopulation/NN/I-NP/O im/IN/B-PP/B-PNP MBR/NN/B-NP/I-PNP zeigte/VB/B-VP/O nach/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP vierw\xc3\xb6chigen/NN/I-NP/I-PNP Wachstumsphase/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP gleich/JJ/I-NP/I-PNP bleibende/NN/I-NP/I-PNP Biomassekonzentration/NN/I-NP/I-PNP 6,6/CD/B-NP/I-PNP g/JJ/I-NP/I-PNP Trockengewicht/NN/I-NP/I-PNP pro/IN/B-PP/B-PNP Liter/NN/B-NP/I-PNP w\xc3\xa4hrend/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Wachstumsphase/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Batch-Kultur/NN/I-NP/I-PNP bereits/RB/B-ADVP/O nach/IN/B-PP/B-PNP wenigen/JJ/B-NP/I-PNP Tagen/NN/I-NP/I-PNP bei/IN/B-PP/O einer/DT/O/O um/IN/B-PP/B-PNP 90/CD/B-NP/I-PNP %/NN/I-NP/I-PNP geringeren/NN/I-NP/I-PNP Zellzahl/NN/I-NP/I-PNP abgeschlossen/VBN/B-VP/I-PNP war/VB/I-VP/O ././O/O

Ein/DT/B-NP/O gleich/JJ/I-NP/O bleibend/JJ/I-NP/O geringer/JJ/I-NP/O Anteil/NN/I-NP/O an/IN/B-PP/B-PNP toten/JJ/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP (/(/O/O 10/CD/B-NP/O %/NN/I-NP/O )/)/O/O ,/,/O/O ein/DT/B-NP/O geringer/JJ/I-NP/O Gehalt/NN/I-NP/O an/IN/B-PP/B-PNP mikroskopisch/JJ/B-NP/I-PNP detektierbaren/NN/I-NP/I-PNP Teilungsstadien/NN/I-NP/I-PNP sowie/RB/B-ADVP/O distinkte/NN/B-NP/O C2/NN/I-NP/O und/CC/O/O C4/NN/B-NP/O Verteilungen/NN/I-NP/O der/DT/B-NP/O DNA/NN/I-NP/O und/CC/O/O das/DT/B-NP/O Fehlen/NN/I-NP/O von/IN/B-PP/B-PNP mikroskopisch/JJ/B-NP/I-PNP sichtbaren/JJ/I-NP/I-PNP Lyseprodukten/NN/I-NP/I-PNP deuten/VB/B-VP/O auf/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP Nicht-Wachstum/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP im/IN/B-PP/B-PNP MBR/NN/B-NP/I-PNP ab/IN/B-PP/B-PNP der/DT/B-NP/I-PNP f\xc3\xbcnften/NN/I-NP/I-PNP Woche/NN/I-NP/I-PNP hin/IN/B-PP/O ././O/O

Im/IN/B-PP/B-PNP weiteren/JJ/B-NP/I-PNP Verlauf/NN/I-NP/I-PNP der/DT/B-NP/I-PNP zehnw\xc3\xb6chigen/NN/I-NP/I-PNP Kultivierung/NN/I-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O Ausbildung/NN/I-NP/O von/IN/B-PP/B-PNP Subpopulationen/NN/B-NP/I-PNP der/DT/I-NP/I-PNP nicht-wachsenden/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP mit/IN/B-PP/B-PNP unterschiedlicher/JJ/B-NP/I-PNP Aktivit\xc3\xa4t/JJ/I-NP/I-PNP observiert/NN/I-NP/I-PNP ././O/O

W\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Anteil/NN/I-NP/I-PNP vermeintlich/JJ/B-NP/I-PNP lebender/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP (/(/O/O BacLight/NN/B-NP/O )/)/O/O im/IN/B-PP/B-PNP MBR/NN/B-NP/I-PNP \xc3\xbcber/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Versuchszeitraum/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP 90/CD/B-NP/I-PNP %/NN/I-NP/I-PNP ann\xc3\xa4hernd/NN/I-NP/I-PNP konstant/JJ/B-NP/I-PNP blieb/NN/I-NP/I-PNP ,/,/O/O nahmen/VB/B-VP/O die/DT/B-NP/O Anteile/NN/I-NP/O potentiell/RB/B-ADVP/O teilungsf\xc3\xa4higer/NNP/B-NP/O Zellen/NNS/I-NP/O (/(/O/O DVC/NN/B-NP/O )/)/O/O ,/,/O/O der/DT/B-NP/O hybridisierbaren/NN/I-NP/O Zellen/NNS/I-NP/O (/(/O/O FISH/NNP/B-NP/O )/)/O/O und/CC/O/O der/DT/B-NP/O metabolisch/JJ/I-NP/O aktiven/JJ/I-NP/O Zellen/NNS/I-NP/O (/(/O/O CTC/NN/B-NP/O )/)/O/O sowie/CC/O/O der/DT/B-NP/O kultivierbaren/NN/I-NP/O Zellen/NNS/I-NP/O (/(/O/O KBE/NN/B-NP/O )/)/O/O ab/RP/O/O ././O/O

Demgegen\xc3\xbcber/RB/B-VP/O stieg/VB/I-VP/O der/DT/B-NP/O Anteil/NN/I-NP/O der/DT/B-NP/O lebensf\xc3\xa4higen/NN/I-NP/O ,/,/O/O aber/CC/O/O nicht/RB/B-ADVP/O kultivierbaren/NN/B-NP/O Zellen/NNS/I-NP/O (/(/O/O VBNC/NN/B-NP/O )/)/O/O bis/IN/B-PP/B-PNP auf/IN/I-PP/I-PNP 60/CD/B-NP/I-PNP %/NN/I-NP/I-PNP an/RP/O/O ././O/O

Der/DT/B-NP/O Batch-Ansatz/NN/I-NP/O zeigte/VB/B-VP/O einen/DT/O/O im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP zum/IN/B-PP/B-PNP MBR/NN/B-NP/I-PNP um/IN/B-PP/O gut/JJ/B-ADJP/O 50/CD/B-NP/O %/NN/I-NP/O verminderten/JJ/B-NP/O Anteil/NN/I-NP/O an/IN/B-PP/B-PNP metabolisch/JJ/B-NP/I-PNP aktiven/JJ/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP (/(/O/O CTC/NN/B-NP/O )/)/O/O ,/,/O/O wohingegen/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Anteil/NN/I-NP/I-PNP an/IN/B-PP/B-PNP kultivierbaren/NN/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP am/IN/B-PP/B-PNP Ende/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Experimentes/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Batch-Ansatz/NN/B-NP/I-PNP um/IN/B-PP/O gut/JJ/B-ADJP/O ein/DT/B-NP/O Drittel/NN/I-NP/O h\xc3\xb6her/JJ/B-ADJP/O war/VB/B-VP/O als/IN/B-PP/B-PNP im/IN/I-PP/I-PNP MBR/NN/B-NP/I-PNP ././O/O

Mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Durchflusszytometrie/NN/I-NP/I-PNP wurde/VB/B-VP/O im/IN/B-PP/B-PNP MBR/NN/B-NP/I-PNP neben/IN/B-PP/O den/DT/O/O auch/RB/B-ADVP/O im/IN/B-PP/B-PNP Batch-Ansatz/NN/B-NP/I-PNP auftretenden/NN/I-NP/I-PNP C2/NN/I-NP/I-PNP und/CC/I-NP/I-PNP C4/NN/I-NP/I-PNP Verteilungen/NN/I-NP/I-PNP der/DT/B-NP/I-PNP DNA/NN/I-NP/I-PNP ,/,/O/O eine/DT/B-NP/O Subpopulation/NN/I-NP/O von/IN/B-PP/B-PNP Zellen/NNS/B-NP/I-PNP (/(/O/O 47/CD/B-NP/O %/NN/I-NP/O )/)/O/O mit/IN/B-PP/B-PNP reduziertem/NN/B-NP/I-PNP DNA-Gehalt/NN/I-NP/I-PNP detektiert/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O im/IN/B-PP/B-PNP Batch-Ansatz/NN/B-NP/I-PNP nicht/RB/I-NP/I-PNP auftrat/NN/I-NP/I-PNP ././O/O

Weitere/JJ/B-NP/O Hinweise/NN/I-NP/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP ver\xc3\xa4nderte/NN/I-NP/I-PNP Zellphysiologie/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Bakterien/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Langzeit-Erhaltungsstoffwechsel/NN/B-NP/I-PNP lieferte/VB/B-VP/O der/DT/B-NP/O Vergleich/NN/I-NP/O der/DT/O/O mittels/IN/B-PP/B-PNP 2D-Gelelektrophorese/NN/B-NP/I-PNP bzw./RB/B-ADVP/O mittels/IN/B-PP/B-PNP MALDI-TOF/NN/B-NP/I-PNP Massenspektrometrie/NN/I-NP/I-PNP visualisierten/JJ/I-NP/I-PNP Proteinmuster/NN/I-NP/I-PNP von/IN/B-PP/B-PNP wachsenden/JJ/B-NP/I-PNP sowie/CC/I-NP/I-PNP kurzzeitig/JJ/I-NP/I-PNP und/CC/I-NP/I-PNP langfristig/JJ/I-NP/I-PNP nicht-wachsenden/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP im/IN/B-PP/B-PNP MBR/NN/B-NP/I-PNP ././O/O

Insgesamt/VBN/B-VP/O wurden/VB/I-VP/O beim/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP von/IN/B-PP/O wachsenden/JJ/B-ADJP/O und/CC/O/O nicht-wachsenden/NN/B-NP/O Zellen/NNS/I-NP/O circa/NN/I-NP/O 146/CD/B-NP/O Proteine/NN/I-NP/O und/CC/O/O beim/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP von/IN/B-PP/B-PNP kurzzeitig/JJ/B-NP/I-PNP und/CC/I-NP/I-PNP langfristig/JJ/I-NP/I-PNP nicht-wachsenden/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP circa/NN/I-NP/I-PNP 73/CD/B-NP/I-PNP Proteine/NN/I-NP/I-PNP unterschiedlich/JJ/B-NP/I-PNP exprimiert/NN/I-NP/I-PNP ././O/O

Weiterhin/RB/B-VP/O konnten/VB/I-VP/O MBR/NN/B-NP/O -/-/O/O bzw./CC/O/O Batch-spezifische/JJ/B-NP/O Proteine/NN/I-NP/O im/IN/B-PP/B-PNP niedermolekularen/JJ/B-NP/I-PNP Bereich/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP MALDI-TOF/NNP/B-NP/I-PNP MS/NNP/I-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Die/DT/O/O in/IN/B-PP/B-PNP Fra\xc3\x9fversuchen/NN/B-NP/I-PNP ermittelte/VB/B-VP/O Verwertbarkeit/NN/B-NP/O der/DT/I-NP/O Bakterien/NN/I-NP/O aus/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP MBR/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP den/DT/B-NP/I-PNP bakterivoren/NN/I-NP/I-PNP Ciliaten/NN/I-NP/I-PNP Tetrahymena/NN/I-NP/I-PNP thermophila/NN/I-NP/I-PNP war/VB/B-VP/O im/IN/B-PP/B-PNP Gegensatz/NN/B-NP/I-PNP zur/IN/B-PP/B-PNP Verwertbarkeit/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Bakterien/NN/B-NP/I-PNP aus/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Batch-Ansatz/NN/I-NP/I-PNP und/CC/O/O aus/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP \xc3\x9cbernachtkultur/NN/I-NP/I-PNP zudem/VB/B-VP/O vermindert/RP/I-VP/O ././O/O

Zusammenfassend/JJ/B-ADJP/O ist/VB/B-VP/O davon/RB/B-ADVP/O auszugehen/NN/B-NP/O ,/,/O/O dass/IN/B-PP/B-PNP nicht-wachsende/NN/B-NP/I-PNP aber/RB/B-ADVP/O kontinuierlich/RB/I-ADVP/O mit/IN/B-PP/B-PNP geringen/JJ/B-NP/I-PNP Substratkonzentrationen/NN/I-NP/I-PNP versorgte/NN/I-NP/I-PNP Bakterien/NN/I-NP/I-PNP im/IN/B-PP/B-PNP MBR/NN/B-NP/I-PNP unter/IN/B-PP/B-PNP Ausbildung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP heterogenen/NN/B-NP/I-PNP Populationen/NN/I-NP/I-PNP komplexe/JJ/I-NP/I-PNP Adaptionsstrategien/NN/I-NP/I-PNP verfolgen/VB/B-VP/O ,/,/O/O die/WDT/B-NP/O sich/PRP/I-NP/O von/IN/B-PP/B-PNP hungernden/NN/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP in/IN/B-PP/B-PNP Batch-Kulturen/NN/B-NP/I-PNP unterscheiden/VB/B-VP/O ././O/O

Die/DT/O/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP an/IN/B-PP/B-PNP Reinkulturen/NN/B-NP/I-PNP durchgef\xc3\xbchrten/JJ/I-NP/I-PNP Untersuchungen/NN/I-NP/I-PNP verdeutlichen/VB/B-VP/O die/DT/B-NP/O Vielschichtigkeit/NN/I-NP/O der/DT/B-NP/O bakteriellen/NN/I-NP/O Anpassungsm\xc3\xb6glichkeiten/NN/I-NP/O und/CC/O/O bilden/VB/B-VP/O die/DT/B-NP/O Grundlage/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP weitere/JJ/B-NP/I-PNP Untersuchungen/NN/I-NP/I-PNP und/CC/O/O das/DT/B-NP/O Verst\xc3\xa4ndnis/NN/I-NP/O der/DT/B-NP/O Vorg\xc3\xa4nge/NN/I-NP/O in/IN/B-PP/B-PNP komplexeren/NN/B-NP/I-PNP Systemen/NN/I-NP/I-PNP wie/IN/B-PP/B-PNP in/IN/I-PP/I-PNP technischen/JJ/B-NP/I-PNP MBR-Anlagen/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP Abwasserreinigung.In/NN/B-NP/I-PNP weiten/PRP$/I-NP/I-PNP Teilen/NN/I-NP/I-PNP der/DT/I-NP/I-PNP Welt/NN/I-NP/I-PNP sind/JJ/B-NP/I-PNP Millionen/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Menschen/NN/B-NP/I-PNP einer/DT/I-NP/I-PNP Exposition/NN/I-NP/I-PNP gegen\xc3\xbcber/IN/B-PP/B-PNP Arsen/NN/B-NP/I-PNP durch/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Trinkwasser/NN/I-NP/I-PNP ausgesetzt/RP/O/O ././O/O

Nach/IN/B-PP/B-PNP chronischer/NN/B-NP/I-PNP Arsenexposition/NN/I-NP/I-PNP kann/VB/B-VP/O es/PRP/B-NP/O neben/IN/B-PP/B-PNP anderen/JJ/B-NP/I-PNP Krankheiten/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Krebsentstehung/NN/I-NP/I-PNP in/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Organen/NN/I-NP/I-PNP kommen/VB/B-VP/O ././O/O

Es/PRP/B-NP/O wird/VB/B-VP/O davon/RB/B-ADVP/O ausgegangen/NN/B-NP/O ,/,/O/O dass/IN/B-PP/B-PNP vor/IN/I-PP/I-PNP allem/DT/B-NP/I-PNP die/DT/I-NP/I-PNP Induktion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP oxidativen/NN/B-NP/I-PNP DNA-Sch\xc3\xa4den/NN/I-NP/I-PNP und/CC/I-NP/I-PNP die/DT/I-NP/I-PNP Hemmung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP DNA-Reparaturprozessen/NN/B-NP/I-PNP eine/DT/I-NP/I-PNP entscheidende/JJ/I-NP/I-PNP Rolle/NN/I-NP/I-PNP in/IN/B-PP/O der/DT/O/O nach/RB/B-ADVP/O wie/IN/B-PP/O vor/RB/B-ADVP/O nicht/RB/B-NP/O vollst\xc3\xa4ndig/JJ/I-NP/O verstandenen/NN/I-NP/O arseninduzierten/NN/I-NP/O Kanzerogenese/JJ/B-NP/O spielt/NN/I-NP/O ././O/O

In/IN/B-PP/B-PNP den/DT/B-NP/I-PNP letzten/JJ/I-NP/I-PNP Jahren/NN/I-NP/I-PNP wurden/VB/B-VP/O reaktive/NN/B-NP/O methylierte/NN/I-NP/O Metabolite/NN/I-NP/O im/IN/B-PP/B-PNP menschlichen/JJ/B-NP/I-PNP Urin/NN/I-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP ,/,/O/O die/DT/B-NP/O ein/DT/I-NP/O \xc3\xa4hnliches/DT/I-NP/O oder/CC/I-NP/O sogar/RB/I-NP/O h\xc3\xb6heres/JJ/I-NP/O genotoxisches/JJ/I-NP/O Potential/NN/I-NP/O als/IN/B-PP/B-PNP das/DT/B-NP/I-PNP anorganische/JJ/I-NP/I-PNP Arsenit/NN/I-NP/I-PNP besitzen/VB/B-VP/O ././O/O

Da/IN/B-PP/B-PNP Arsen/NN/B-NP/I-PNP eine/DT/I-NP/I-PNP hohe/JJ/I-NP/I-PNP Affinit\xc3\xa4t/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP Thiolgruppen/NN/B-NP/I-PNP besitzt/NN/I-NP/I-PNP ,/,/O/O stellen/VB/B-VP/O so/RB/B-NP/O genannte/JJ/I-NP/O Zinkfingerstrukturen/NN/I-NP/O ,/,/O/O in/IN/B-PP/O denen/WP/O/O Zink/NN/B-NP/O durch/IN/B-PP/B-PNP vier/CD/B-NP/I-PNP Cystein/NNP/I-NP/I-PNP -/-/O/O und&slash;oder/NN/B-NP/O Histidin-Reste/NN/I-NP/O komplexiert/NN/I-NP/O wird/VB/B-VP/O ,/,/O/O einen/DT/B-NP/O potentiellen/JJ/I-NP/O Angriffspunkt/NN/I-NP/O dar/RP/O/O ././O/O

In/IN/B-PP/B-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurden/VB/B-VP/O daher/RB/B-ADVP/O die/DT/B-NP/O drei/CD/I-NP/O DNA-Zinkfinger-Reparaturproteine/JJ/I-NP/O Formamidopyrimidin-DNA-Glykosylase/NN/I-NP/O (/(/O/O Fpg/NN/B-NP/O )/)/O/O ,/,/O/O Xeroderma/NN/B-NP/O Pigmentosum/NNP/I-NP/O Protein/JJ/I-NP/O A/NN/I-NP/O (/(/O/O XPA/NNP/B-NP/O )/)/O/O und/CC/O/O Poly(ADP-Ribose)polymerase-1/LS/O/O (/(/O/O PARP-1/NN/B-NP/O )/)/O/O auf/IN/B-PP/B-PNP ihre/PRP$/B-NP/I-PNP Wechselwirkungen/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Arsenverbindungen/NN/B-NP/I-PNP untersucht/RP/O/O ././O/O

In/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP ersten/JJ/I-NP/I-PNP Versuch/NN/I-NP/I-PNP konnte/VB/B-VP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP bakterielle/NN/I-NP/I-PNP Fpg/NN/I-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP methylierten/NN/I-NP/I-PNP dreiwertigen/NN/I-NP/I-PNP Arsenverbindungen/NN/I-NP/I-PNP monomethylarsonige/JJ/B-NP/I-PNP S\xc3\xa4ure/NN/I-NP/I-PNP (/(/O/O MMA(III/NNP/B-NP/O )/)/O/O )/)/O/O und/CC/O/O dimethylarsinige/JJ/B-NP/O S\xc3\xa4ure/NN/I-NP/O (/(/O/O DMA(III/NNP/B-NP/O )/)/O/O )/)/O/O in/IN/B-PP/B-PNP mikromolaren/NN/B-NP/I-PNP bis/IN/B-PP/B-PNP millimolaren/JJ/B-NP/I-PNP Konzentrationen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Lage/NN/I-NP/I-PNP sind/VB/B-VP/O ,/,/O/O eine/DT/B-NP/O Hemmung/NN/I-NP/O hervorzurufen/NN/I-NP/O ,/,/O/O w\xc3\xa4hrend/IN/B-PP/B-PNP Arsenit/NN/B-NP/I-PNP und/CC/I-NP/I-PNP die/DT/I-NP/I-PNP f\xc3\xbcnfwertigen/NN/I-NP/I-PNP Metabolite/JJ/B-NP/I-PNP Monomethylarsons\xc3\xa4ure/NN/I-NP/I-PNP (/(/O/O MMA(V/NNP/B-NP/O )/)/O/O )/)/O/O und/CC/O/O Dimethylarsins\xc3\xa4ure/NN/B-NP/O (/(/O/O DMA(V/NNP/B-NP/O )/)/O/O )/)/O/O keine/JJ/B-NP/O Reaktion/NN/I-NP/O zeigten/VB/B-VP/O ././O/O

Im/IN/B-PP/B-PNP Falle/NN/B-NP/I-PNP von/IN/B-PP/B-PNP menschlichem/NNP/B-NP/I-PNP XPA/NNP/I-NP/I-PNP wurde/RB/B-VP/O untersucht/VBN/I-VP/O ,/,/O/O ob/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Arsenverbindungen/JJ/I-NP/I-PNP Zink/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP synthetischen/JJ/I-NP/I-PNP Zinkfingerdom\xc3\xa4ne/NN/I-NP/I-PNP freizusetzen/NN/I-NP/I-PNP k\xc3\xb6nnen/VB/B-VP/O ././O/O

Auch/RB/B-VP/O hier/RB/I-VP/O konnte/VB/I-VP/O ausschlie\xc3\x9flich/RB/B-ADVP/O die/DT/B-NP/O dreiwertigen/NN/I-NP/O Verbindungen/NN/I-NP/O eine/DT/B-NP/O Zinkfreisetzung/NN/I-NP/O nachgewiesen/VBN/B-VP/O werden/VB/I-VP/O ,/,/O/O wobei/WRB/O/O die/DT/B-NP/O methylierten/JJ/I-NP/O Metabolite/NN/I-NP/O in/IN/B-PP/B-PNP 10-fach/NN/B-NP/I-PNP niedrigeren/JJ/I-NP/I-PNP Konzentrationen/NN/I-NP/I-PNP reagierten/NN/I-NP/I-PNP als/IN/B-PP/B-PNP anorganisches/JJ/B-NP/I-PNP Arsenit/NN/I-NP/I-PNP ././O/O

Als/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP m\xc3\xb6glicher/JJ/I-NP/I-PNP erster/JJ/I-NP/I-PNP molekularer/JJ/I-NP/I-PNP Ansatzpunkt/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP zellul\xc3\xa4rer/NN/B-NP/I-PNP Ebene/NN/I-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O zwei/CD/I-NP/O Zinkfingerstrukturen/NN/I-NP/O enthaltende/NN/I-NP/O PARP-1/JJ/B-NP/O identifiziert/NN/I-NP/O ././O/O

Hier/RB/B-VP/O konnte/VB/I-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP Arsenit/NN/B-NP/I-PNP und/CC/I-NP/I-PNP seine/PRP$/I-NP/I-PNP dreiwertigen/NN/I-NP/I-PNP methylierten/NN/I-NP/I-PNP Metabolite/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Poly(ADP-Ribosyl)ierung/NN/I-NP/I-PNP in/IN/B-PP/O niedrigen/VB/B-VP/O nanomolaren/NN/B-NP/O Konzentrationen/NN/I-NP/O reduzieren/VB/B-VP/O ,/,/O/O w\xc3\xa4hrend/IN/B-PP/B-PNP die/DT/B-NP/I-PNP f\xc3\xbcnfwertigen/NN/I-NP/I-PNP methylierten/JJ/B-NP/I-PNP Metabolite/NN/I-NP/I-PNP bis/IN/B-PP/B-PNP zu/IN/I-PP/I-PNP einer/DT/B-NP/I-PNP Konzentration/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 500/CD/B-NP/I-PNP \xc2\xb5M/NN/I-NP/I-PNP keinen/JJ/B-NP/I-PNP Effekt/JJ/I-NP/I-PNP hervorriefen/NN/I-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP Folgenden/NN/B-NP/I-PNP konnte/VB/B-VP/O zus\xc3\xa4tzlich/JJ/B-ADJP/O gezeigt/VBN/B-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP auch/IN/I-PP/I-PNP isolierte/JJ/B-NP/I-PNP PARP-1/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP dreiwertigen/NN/I-NP/I-PNP Arsenverbindungen/NN/I-NP/I-PNP gehemmt/VBN/B-VP/I-PNP wird/VB/I-VP/O ,/,/O/O wobei/WRB/O/O die/DT/B-NP/O Hemmung/NN/I-NP/O erst/RB/B-ADVP/O in/IN/B-PP/B-PNP h\xc3\xb6heren/JJ/B-NP/I-PNP Konzentrationen/NN/I-NP/I-PNP als/IN/B-PP/B-PNP im/IN/I-PP/I-PNP zellul\xc3\xa4ren/NN/B-NP/I-PNP System/JJ/I-NP/I-PNP auftrat/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Hemmung/NN/I-NP/O der/DT/B-NP/O Poly(ADP-Ribosyl)ierung/NN/I-NP/O durch/IN/B-PP/B-PNP dreiwertige/NN/B-NP/I-PNP Arsenverbindungen/NN/I-NP/I-PNP ist/VB/B-VP/O sowohl/CC/O/O im/IN/B-PP/B-PNP zellul\xc3\xa4ren/NN/B-NP/I-PNP ,/,/O/O wie/CC/O/O auch/RB/B-ADVP/O im/IN/B-PP/B-PNP isolierten/NN/B-NP/I-PNP System/NN/I-NP/I-PNP die/DT/O/O bisher/IN/B-PP/B-PNP sensitivste/NN/B-NP/I-PNP St\xc3\xb6rung/NN/I-NP/I-PNP einer/DT/I-NP/I-PNP enzymatischen/JJ/I-NP/I-PNP Reaktion/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O direkt/JJ/B-ADJP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Reparatur/NN/I-NP/I-PNP der/DT/B-NP/I-PNP DNA/NN/I-NP/I-PNP verbunden/VBN/B-VP/I-PNP ist/VB/I-VP/O ././O/O

Die/DT/B-NP/O Hemmung/NN/I-NP/O von/IN/B-PP/B-PNP wichtigen/JJ/B-NP/I-PNP DNA-Reparaturproteinen/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Zinkfingerstrukturen/NN/B-NP/I-PNP wie/IN/B-PP/B-PNP PARP-1/NN/B-NP/I-PNP oder/RB/I-NP/I-PNP XPA/NNP/I-NP/I-PNP speziell/JJ/B-ADJP/O durch/IN/B-PP/B-PNP dreiwertige/NN/B-NP/I-PNP Arsenmetabolite/NN/I-NP/I-PNP k\xc3\xb6nnte/VB/B-VP/O damit/RB/B-ADVP/O einen/DT/B-NP/O entscheidenden/NN/I-NP/O Mechanismus/NN/I-NP/O der/DT/B-NP/O arseninduzierten/NN/I-NP/O Genotoxizit\xc3\xa4t/NN/I-NP/O und/CC/O/O damit/RB/B-ADVP/O auch/RB/I-ADVP/O der/DT/B-NP/O Kanzerogenese/NN/I-NP/O darstellen/VB/B-VP/O ././O/O

Gedruckte/JJ/B-NP/O Version/NN/I-NP/O im/IN/B-PP/B-PNP Logos/NN/B-NP/I-PNP Verlag/NN/I-NP/I-PNP Berlin/NNP/I-NP/I-PNP [/NNP/I-NP/I-PNP http:&slash;&slash;www.logos-verlag.de]erschienen.Im/NNP/I-NP/I-PNP Rahmen/NNP/I-NP/I-PNP der/DT/I-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurden/VB/B-VP/O aus/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP experimentellen/JJ/I-NP/I-PNP Infektionsversuch/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Mastgefl\xc3\xbcgel/NN/B-NP/I-PNP insgesamt/RB/B-ADVP/O 747/CD/B-NP/O verd\xc3\xa4chtige/NN/I-NP/O Yersinia/JJ/B-NP/O spp/NN/I-NP/O ././O/O

-/-/O/O St\xc3\xa4mme/NNS/B-NP/O aus/IN/B-PP/B-PNP 15/CD/B-NP/I-PNP Durchg\xc3\xa4nge/NNS/I-NP/I-PNP (/(/O/O A/NN/B-NP/O \xe2\x80\x93/NN/I-NP/O O/NN/I-NP/O )/)/O/O nicht/RB/B-ADJP/O nur/RB/I-ADJP/O biochemisch/JJ/I-ADJP/O sondern/CC/O/O auch/RB/B-ADVP/O mittels/IN/B-PP/B-PNP PCR/NN/B-NP/I-PNP -/-/O/O Verfahren/JJ/B-NP/O spezifiziert/NN/I-NP/O ././O/O

Hierbei/VBN/B-VP/O wurde/VB/I-VP/O das/DT/B-NP/O Genus/NN/I-NP/O (/(/O/O Yersinien/NN/B-NP/O )/)/O/O ,/,/O/O die/WDT/O/O Spezies/RB/B-ADVP/O (/(/O/O Yersinia/NN/B-NP/O enterocolitica/NN/I-NP/O )/)/O/O und/CC/O/O die/DT/B-NP/O Pathogenit\xc3\xa4t/NN/I-NP/O (/(/O/O yopT/NNP/B-NP/O -/-/O/O Gen/NN/B-NP/O )/)/O/O der/DT/B-NP/O Feldst\xc3\xa4mme/NN/I-NP/O mittels/IN/B-PP/B-PNP Multiplex/NN/B-NP/I-PNP -/-/O/O PCR/NN/B-NP/O -/-/O/O Verfahren/NN/B-NP/O ermittelt/RP/O/O ././O/O

Die/DT/B-NP/O PCR/NN/I-NP/O -/-/O/O Ergebnisse/NN/B-NP/O zeigten/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O 596/CD/O/O (/(/O/O 79,8%/CD/O/O )/)/O/O Isolate/NN/B-NP/O als/IN/B-PP/B-PNP Yersinia/NN/B-NP/I-PNP -/-/O/O negativ/JJ/B-ADJP/O ,/,/O/O 130/CD/O/O (/(/O/O 17,4%/CD/O/O )/)/O/O Isolate/NN/B-NP/O als/IN/B-PP/B-PNP Y./JJ/B-NP/I-PNP enterocolitica/NN/I-NP/I-PNP (/(/O/O yopT/NNP/B-NP/O +/NNP/I-NP/O )/)/O/O und/CC/O/O 21/CD/O/O (/(/O/O 2,8%/CD/O/O )/)/O/O Isolate/NN/B-NP/O als/IN/B-PP/B-PNP Yersinia/JJ/B-NP/I-PNP enterocolitica/NN/I-NP/I-PNP (/(/O/O yopT/NNP/B-NP/O -/-/O/O )/)/O/O anzusehen/VB/B-VP/O waren/VB/I-VP/O ././O/O

Die/DT/B-NP/O meiste/NN/I-NP/O Yersinia/NN/I-NP/O enterocolitica/NN/I-NP/O -/-/O/O positive/JJ/B-NP/O St\xc3\xa4mme/NNS/I-NP/O wurden/VB/B-VP/O 2/CD/O/O ././O/O

bis/IN/B-PP/O 10/CD/O/O ././O/O

Tag/JJ/B-NP/O post/NN/I-NP/O infectionem/NN/I-NP/O gefunden/RP/O/O ././O/O

Ab/IN/B-PP/O dem/DT/O/O 12/CD/O/O ././O/O

Tag/JJ/B-NP/O post/NN/I-NP/O infectionem/NN/I-NP/O wurden/VB/B-VP/O keine/JJ/B-NP/O Yersinia/JJ/I-NP/O spp/NN/I-NP/O ././O/O

-/-/O/O St\xc3\xa4mme/NNS/B-NP/O identifiziert/NN/I-NP/O ././O/O

Insgesamt/VBN/B-VP/O wurden/VB/I-VP/O 130/CD/B-NP/O Yersinia/JJ/I-NP/O spp/NN/I-NP/O ././O/O

-/-/O/O Isolate/NN/B-NP/O (/(/O/O yopT/NNP/B-NP/O +/NNP/I-NP/O )/)/O/O und/CC/O/O 21/CD/B-NP/O Isolate/NN/I-NP/O (/(/O/O yopT/NNP/B-NP/O -/-/O/O )/)/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Feintypisierung/NN/I-NP/I-PNP mittels/IN/B-PP/B-PNP PFGE/NN/B-NP/I-PNP -/-/O/O und/CC/O/O AFLP/NNP/B-NP/O -/-/O/O Methode/JJ/B-NP/O ausgew\xc3\xa4hlt/NN/I-NP/O ././O/O

Als/IN/B-PP/B-PNP Referenzstamm/NN/B-NP/I-PNP wurden/VB/B-VP/O wie/IN/B-PP/B-PNP bei/IN/I-PP/I-PNP der/DT/B-NP/I-PNP PCR/NN/I-NP/I-PNP -/-/O/O Methode/NN/B-NP/O die/DT/I-NP/O Yersinia/NN/I-NP/O enterocolitica/NN/I-NP/O DSM/NN/I-NP/O 13030/CD/O/O (/(/O/O 4&slash;O:3/NN/B-NP/O )/)/O/O benutzt/RP/O/O ././O/O

Zus\xc3\xa4tzlich/VBN/B-VP/O wurden/VB/I-VP/O drei/CD/B-NP/O Yersinia/NN/I-NP/O enterocolitica/NN/I-NP/O -/-/O/O St\xc3\xa4mme/NNS/B-NP/O unterschiedlicher/JJ/I-NP/O Bioserotypen/NN/I-NP/O (/(/O/O 4&slash;O:3/NN/B-NP/O yopT/NNP/I-NP/O -/-/O/O negativ/JJ/B-ADJP/O ;/:/O/O O:5,27/NN/B-NP/O ;/:/O/O 1A&slash;O:7,8)/LS/O/O und/CC/O/O Yersinia/JJ/B-NP/O pseudotuberculosis/NN/I-NP/O (/(/O/O ATCC/NN/B-NP/O 29833/CD/O/O )/)/O/O mitgef\xc3\xbchrt/NN/B-NP/O um/IN/B-PP/B-PNP die/DT/B-NP/I-PNP genotypische/JJ/I-NP/I-PNP Unterschiede/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Referenzst\xc3\xa4mmen/NN/I-NP/I-PNP und/CC/O/O innerhalb/IN/B-PP/O der/DT/O/O Spezies/IN/B-PP/B-PNP Yersinia/NN/B-NP/I-PNP enterocolitica/NN/I-NP/I-PNP zu/TO/B-VP/O untersuchen/VB/I-VP/O ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O der/DT/B-NP/O PFGE/NN/I-NP/O -/-/O/O und/CC/O/O AFLP/NNP/B-NP/O -/-/O/O Typisierung/NN/B-NP/O von/IN/B-PP/B-PNP Referenzst\xc3\xa4mmen/NN/B-NP/I-PNP zeigten/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O es/PRP/B-NP/O mittels/IN/B-PP/B-PNP beider/JJ/B-NP/I-PNP Methoden/NN/I-NP/I-PNP m\xc3\xb6glich/JJ/B-ADJP/O war/VB/B-VP/O ,/,/O/O innerhalb/IN/B-PP/O der/DT/O/O Spezies/IN/B-PP/B-PNP Yersinia/NN/B-NP/I-PNP enterocolitica/NN/I-NP/I-PNP die/DT/I-NP/I-PNP Bioserotypen/NN/I-NP/I-PNP voneinander/NN/I-NP/I-PNP zu/TO/B-VP/O unterscheiden/VB/I-VP/O ././O/O

Hierbei/RB/B-VP/O konnte/VB/I-VP/O festgestellt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Profil/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Bandenmuster/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Yersinia/NN/B-NP/I-PNP enterocolitica/NN/I-NP/I-PNP -/-/O/O St\xc3\xa4mmen/NN/B-NP/O des/DT/I-NP/O Bioserovars/NN/I-NP/O 4&slash;O:3/VB/B-VP/O sich/PRP/B-NP/O zu/TO/O/O 83,3/CD/O/O bis/IN/B-PP/B-PNP 87%/CD/B-NP/I-PNP \xc3\xa4hnelte/NN/I-NP/I-PNP ././O/O

Alle/JJ/B-NP/O Yersinia/JJ/I-NP/O spp/NN/I-NP/O ././O/O

-/-/O/O St\xc3\xa4mme/NNS/B-NP/O ,/,/O/O die/WDT/O/O in/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Versuchstagen/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Infektion/NN/I-NP/I-PNP isoliert/NN/I-NP/I-PNP wurden/VB/B-VP/O ,/,/O/O wiesen/VB/B-VP/O eine/DT/B-NP/O enge/JJ/I-NP/O genetische/JJ/I-NP/O Verwandtschaft/NN/I-NP/O zum/IN/B-PP/B-PNP Yersinia/JJ/B-NP/I-PNP enterocolitica/NN/I-NP/I-PNP (/(/O/O DSM/NN/B-NP/O 13030/CD/O/O )/)/O/O -/-/O/O Stamm/NN/B-NP/O auf/RP/O/O und/CC/O/O wurden/VB/B-VP/O aus/IN/B-PP/B-PNP diesem/DT/B-NP/I-PNP Grund/NN/I-NP/I-PNP als/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP Genotyp/NN/I-NP/I-PNP bezeichnet/RP/O/O ././O/O

Die/DT/B-NP/O Bandenmuster/NN/I-NP/O -/-/O/O \xc3\x84hnlichkeit/NN/B-NP/O der/DT/I-NP/O Yersinia/JJ/I-NP/O spp/NN/I-NP/O ././O/O

-/-/O/O St\xc3\xa4mme/NNS/B-NP/O betrug/VB/B-VP/O bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP PFGE/NN/I-NP/I-PNP -/-/O/O Methode/NN/B-NP/O (/(/O/O 91,7/CD/B-NP/O \xe2\x80\x93/NN/I-NP/O 100%/CD/O/O )/)/O/O und/CC/O/O bei/IN/B-PP/B-PNP AFLP/NNP/B-NP/I-PNP -/-/O/O Methode/NN/B-NP/O (/(/O/O 90,1/CD/B-NP/O \xe2\x80\x93/NN/I-NP/O 99,8%/CD/O/O )/)/O/O ././O/O

Die/DT/B-NP/O PFGE/NN/I-NP/O -/-/O/O und/CC/O/O AFLP/NNP/B-NP/O -/-/O/O Untersuchungen/NN/B-NP/O zeigten/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O der/DT/O/O im/IN/B-PP/B-PNP Tierversuch/NN/B-NP/I-PNP eingesetzte/NN/I-NP/I-PNP Yersinia/NN/I-NP/I-PNP enterocolitica/NN/I-NP/I-PNP DSM/NN/I-NP/I-PNP 13030/CD/O/O -/-/O/O Stamm/NN/B-NP/O in/IN/B-PP/B-PNP allen/JJ/B-NP/I-PNP Isolaten/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O mittels/IN/B-PP/B-PNP PCR/NN/B-NP/I-PNP best\xc3\xa4tigt/VBN/B-VP/I-PNP wurden/VB/I-VP/O ,/,/O/O wieder/RB/B-VP/O zu/TO/I-VP/O finden/VB/I-VP/O war/VB/I-VP/O ././O/O

Mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP beiden/DT/I-NP/I-PNP Methoden/NN/I-NP/I-PNP wurden/VB/B-VP/O genetische/JJ/B-NP/O Fingerabdr\xc3\xbccke/NN/I-NP/O der/DT/B-NP/O Isolate/NN/I-NP/O hergestellt/VBN/B-VP/O ,/,/O/O die/WDT/B-NP/O sich/PRP/I-NP/O in/IN/B-PP/B-PNP ihrer/PRP$/B-NP/I-PNP diskriminierenden/NN/I-NP/I-PNP Aussagekraft/NN/I-NP/I-PNP unterschieden/RP/O/O ././O/O

Beide/JJ/B-NP/O Typisierungsmethoden/JJ/I-NP/O basierten/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Darstellung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Teilen/NN/B-NP/I-PNP (/(/O/O Fragmenten/NN/B-NP/O )/)/O/O des/DT/B-NP/O gesamten/JJ/I-NP/O Genoms/NN/I-NP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Vergleich/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Bandenmuster/NN/I-NP/I-PNP wurden/VB/B-VP/O bei/IN/B-PP/B-PNP beiden/DT/B-NP/I-PNP Methoden/NN/I-NP/I-PNP die/DT/B-NP/I-PNP cut/NN/I-NP/I-PNP -/-/O/O off/NN/B-NP/O -/-/O/O Werte/NN/B-NP/O der/DT/I-NP/O Auswertungs/NN/I-NP/O -/-/O/O Software/NN/B-NP/O bei/IN/B-PP/O 90%/CD/O/O festgelegt/RP/O/O ././O/O

Alle/JJ/B-NP/O Isolate/NN/I-NP/O die/DT/B-NP/O eine/DT/I-NP/O \xc3\x84hnlichkeit/NN/I-NP/O von/IN/B-PP/O mehr/RB/B-ADVP/O als/IN/B-PP/B-PNP \xef\x80\xa090%/NN/B-NP/I-PNP zeigten/JJ/B-ADJP/O ,/,/O/O wurden/VB/B-VP/O als/IN/B-PP/O genetisch/JJ/B-ADJP/O eng/JJ/I-ADJP/O miteinander/RB/I-ADJP/O verwandt/JJ/I-ADJP/O bezeichnet/VB/B-VP/O (/(/O/O klonal/NN/B-NP/O )/)/O/O ././O/O

Der/DT/B-NP/O Vergleich/NN/I-NP/O der/DT/B-NP/O beiden/DT/I-NP/O Methoden/NN/I-NP/O miteinander/JJ/B-ADJP/O zeigte/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O die/DT/B-NP/O AFLP/NNP/I-NP/O -/-/O/O Methode/NN/B-NP/O aufgrund/IN/B-PP/B-PNP h\xc3\xb6herer/JJ/B-NP/I-PNP Diskriminierungsst\xc3\xa4rke/NN/I-NP/I-PNP ,/,/O/O ihrem/PRP$/B-NP/O geringen/JJ/I-NP/O zeitlichen/JJ/I-NP/O Aufwand/NN/I-NP/O ,/,/O/O ihrer/PRP$/B-NP/O sehr/RB/I-NP/O guten/JJ/I-NP/O Reproduzierbarkeit/NN/I-NP/O und/CC/O/O besseren/JJ/B-NP/O Handhabung/NN/I-NP/O eine/DT/B-NP/O hervorragende/JJ/I-NP/O Methode/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Genotypisierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Yersinia/JJ/B-NP/I-PNP spp/NN/I-NP/I-PNP ././O/O

-/-/O/O St\xc3\xa4mmen/NN/B-NP/O darstellt.Das/VB/B-VP/O Bakterium/NN/B-NP/O Sinorhizobium/NN/I-NP/O meliloti/NN/I-NP/O ,/,/O/O welches/WDT/O/O symbiontisch/JJ/B-ADJP/O mit/IN/B-PP/B-PNP Leguminosen/NN/B-NP/I-PNP Stickstoff-fixierende/NN/I-NP/I-PNP Wurzelkn\xc3\xb6llchen/JJ/B-ADJP/O bilden/VB/B-VP/O kann/VB/I-VP/O ,/,/O/O besitzt/NN/B-NP/O au\xc3\x9fer/IN/B-PP/B-PNP den/DT/B-NP/I-PNP typischen/JJ/I-NP/I-PNP Phosphor-haltigen/NN/I-NP/I-PNP Membranlipiden/NN/I-NP/I-PNP auch/VB/B-VP/O die/DT/B-NP/O Phosphor-freien/NN/I-NP/O Membran-bildenden/NN/I-NP/O Lipide/NN/I-NP/O Sulfolipid/NN/I-NP/O ,/,/O/O Ornithinlipid/NN/B-NP/O und/CC/I-NP/O Diacylglycerol-N,N,N-Trimethylhomoserin/NN/I-NP/O (/(/O/O DGTS/NNP/B-NP/O )/)/O/O ././O/O

Diese/DT/B-NP/O Phosphor-freien/NN/I-NP/O Membranlipide/NN/I-NP/O werden/VB/B-VP/O verst\xc3\xa4rkt/VB/I-VP/O (/(/O/O Sulfolipid/NN/B-NP/O und/CC/I-NP/O Ornithinlipid/NN/I-NP/O )/)/O/O oder/CC/O/O ausschlie\xc3\x9flich/RB/B-ADVP/O (/(/O/O DGTS/NNP/B-NP/O )/)/O/O unter/IN/B-PP/B-PNP Phosphat-limitierenden/JJ/B-NP/I-PNP Wachstumsbedingungen/NN/I-NP/I-PNP anstelle/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Phospholipide/NN/I-NP/I-PNP gebildet/RP/O/O ././O/O

Da/IN/B-PP/B-PNP \xc3\xbcber/IN/I-PP/I-PNP die/DT/B-NP/I-PNP Funktion/NN/I-NP/I-PNP dieser/DT/B-NP/I-PNP ungew\xc3\xb6hnlichen/JJ/I-NP/I-PNP Phosphor-freien/JJ/I-NP/I-PNP Membranlipide/NN/I-NP/I-PNP von/IN/B-PP/O S./VB/B-VP/O meliloti/NN/B-NP/O bisher/RB/B-VP/O nichts/RB/I-VP/O bekannt/VBN/I-VP/O war/VB/I-VP/O ,/,/O/O sollte/MD/B-VP/O gekl\xc3\xa4rt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O ob/IN/B-PP/B-PNP diese/WDT/B-NP/I-PNP Lipide/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP Rolle/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Ausbildung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Wurzelkn\xc3\xb6llchensymbiose/NN/I-NP/I-PNP spielen/VB/B-VP/O ././O/O

Da/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Bildung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP DGTS/NNP/B-NP/I-PNP nur/RB/B-VP/O erfolgt/VB/I-VP/O ,/,/O/O wenn/RB/B-ADVP/O ein/DT/B-NP/O funktioneller/NN/I-NP/O PhoB-Regulator/NN/I-NP/O im/IN/B-PP/B-PNP Bakterium/NN/B-NP/I-PNP vorhanden/JJ/B-ADJP/O ist/VB/B-VP/O und/CC/O/O da/RB/B-ADVP/O PhoB-defiziente/NN/B-NP/O Mutanten/NN/I-NP/O immer/VB/B-VP/O noch/IN/B-PP/B-PNP Stickstoff-fixierende/NN/B-NP/I-PNP Kn\xc3\xb6llchen/NN/I-NP/I-PNP bilden/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ,/,/O/O scheint/VB/B-VP/O DGTS/NNP/B-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP symbiontische/JJ/I-NP/I-PNP Lebensweise/NN/I-NP/I-PNP von/IN/B-PP/O S./VB/B-VP/O meliloti/NN/B-NP/O nicht/RB/B-ADVP/O von/IN/B-PP/B-PNP Bedeutung/NN/B-NP/I-PNP zu/TO/B-VP/O sein/VB/I-VP/O ././O/O

Die/DT/B-NP/O Isolierung/NN/I-NP/O der/DT/O/O an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Sulfolipid-Biosynthese/NN/I-NP/I-PNP beteiligten/VB/B-VP/O Gene/NN/B-NP/O (/(/O/O sqdB/NN/B-NP/O ,/,/O/O sqdC/NN/B-NP/O ,/,/O/O sqdD/NN/B-NP/O )/)/O/O aus/IN/B-PP/O S./VB/B-VP/O meliloti/NN/B-NP/O zeigte/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O diese/WDT/B-NP/O Gene/NN/I-NP/O bakteriellen/NN/I-NP/O Ursprungs/NN/I-NP/O sind/VB/B-VP/O und/CC/O/O nicht/RB/B-ADVP/O durch/IN/B-PP/B-PNP horizontalen/JJ/B-NP/I-PNP Gentransfer/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Wirtspflanzen/NN/B-NP/I-PNP erhalten/VBN/B-VP/I-PNP wurden/VB/I-VP/O ././O/O

Die/DT/B-NP/O Inaktivierung/NN/I-NP/O des/DT/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Sulfolipid-Biosynthese/NN/I-NP/I-PNP essentiellen/NN/I-NP/I-PNP sqdB-Gens/NN/I-NP/I-PNP f\xc3\xbchrte/VB/B-VP/O zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Sulfolipid-defizienten/NN/I-NP/I-PNP Mutante/NN/I-NP/I-PNP ,/,/O/O die/DT/B-NP/O Wachstumseigenschaften/NN/I-NP/O wie/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Wildtyp/NN/I-NP/I-PNP besa\xc3\x9f/NN/I-NP/I-PNP und/CC/O/O auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Wirtspflanzen/NN/I-NP/I-PNP Alfalfa/NN/I-NP/I-PNP genauso/VB/B-VP/O gut/JJ/B-NP/O Stickstoff-fixierende/NN/I-NP/O Kn\xc3\xb6llchen/NN/I-NP/O bilden/VB/B-VP/O konnte/VB/I-VP/O wie/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Wildtyp/NN/I-NP/I-PNP ././O/O

Komplementierung/NN/B-NP/O chemischer/JJ/I-NP/O Ornithinlipid-defizienter/JJ/I-NP/O Mutanten/NN/I-NP/O mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP sinorhizobiellen/NN/I-NP/I-PNP Genbank/NN/I-NP/I-PNP f\xc3\xbchrten/VB/B-VP/O zur/IN/B-PP/B-PNP Identifizierung/NN/B-NP/I-PNP der/DT/O/O an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Ornithinlipid-Biosynthese/NN/I-NP/I-PNP beteiligten/VB/B-VP/O Gene/NN/B-NP/O olsA/NNP/I-NP/O und/CC/I-NP/O olsB/NNP/I-NP/O ././O/O

Eine/DT/B-NP/O sinorhizobielle/NN/I-NP/O OlsA-inaktivierte/NN/I-NP/O Mutante/NN/I-NP/O besa\xc3\x9f/NN/I-NP/O Wachstumseigenschaften/NN/I-NP/O wie/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Wildtyp/NN/I-NP/I-PNP und/CC/O/O konnte/VB/B-VP/O auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Wirtspflanzen/NN/I-NP/I-PNP Alfalfa/NN/I-NP/I-PNP genauso/VB/B-VP/O gut/JJ/B-NP/O Stickstoff-fixierende/NN/I-NP/O Kn\xc3\xb6llchen/NN/I-NP/O bilden/VB/B-VP/O wie/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Wildtyp/NN/I-NP/I-PNP ././O/O

Weitere/DT/B-NP/O Befunde/NNS/I-NP/O lie\xc3\x9fen/NN/I-NP/O zudem/VB/B-VP/O vermuten/VB/I-VP/O ,/,/O/O dass/RB/B-ADVP/O OlsB/NN/B-NP/O f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP N-Acyltransferase/NN/I-NP/I-PNP codiert/NN/I-NP/I-PNP ,/,/O/O welche/WDT/B-NP/O die/DT/I-NP/O Kondensation/NN/I-NP/O einer/DT/B-NP/O 3-Hydroxyfetts\xc3\xa4ure/NN/I-NP/O an/IN/B-PP/B-PNP Ornithin/NN/B-NP/I-PNP unter/IN/B-PP/B-PNP Bildung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Lyso-Ornithinlipid/NN/B-NP/I-PNP katalysiert/NN/I-NP/I-PNP ,/,/O/O w\xc3\xa4hrend/IN/B-PP/B-PNP OlsA/NNP/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP O-Acyltransferase/NN/I-NP/I-PNP codiert/NN/I-NP/I-PNP ,/,/O/O welche/WDT/B-NP/O die/DT/I-NP/O Umwandlung/NN/I-NP/O von/IN/B-PP/B-PNP Lyso-Ornithinlipid/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Ornithinlipid/NN/B-NP/I-PNP vermittelt/VB/B-VP/O ././O/O

Da/IN/B-PP/B-PNP keines/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Phosphor-freien/JJ/I-NP/I-PNP Membranlipide/NN/I-NP/I-PNP (/(/O/O Sulfolipid/NN/B-NP/O ,/,/O/O Ornithinlipid/NN/B-NP/O oder/RB/I-NP/O DGTS/NNP/I-NP/O )/)/O/O von/IN/B-PP/O S./VB/B-VP/O meliloti/JJ/B-NP/O essentiell/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Ausbildung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Wurzelkn\xc3\xb6llchensymbiose/NN/I-NP/I-PNP ist/VB/B-VP/O ,/,/O/O vermuten/VB/B-VP/O wir/PRP/B-NP/O ,/,/O/O dass/IN/B-PP/B-PNP diese/WDT/B-NP/I-PNP Lipide/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP wichtige/JJ/I-NP/I-PNP Funktion/NN/I-NP/I-PNP beim/IN/B-PP/B-PNP \xc3\x9cberleben/NN/B-NP/I-PNP unter/IN/B-PP/B-PNP Phosphatmangelbedingungen/NN/B-NP/I-PNP ,/,/O/O wie/IN/B-PP/O sie/JJ/B-ADJP/O in/IN/B-PP/B-PNP B\xc3\xb6den/NN/B-NP/I-PNP h\xc3\xa4ufig/JJ/B-ADJP/O herrschen/VB/B-VP/O ,/,/O/O spielen.Infektionen/NN/B-NP/O mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP \xce\xb2-Herpesviren/NN/I-NP/I-PNP humanes/JJ/B-NP/I-PNP Cytomegalievirus/NN/I-NP/I-PNP (/(/O/O HCMV/NNP/B-NP/O )/)/O/O und/CC/O/O humanes/JJ/B-NP/O Herpesvirus-6/NN/I-NP/O (/(/O/O HHV-6/NN/B-NP/O )/)/O/O sind/NN/B-NP/O mit/IN/B-PP/B-PNP bis/IN/I-PP/I-PNP zu/IN/I-PP/I-PNP 90/CD/B-NP/I-PNP %/NN/I-NP/I-PNP Seroposititvit\xc3\xa4t/NN/I-NP/I-PNP aller/JJ/B-NP/I-PNP Erwachsenen/NN/I-NP/I-PNP sehr/RB/B-ADJP/O weit/JJ/I-ADJP/O verbreitet/JJ/I-ADJP/O ././O/O

ie/PRP/B-NP/O verlaufen/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Regel/NN/I-NP/I-PNP asymptomatisch/JJ/B-ADJP/O ,/,/O/O k\xc3\xb6nnen/VB/B-VP/O jedoch/RB/B-ADVP/O bei/IN/B-PP/B-PNP immunsupprimierten/NN/B-NP/I-PNP Patienten/NN/I-NP/I-PNP zum/IN/B-PP/B-PNP Teil/NN/B-NP/I-PNP lebensbedrohliche/JJ/I-NP/I-PNP Erkrankungen/NNS/I-NP/I-PNP hervorrufen/VB/B-VP/O ,/,/O/O z.B./IN/B-PP/B-PNP Entz\xc3\xbcndungen/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Lunge/NN/I-NP/I-PNP ,/,/O/O des/DT/B-NP/O Gehirns/NN/I-NP/O oder/RB/B-ADVP/O der/DT/B-NP/O Netzhaut/NN/I-NP/O ././O/O

Gegenw\xc3\xa4rtig/VBN/B-VP/O werden/VB/I-VP/O verschiedene/JJ/B-NP/O antiherpale/NN/I-NP/O Medikamente/NNS/I-NP/O verwendet/VB/B-VP/O ,/,/O/O die/DT/B-NP/O partiell/JJ/I-NP/O ernsthafte/JJ/I-NP/O Nebenwirkungen/NN/I-NP/O hervorrufen/VB/B-VP/O ././O/O

Au\xc3\x9ferdem/RB/B-VP/O ist/VB/I-VP/O die/DT/B-NP/O Verbreitung/NN/I-NP/O resistenter/NN/I-NP/O St\xc3\xa4mme/NNS/I-NP/O zu/TO/B-VP/O beobachten/VB/I-VP/O ././O/O

Daher/RB/B-VP/O existiert/VB/I-VP/O ein/DT/B-NP/O verst\xc3\xa4rktes/JJ/I-NP/O Interesse/NN/I-NP/O an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Entwicklung/NN/I-NP/I-PNP neuartiger/NNP/I-NP/I-PNP antiviraler/NNP/I-NP/I-PNP Substanzen/NNS/I-NP/I-PNP ././O/O

Naturstoffe/RB/B-VP/O spielen/VB/I-VP/O dabei/RB/B-ADVP/O wegen/IN/B-PP/B-PNP ihrer/PRP$/B-NP/I-PNP gro\xc3\x9fen/JJ/I-NP/I-PNP Strukturvielfalt/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP zentrale/JJ/I-NP/I-PNP Rolle/NN/I-NP/I-PNP ,/,/O/O wobei/WRB/O/O Verbindungen/NN/B-NP/O aus/IN/B-PP/O aquatischen/VB/B-VP/O ,/,/O/O phototrophen/JJ/B-NP/O Mikroorganismen/NN/I-NP/O (/(/O/O pMO/NNP/B-NP/O ,/,/O/O Mikroalgen/NN/B-NP/O und/CC/I-NP/O Cyanobakterien/NN/I-NP/O )/)/O/O ,/,/O/O ein/DT/B-NP/O bisher/RB/I-NP/O unzureichend/JJ/I-NP/O genutztes/NN/I-NP/O Potential/NN/I-NP/O darstellen/VB/B-VP/O ././O/O

Die/DT/B-NP/O vorliegende/JJ/I-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O Teil/NN/B-NP/O eines/DT/I-NP/O Projektes/NN/I-NP/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Ziel/NN/I-NP/I-PNP ,/,/O/O antivirale/NN/B-NP/O Substanzen/NNS/I-NP/O aus/IN/B-PP/B-PNP pMO/NNP/B-NP/I-PNP zu/TO/B-VP/O identifizieren/VB/I-VP/O und/CC/O/O zu/TO/B-VP/O isolieren/VB/I-VP/O ././O/O

Die/DT/B-NP/O Substanzen/NNS/I-NP/O wurden/VB/B-VP/O aus/IN/B-PP/B-PNP monoseptischen/JJ/B-NP/I-PNP pMO-Kulturen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP sterilisierbaren/NN/B-NP/I-PNP Photobioreaktoren/NN/I-NP/I-PNP aufgearbeitet/NN/I-NP/I-PNP ,/,/O/O ihre/PRP$/B-NP/O chemische/JJ/I-NP/O Struktur/NN/I-NP/O bestimmt/VBN/B-VP/O und/CC/O/O im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP der/DT/I-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP hinsichtlich/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP antiviralen/JJ/I-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP gegen\xc3\xbcber/IN/B-PP/B-PNP HCMV/NNP/B-NP/I-PNP getestet/NNP/I-NP/I-PNP ././O/O

Antiviral/NN/B-NP/O aktive/JJ/I-NP/O Substanzen/NNS/I-NP/O wurden/VB/B-VP/O ferner/RB/B-ADVP/O hinsichtlich/IN/B-PP/B-PNP ihrer/PRP$/B-NP/I-PNP Wirkungsweise/NN/I-NP/I-PNP untersucht/RP/O/O ././O/O

Zun\xc3\xa4chst/VBN/B-VP/O wurden/VB/I-VP/O die/DT/B-NP/O Screeningmethoden/NN/I-NP/O zur/IN/B-PP/B-PNP Bestimmung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Zellvitalit\xc3\xa4t/NN/I-NP/I-PNP von/IN/B-PP/B-PNP MRC-5-Fibroblasten/NN/B-NP/I-PNP (/(/O/O WST-1-Test/NN/B-NP/O )/)/O/O und/CC/O/O der/DT/B-NP/O anti-HCMV-Aktivit\xc3\xa4t/NN/I-NP/O (/(/O/O Peroxidasef\xc3\xa4rbung/NN/B-NP/O viraler/NN/I-NP/O Antigene/NN/I-NP/O )/)/O/O etabliert/NN/B-NP/O und/CC/O/O mit/IN/B-PP/O dem/DT/O/O bei/IN/B-PP/B-PNP HCMV-Infektionen/NN/B-NP/I-PNP klinisch/JJ/I-NP/I-PNP eingesetzten/NN/I-NP/I-PNP Basenanalogon/NNP/I-NP/I-PNP Ganciclovir/NNP/I-NP/I-PNP (/(/O/O GCV/NNP/B-NP/O )/)/O/O als/IN/B-PP/B-PNP Referenzsubstanz/JJ/B-NP/I-PNP getestet/NN/I-NP/I-PNP ././O/O

Im/IN/B-PP/O entwickelten/VB/B-VP/O Screeningsystem/NN/B-NP/O inhibiert/NN/I-NP/O es/PRP/I-NP/O bei/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Konzentration/NN/I-NP/I-PNP von/IN/B-PP/O etwa/RB/B-ADVP/O 6/CD/B-NP/O mg&slash;ml/NN/I-NP/O die/DT/B-NP/O Zellvitalit\xc3\xa4t/NN/I-NP/O um/IN/B-PP/B-PNP 50/CD/B-NP/I-PNP %/NN/I-NP/I-PNP (/(/O/O CC50/NN/B-NP/O )/)/O/O und/CC/O/O bei/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Konzentration/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 14/CD/B-NP/I-PNP \xc2\xb5g&slash;ml/NN/I-NP/I-PNP die/DT/B-NP/I-PNP HCMV-Replikation/NN/I-NP/I-PNP um/IN/B-PP/B-PNP 50/CD/B-NP/I-PNP %/NN/I-NP/I-PNP (/(/O/O IC50/NN/B-NP/O )/)/O/O ././O/O

Aus/IN/B-PP/O fast/VB/B-VP/O 500/CD/B-NP/O unterschiedlich/JJ/I-NP/O gewonnenen/NN/I-NP/O Extrakten/NN/I-NP/O wurden/VB/B-VP/O die/DT/B-NP/O folgenden/JJ/I-NP/O wirksamen/JJ/I-NP/O Substanzen/NNS/I-NP/O erfolgreich/JJ/B-NP/O identifiziert/NN/I-NP/O und/CC/O/O charakterisiert/NN/B-NP/O :/:/O/O 1/CD/O/O ././O/O

Das/DT/B-NP/O anionische/JJ/I-NP/O Exopolysaccharid/NN/I-NP/O (/(/O/O EPS/NNP/B-NP/O )/)/O/O aus/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Rhodophyten/NN/I-NP/I-PNP Porphyridium/NN/I-NP/I-PNP purpureum/NN/I-NP/I-PNP weist/VB/B-VP/O im/IN/B-PP/B-PNP Screeningsystem/NN/B-NP/I-PNP eine/DT/I-NP/I-PNP anti-HCMV-Aktivit\xc3\xa4t/NN/I-NP/I-PNP von/IN/B-PP/B-PNP IC50/NN/B-NP/I-PNP =/NN/I-NP/I-PNP 90/CD/I-NP/I-PNP \xc2\xb5g&slash;ml/NN/I-NP/I-PNP auf/IN/B-PP/O (/(/O/O CC50/NN/B-NP/O &/NN/I-NP/O gt/VBN/B-VP/O ;/:/O/O 5/CD/B-NP/O mg&slash;ml/NN/I-NP/O )/)/O/O ././O/O

Die/DT/B-NP/O Substanz/NN/I-NP/O ist/VB/B-VP/O au\xc3\x9ferdem/RB/B-ADJP/O wirksam/JJ/I-ADJP/O gegen/IN/B-PP/B-PNP HHV-6/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Vacciniavirus/NN/I-NP/I-PNP (/(/O/O VV/NNP/B-NP/O )/)/O/O ././O/O

Damit/RB/B-VP/O werden/VB/I-VP/O erstmals/IN/B-PP/B-PNP Aktivit\xc3\xa4ten/NN/B-NP/I-PNP aus/IN/B-PP/B-PNP P./JJ/B-NP/I-PNP purpureum/NN/I-NP/I-PNP gegen/IN/B-PP/B-PNP \xc3\xaf?\xc2\xa2-Herpesviren/NN/B-NP/I-PNP und/CC/I-NP/I-PNP VV/NNP/I-NP/I-PNP beschrieben/NNP/I-NP/I-PNP ././O/O

2/CD/O/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP intrazellul\xc3\xa4re/JJ/I-NP/I-PNP aPS/NNP/I-NP/I-PNP TK/NNP/I-NP/I-PNP V2/NNP/I-NP/I-PNP aus/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Biomasse/NNP/I-NP/I-PNP des/DT/B-NP/I-PNP Cyanobakteriums/NN/I-NP/I-PNP Arthrospira/NN/I-NP/I-PNP platensis/NN/I-NP/I-PNP wurde/VB/B-VP/O eine/DT/B-NP/O Wirksamkeit/NN/I-NP/O von/IN/B-PP/B-PNP IC50/NN/B-NP/I-PNP =/NN/I-NP/I-PNP 39/CD/I-NP/I-PNP \xc2\xb5g&slash;ml/NN/I-NP/I-PNP nachgewiesen/VB/B-VP/O (/(/O/O CC50/NN/B-NP/O &/NN/I-NP/O gt/VBN/B-VP/O ;/:/O/O 5/CD/B-NP/O mg&slash;ml/NN/I-NP/O )/)/O/O ././O/O

In/IN/B-PP/B-PNP diesem/DT/B-NP/I-PNP Extrakt/NN/I-NP/I-PNP ist/VB/B-VP/O wahrscheinlich/JJ/B-ADJP/O das/DT/O/O bereits/IN/B-PP/B-PNP beschriebene/NN/B-NP/I-PNP Ca-Spirulan/NN/I-NP/I-PNP enthalten/RP/O/O ././O/O

3/CD/O/O ././O/O

Das/DT/O/O davon/RB/B-ADVP/O zu/IN/B-PP/B-PNP unterscheidende/NN/B-NP/I-PNP ,/,/O/O bisher/IN/B-PP/B-PNP unbekannte/NN/B-NP/I-PNP anionische/JJ/I-NP/I-PNP Exopolysaccharid/NN/I-NP/I-PNP TK/NNP/I-NP/I-PNP V3/NNP/I-NP/I-PNP aus/IN/B-PP/B-PNP A./NNP/B-NP/I-PNP platensis/NNP/I-NP/I-PNP zeigt/VB/B-VP/O sogar/RB/B-ADVP/O eine/DT/B-NP/O 10fach/NN/I-NP/O h\xc3\xb6here/JJ/B-NP/O antivirale/JJ/I-NP/O Aktivit\xc3\xa4t/NN/I-NP/O (/(/O/O IC50/NN/B-NP/O =/NN/I-NP/O 4/CD/I-NP/O \xc2\xb5g&slash;ml/NN/I-NP/O ,/,/O/O CC50/NN/B-NP/O &/NN/I-NP/O gt/VBN/B-VP/O ;/:/O/O 5/CD/B-NP/O mg&slash;ml/NN/I-NP/O )/)/O/O als/IN/B-PP/B-PNP TK/NNP/B-NP/I-PNP V2/NNP/I-NP/I-PNP und/CC/O/O ist/VB/B-VP/O dar\xc3\xbcber/RB/B-ADVP/O hinaus/IN/B-PP/B-PNP etwa/IN/I-PP/I-PNP 3,5fach/NN/B-NP/I-PNP besser/RB/B-ADVP/O als/IN/B-PP/O das/DT/O/O herk\xc3\xb6mmlich/JJ/B-ADJP/O verwendete/VB/B-VP/O GCV/NNP/B-NP/O ././O/O

Hervorzuheben/VB/B-VP/O ist/VB/I-VP/O weiterhin/RB/B-ADVP/O die/DT/B-NP/O 100/CD/I-NP/O %ige/NN/I-NP/O Inhibierung/NN/I-NP/O der/DT/B-NP/O HCMV-Replikation/NN/I-NP/O mit/IN/B-PP/O lediglich/RB/B-ADVP/O 20/CD/B-NP/O \xc2\xb5g&slash;ml/NN/I-NP/O TK/NNP/I-NP/O V3/NNP/I-NP/O ,/,/O/O was/WDT/O/O mit/IN/B-PP/B-PNP 250/CD/B-NP/I-PNP \xc2\xb5g&slash;ml/NNP/I-NP/I-PNP EPS/NNP/I-NP/I-PNP ,/,/O/O 40/CD/B-NP/O \xc2\xb5g&slash;ml/NN/I-NP/O TK/NNP/I-NP/O V2/NNP/I-NP/O und/CC/O/O ebenso/RB/B-ADVP/O mit/IN/B-PP/B-PNP 40/CD/B-NP/I-PNP \xc2\xb5g&slash;ml/NN/I-NP/I-PNP GCV/NNP/I-NP/I-PNP nicht/RB/B-VP/O erzielt/VBN/I-VP/O werden/VB/I-VP/O konnte/VBN/I-VP/O ././O/O

owohl/CC/O/O TK/NNP/B-NP/O V2/NNP/I-NP/O als/CC/O/O auch/RB/B-ADVP/O TK/NNP/B-NP/O V3/NNP/I-NP/O besitzen/VB/B-VP/O au\xc3\x9ferdem/RB/B-ADVP/O eine/DT/B-NP/O Wirksamkeit/NN/I-NP/O gegen/IN/B-PP/B-PNP HHV-6/NN/B-NP/I-PNP ,/,/O/O VV/NNP/B-NP/O ,/,/O/O das/DT/B-NP/O Herpes/NN/I-NP/O Simplex-Virus-1/NN/I-NP/O und/CC/O/O das/DT/B-NP/O Humane/JJ/I-NP/O Immundefizienz-Virus-1/NN/I-NP/O ././O/O

Anhand/IN/B-PP/B-PNP von/IN/I-PP/I-PNP in/IN/I-PP/I-PNP vitro/NN/B-NP/I-PNP Infektionskinetiken/NN/I-NP/I-PNP wurde/VB/B-VP/O f\xc3\xbcr/IN/B-PP/B-PNP EPS/NNP/B-NP/I-PNP ,/,/O/O TK/NNP/B-NP/O V2/NNP/I-NP/O und/CC/I-NP/O TK/NN/I-NP/O V3/NN/I-NP/O weiterhin/IN/B-PP/B-PNP veranschaulicht/NN/B-NP/I-PNP ,/,/O/O dass/IN/B-PP/O sie/JJ/B-ADJP/O zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP signifikanten/NN/I-NP/I-PNP Reduktion/NN/I-NP/I-PNP der/DT/B-NP/I-PNP viralen/JJ/I-NP/I-PNP DNA/NN/I-NP/I-PNP -/-/O/O und/CC/O/O RNA-Replikation/NN/B-NP/O f\xc3\xbchren/VB/B-VP/O ././O/O

Das/DT/B-NP/O herausragende/NN/I-NP/O Charakteristikum/NN/I-NP/O der/DT/B-NP/O aPS/NNP/I-NP/O ist/VB/B-VP/O die/DT/B-NP/O Verminderung/NN/I-NP/O der/DT/B-NP/O Virusreplikation/NN/I-NP/O durch/IN/B-PP/B-PNP Inhibierung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Adsorption/NN/I-NP/I-PNP und&slash;oder/NN/I-NP/I-PNP Fusion/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Viruspartikel/NN/I-NP/I-PNP an/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Zellmembran/NN/I-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP Gegensatz/NN/B-NP/I-PNP dazu/VB/B-VP/O hemmen/VB/I-VP/O herk\xc3\xb6mmliche/JJ/B-NP/O Virostatika/NN/I-NP/O direkt/JJ/B-ADJP/O die/DT/B-NP/O DNA-Replikation/NN/I-NP/O ,/,/O/O zum/IN/B-PP/B-PNP Beispiel/NN/B-NP/I-PNP Basenanaloga/NNP/I-NP/I-PNP ././O/O

Die/DT/B-NP/O mikrobiellen/NN/I-NP/O aPS/NN/I-NP/O stellen/VB/B-VP/O somit/RB/B-ADVP/O eine/DT/B-NP/O Erfolg/NN/I-NP/O versprechende/JJ/B-NP/O Basis/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Entwicklung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Virostatika/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP neuartigem/NN/B-NP/I-PNP Wirkmechanismus/NN/I-NP/I-PNP und/CC/O/O dar\xc3\xbcber/RB/B-ADVP/O hinaus/IN/B-PP/B-PNP mit/IN/I-PP/I-PNP einem/DT/B-NP/I-PNP sehr/RB/I-NP/I-PNP breiten/JJ/I-NP/I-PNP antiviralen/JJ/I-NP/I-PNP Wirkungsspektrum/NN/I-NP/I-PNP dar.Chlamydia/VB/B-VP/O trachomatis/NN/B-NP/O ,/,/O/O ein/DT/B-NP/O wichtiges/JJ/I-NP/O humanpathogenes/NN/I-NP/O Bakterium/NN/I-NP/O ,/,/O/O sekretiert/NN/B-NP/O w\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Invasion/NN/I-NP/I-PNP in/IN/B-PP/B-PNP seine/PRP$/B-NP/I-PNP Wirtszelle/NN/I-NP/I-PNP das/DT/I-NP/I-PNP Typ/NN/I-NP/I-PNP III/CD/B-NP/I-PNP Effektorprotein/NNP/I-NP/I-PNP Tarp/NNP/I-NP/I-PNP ././O/O

In/IN/B-PP/B-PNP silico/NN/B-NP/I-PNP Analysen/NN/I-NP/I-PNP offenbarten/NN/I-NP/I-PNP eine/DT/I-NP/I-PNP Homologie/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP Tarp/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Src-Kinasesubstraten/NN/I-NP/I-PNP ././O/O

Diese/DT/B-NP/O Analyse/NN/I-NP/O lie\xc3\x9f/VB/B-VP/O sich/PRP/B-NP/O unter/IN/B-PP/B-PNP Verwendung/NN/B-NP/I-PNP verschiedener/JJ/I-NP/I-PNP biochemischer/NN/I-NP/I-PNP Methoden/NN/I-NP/I-PNP best\xc3\xa4tigen/VB/B-VP/O ././O/O

o/RB/B-VP/O zeigte/VB/I-VP/O sich/PRP/B-NP/O ,/,/O/O dass/RB/B-ADVP/O sich/PRP/B-NP/O die/DT/B-NP/O Tarp/JJ/I-NP/O Tyrosinphosphorylierung/NN/I-NP/O durch/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP Src-spezifischen/JJ/I-NP/I-PNP Inhibitor/NN/I-NP/I-PNP blockieren/VB/B-VP/O l\xc3\xa4sst/VB/I-VP/O und/CC/O/O dass/RB/B-ADVP/O Tarp/NN/B-NP/O durch/IN/B-PP/O rekombinantes/FW/O/O Src/FW/O/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP phosphoryliert/NN/I-NP/I-PNP wird/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP konnte/VB/B-VP/O best\xc3\xa4tigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP Tarp/NN/B-NP/I-PNP nicht/RB/B-ADVP/O in/IN/B-PP/O src/FW/O/O -/-/O/O ,/,/O/O fyn/NN/B-NP/O -/-/O/O und/CC/O/O yes-defizienten/NN/B-NP/O Zellen/NNS/I-NP/O phosphoryliert/NN/I-NP/O wird/VB/B-VP/O ././O/O

Inhibiert/NN/B-NP/O man/DT/I-NP/O die/DT/I-NP/O Src-Kinasen/NN/I-NP/O w\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Invasion/NN/I-NP/I-PNP ,/,/O/O so/RB/B-VP/O f\xc3\xbchrt/VB/I-VP/O dies/DT/O/O zu/IN/B-PP/O einer/DT/O/O um/IN/B-PP/B-PNP 60%/CD/B-NP/I-PNP abgeschw\xc3\xa4chten/JJ/I-NP/I-PNP Chlamydieninfektion/NN/I-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP zweiten/JJ/B-NP/I-PNP Teil/NN/I-NP/I-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O Interaktion/NN/I-NP/O von/IN/B-PP/B-PNP phosphoryliertem/JJ/B-NP/I-PNP Tarp/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP zellul\xc3\xa4ren/NN/B-NP/I-PNP Komponenten/NN/I-NP/I-PNP untersucht/RP/O/O ././O/O

Experimente/NN/B-NP/O mit/IN/B-PP/B-PNP SH2-Dom\xc3\xa4nenarrays/NN/B-NP/I-PNP haben/VB/B-VP/O eine/DT/B-NP/O Interaktion/NN/I-NP/O mit/IN/B-PP/B-PNP PLC\xce\xb3/NN/B-NP/I-PNP ,/,/O/O Shc/NN/B-NP/O ,/,/O/O Lck/NN/B-NP/O und/CC/I-NP/O Shp-2/NN/I-NP/O gezeigt/RP/O/O ././O/O

Die/DT/B-NP/O Interaktion/NN/I-NP/O zwischen/IN/B-PP/B-PNP Tarp/NN/B-NP/I-PNP und/CC/I-NP/I-PNP PLC\xce\xb3/NN/I-NP/I-PNP ,/,/O/O bzw./CC/O/O Tarp/NN/B-NP/O und/CC/O/O Shc/FW/O/O lie\xc3\x9f/VB/B-VP/O sich/PRP/B-NP/O mittels/IN/B-PP/B-PNP Immunpr\xc3\xa4zipitation/NN/B-NP/I-PNP best\xc3\xa4tigen/VB/B-VP/O ,/,/O/O eine/DT/B-NP/O morphologische/JJ/I-NP/O Charakterisierung/NN/I-NP/O mittels/IN/B-PP/B-PNP Immunfluoreszenz/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Anschluss/NN/B-NP/I-PNP zeigte/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O PLC\xce\xb3/NN/B-NP/O mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Bakterien/NN/I-NP/I-PNP w\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Invasion/JJ/I-NP/I-PNP kolokalisiert/NN/I-NP/I-PNP ././O/O

Inhibiert/NN/B-NP/O man/DT/I-NP/O PLC\xce\xb3/NN/I-NP/O w\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Invasion/NN/I-NP/I-PNP verhindert/VB/B-VP/O dies/DT/B-NP/O die/DT/I-NP/O Inklusionsbildung/NN/I-NP/O der/DT/B-NP/O C./NN/I-NP/O trachomatis-Infektion/NN/I-NP/O nahezu/VB/B-VP/O vollst\xc3\xa4ndig/JJ/B-ADJP/O ././O/O

Eine/DT/B-NP/O Inhibition/NN/I-NP/O nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Invasion/NN/I-NP/I-PNP hingegen/VBN/B-VP/I-PNP hatte/VB/I-VP/O nur/RB/B-ADVP/O einen/DT/B-NP/O sehr/RB/I-NP/O geringen/JJ/I-NP/O Einfluss/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Infektion/NN/I-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP dritten/JJ/B-NP/I-PNP Teil/NN/I-NP/I-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurde/RB/B-VP/O untersucht/VBN/I-VP/O ,/,/O/O welche/WP/O/O Bedeutung/NN/B-NP/O die/DT/I-NP/O Rekrutierung/NN/I-NP/O von/IN/B-PP/B-PNP PLC\xce\xb3/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Invasionsprozess/NN/I-NP/I-PNP hat/VB/B-VP/O ././O/O

Mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP konfokaler/NN/I-NP/I-PNP Echtzeitmikroskopie/NN/I-NP/I-PNP wurde/RB/B-ADVP/O der/DT/B-NP/O Phosphoinositolmetabolismus/NN/I-NP/O untersucht/VBN/B-VP/O und/CC/O/O es/PRP/B-NP/O zeigte/VB/B-VP/O sich/PRP/B-NP/O ,/,/O/O dass/RB/B-ADVP/O Chlamydien/NN/B-NP/O eine/DT/O/O PtdIns(3,4,5)-P3-angereicherte/LS/O/O fr\xc3\xbche/NN/B-NP/O Inklusion/NN/I-NP/O bilden/VB/B-VP/O ././O/O

Biochemische/JJ/B-NP/O Experimente/NN/I-NP/O lie\xc3\x9fen/NN/I-NP/O erkennen/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O die/DT/B-NP/O Bildung/NN/I-NP/O dieser/DT/B-NP/O fr\xc3\xbchen/JJ/I-NP/O Inklusion/NN/I-NP/O PI3K/NNP/I-NP/O -/-/O/O und/CC/O/O PLC\xce\xb3/NN/B-NP/O -/-/O/O abh\xc3\xa4ngig/JJ/B-ADJP/O ist/VB/B-VP/O ,/,/O/O und/CC/O/O dass/RB/B-ADVP/O die/DT/B-NP/O Inhibition/NN/I-NP/O dieser/DT/B-NP/O Enzyme/NN/I-NP/O zur/IN/B-PP/B-PNP lysosomalen/JJ/B-NP/I-PNP Degradation/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Bakterien/NN/I-NP/I-PNP f\xc3\xbchrt/VB/B-VP/O ././O/O

Die/DT/B-NP/O Bildung/NN/I-NP/O einer/DT/O/O PtdIns(3,4,5)-P3-angereicherten/LS/O/O fr\xc3\xbchen/JJ/B-NP/O Inklusion/NN/I-NP/O stellt/VB/B-VP/O demnach/RB/B-ADVP/O einen/DT/B-NP/O bisher/RB/I-NP/O unbekannten/JJ/I-NP/O bakteriellen/NN/I-NP/O Mechanismus/NN/I-NP/O zur/IN/B-PP/B-PNP Vermeidung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Degradation/NN/I-NP/I-PNP dar.L-G3P/NNP/I-NP/I-PNP ist/VB/B-VP/O ein/DT/B-NP/O intrazellul\xc3\xa4res/NN/I-NP/O phosphoryliertes/NN/I-NP/O Stoffwechselzwischenprodukt/NN/I-NP/O und/CC/O/O z\xc3\xa4hlte/VB/B-VP/O als/IN/B-PP/O solches/DT/O/O bisher/RB/B-ADVP/O nicht/RB/I-ADVP/O zur/IN/B-PP/B-PNP Produktpalette/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Hefe-Fermentationen/NN/B-NP/I-PNP ././O/O

Um/IN/B-PP/B-PNP L-G3P/NNP/B-NP/I-PNP als/IN/B-PP/B-PNP Baustein/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP enzymatische/JJ/I-NP/I-PNP Synthese/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Monosacchariden/NN/B-NP/I-PNP und/CC/O/O f\xc3\xbcr/IN/B-PP/B-PNP andere/JJ/B-NP/I-PNP Anwendungen/NN/I-NP/I-PNP zu/TO/B-VP/O gewinnen/VB/I-VP/O ,/,/O/O wurden/RB/B-ADVP/O Bedingungen/NN/B-NP/O gesucht/VBN/B-VP/O ,/,/O/O unter/IN/B-PP/O denen/WDT/O/O ein/DT/O/O S./VB/B-VP/O cerevisiae-Produktionsstamm/NN/B-NP/O mit/IN/B-PP/B-PNP ausgeschalteter/JJ/B-NP/I-PNP Glycerol-3-Phosphatase/NN/I-NP/I-PNP (/(/O/O gpp1&slash;2/NN/B-NP/O )/)/O/O und/CC/O/O \xc3\x9cberexpression/NN/B-NP/O der/DT/B-NP/O cytosolischen/JJ/I-NP/O Glycerol-3-Phosphat-Dehydrogenase/NN/I-NP/O (/(/O/O GPD1/NN/B-NP/O )/)/O/O gleichzeitig/RB/B-NP/O gute/JJ/I-NP/O L-G3P-Produktion/NN/I-NP/O und/CC/O/O akzeptable/NN/B-NP/O Biomasseproduktion/NN/I-NP/O zeigt/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Zwei-Phasen-Fed-Batch-Fermentation/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Glucose/NN/B-NP/I-PNP ,/,/O/O bei/IN/B-PP/O der/DT/O/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP aerobe/JJ/I-NP/I-PNP Phase/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP respirofermentativem/NN/B-NP/I-PNP Stoffwechsel/NN/I-NP/I-PNP und/CC/I-NP/I-PNP Biomasseproduktion/NN/I-NP/I-PNP von/IN/B-PP/O rund/RB/B-ADVP/O 14/CD/B-NP/O g&slash;l/NN/I-NP/O eine/DT/B-NP/O strikt/JJ/I-NP/O anaerobe/JJ/I-NP/O Phase/NN/I-NP/O mit/IN/B-PP/B-PNP fermentativem/NN/B-NP/I-PNP Stoffwechsel/NN/I-NP/I-PNP und/CC/O/O nahezu/RB/B-ADVP/O ohne/IN/B-PP/B-PNP Wachstum/NN/B-NP/I-PNP folgte/VB/B-VP/O ,/,/O/O wurde/VB/B-VP/O ein/DT/B-NP/O maximaler/JJ/I-NP/O Produkttiter/NN/I-NP/O von/IN/B-PP/B-PNP 325/CD/B-NP/I-PNP mg&slash;l/NN/I-NP/I-PNP erreicht/VBN/B-VP/I-PNP ,/,/O/O was/WDT/B-NP/O dem/DT/I-NP/O 25-fachen/NN/I-NP/O der/DT/B-NP/O Ausgangssituation/NN/I-NP/O entspricht/VB/B-VP/O ././O/O

Der/DT/B-NP/O Vergleich/NN/I-NP/O zweier/JJ/B-NP/O Fermentationen/NN/I-NP/O mit/IN/B-PP/B-PNP unterschiedlichem/JJ/B-NP/I-PNP Bel\xc3\xbcftungsprofil/NN/I-NP/I-PNP (/(/O/O Zwei-Phasen-Fermentation/NN/B-NP/O aerob&slash;anaerob/NN/I-NP/O und/CC/I-NP/O microaerobe/NN/I-NP/O Fermentation/NN/I-NP/O )/)/O/O erbrachte/NN/B-NP/O au\xc3\x9ferdem/VB/B-VP/O als/IN/B-PP/B-PNP relevante/NN/B-NP/I-PNP ph\xc3\xa4notypische/JJ/I-NP/I-PNP Eigenschaften/NNS/I-NP/I-PNP des/DT/B-NP/I-PNP Produktionsstammes/NN/I-NP/I-PNP eine/DT/O/O teilweise/IN/B-PP/B-PNP wachstumsgekoppelte/NN/B-NP/I-PNP L-G3P-Produktion/NN/I-NP/I-PNP und/CC/I-NP/I-PNP die/DT/I-NP/I-PNP sauerstoffabh\xc3\xa4ngige/JJ/I-NP/I-PNP Auspr\xc3\xa4gung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Maxima/NN/B-NP/I-PNP des/DT/I-NP/I-PNP intrazellul\xc3\xa4ren/JJ/I-NP/I-PNP L-G3P-Spiegels/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Abnahme/NN/I-NP/O von/IN/B-PP/B-PNP intrazellul\xc3\xa4rem/NNP/B-NP/I-PNP L-G3P/NNP/I-NP/I-PNP nach/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Erreichen/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Maxima/NN/I-NP/I-PNP beruhte/VB/B-VP/O auf/IN/B-PP/O mindestens/RB/B-ADVP/O zwei/CD/B-NP/O unerwarteten/JJ/I-NP/O Ph\xc3\xa4nomenen/NN/I-NP/O :/:/O/O der/DT/B-NP/O Produktion/NN/I-NP/O erheblicher/JJ/B-NP/O Mengen/NN/I-NP/O des/DT/B-NP/O Nebenproduktes/NN/I-NP/O Glycerol/NN/I-NP/O und/CC/O/O der/DT/B-NP/O Freisetzung/NN/I-NP/O von/IN/B-PP/B-PNP L-G3P/NNP/B-NP/I-PNP aus/IN/B-PP/B-PNP lebenden/NN/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Kultur\xc3\xbcberstand/NN/I-NP/I-PNP ././O/O

Zum/IN/B-PP/B-PNP Ph\xc3\xa4notyp/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Produktionsstammes/NN/I-NP/I-PNP geh\xc3\xb6rte/VB/B-VP/O au\xc3\x9ferdem/RB/B-ADVP/O eine/DT/B-NP/O ausgepr\xc3\xa4gte/NN/I-NP/O Ethanolsensitivit\xc3\xa4t/NN/I-NP/O ,/,/O/O die/WDT/B-NP/O das/DT/I-NP/O Wachstum/NN/I-NP/O bei/IN/B-PP/O relativ/RB/B-VP/O niedrigen/VB/I-VP/O Zelldichten/NN/B-NP/O begrenzte/NN/I-NP/O ././O/O

Da/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Degradation/NN/I-NP/I-PNP von/IN/B-PP/B-PNP L-G3P/NNP/B-NP/I-PNP anscheinend/IN/B-PP/B-PNP intrazellul\xc3\xa4r/NN/B-NP/I-PNP erfolgte/VB/B-VP/O ,/,/O/O ist/RB/B-ADVP/O eine/DT/B-NP/O schnellere/NN/I-NP/O spezifische/JJ/B-NP/O Freisetzung/NN/I-NP/O von/IN/B-PP/B-PNP L-G3P/NNP/B-NP/I-PNP aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP w\xc3\xbcnschenswert/JJ/B-ADJP/O ././O/O

Daher/RB/B-VP/O wurde/VB/I-VP/O der/DT/B-NP/O sekund\xc3\xa4raktive/NN/I-NP/O L-G3P-Transporter/NN/I-NP/O GlpT/NNP/I-NP/O aus/IN/B-PP/B-PNP Escherichia/NN/B-NP/I-PNP coli/NN/I-NP/I-PNP im/IN/B-PP/O S./VB/B-VP/O cerevisiae-Produktionsstamm/NN/B-NP/O \xc3\xbcberexprimiert/NN/I-NP/O und/CC/O/O konnte/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP membrangebundenen/NN/I-NP/I-PNP Fraktion/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Proteine/NN/I-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Der/DT/B-NP/O bakterielle/NN/I-NP/O Transporter/JJ/B-ADJP/O trat/VB/B-VP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP sekretorischen/JJ/I-NP/I-PNP Weg/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Hefezellen/NN/I-NP/I-PNP ein/RP/O/O ,/,/O/O indem/IN/B-PP/B-PNP er/JJ/B-NP/I-PNP wahrscheinlich/JJ/I-NP/I-PNP cotranslational/NN/I-NP/I-PNP in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP ER-Membran/NN/I-NP/I-PNP integrierte/NN/I-NP/I-PNP ,/,/O/O er/PRP/B-NP/O wurde/VB/B-VP/O nicht/RB/B-ADVP/O glykosyliert/NN/B-NP/O ././O/O

\xc3\x9cberexpression/NN/B-NP/O von/IN/B-PP/B-PNP GlpT/NN/B-NP/I-PNP f\xc3\xbchrte/VB/B-VP/O dennoch/RB/B-ADVP/O nicht/RB/I-ADVP/O zur/IN/B-PP/B-PNP verst\xc3\xa4rkten/JJ/B-NP/I-PNP Ausscheidung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP L-G3P/NNP/B-NP/I-PNP aus/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Produktionsstamm/NN/I-NP/I-PNP ././O/O

Grund/NN/B-NP/O daf\xc3\xbcr/VB/B-VP/O war/VB/I-VP/O die/DT/B-NP/O Misslokalisierung/NN/I-NP/O des/DT/B-NP/O Transporters/NN/I-NP/O ,/,/O/O der/WDT/O/O zum/IN/B-PP/B-PNP gr\xc3\xb6\xc3\x9ften/JJ/B-NP/I-PNP Teil/NN/I-NP/I-PNP im/IN/B-PP/B-PNP ER/PRP/B-NP/I-PNP festgehalten/VB/B-VP/O wurde/VB/I-VP/O und/CC/O/O die/DT/B-NP/O Plasmamembran/NN/I-NP/O nicht/RB/B-VP/O erreichte/VB/I-VP/O ././O/O

Dies/DT/O/O wurde/RB/B-ADVP/O mit/IN/B-PP/B-PNP Immunfluoreszenz-Mikroskopie/NN/B-NP/I-PNP gezeigt/RP/O/O ././O/O

Die/DT/B-NP/O Fusion/NN/I-NP/O von/IN/B-PP/B-PNP N-terminalen/JJ/B-NP/I-PNP Sequenzen/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Hefe-Plasmamembranproteins/JJ/I-NP/I-PNP Ste2p/NN/I-NP/I-PNP an/IN/B-PP/B-PNP GlpT/NNP/B-NP/I-PNP verbesserte/VB/B-VP/O die/DT/B-NP/O Lokalisierung/NN/I-NP/O nicht/RB/B-ADVP/O ././O/O

Da/IN/B-PP/B-PNP zellul\xc3\xa4re/JJ/B-NP/I-PNP Qualit\xc3\xa4tskontrollsysteme/NN/I-NP/I-PNP des/DT/B-NP/I-PNP ER/PRP$/I-NP/I-PNP ,/,/O/O des/DT/B-NP/O Golgi-Apparats/NN/I-NP/O und/CC/O/O der/DT/B-NP/O Plasmamembran/NN/I-NP/O bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Degradation/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Vakuole/NN/I-NP/I-PNP konvergieren/VB/B-VP/O ,/,/O/O gibt/RB/B-ADVP/O die/DT/B-NP/O Abh\xc3\xa4ngigkeit/NN/I-NP/O der/DT/B-NP/O Expressionsst\xc3\xa4rke/NN/I-NP/O von/IN/B-PP/B-PNP GlpT/NNP/B-NP/I-PNP von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP vakuol\xc3\xa4ren/NN/I-NP/I-PNP Proteinase/JJ/B-NP/I-PNP A/NN/I-NP/I-PNP (/(/O/O Pep4p/NN/B-NP/O )/)/O/O keine/JJ/B-NP/O Auskunft/NN/I-NP/O dar\xc3\xbcber/VB/B-VP/O ,/,/O/O welche/WDT/O/O dieser/WDT/B-NP/O Systeme/NN/I-NP/O GlpT/NNP/I-NP/O angreifen.Biomarker/NNP/I-NP/O ,/,/O/O die/DT/B-NP/O eine/DT/I-NP/O Diagnose/NN/I-NP/O der/DT/B-NP/O Brustkrebserkrankung/NN/I-NP/O zu/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP fr\xc3\xbchen/JJ/I-NP/I-PNP Stadium/NN/I-NP/I-PNP erm\xc3\xb6glichen/VB/B-VP/O ,/,/O/O die/DT/B-NP/O eine/DT/I-NP/O Prognose/NN/I-NP/O des/DT/B-NP/O Ausgangs/NN/I-NP/O der/DT/B-NP/O Erkrankung/NN/I-NP/O oder/RB/B-ADVP/O die/WDT/O/O das/DT/O/O Ansprechen/JJ/B-ADJP/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP bestimmte/JJ/I-NP/I-PNP Behandlung/NN/I-NP/I-PNP erlauben/VB/B-VP/O ,/,/O/O sind/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Verbesserung/NN/I-NP/I-PNP des/DT/O/O Managements/FW/O/O der/DT/B-NP/O Erkrankung/NN/I-NP/O von/IN/B-PP/B-PNP gro\xc3\x9fem/JJ/B-NP/I-PNP klinischen/JJ/I-NP/I-PNP Interesse/NN/I-NP/I-PNP ././O/O

DNA/JJ/B-NP/O Methylierung/NN/I-NP/O spielt/NN/I-NP/O eine/DT/B-NP/O wesentliche/JJ/I-NP/O Rolle/NN/I-NP/O bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Karzinogenese/NN/I-NP/I-PNP und/CC/O/O stellt/VB/B-VP/O damit/RB/B-ADVP/O eine/DT/B-NP/O wertvolle/JJ/I-NP/O Quelle/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP Brustkrebsbiomarker/NN/B-NP/I-PNP dar/RP/O/O ././O/O

Ziel/NN/B-NP/O dieser/DT/I-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O die/DT/B-NP/O Charakterisierung/NN/I-NP/O bekannter/JJ/B-NP/O Methylierungsbiomarker/NN/I-NP/O ,/,/O/O wie/IN/B-PP/B-PNP der/DT/B-NP/I-PNP prognostischen/JJ/I-NP/I-PNP Biomarker/NN/I-NP/I-PNP TFF1/NN/I-NP/I-PNP ,/,/O/O PITX2/NN/B-NP/O und/CC/I-NP/O uPA/NNP/I-NP/O und/CC/O/O der/DT/B-NP/O diagnostischen/JJ/I-NP/O Biomarker/NNP/I-NP/O RASSF1A/NNP/I-NP/O ,/,/O/O LIMK1/NN/B-NP/O ,/,/O/O SLIT2/NN/B-NP/O ,/,/O/O SLITRK1/NN/B-NP/O und/CC/I-NP/O HS3ST2/NN/I-NP/O ././O/O

Zus\xc3\xa4tzlich/VBN/B-VP/O wurden/VB/I-VP/O Kandidatengene/NN/B-NP/O analysiert/VBN/B-VP/O ,/,/O/O um/IN/B-PP/B-PNP neue/JJ/B-NP/I-PNP Biomarker/NN/I-NP/I-PNP zu/TO/B-VP/O identifizieren/VB/I-VP/O ././O/O

Das/DT/B-NP/O PITX2/NN/I-NP/O Gen/JJ/B-NP/O kodiert/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP drei/CD/B-NP/I-PNP Transkripte/NN/I-NP/I-PNP :/:/O/O PITX2/NN/B-NP/O A/NN/I-NP/O ,/,/O/O B/FW/O/O and/NN/B-NP/O C./NNP/I-NP/O Die/DT/I-NP/O Isoform/NN/I-NP/O C/NNP/I-NP/O wird/VB/B-VP/O durch/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP alternativen/NN/I-NP/I-PNP Promotor/JJ/B-NP/I-PNP reguliert/NN/I-NP/I-PNP ././O/O

Eine/DT/B-NP/O Analyse/NN/I-NP/O von/IN/B-PP/B-PNP Brustkrebszelllinien/NN/B-NP/I-PNP zeigte/VB/B-VP/O eine/DT/B-NP/O Korrelation/NN/I-NP/O der/DT/B-NP/O Methylierung/NN/I-NP/O der/DT/B-NP/O Promotorregionen/NN/I-NP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Expression/NN/I-NP/I-PNP der/DT/B-NP/I-PNP entsprechenden/JJ/I-NP/I-PNP Transkripte/NN/I-NP/I-PNP ././O/O

Es/PRP/B-NP/O konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP Promotormethylierung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Transkriptvarianten/NN/I-NP/I-PNP A/NN/I-NP/I-PNP und/CC/O/O B/NN/B-NP/O ein/DT/B-NP/O st\xc3\xa4rkerer/JJ/I-NP/O prognostischer/NN/I-NP/O Biomarker/NN/I-NP/O verglichen/JJ/B-ADJP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Promotormethylierung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Variante/NN/I-NP/I-PNP C/NNP/I-NP/I-PNP ist/VB/B-VP/O ././O/O

Die/DT/B-NP/O Analyse/NN/I-NP/O von/IN/B-PP/B-PNP Tumoren/NN/B-NP/I-PNP von/IN/B-PP/B-PNP 384/CD/B-NP/I-PNP Brustkrebspatientinnen/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP einer/DT/I-NP/I-PNP DNA/NN/I-NP/I-PNP Mikroarraystudie/NN/I-NP/I-PNP f\xc3\xbchrte/VB/B-VP/O zu/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Identifizierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP BMP4/NN/B-NP/I-PNP ,/,/O/O NR5A1/NN/B-NP/O ,/,/O/O BARX1/NN/B-NP/O und/CC/I-NP/O FGF4/NN/I-NP/O als/IN/B-PP/B-PNP Methylierungsbiomarker/NN/B-NP/I-PNP ,/,/O/O welche/WDT/B-NP/O eine/DT/I-NP/O Vorhersage/NN/I-NP/O des/DT/B-NP/O Ausgangs/NN/I-NP/O der/DT/B-NP/O Krankheit/NN/I-NP/O bei/IN/B-PP/B-PNP Lymphknoten-positiven/NN/B-NP/I-PNP ,/,/O/O Steroidhormonrezeptor-positiven/NN/B-NP/O Brustkrebspatientinnen/NNP/I-NP/O erlaubt/VBN/B-VP/O ,/,/O/O die/DT/B-NP/O eine/DT/I-NP/O adjuvante/NN/I-NP/O Anthrazyklin-basierte/NN/I-NP/O Chemotherapie/NN/I-NP/O erhalten/VBN/B-VP/O haben/VB/I-VP/O ././O/O

Bis/IN/B-PP/O heute/VB/B-VP/O ist/VB/I-VP/O nicht/RB/B-ADJP/O klar/JJ/I-ADJP/O ,/,/O/O wie/IN/B-PP/B-PNP die/DT/B-NP/I-PNP verschiedenen/JJ/I-NP/I-PNP Komponenten/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Tumors/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP der/DT/B-NP/I-PNP gemessenen/NN/I-NP/I-PNP Methylierung/NN/I-NP/I-PNP beitragen/VB/B-VP/O ././O/O

Die/DT/B-NP/O Lasermikrodissektion/NN/I-NP/O ist/VB/B-VP/O eine/DT/B-NP/O Technologie/NN/I-NP/O ,/,/O/O die/WDT/B-NP/O die/DT/I-NP/O Isolierung/NN/I-NP/O bestimmter/JJ/B-NP/O Zellen/NNS/I-NP/O erm\xc3\xb6glicht/VB/B-VP/O aber/RB/B-ADVP/O nicht/RB/B-NP/O gen\xc3\xbcgend/JJ/I-NP/O Material/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP meisten/DT/I-NP/I-PNP Standardmethoden/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP Methylierungsmessung/JJ/B-NP/I-PNP liefert/NN/I-NP/I-PNP ././O/O

Eine/DT/B-NP/O zus\xc3\xa4tzliche/JJ/I-NP/O Herausforderung/NN/I-NP/O tritt/VB/B-VP/O bei/IN/B-PP/B-PNP Proben/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Formalin-fixierten/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Paraffin-eingebetteten/JJ/I-NP/I-PNP Geweben/NN/I-NP/I-PNP auf/RP/O/O ,/,/O/O welche/WDT/O/O nur/IN/B-PP/B-PNP fragmentierte/NN/B-NP/I-PNP DNA/NN/I-NP/I-PNP niedriger/JJ/I-NP/I-PNP Qualit\xc3\xa4t/NN/I-NP/I-PNP enth\xc3\xa4lt/VB/B-VP/O ././O/O

Deshalb/RB/B-VP/O wurde/VB/I-VP/O eine/DT/B-NP/O Methode/NN/I-NP/O zur/IN/B-PP/B-PNP simultanen/NN/B-NP/I-PNP Analyse/NN/I-NP/I-PNP mehrerer/JJ/I-NP/I-PNP Gene/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP limitierten/JJ/I-NP/I-PNP Anzahl/NN/I-NP/I-PNP von/IN/B-PP/B-PNP dissezierten/NN/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP aus/IN/B-PP/B-PNP Formalin-fixierten/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Paraffin-eingebetteten/NN/I-NP/I-PNP Geweben/NN/I-NP/I-PNP entwickelt/VB/B-VP/O ././O/O

Diese/DT/B-NP/O Methode/NN/I-NP/O umfasst/VB/B-VP/O :/:/O/O 1/CD/O/O ././O/O

in/DT/B-NP/O optimiertes/NN/I-NP/O ,/,/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Konversion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP DNA/NN/B-NP/I-PNP aus/IN/B-PP/B-PNP einigen/JJ/B-NP/I-PNP wenigen/JJ/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP geeignetes/VB/B-VP/O ,/,/O/O Bisulfitbehandlungsprotokoll/NN/B-NP/O ,/,/O/O 2/CD/O/O ././O/O

sequentielle/JJ/B-NP/O PCR/NN/I-NP/O Amplifikationen/NN/I-NP/O und/CC/O/O 3/CD/O/O ././O/O

ine/DT/B-NP/O neue/JJ/I-NP/O Methode/NN/I-NP/O zur/IN/B-PP/B-PNP quantitativen/JJ/B-NP/I-PNP Bisulfitsequenzierung/NN/I-NP/I-PNP basierend/JJ/B-ADJP/O auf/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Einf\xc3\xbchrung/NN/I-NP/I-PNP eines/DT/B-NP/I-PNP Normalisierungssignals/NN/I-NP/I-PNP in/IN/B-PP/B-PNP das/DT/B-NP/I-PNP PCR/JJ/I-NP/I-PNP Produkt/NN/I-NP/I-PNP ././O/O

Diese/DT/B-NP/O Methode/NN/I-NP/O wurde/VB/B-VP/O verwendet/VBN/I-VP/O ,/,/O/O um/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Methylierung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Gene/NN/I-NP/I-PNP PITX2/NN/I-NP/I-PNP ,/,/O/O RASSF1A/NNP/B-NP/O ,/,/O/O uPA/NNP/B-NP/O ,/,/O/O LHX3/NN/B-NP/O ,/,/O/O PITX3/NN/B-NP/O ,/,/O/O LIMK1/NN/B-NP/O ,/,/O/O SLITRK1/NN/B-NP/O ,/,/O/O SLIT2/NN/B-NP/O ,/,/O/O HS3ST2/NN/B-NP/O und/CC/I-NP/O TFF1/NN/I-NP/O bei/IN/B-PP/O drei/CD/O/O ausgew\xc3\xa4hlten/VB/B-VP/O ,/,/O/O invasiven/NN/B-NP/O duktalen/JJ/I-NP/O Brustkrebsf\xc3\xa4llen/NN/I-NP/O zu/TO/B-VP/O analysieren/VB/I-VP/O ././O/O

Mikrodissezierte/JJ/B-NP/O Proben/NN/I-NP/O wurden/VB/B-VP/O von/IN/B-PP/B-PNP intraduktalem/NN/B-NP/I-PNP und/CC/I-NP/I-PNP invasivem/NN/I-NP/I-PNP Karzinom/NN/I-NP/I-PNP ,/,/O/O Stroma/NN/B-NP/O ,/,/O/O Tumor-infiltrierenden/NN/B-NP/O Lymphozyten/NNP/I-NP/O ,/,/O/O Fettgewebe/NN/B-NP/O ,/,/O/O Brustwandmuskel/NN/B-NP/O ,/,/O/O Adenose/NN/B-NP/O und/CC/I-NP/O normalem/JJ/I-NP/O Dr\xc3\xbcsenepithel/NN/I-NP/O gewonnen/RP/O/O ././O/O

Alle/JJ/B-NP/O analysierten/NN/I-NP/O Gene/NN/I-NP/O zeigten/JJ/B-NP/O Hypermethylierung/NN/I-NP/O in/IN/B-PP/B-PNP invasiven/NN/B-NP/I-PNP und/CC/I-NP/I-PNP intraduktalen/JJ/I-NP/I-PNP Krebszellen/NN/I-NP/I-PNP verglichen/JJ/B-ADJP/O mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP anderen/JJ/I-NP/I-PNP Gewebekomponenten/NN/I-NP/I-PNP ,/,/O/O mit/IN/B-PP/B-PNP Ausnahme/NN/B-NP/I-PNP von/IN/B-PP/B-PNP TFF1/NN/B-NP/I-PNP ,/,/O/O welches/WDT/B-NP/O eine/DT/I-NP/O umgekehrte/NN/I-NP/O Methylierung/NN/I-NP/O aufwies/RP/O/O ././O/O

Einige/JJ/B-NP/O Gene/NN/I-NP/O zeigten/JJ/B-NP/O geringe/JJ/I-NP/O Methylierung/NN/I-NP/O im/IN/B-PP/B-PNP normalen/JJ/B-NP/I-PNP anliegenden/NN/I-NP/I-PNP Brustgewebe/NN/I-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP Tumor-infiltrierenden/JJ/B-NP/I-PNP Lymphozyten/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Methylierung/NN/I-NP/O variierte/NN/I-NP/O wenig/VB/B-VP/O innerhalb/IN/B-PP/B-PNP eines/DT/B-NP/I-PNP Gewebetypes/NN/I-NP/I-PNP und/CC/O/O zwischen/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Paraffinbl\xc3\xb6cken/NN/I-NP/I-PNP eines/DT/O/O Brustkrebsfalls/RP/O/O ././O/O

Die/DT/B-NP/O entwickelte/JJ/I-NP/O Methode/NN/I-NP/O ist/VB/B-VP/O ein/DT/B-NP/O leistungsstarkes/JJ/I-NP/O Werkzeug/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Methylierungsanalyse/NN/I-NP/I-PNP von/IN/B-PP/B-PNP multiplen/JJ/B-NP/I-PNP Markern/NN/I-NP/I-PNP in/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP mikrodissezierten/NN/I-NP/I-PNP Gewebekomponenten/NN/I-NP/I-PNP und/CC/O/O kann/VB/B-VP/O hilfreich/JJ/B-ADJP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Analyse/NN/I-NP/I-PNP der/DT/B-NP/I-PNP verschiedenen/JJ/I-NP/I-PNP \xc3\x9cbergangsstadien/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Brust/NN/B-NP/I-PNP und/CC/I-NP/I-PNP anderen/JJ/I-NP/I-PNP Krebsformen/NN/I-NP/I-PNP sein/VB/B-VP/O ././O/O

Diese/DT/B-NP/O Methode/NN/I-NP/O ist/VB/B-VP/O au\xc3\x9ferdem/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP viele/DT/B-NP/I-PNP Anwendungen/NN/I-NP/I-PNP neben/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Analyse/NN/I-NP/I-PNP mikrodissezierter/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP geeignet/JJ/B-ADJP/O ,/,/O/O wie/IN/B-PP/B-PNP z.B./IN/I-PP/I-PNP Methylierungsanalyse/NN/B-NP/I-PNP mehrerer/JJ/I-NP/I-PNP Gene/NN/I-NP/I-PNP in/IN/B-PP/B-PNP K\xc3\xb6rperfl\xc3\xbcssigkeiten/NN/B-NP/I-PNP (/(/O/O Serum/NN/B-NP/O ,/,/O/O Plasma/NN/B-NP/O ,/,/O/O Urin/NN/B-NP/O )/)/O/O ,/,/O/O Sp\xc3\xbclfl\xc3\xbcssigkeiten/NN/B-NP/O ,/,/O/O disseminierten/NN/B-NP/O Tumorzellen/NNP/I-NP/O ,/,/O/O embryonalen/JJ/B-NP/O Zellen/NNS/I-NP/O ,/,/O/O isolierten/NN/B-NP/O Stammzellen/NNP/I-NP/O ,/,/O/O etc.Der/JJ/B-NP/O Trockenwald/NN/I-NP/O an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Nordk\xc3\xbcste/NN/I-NP/I-PNP Perus/NNS/I-NP/I-PNP (/(/O/O ca/NN/B-NP/O ././O/O

28.000/CD/B-NP/O km\xc2\xb2/NN/I-NP/O )/)/O/O bildet/VBN/B-VP/O mit/IN/B-PP/B-PNP seiner/PRP$/B-NP/I-PNP beinahe/RB/I-NP/I-PNP \xc3\xa4quatorialen/JJ/I-NP/I-PNP Lage/NN/I-NP/I-PNP einen/DT/B-NP/I-PNP weltweit/JJ/I-NP/I-PNP einmaligen/JJ/I-NP/I-PNP Lebensraum/NN/I-NP/I-PNP ././O/O

ine/PRP$/B-NP/O Existenz/NN/I-NP/O unter/IN/B-PP/B-PNP ariden/NN/B-NP/I-PNP und/CC/I-NP/I-PNP semi-ariden/NN/I-NP/I-PNP Bedingungen/NN/I-NP/I-PNP verdankt/NN/I-NP/I-PNP er/PRP/I-NP/I-PNP dem/DT/B-NP/I-PNP periodischen/JJ/I-NP/I-PNP El-Nino-Ph\xc3\xa4nomen/NN/I-NP/I-PNP ,/,/O/O das/WDT/O/O im/IN/B-PP/B-PNP mehrj\xc3\xa4hrigen/NN/B-NP/I-PNP Rhythmus/NN/I-NP/I-PNP die/DT/I-NP/I-PNP Grundwassererneuerung/NN/I-NP/I-PNP gew\xc3\xa4hrleistet/RP/O/O ././O/O ././O/O

Bereits/RB/B-ADVP/O seit/IN/B-PP/B-PNP pr\xc3\xa4kolumbianischer/NN/B-NP/I-PNP Zeit/NN/I-NP/I-PNP unterlag/NN/I-NP/I-PNP er/PRP/I-NP/I-PNP menschlicher/JJ/I-NP/I-PNP Nutzung/NN/I-NP/I-PNP ,/,/O/O aber/CC/O/O erst/RB/B-ADVP/O durch/IN/B-PP/O die/DT/O/O verst\xc3\xa4rkte/VB/B-VP/O Abholzung/NN/B-NP/O und/CC/I-NP/O Ziegenhaltung/NN/I-NP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP letzten/JJ/I-NP/I-PNP Jahrzehnten/NN/I-NP/I-PNP ist/VB/B-VP/O er/PRP/B-NP/O in/IN/B-PP/B-PNP seinem/PRP$/B-NP/I-PNP Fortbestand/NN/I-NP/I-PNP gef\xc3\xa4hrdet/VB/B-VP/O ././O/O

Die/DT/B-NP/O Regenerierung/NN/I-NP/O des/DT/B-NP/O Trockenwaldes/NN/I-NP/O (/(/O/O 1,2/CD/B-NP/O m3&slash;ha&slash;Jahr/NN/I-NP/O )/)/O/O kann/VBN/B-VP/O gegenw\xc3\xa4rtig/RB/B-ADVP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Degradierung/NN/I-NP/I-PNP (/(/O/O 2/CD/B-NP/O m3&slash;ha.&slash;Jahr/NN/I-NP/O )/)/O/O nicht/RB/B-ADVP/O Schritt/NN/B-NP/O halten/VB/B-VP/O ././O/O

Das/DT/O/O 1977/CD/O/O als/IN/B-PP/B-PNP MaB-Projekt/NN/B-NP/I-PNP eingerichtete/JJ/I-NP/I-PNP Biosph\xc3\xa4renreservat/NN/I-NP/I-PNP soll/MD/B-VP/O zum/IN/B-PP/B-PNP Schutz/NN/B-NP/I-PNP und/CC/O/O zur/IN/B-PP/B-PNP Regenerierung/NN/B-NP/I-PNP des/DT/I-NP/I-PNP verbliebenen/NN/I-NP/I-PNP Trockenwalds/NN/I-NP/I-PNP beitragen/VB/B-VP/O ././O/O

Wegen/IN/B-PP/B-PNP der/DT/B-NP/I-PNP peripheren/JJ/I-NP/I-PNP Lage/NN/I-NP/I-PNP innerhalb/IN/B-PP/B-PNP Perus/NNS/B-NP/I-PNP und/CC/I-NP/I-PNP der/DT/I-NP/I-PNP Unzug\xc3\xa4nglichkeit/NN/I-NP/I-PNP sind/VB/B-VP/O viele/DT/B-NP/O Aspekte/NN/I-NP/O der/DT/B-NP/O \xc3\x96kologie/NN/I-NP/O und/CC/O/O Nutzung/NN/B-NP/O des/DT/B-NP/O Trockenwaldes/NN/I-NP/O noch/RB/B-ADVP/O nicht/RB/I-ADVP/O genau/RB/I-ADVP/O untersucht/RP/O/O ././O/O

Ziel/NN/B-NP/O der/DT/I-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O es/PRP/B-NP/O daher/RB/B-ADVP/O ,/,/O/O einen/DT/B-NP/O \xc3\x9cberblick/NN/I-NP/O zur/IN/B-PP/B-PNP Vegetation/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Abh\xc3\xa4ngigkeit/NN/B-NP/I-PNP von/IN/B-PP/B-PNP den/DT/B-NP/I-PNP nat\xc3\xbcrlichen/NNP/I-NP/I-PNP und/CC/O/O sozio-kulturellen/NNP/B-NP/O Standortbedingungen/NNP/I-NP/O und/CC/O/O zu/IN/B-PP/B-PNP ihrer/PRP$/B-NP/I-PNP Degradation/NN/I-NP/I-PNP zu/TO/B-VP/O gewinnen/VB/I-VP/O ././O/O

Im/IN/B-PP/B-PNP Mittelpunkt/NN/B-NP/I-PNP steht/VB/B-VP/O die/DT/B-NP/O weidewirtschaftliche/JJ/I-NP/O Nutzung/NN/I-NP/O durch/IN/B-PP/B-PNP Ziegen/NN/B-NP/I-PNP und/CC/I-NP/I-PNP die/DT/I-NP/I-PNP Frage/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP bestandsregulierenden/JJ/I-NP/I-PNP Funktion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Ipomoea/NN/B-NP/I-PNP carnea/NN/I-NP/I-PNP ,/,/O/O einer/DT/B-NP/O Solanacee/NN/I-NP/O ,/,/O/O die/WDT/B-NP/O sich/PRP/I-NP/O erst/RB/B-ADVP/O als/IN/B-PP/B-PNP Folge/NN/B-NP/I-PNP der/DT/I-NP/I-PNP \xc3\x9cberweidung/NN/I-NP/I-PNP ausbreitet/NN/I-NP/I-PNP ,/,/O/O dann/RB/B-ADVP/O aber/RB/I-ADVP/O wieder/RB/I-ADVP/O wegen/IN/B-PP/B-PNP ihrer/PRP$/B-NP/I-PNP Toxidizit\xc3\xa4t/NN/I-NP/I-PNP den/DT/I-NP/I-PNP Bestand/NN/I-NP/I-PNP an/IN/B-PP/B-PNP Weidetieren/NN/B-NP/I-PNP begrenzt/RP/O/O ././O/O

Wie/IN/B-PP/O weit/JJ/B-ADJP/O kann/JJ/I-ADJP/O die/DT/B-NP/O Pflanze/NN/I-NP/O zu/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP labilen/NN/I-NP/I-PNP Gleichgewicht/NN/I-NP/I-PNP beitragen/VB/B-VP/O ,/,/O/O bei/IN/B-PP/B-PNP dem/WDT/B-NP/I-PNP der/DT/I-NP/I-PNP Erhalt/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Trockenwalds/NN/I-NP/I-PNP ebenso/RB/B-VP/O gew\xc3\xa4hrleistet/VB/I-VP/O ist/RB/B-ADVP/O wie/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP begrenzte/JJ/I-NP/I-PNP Waldweide/NN/I-NP/I-PNP ?/./O/O

Der/DT/B-NP/O erste/JJ/I-NP/O Teil/NN/I-NP/O der/DT/B-NP/O Arbeit/NN/I-NP/O stellt/VB/B-VP/O die/DT/B-NP/O physische/JJ/I-NP/O Geographie/NN/I-NP/O und/CC/O/O die/DT/B-NP/O Landnutzungstypen/NN/I-NP/O der/DT/B-NP/O Trockenwaldregion/NN/I-NP/O vor/RP/O/O ././O/O

Anschlie\xc3\x9fend/RB/B-VP/O geht/VB/I-VP/O es/PRP/B-NP/O um/IN/B-PP/B-PNP den/DT/B-NP/I-PNP detaillierten/JJ/I-NP/I-PNP Vergleich/NN/I-NP/I-PNP zweier/JJ/B-NP/I-PNP repr\xc3\xa4sentativer/NN/I-NP/I-PNP Standorte/NN/I-NP/I-PNP ,/,/O/O einen/DT/O/O mit/IN/B-PP/O erheblicher/JJ/B-ADJP/O (/(/O/O Las/NN/B-NP/O Lomas&slash;Jaguay/NNP/I-NP/O Negro/NNP/I-NP/O )/)/O/O und/CC/O/O einen/DT/O/O zweiten/JJ/B-ADJP/O mit/IN/B-PP/B-PNP geringerer/NNP/B-NP/I-PNP anthropozoogener/NNP/I-NP/I-PNP Belastung/NNP/I-NP/I-PNP (/(/O/O Jagdgebiet/NN/B-NP/O El/NN/I-NP/O Angolo/NN/I-NP/O )/)/O/O ././O/O

Die/DT/B-NP/O Untersuchungen/NN/I-NP/O bezogen/VBN/B-VP/O sich/PRP/B-NP/O auf/RP/O/O :/:/O/O \xe2\x80\xa2/NN/B-NP/O die/DT/I-NP/O Ph\xc3\xa4nologie/NN/I-NP/O von/IN/B-PP/B-PNP Ipomoea/NN/B-NP/I-PNP carnea/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Gew\xc3\xa4chshaus/NN/B-NP/I-PNP und/CC/O/O im/IN/B-PP/B-PNP Arbeitsgebiet/NN/B-NP/I-PNP ././O/O

\xe2\x80\xa2/NN/B-NP/O den/DT/I-NP/O Selengehalt/NN/I-NP/O der/DT/B-NP/O Bl\xc3\xa4tter/NN/I-NP/O ,/,/O/O St\xc3\xa4ngel/NN/B-NP/O und/CC/I-NP/O Samen/NN/I-NP/O von/IN/B-PP/B-PNP Ipomoea/NN/B-NP/I-PNP carnea/NN/I-NP/I-PNP sowie/RB/B-ADVP/O den/DT/B-NP/O Selengehalt/NN/I-NP/O der/DT/B-NP/O B\xc3\xb6den/NN/I-NP/O ,/,/O/O wobei/WRB/O/O sich/PRP/B-NP/O der/DT/O/O anfangs/IN/B-PP/B-PNP vermutete/JJ/B-NP/I-PNP Zusammenhang/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Selengehalt/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Boden/NN/B-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Pflanze/NN/I-NP/I-PNP nicht/RB/B-VP/O best\xc3\xa4tigte/VB/I-VP/O ././O/O

\xe2\x80\xa2/JJ/B-NP/O Vegetationsanalysen/NN/I-NP/O nach/IN/B-PP/B-PNP Braun-Blanquett/NN/B-NP/I-PNP ,/,/O/O erg\xc3\xa4nzt/JJ/B-ADJP/O durch/IN/B-PP/B-PNP Untersuchungen/NN/B-NP/I-PNP der/DT/I-NP/I-PNP floristischen/JJ/I-NP/I-PNP Komposition/NN/I-NP/I-PNP ,/,/O/O des/DT/B-NP/O Bodentyps/NN/I-NP/O ,/,/O/O der/DT/B-NP/O Bodenchemie/NN/I-NP/O und/CC/O/O der/DT/B-NP/O Pflanzengesellschaften/NN/I-NP/O ././O/O

\xe2\x80\xa2/NN/B-NP/O den/DT/I-NP/O Sekund\xc3\xa4rsukzessionsproze\xc3\x9f/NN/I-NP/O des/DT/B-NP/O Waldes/NN/I-NP/O ,/,/O/O der/WDT/O/O auf/IN/B-PP/B-PNP Vegetationsparzellen/NN/B-NP/I-PNP studiert/VBN/B-VP/I-PNP wurde/VB/I-VP/O ././O/O ././O/O

\xe2\x80\xa2/NN/B-NP/O die/DT/I-NP/O Verbissintensit\xc3\xa4t/NN/I-NP/O und/CC/O/O Weidebelastung/NN/B-NP/O ,/,/O/O bestimmt/JJ/B-ADJP/O durch/IN/B-PP/B-PNP Messungen/NNS/B-NP/I-PNP im/IN/B-PP/B-PNP Gel\xc3\xa4nde/NN/B-NP/I-PNP ././O/O ././O/O

Die/DT/B-NP/O Vegetationsaufnahmen/NN/I-NP/O belegen.den/NN/I-NP/O Wandel/NN/I-NP/O der/DT/B-NP/O Vegetation/NN/I-NP/O durch/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Weidegang/NN/I-NP/I-PNP bzw./RB/B-ADVP/O die/DT/B-NP/O \xc3\x9cberweidung/NN/I-NP/O ././O/O

Den/DT/B-NP/O Abschluss/NN/I-NP/O bildet/VB/B-VP/O die/DT/B-NP/O Diskussion/NN/I-NP/O zuk\xc3\xbcnftiger/JJ/B-NP/O Nutzungsoptionen.Herstellung/NN/I-NP/O einer/DT/B-NP/O Biosynthesemutante/NN/I-NP/O von/IN/B-PP/B-PNP Amycolatopsis/JJ/B-NP/I-PNP balhimycina/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP Modulinsertion/NN/B-NP/I-PNP in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP nicht-ribosomale/NN/I-NP/I-PNP Peptidsynthetase/JJ/B-NP/I-PNP BpsB/NN/I-NP/I-PNP mittels/IN/B-PP/B-PNP eines/DT/B-NP/I-PNP kombinatorisch-biosynthetischen/JJ/I-NP/I-PNP Ansatzes/NN/I-NP/I-PNP und/CC/O/O deren/DT/B-NP/O massenspektro-metrische/JJ/I-NP/O Charakterisierung/NN/I-NP/O Die/DT/B-NP/O vorliegende/JJ/I-NP/O Arbeit/NN/I-NP/O besch\xc3\xa4ftigt/VBN/B-VP/O sich/PRP/B-NP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP kombinatorischen/JJ/I-NP/I-PNP Biosynthese/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP nicht-ribosomalen/JJ/B-NP/I-PNP Peptidsynthetasen/NN/I-NP/I-PNP (/(/O/O NRPS/NNP/B-NP/O )/)/O/O ,/,/O/O die/WDT/O/O aufgrund/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Komplexit\xc3\xa4t/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Strukturen/NN/I-NP/I-PNP von/IN/B-PP/B-PNP nicht-ribosomal/NN/B-NP/I-PNP synthetisierten/NN/I-NP/I-PNP Peptiden/NN/I-NP/I-PNP eine/DT/I-NP/I-PNP ernstzunehmende/NN/I-NP/I-PNP Alternative/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP chemischen/JJ/B-NP/I-PNP Synthese/NN/I-NP/I-PNP darstellt/VB/B-VP/O ,/,/O/O um/IN/B-PP/B-PNP Strukturderivate/NN/B-NP/I-PNP zu/TO/B-VP/O erzeugen/VB/I-VP/O ././O/O

Ziel/NN/B-NP/O dieser/DT/I-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O die/DT/B-NP/O Komplettierung/NN/I-NP/O der/DT/O/O bisher/RB/B-ADVP/O bei/IN/B-PP/B-PNP NRPS/NNP/B-NP/I-PNP literaturbekannten/NNP/I-NP/I-PNP Modul-manipulationen/NNP/I-NP/I-PNP \xe2\x80\x9eModulaustausch\xe2\x80\x9c/NNP/I-NP/I-PNP und/CC/I-NP/I-PNP \xe2\x80\x9eModuldeletion\xe2\x80\x9c/NNP/I-NP/I-PNP durch/IN/B-PP/O das/DT/O/O noch/IN/B-PP/B-PNP ausstehende/NN/B-NP/I-PNP Experiment/NN/I-NP/I-PNP der/DT/I-NP/I-PNP \xe2\x80\x9eModulinsertion\xe2\x80\x9c/NN/I-NP/I-PNP ././O/O

Als/IN/B-PP/B-PNP Modellverbindung/NN/B-NP/I-PNP diente/JJ/B-ADJP/O das/DT/O/O von/IN/B-PP/B-PNP A./NNP/B-NP/I-PNP balhimycina/NNP/I-NP/I-PNP synthetisierte/NNP/I-NP/I-PNP Vancomycin-Typ/NNP/I-NP/I-PNP Glykopeptidantibiotikum/NNP/I-NP/I-PNP Balhimycin/NNP/I-NP/I-PNP ,/,/O/O welches/WDT/O/O durch/TO/B-VP/O sein/VB/I-VP/O stark/JJ/B-NP/O modifiziertes/JJ/I-NP/O Peptidgrundger\xc3\xbcst/NN/I-NP/O (/(/O/O Chlorierung/NN/B-NP/O ,/,/O/O oxidative/NN/B-NP/O Seitenkettenzyklisierung/NNP/I-NP/O ,/,/O/O N-Methylierung/NN/B-NP/O und/CC/I-NP/O Glykosylierung/NN/I-NP/O )/)/O/O ein/DT/B-NP/O sehr/RB/I-NP/O komplexes/JJ/I-NP/O Beispiel/NN/I-NP/O einer/DT/B-NP/O nicht-ribosomalen/JJ/I-NP/O Peptidsynthese/NN/I-NP/O darstellt/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP ist/VB/B-VP/O es/PRP/B-NP/O gelungen/VB/B-VP/O ,/,/O/O ein/DT/B-NP/O zus\xc3\xa4tzliches/JJ/I-NP/O Modul/NN/I-NP/O in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP NRPS/NNP/I-NP/I-PNP BpsB/NNP/I-NP/I-PNP von/IN/B-PP/B-PNP A./NNP/B-NP/I-PNP balhimycina/NNP/I-NP/I-PNP \xc3\xbcber/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP double/NN/I-NP/I-PNP crossover-Strategie/NN/I-NP/I-PNP einzuf\xc3\xbchren/VB/B-VP/O ,/,/O/O was/WDT/O/O sowohl/CC/O/O auf/IN/B-PP/B-PNP genetischer/JJ/B-NP/I-PNP Ebene/NN/I-NP/I-PNP mittels/IN/B-PP/B-PNP PCR/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Southern/NN/I-NP/I-PNP Blot-Hybridisierung/NN/I-NP/I-PNP als/CC/O/O auch/RB/B-ADVP/O auf/IN/B-PP/B-PNP Proteinebene/NN/B-NP/I-PNP mittels/IN/B-PP/B-PNP Disk-SDS-PAGE/NN/B-NP/I-PNP und/CC/I-NP/I-PNP anschlie\xc3\x9fende/NN/I-NP/I-PNP massenspektrometrische/JJ/B-NP/I-PNP Identifizierung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Gelbande/NN/I-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O konnte/VBN/I-VP/O ././O/O

Daran/RB/B-VP/O schloss/VB/I-VP/O sich/PRP/B-NP/O eine/DT/I-NP/O eingehende/JJ/I-NP/O Charakterisierung/NN/I-NP/O des/DT/B-NP/O Produktionsprofils/NN/I-NP/O dieser/DT/B-NP/O kombinatorischen/JJ/I-NP/O Biosynthese-Mutante/NN/I-NP/O mittels/IN/B-PP/B-PNP HPLC-ESI-MS/NNP/B-NP/I-PNP und/CC/O/O -/-/O/O MS&slash;MS/NNP/B-NP/O an/RP/O/O ././O/O

Diese/DT/B-NP/O Analyse/NN/I-NP/O erbrachte/NN/I-NP/O den/DT/B-NP/O Beweis/NN/I-NP/O ,/,/O/O dass/IN/B-PP/B-PNP das/DT/B-NP/I-PNP eingef\xc3\xbchrte/JJ/I-NP/I-PNP Modul/NN/I-NP/I-PNP auch/RB/B-NP/I-PNP enzymatische/JJ/I-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP besitzt/NN/I-NP/I-PNP und/CC/O/O somit/RB/B-ADVP/O das/DT/B-NP/O Peptidr\xc3\xbcckgrat/NN/I-NP/O des/DT/B-NP/O Balhimycins/NN/I-NP/O um/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Aminos\xc3\xa4ure/NN/I-NP/I-PNP erweitert/RP/O/O ././O/O

Neben/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Beweis/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Machbarkeit/NN/I-NP/I-PNP einer/DT/B-NP/I-PNP Modulinsertion/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP NRPS/NNP/B-NP/I-PNP gew\xc3\xa4hrte/NNP/I-NP/I-PNP dieses/DT/I-NP/I-PNP kombinatorische/JJ/I-NP/I-PNP Biosynthese-Experiment/NN/I-NP/I-PNP auch/IN/B-PP/B-PNP Einblicke/NN/B-NP/I-PNP in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Flexibilit\xc3\xa4t/NN/I-NP/I-PNP des/DT/B-NP/I-PNP gesamten/JJ/I-NP/I-PNP Biosyntheseapparates/NN/I-NP/I-PNP ././O/O

Beispielsweise/RB/B-VP/O war/VB/I-VP/O die/DT/B-NP/O Chlorierung/NN/I-NP/O der/DT/B-NP/O Produkte/NN/I-NP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Halogenase/NN/I-NP/I-PNP BhaA/NNP/I-NP/I-PNP nicht/RB/B-VP/O beeintr\xc3\xa4chtigt/VBN/I-VP/O ,/,/O/O w\xc3\xa4hrend/IN/B-PP/B-PNP N-Methylierung/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Glykosylierung/NN/I-NP/I-PNP in/IN/B-PP/B-PNP allen/DT/B-NP/I-PNP 17/CD/I-NP/I-PNP nachgewiesenen/NN/I-NP/I-PNP Biosyntheseprodukten/NN/I-NP/I-PNP fehlten/VB/B-VP/O ././O/O

Bez\xc3\xbcglich/IN/B-PP/B-PNP der/DT/B-NP/I-PNP oxidativen/NN/I-NP/I-PNP Seitenkettenzyklisierungen/NN/I-NP/I-PNP brachte/VB/B-VP/O die/DT/B-NP/O erste/JJ/I-NP/O P450-abh\xc3\xa4ngige/NN/I-NP/O Monooxygenase/NN/I-NP/O OxyB/NN/I-NP/O noch/VB/B-VP/O eine/DT/B-NP/O gewisse/JJ/I-NP/O Toleranz/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP neue/JJ/I-NP/I-PNP Substrat/NN/I-NP/I-PNP bzw./RB/B-ADVP/O die/DT/O/O ver\xc3\xa4nderte/VB/B-VP/O NRPS/NNP/B-NP/O auf/RP/O/O ,/,/O/O w\xc3\xa4hrend/IN/B-PP/B-PNP OxyA/NNP/B-NP/I-PNP und/CC/I-NP/I-PNP OxyC/NNP/I-NP/I-PNP keine/DT/B-NP/I-PNP nachweisbare/JJ/I-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP mehr/IN/B-PP/B-PNP zeigten.Ein/NN/B-NP/I-PNP limitierender/NN/I-NP/I-PNP Faktor/NN/I-NP/I-PNP des/DT/I-NP/I-PNP Probendurchsatzes/NN/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O Kosten/NN/I-NP/O von/IN/B-PP/B-PNP DNA-Sequenzierung/NN/B-NP/I-PNP mittels/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Sanger-Methode/NN/I-NP/I-PNP ist/VB/B-VP/O die/DT/B-NP/O zuverl\xc3\xa4ssige/NN/I-NP/O Herstellung/NN/I-NP/O qualitativ/JJ/B-NP/O hochwertiger/JJ/I-NP/O DNA/NN/I-NP/O als/IN/B-PP/B-PNP Template/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Sequenzierungsreaktion/NN/I-NP/I-PNP ././O/O

Durch/IN/B-PP/B-PNP gr\xc3\xb6\xc3\x9fenselektive/JJ/B-NP/I-PNP Pr\xc3\xa4zipitation/NN/I-NP/I-PNP in/IN/B-PP/B-PNP PEG/NN/B-NP/I-PNP &slash;/RB/B-ADJP/O Salz-Gemischen/JJ/I-ADJP/O ist/VB/B-VP/O es/PRP/B-NP/O m\xc3\xb6glich/JJ/B-ADJP/O ein/DT/B-NP/O weites/JJ/I-NP/O Spektrum/NN/I-NP/O von/IN/B-PP/B-PNP DNA-Templates/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Sequenzierung/JJ/I-NP/I-PNP aufzubereiten/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O genauere/NN/I-NP/O Betrachtung/NN/I-NP/O der/DT/B-NP/O Einflussgr\xc3\xb6\xc3\x9fen/NN/I-NP/O PEG/NN/I-NP/O -/-/O/O und/CC/O/O Salz-Konzentration/NN/B-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP gr\xc3\xb6\xc3\x9fenselektive/NN/I-NP/I-PNP F\xc3\xa4llung/NN/I-NP/I-PNP erm\xc3\xb6glichte/VB/B-VP/O es/PRP/B-NP/O ,/,/O/O die/DT/B-NP/O problematischen/JJ/I-NP/O rheologischen/JJ/I-NP/O Eigenschaften/NNS/I-NP/O von/IN/B-PP/B-PNP PEG/NN/B-NP/I-PNP &slash;/RB/B-ADJP/O Salz-Gemischen/JJ/I-ADJP/O durch/IN/B-PP/B-PNP Zusatz/NN/B-NP/I-PNP von/IN/B-PP/B-PNP 2-Propanol/NN/B-NP/I-PNP zu/TO/B-VP/O verbessern/VB/I-VP/O und/CC/O/O ein/DT/B-NP/O automatisiertes/JJ/I-NP/O Verfahren/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Aufreinigung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Plasmid/NN/B-NP/I-PNP -/-/O/O ,/,/O/O Fosmid/NN/B-NP/O -/-/O/O und/CC/O/O BAC-DNA/NNP/B-NP/O im/IN/B-PP/B-PNP 384er/NN/B-NP/I-PNP Format/NN/I-NP/I-PNP zu/TO/B-VP/O entwickeln/VB/I-VP/O ././O/O

Die/DT/B-NP/O konzipierte/NN/I-NP/O Anlage/NN/I-NP/O bew\xc3\xa4ltigt/JJ/B-ADJP/O bis/IN/B-PP/B-PNP zu/IN/I-PP/I-PNP 36.834/CD/B-NP/I-PNP Proben/NN/I-NP/I-PNP pro/IN/B-PP/B-PNP Tag/NN/B-NP/I-PNP ,/,/O/O wobei/WRB/O/O die/DT/B-NP/O Kosten/NN/I-NP/O pro/IN/B-PP/B-PNP Probe/NN/B-NP/I-PNP unter/IN/B-PP/B-PNP 0,01/CD/B-NP/I-PNP Euro/NN/I-NP/I-PNP betragen/VB/B-VP/O ././O/O

Mehrere/JJ/B-NP/O Millionen/JJ/I-NP/O DNA-Templates/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP zahlreiche/JJ/B-NP/I-PNP Sequenzierungsprojekte/NN/I-NP/I-PNP wurden/VB/B-VP/O mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Anlage/NN/I-NP/I-PNP aufgereinigt/RP/O/O ././O/O

Besonders/IN/B-PP/B-PNP profitierte/NN/B-NP/I-PNP die/DT/I-NP/I-PNP Endsequenzierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Fosmid/NN/B-NP/I-PNP -/-/O/O und/CC/O/O BAC-Banken/NN/B-NP/O von/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP System/NN/I-NP/I-PNP ././O/O

o/RB/B-VP/O konnten/VB/I-VP/O 102.282/CD/B-NP/O Endsequenzen/NN/I-NP/O einer/DT/B-NP/O BAC-Bank/NN/I-NP/O von/IN/B-PP/B-PNP Dicentrarchus/JJ/B-NP/I-PNP labrax/NN/I-NP/I-PNP (/(/O/O Wolfsbarsch/NN/B-NP/O )/)/O/O bestimmt/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Durch/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Vergleich/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Endsequenzen/NN/I-NP/I-PNP mit/IN/B-PP/O dem/DT/O/O nahe/IN/B-PP/B-PNP verwandten/NN/B-NP/I-PNP Fisch/NN/I-NP/I-PNP G./JJ/I-NP/I-PNP aculeatus/NN/I-NP/I-PNP (/(/O/O Stichling/NN/B-NP/O )/)/O/O war/NN/B-NP/O es/PRP/I-NP/O m\xc3\xb6glich/JJ/I-NP/O BAC-Klone/NN/I-NP/O anzuordnen/VBN/B-VP/O und/CC/O/O eine/DT/B-NP/O hochaufl\xc3\xb6sende/NN/I-NP/O komparative/NN/I-NP/O Genomkarte/NN/I-NP/O zu/TO/B-VP/O erstellen/VB/I-VP/O ././O/O

Der/DT/B-NP/O Abgleich/NN/I-NP/O der/DT/B-NP/O Karte/NN/I-NP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP genetischen/JJ/I-NP/I-PNP Kopplungskartierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP D./JJ/B-NP/I-PNP labrax/NN/I-NP/I-PNP und/CC/O/O Kartierungen/NN/B-NP/O anderer/JJ/B-NP/O Fischgenome/NN/I-NP/O zeigte/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O die/DT/B-NP/O komparative/NN/I-NP/O Kartierung/NN/I-NP/O einer/DT/B-NP/O physikalischen/JJ/I-NP/O Karte/NN/I-NP/O des/DT/B-NP/O Genoms/NN/I-NP/O nahe/IN/B-PP/O kommt/VB/B-VP/O ././O/O

Indem/IN/B-PP/B-PNP 109/CD/B-NP/I-PNP \xc3\xbcberlappende/JJ/I-NP/I-PNP BAC-Klone/NN/I-NP/I-PNP anhand/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Kartierung/NN/I-NP/I-PNP ausgew\xc3\xa4hlt/NN/I-NP/I-PNP wurden/VB/B-VP/O ,/,/O/O konnten/VBN/B-VP/O durch/IN/B-PP/B-PNP Nutzung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Sequenzierungstechniken/NN/B-NP/I-PNP der/DT/I-NP/I-PNP zweiten/JJ/I-NP/I-PNP Generation/NN/I-NP/I-PNP (/(/O/O GS20/NN/B-NP/O ,/,/O/O Roche/NN/B-NP/O &slash;/RB/B-ADVP/O 454/CD/O/O )/)/O/O in/IN/B-PP/B-PNP Kombination/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP Sanger-Sequenzierung/NN/B-NP/I-PNP gro\xc3\x9fe/JJ/I-NP/I-PNP Bereiche/NN/I-NP/I-PNP eines/DT/B-NP/I-PNP D./JJ/I-NP/I-PNP labrax-Chromosoms/NN/I-NP/I-PNP sequenziert/NN/I-NP/I-PNP werden/VB/B-VP/O (/(/O/O &/NN/B-NP/O gt/VBN/B-VP/O ;/:/O/O 80%/CD/O/O )/)/O/O ././O/O

Die/DT/B-NP/O komparative/NN/I-NP/O Kartierung/NN/I-NP/O des/DT/B-NP/O Genoms/NN/I-NP/O erweist/VB/B-VP/O sich/PRP/B-NP/O somit/RB/B-ADVP/O als/IN/B-PP/B-PNP sinnvoller/JJ/B-NP/I-PNP Schritt/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP zuk\xc3\xbcnftige/JJ/I-NP/I-PNP Sequenzierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP D./JJ/B-NP/I-PNP labrax/NN/I-NP/I-PNP anhand/IN/B-PP/B-PNP neuer/JJ/B-NP/I-PNP Sequenzierungs\xc2\xactechniken.In/NN/I-NP/I-PNP der/DT/B-NP/I-PNP zellul\xc3\xa4ren/NN/I-NP/I-PNP Biotechnologie/NN/I-NP/I-PNP besteht/VB/B-VP/O eine/DT/B-NP/O gro\xc3\x9fe/JJ/I-NP/O Nachfrage/NN/I-NP/O nach/IN/B-PP/B-PNP Methoden/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/O eine/DT/O/O m\xc3\xb6glichst/IN/B-PP/B-PNP schonende/JJ/B-NP/I-PNP Handhabung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Zellen/NNS/B-NP/I-PNP ././O/O

Ein/DT/B-NP/O wichtiger/JJ/I-NP/O Ansatz/NN/I-NP/O hierf\xc3\xbcr/VB/B-VP/O ist/RB/B-ADVP/O die/DT/O/O kontrollierte/VB/B-VP/O und/CC/O/O schonende/NN/B-NP/O Abl\xc3\xb6sung/NN/I-NP/O adh\xc3\xa4renter/NN/I-NP/O Zellen/NNS/I-NP/O von/IN/B-PP/O Oberfl\xc3\xa4chen/VB/B-VP/O ,/,/O/O um/IN/B-PP/B-PNP zellul\xc3\xa4re/JJ/B-NP/I-PNP Ver\xc3\xa4nderungen/NN/I-NP/I-PNP zu/TO/B-VP/O vermeiden/VB/I-VP/O ././O/O

Die/DT/B-NP/O vorliegende/JJ/I-NP/O Arbeit/NN/I-NP/O erweitert/VB/B-VP/O bisherige/JJ/B-NP/O Ans\xc3\xa4tze/NNS/I-NP/O thermoresponsiver/NN/I-NP/O Polymeroberfl\xc3\xa4chen/VB/B-VP/O hinsichtlich/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Erzeugung/NN/I-NP/I-PNP und/CC/O/O Anwendung/NN/B-NP/O mit/IN/B-PP/B-PNP besonderem/JJ/B-NP/I-PNP Blick/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Einzelzellabl\xc3\xb6sung/NN/I-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP Fokus/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP stand/VB/B-VP/O ,/,/O/O die/DT/B-NP/O Erzeugung/NN/I-NP/O thermoresponsiver/NN/I-NP/O Polymeroberfl\xc3\xa4chen/VB/B-VP/O zu/TO/I-VP/O erleichtern/VB/I-VP/O und/CC/O/O eine/DT/B-NP/O exakte/JJ/I-NP/O Kontrolle/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP Zellen/NNS/B-NP/I-PNP mit/IN/B-PP/B-PNP unterschiedlichem/JJ/B-NP/I-PNP Adh\xc3\xa4sionsverhalten/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP einstellbare/JJ/B-NP/I-PNP Oberfl\xc3\xa4cheneigenschaften/NN/I-NP/I-PNP zu/TO/B-VP/O erm\xc3\xb6glichen/VB/I-VP/O ././O/O

Das/DT/B-NP/O thermoresponsive/NN/I-NP/O Copolymer/NN/I-NP/O Poly(N-isopropylacrylamid)-poly(ethylenglykol/LS/O/O )/)/O/O PNIPAAm-PEG(15%)-SH/NNP/B-NP/O (/(/O/O P15/NNP/B-NP/O )/)/O/O wurde/VB/B-VP/O an/IN/B-PP/O Goldoberfl\xc3\xa4chen/JJ/B-ADJP/O (/(/O/O P15-Au/NN/B-NP/O )/)/O/O gebunden/VBN/B-VP/O ,/,/O/O um/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Kontrolle/NN/I-NP/I-PNP \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Zelladh\xc3\xa4sion/NN/I-NP/I-PNP zu/TO/B-VP/O gew\xc3\xa4hrleisten/VB/I-VP/O ././O/O

Die/DT/B-NP/O Kontaktwinkeldaten/NN/I-NP/O von/IN/B-PP/B-PNP P15-Au/NN/B-NP/I-PNP lassen/VB/B-VP/O eine/DT/B-NP/O \xc3\x84nderung/NN/I-NP/O der/DT/B-NP/O Oberfl\xc3\xa4chenbenetzbarkeit/NN/I-NP/O erkennen/VB/B-VP/O ,/,/O/O welche/WDT/B-NP/O dem/DT/I-NP/O \xc3\x9cbergang/NN/I-NP/O von/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP hydratisierten/NN/I-NP/I-PNP (/(/O/O bei/IN/B-PP/B-PNP 20/CD/B-NP/I-PNP \xc2\xb0C/NN/I-NP/I-PNP )/)/O/O zu/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP dehydratisierten/JJ/I-NP/I-PNP Polymerzustand/NN/I-NP/I-PNP (/(/O/O bei/IN/B-PP/B-PNP 45/CD/B-NP/I-PNP \xc2\xb0C/NN/I-NP/I-PNP )/)/O/O entspricht/VB/B-VP/O ././O/O

L929/JJ/B-NP/O Fibroblasten/NN/I-NP/O konnten/VB/B-VP/O gut/JJ/B-ADJP/O auf/IN/B-PP/B-PNP P15-Au/NN/B-NP/I-PNP bei/IN/B-PP/B-PNP 37/CD/B-NP/I-PNP \xc2\xb0C/NN/I-NP/I-PNP kultiviert/NN/I-NP/I-PNP werden/VB/B-VP/O und/CC/O/O rundeten/VBN/B-VP/O sich/PRP/B-NP/O bei/IN/B-PP/B-PNP Temperatur\xc3\xa4nderung/NN/B-NP/I-PNP auf/IN/B-PP/B-PNP 25/CD/B-NP/I-PNP \xc2\xb0C/NN/I-NP/I-PNP innerhalb/IN/B-PP/B-PNP von/IN/I-PP/I-PNP 30/CD/B-NP/I-PNP Minuten/NN/I-NP/I-PNP von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Oberfl\xc3\xa4che/NN/I-NP/I-PNP ab/RP/O/O ././O/O

Durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Integration/NN/I-NP/I-PNP von/IN/B-PP/B-PNP P15-Au/NN/B-NP/I-PNP in/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP mikrofluidisches/JJ/I-NP/I-PNP System/NN/I-NP/I-PNP konnte/VB/B-VP/O die/DT/O/O f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP komplette/JJ/I-NP/I-PNP Zellabl\xc3\xb6sung/NN/I-NP/I-PNP notwendige/JJ/B-NP/I-PNP Kraft/NN/I-NP/I-PNP kontrolliert/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Auf/IN/B-PP/B-PNP P15-Au/NN/B-NP/I-PNP wurde/RB/I-NP/I-PNP Fibronektin/NN/I-NP/I-PNP strukturiert/VBN/B-VP/I-PNP aufgebracht/VBN/I-VP/I-PNP ,/,/O/O um/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP Substrat/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP zellattraktiven/NN/I-NP/I-PNP und/CC/O/O einem/DT/B-NP/O schaltbaren/NN/I-NP/O Bereich/JJ/B-NP/O herzustellen/NN/I-NP/O ././O/O

Dadurch/RB/B-VP/O konnten/VB/I-VP/O die/DT/B-NP/O Zellen/NNS/I-NP/O ,/,/O/O die/WDT/O/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP zellattraktiven/NN/I-NP/I-PNP Fibronektinbereiche/NN/I-NP/I-PNP migrierten/NN/I-NP/I-PNP ,/,/O/O von/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP getrennt/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O die/WDT/O/O auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP schaltbaren/NN/I-NP/I-PNP Polymerbereich/JJ/B-NP/I-PNP verweilten/NN/I-NP/I-PNP ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Optimierung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Schaltkinetik/NN/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O Schalteffizienz/NN/I-NP/O von/IN/B-PP/B-PNP schaltbaren/NN/B-NP/I-PNP Polymeroberfl\xc3\xa4chen/VB/B-VP/O wurde/VB/I-VP/O ein/DT/B-NP/O neues/JJ/I-NP/O Copolymer/NN/I-NP/O mit/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP intramolekularen/JJ/I-NP/I-PNP PEG-Gehalt/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 19%wt/NN/B-NP/I-PNP an/IN/B-PP/O Goldoberfl\xc3\xa4chen/JJ/B-ADJP/O gebunden/VB/B-VP/O (/(/O/O P19-Au/NN/B-NP/O )/)/O/O ././O/O

Bei/IN/B-PP/B-PNP 25/CD/B-NP/I-PNP \xc2\xb0C/NN/I-NP/I-PNP war/VB/B-VP/O die/DT/B-NP/O Abl\xc3\xb6sung/NN/I-NP/O adh\xc3\xa4renter/JJ/B-NP/O Fibroblasten/NN/I-NP/O bei/IN/B-PP/B-PNP gleich/JJ/B-NP/I-PNP bleibendem/RB/I-NP/I-PNP Zellabrundungsanteil/NN/I-NP/I-PNP doppelt/JJ/B-ADJP/O so/RB/I-ADJP/O schnell/JJ/I-ADJP/O wie/IN/B-PP/B-PNP auf/IN/I-PP/I-PNP P15-Au/NN/B-NP/I-PNP ././O/O

Da/IN/B-PP/B-PNP stark/JJ/B-NP/I-PNP adh\xc3\xa4rente/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP (/(/O/O z.B./IN/B-PP/B-PNP Osteoblasten/NN/B-NP/I-PNP )/)/O/O auf/IN/B-PP/B-PNP P19-Au/NN/B-NP/I-PNP bei/IN/B-PP/B-PNP Temperaturwechsel/NN/B-NP/I-PNP (/(/O/O 37/CD/B-NP/O \xc2\xb0C/NN/I-NP/O \xe2\x86\x92/NN/I-NP/O 25/CD/B-NP/O \xc2\xb0C/NN/I-NP/O )/)/O/O sich/PRP/B-NP/O nicht/RB/I-NP/O abrundeten/NN/I-NP/O bzw./RB/B-ADVP/O abl\xc3\xb6sten/NN/B-NP/O ,/,/O/O wurde/VB/B-VP/O P19-Au/NN/B-NP/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP zellrepellierendem/NN/I-NP/I-PNP Polymer/NN/I-NP/I-PNP CH3O-PEG-SH/NNP/I-NP/I-PNP (/(/O/O PG/NN/B-NP/O )/)/O/O modifiziert/NN/B-NP/O (/(/O/O P19&slash;PG-Au/NN/B-NP/O )/)/O/O ././O/O

Die/DT/B-NP/O Daten/NN/I-NP/O der/DT/B-NP/O R\xc3\xb6ntgenphotoelektronenspektroskopie/NN/I-NP/O (/(/O/O XPS/NNP/B-NP/O )/)/O/O best\xc3\xa4tigten/NN/B-NP/O die/DT/I-NP/O erwartete/JJ/I-NP/O Oberfl\xc3\xa4chenzusammensetzung/NN/I-NP/O von/IN/B-PP/B-PNP P19-Au/NN/B-NP/I-PNP und/CC/I-NP/I-PNP der/DT/I-NP/I-PNP modifizierten/JJ/I-NP/I-PNP P19&slash;PG-Au/NN/I-NP/I-PNP ././O/O

Der/DT/B-NP/O Vergleich/NN/I-NP/O der/DT/B-NP/O Kontaktwinkeldaten/NN/I-NP/O beider/DT/O/O Polymeroberfl\xc3\xa4chen/JJ/B-ADJP/O zeigte/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O die/DT/B-NP/O Schaltbarkeit/NN/I-NP/O von/IN/B-PP/B-PNP P19&slash;PG-Au/NN/B-NP/I-PNP durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Modifikation/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP PG/NN/B-NP/I-PNP nicht/RB/B-VP/O ver\xc3\xa4ndert/VBN/I-VP/O wurde/VB/I-VP/O ././O/O

Ca/NN/B-NP/O ././O/O

74/CD/B-NP/O %/NN/I-NP/O der/DT/B-NP/O stark/JJ/I-NP/O adh\xc3\xa4renten/NN/I-NP/O MG63/NN/I-NP/O Zellen/NNS/I-NP/O l\xc3\xb6sten/VB/B-VP/O sich/PRP/B-NP/O nach/IN/B-PP/B-PNP Temperatur\xc3\xa4nderung/NN/B-NP/I-PNP innerhalb/IN/B-PP/B-PNP von/IN/I-PP/I-PNP 30/CD/B-NP/I-PNP Minuten/NN/I-NP/I-PNP von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Oberfl\xc3\xa4che/NN/I-NP/I-PNP ././O/O

Um/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Kultivierungsdauer/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP schwach/JJ/B-NP/I-PNP adh\xc3\xa4rente/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP auf/IN/B-PP/B-PNP P19-Au/NN/B-NP/I-PNP zu/TO/B-VP/O verk\xc3\xbcrzen/VB/I-VP/O ,/,/O/O wurde/VB/B-VP/O P19-Au/NN/B-NP/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Fibroblasten-attraktiven/NN/I-NP/I-PNP Peptidmotiv/NN/I-NP/I-PNP CGGRGDS/NNP/I-NP/I-PNP (/(/O/O RGD/NN/B-NP/O )/)/O/O modifiziert/NN/B-NP/O (/(/O/O P19&slash;RGD-Au/NN/B-NP/O )/)/O/O ././O/O

Bei/IN/B-PP/B-PNP Temperatur\xc3\xa4nderung/NN/B-NP/I-PNP war/VB/B-VP/O der/DT/B-NP/O Abrundungsanteil/NN/I-NP/O adh\xc3\xa4renter/NN/I-NP/O Zellen/NNS/I-NP/O auf/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Oberfl\xc3\xa4che/NN/I-NP/I-PNP vergleichbar/JJ/B-ADJP/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Zellabrundungsanteil/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP P19-Au.Die/NN/B-NP/I-PNP Grundlage/NN/I-NP/I-PNP der/DT/I-NP/I-PNP neuronalen/JJ/I-NP/I-PNP Signal\xc3\xbcbertragung/NN/I-NP/I-PNP ist/VB/B-VP/O die/DT/B-NP/O regulierte/NN/I-NP/O Freisetzung/NN/I-NP/O vesikul\xc3\xa4rer/JJ/B-NP/O Neurotransmitter/NN/I-NP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP synaptischen/JJ/I-NP/I-PNP Spalt/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O synaptische/JJ/I-NP/O Signal\xc3\xbcbertragung/NN/I-NP/O unterliegt/VB/B-VP/O dabei/RB/B-ADVP/O einer/DT/B-NP/O Vielzahl/NN/I-NP/O regulatorischer/NN/I-NP/O pr\xc3\xa4/NN/I-NP/O -/-/O/O und/CC/O/O postsynaptischer/JJ/B-NP/O Prozesse/NN/I-NP/O ././O/O

Die/DT/B-NP/O Beeinflussung/NN/I-NP/O des/DT/B-NP/O vesikul\xc3\xa4ren/NN/I-NP/O F\xc3\xbcllungszustandes/NN/I-NP/O stellt/VB/B-VP/O dabei/RB/B-ADVP/O eine/DT/B-NP/O M\xc3\xb6glichkeit/NN/I-NP/O dar/RB/B-ADVP/O ,/,/O/O die/DT/B-NP/O synaptische/JJ/I-NP/O \xc3\x9cbertragung/NN/I-NP/O pr\xc3\xa4synaptisch/JJ/B-ADJP/O zu/IN/B-PP/B-PNP modulieren/NN/B-NP/I-PNP ././O/O

Vorangegangene/JJ/B-NP/O Arbeiten/NN/I-NP/O konnten/VB/B-VP/O zeigen/VB/I-VP/O ,/,/O/O dass/RB/B-ADVP/O der/DT/B-NP/O F\xc3\xbcllungszustand/NN/I-NP/O monoaminerger/JJ/B-NP/O Vesikel/NN/I-NP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Go2alpha-Untereinheit/NN/I-NP/I-PNP heterotrimerer/NN/I-NP/I-PNP G-Proteine/NN/I-NP/I-PNP reguliert/NN/I-NP/I-PNP wird/VB/B-VP/O ././O/O

Der/DT/B-NP/O vesikul\xc3\xa4re/JJ/I-NP/O F\xc3\xbcllungszustand/NN/I-NP/O ist/VB/B-VP/O dabei/RB/B-ADVP/O das/DT/B-NP/O ausl\xc3\xb6sende/NN/I-NP/O Signal/NN/I-NP/O der/DT/B-NP/O G-Proteinregulation/NN/I-NP/O ././O/O

Die/DT/O/O daran/RB/B-VP/O beteiligten/VB/I-VP/O zellul\xc3\xa4ren/NN/B-NP/O Prozesse/NN/I-NP/O und/CC/I-NP/O Signaltransduktionswege/NN/I-NP/O sowie/RB/B-ADVP/O die/DT/B-NP/O Bedeutung/NN/I-NP/O dieser/DT/B-NP/O Regulation/NN/I-NP/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP sind/VB/B-VP/O aber/RB/B-ADVP/O bisher/IN/B-PP/B-PNP unverstanden/NN/B-NP/I-PNP ././O/O

Ziel/NN/B-NP/O dieser/DT/I-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O es/PRP/B-NP/O daher/RB/B-ADVP/O ,/,/O/O vor/IN/B-PP/O -/-/O/O und/CC/O/O nachgeschaltete/NN/B-NP/O Signalwege/NN/I-NP/O zu/TO/B-VP/O identifizieren/VB/I-VP/O und/CC/O/O physiologische/JJ/B-NP/O Effekte/NNS/I-NP/O der/DT/B-NP/O Inaktivierung/NN/I-NP/O von/IN/B-PP/B-PNP Go2alpha/NN/B-NP/I-PNP zu/TO/B-VP/O analysieren/VB/I-VP/O ././O/O

Monoamine/NN/B-NP/O werden/VB/B-VP/O durch/IN/B-PP/B-PNP zwei/CD/B-NP/I-PNP Isoformen/NN/I-NP/I-PNP des/DT/B-NP/I-PNP vesikul\xc3\xa4ren/JJ/I-NP/I-PNP Monoamintransporters/NN/I-NP/I-PNP (/(/O/O VMAT/NNP/B-NP/O )/)/O/O in/IN/B-PP/B-PNP Vesikeln/JJ/B-NP/I-PNP gespeichert/NN/I-NP/I-PNP ././O/O

In/IN/B-PP/B-PNP Neurotransmitteraufnahmeexperimenten/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP CHO-Zellen/NN/B-NP/I-PNP ,/,/O/O die/WDT/O/O mit/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP mutierten/NN/I-NP/I-PNP Konstrukten/NN/I-NP/I-PNP des/DT/B-NP/I-PNP VMAT2/NN/I-NP/I-PNP transfiziert/NN/I-NP/I-PNP ,/,/O/O als/IN/B-PP/B-PNP stark/JJ/B-NP/I-PNP vereinfachtes/NN/I-NP/I-PNP Modellsystem/NN/I-NP/I-PNP dienten/VB/B-VP/O ,/,/O/O konnte/VBN/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP erste/JJ/I-NP/I-PNP intraluminale/NN/I-NP/I-PNP Schleife/NN/I-NP/I-PNP des/DT/B-NP/I-PNP VMAT2/NN/I-NP/I-PNP an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Signaltransduktion/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Vesikellumen/NN/I-NP/I-PNP beteiligt/VBN/B-VP/I-PNP ist/VB/I-VP/O ././O/O

\xc3\x84hnliche/JJ/B-NP/O Untersuchungen/NN/I-NP/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP VMAT1/NN/I-NP/I-PNP legen/VB/B-VP/O eine/DT/B-NP/O vergleichbare/JJ/I-NP/O Bedeutung/NN/I-NP/O der/DT/B-NP/O ersten/JJ/I-NP/O intraluminalen/JJ/I-NP/O Schleife/NN/I-NP/O als/IN/B-PP/B-PNP intravesikul\xc3\xa4re/JJ/B-NP/I-PNP Rezeptorstruktur/NN/I-NP/I-PNP nahe/RP/O/O ././O/O

Einen/DT/B-NP/O weiteren/JJ/I-NP/O Schwerpunkt/NN/I-NP/O der/DT/B-NP/O Arbeit/NN/I-NP/O bildete/VB/B-VP/O die/DT/B-NP/O Identifikation/NN/I-NP/O potentieller/NN/I-NP/O nachgeschalteter/JJ/B-NP/O Signalproteine/NN/I-NP/O ././O/O

Dabei/RB/B-VP/O stellte/VB/I-VP/O sich/PRP/B-NP/O heraus/RB/B-ADVP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Proteine/NN/I-NP/I-PNP CAPS1/NN/I-NP/I-PNP und/CC/O/O CAPS2/NN/B-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Lage/NN/I-NP/I-PNP sind/VB/B-VP/O ,/,/O/O den/DT/B-NP/O vesikul\xc3\xa4ren/NN/I-NP/O Monoamintransport/NN/I-NP/O und/CC/O/O die/DT/B-NP/O Speicherf\xc3\xa4higkeit/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP Monoamine/NN/B-NP/I-PNP zu/TO/B-VP/O erh\xc3\xb6hen/VB/I-VP/O ././O/O

Durch/IN/B-PP/B-PNP systematisches/JJ/B-NP/I-PNP Durchmustern/NN/I-NP/I-PNP einer/DT/B-NP/I-PNP cDNA-Bibliothek/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP konstitutiv/NN/B-NP/I-PNP aktivem/JJ/I-NP/I-PNP Go2alpha/NN/I-NP/I-PNP in/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Yeast-two-Hybrid-System/NN/I-NP/I-PNP wurden/VB/B-VP/O 15/CD/B-NP/O Proteine/NN/I-NP/O identifiziert/NN/I-NP/O ,/,/O/O die/DT/O/O als/IN/B-PP/B-PNP potentielle/JJ/B-NP/I-PNP Zielproteine/NN/I-NP/I-PNP an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP G-Proteinregulation/NN/I-NP/I-PNP der/DT/B-NP/I-PNP VMAT/NNP/I-NP/I-PNP beteiligt/VBN/B-VP/I-PNP sind/VB/I-VP/O ././O/O

Dar\xc3\xbcber/RB/B-ADVP/O hinaus/IN/B-PP/O konnten/JJ/B-ADJP/O verschiedene/VB/B-VP/O ,/,/O/O dabei/RB/B-ADVP/O identifizierte/NN/B-NP/O Go2alpha-bindende/NN/I-NP/O Proteine/NN/I-NP/O bereits/VB/B-VP/O im/IN/B-PP/B-PNP Zellkern/NN/B-NP/I-PNP lokalisiert/NN/I-NP/I-PNP bzw./RB/I-NP/I-PNP assoziiert/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Zytoskelett/NN/I-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O und/CC/O/O deuten/VB/B-VP/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Funktion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Go2alpha/NN/B-NP/I-PNP an/IN/B-PP/B-PNP diesen/DT/B-NP/I-PNP Strukturen/NN/I-NP/I-PNP hin/IN/B-PP/O ././O/O

In/IN/B-PP/O genetisch/JJ/B-ADJP/O ver\xc3\xa4nderten/VB/B-VP/O M\xc3\xa4usen/NN/B-NP/O ,/,/O/O die/DT/O/O nicht/RB/B-ADVP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Lage/NN/I-NP/I-PNP sind/VB/B-VP/O ,/,/O/O Go2alpha/NN/B-NP/O zu/IN/B-PP/B-PNP exprimieren/NN/B-NP/I-PNP ,/,/O/O konnten/VB/B-VP/O im/IN/B-PP/B-PNP Striatum/NN/B-NP/I-PNP ,/,/O/O einer/DT/B-NP/O Gehirnregion/NN/I-NP/O die/DT/O/O besonders/RB/B-ADVP/O an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP motorischen/JJ/I-NP/I-PNP Feinregulation/NN/I-NP/I-PNP beteiligt/VBN/B-VP/I-PNP ist/VB/I-VP/O ,/,/O/O verminderte/NN/B-NP/O Dopaminspiegel/NNP/I-NP/O festgestellt/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Diese/DT/B-NP/O verminderten/NN/I-NP/O Monoaminspiegel/JJ/B-NP/O korrelieren/NN/I-NP/O mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP verminderten/NN/I-NP/I-PNP Bewegungsaktivit\xc3\xa4t/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Go2a-defizienten/JJ/I-NP/I-PNP M\xc3\xa4use/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP Stimulation/NN/B-NP/I-PNP des/DT/I-NP/I-PNP dopaminergen/JJ/I-NP/I-PNP Systems/NN/I-NP/I-PNP mittels/IN/B-PP/B-PNP Amphetamin/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Kokain/NN/I-NP/I-PNP ././O/O

Zus\xc3\xa4tzlich/JJ/B-ADJP/O bleibt/VB/B-VP/O nach/IN/B-PP/B-PNP mehrfacher/JJ/B-NP/I-PNP Behandlung/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Kokain/NN/B-NP/I-PNP die/DT/O/O in/IN/B-PP/B-PNP Wildtyptieren/NN/B-NP/I-PNP einsetzende/JJ/I-NP/I-PNP substanzvermittelte/JJ/I-NP/I-PNP Sensibilisierung/NN/I-NP/I-PNP aus/RP/O/O ,/,/O/O die/WDT/O/O auf/IN/B-PP/B-PNP zus\xc3\xa4tzliche/JJ/B-NP/I-PNP St\xc3\xb6rungen/NN/I-NP/I-PNP des/DT/B-NP/I-PNP dopaminergen/NN/I-NP/I-PNP Systems/NN/I-NP/I-PNP hinweist.Mit/NN/I-NP/I-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP wird/VB/B-VP/O das/DT/B-NP/O erste/JJ/I-NP/O Octopamin-Rezeptorgen/NN/I-NP/O (/(/O/O Amoct1/NN/B-NP/O )/)/O/O aus/IN/B-PP/B-PNP Apis/NN/B-NP/I-PNP mellifera/JJ/I-NP/I-PNP beschrieben/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O rezeptorkodierende/NN/I-NP/O cDNA/NNP/I-NP/O wurde/VB/B-VP/O funktionell/JJ/B-ADJP/O in/IN/B-PP/B-PNP Ammenzellen/NN/B-NP/I-PNP (/(/O/O HEK/NNP/B-NP/O 293/CD/O/O )/)/O/O exprimiert/NN/B-NP/O und/CC/I-NP/O der/DT/I-NP/O Rezeptor/NN/I-NP/O auf/IN/B-PP/B-PNP seine/PRP$/B-NP/I-PNP funktionelle/JJ/I-NP/I-PNP Kopplung/NN/I-NP/I-PNP an/IN/B-PP/B-PNP intrazellul\xc3\xa4re/JJ/B-NP/I-PNP Botenstoff-Wege/NN/I-NP/I-PNP untersucht/RP/O/O ././O/O

Die/DT/B-NP/O Aktivierung/NN/I-NP/O des/DT/B-NP/O Rezeptors/NN/I-NP/O mit/IN/B-PP/B-PNP spezifischen/JJ/B-NP/I-PNP Liganden/NN/I-NP/I-PNP bewirkt/VB/B-VP/O in/IN/B-PP/B-PNP HEK/NNP/B-NP/I-PNP 293/CD/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP eine/DT/B-NP/I-PNP konzentrationsabh\xc3\xa4ngige/NN/I-NP/I-PNP Erh\xc3\xb6hung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP [/NN/I-NP/I-PNP Ca2+]i/NN/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O [/JJ/I-NP/O cAMP]i/NN/I-NP/O ././O/O

Die/DT/B-NP/O Ca2+-Antwort/NN/I-NP/O der/DT/B-NP/O Zellen/NNS/I-NP/O erfolgt/VB/B-VP/O bereits/RB/B-ADVP/O bei/IN/B-PP/B-PNP submikromolaren/NN/B-NP/I-PNP Konzentrationen/JJ/I-NP/I-PNP Octopamin/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O cAMP-Akkumulation/NN/I-NP/O setzt/VB/B-VP/O erst/RB/B-ADVP/O bei/IN/B-PP/B-PNP mikromolaren/NN/B-NP/I-PNP Octopamin-Konzentrationen/NN/I-NP/I-PNP ein/RP/O/O ././O/O

Das/DT/B-NP/O Expressionsmuster/NN/I-NP/O der/DT/B-NP/O Amoct1-mRNA/NNP/I-NP/O im/IN/B-PP/B-PNP Gehirn/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Biene/NN/I-NP/I-PNP wurde/VB/B-VP/O durch/IN/B-PP/B-PNP in/IN/I-PP/I-PNP situ-Hybridisierungen/JJ/B-NP/I-PNP aufgekl\xc3\xa4rt/NN/I-NP/I-PNP ././O/O

Amoct1-mRNA/NNP/B-NP/O wurde/VB/B-VP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Somata/NN/I-NP/I-PNP aller/DT/O/O Gehirnbereiche/JJ/B-ADJP/O nachgewiesen/RP/O/O ././O/O

Besonders/RB/B-NP/O starke/JJ/I-NP/O Markierungen/NN/I-NP/O wurden/VB/B-VP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Somata/NN/I-NP/I-PNP der/DT/B-NP/I-PNP intrinsischen/JJ/I-NP/I-PNP Pilzk\xc3\xb6rperzellen/NN/I-NP/I-PNP gefunden/RP/O/O ././O/O

Die/DT/B-NP/O zellul\xc3\xa4re/JJ/I-NP/O Lokalisation/NN/I-NP/O des/DT/B-NP/O Octopamin-Rezeptors/NN/I-NP/O ,/,/O/O AmOCT1/NN/B-NP/O ,/,/O/O wurde/VB/B-VP/O mit/IN/B-PP/B-PNP spezifischen/JJ/B-NP/I-PNP polyklonalen/JJ/I-NP/I-PNP Antik\xc3\xb6rpern/NN/I-NP/I-PNP an/IN/B-PP/B-PNP Gehirnschnitten/NN/B-NP/I-PNP adulter/NN/I-NP/I-PNP Arbeiterinnen/NNS/I-NP/I-PNP bestimmt/RP/O/O ././O/O

Das/DT/B-NP/O Rezeptorprotein/NNP/I-NP/O ist/VB/B-VP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP meisten/DT/I-NP/I-PNP Gehirnregionen/NN/I-NP/I-PNP vorhanden/JJ/B-ADJP/O ././O/O

Neben/IN/B-PP/O den/DT/O/O bereits/RB/B-ADVP/O aus/IN/B-PP/B-PNP Apis/NN/B-NP/I-PNP mellifera/NN/I-NP/I-PNP klonierten/NN/I-NP/I-PNP Tyramin/NN/I-NP/I-PNP -/-/O/O und/CC/O/O Dopamin-Rezeptoren/NN/B-NP/O ist/VBN/B-VP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Klonierung/NN/I-NP/I-PNP und/CC/O/O funktionellen/NN/B-NP/O Charakterisierung/NN/I-NP/O des/DT/B-NP/O Octopamin-Rezeptors/NN/I-NP/O ,/,/O/O AmOCT1/NN/B-NP/O ,/,/O/O nun/RB/B-ADVP/O eine/DT/B-NP/O weitere/JJ/I-NP/O wichtige/JJ/I-NP/O Grundlage/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Untersuchung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP molekularen/JJ/I-NP/I-PNP Mechanismen/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Lern/NN/B-NP/I-PNP -/-/O/O und/CC/O/O Ged\xc3\xa4chtnisprozessen/NN/B-NP/O geschaffen/VB/B-VP/O worden.Phyllochinon/NN/B-NP/O (/(/O/O Vitamin/NN/B-NP/O K1/NNP/I-NP/O )/)/O/O wird/VB/B-VP/O in/IN/B-PP/B-PNP Cyanobakterien/NN/B-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Chloroplasten/NN/I-NP/I-PNP h\xc3\xb6herer/JJ/B-NP/I-PNP Pflanzen/JJ/I-NP/I-PNP synthetisiert/NN/I-NP/I-PNP ././O/O

Dort/RB/B-VP/O ist/VB/I-VP/O es/PRP/B-NP/O integraler/NN/I-NP/O Bestandteil/NN/I-NP/O des/DT/I-NP/O Photosystems/NN/I-NP/O I/CD/O/O ist/VB/B-VP/O und/CC/O/O fungiert/RB/B-ADVP/O als/IN/B-PP/B-PNP Elektronen\xc3\xbcbertr\xc3\xa4ger/NN/B-NP/I-PNP ././O/O

Der/DT/B-NP/O erste/JJ/I-NP/O Schritt/NN/I-NP/O der/DT/B-NP/O Phyllochinon-Biosynthese/NN/I-NP/O ist/VB/B-VP/O die/DT/O/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP einer/DT/B-NP/I-PNP Isochorismatsynthase/NN/I-NP/I-PNP (/(/O/O ICS/NNP/B-NP/O )/)/O/O katalysierte/JJ/B-NP/O Umwandlung/NN/I-NP/O von/IN/B-PP/B-PNP Chorismat/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP Isochorismat/NN/B-NP/I-PNP ,/,/O/O welches/WP/O/O Vorstufe/NN/B-NP/O der/DT/I-NP/O Phyllochinon/NN/I-NP/O -/-/O/O als/CC/O/O auch/IN/B-PP/B-PNP Salicylatbiosynthese/NN/B-NP/I-PNP ist/VB/B-VP/O ././O/O

alicylat/JJ/B-NP/O spielt/NN/I-NP/O in/IN/B-PP/B-PNP Pflanzen/NN/B-NP/I-PNP vor/IN/B-PP/O allem/DT/O/O als/IN/B-PP/B-PNP Mittler/NN/B-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Abwehr/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Pathogenen/NN/B-NP/I-PNP eine/DT/I-NP/I-PNP wichtige/JJ/I-NP/I-PNP Rolle/NN/I-NP/I-PNP ././O/O

In/IN/B-PP/B-PNP Arabidopsis/NN/B-NP/I-PNP kodieren/VB/B-VP/O zwei/CD/B-NP/O Gene/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Isochorismatsynthase/NN/I-NP/I-PNP :/:/O/O ICS1/NN/B-NP/O und/CC/I-NP/O ICS2/NN/I-NP/O ././O/O

Beide/JJ/B-NP/O Gene/NN/I-NP/O sind/VB/B-VP/O an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Phyllochinonbiosynthese/NN/I-NP/I-PNP beteiligt/RP/O/O ././O/O

ICS1/RB/B-VP/O ist/VB/I-VP/O zudem/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Salicylatbiosynthese/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Bedeutung/NN/B-NP/I-PNP ist/VB/B-VP/O ././O/O

Die/DT/B-NP/O Tatsache/NN/I-NP/O ,/,/O/O dass/IN/B-PP/B-PNP in/IN/I-PP/I-PNP der/DT/B-NP/I-PNP Nullmutante/NN/I-NP/I-PNP ics1/NN/I-NP/I-PNP noch/IN/B-PP/B-PNP Salicylat/NN/B-NP/I-PNP akkumuliert/NN/I-NP/I-PNP ,/,/O/O l\xc3\xa4sst/VB/B-VP/O die/DT/B-NP/O Vermutung/NN/I-NP/O zu/TO/O/O ,/,/O/O dass/IN/B-PP/O auch/RB/B-ADVP/O das/DT/B-NP/O zweite/JJ/I-NP/O Isochorismatgen/NN/I-NP/O ICS2/NN/I-NP/O oder/RB/B-ADVP/O ein/DT/B-NP/O alternativer/JJ/I-NP/O Biosyntheseweg/NN/I-NP/O an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Bildung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Salicylat/NN/B-NP/I-PNP beteiligt/VBN/B-VP/I-PNP ist/VB/I-VP/O ././O/O

In/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Gen/NN/I-NP/I-PNP ICS2/NN/I-NP/I-PNP ein/DT/B-NP/I-PNP funktionell/JJ/I-NP/I-PNP aktives/JJ/I-NP/I-PNP Enzym/NN/I-NP/I-PNP kodiert/NN/I-NP/I-PNP ,/,/O/O welches/WDT/O/O in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Salicylatbiosynthese/NN/I-NP/I-PNP involviert/NN/I-NP/I-PNP ist/VB/B-VP/O ././O/O

Die/DT/B-NP/O Hauptaktivit\xc3\xa4t/NN/I-NP/O besitzt/NN/I-NP/O jedoch/VB/B-VP/O die/DT/O/O durch/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Gen/NN/I-NP/I-PNP ICS1/NN/I-NP/I-PNP kodierte/NN/I-NP/I-PNP Isochorismatsynthase/NN/I-NP/I-PNP 1/CD/O/O ././O/O

Dass/IN/B-PP/B-PNP in/IN/I-PP/I-PNP der/DT/B-NP/I-PNP phyllochinonfreien/NN/I-NP/I-PNP Doppelmutante/NN/I-NP/I-PNP ics1ics2/NN/I-NP/I-PNP noch/VB/B-VP/O geringe/JJ/B-NP/O Mengen/NN/I-NP/O an/IN/B-PP/B-PNP Salicylat/NN/B-NP/I-PNP detektiert/NN/I-NP/I-PNP werden/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ,/,/O/O best\xc3\xa4tigt/VB/B-VP/O die/DT/B-NP/O Vermutung/NN/I-NP/O ,/,/O/O dass/IN/B-PP/B-PNP in/IN/I-PP/I-PNP Arabidopsis/NN/B-NP/I-PNP zudem/VB/B-VP/O ein/DT/B-NP/O ICS-unabh\xc3\xa4ngiger/NN/I-NP/O Salicylatbiosyntheseweg/NN/I-NP/O existiert/VB/B-VP/O ././O/O

Die/DT/B-NP/O Methylierung/NN/I-NP/O von/IN/B-PP/B-PNP 2-Phytyl-1,4-naphthochinon/NN/B-NP/I-PNP (/(/O/O PNQ/NN/B-NP/O )/)/O/O zu/IN/B-PP/B-PNP Phyllochinon/NN/B-NP/I-PNP ist/VB/B-VP/O der/DT/B-NP/O letzte/JJ/I-NP/O Schritt/NN/I-NP/O der/DT/B-NP/O Phyllochonbiosynthese/NN/I-NP/O in/IN/B-PP/B-PNP Cyanobakterien/NN/B-NP/I-PNP und/CC/O/O wird/VB/B-VP/O katalysiert/NN/B-NP/O durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Methyltransfearse/JJ/I-NP/I-PNP menG/NN/I-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP zweiten/JJ/B-NP/I-PNP Teil/NN/I-NP/I-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurde/RB/B-VP/O gezeigt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP in/IN/I-PP/I-PNP der/DT/B-NP/I-PNP phyllochinonfreien/NN/I-NP/I-PNP Mutante/NN/I-NP/I-PNP AtmenG/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Vorstufe/NN/I-NP/I-PNP PNQ/JJ/B-NP/I-PNP akkumuliert/NN/I-NP/I-PNP ././O/O

PNQ/NN/B-NP/O wie/CC/O/O auch/IN/B-PP/B-PNP Phyllochinon/NN/B-NP/I-PNP sind/VB/B-VP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Thylakoidmembranen/JJ/I-NP/I-PNP lokalisiert/NN/I-NP/I-PNP ././O/O

\xc3\x9cbersch\xc3\xbcssige/JJ/B-NP/O Mengen/NN/I-NP/O beider/JJ/B-NP/O Molek\xc3\xbcle/NN/I-NP/O werden/VB/B-VP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Plastoglobuli/JJ/I-NP/I-PNP gespeichert/NN/I-NP/I-PNP ././O/O

In/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Mutante/NN/I-NP/I-PNP AtmenG/NN/I-NP/I-PNP \xc3\xbcbernimmt/VB/B-VP/O PNQ/NN/B-NP/O teilweise/RB/B-ADVP/O die/DT/B-NP/O Funktion/NN/I-NP/O des/DT/B-NP/O fehlenden/JJ/I-NP/O Phyllochinons/NN/I-NP/O innerhalb/IN/B-PP/B-PNP des/DT/B-NP/I-PNP Photosystems/NN/I-NP/I-PNP I./VB/B-VP/O Die/DT/B-NP/O Ergebnisse/NN/I-NP/O dieser/DT/B-NP/O Arbeit/NN/I-NP/O belegen/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O in/IN/B-PP/B-PNP AtmenG/NN/B-NP/I-PNP u.a./VB/B-VP/O die/DT/B-NP/O Menge/NN/I-NP/O an/IN/B-PP/B-PNP funktionellem/NN/B-NP/I-PNP Photosystem/NN/I-NP/I-PNP I/CD/O/O ebenso/RB/B-ADVP/O wie/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Quantenausbeute/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Photosystems/NN/I-NP/I-PNP II/CD/B-NP/I-PNP verringert/NN/I-NP/I-PNP sind/VB/B-VP/O ././O/O

Besonders/RB/B-ADVP/O unter/IN/B-PP/B-PNP Hochlichtbedingungen/NN/B-NP/I-PNP wird/VB/B-VP/O deutlich/JJ/B-ADJP/O ,/,/O/O dass/RB/B-ADVP/O die/DT/B-NP/O Methylierung/NN/I-NP/O von/IN/B-PP/B-PNP Phyllochinon/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Arabidopsis/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP maximale/NN/I-NP/I-PNP photosynthetische/JJ/B-NP/I-PNP Effizienz/NN/I-NP/I-PNP von/IN/B-PP/B-PNP gro\xc3\x9fer/JJ/B-NP/I-PNP Bedeutung/NN/I-NP/I-PNP ist.Um/NN/I-NP/I-PNP neue/JJ/B-NP/I-PNP Zielmolek\xc3\xbcle/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP rationale/JJ/I-NP/I-PNP Medikamentenentwicklung/NN/I-NP/I-PNP gegen/IN/B-PP/B-PNP Tumorerkrankungen/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Brust/NN/I-NP/I-PNP identifizieren/JJ/B-ADJP/O zu/TO/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ,/,/O/O wurden/VB/B-VP/O anhand/IN/B-PP/B-PNP von/IN/I-PP/I-PNP Genchip/NN/B-NP/I-PNP Hybridisierungsdaten/NN/I-NP/I-PNP die/DT/O/O im/IN/B-PP/B-PNP Mammakarzinom/NN/B-NP/I-PNP \xc3\xbcberexprimierten/NN/I-NP/I-PNP Gene/NN/I-NP/I-PNP LIV-1/NN/I-NP/I-PNP und/CC/I-NP/I-PNP Stromelysin-3/NN/I-NP/I-PNP (/(/O/O SL-3/NN/B-NP/O )/)/O/O f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP weitere/JJ/I-NP/I-PNP Analyse/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Proteinexpressionsmusters/NN/I-NP/I-PNP bzw./RB/B-ADVP/O der/DT/B-NP/O Tumorrelevanz/JJ/I-NP/O ausgew\xc3\xa4hlt/NN/I-NP/O ././O/O

Die/DT/B-NP/O \xc3\x9cberexpression/NN/I-NP/O auf/IN/B-PP/B-PNP mRNA/NNP/B-NP/I-PNP Ebene/NNP/I-NP/I-PNP wurde/VB/B-VP/O zuvor/RB/B-ADVP/O mittels/IN/B-PP/B-PNP quantitativer/NN/B-NP/I-PNP RT-PCR/NN/I-NP/I-PNP best\xc3\xa4tigt/RP/O/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Transkripte/NN/I-NP/I-PNP des/DT/B-NP/I-PNP putativen/NN/I-NP/I-PNP Zinktransporters/NN/I-NP/I-PNP LIV-1/NN/I-NP/I-PNP wurde/VB/B-VP/O durch/IN/B-PP/B-PNP in/IN/I-PP/I-PNP situ/JJ/B-NP/I-PNP Hybridisierung/NN/I-NP/I-PNP an/IN/B-PP/B-PNP 111/CD/B-NP/I-PNP Tumor/NN/I-NP/I-PNP -/-/O/O und/CC/O/O dazugeh\xc3\xb6rigen/RB/B-ADVP/O Normalgeweben/NN/B-NP/O der/DT/B-NP/O Brust/NN/I-NP/O die/DT/B-NP/O Assoziation/NN/I-NP/O mit/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP positiven/JJ/I-NP/I-PNP \xc3\x96strogenrezeptor/NN/I-NP/I-PNP -/-/O/O ?/./O/O

atus/NN/B-NP/O sowie/RB/B-ADVP/O deren/DT/B-NP/O \xc3\x9cberexpression/NN/I-NP/O in/IN/B-PP/B-PNP ca/NN/B-NP/I-PNP ././O/O

50%/CD/B-NP/O der/DT/I-NP/O Brusttumorproben/NN/I-NP/O best\xc3\xa4tigt/RP/O/O ././O/O

Da/IN/B-PP/B-PNP gezeigt/VBN/B-VP/I-PNP werden/VB/I-VP/O konnte/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP LIV-1/NN/I-NP/I-PNP Expressionsh\xc3\xb6he/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP des/DT/B-NP/I-PNP \xc3\x96strogenrezeptor/NN/I-NP/I-PNP -/-/O/O ?/./O/O

besser/IN/B-PP/B-PNP reflektiert/NN/B-NP/I-PNP als/IN/B-PP/O der/DT/O/O derzeit/RB/B-ADVP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP klinischen/JJ/I-NP/I-PNP Diagnostik/NN/I-NP/I-PNP verwendete/VB/B-VP/O Progesteronrezeptorstatus/NN/B-NP/O ,/,/O/O k\xc3\xb6nnten/VB/B-VP/O diese/WDT/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Entscheidung/NN/I-NP/I-PNP \xc3\xbcber/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP anti-hormonale/NN/I-NP/I-PNP Therapie/NN/I-NP/I-PNP verwendet/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Herstellung/NN/I-NP/I-PNP und/CC/O/O Validierung/NN/B-NP/O eines/DT/B-NP/O LIV-1/NN/I-NP/O spezifischen/JJ/B-NP/O polyklonalen/JJ/I-NP/O Antik\xc3\xb6rpers/NN/I-NP/O war/VB/B-VP/O es/PRP/B-NP/O m\xc3\xb6glich/JJ/B-ADJP/O ,/,/O/O die/DT/B-NP/O Lokalisation/NN/I-NP/O des/DT/B-NP/O Proteins/NN/I-NP/O im/IN/B-PP/B-PNP endoplasmatischen/JJ/B-NP/I-PNP Retikulum/NN/I-NP/I-PNP nachzuweisen/VB/B-VP/O ././O/O

Anhand/IN/B-PP/B-PNP von/IN/I-PP/I-PNP immunhistochemischen/JJ/B-NP/I-PNP F\xc3\xa4rbungen/NN/I-NP/I-PNP wurde/RB/B-VP/O festgestellt/VBN/I-VP/O ,/,/O/O da/IN/B-PP/B-PNP LIV-1/NN/B-NP/I-PNP mRNA/NNP/I-NP/I-PNP -/-/O/O und/CC/O/O Proteinexpressionsh\xc3\xb6hen/NN/B-NP/O weder/RB/B-ADVP/O in/IN/B-PP/B-PNP Normal/NN/B-NP/I-PNP -/-/O/O noch/IN/B-PP/B-PNP Tumorgeweben/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Brust/NN/I-NP/I-PNP miteinander/IN/B-PP/B-PNP korrelieren/NN/B-NP/I-PNP ././O/O

Dies/DT/B-NP/O deutet/NN/I-NP/O auf/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Vorhandensein/NN/I-NP/I-PNP posttranskriptionaler/NN/I-NP/I-PNP Regulationsmechanismen/NN/I-NP/I-PNP hin/IN/B-PP/O ././O/O

Allerdings/VBN/B-VP/O wurde/RB/I-VP/O nachgewiesen/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP LIV-1/JJ/I-NP/I-PNP Proteinmengen/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Prognose/NN/I-NP/I-PNP der/DT/B-NP/I-PNP L\xc3\xa4nge/NN/I-NP/I-PNP des/DT/B-NP/I-PNP krankheitsfreien/NN/I-NP/I-PNP Intervalls/RB/B-ADJP/O geeignet/JJ/I-ADJP/O sind/VB/B-VP/O ././O/O

Im/IN/B-PP/B-PNP Gegensatz/NN/B-NP/I-PNP zur/IN/B-PP/B-PNP mRNA/NNP/B-NP/I-PNP -/-/O/O war/VB/B-VP/O die/DT/B-NP/O Proteinexpression/NN/I-NP/O in/IN/B-PP/B-PNP aggressiven/JJ/B-NP/I-PNP Tumoren/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP zum/IN/B-PP/B-PNP Brustnormalgewebe/NN/B-NP/I-PNP signifikant/JJ/B-ADJP/O erniedrigt/VBN/B-VP/O ,/,/O/O was/WDT/O/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Funktion/NN/I-NP/I-PNP als/IN/B-PP/B-PNP neues/JJ/B-NP/I-PNP Tumorsuppressorprotein/NNP/I-NP/I-PNP hindeutet/NNP/I-NP/I-PNP ././O/O

Da/IN/B-PP/O au\xc3\x9ferdem/RB/B-ADVP/O eine/DT/B-NP/O hohe/JJ/I-NP/O Expression/NN/I-NP/O des/DT/B-NP/O Proteins/NN/I-NP/O in/IN/B-PP/B-PNP Normalgeweben/NNP/B-NP/I-PNP lebenswichtiger/NNP/I-NP/I-PNP Organe/NNP/I-NP/I-PNP gezeigt/VBN/B-VP/I-PNP wurde/VB/I-VP/O ,/,/O/O scheint/VBN/B-VP/O LIV-1/NN/B-NP/O als/IN/B-PP/B-PNP potentielles/JJ/B-NP/I-PNP Zielmolek\xc3\xbcl/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Entwicklung/NN/I-NP/I-PNP therapeutischer/NN/I-NP/I-PNP Inhibitoren/NN/I-NP/I-PNP ungeeignet/NN/I-NP/I-PNP zu/TO/B-VP/O sein/VB/I-VP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP sekretierte/NN/I-NP/I-PNP Matrix-Metalloprotease/NN/I-NP/I-PNP SL-3/NN/I-NP/I-PNP ,/,/O/O deren/WDT/B-NP/O prognostische/JJ/I-NP/O Signifikanz/NN/I-NP/O bereits/RB/B-VP/O bekannt/VBN/I-VP/O war/VB/I-VP/O ,/,/O/O wurde/RB/B-VP/O gezeigt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP \xc3\x9cberexpression/NN/I-NP/I-PNP in/IN/B-PP/B-PNP humanen/NN/B-NP/I-PNP Brusttumorzelllinien/NN/I-NP/I-PNP deren/DT/I-NP/I-PNP Zellzahl/NN/I-NP/I-PNP in/IN/B-PP/B-PNP 3D/NN/B-NP/I-PNP Zellkulturmodellen/NN/I-NP/I-PNP erh\xc3\xb6ht/RP/O/O ././O/O

Dieser/DT/B-NP/O Effekt/NN/I-NP/O war/VB/B-VP/O abh\xc3\xa4ngig/JJ/B-ADJP/O von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP IGF-1/JJ/I-NP/I-PNP Signalkaskade/NN/I-NP/I-PNP ././O/O

Au\xc3\x9ferdem/RB/B-ADVP/O steigerte/NN/B-NP/O SL-3/NN/I-NP/O sowohl/RB/B-ADVP/O in/IN/B-PP/B-PNP in/IN/I-PP/I-PNP vitro/NN/B-NP/I-PNP Softagartests/NN/I-NP/I-PNP als/CC/O/O auch/RB/B-ADVP/O in/IN/B-PP/B-PNP in/IN/I-PP/I-PNP vivo/NN/B-NP/I-PNP Xenograft/JJ/I-NP/I-PNP Tumormodellen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Nacktm\xc3\xa4usen/NN/B-NP/I-PNP die/DT/I-NP/I-PNP Tumorgenit\xc3\xa4t/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Zelllinien/NN/I-NP/I-PNP ././O/O

In/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP f\xc3\xbchrte/VB/B-VP/O die/DT/B-NP/O SL-3/NN/I-NP/O \xc3\x9cberexpression/NN/I-NP/O zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP h\xc3\xb6heren/JJ/I-NP/I-PNP Anwachsrate/NN/I-NP/I-PNP sowie/RB/B-ADVP/O einer/DT/B-NP/O Volumenzunahme/NN/I-NP/O der/DT/B-NP/O Tumore/NN/I-NP/O ././O/O

Dieser/DT/B-NP/O Effekt/NN/I-NP/O war/VB/B-VP/O ebenfalls/RB/B-ADJP/O abh\xc3\xa4ngig/JJ/I-ADJP/O von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Anwesenheit/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Wachstumsfaktoren/NN/B-NP/I-PNP ././O/O

Die/DT/B-NP/O gewonnenen/NN/I-NP/O Daten/NN/I-NP/O zeigen/VB/B-VP/O somit/RP/I-VP/O ,/,/O/O dass/RB/B-ADVP/O LIV-1/NN/B-NP/O als/IN/B-PP/B-PNP prognostischer/NN/B-NP/I-PNP Marker/VB/B-VP/O sowohl/CC/O/O auf/IN/B-PP/B-PNP mRNA/NNP/B-NP/I-PNP -/-/O/O als/CC/O/O auch/RB/B-ADVP/O auf/IN/B-PP/B-PNP Proteinebene/NN/B-NP/I-PNP klinische/JJ/I-NP/I-PNP Relevanz/NN/I-NP/I-PNP beweisen/VB/B-VP/O k\xc3\xb6nnte/VB/I-VP/O ././O/O

l-3/NN/B-NP/O hingegen/JJ/B-ADJP/O stellt/VB/B-VP/O aufgrund/IN/B-PP/B-PNP seiner/PRP$/B-NP/I-PNP hohen/JJ/I-NP/I-PNP \xc3\x9cberexpression/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Mammakarzinom/NN/B-NP/I-PNP und/CC/I-NP/I-PNP der/DT/I-NP/I-PNP gezeigten/JJ/I-NP/I-PNP Tumorrelevanz/NN/I-NP/I-PNP in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP einen/DT/O/O viel/IN/B-PP/B-PNP versprechenden/JJ/B-NP/I-PNP Kandidaten/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Entwicklung/NN/I-NP/I-PNP eines/DT/B-NP/I-PNP spezifischen/JJ/I-NP/I-PNP Therapieansatzes/NN/I-NP/I-PNP dar.P/NNP/I-NP/I-PNP ././O/O

aeruginosa/JJ/B-NP/O synthetisiert/JJ/I-NP/O aerob/NN/I-NP/O auf/IN/B-PP/B-PNP Ethanol/NN/B-NP/I-PNP eine/DT/I-NP/I-PNP Quinoprotein-Ethanoldehydrogenase/NN/I-NP/I-PNP (/(/O/O QEDH/NNP/B-NP/O ;/:/O/O kodiert/NN/B-NP/O von/IN/B-PP/B-PNP exaA/NNP/B-NP/I-PNP )/)/O/O ,/,/O/O eine/DT/B-NP/O NAD+-abh\xc3\xa4ngige/NN/I-NP/O Acetaldehyd-DH/NN/I-NP/O (/(/O/O kodiert/NN/B-NP/O von/IN/B-PP/B-PNP exaB/NN/B-NP/I-PNP )/)/O/O ,/,/O/O ein/DT/B-NP/O Cytochrom/JJ/I-NP/O c550/NN/I-NP/O (/(/O/O kodiert/NN/B-NP/O von/IN/B-PP/B-PNP exaC/NN/B-NP/I-PNP )/)/O/O und/CC/O/O den/DT/B-NP/O Kofaktor/JJ/I-NP/O PQQ/NN/I-NP/O (/(/O/O kodiert/NN/B-NP/O von/IN/B-PP/B-PNP pqqABCDE/NN/B-NP/I-PNP )/)/O/O ././O/O

An/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Regulation/NN/I-NP/I-PNP dieser/DT/B-NP/I-PNP Komponenten/NN/I-NP/I-PNP ist/VB/B-VP/O ein/DT/B-NP/O hierarchisch/JJ/I-NP/O aufgebautes/JJ/I-NP/O System/NN/I-NP/O aus/IN/B-PP/B-PNP Sensorkinasen/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Responsregulatoren/NN/I-NP/I-PNP beteiligt/VBN/B-VP/I-PNP :/:/O/O Das/DT/B-NP/O Zweikomponentensystem/NN/I-NP/O ExaDE/NN/I-NP/O kontrolliert/VB/B-VP/O die/DT/B-NP/O Transkription/NN/I-NP/O von/IN/B-PP/B-PNP exaA/NNP/B-NP/I-PNP ././O/O

Der/DT/B-NP/O Responsregulator/NN/I-NP/O AgmR/NN/I-NP/O steuert/NN/I-NP/O die/DT/B-NP/O Transkription/NN/I-NP/O von/IN/B-PP/B-PNP exaBC/NN/B-NP/I-PNP ,/,/O/O exaDE/NN/B-NP/O und/CC/I-NP/O pqqABCDE/NN/I-NP/O ././O/O

Der/DT/B-NP/O Responsregulator/NN/I-NP/O PA3604/NN/I-NP/O aktiviert/NN/I-NP/O als/IN/B-PP/B-PNP genereller/JJ/B-NP/I-PNP Regulator/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Transkription/NN/I-NP/I-PNP von/IN/B-PP/B-PNP agmR/NN/B-NP/I-PNP ././O/O

Die/DT/B-NP/O eisenabh\xc3\xa4ngige/NN/I-NP/O ADH/NNP/I-NP/O kodiert/NNP/I-NP/O von/IN/B-PP/B-PNP PA1991/NN/B-NP/I-PNP wurde/VB/B-VP/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP als/IN/B-PP/B-PNP regulatorisches/JJ/B-NP/I-PNP Enzym/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP Induktion/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Ethanol-oxidierenden/NN/I-NP/I-PNP Systems/JJ/B-NP/I-PNP identifiziert/NN/I-NP/I-PNP ././O/O

Das/DT/B-NP/O Enzym/NN/I-NP/O oxidiert/NN/I-NP/O 1,3-Propandiol/NN/I-NP/O und/CC/O/O andere/JJ/B-NP/O Alkohole/NNS/I-NP/O ././O/O

Das/DT/B-NP/O Gen/NN/I-NP/O PA1991/NN/I-NP/O wurde/VB/B-VP/O durch/IN/B-PP/B-PNP Insertionsmutagenese/JJ/B-NP/I-PNP inaktiviert/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O erzeugte/NN/I-NP/O Mutante/NN/I-NP/O NH1/NN/I-NP/O konnte/VB/B-VP/O auf/IN/B-PP/B-PNP Ethanol/NN/B-NP/I-PNP erst/RB/B-ADVP/O nach/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP extrem/JJ/I-NP/I-PNP langen/JJ/I-NP/I-PNP lag-Phase/NN/I-NP/I-PNP wachsen/VB/B-VP/O ././O/O

Das/DT/B-NP/O schlechte/JJ/I-NP/O Wachstum/NN/I-NP/O der/DT/B-NP/O Mutante/NN/I-NP/O NH1/JJ/B-NP/O korrelierte/NN/I-NP/O mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP gemessenen/NN/I-NP/I-PNP geringen/JJ/B-NP/I-PNP Enzymaktivit\xc3\xa4ten/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Rohextrakt/NN/B-NP/I-PNP ././O/O

Nach/IN/B-PP/B-PNP Induktion/NN/B-NP/I-PNP auf/IN/B-PP/B-PNP Ethanol/NN/B-NP/I-PNP waren/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP NH1-Mutante/NN/I-NP/I-PNP keine/JJ/B-NP/I-PNP QEDH-Aktivit\xc3\xa4t/NN/I-NP/I-PNP und/CC/O/O nur/RB/B-ADVP/O eine/DT/B-NP/O stark/JJ/I-NP/O reduzierte/JJ/I-NP/O Aktivit\xc3\xa4t/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP eisenabh\xc3\xa4ngige/NN/I-NP/I-PNP ADH/NN/I-NP/I-PNP nachweisbar/JJ/B-ADJP/O ././O/O

Nach/IN/B-PP/B-PNP Komplementation/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP intakten/NN/I-NP/I-PNP Gen/NN/I-NP/I-PNP PA1991/NN/I-NP/I-PNP wurde/VB/B-VP/O das/DT/B-NP/O Wachstum/NN/I-NP/O des/DT/B-NP/O Wildtypes/NN/I-NP/O wieder/RB/B-ADVP/O hergestellt/RP/O/O ././O/O

Weitergehende/JJ/B-NP/O Analysen/NN/I-NP/O mit/IN/B-PP/B-PNP Reportergenkonstrukten/NN/B-NP/I-PNP ergaben/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Mutante/NN/I-NP/I-PNP NH1/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP verringerte/NN/I-NP/I-PNP Transkription/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Gene/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Ethanol-oxidierenden/NN/I-NP/I-PNP Systems/NN/I-NP/I-PNP agmR/NN/I-NP/I-PNP ,/,/O/O exaDE/NN/B-NP/O ,/,/O/O exaA/NNP/B-NP/O ,/,/O/O exaBC/NN/B-NP/O und/CC/I-NP/O pqqABCDE/NN/I-NP/O im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP zum/IN/B-PP/B-PNP Wildtyp/NN/B-NP/I-PNP ././O/O

In/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Mutante/NN/I-NP/I-PNP NH1/NN/I-NP/I-PNP verst\xc3\xa4rkte/VB/B-VP/O die/DT/B-NP/O konstitutive/JJ/I-NP/O Expression/NN/I-NP/O von/IN/B-PP/B-PNP ExaDE/NN/B-NP/I-PNP die/DT/I-NP/I-PNP Transkription/NN/I-NP/I-PNP von/IN/B-PP/B-PNP exaA/NNP/B-NP/I-PNP und/CC/I-NP/I-PNP die/DT/I-NP/I-PNP konstitutive/JJ/I-NP/I-PNP Expression/NN/I-NP/I-PNP von/IN/B-PP/B-PNP AgmR/NN/B-NP/I-PNP die/DT/I-NP/I-PNP Transkription/NN/I-NP/I-PNP von/IN/B-PP/B-PNP exaA/NNP/B-NP/I-PNP ,/,/O/O exaBC/NN/B-NP/O und/CC/I-NP/O pqqABCDE/NN/I-NP/O ././O/O

Das/DT/B-NP/O Gen/NN/I-NP/O PA1991/NN/I-NP/O bildet/VBN/B-VP/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP stromabw\xc3\xa4rts/NN/I-NP/I-PNP gelegenen/JJ/B-NP/I-PNP Gen/JJ/I-NP/I-PNP PA1992/NN/I-NP/I-PNP (/(/O/O kodiert/NN/B-NP/O f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Sensorkinase/NN/I-NP/I-PNP )/)/O/O ein/DT/B-NP/O Operon/NN/I-NP/O ././O/O

Mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Reportergenkonstrukten/NN/B-NP/I-PNP sowie/RB/B-ADVP/O durch/IN/B-PP/B-PNP Identifizierung/NN/B-NP/I-PNP einer/DT/I-NP/I-PNP gemeinsamen/JJ/I-NP/I-PNP mRNA/NN/I-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O Transkriptionseinheit/NN/I-NP/O der/DT/B-NP/O beiden/DT/I-NP/O Gene/NN/I-NP/O best\xc3\xa4tigt/RP/O/O ././O/O

Die/DT/B-NP/O Gene/NN/I-NP/O PA1991/NN/I-NP/O und/CC/O/O PA1992/NN/B-NP/O werden/VB/B-VP/O koexprimiert/NN/B-NP/O ,/,/O/O eine/DT/B-NP/O direkte/JJ/I-NP/O Wechselwirkung/NN/I-NP/O der/DT/B-NP/O beiden/DT/I-NP/O Proteine/NN/I-NP/O konnte/VB/B-VP/O jedoch/RB/I-VP/O nicht/RB/I-VP/O nachgewiesen/VBN/I-VP/O werden/VB/I-VP/O ././O/O

Die/DT/B-NP/O Transkription/NN/I-NP/O des/DT/B-NP/O Operons/NN/I-NP/O PA1991&slash;PA1992/NN/I-NP/O wird/VB/B-VP/O auf/IN/B-PP/B-PNP kurzkettigen/JJ/B-NP/I-PNP Alkoholen/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Responsregulators/NN/I-NP/I-PNP PA3604/JJ/B-NP/I-PNP aktiviert/NN/I-NP/I-PNP ././O/O

Bei/IN/B-PP/B-PNP inaktiviertem/NN/B-NP/I-PNP Gen/JJ/I-NP/I-PNP PA3604/NN/I-NP/I-PNP (/(/O/O Mutante/NN/B-NP/O MD1/NNP/I-NP/O )/)/O/O wurde/VB/B-VP/O das/DT/B-NP/O Operon/NN/I-NP/O PA1991&slash;PA1992/NN/I-NP/O nicht/RB/B-ADVP/O mehr/IN/B-PP/B-PNP transkribiert.Taxol/NN/B-NP/I-PNP ist/VB/B-VP/O ein/DT/B-NP/O hochwirksames/JJ/I-NP/O Antikrebsmittel/NN/I-NP/O gegen/IN/B-PP/B-PNP Brust/NN/B-NP/I-PNP -/-/O/O und/CC/O/O Eierstockkrebs/NN/B-NP/O ,/,/O/O das/WDT/O/O in/IN/B-PP/B-PNP geringen/JJ/B-NP/I-PNP Mengen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Rinde/NN/I-NP/I-PNP aller/JJ/B-NP/I-PNP Taxus-Arten/NN/I-NP/I-PNP gefunden/VBN/B-VP/I-PNP wird/VB/I-VP/O ././O/O

Taxol/RB/B-VP/O stellt/VB/I-VP/O ein/DT/B-NP/O hoch/JJ/I-NP/O funktionalisiertes/NN/I-NP/O cyclisches/JJ/B-NP/O Diterpen/NN/I-NP/O dar/RB/B-ADVP/O ,/,/O/O das/WDT/O/O durch/IN/B-PP/B-PNP chemische/JJ/B-NP/I-PNP Synthese/NN/I-NP/I-PNP nur/RB/B-ADJP/O schwer/JJ/I-ADJP/O zug\xc3\xa4nglich/JJ/I-ADJP/O ist/VB/B-VP/O ././O/O

Durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP begrenzte/JJ/I-NP/I-PNP Verf\xc3\xbcgbarkeit/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Taxol/NN/B-NP/I-PNP durch/IN/B-PP/B-PNP nat\xc3\xbcrliche/IN/I-PP/I-PNP Ressourcen/NN/B-NP/I-PNP ,/,/O/O ist/VB/B-VP/O es/PRP/B-NP/O von/IN/B-PP/B-PNP gro\xc3\x9fem/JJ/B-NP/I-PNP biotechnologischem/NN/I-NP/I-PNP Interesse/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Biosynthese/NN/I-NP/I-PNP beteiligten/VB/B-VP/O Enzyme/NN/B-NP/O zu/TO/B-VP/O erforschen/VB/I-VP/O ././O/O

Die/DT/B-NP/O vorliegende/JJ/I-NP/O Arbeit/NN/I-NP/O besch\xc3\xa4ftigte/VBN/B-VP/O sich/PRP/B-NP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Klonierung/NN/I-NP/I-PNP und/CC/O/O Expression/NN/B-NP/O des/DT/O/O Taxa-4(5),11(12)-dien-Synthase-Gens/LS/O/O aus/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Europ\xc3\xa4ischen/JJ/I-NP/I-PNP Eibe/NN/I-NP/I-PNP Taxus/JJ/B-NP/I-PNP baccata/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Taxadien-Synthase/NN/I-NP/O stellt/VB/B-VP/O ein/DT/B-NP/O Schl\xc3\xbcsselenzym/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Biosynthese/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Taxols/NN/I-NP/I-PNP dar/RP/O/O ././O/O

ie/PRP/B-NP/O katalysiert/NN/I-NP/O die/DT/I-NP/O Cyclisierung/NN/I-NP/O des/DT/B-NP/O Diterpens/NN/I-NP/O Geranylgeranylpyrophosphat/NN/I-NP/O zu/TO/O/O Taxa-4(5),11(12)-dien/LS/O/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Charakterisierung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Taxadien-Synthase-Gens/NN/I-NP/I-PNP wurde/VB/B-VP/O dieses/DT/O/O mittels/IN/B-PP/B-PNP PCR/NN/B-NP/I-PNP amplifiziert/NN/I-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP Escherichia/NN/B-NP/I-PNP coli/JJ/I-NP/I-PNP kloniert/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Sequenzanalyse/NN/I-NP/O des/DT/B-NP/O Gens/NN/I-NP/O ergab/VB/B-VP/O einen/DT/B-NP/O offenen/JJ/I-NP/O Leserahmen/NN/I-NP/O von/IN/B-PP/B-PNP 3980/CD/B-NP/I-PNP bp/NN/I-NP/I-PNP ,/,/O/O bestehend/JJ/B-ADJP/O aus/IN/B-PP/B-PNP 13/CD/B-NP/I-PNP Exons/NN/I-NP/I-PNP und/CC/O/O 12/CD/B-NP/O Introns/NN/I-NP/O ././O/O

Aus/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP ORF/NN/I-NP/I-PNP l\xc3\xa4sst/VB/B-VP/O sich/PRP/B-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Taxadien-Synthase/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP Gr\xc3\xb6\xc3\x9fe/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 98/CD/B-NP/I-PNP kDa/NN/I-NP/I-PNP vorhersagen/VB/B-VP/O ././O/O

Ein/DT/B-NP/O Sequenzvergleich/NN/I-NP/O mit/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP pflanzlichen/JJ/I-NP/I-PNP Isoprensynthasen/NN/I-NP/I-PNP zeigte/VB/B-VP/O eine/DT/B-NP/O hohe/JJ/I-NP/O \xc3\x9cbereinstimmung/NN/I-NP/O hinsichtlich/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Intron&slash;Exon-Struktur/NN/I-NP/I-PNP im/IN/B-PP/B-PNP C-terminalen/JJ/B-NP/I-PNP Bereich/NN/I-NP/I-PNP ,/,/O/O als/CC/O/O auch/RB/B-ADVP/O das/DT/B-NP/O Vorhandensein/NN/I-NP/O eines/RP/O/O ,/,/O/O in/IN/B-PP/B-PNP allen/JJ/B-NP/I-PNP verglichenen/NN/I-NP/I-PNP Isoprensynthasen/NN/I-NP/I-PNP vorhandenen/VB/B-VP/O ,/,/O/O konservierten/NN/B-NP/O Motivs/NNP/I-NP/O DDXXD/NNP/I-NP/O ././O/O

Interessanterweise/RB/B-VP/O weist/VB/I-VP/O die/DT/B-NP/O Isoprensynthase/NN/I-NP/O aus/IN/B-PP/B-PNP T./NN/B-NP/I-PNP baccata/NN/I-NP/I-PNP h\xc3\xb6here/JJ/I-NP/I-PNP \xc3\x84hnlichkeit/NN/I-NP/I-PNP im/IN/B-PP/B-PNP mittleren/JJ/B-NP/I-PNP Bereich/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Gen-Struktur/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Linalool-Synthase/NN/I-NP/I-PNP ,/,/O/O eine/DT/B-NP/O Hydroxylase/NN/I-NP/O ,/,/O/O aus/IN/B-PP/B-PNP Clarkia/JJ/B-NP/I-PNP concinna/NN/I-NP/I-PNP auf/RB/B-ADVP/O als/IN/B-PP/B-PNP zu/IN/I-PP/I-PNP den/DT/B-NP/I-PNP anderen/JJ/I-NP/I-PNP Isoprencyclasen/NN/I-NP/I-PNP ././O/O

Der/DT/B-NP/O N-terminale/NN/I-NP/O Bereich/NN/I-NP/O der/DT/B-NP/O Isoprensynthase-Gene/NN/I-NP/O zeichnet/VB/B-VP/O sich/PRP/B-NP/O durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP hohe/JJ/I-NP/I-PNP Variabilit\xc3\xa4t/NN/I-NP/I-PNP aus/RP/O/O ,/,/O/O da/IN/B-PP/B-PNP dieser/WDT/B-NP/I-PNP Bereich/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Signalpeptid/NN/I-NP/I-PNP codiert/NN/I-NP/I-PNP ,/,/O/O das/WDT/O/O f\xc3\xbcr/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Transport/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Synthasen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP jeweiligen/JJ/I-NP/I-PNP Plastide/NN/I-NP/I-PNP zust\xc3\xa4ndig/JJ/B-ADJP/O ist/VB/B-VP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Expression/NN/I-NP/I-PNP der/DT/B-NP/I-PNP rekombinaten/JJ/I-NP/I-PNP Synthase/NN/I-NP/I-PNP in/IN/B-PP/B-PNP E./JJ/B-NP/I-PNP coli/NN/I-NP/I-PNP wurde/VB/B-VP/O mittels/IN/B-PP/B-PNP RT-PCR/NN/B-NP/I-PNP die/DT/I-NP/I-PNP entsprechende/JJ/I-NP/I-PNP cDNA/NNP/I-NP/I-PNP isoliert/NNP/I-NP/I-PNP ,/,/O/O und/CC/O/O anschlie\xc3\x9fend/JJ/B-ADJP/O das/DT/B-NP/O Protein/NN/I-NP/O durch/IN/B-PP/B-PNP Affinit\xc3\xa4ts-Chromatographie/NN/B-NP/I-PNP an/IN/B-PP/B-PNP Nickel-Agarose/NN/B-NP/I-PNP angereinigt/RP/O/O ././O/O

Die/DT/B-NP/O Ausbeute/NN/I-NP/O an/IN/B-PP/B-PNP Taxadien-Synthase/NN/B-NP/I-PNP betrug/VB/B-VP/O 20/CD/B-NP/O mg&slash;l/JJ/I-NP/O Kulturmedium/NN/I-NP/O ././O/O

Durch/IN/B-PP/B-PNP Western/JJ/B-NP/I-PNP Blot-Analyse/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Antik\xc3\xb6rpern/NN/B-NP/I-PNP sowohl/RB/B-ADVP/O gegen/IN/B-PP/B-PNP His5-Tag/NN/B-NP/I-PNP als/CC/O/O auch/RB/B-ADVP/O gegen/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP Peptid/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Taxadien-Synthase/NN/I-NP/I-PNP und/CC/O/O durch/IN/B-PP/B-PNP GC-MS-Analyse/NN/B-NP/I-PNP konnte/VB/B-VP/O das/DT/B-NP/O funktionale/NN/I-NP/O Enzym/NN/I-NP/O nachgewiesen/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Mittels/IN/B-PP/B-PNP SDS-PAGE/NN/B-NP/I-PNP unter/IN/B-PP/B-PNP denaturierenden/NN/B-NP/I-PNP Bedingungen/NN/I-NP/I-PNP konnte/VB/B-VP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP rekombinante/NN/I-NP/I-PNP Taxadien-Synthase/NN/I-NP/I-PNP ein/DT/B-NP/I-PNP Molekulargewicht/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 97/CD/B-NP/I-PNP kDa/NN/I-NP/I-PNP bestimmt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Im/IN/B-PP/B-PNP Gegensatz/NN/B-NP/I-PNP dazu/VB/B-VP/O ist/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP native/JJ/I-NP/I-PNP Protein/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP T./NN/B-NP/I-PNP brevifolia/NN/I-NP/I-PNP eine/DT/I-NP/I-PNP Gr\xc3\xb6\xc3\x9fe/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 80/CD/B-NP/I-PNP kDa/NN/I-NP/I-PNP beschrieben/VBN/B-VP/I-PNP worden/VBN/I-VP/I-PNP ././O/O

Diese/DT/B-NP/O Diskrepanz/NN/I-NP/O l\xc3\xa4sst/VB/B-VP/O den/DT/B-NP/O Schluss/NN/I-NP/O zu/TO/O/O ,/,/O/O dass/IN/B-PP/B-PNP das/DT/B-NP/I-PNP rekombinante/JJ/I-NP/I-PNP Protein/NN/I-NP/I-PNP (/(/O/O Preprotein/NNP/B-NP/O )/)/O/O aus/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Transitpeptid/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Plastid/NN/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O eigentlichen/JJ/I-NP/O Isoprensynthase/NN/I-NP/O besteht/VB/B-VP/O ././O/O

Ein/DT/B-NP/O Vergleich/NN/I-NP/O der/DT/B-NP/O Aminos\xc3\xa4ure-Sequenzen/NN/I-NP/O der/DT/B-NP/O Taxadien-Synthasen/NN/I-NP/O aus/IN/B-PP/B-PNP T./NN/B-NP/I-PNP baccata/NN/I-NP/I-PNP ,/,/O/O T./NN/B-NP/O brevifolia/NNP/I-NP/O und/CC/I-NP/O T./NNP/I-NP/O chinensis/NNP/I-NP/O zeigt/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O der/DT/B-NP/O Verwandtschaftsgrad/NN/I-NP/O der/DT/B-NP/O Synthasen/NN/I-NP/O aus/IN/B-PP/B-PNP T./NN/B-NP/I-PNP baccata/NN/I-NP/I-PNP und/CC/I-NP/I-PNP T./NN/I-NP/I-PNP brevifolia/NN/I-NP/I-PNP untereinander/NN/I-NP/I-PNP h\xc3\xb6her/JJ/B-ADJP/O ist/VB/B-VP/O als/IN/B-PP/B-PNP zu/IN/I-PP/I-PNP der/DT/B-NP/I-PNP Taxadien-Synthase/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP T./NN/B-NP/I-PNP chinensis.F\xc3\xbcr/NN/I-NP/I-PNP den/DT/I-NP/I-PNP qualitativen/JJ/I-NP/I-PNP Nachweis/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Enterobacteriaceae/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Lebensmitteln/NN/B-NP/I-PNP wurde/VB/B-VP/O eine/DT/B-NP/O spezifische/JJ/I-NP/O Real-Time-PCR-Anwendung/NN/I-NP/O entwickelt/VB/B-VP/O ././O/O

Nach/IN/B-PP/B-PNP kultureller/JJ/B-NP/I-PNP Anreicherung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Lebensmittelprobe/NN/I-NP/I-PNP erfolgt/VB/B-VP/O die/DT/B-NP/O Durchf\xc3\xbchrung/NN/I-NP/O der/DT/B-NP/O PCR/NN/I-NP/O im/IN/B-PP/B-PNP LightCycler\xc2\xae/NN/B-NP/I-PNP ././O/O

Das/DT/B-NP/O entwickelte/JJ/I-NP/O Nachweisverfahren/NN/I-NP/O erreicht/JJ/B-ADJP/O gegen\xc3\xbcber/IN/B-PP/B-PNP den/DT/B-NP/I-PNP konventionellen/JJ/I-NP/I-PNP mikrobiologischen/JJ/I-NP/I-PNP Methoden/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP Spezifit\xc3\xa4t/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 100/CD/B-NP/I-PNP %/NN/I-NP/I-PNP und/CC/O/O f\xc3\xbchrt/VBN/B-VP/O mit/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP zeitlichen/JJ/I-NP/I-PNP Aufwand/NN/I-NP/I-PNP von/IN/B-PP/O maximal/RB/B-ADVP/O einem/DT/B-NP/O Tag/NN/I-NP/O zu/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP zuverl\xc3\xa4ssigen/JJ/I-NP/I-PNP Ergebnis/NN/I-NP/I-PNP ././O/O

Der/DT/B-NP/O Nachweis/NN/I-NP/O erm\xc3\xb6glicht/VB/B-VP/O die/DT/B-NP/O Detektion/NN/I-NP/O einer/DT/B-NP/O einzelnen/JJ/I-NP/O Bakterienzelle/NN/I-NP/O ././O/O

Er/PRP/B-NP/O eignet/VB/B-VP/O sich/PRP/B-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Qualit\xc3\xa4tskontrolle/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Lebensmitteln/NN/B-NP/I-PNP unterschiedlichster/NN/I-NP/I-PNP Produktgruppen/NN/I-NP/I-PNP sowie/RB/B-ADVP/O die/DT/B-NP/O \xc3\x9cberwachung/NN/I-NP/O aller/DT/B-NP/O kritischen/JJ/I-NP/O Prozessstufen/NN/I-NP/O in/IN/B-PP/B-PNP lebensmittelproduzierenden/JJ/B-NP/I-PNP Betrieben/NN/I-NP/I-PNP ././O/O

Mit/IN/B-PP/B-PNP 72/CD/B-NP/I-PNP Lebensmittelproben/NN/I-NP/I-PNP verschiedener/JJ/B-NP/I-PNP Produzenten/NNS/I-NP/I-PNP ,/,/O/O Kategorien/NN/B-NP/O und/CC/I-NP/O Matrices/NN/I-NP/O wurde/VB/B-VP/O die/DT/B-NP/O Funktionalit\xc3\xa4t/NN/I-NP/O des/DT/B-NP/O Nachweises/NN/I-NP/O im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Horizontalverfahren/NN/I-NP/I-PNP zum/IN/B-PP/B-PNP qualitativen/JJ/B-NP/I-PNP Nachweis/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Enterobacteriaceae/NN/B-NP/I-PNP \xc3\xbcberpr\xc3\xbcft/RP/O/O ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O aller/JJ/B-NP/O Untersuchungen/JJ/I-NP/O stimmten/NN/I-NP/O mit/IN/B-PP/B-PNP denen/WDT/B-NP/I-PNP des/DT/I-NP/I-PNP ph\xc3\xa4notypischen/JJ/I-NP/I-PNP Nachweises/NN/I-NP/I-PNP \xc3\xbcberein/RP/O/O ././O/O

Zielmolek\xc3\xbcl/NN/B-NP/O der/DT/I-NP/O Real-Time-PCR/NN/I-NP/O ist/VB/B-VP/O die/DT/O/O f\xc3\xbcr/IN/B-PP/B-PNP 23S/NNP/B-NP/I-PNP rRNA/NNP/I-NP/I-PNP codierende/NNP/I-NP/I-PNP DNA-Sequenz/NNP/I-NP/I-PNP der/DT/I-NP/I-PNP Enterobacteriaceen/NN/I-NP/I-PNP ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Nachweissystem/NN/I-NP/I-PNP wurden/VB/B-VP/O forward/NNP/B-NP/O -/-/O/O und/CC/O/O reverse-Primer/NN/B-NP/O sowie/RB/B-NP/O Sonden/JJ/I-NP/O generiert/NN/I-NP/O ././O/O

Das/DT/O/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP PCR/NN/I-NP/I-PNP entstehende/NN/I-NP/I-PNP partielle/NN/I-NP/I-PNP Amplifikat/NN/I-NP/I-PNP der/DT/B-NP/I-PNP 23S/NNP/I-NP/I-PNP rDNA/NNP/I-NP/I-PNP hat/VB/B-VP/O eine/DT/B-NP/O Gr\xc3\xb6\xc3\x9fe/NN/I-NP/O von/IN/B-PP/B-PNP 225/CD/B-NP/I-PNP bp/NN/I-NP/I-PNP ././O/O

Zum/IN/B-PP/B-PNP Ausschluss/NN/B-NP/I-PNP falsch/JJ/I-NP/I-PNP negativer/NN/I-NP/I-PNP Ergebnisse/NN/I-NP/I-PNP wurde/VB/B-VP/O eine/DT/B-NP/O Interne/NN/I-NP/O Amplifikationskontrolle/NN/I-NP/O entwickelt/VB/B-VP/O ././O/O

Bei/IN/B-PP/B-PNP Anwendung/NN/B-NP/I-PNP des/DT/I-NP/I-PNP PCR-Systems/NN/I-NP/I-PNP kam/VB/B-VP/O es/PRP/B-NP/O auch/RB/B-ADVP/O zu/IN/B-PP/B-PNP positiven/JJ/B-NP/I-PNP Ergebnissen/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Proben/NN/B-NP/I-PNP ,/,/O/O in/IN/B-PP/B-PNP denen/WDT/B-NP/I-PNP sich/PRP/I-NP/I-PNP keine/DT/B-NP/I-PNP Ziel-DNA/NNP/I-NP/I-PNP befinden/VB/B-VP/O sollte/MD/B-VP/O ././O/O

Es/PRP/B-NP/O konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP es/JJ/B-NP/I-PNP sich/PRP/I-NP/I-PNP hierbei/NN/I-NP/I-PNP um/IN/B-PP/B-PNP Amplifikationen/NN/B-NP/I-PNP kontaminierender/JJ/I-NP/I-PNP DNA/NN/I-NP/I-PNP in/IN/B-PP/B-PNP allen/JJ/B-NP/I-PNP \xc3\xbcberpr\xc3\xbcften/NN/I-NP/I-PNP Taq-DNA-Polymerasen/NN/I-NP/I-PNP diverser/NN/I-NP/I-PNP Hersteller/NN/I-NP/I-PNP handelte/VB/B-VP/O ././O/O

Durch/IN/B-PP/B-PNP enzymatischen/JJ/B-NP/I-PNP Verdau/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP DNase/NN/B-NP/I-PNP I/CD/O/O konnte/VB/B-VP/O reproduzierbar/JJ/B-ADJP/O die/DT/B-NP/O vollst\xc3\xa4ndige/NN/I-NP/O Dekontamination/NN/I-NP/O erreicht/VB/B-VP/O werden.Die/JJ/B-NP/O \xc3\x84tiologie/NN/I-NP/O von/IN/B-PP/B-PNP Chronisch/JJ/B-NP/I-PNP Entz\xc3\xbcndlichen/JJ/I-NP/I-PNP Darmerkrankungen/NN/I-NP/I-PNP (/(/O/O CED/NN/B-NP/O )/)/O/O wie/IN/B-PP/B-PNP Morbus/JJ/B-NP/I-PNP Crohn/NN/I-NP/I-PNP (/(/O/O M./NN/B-NP/O Crohn/NN/I-NP/O )/)/O/O und/CC/O/O Colitis/NN/B-NP/O ulcerosa/NN/I-NP/O ist/VB/B-VP/O nicht/RB/B-ADJP/O vollst\xc3\xa4ndig/JJ/I-ADJP/O gekl\xc3\xa4rt/RP/O/O ././O/O

Es/PRP/B-NP/O wird/RB/B-VP/O angenommen/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP es/JJ/B-NP/I-PNP sich/PRP/I-NP/I-PNP um/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP multifaktorielle/NN/I-NP/I-PNP Erkrankung/NN/I-NP/I-PNP handelt/VB/B-VP/O ,/,/O/O an/IN/B-PP/B-PNP deren/WDT/B-NP/I-PNP Pathogenese/NN/I-NP/I-PNP genetische/JJ/B-NP/I-PNP Faktoren/NN/I-NP/I-PNP ,/,/O/O Umweltfaktoren/NN/B-NP/O und/CC/I-NP/O eine/DT/I-NP/O fehlregulierte/NN/I-NP/O mukosale/JJ/B-NP/O Immunantwort/NN/I-NP/O gegen/IN/B-PP/B-PNP kommensale/NN/B-NP/I-PNP Bakterien/NN/I-NP/I-PNP beteiligt/VBN/B-VP/I-PNP sind/VB/I-VP/O ././O/O

Vermutlich/JJ/B-ADJP/O ist/VB/B-VP/O Escherichia/IN/B-PP/B-PNP coli/NN/B-NP/I-PNP (/(/O/O E./JJ/B-NP/O coli/NN/I-NP/O )/)/O/O mit/IN/B-PP/B-PNP CED/JJ/B-NP/I-PNP assoziiert/NN/I-NP/I-PNP ././O/O

Zudem/RB/B-NP/O kreuzreagieren/JJ/I-NP/O T-Zellen/NN/I-NP/O von/IN/B-PP/B-PNP CED-Patienten/NN/B-NP/I-PNP gegen\xc3\xbcber/IN/B-PP/O verschiedenen/VB/B-VP/O Bakterienspezies/RP/I-VP/O ,/,/O/O sodass/CC/O/O diese/WDT/B-NP/O T-Zellantworten/NN/I-NP/O vermutlich/JJ/B-ADJP/O gegen/IN/B-PP/B-PNP konservierte/NN/B-NP/I-PNP bakterielle/NN/I-NP/I-PNP Proteine/NN/I-NP/I-PNP gerichtet/NN/I-NP/I-PNP sind/VB/B-VP/O ././O/O

Im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurden/VB/B-VP/O neben/IN/B-PP/B-PNP hochkonservierten/NN/B-NP/I-PNP Proteinen/NN/I-NP/I-PNP auch/IN/B-PP/B-PNP Pathogenit\xc3\xa4tsfaktoren/NN/B-NP/I-PNP von/IN/B-PP/B-PNP E./JJ/B-NP/I-PNP coli/NN/I-NP/I-PNP als/IN/B-PP/B-PNP Test-Antigene/NN/B-NP/I-PNP hergestellt/VBN/B-VP/I-PNP ,/,/O/O um/IN/B-PP/B-PNP abnormale/JJ/B-NP/I-PNP T-Zellantworten/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP Patienten/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP M./NN/B-NP/I-PNP Crohn/NN/I-NP/I-PNP und/CC/I-NP/I-PNP Spondylitis/JJ/I-NP/I-PNP ankylosans/NN/I-NP/I-PNP (/(/O/O S./VB/B-VP/O ankylosans/NN/B-NP/O )/)/O/O zu/TO/B-VP/O untersuchen/VB/I-VP/O ././O/O

\xc3\xa4mtliche/JJ/B-NP/O Proteine/NN/I-NP/O wurden/VB/B-VP/O zun\xc3\xa4chst/RB/B-ADVP/O in/IN/B-PP/B-PNP E./JJ/B-NP/I-PNP coli/NN/I-NP/I-PNP im/IN/B-PP/B-PNP kleinen/JJ/B-NP/I-PNP Ma\xc3\x9fstab/NN/I-NP/I-PNP exprimiert/NN/I-NP/I-PNP und/CC/O/O unter/IN/B-PP/B-PNP nativen/JJ/B-NP/I-PNP Bedingungen/NN/I-NP/I-PNP mittels/IN/B-PP/B-PNP His-Tag/NN/B-NP/I-PNP affinit\xc3\xa4tschromatografisch/JJ/B-ADJP/O gereinigt/RP/O/O ././O/O

Konservierte/JJ/B-NP/O Proteine/NN/I-NP/O ,/,/O/O deren/WDT/B-NP/O Reinigung/NN/I-NP/O nur/RB/B-ADVP/O mit/IN/B-PP/B-PNP schwacher/JJ/B-NP/I-PNP Ausbeute/NN/I-NP/I-PNP gelang/NN/I-NP/I-PNP ,/,/O/O wurden/VB/B-VP/O mit/IN/B-PP/B-PNP MBP/NNP/B-NP/I-PNP ,/,/O/O GST/NNP/B-NP/O und/CC/I-NP/O NusA/NNP/I-NP/O fusioniert/NNP/I-NP/O ,/,/O/O da/IN/B-PP/B-PNP diese/WDT/B-NP/I-PNP Fusionspartner/NN/I-NP/I-PNP die/DT/B-NP/I-PNP L\xc3\xb6slichkeit/NN/I-NP/I-PNP und/CC/O/O somit/RB/B-ADVP/O die/DT/B-NP/O Ausbeute/NN/I-NP/O des/DT/B-NP/O Fusionsproteins/NN/I-NP/O steigern/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ././O/O

Dagegen/RB/B-VP/O erfolgte/VB/I-VP/O die/DT/B-NP/O Reinigung/NN/I-NP/O der/DT/B-NP/O Pathogenit\xc3\xa4tsfaktoren/NN/I-NP/O mittels/IN/B-PP/B-PNP His-Tag/NN/B-NP/I-PNP unter/IN/B-PP/B-PNP denaturierenden/JJ/B-NP/I-PNP Bedingungen/NN/I-NP/I-PNP ././O/O

Nach/IN/B-PP/B-PNP Expression/NN/B-NP/I-PNP jedes/JJ/I-NP/I-PNP Proteins/NN/I-NP/I-PNP im/IN/B-PP/B-PNP gro\xc3\x9fen/JJ/B-NP/I-PNP Ma\xc3\x9fstab/NN/I-NP/I-PNP erfolgte/VB/B-VP/O die/DT/B-NP/O Entfernung/NN/I-NP/O von/IN/B-PP/B-PNP Lipopolysaccharid/NN/B-NP/I-PNP aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Proteinpr\xc3\xa4parationen/NN/I-NP/I-PNP mittels/IN/B-PP/B-PNP Polymyxin-B/NN/B-NP/I-PNP beschichteten/NN/I-NP/I-PNP magnetischen/JJ/I-NP/I-PNP Kugeln/NNS/I-NP/I-PNP ././O/O

Insgesamt/IN/B-PP/B-PNP gelang/NN/B-NP/I-PNP es/PRP/I-NP/I-PNP 197/CD/I-NP/I-PNP konservierte/NN/I-NP/I-PNP Proteine/NN/I-NP/I-PNP und/CC/O/O 13/CD/B-NP/O Pathogenit\xc3\xa4tsfaktoren/NN/I-NP/O von/IN/B-PP/B-PNP E./JJ/B-NP/I-PNP coli/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Mindestmenge/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 500/CD/B-NP/I-PNP \xc2\xb5g/JJ/I-NP/I-PNP herzustellen/NN/I-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP anschlie\xc3\x9fenden/JJ/B-NP/I-PNP Vollblut-Assay/NNP/I-NP/I-PNP wurden/VB/B-VP/O Gemische/JJ/B-ADJP/O mit/IN/B-PP/O jeweils/RB/B-ADVP/O 10/CD/B-NP/O konservierten/NN/I-NP/O Proteinen/NN/I-NP/O eingesetzt/RP/O/O ././O/O

Die/DT/B-NP/O Pathogenit\xc3\xa4tsfaktoren/NN/I-NP/O wurden/VB/B-VP/O einzeln/JJ/B-NP/O getestet/NN/I-NP/O ././O/O

Im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP gesunden/PRP$/B-NP/I-PNP Kontrollpersonen/NN/I-NP/I-PNP konnten/VB/B-VP/O bei/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP signifikant/JJ/I-NP/I-PNP kleineren/JJ/I-NP/I-PNP Zahl/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Patienten/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP M./NN/B-NP/I-PNP Crohn/NN/I-NP/I-PNP und/CC/O/O S./VB/B-VP/O ankylosans/NN/B-NP/O CD4/NN/I-NP/O +/JJ/I-NP/O T-Zellantworten/NN/I-NP/O gegen\xc3\xbcber/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Reihe/NN/I-NP/I-PNP von/IN/B-PP/O Proteingemischen/JJ/B-ADJP/O beobachtet/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Zudem/RB/B-NP/O reagierten/JJ/I-NP/O Patienten/NN/I-NP/O mit/IN/B-PP/B-PNP M./NN/B-NP/I-PNP Crohn/NN/I-NP/I-PNP und/CC/O/O S./VB/B-VP/O ankylosans/NN/B-NP/O gegen\xc3\xbcber/IN/B-PP/O dem/DT/O/O Superantigen/FW/O/O Staphylococcus/FW/O/O aureus/FW/O/O enterotoxin/FW/O/O B/FW/O/O mit/IN/B-PP/B-PNP signifikant/JJ/B-NP/I-PNP geringeren/JJ/I-NP/I-PNP Frequenzen/NN/I-NP/I-PNP von/IN/B-PP/B-PNP CD4/NN/B-NP/I-PNP +/JJ/I-NP/I-PNP T-Zellen/NN/I-NP/I-PNP ././O/O

Diese/DT/B-NP/O Ergebnisse/NN/I-NP/O sprachen/VB/B-VP/O eher/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP generelle/JJ/I-NP/I-PNP Immunsuppression/NN/I-NP/I-PNP als/IN/B-PP/B-PNP Grund/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP niedrige/JJ/I-NP/I-PNP T-Zellantwort/NN/I-NP/I-PNP ././O/O

Jedoch/RB/B-VP/O konnten/VB/I-VP/O diese/DT/B-NP/O niedrigen/JJ/I-NP/O T-Zellantworten/NN/I-NP/O nach/IN/B-PP/B-PNP Stimulierung/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP \xe2\x80\x9eRecall-Antigenen\xe2\x80\x9c/NN/I-NP/I-PNP Cytomegalievirus/NN/I-NP/I-PNP Phosphoprotein/NNP/I-NP/I-PNP 65/CD/B-NP/I-PNP kDa/NN/I-NP/I-PNP und/CC/O/O Tetanus/NN/B-NP/O Toxoid/NN/I-NP/O nicht/RB/B-VP/O best\xc3\xa4tigt/VBN/I-VP/O werden/VB/I-VP/O ././O/O

M\xc3\xb6glicherweise/RB/B-VP/O lassen/VB/I-VP/O sich/PRP/B-NP/O diese/DT/I-NP/O letzteren/NN/I-NP/O Ergebnisse/NN/I-NP/O so/VB/B-VP/O deuten/VB/I-VP/O ,/,/O/O dass/RB/B-ADVP/O bei/IN/B-PP/B-PNP M./NN/B-NP/I-PNP Crohn/NN/I-NP/I-PNP und/CC/O/O S./VB/B-VP/O ankylosans/NN/B-NP/O die/DT/I-NP/O E./JJ/I-NP/O coli-spezifischen/JJ/I-NP/O T-Zellen/JJ/I-NP/O selektiv/NN/I-NP/O an/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Ort/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Entz\xc3\xbcndung/NN/I-NP/I-PNP (/(/O/O Darm/NN/B-NP/O )/)/O/O rekrutiert/NN/B-NP/O und/CC/O/O dort/RB/B-ADJP/O spezifisch/JJ/I-ADJP/O gebunden/VBN/B-VP/O werden/VB/I-VP/O ,/,/O/O jedoch/RB/B-ADVP/O nicht/RB/B-NP/O andere/JJ/I-NP/O antigenspezifische/JJ/I-NP/O T-Zellen.Ziel/NN/I-NP/O der/DT/B-NP/O vorliegenden/JJ/I-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O die/DT/B-NP/O Optimierung/NN/I-NP/O von/IN/B-PP/B-PNP Brauhefen/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP des/DT/O/O Inverse/FW/O/O Metabolic/FW/O/O Engineering/FW/O/O ././O/O

Im/IN/B-PP/B-PNP Vordergrund/NN/B-NP/I-PNP stand/VB/B-VP/O die/DT/B-NP/O Frage/NN/I-NP/O ,/,/O/O ob/IN/B-PP/B-PNP physiologische/JJ/B-NP/I-PNP Differenzen/NN/I-NP/I-PNP von/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Brauhefen/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Expressionslevel/NN/I-NP/I-PNP der/DT/O/O am/IN/B-PP/B-PNP jeweiligen/JJ/B-NP/I-PNP Stoffwechsel/NN/I-NP/I-PNP beteiligten/VB/B-VP/O Gene/NN/B-NP/O korreliert/NN/I-NP/O werden/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ././O/O

Weiterhin/RB/B-VP/O sollte/MD/I-VP/O gekl\xc3\xa4rt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O ob/IN/B-PP/B-PNP das/DT/B-NP/I-PNP gewonnene/JJ/I-NP/I-PNP Wissen/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP Brauhefestamm/NN/I-NP/I-PNP \xc3\xbcbertragen/VBN/B-VP/I-PNP werden/VB/I-VP/O kann/VBN/I-VP/O ././O/O

Das/DT/O/O proof/FW/O/O of/FW/O/O concept/FW/O/O sollte/MD/B-VP/O am/IN/B-PP/B-PNP Beispiel/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Diacetylproduktion/NN/I-NP/I-PNP erbracht/NN/I-NP/I-PNP werden/VB/B-VP/O ,/,/O/O da/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Senkung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Diacetylgehalts/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Jungbier/NN/B-NP/I-PNP von/IN/B-PP/B-PNP gro\xc3\x9fem/JJ/B-NP/I-PNP Interesse/NN/I-NP/I-PNP ist/VB/B-VP/O ././O/O

Zun\xc3\xa4chst/VBN/B-VP/O wurden/VB/I-VP/O verschiedene/JJ/B-NP/O Brauhefest\xc3\xa4mme/NN/I-NP/O auf/IN/B-PP/B-PNP ihre/PRP$/B-NP/I-PNP brauereirelevanten/NN/I-NP/I-PNP Merkmale/NN/I-NP/I-PNP untersucht/RP/O/O ././O/O

Nach/IN/B-PP/B-PNP Aufzeigen/NN/B-NP/I-PNP der/DT/I-NP/I-PNP entsprechenden/JJ/I-NP/I-PNP genetischen/JJ/I-NP/I-PNP Basis/NN/I-NP/I-PNP der/DT/B-NP/I-PNP jeweiligen/JJ/I-NP/I-PNP Hefen/NN/I-NP/I-PNP konnten/VB/B-VP/O Kandidatengene/NN/B-NP/O identifiziert/NN/I-NP/O werden/VB/B-VP/O ,/,/O/O die/WDT/O/O anschlie\xc3\x9fend/JJ/B-ADJP/O den/DT/B-NP/O Ausgangspunkt/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP genetische/JJ/B-NP/I-PNP Ver\xc3\xa4nderungen/NN/I-NP/I-PNP bez\xc3\xbcglich/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Diacetylreduktion/NN/I-NP/I-PNP darstellten/VB/B-VP/O ././O/O

Diese/DT/B-NP/O Gene/NN/I-NP/O waren/VB/B-VP/O ILV3/NN/B-NP/O ,/,/O/O ILV6/NN/B-NP/O ,/,/O/O BAT1/NN/B-NP/O und/CC/I-NP/O BAT2/NN/I-NP/O des/DT/B-NP/O Valinstoffwechsels/NN/I-NP/O ././O/O

Nachdem/IN/B-PP/B-PNP die/DT/B-NP/I-PNP beiden/DT/I-NP/I-PNP letztgenannten/NN/I-NP/I-PNP Gene/NN/I-NP/I-PNP zus\xc3\xa4tzlich/JJ/B-ADJP/O in/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP brauereirelevante/NN/I-NP/I-PNP Hefe/NN/I-NP/I-PNP und/CC/O/O die/DT/B-NP/O \xce\x94\xce\x94ilv6-Mutante/NN/I-NP/O ,/,/O/O der/WDT/O/O bereits/RB/B-ADVP/O die/DT/B-NP/O ILV6-Gene/NN/I-NP/O fehlten/JJ/B-ADJP/O ,/,/O/O eingebracht/VBN/B-VP/O wurden/VB/I-VP/O ,/,/O/O folgten/VBN/B-VP/O wiederum/IN/B-PP/B-PNP Nebenproduktanalysen/NN/B-NP/I-PNP ,/,/O/O um/IN/B-PP/B-PNP eventuelle/NN/B-NP/I-PNP ,/,/O/O messbare/JJ/B-NP/O Konzentrationsunterschiede/NN/I-NP/O bez\xc3\xbcglich/IN/B-PP/B-PNP des/DT/B-NP/I-PNP Diacetyls/NN/I-NP/I-PNP festzustellen/VB/B-VP/O ././O/O

Durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Modifizierungen/NN/I-NP/I-PNP konnte/VB/B-VP/O die/DT/B-NP/O Diacetylproduktion/NN/I-NP/O um/IN/B-PP/O 14%/CD/O/O (/(/O/O \xc3\x9cberexpression/NN/B-NP/O des/DT/I-NP/O BAT1/NN/I-NP/O in/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP brauereirelevanten/NN/I-NP/I-PNP Hefe/NN/I-NP/I-PNP )/)/O/O bzw./CC/O/O um/IN/B-PP/B-PNP ca/NN/B-NP/I-PNP ././O/O

40%/CD/O/O (/(/O/O \xc3\x9cberexpression/NN/B-NP/O des/DT/I-NP/O BAT1/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP \xce\x94\xce\x94ilv6-Mutante/NN/I-NP/I-PNP )/)/O/O am/IN/B-PP/B-PNP Ende/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Fermentation/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP zum/IN/B-PP/B-PNP Wildtyp/NN/B-NP/I-PNP reduziert/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Dabei/RB/B-VP/O wurden/VB/I-VP/O aber/RB/B-NP/O keine/JJ/I-NP/O Unterschiede/NN/I-NP/O im/IN/B-PP/B-PNP G\xc3\xa4rverhalten/NN/B-NP/I-PNP bez\xc3\xbcglich/IN/B-PP/B-PNP des/DT/B-NP/I-PNP Wachstums/NN/I-NP/I-PNP ,/,/O/O der/DT/B-NP/O Fermentationsdauer/NN/I-NP/O oder/RB/B-NP/O anderer/JJ/I-NP/O Nebenprodukte/NN/I-NP/O festgestellt/VBN/B-VP/O ,/,/O/O die/WDT/O/O ebenfalls/RB/B-ADVP/O zum/IN/B-PP/B-PNP Geschmack/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Bieres/NN/I-NP/I-PNP beitragen/VB/B-VP/O ././O/O

Diese/DT/B-NP/O Senkung/NN/I-NP/O des/DT/O/O im/IN/B-PP/B-PNP Bier/NN/B-NP/I-PNP am/IN/B-PP/B-PNP meisten/DT/B-NP/I-PNP st\xc3\xb6renden/NN/I-NP/I-PNP Nebenprodukts/NN/I-NP/I-PNP macht/VB/B-VP/O es/PRP/B-NP/O damit/RB/I-NP/O Brauereien/NN/I-NP/O m\xc3\xb6glich/JJ/B-ADJP/O ,/,/O/O ihre/PRP$/B-NP/O eigenen/JJ/I-NP/O Produktionsst\xc3\xa4mme/NN/I-NP/O mit/IN/B-PP/B-PNP positiven/JJ/B-NP/I-PNP Eigenschaften/NNS/I-NP/I-PNP anderer/JJ/B-NP/I-PNP St\xc3\xa4mme/NNS/I-NP/I-PNP \xe2\x80\x9enachzur\xc3\xbcsten\xe2\x80\x9c/NN/I-NP/I-PNP ././O/O

Der/DT/B-NP/O gro\xc3\x9fe/JJ/I-NP/O praktische/JJ/I-NP/O Nutzen/NN/I-NP/O liegt/VB/B-VP/O darin/RB/B-ADVP/O ,/,/O/O dass/RB/B-ADVP/O der/DT/B-NP/O zeitliche/JJ/I-NP/O Aufwand/NN/I-NP/O ,/,/O/O um/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Diacetyl/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Nachg\xc3\xa4rungen/NN/B-NP/I-PNP abzubauen/VB/B-VP/O ,/,/O/O nun/IN/B-PP/B-PNP wegf\xc3\xa4llt/NN/B-NP/I-PNP ././O/O

Die/DT/B-NP/O gewonnene/JJ/I-NP/O Kenntnis/NN/I-NP/O von/IN/B-PP/B-PNP Genen/NN/B-NP/I-PNP ,/,/O/O deren/WDT/B-NP/O Aktivit\xc3\xa4t/NN/I-NP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP erw\xc3\xbcnschten/NN/I-NP/I-PNP G\xc3\xa4reigenschaft/NN/I-NP/I-PNP korreliert/NN/I-NP/I-PNP ,/,/O/O erlaubt/VB/B-VP/O es/PRP/B-NP/O au\xc3\x9ferdem/RB/B-ADVP/O ,/,/O/O im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP der/DT/I-NP/I-PNP klassischen/JJ/I-NP/I-PNP Stammoptimierung/NN/I-NP/I-PNP aufw\xc3\xa4ndige/JJ/B-NP/I-PNP Versuchsg\xc3\xa4rungen/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP einfaches/JJ/I-NP/I-PNP Screening/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Kandidatengene/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP ersetzen.Laborstudien/NN/B-NP/I-PNP an/IN/B-PP/B-PNP Honigbienen/NN/B-NP/I-PNP konnten/VB/B-VP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP letzten/JJ/I-NP/I-PNP Jahren/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP Reihe/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Korrelationen/NN/B-NP/I-PNP zwischen/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Sukroseempfindlichkeit/NN/I-NP/I-PNP und/CC/O/O verschiedenen/JJ/B-NP/O komplexen/JJ/I-NP/O Formen/NN/I-NP/O des/DT/B-NP/O Verhaltens/NN/I-NP/O ,/,/O/O wie/IN/B-PP/O z.B./RB/B-ADVP/O der/DT/B-NP/O Arbeitsteilung/NN/I-NP/O ,/,/O/O dem/DT/B-NP/O Lernverhalten/NN/I-NP/O und/CC/O/O der/DT/B-NP/O Ged\xc3\xa4chtnisbildung/NN/I-NP/O zeigen/VB/B-VP/O ././O/O

Die/DT/B-NP/O vorliegende/JJ/I-NP/O Arbeit/NN/I-NP/O widmet/VB/B-VP/O sich/PRP/B-NP/O der/DT/I-NP/O Fragestellung/NN/I-NP/O ,/,/O/O welche/WP/O/O Signifikanz/NN/B-NP/O die/DT/I-NP/O Sukroseempfindlichkeit/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Verhalten/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Tiere/NN/I-NP/I-PNP unter/IN/B-PP/B-PNP nat\xc3\xbcrlichen/IN/I-PP/I-PNP Bedingungen/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP hat/VB/B-VP/O und/CC/O/O welche/WP/O/O Beziehungen/NN/B-NP/O zwischen/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Verhalten/NN/I-NP/I-PNP eines/DT/B-NP/I-PNP Tieres/NN/I-NP/I-PNP unter/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP -/-/O/O und/CC/O/O Laborbedingungen/NN/B-NP/O bestehen/VB/B-VP/O ././O/O

Versuche/NN/B-NP/O zur/IN/B-PP/B-PNP gustatorischen/JJ/B-NP/I-PNP Empfindlichkeit/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP konnten/VB/B-VP/O zeigen/VB/I-VP/O ,/,/O/O dass/RB/B-ADJP/O individuelle/JJ/I-ADJP/O Nektarsammlerinnen/VB/B-VP/O sich/PRP/B-NP/O anhand/IN/B-PP/B-PNP ihrer/PRP$/B-NP/I-PNP Akzeptanzschwellen/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP Zuckerwasserkonzentrationen/NN/B-NP/I-PNP in/IN/B-PP/B-PNP drei/CD/B-NP/I-PNP Gruppen/NN/I-NP/I-PNP unterscheiden/VB/B-VP/O lassen/VB/I-VP/O :(/NN/B-NP/O 1/CD/O/O )/)/O/O Unempfindliche/JJ/B-NP/O Sammlerinnen/NN/I-NP/O mit/IN/B-PP/B-PNP Akzeptanzschwellen/NN/B-NP/I-PNP \xc3\xbcber/IN/B-PP/O 10%/CD/O/O (/(/O/O w&slash;w/NN/B-NP/O )/)/O/O Sukrose/NN/B-NP/O ,/,/O/O (/(/O/O 2/CD/O/O )/)/O/O Sammlerinnen/NN/B-NP/O mit/IN/B-PP/B-PNP mittlerer/JJ/B-NP/I-PNP Empfindlichkeit/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP Sukrose/NN/B-NP/I-PNP ,/,/O/O die/WDT/O/O bei/IN/B-PP/O niedrigen/VB/B-VP/O Zuckerwasserkonzentrationen/NN/B-NP/O das/DT/I-NP/O Sammeln/NN/I-NP/O einstellen/VB/B-VP/O ,/,/O/O aber/CC/O/O nach/IN/B-PP/B-PNP Alarmierung/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Stock/NN/B-NP/I-PNP auch/IN/B-PP/B-PNP Wasser/NN/B-NP/I-PNP an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Futterstelle/NN/I-NP/I-PNP sammeln/VB/B-VP/O und/CC/O/O (/(/O/O 3/CD/O/O )/)/O/O extrem/JJ/B-NP/O empfindliche/JJ/I-NP/O Nektarsammlerinnen/NN/I-NP/O ,/,/O/O die/WDT/B-NP/O alle/DT/I-NP/O angebotenen/JJ/I-NP/O Sukrosekonzentrationen/NN/I-NP/O und/CC/O/O Wasser/NN/B-NP/O sammeln/VB/B-VP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP direkten/JJ/I-NP/I-PNP Vergleich/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Verhalten/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP und/CC/O/O im/IN/B-PP/B-PNP Labor/NN/B-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O Sukroseempfindlichkeit/NN/I-NP/O derselben/NN/I-NP/O Tiere/NN/I-NP/O anschlie\xc3\x9fend/JJ/B-ADJP/O im/IN/B-PP/B-PNP Labor/NN/B-NP/I-PNP anhand/IN/B-PP/B-PNP der/DT/B-NP/I-PNP PER-Messung/NN/I-NP/I-PNP bestimmt/RP/O/O ././O/O

Die/DT/B-NP/O Versuche/NN/I-NP/O zeigten/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O die/DT/B-NP/O PER-Empfindlichkeit/NN/I-NP/O der/DT/B-NP/O Tiere/NN/I-NP/O im/IN/B-PP/B-PNP Labor/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Durchschnitt/NN/B-NP/I-PNP niedriger/JJ/B-ADJP/O war/VB/B-VP/O als/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Akzeptanz/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP ././O/O

Die/DT/B-NP/O konzentrationsabh\xc3\xa4ngige/NN/I-NP/O Akzeptanz/NN/I-NP/O im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP konnte/VBN/B-VP/I-PNP mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Hilfe/NN/I-NP/I-PNP eines/DT/B-NP/I-PNP additiven/NN/I-NP/I-PNP mathematischen/VB/B-VP/O Modells/IN/B-PP/B-PNP beschrieben/NN/B-NP/I-PNP werden/VB/B-VP/O ,/,/O/O in/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Interaktionen/NN/I-NP/I-PNP von/IN/B-PP/B-PNP hypothetischen/JJ/B-NP/I-PNP Sukrose/NN/I-NP/I-PNP -/-/O/O und/CC/O/O Wasserrezeptoren/NN/B-NP/O angenommen/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Die/DT/B-NP/O Reaktionen/NN/I-NP/O der/DT/B-NP/O Sukroserezeptoren/NN/I-NP/O und/CC/O/O die/DT/B-NP/O relative/NN/I-NP/O Beteiligung/NN/I-NP/O der/DT/B-NP/O Wasserrezeptoren/NN/I-NP/O in/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Tier/NN/I-NP/I-PNP scheinen/VB/B-VP/O nach/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Ergebnissen/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Freilandexperimenten/NN/I-NP/I-PNP und/CC/O/O dem/DT/O/O daraus/RB/B-VP/O entwickelten/VB/I-VP/O Modell/NN/B-NP/O miteinander/RB/B-VP/O gekoppelt/VBN/I-VP/O zu/TO/I-VP/O sein/VB/I-VP/O ././O/O

In/IN/B-PP/B-PNP weiteren/JJ/B-NP/I-PNP Freilandexperimenten/NN/I-NP/I-PNP konnte/VB/B-VP/O nachgewiesen/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP frei/JJ/B-NP/I-PNP fliegende/NN/I-NP/I-PNP Nektarsammlerinnen/NN/I-NP/I-PNP Sukrosekonzentrationen/NN/I-NP/I-PNP unterscheiden/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ,/,/O/O deren/WDT/B-NP/O Konzentrationen/NN/I-NP/O um/IN/B-PP/O weniger/RB/B-ADVP/O als/IN/B-PP/B-PNP 0,2/CD/B-NP/I-PNP relative/NN/I-NP/I-PNP Log-Einheiten/NN/I-NP/I-PNP verschieden/VB/B-VP/O sind/RB/B-ADVP/O ././O/O

Die/DT/B-NP/O Versuche/NN/I-NP/O zum/IN/B-PP/B-PNP gustatorischen/JJ/B-NP/I-PNP Verhalten/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Labor/NN/I-NP/I-PNP machen/VB/B-VP/O deutlich/JJ/B-ADJP/O ,/,/O/O dass/RB/B-ADVP/O zwischen/IN/B-PP/B-PNP Akzeptanz/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Diskriminierung/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP und/CC/I-NP/I-PNP PER-Reaktionen/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Labor/NN/B-NP/I-PNP nur/RB/B-ADVP/O teilweise/IN/B-PP/B-PNP Korrelationen/NN/B-NP/I-PNP bestehen/VB/B-VP/O und/CC/O/O direkte/JJ/B-NP/O R\xc3\xbcckschl\xc3\xbcsse/NN/I-NP/O aus/IN/B-PP/B-PNP PER-Messungen/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Labor/NN/B-NP/I-PNP auf/IN/B-PP/O die/DT/O/O im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP gesammelten/NN/I-NP/I-PNP und/CC/I-NP/I-PNP akzeptierten/NN/I-NP/I-PNP Sukrosekonzentrationen/NN/I-NP/I-PNP nicht/RB/B-ADJP/O m\xc3\xb6glich/JJ/I-ADJP/O sind/VB/B-VP/O ././O/O

Weitere/JJ/B-NP/O Versuche/NN/I-NP/O zur/IN/B-PP/B-PNP Modulation/NN/B-NP/I-PNP der/DT/I-NP/I-PNP PER/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Labor/NN/I-NP/I-PNP zeigten/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O vor/IN/B-PP/B-PNP allem/DT/B-NP/I-PNP die/DT/I-NP/I-PNP gesammelte/JJ/I-NP/I-PNP Menge/NN/I-NP/I-PNP an/IN/B-PP/B-PNP Zuckerwasser/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Honigmagen/NN/B-NP/I-PNP und/CC/I-NP/I-PNP die/DT/I-NP/I-PNP Trinkdauer/NN/I-NP/I-PNP an/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Futterstelle/NN/I-NP/I-PNP wichtige/JJ/B-NP/I-PNP Modulatoren/NN/I-NP/I-PNP der/DT/B-NP/I-PNP PER-Schwellen/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP Nektarsammlerinnen/NN/B-NP/I-PNP sind/VB/B-VP/O ././O/O

F\xc3\xbctterungsversuche/NN/B-NP/O im/IN/B-PP/B-PNP Labor/NN/B-NP/I-PNP zeigten/VB/B-VP/O eine/DT/B-NP/O systematische/JJ/I-NP/O Abh\xc3\xa4ngigkeit/NN/I-NP/O der/DT/B-NP/O PER/NN/I-NP/O von/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP gef\xc3\xbctterten/JJ/I-NP/I-PNP Volumen/NN/I-NP/I-PNP an/IN/B-PP/B-PNP Zuckerwasser/NN/B-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP konnte/VB/B-VP/O eine/DT/B-NP/O Modulation/NN/I-NP/O der/DT/B-NP/O PER-Schwellen/NN/I-NP/O bereits/RB/B-ADVP/O nach/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Trinkdauer/NN/I-NP/I-PNP von/IN/B-PP/B-PNP wenigen/JJ/B-NP/I-PNP Sekunden/NNS/I-NP/I-PNP beobachtet/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Die/DT/B-NP/O Versuche/NN/I-NP/O machten/VB/B-VP/O deutlich/JJ/B-ADJP/O ,/,/O/O dass/RB/B-ADVP/O der/DT/B-NP/O Verhaltenskontext/NN/I-NP/O von/IN/B-PP/B-PNP Tieren/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP einen/DT/I-NP/I-PNP entscheidenden/JJ/I-NP/I-PNP Einfluss/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Reaktionen/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Labor/NN/B-NP/I-PNP hat/VB/B-VP/O ././O/O

Die/DT/B-NP/O Lernexperimente/NN/I-NP/O im/IN/B-PP/B-PNP Feiland/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Labor/NN/I-NP/I-PNP zeigten/VB/B-VP/O des/DT/B-NP/O Weiteren/NN/I-NP/O ,/,/O/O dass/IN/B-PP/B-PNP Unterschiede/NN/B-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Sukroseakzeptanz/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Nektarsammlerinnen/NN/B-NP/I-PNP im/IN/B-PP/O Freiland/VB/B-VP/O sich/PRP/B-NP/O auch/RB/B-ADVP/O im/IN/B-PP/B-PNP assoziativen/NN/B-NP/I-PNP Lernen/NN/I-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Ged\xc3\xa4chtnisbildung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Tiere/JJ/I-NP/I-PNP widerspiegeln/NN/I-NP/I-PNP ././O/O

Bienen/NN/B-NP/O ,/,/O/O die/DT/B-NP/O niedrige/NN/I-NP/O Sukrosekonzentrationen/NN/I-NP/O akzeptieren/VB/B-VP/O ,/,/O/O erreichen/VB/B-VP/O bei/IN/B-PP/B-PNP Konditionierungsexperimenten/NN/B-NP/I-PNP sowohl/RB/B-ADVP/O im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP als/CC/O/O auch/RB/B-ADVP/O im/IN/B-PP/B-PNP Labor/NN/B-NP/I-PNP ein/DT/I-NP/I-PNP signifikant/JJ/I-NP/I-PNP h\xc3\xb6heres/JJ/I-NP/I-PNP Lernniveau/NN/I-NP/I-PNP und/CC/O/O besseres/NN/B-NP/O Ged\xc3\xa4chtnis/NN/I-NP/O als/IN/B-PP/B-PNP unempfindliche/JJ/B-NP/I-PNP Tiere/NN/I-NP/I-PNP ././O/O

Dabei/RB/B-VP/O unterschieden/VBN/I-VP/O sich/PRP/B-NP/O die/DT/I-NP/O PER-Reaktionen/NN/I-NP/O dieser/DT/B-NP/O Tiere/NN/I-NP/O nicht/RB/B-NP/O signifikant/JJ/I-NP/O voneinander/NN/I-NP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP assoziative/NN/I-NP/I-PNP Lernen/NN/I-NP/I-PNP und/CC/O/O die/DT/B-NP/O Ged\xc3\xa4chtnisbildung/NN/I-NP/O scheint/VB/B-VP/O die/DT/B-NP/O Sukroseakzeptanz/NN/I-NP/O im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP demnach/RB/B-ADVP/O ein/DT/B-NP/O besserer/NN/I-NP/O Pr\xc3\xa4diktor/NN/I-NP/O zu/TO/B-VP/O sein/VB/I-VP/O als/IN/B-PP/B-PNP die/DT/B-NP/I-PNP PER-Konzentrationsabh\xc3\xa4ngigkeit/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O im/IN/B-PP/B-PNP Labor/NN/B-NP/I-PNP gemessen/VBN/B-VP/I-PNP wurde/VB/I-VP/O ././O/O

In/IN/B-PP/B-PNP biochemischen/JJ/B-NP/I-PNP Untersuchungen/NN/I-NP/I-PNP wurde/RB/B-VP/O \xc3\xbcberpr\xc3\xbcft/VBN/I-VP/O ,/,/O/O ob/IN/B-PP/B-PNP Unterschiede/NN/B-NP/I-PNP bei/IN/B-PP/B-PNP Tieren/NN/B-NP/I-PNP ,/,/O/O die/WDT/B-NP/O sich/PRP/I-NP/O im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP in/IN/B-PP/B-PNP den/WDT/B-NP/I-PNP der/DT/I-NP/I-PNP Sukroseempfindlichkeit/NN/I-NP/I-PNP wie/CC/O/O auch/RB/B-ADVP/O dem/DT/B-NP/O Lernen/NN/I-NP/O und/CC/O/O Ged\xc3\xa4chtnis/NN/B-NP/O unterscheiden/VB/B-VP/O ,/,/O/O auch/RB/B-ADVP/O auf/IN/B-PP/B-PNP zellul\xc3\xa4rer/NN/B-NP/I-PNP Ebene/NN/I-NP/I-PNP zu/TO/B-VP/O finden/VB/I-VP/O sind/VB/I-VP/O ././O/O

Dazu/RB/B-VP/O wurden/VB/I-VP/O zwei/CD/B-NP/O Membranproteine/NN/I-NP/O ,/,/O/O die/DT/B-NP/O Adenylylzyklasen/NN/I-NP/O AmAC3/NN/I-NP/O und/CC/O/O AmAC8/NN/B-NP/O ,/,/O/O zum/IN/B-PP/B-PNP ersten/JJ/B-NP/I-PNP Mal/NN/I-NP/I-PNP immunzytochemisch/JJ/B-ADJP/O im/IN/B-PP/B-PNP Gehirn/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Honigbiene/JJ/I-NP/I-PNP charakterisiert/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O immunhistologischen/JJ/I-NP/O F\xc3\xa4rbungen/NN/I-NP/O zeigen/JJ/B-NP/O Immunreaktivit\xc3\xa4t/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP beide/JJ/B-NP/I-PNP Adenylylzyklasen/NN/I-NP/I-PNP \xc3\xbcberwiegend/JJ/B-ADJP/O in/IN/B-PP/B-PNP sensorischen/JJ/B-NP/I-PNP und/CC/I-NP/I-PNP motorischen/JJ/I-NP/I-PNP Neuropilen/NN/I-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP Bereichen/NN/B-NP/I-PNP ,/,/O/O die/WDT/O/O an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Informationsverarbeitung/NN/I-NP/I-PNP h\xc3\xb6herer/JJ/B-NP/I-PNP Ordnung/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Bienengehirn/NN/B-NP/I-PNP beteiligt/VBN/B-VP/I-PNP sind/VB/I-VP/O ././O/O

Anschlie\xc3\x9fende/JJ/B-NP/O quantitative/NN/I-NP/O PCR-Analysen/NN/I-NP/O ergaben/VB/B-VP/O einen/DT/B-NP/O hoch/JJ/I-NP/O signifikanten/JJ/I-NP/O Unterschied/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP mRNA-Menge/NN/I-NP/I-PNP der/DT/B-NP/I-PNP AmAC3/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP Tieren/NN/B-NP/I-PNP ,/,/O/O die/DT/B-NP/O entweder/CC/I-NP/O 50%/CD/I-NP/O Sukrose/NN/I-NP/O oder/RB/B-ADVP/O 3%/CD/B-NP/O Sukrose/NN/I-NP/O im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP akzeptieren/VB/B-VP/O ././O/O

Im/IN/B-PP/B-PNP Gegensatz/NN/B-NP/I-PNP zur/IN/B-PP/B-PNP Sukroseakzeptanz/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP korrelierten/NN/I-NP/I-PNP die/DT/I-NP/I-PNP PER-Schwellen/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Labor/NN/B-NP/I-PNP nicht/RB/B-ADVP/O mit/IN/B-PP/B-PNP Unterschieden/NN/B-NP/I-PNP der/DT/I-NP/I-PNP mRNA/NNP/I-NP/I-PNP Mengen/NNP/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP AmAC3/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Gehirn.Hefen/NN/B-NP/I-PNP ,/,/O/O die/WDT/O/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP industriellen/JJ/I-NP/I-PNP Produktion/NN/I-NP/I-PNP wie/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Lebensmittelherstellung/NN/I-NP/I-PNP oder/RB/B-ADVP/O der/DT/B-NP/O Fermentationstechnologie/NN/I-NP/O Anwendung/NN/I-NP/O finden/VB/B-VP/O ,/,/O/O weisen/VB/B-VP/O h\xc3\xa4ufig/JJ/B-NP/O art/NNP/I-NP/O -/-/O/O oder/CC/O/O stammspezifische/JJ/B-NP/O Defizite/NN/I-NP/O auf/RP/O/O ././O/O

Dazu/RB/B-VP/O geh\xc3\xb6ren/VB/I-VP/O die/DT/B-NP/O Verwertung/NN/I-NP/O nur/RB/B-NP/O bestimmter/JJ/I-NP/O Rohstoffe/NN/I-NP/O oder/RB/B-ADVP/O eine/DT/O/O zu/IN/B-PP/B-PNP geringe/JJ/B-NP/I-PNP Bildung/NN/I-NP/I-PNP erw\xc3\xbcnschter/JJ/B-NP/I-PNP G\xc3\xa4rungsprodukte/NN/I-NP/I-PNP ././O/O

K\xc3\xb6nnten/VB/B-VP/O diese/DT/O/O durch/IN/B-PP/B-PNP genetische/JJ/B-NP/I-PNP Modifikationen/NN/I-NP/I-PNP kompensiert/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O w\xc3\xbcrden/VB/B-VP/O sie/PRP/B-NP/O technologische/JJ/I-NP/O sowie/CC/I-NP/O technische/JJ/I-NP/O Vorteile/NN/I-NP/O bringen/VB/B-VP/O ././O/O

Die/DT/B-NP/O Folgen/NN/I-NP/O w\xc3\xa4ren/VB/B-VP/O zum/IN/B-PP/B-PNP Beispiel/NN/B-NP/I-PNP effizientere/NN/I-NP/I-PNP Prozesse/NN/I-NP/I-PNP ,/,/O/O Rohstoff/NN/B-NP/O -/-/O/O oder/CC/O/O Hilfsstoffeinsparungen/NN/B-NP/O oder/RB/B-NP/O umweltfreundlichere/JJ/I-NP/O Verfahren/NN/I-NP/O ././O/O

Neben/IN/B-PP/B-PNP diesen/DT/B-NP/I-PNP technisch&slash;technologischen/JJ/I-NP/I-PNP Faktoren/NN/I-NP/I-PNP w\xc3\xbcrden/VB/B-VP/O sich/PRP/B-NP/O auch/RB/I-NP/O \xc3\xb6konomische/JJ/I-NP/O Vorteile/NN/I-NP/O ergeben/VB/B-VP/O ././O/O

Ziel/NN/B-NP/O dieser/DT/I-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O es/PRP/B-NP/O ,/,/O/O eine/DT/B-NP/O Methode/NN/I-NP/O zu/TO/B-VP/O entwickeln/VB/I-VP/O ,/,/O/O mit/IN/B-PP/B-PNP deren/WDT/B-NP/I-PNP Hilfe/NN/I-NP/I-PNP Eigenschaften/NNS/I-NP/I-PNP von/IN/B-PP/B-PNP Hefen/NN/B-NP/I-PNP der/DT/O/O Art/FW/O/O Saccharomyces/FW/O/O cerevisiae/FW/O/O ,/,/O/O die/WDT/O/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP industriellen/JJ/I-NP/I-PNP Anwendung/NN/I-NP/I-PNP genutzt/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O schnell/JJ/B-NP/O und/CC/I-NP/O effizient/JJ/I-NP/O optimiert/NN/I-NP/O werden/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ././O/O

Dabei/RB/B-VP/O wurden/VB/I-VP/O unterg\xc3\xa4rige/NN/B-NP/O Brauhefen/NN/I-NP/O als/IN/B-PP/B-PNP Zielorganismen/NN/B-NP/I-PNP sowohl/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Sulfitbildung/NN/I-NP/I-PNP als/CC/O/O auch/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Esterbildung/NN/I-NP/I-PNP gew\xc3\xa4hlt/RP/O/O ././O/O

Als/IN/B-PP/B-PNP Zielgene/NN/B-NP/I-PNP zur/IN/B-PP/B-PNP Optimierung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP genannten/JJ/I-NP/I-PNP Stoffwechselleistungen/NN/I-NP/I-PNP wurden/VB/B-VP/O die/DT/B-NP/O Gene/NN/I-NP/O SSU1/NN/I-NP/O ,/,/O/O MET14/NN/B-NP/O und/CC/I-NP/O FZF1/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Sulfitbildung/NN/I-NP/I-PNP und/CC/O/O die/DT/B-NP/O Gene/NN/I-NP/O ATF1/NN/I-NP/O ,/,/O/O ATF2/NN/B-NP/O sowie/RB/I-NP/O EHT1/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Esterbildung/NN/I-NP/I-PNP verwendet/VB/B-VP/O ././O/O

Zun\xc3\xa4chst/VBN/B-VP/O wurde/VB/I-VP/O das/DT/B-NP/O System/NN/I-NP/O zur/IN/B-PP/B-PNP Optimierung/NN/B-NP/I-PNP von/IN/B-PP/O Saccharomyces/FW/O/O cerevisiae/FW/O/O Industriehefen/FW/O/O etabliert/FW/O/O ././O/O

Dabei/RB/B-VP/O wird/VB/I-VP/O eine/DT/O/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP entsprechenden/JJ/I-NP/I-PNP Gen/NN/I-NP/I-PNP und/CC/O/O einem/DT/B-NP/O dominanten/NN/I-NP/O Marker/JJ/B-NP/O beladene/JJ/I-NP/O Integrationskassette/NN/I-NP/O in/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Hefegenom/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP homologe/NN/B-NP/I-PNP Rekombination/NN/I-NP/I-PNP integriert/RP/O/O ././O/O

Als/IN/B-PP/B-PNP Zielsequenz/NN/B-NP/I-PNP der/DT/I-NP/I-PNP homologen/NN/I-NP/I-PNP Rekombination/NN/I-NP/I-PNP wurden/VB/B-VP/O die/DT/B-NP/O \xc3\xaf?\xc2\xa4-Sequenzen/NN/I-NP/O ,/,/O/O flankierende/NN/B-NP/O Bereiche/NNP/I-NP/O der/DT/I-NP/O Ty/NNP/I-NP/O Elemente/NNP/I-NP/O der/DT/B-NP/O Hefe/NN/I-NP/O ,/,/O/O gew\xc3\xa4hlt/RP/O/O ././O/O

Anschlie\xc3\x9fend/VBN/B-VP/O wird/VB/I-VP/O der/DT/B-NP/O dominante/NN/I-NP/O Marker/VB/B-VP/O ,/,/O/O der/WDT/O/O aus/IN/B-PP/B-PNP lebensmittelrechtlichen/JJ/B-NP/I-PNP Gr\xc3\xbcnden/NN/I-NP/I-PNP nicht/RB/B-ADVP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Zelle/NN/I-NP/I-PNP verbleiben/VB/B-VP/O darf/VB/I-VP/O ,/,/O/O aber/CC/O/O f\xc3\xbcr/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP schnelles/NN/I-NP/I-PNP und/CC/O/O effizientes/JJ/B-NP/O screening/NN/I-NP/O positiver/JJ/B-NP/O Zellen/NNS/I-NP/O n\xc3\xb6tig/JJ/B-ADJP/O ist/VB/B-VP/O ,/,/O/O wieder/RB/B-ADVP/O aus/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Genom/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Hefe/NN/I-NP/I-PNP entfernt/JJ/B-ADJP/O ././O/O

Dies/DT/O/O wird/VB/B-VP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Kw/NN/I-NP/I-PNP Rekombinase/NN/I-NP/I-PNP ,/,/O/O eine/DT/B-NP/O Rekombinase/NN/I-NP/O aus/IN/B-PP/O Kluyveromyces/FW/O/O waltii/FW/O/O ,/,/O/O die/WDT/O/O \xc3\xbcber/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP episomales/JJ/I-NP/I-PNP Plasmid/NN/I-NP/I-PNP in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Zelle/NN/I-NP/I-PNP eingebracht/VBN/B-VP/I-PNP wird/VB/I-VP/O ,/,/O/O katalysiert/NN/B-NP/O ././O/O

Der/DT/B-NP/O Vorgang/NN/I-NP/O des/DT/B-NP/O Herausklonierens/NN/I-NP/O verl\xc3\xa4uft/NN/I-NP/O ebenfalls/VB/B-VP/O nach/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Mechanismus/NN/I-NP/I-PNP der/DT/B-NP/I-PNP homologen/JJ/I-NP/I-PNP Rekombination/NN/I-NP/I-PNP ././O/O

Die/DT/O/O so/IN/B-PP/B-PNP optimierten/NN/B-NP/I-PNP Brauhefest\xc3\xa4mme/NN/I-NP/I-PNP wurden/VB/B-VP/O anschlie\xc3\x9fend/JJ/B-ADJP/O auf/IN/B-PP/B-PNP ihre/PRP$/B-NP/I-PNP modifizierten/NN/I-NP/I-PNP Stoffwechselleistungen/NN/I-NP/I-PNP hin/IN/B-PP/O untersucht/RP/O/O ././O/O

Dabei/RB/B-VP/O konnte/VB/I-VP/O festgestellt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP sich/PRP/B-NP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP entwickelten/JJ/I-NP/I-PNP System/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Abh\xc3\xa4ngigkeit/NN/B-NP/I-PNP der/DT/I-NP/I-PNP eingesetzten/NN/I-NP/I-PNP Gene/NN/I-NP/I-PNP sowohl/RB/B-ADVP/O die/DT/B-NP/O Bildung/NN/I-NP/O und/CC/O/O Freisetzung/NN/B-NP/O von/IN/B-PP/B-PNP Sulfit/NN/B-NP/I-PNP als/CC/O/O auch/IN/B-PP/B-PNP geschmacksaktiver/NNP/B-NP/I-PNP Ester/NNP/I-NP/I-PNP erh\xc3\xb6hen/VB/B-VP/O l\xc3\xa4sst/VB/I-VP/O und/CC/O/O somit/RB/B-ADVP/O die/DT/B-NP/O Biere/NNS/I-NP/O gegen/IN/B-PP/B-PNP Alterung/NN/B-NP/I-PNP weitgehend/JJ/B-ADJP/O gesch\xc3\xbctzt/VBN/B-VP/O sind/VB/I-VP/O oder/CC/O/O Biere/NNS/B-NP/O mit/IN/B-PP/B-PNP ver\xc3\xa4ndertem/NN/B-NP/I-PNP Geschmacksprofil/NN/I-NP/I-PNP ergeben/VB/B-VP/O ././O/O

Die/DT/B-NP/O Hefen/NN/I-NP/O behielten/NN/I-NP/O ihre/PRP$/I-NP/O physiologischen/JJ/B-NP/O Eigenschaften/NNS/I-NP/O bei/RP/O/O ././O/O

Dabei/RB/B-VP/O blieben/VB/I-VP/O die/DT/O/O bisherigen/VB/B-VP/O ,/,/O/O verfahrenstechnischen/JJ/B-NP/O betrieblichen/JJ/I-NP/O Abl\xc3\xa4ufe/NN/I-NP/O bestehen.Die/NN/I-NP/O Alzheimer/NN/I-NP/O Krankheit/NN/I-NP/O ist/VB/B-VP/O die/DT/B-NP/O h\xc3\xa4ufigste/NN/I-NP/O Form/NN/I-NP/O der/DT/B-NP/O Demenz/NN/I-NP/O ././O/O

Charakteristische/JJ/B-NP/O Merkmale/NN/I-NP/O der/DT/B-NP/O Erkrankung/NN/I-NP/O sind/VB/B-VP/O die/DT/B-NP/O Entstehung/NN/I-NP/O von/IN/B-PP/B-PNP neurofibrill\xc3\xa4ren/NN/B-NP/I-PNP B\xc3\xbcndeln/NN/I-NP/I-PNP und/CC/I-NP/I-PNP die/DT/I-NP/I-PNP Ablagerung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP A\xce\xb2-Plaques/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Gehirn/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Betroffenen/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O A\xce\xb2-Plaques/NN/I-NP/O bestehen/VB/B-VP/O haupts\xc3\xa4chlich/RB/B-ADVP/O aus/IN/B-PP/B-PNP Amyloid/JJ/B-NP/I-PNP \xce\xb2-Peptiden/NN/I-NP/I-PNP (/(/O/O A\xce\xb2/NN/B-NP/O )/)/O/O ,/,/O/O welche/WDT/O/O durch/IN/B-PP/B-PNP sequentielle/NN/B-NP/I-PNP proteolytische/JJ/I-NP/I-PNP Spaltung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Amyloid-Precursor-Proteins/NN/I-NP/I-PNP (/(/O/O APP/NNP/B-NP/O )/)/O/O durch/IN/B-PP/B-PNP \xce\xb2-Sekretasen/NN/B-NP/I-PNP und/CC/I-NP/I-PNP \xce\xb3-Sekretasen/NN/I-NP/I-PNP freigesetzt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Die/DT/B-NP/O schwedische/JJ/I-NP/O Doppelmutation/NN/I-NP/O im/IN/B-PP/B-PNP APP/NNP/B-NP/I-PNP (/(/O/O APPswe/NN/B-NP/O )/)/O/O verst\xc3\xa4rkt/VB/B-VP/O die/DT/B-NP/O \xce\xb2-Sekretase-Prozessierung/NN/I-NP/O und/CC/O/O verursacht/VB/B-VP/O so/RB/B-ADVP/O eine/DT/O/O stark/JJ/B-ADJP/O erh\xc3\xb6hte/VB/B-VP/O A\xce\xb2-Sekretion/NN/B-NP/O ././O/O

Wir/PRP/B-NP/O zeigen/VB/B-VP/O durch/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Vergleich/NN/I-NP/I-PNP von/IN/B-PP/B-PNP stabil/JJ/B-NP/I-PNP \xc3\xbcberexprimierenden/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP ,/,/O/O dass/IN/B-PP/B-PNP wildtyp/NN/B-NP/I-PNP APP/NNP/I-NP/I-PNP und/CC/I-NP/I-PNP APPswe/NNP/I-NP/I-PNP zum/IN/B-PP/B-PNP gr\xc3\xb6\xc3\x9ften/JJ/B-NP/I-PNP Teil/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP unterschiedliche/JJ/B-NP/I-PNP \xce\xb2-Sekretase-Aktivit\xc3\xa4ten/NN/I-NP/I-PNP geschnitten/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

W\xc3\xa4hrend/IN/B-PP/B-PNP die/DT/B-NP/I-PNP \xce\xb2-Sekretase-Prozessierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP wildtyp/NNP/B-NP/I-PNP APP/NNP/I-NP/I-PNP haupts\xc3\xa4chlich/NNP/I-NP/I-PNP oder/CC/O/O ausschlie\xc3\x9flich/RB/B-ADVP/O in/IN/B-PP/B-PNP endozytotischen/JJ/B-NP/I-PNP Kompartimenten/NN/I-NP/I-PNP erfolgt/VB/B-VP/O ,/,/O/O wird/VB/B-VP/O die/DT/B-NP/O amyloidogene/NN/I-NP/O Prozessierung/NN/I-NP/O beim/IN/B-PP/B-PNP APP/NNP/B-NP/I-PNP mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP schwedischen/JJ/I-NP/I-PNP Mutation/NN/I-NP/I-PNP gr\xc3\xb6\xc3\x9ftenteils/NN/I-NP/I-PNP im/IN/B-PP/B-PNP sekretorischen/JJ/B-NP/I-PNP Transportweg/NN/I-NP/I-PNP ,/,/O/O vermutlich/JJ/B-ADJP/O in/IN/B-PP/B-PNP vom/IN/I-PP/I-PNP Golgi/NN/B-NP/I-PNP abgeschn\xc3\xbcrten/NN/I-NP/I-PNP sekretorischen/JJ/I-NP/I-PNP Vesikeln/NN/I-NP/I-PNP ,/,/O/O initiiert/NN/B-NP/O ././O/O

Ungeachtet/IN/B-PP/B-PNP der/DT/B-NP/I-PNP unver\xc3\xa4nderten/NN/I-NP/I-PNP APPs\xce\xb2swe-Sekretion/NN/I-NP/I-PNP verursachen/PRP$/I-NP/I-PNP Mutationen/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Endozytosesignal/NN/B-NP/I-PNP von/IN/B-PP/B-PNP schwedischem/JJ/B-NP/I-PNP APP/NNP/I-NP/I-PNP eine/DT/B-NP/I-PNP starke/JJ/I-NP/I-PNP Abnahme/NN/I-NP/I-PNP der/DT/B-NP/I-PNP C99-Fragmente/NN/I-NP/I-PNP und/CC/O/O infolgedessen/RB/B-ADVP/O eine/DT/B-NP/O 50%ige/NN/I-NP/O Abnahme/NN/I-NP/O sowohl/RB/B-ADVP/O der/DT/B-NP/O A\xce\xb240/NN/I-NP/O -/-/O/O als/CC/O/O auch/RB/B-ADVP/O der/DT/B-NP/O A\xce\xb242-Produktion/NN/I-NP/O ././O/O

Wir/PRP/B-NP/O zeigen/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O diese/WDT/B-NP/O stark/JJ/I-NP/O erniedrigte/JJ/I-NP/O C99-Menge/NN/I-NP/O von/IN/B-PP/B-PNP internalisierungsdefizientem/JJ/B-NP/I-PNP APPswe/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP \xce\xb1-Sekretase-vermittelte/NN/I-NP/I-PNP Umwandlung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP C99-Fragmente/NN/I-NP/I-PNP in/IN/B-PP/B-PNP C83/NN/B-NP/I-PNP verursacht/VBN/B-VP/I-PNP wird/VB/I-VP/O ././O/O

Zudem/RB/B-VP/O tr\xc3\xa4gt/VB/I-VP/O diese/DT/B-NP/O Prozessierung/NN/I-NP/O der/DT/B-NP/O C99-Fragmente/NN/I-NP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP \xce\xb1-Sekretase/NN/I-NP/I-PNP neben/IN/B-PP/B-PNP der/DT/B-NP/I-PNP verminderten/NN/I-NP/I-PNP \xce\xb2-Sekretase/NN/I-NP/I-PNP Prozessierung/NN/I-NP/I-PNP zu/RB/B-ADVP/O der/DT/B-NP/O stark/JJ/I-NP/O erniedrigten/JJ/I-NP/O A\xce\xb2-Produktion/NN/I-NP/O von/IN/B-PP/B-PNP internalisierungsdefizientem/NN/B-NP/I-PNP wildtyp/NN/I-NP/I-PNP APP/NNP/I-NP/I-PNP bei/RP/O/O ././O/O

Dagegen/RB/B-VP/O verursachte/VB/I-VP/O die/DT/B-NP/O Inhibition/NN/I-NP/O der/DT/B-NP/O \xce\xb1-Sekretase-Prozessierung/NN/I-NP/O sowohl/RB/B-ADVP/O im/IN/B-PP/B-PNP schwedischen/JJ/B-NP/I-PNP APP/NNP/I-NP/I-PNP ,/,/O/O im/IN/B-PP/B-PNP wildtyp/NN/B-NP/I-PNP APP/NN/I-NP/I-PNP als/CC/O/O auch/RB/B-ADVP/O im/IN/B-PP/B-PNP C99/NN/B-NP/I-PNP eine/DT/O/O stark/JJ/B-ADJP/O erh\xc3\xb6hte/VB/B-VP/O A\xce\xb2-Sekretion/NN/B-NP/O ././O/O

Diese/DT/B-NP/O Ergebnisse/NN/I-NP/O deuten/VB/B-VP/O darauf/RB/B-ADVP/O hin/IN/B-PP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP \xce\xb1-Sekretase-Prozessierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP C99/NN/B-NP/I-PNP ein/DT/I-NP/I-PNP physiologisches/JJ/I-NP/I-PNP Ereignis/NN/I-NP/I-PNP der/DT/B-NP/I-PNP APP-Prozessierung/NN/I-NP/I-PNP ist/VB/B-VP/O ,/,/O/O das/WDT/B-NP/O die/DT/I-NP/O A\xce\xb2-Sekretion/NN/I-NP/O limitiert.Osteoarthrose/NN/I-NP/O ist/VB/B-VP/O eine/DT/B-NP/O Volkskrankheit/NN/I-NP/O und/CC/O/O bislang/RB/B-VP/O gibt/VB/I-VP/O es/PRP/B-NP/O noch/RB/I-NP/O keine/JJ/I-NP/O Therapie/NN/I-NP/O mit/IN/B-PP/B-PNP Langzeiterfolg/NN/B-NP/I-PNP ././O/O

Bei/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP nicht/RB/I-NP/I-PNP entz\xc3\xbcndlichen/JJ/I-NP/I-PNP Osteoarthrose/NN/I-NP/I-PNP ist/VB/B-VP/O die/DT/B-NP/O Knorpel-schutzschicht/NN/I-NP/O auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP artikul\xc3\xa4ren/NN/I-NP/I-PNP Gelenken/JJ/B-NP/I-PNP degeneriert/NN/I-NP/I-PNP ././O/O

Dieser/DT/B-NP/O Prozess/NN/I-NP/O ist/VB/B-VP/O irreversibel/JJ/B-ADJP/O ././O/O

Die/DT/B-NP/O Zellen/NNS/I-NP/O in/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Gewebe/NN/I-NP/I-PNP sind/VB/B-VP/O im/IN/B-PP/B-PNP ausdifferenzierten/NN/B-NP/I-PNP Zustand/NN/I-NP/I-PNP nicht/RB/B-ADJP/O mehr/RB/I-ADJP/O teilungsf\xc3\xa4hig/JJ/I-ADJP/O ././O/O

Bei/IN/B-PP/B-PNP traumatischer/NN/B-NP/I-PNP Sch\xc3\xa4digung/NN/I-NP/I-PNP der/DT/I-NP/I-PNP Schicht/NN/I-NP/I-PNP oder/RB/B-ADVP/O einem/DT/B-NP/O Abbau/NN/I-NP/O des/DT/B-NP/O Gewebes/NN/I-NP/O infolge/IN/B-PP/B-PNP von/IN/I-PP/I-PNP Fehl/NN/B-NP/I-PNP -/-/O/O oder/CC/O/O \xc3\x9cberbelastung/NN/B-NP/O der/DT/B-NP/O Gelenke/NN/I-NP/O kann/VB/B-VP/O nur/RB/B-ADVP/O eine/DT/B-NP/O Gewebeersatztherapie/NN/I-NP/O erfolgen/VB/B-VP/O ././O/O

Der/DT/B-NP/O Bedarf/NN/I-NP/O an/IN/B-PP/B-PNP alternativen/NN/B-NP/I-PNP Therapieans\xc3\xa4tzen/NN/I-NP/I-PNP ist/VB/B-VP/O hoch/JJ/B-ADJP/O ././O/O

Aktuelle/JJ/B-NP/O Strategien/NN/I-NP/O zielen/VB/B-VP/O immer/RB/B-ADVP/O mehr/RB/I-ADVP/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Bereitstellung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Gewebeaufbauenden/NN/B-NP/I-PNP Bedingungen/NN/I-NP/I-PNP ab/RB/B-ADVP/O und/CC/O/O favorisieren/VB/B-VP/O den/DT/B-NP/O Einsatz/NN/I-NP/O von/IN/B-PP/B-PNP Vorl\xc3\xa4uferzellen/NN/B-NP/I-PNP ,/,/O/O die/WDT/O/O im/IN/B-PP/B-PNP Gewebe/NN/B-NP/I-PNP differenzieren/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O und/CC/O/O neues/JJ/B-NP/O Gewebe/NN/I-NP/O aufbauen/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP solche/DT/B-NP/I-PNP Ans\xc3\xa4tze/NNS/I-NP/I-PNP ist/VB/B-VP/O eine/DT/B-NP/O Kenntnis/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP molekularen/JJ/I-NP/I-PNP Ursachen/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Gewebedegeneration/NN/I-NP/I-PNP ebenso/RB/B-ADJP/O wichtig/JJ/I-ADJP/O ,/,/O/O wie/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Aufkl\xc3\xa4rung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Entstehung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Gewebe/NN/B-NP/I-PNP ././O/O

Nur/RB/B-ADVP/O auf/IN/B-PP/B-PNP diesem/DT/B-NP/I-PNP Weg/NN/I-NP/I-PNP k\xc3\xb6nnen/VB/B-VP/O letztlich/IN/B-PP/B-PNP Faktoren/NN/B-NP/I-PNP identifiziert/NN/I-NP/I-PNP werden/VB/B-VP/O ,/,/O/O die/WDT/B-NP/O den/DT/I-NP/O Degenerationsprozess/NN/I-NP/O im/IN/B-PP/B-PNP Gewebe/NN/B-NP/I-PNP umkehren/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ././O/O

In/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP stand/VB/B-VP/O die/DT/B-NP/O Untersuchung/NN/I-NP/O der/DT/B-NP/O initialen/JJ/I-NP/O Schritte/NN/I-NP/O der/DT/B-NP/O Entstehung/NN/I-NP/O mesenchymaler/NN/I-NP/O Gewebe/NN/I-NP/O im/IN/B-PP/B-PNP Vordergrund/NN/B-NP/I-PNP ././O/O

Dazu/RB/B-VP/O wurden/VB/I-VP/O prim\xc3\xa4re/JJ/B-NP/O Zellen/NNS/I-NP/O mesen-chymalen/JJ/B-NP/O Ursprungs/NN/I-NP/O mit/IN/B-PP/B-PNP mesenchymalem/JJ/B-NP/I-PNP Differenzierungspotential/NN/I-NP/I-PNP in/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP ge-eigneten/NN/I-NP/I-PNP in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP Kultursystem/NN/I-NP/I-PNP untersucht/RP/O/O ././O/O

Die/DT/B-NP/O mesenchymale/NN/I-NP/O Kondensation/NN/I-NP/O als/IN/B-PP/B-PNP initialer/NN/B-NP/I-PNP Schritt/NN/I-NP/I-PNP mesenchymaler/NN/I-NP/I-PNP Gewebedifferenzierung/NN/I-NP/I-PNP kann/VB/B-VP/O in/IN/B-PP/B-PNP Low/NN/B-NP/I-PNP Attachment/NN/I-NP/I-PNP Kulturplatten/NN/I-NP/I-PNP der/DT/O/O Firma/FW/O/O Corning/FW/O/O nachgestellt/FW/O/O und/CC/O/O analysiert/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Genomweite/JJ/B-NP/O Genexpressionsanalysen/NN/I-NP/O zu/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Zeitpunkten/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Zellkon-densation/NN/I-NP/I-PNP haben/RB/B-VP/O gezeigt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Inhibitor/NN/I-NP/I-PNP des/DT/B-NP/I-PNP WNT/NNP/I-NP/I-PNP Signalweges/NNP/I-NP/I-PNP DKK1/NNP/I-NP/I-PNP der/DT/O/O am/IN/B-PP/B-PNP st\xc3\xa4rksten/NN/B-NP/I-PNP herab/NN/I-NP/I-PNP regulierte/JJ/I-NP/I-PNP Faktor/NN/I-NP/I-PNP in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP kondensierenden/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP ist/VB/B-VP/O ././O/O

Neben/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Signalwegen/NN/I-NP/I-PNP der/DT/B-NP/I-PNP FGF/NN/I-NP/I-PNP und/CC/O/O TGF/NN/B-NP/O Familie/NN/I-NP/O wird/VB/B-VP/O auch/RB/B-ADVP/O der/DT/B-NP/O WNT/NNP/I-NP/O Signalweg/NNP/I-NP/O zunehmend/JJ/B-ADJP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Zusammenhang/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP mesenchymalen/JJ/B-NP/I-PNP Differenzierungs-vorg\xc3\xa4ngen/NN/I-NP/I-PNP gebracht/RP/O/O ././O/O

Bislang/RB/B-VP/O liegen/VB/I-VP/O noch/RB/B-ADVP/O keine/DT/B-NP/O verl\xc3\xa4sslichen/JJ/I-NP/O humanen/JJ/I-NP/O Daten/NN/I-NP/O vor/RP/O/O ././O/O

Lediglich/RB/B-NP/O erste/JJ/I-NP/O Ergebnisse/NN/I-NP/O aus/IN/B-PP/B-PNP Tiermodellen/NN/B-NP/I-PNP geben/VB/B-VP/O einen/DT/B-NP/O Hinweis/NN/I-NP/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Beteiligung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP WNT/NNP/B-NP/I-PNP Vertretern/NNP/I-NP/I-PNP an/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Prozess/NN/I-NP/I-PNP aktiver/JJ/B-NP/I-PNP Zell-Zellinteraktionen/NN/I-NP/I-PNP beim/IN/B-PP/B-PNP \xc3\x9cbergang/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Proliferation/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP Differenzierung/NN/B-NP/I-PNP ././O/O

In/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Runterregulation/NN/I-NP/I-PNP von/IN/B-PP/B-PNP DKK1/NN/B-NP/I-PNP assoziiert/NN/I-NP/I-PNP ist/VBN/B-VP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Kondensationsereignis/NN/I-NP/I-PNP ././O/O

Eine/DT/B-NP/O Stimulation/NN/I-NP/O mit/IN/B-PP/B-PNP chondrogenen/NN/B-NP/I-PNP Faktoren/NN/I-NP/I-PNP wie/IN/B-PP/B-PNP Hypoxie/NN/B-NP/I-PNP und/CC/I-NP/I-PNP TGF\xc3\x9f1/NN/I-NP/I-PNP hat/VB/B-VP/O keinen/JJ/B-NP/O Einfluss/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP DKK1/JJ/I-NP/I-PNP Expression/NN/I-NP/I-PNP ././O/O

Weitere/JJ/B-NP/O Untersuchungen/NN/I-NP/O konnten/VB/B-VP/O zeigen/VB/I-VP/O ,/,/O/O dass/RB/B-ADVP/O eine/DT/B-NP/O stabile/JJ/I-NP/O Inhibierung/NN/I-NP/O von/IN/B-PP/B-PNP DKK1/NN/B-NP/I-PNP in/IN/B-PP/O nicht/RB/B-ADVP/O kondensierenden/NN/B-NP/O Zellen/NNS/I-NP/O auf/IN/B-PP/B-PNP transkriptioneller/NN/B-NP/I-PNP Ebene/NN/I-NP/I-PNP eine/DT/I-NP/I-PNP Hochregulation/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Zell-Zellsignaling/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Adh\xc3\xa4sionsmolek\xc3\xbclen/NN/I-NP/I-PNP bewirkt/VB/B-VP/O ././O/O

Wenngleich/CC/O/O auch/RB/B-ADVP/O eine/DT/B-NP/O spontane/JJ/I-NP/O Kondensation/NN/I-NP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Inhibierung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Faktors/NN/I-NP/I-PNP nicht/RB/B-ADVP/O initiiert/NN/B-NP/O werden/VB/B-VP/O konnte/VBN/I-VP/O ,/,/O/O so/RB/B-VP/O erfolgt/VB/I-VP/O dennoch/RB/B-ADVP/O bereits/RB/I-ADVP/O eine/DT/B-NP/O Umstellung/NN/I-NP/O auf/IN/B-PP/B-PNP Zellinteraktionsvorg\xc3\xa4nge/NN/B-NP/I-PNP ././O/O

Die/DT/B-NP/O Daten/NN/I-NP/O der/DT/B-NP/O kondensierenden/NN/I-NP/O Zellen/NNS/I-NP/O sind/VBN/B-VP/O vergleichbar/JJ/B-ADJP/O mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Daten/NN/I-NP/I-PNP transduzierten/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP bei/IN/B-PP/B-PNP inhibierter/NN/B-NP/I-PNP DKK1/JJ/I-NP/I-PNP Expression/NN/I-NP/I-PNP ././O/O

Weitere/JJ/B-NP/O Versuche/NN/I-NP/O werden/VB/B-VP/O zeigen/VBN/I-VP/O ,/,/O/O ob/IN/B-PP/B-PNP sich/PRP/B-NP/I-PNP Interventionen/NNS/I-NP/I-PNP in/IN/B-PP/B-PNP DKK1/NN/B-NP/I-PNP gesteuertes/NN/I-NP/I-PNP WNT/NNP/I-NP/I-PNP Signaling/NNP/I-NP/I-PNP eignen/VB/B-VP/O ,/,/O/O den/DT/B-NP/O Kondensations/NN/I-NP/O -/-/O/O und/CC/O/O Differenzierungsprozess/NN/B-NP/O f\xc3\xbcr/IN/B-PP/B-PNP regenerative/NN/B-NP/I-PNP Therapieans\xc3\xa4tze/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP verfolgen.Die/NN/B-NP/I-PNP Parodontitis/NN/I-NP/I-PNP ist/VB/B-VP/O eine/DT/O/O durch/IN/B-PP/B-PNP bakteriellen/NNP/B-NP/I-PNP Biofilm/NNP/I-NP/I-PNP und/CC/O/O der/DT/O/O k\xc3\xb6rpereigenen/MD/B-VP/O Immunantwort/NN/B-NP/O verursachte/VB/B-VP/O entz\xc3\xbcndliche/JJ/B-NP/O Erkrankung/NN/I-NP/O des/DT/B-NP/O Zahnhalteapparates/NN/I-NP/O ,/,/O/O die/DT/O/O zu/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP irreversiblen/NN/I-NP/I-PNP Verlust/NN/I-NP/I-PNP desselben/NN/I-NP/I-PNP f\xc3\xbchren/VB/B-VP/O kann/VB/I-VP/O und/CC/O/O neben/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Karies/NN/I-NP/I-PNP als/IN/B-PP/B-PNP h\xc3\xa4ufigste/JJ/B-NP/I-PNP Infektionskrankheit/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP westlichen/JJ/I-NP/I-PNP Welt/NN/I-NP/I-PNP angesehen/VBN/B-VP/I-PNP wird/VB/I-VP/O ././O/O

Um/IN/B-PP/B-PNP den/DT/B-NP/I-PNP parodontalen/JJ/I-NP/I-PNP Biofilm/NNP/I-NP/I-PNP zerst\xc3\xb6rungsfrei/NNP/I-NP/I-PNP untersuchen/JJ/B-ADJP/O zu/TO/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ,/,/O/O wurden/VB/B-VP/O zu/IN/B-PP/B-PNP diesem/DT/B-NP/I-PNP Zweck/NN/I-NP/I-PNP konstruierte/NN/I-NP/I-PNP Biofilm/NNP/I-NP/I-PNP -/-/O/O Carrier/NN/B-NP/O in/IN/B-PP/O Parodontaltaschen/JJ/B-ADJP/O von/IN/B-PP/B-PNP Patienten/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP aggressiver/JJ/B-NP/I-PNP Parodontitis/NN/I-NP/I-PNP eingesetzt/RP/O/O ././O/O

Die/DT/O/O auf/IN/B-PP/B-PNP diesen/DT/B-NP/I-PNP Carriern/NN/I-NP/I-PNP gebildeten/NN/I-NP/I-PNP Biofilme/NN/I-NP/I-PNP wurden/VB/B-VP/O nachfolgend/JJ/B-ADJP/O mit/IN/B-PP/B-PNP elektronenmikroskopischen/JJ/B-NP/I-PNP Methoden/NN/I-NP/I-PNP und/CC/O/O dem/DT/O/O konfokalen/JJ/B-ADJP/O Laser/FW/O/O Scanning/FW/O/O Mikroskop/FW/O/O dokumentiert/FW/O/O ././O/O

Als/IN/B-PP/B-PNP Pioniere/NNS/B-NP/I-PNP bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Besiedlung/NN/I-NP/I-PNP der/DT/O/O Carrieroberfl\xc3\xa4chen/VB/B-VP/O wurden/VB/I-VP/O vor/IN/B-PP/B-PNP allem/DT/B-NP/I-PNP begei\xc3\x9felte/NN/I-NP/I-PNP St\xc3\xa4bchen/NN/I-NP/I-PNP ,/,/O/O Treponemen/NN/B-NP/O und/CC/I-NP/O Matrix/NN/I-NP/O -/-/O/O bildende/NN/B-NP/O Bakterien/NN/I-NP/O gefunden/RP/O/O ././O/O

An/IN/B-PP/B-PNP diesen/DT/B-NP/I-PNP adh\xc3\xa4rierten/NN/I-NP/I-PNP dann/RB/B-NP/I-PNP weitere/JJ/I-NP/I-PNP Bakterien/NN/I-NP/I-PNP ,/,/O/O so/RB/B-ADVP/O dass/IN/B-PP/B-PNP sich/PRP/B-NP/I-PNP kleine/RB/B-ADVP/O ,/,/O/O einschichtige/NN/B-NP/O Mikrokolonien/NNP/I-NP/O bildeten/VB/B-VP/O ,/,/O/O die/WDT/B-NP/O sich/PRP/I-NP/O fl\xc3\xa4chenm\xc3\xa4\xc3\x9fig/JJ/B-ADJP/O immer/RB/B-ADVP/O weiter/IN/B-PP/B-PNP ausdehnten/NN/B-NP/I-PNP ././O/O

Gro\xc3\x9ffl\xc3\xa4chige/NN/B-NP/O Kolonien/NNS/I-NP/O wuchsen/NN/I-NP/O schlie\xc3\x9flich/RB/B-ADVP/O an/IN/B-PP/B-PNP ihren/PRP$/B-NP/I-PNP R\xc3\xa4ndern/NN/I-NP/I-PNP in/IN/B-PP/B-PNP einander/PRP/B-NP/I-PNP \xc3\xbcber/RP/O/O ,/,/O/O so/RB/B-ADVP/O dass/IN/B-PP/O schlie\xc3\x9flich/RB/B-ADVP/O ein/DT/B-NP/O zusammenh\xc3\xa4ngender/JJ/I-NP/O Biofilm/NN/I-NP/O entstand/VB/B-VP/O ././O/O

Bemerkenswert/JJ/B-ADJP/O war/VB/B-VP/O die/DT/B-NP/O H\xc3\xa4ufigkeit/NN/I-NP/O ,/,/O/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP begei\xc3\x9felte/NN/I-NP/I-PNP St\xc3\xa4bchen/NN/I-NP/I-PNP im/IN/B-PP/B-PNP subgingivalen/JJ/B-NP/I-PNP Biofilm/NNP/I-NP/I-PNP gefunden/VBN/B-VP/I-PNP wurden/VB/I-VP/O ,/,/O/O wobei/WRB/O/O sie/PRP/B-NP/O stets/RB/B-ADVP/O mit/IN/B-PP/B-PNP ihren/PRP$/B-NP/I-PNP Gei\xc3\x9feln/NN/I-NP/I-PNP an/IN/B-PP/B-PNP anderen/JJ/B-NP/I-PNP Bakterien/JJ/I-NP/I-PNP adh\xc3\xa4rierten/NN/I-NP/I-PNP ././O/O

Das/DT/B-NP/O Erscheinungsbild/NN/I-NP/O der/DT/B-NP/O exopolymeren/JJ/I-NP/O Matrix/NN/I-NP/O (/(/O/O EPS/NNP/B-NP/O )/)/O/O wies/NN/B-NP/O eine/DT/I-NP/O ungeahnte/JJ/I-NP/O Vielfalt/NN/I-NP/O auf/RP/O/O ././O/O

Dies/DT/O/O zeigte/VB/B-VP/O sich/PRP/B-NP/O besonders/RB/B-ADVP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP charakteristischen/JJ/I-NP/I-PNP Gestalt/NN/I-NP/I-PNP und/CC/O/O Musterung/NN/B-NP/O der/DT/B-NP/O EPS/NNP/I-NP/O -/-/O/O Kapseln/NN/B-NP/O auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP transmissionselektronenmikroskopischen/JJ/I-NP/I-PNP Aufnahmen/NN/I-NP/I-PNP ././O/O

Auch/RB/B-ADVP/O bei/IN/B-PP/B-PNP Co-Aggregationsereignissen/NN/B-NP/I-PNP spielte/NN/I-NP/I-PNP EPS/NNP/I-NP/I-PNP eine/DT/I-NP/I-PNP wichtige/JJ/I-NP/I-PNP Rolle/NN/I-NP/I-PNP ././O/O

Hierbei/RB/B-VP/O bildete/VB/I-VP/O die/DT/B-NP/O EPS/NNP/I-NP/O das/DT/B-NP/O \xe2\x80\x9eKlebematerial\xe2\x80\x9c/NN/I-NP/O zwischen/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Co-Aggregationspartnern/NN/I-NP/I-PNP ,/,/O/O durch/IN/B-PP/B-PNP das/WDT/B-NP/I-PNP die/DT/I-NP/I-PNP Bakterienzellen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP enger/JJ/B-NP/I-PNP Nachbarschaft/NN/I-NP/I-PNP gehalten/VBN/B-VP/I-PNP wurden/VB/I-VP/O ././O/O

Ein/DT/B-NP/O anderer/JJ/I-NP/O Aspekt/NN/I-NP/O von/IN/B-PP/B-PNP Co-Aggregationen/NN/B-NP/I-PNP konnte/VB/B-VP/O bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Dokumentation/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Entwicklung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP sogenannten/JJ/B-NP/I-PNP \xc3\xa2\xe2\x82\xac\xc5\x93Maiskolben\xc3\xa2\xe2\x82\xac/NN/I-NP/I-PNP ?/./O/O

gezeigt/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Im/IN/B-PP/B-PNP Endstadium/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Entwicklungssequenz/NN/I-NP/I-PNP existierte/VB/B-VP/O das/DT/O/O zentrale/JJ/B-ADJP/O Langst\xc3\xa4bchen/VB/B-VP/O nur/RB/B-ADVP/O noch/RB/I-ADVP/O als/IN/B-PP/B-PNP leerer/NN/B-NP/I-PNP Zelltorso/RP/O/O ,/,/O/O w\xc3\xa4hrend/IN/B-PP/B-PNP alle/JJ/B-NP/I-PNP umgebenen/NN/I-NP/I-PNP Bakterien/NN/I-NP/I-PNP deutlich/JJ/B-NP/I-PNP Zytoplasmas/JJ/I-NP/I-PNP aufwiesen/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Auswertung/NN/I-NP/O der/DT/B-NP/O Biofilme/NN/I-NP/O auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP einzelnen/JJ/I-NP/I-PNP Carriern/NN/I-NP/I-PNP ergab/VB/B-VP/O ein/DT/O/O sehr/IN/B-PP/B-PNP heterogenes/JJ/B-NP/I-PNP Bild/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Bakterienmenge/NN/I-NP/O pro/IN/B-PP/B-PNP Carrier/NN/B-NP/I-PNP konnte/VB/B-VP/O sich/PRP/B-NP/O trotz/IN/B-PP/B-PNP gleicher/JJ/B-NP/I-PNP Verweilzeit/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Carriers/NN/I-NP/I-PNP und/CC/O/O vergleichbarer/NN/B-NP/O klinischer/JJ/B-NP/O Parameter/NN/I-NP/O sehr/RB/B-ADJP/O stark/JJ/I-ADJP/O unterscheiden/VB/B-VP/O ././O/O

Dies/DT/O/O gilt/VB/B-VP/O sogar/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/O unmittelbar/JJ/B-ADJP/O benachbarte/JJ/I-ADJP/O Parodontaltaschen/VB/B-VP/O ././O/O

Insgesamt/VBN/B-VP/O wurden/VB/I-VP/O nur/RB/B-NP/O wenige/JJ/I-NP/O allgemeing\xc3\xbcltige/JJ/I-NP/O Zusammenh\xc3\xa4nge/NN/I-NP/O zwischen/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP klinischen/JJ/I-NP/I-PNP Behandlungserfolg/NN/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O Menge/NN/I-NP/O und/CC/O/O Zusammensetzung/NN/B-NP/O der/DT/B-NP/O mikrobiologischen/JJ/I-NP/O Gemeinschaft/NN/I-NP/O festgestellt/RP/O/O ././O/O

hs/CD/B-NP/O Monate/NN/I-NP/O nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Behandlung/NN/I-NP/I-PNP wiesen/VB/B-VP/O die/DT/B-NP/O Carrier/NN/I-NP/O eine/DT/B-NP/O zumeist/NN/I-NP/O deutlich/JJ/B-NP/O geringere/NN/I-NP/O Gesamtbakterienlast/NN/I-NP/O als/IN/B-PP/B-PNP vor/IN/I-PP/I-PNP der/DT/B-NP/I-PNP Behandlung/NN/I-NP/I-PNP auf/RP/O/O ,/,/O/O wobei/WRB/O/O Kokken/NN/B-NP/O und/CC/I-NP/O pleomorphen/NN/I-NP/O St\xc3\xa4bchen/NN/I-NP/O einen/DT/B-NP/O gr\xc3\xb6\xc3\x9feren/JJ/I-NP/O Anteil/NN/I-NP/O am/IN/B-PP/B-PNP Biofilm/NNP/B-NP/I-PNP ausmachten/NNP/I-NP/I-PNP ././O/O

Bei/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Versuch/NN/I-NP/I-PNP klinische/JJ/B-NP/I-PNP Patientendaten/NN/I-NP/I-PNP und/CC/O/O mikrobielle/NN/B-NP/O Parameter/NN/I-NP/O miteinander/VB/B-VP/O in/IN/B-PP/B-PNP Beziehung/NN/B-NP/I-PNP zu/TO/B-VP/O setzen/VB/I-VP/O ,/,/O/O ergab/VB/B-VP/O sich/PRP/B-NP/O schlie\xc3\x9flich/RB/B-ADVP/O eine/DT/B-NP/O stark/JJ/I-NP/O positive/JJ/I-NP/O Korrelation/NN/I-NP/O zwischen/IN/B-PP/B-PNP der/DT/B-NP/I-PNP medianen/JJ/I-NP/I-PNP Gesamtbakterienlast/NN/I-NP/I-PNP pro/IN/B-PP/B-PNP Carrier/NN/B-NP/I-PNP und/CC/I-NP/I-PNP der/DT/I-NP/I-PNP prozentualen/JJ/I-NP/I-PNP Anzahl/NN/I-NP/I-PNP von/IN/B-PP/O tiefen/JJ/B-ADJP/O Parodontaltaschen/JJ/I-ADJP/O pro/IN/B-PP/B-PNP Patient.Das/NN/B-NP/I-PNP Hauptziel/NN/I-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP ist/VB/B-VP/O es/PRP/B-NP/O ,/,/O/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Kombination/NN/I-NP/I-PNP verschiedener/JJ/B-NP/I-PNP Oberfl\xc3\xa4chenfunktionalisierungsmethoden/NN/I-NP/I-PNP und/CC/O/O biophysikalischer/NN/B-NP/O Techniken/JJ/B-NP/O Biomembranreaktoren/NN/I-NP/O aus/IN/B-PP/O k\xc3\xbcnstlichen/JJ/B-ADJP/O wie/IN/B-PP/B-PNP nat\xc3\xbcrlichen/IN/I-PP/I-PNP Biomembranen/NN/B-NP/I-PNP auf/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Festk\xc3\xb6rperoberfl\xc3\xa4chen/NN/I-NP/I-PNP herzustellen/NN/I-NP/I-PNP ,/,/O/O um/IN/B-PP/O diese/WDT/O/O auf/IN/B-PP/B-PNP ihre/PRP$/B-NP/I-PNP technische/JJ/I-NP/I-PNP Anwendungsm\xc3\xb6glichkeit/NN/I-NP/I-PNP hin/IN/B-PP/O zu/TO/B-VP/O untersuchen/VB/I-VP/O ././O/O

Der/DT/B-NP/O erste/JJ/I-NP/O Teil/NN/I-NP/O beschreibt/NN/I-NP/O die/DT/B-NP/O Etablierung/NN/I-NP/O einer/DT/O/O neuen/VB/B-VP/O ,/,/O/O gerichteten/JJ/B-NP/O Einbaumethode/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP gro\xc3\x9fe/JJ/B-NP/I-PNP transmembrane/JJ/I-NP/I-PNP Proteine/NN/I-NP/I-PNP (/(/O/O FOF1/NN/B-NP/O ATP-Synthase/NN/I-NP/O ,/,/O/O MW/NNP/B-NP/O =/NN/I-NP/O 550/CD/I-NP/O kDa/NN/I-NP/O )/)/O/O durch/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Einsatz/NN/I-NP/I-PNP eines/DT/B-NP/I-PNP \xe2\x80\x9eschwachen\xe2\x80\x9c/NN/I-NP/I-PNP Detergens/NN/I-NP/I-PNP ,/,/O/O welches/WDT/B-NP/O die/DT/I-NP/O Lipidmembran/NN/I-NP/O gering/JJ/B-NP/O st\xc3\xb6rt/NN/I-NP/O ././O/O

Mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP Dynamischer/NN/I-NP/I-PNP Lichtstreuung/NN/I-NP/I-PNP wurde/RB/B-VP/O gezeigt/VBN/I-VP/O ,/,/O/O da\xc3\x9f/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Einbau/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Proteine/NN/I-NP/I-PNP in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Lipidmembran/NN/I-NP/I-PNP ohne/IN/B-PP/B-PNP deren/DT/B-NP/I-PNP Zerst\xc3\xb6rung/NN/I-NP/I-PNP erfolgte/VB/B-VP/O ././O/O

Obwohl/IN/B-PP/O es/JJ/B-ADJP/O nicht/RB/I-ADJP/O m\xc3\xb6glich/JJ/I-ADJP/O ist/VB/B-VP/O ,/,/O/O Proteoliposomen/NN/B-NP/O auf/IN/B-PP/B-PNP Glas/NN/B-NP/I-PNP -/-/O/O oder/CC/O/O Quartzoberfl\xc3\xa4chen/JJ/B-NP/O aufzuspreiten/NN/I-NP/O ,/,/O/O konnten/JJ/B-NP/O Membranen/NN/I-NP/O mit/IN/B-PP/B-PNP einheitlich/JJ/B-NP/I-PNP pr\xc3\xa4sentierenden/NN/I-NP/I-PNP F1/JJ/B-NP/I-PNP K\xc3\xb6pfen/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP ultrad\xc3\xbcnnen/JJ/B-NP/I-PNP Zellulosefilmen/NN/I-NP/I-PNP (/(/O/O 5/CD/B-NP/O \xe2\x80\x93/NN/I-NP/O 10/CD/B-NP/O nm/NN/I-NP/O )/)/O/O ausgebildet/VBN/B-VP/O und/CC/O/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Rasterkraftmikroskopie/NN/I-NP/I-PNP und/CC/O/O Antik\xc3\xb6rpermarkierung/NN/B-NP/O beobachtet/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Das/DT/B-NP/O zweite/JJ/I-NP/O und/CC/I-NP/O dritte/JJ/I-NP/O Kapitel/NN/I-NP/O beschreibt/NN/I-NP/O die/DT/B-NP/O Immobilisierung/NN/I-NP/O zwei/CD/O/O verschiedener/VB/B-VP/O nat\xc3\xbcrlicher/IN/B-PP/B-PNP Membranen/NN/B-NP/I-PNP (/(/O/O Ghostzellen/NN/B-NP/O aus/IN/B-PP/B-PNP humanen/NN/B-NP/I-PNP Erythrozyten/NN/I-NP/I-PNP und/CC/I-NP/I-PNP Fragmente/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Sarkoplasmatischen/JJ/I-NP/I-PNP Retikulums/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP Kaninchenmuskeln/NN/B-NP/I-PNP )/)/O/O auf/IN/B-PP/B-PNP Silicamikropartikel/NN/B-NP/I-PNP ././O/O

ilicamikropartikel/RB/B-VP/O bieten/VB/I-VP/O einen/DT/B-NP/O besonderen/JJ/I-NP/O Vorteil/NN/I-NP/O gegen\xc3\xbcber/IN/B-PP/B-PNP planaren/NN/B-NP/I-PNP Oberfl\xc3\xa4chen/VB/B-VP/O :/:/O/O Auf/IN/B-PP/O den/DT/O/O Partikeloberfl\xc3\xa4chen/JJ/B-ADJP/O k\xc3\xb6nnen/VB/B-VP/O mit/IN/B-PP/B-PNP geringem/JJ/B-NP/I-PNP Aufwand/NN/I-NP/I-PNP k\xc3\xbcnstliche/VB/B-VP/O und/CC/O/O nat\xc3\xbcrliche/IN/B-PP/B-PNP Membranen/NN/B-NP/I-PNP ohne/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP biokompatible/NN/I-NP/I-PNP Zellulosebeschichtung/NN/I-NP/I-PNP immobilisiert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Dar\xc3\xbcber/RB/B-ADVP/O hinaus/IN/B-PP/O bieten/VB/B-VP/O Partikel/NN/B-NP/O eine/DT/O/O gr\xc3\xb6\xc3\x9fere/VB/B-VP/O ,/,/O/O zug\xc3\xa4nglichere/NN/B-NP/O Oberfl\xc3\xa4che/NNP/I-NP/O ,/,/O/O wodurch/RB/B-ADVP/O das/DT/B-NP/O Signal/NN/I-NP/O von/IN/B-PP/B-PNP Membranproteinen/NN/B-NP/I-PNP signifikant/JJ/B-ADJP/O erh\xc3\xb6ht/VBN/B-VP/O wird/VB/I-VP/O ././O/O

Der/DT/B-NP/O erste/JJ/I-NP/O Aspekt/NN/I-NP/O wird/VB/B-VP/O in/IN/B-PP/B-PNP Kapitel/NN/B-NP/I-PNP 2/CD/O/O untersucht/VBN/B-VP/O ,/,/O/O in/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP demonstriert/NN/I-NP/I-PNP wird/VB/B-VP/O ,/,/O/O da\xc3\x9f/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Aufspreitkinetik/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Ghostzellmembranen/NN/B-NP/I-PNP tats\xc3\xa4chlich/JJ/B-ADJP/O von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Partikelgr\xc3\xb6\xc3\x9fe/NN/I-NP/I-PNP und/CC/O/O somit/RB/B-ADVP/O dem/DT/B-NP/O Kontaktwinkel/NN/I-NP/O abh\xc3\xa4ngig/JJ/B-ADJP/O ist/VB/B-VP/O ././O/O

Kapitel/NN/B-NP/O 3/CD/O/O schlie\xc3\x9flich/IN/B-PP/B-PNP beschreibt/NN/B-NP/I-PNP die/DT/I-NP/I-PNP Entwicklung/NN/I-NP/I-PNP eines/DT/B-NP/I-PNP Prototyps/NN/I-NP/I-PNP eines/DT/B-NP/I-PNP Membranbioreaktors/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP beschichteten/JJ/B-NP/I-PNP Silicapartikeln/NN/I-NP/I-PNP in/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Chromatographies\xc3\xa4ule/NN/I-NP/I-PNP ././O/O

Dieser/DT/B-NP/O Aufbau/NN/I-NP/O erlaubt/VB/B-VP/O die/DT/B-NP/O vereinfachte/NN/I-NP/O Beobachtung/NN/I-NP/O der/DT/B-NP/O quantitativen/JJ/I-NP/O Funktion/NN/I-NP/O der/DT/B-NP/O Ca2/NN/I-NP/O +/JJ/B-NP/O ATPase/NN/I-NP/O in/IN/B-PP/B-PNP Membranen/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Sarkoplasmatischen/JJ/I-NP/I-PNP Retikulums/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O ermittelten/JJ/I-NP/O Daten/NN/I-NP/O demonstrieren/VB/B-VP/O eindrucksvoll/JJ/B-ADJP/O ,/,/O/O da\xc3\x9f/RB/B-ADVP/O die/DT/B-NP/O Kombination/NN/I-NP/O von/IN/B-PP/B-PNP Oberfl\xc3\xa4chenchemie/NN/B-NP/I-PNP ,/,/O/O Biophysik/NN/B-NP/O und/CC/I-NP/O Bioverfahrenstechnologie/NN/I-NP/O eine/DT/B-NP/O leistungsf\xc3\xa4hige/NN/I-NP/O Strategie/NN/I-NP/O zur/IN/B-PP/B-PNP Entwicklung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP biochemischen/JJ/B-NP/I-PNP Membranbioreaktoren/NN/I-NP/I-PNP ist.Die/JJ/B-NP/I-PNP Produktion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Biogas/NN/B-NP/I-PNP aus/IN/B-PP/B-PNP landwirtschaftlichen/JJ/B-NP/I-PNP Prim\xc3\xa4rprodukten/NN/I-NP/I-PNP oder/RB/B-ADVP/O Reststoffen/NN/B-NP/O stellt/VB/B-VP/O einen/DT/B-NP/O we-sentlichen/JJ/I-NP/O Beitrag/NN/I-NP/O zur/IN/B-PP/B-PNP Reduktion/NN/B-NP/I-PNP des/DT/I-NP/I-PNP CO2-Aussto\xc3\x9fes/NN/I-NP/I-PNP sowie/RB/B-ADVP/O zur/IN/B-PP/B-PNP Entwicklung/NN/B-NP/I-PNP einer/DT/I-NP/I-PNP nachhaltigen/JJ/I-NP/I-PNP Landbewirtschaftung/NN/I-NP/I-PNP dar/RP/O/O ././O/O

Gegenw\xc3\xa4rtig/RB/B-VP/O stehen/VB/I-VP/O im/IN/B-PP/B-PNP Fokus/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Forschung/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Entwicklung/NN/I-NP/I-PNP und/CC/O/O Optimierung/NN/B-NP/O von/IN/B-PP/B-PNP Biogasreaktoren/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Betriebstechniken/NN/I-NP/I-PNP sowie/RB/B-ADVP/O die/DT/B-NP/O Optimierung/NN/I-NP/O der/DT/B-NP/O Substratbereitstellung/NN/I-NP/O ././O/O

\xc3\x9cber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Zusammensetzung/NN/I-NP/I-PNP der/DT/O/O an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Biogasbildung/NN/I-NP/I-PNP beteiligten/VB/B-VP/O mikrobiellen/JJ/B-NP/O Lebensgemeinschaften/NN/I-NP/O in/IN/B-PP/B-PNP landwirt-schaftlichen/JJ/B-NP/I-PNP Biogasanlagen/NN/I-NP/I-PNP gibt/VB/B-VP/O es/PRP/B-NP/O jedoch/RB/B-ADVP/O bis/IN/B-PP/O heute/VB/B-VP/O nur/RB/B-NP/O wenige/JJ/I-NP/O Informationen/NN/I-NP/O ././O/O

Im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Studie/NN/I-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O Struktur/NN/I-NP/O der/DT/B-NP/O methanogenen/JJ/I-NP/O Bioz\xc3\xb6nose/NN/I-NP/O in/IN/B-PP/B-PNP zehn/CD/B-NP/I-PNP landwirtschaftlichen/JJ/I-NP/I-PNP Biogasanlagen/NN/I-NP/I-PNP ,/,/O/O welche/WDT/O/O auf/IN/B-PP/B-PNP Basis/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Nachwachsenden/JJ/B-NP/I-PNP Rohstoffen/NN/I-NP/I-PNP (/(/O/O NawaRo/NN/B-NP/O )/)/O/O betrieben/VBN/B-VP/O wurden/VB/I-VP/O ,/,/O/O unter-sucht/NN/B-NP/O ././O/O

Hierzu/VBN/B-VP/O wurde/VB/I-VP/O ein/DT/B-NP/O polyphasischer/JJ/I-NP/O Ansatz/NN/I-NP/O mit/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP kultivierungsunabh\xc3\xa4ngigen/NN/I-NP/I-PNP ,/,/O/O molekularen/JJ/B-NP/O Verfahren/NN/I-NP/O gew\xc3\xa4hlt/RP/O/O ././O/O

Prim\xc3\xa4r/VBN/B-VP/O wurde/VB/I-VP/O eine/DT/B-NP/O PCR-RFLP/NN/I-NP/O Analyse/NN/I-NP/O der/DT/B-NP/O Nukleotidsequenz/NN/I-NP/O der/DT/B-NP/O 16S/NNP/I-NP/O rDNA/NNP/I-NP/O sowie/CC/O/O des/DT/B-NP/O mcrA/NNP/I-NP/O Gens/NNP/I-NP/O durchgef\xc3\xbchrt/RP/O/O ././O/O

Die/DT/B-NP/O Bestimmung/NN/I-NP/O der/DT/B-NP/O relativen/NN/I-NP/O H\xc3\xa4ufigkeit/NN/I-NP/O der/DT/B-NP/O Methan/NN/I-NP/O bil-denden/JJ/B-NP/O Mikroorganismen/NN/I-NP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Proben/NN/I-NP/I-PNP erfolgte/VB/B-VP/O mittels/IN/B-PP/B-PNP quantitativer/NN/B-NP/I-PNP real-time/JJ/I-NP/I-PNP PCR/NN/I-NP/I-PNP (/(/O/O Q-PCR/NN/B-NP/O )/)/O/O auf/IN/B-PP/B-PNP Basis/NN/B-NP/I-PNP gruppenspezifischer/JJ/I-NP/I-PNP Primer/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP 16S/NNP/I-NP/I-PNP rDNA/NNP/I-NP/I-PNP Gen/NNP/I-NP/I-PNP ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP ausgew\xc3\xa4hlte/JJ/B-NP/I-PNP Biogasreaktoren/NN/I-NP/I-PNP wurde/VB/B-VP/O erg\xc3\xa4nzend/JJ/B-ADJP/O eine/DT/B-NP/O mikroskopische/JJ/I-NP/O Quantifizierung/NN/I-NP/O mittels/IN/B-PP/B-PNP Fluoreszenz/NN/B-NP/I-PNP in/IN/B-PP/B-PNP situ/JJ/B-NP/I-PNP Hybridisierung/NN/I-NP/I-PNP (/(/O/O FISH/NNP/B-NP/O )/)/O/O durchgef\xc3\xbchrt/RP/O/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP FISH/NNP/I-NP/I-PNP wurden/VB/B-VP/O spezifische/JJ/B-NP/O Sonden/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Dom\xc3\xa4nen/JJ/I-NP/I-PNP Bacteria/NN/I-NP/I-PNP (/(/O/O EUB338)/LS/O/O und/CC/O/O Archaea/NN/B-NP/O (/(/O/O ARCH915/NN/B-NP/O )/)/O/O so-wie/NN/B-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Ordnungen/JJ/I-NP/I-PNP Methanomicrobiales/NN/I-NP/I-PNP (/(/O/O MG1200/NN/B-NP/O )/)/O/O ,/,/O/O Methanobacteriales/NN/B-NP/O (/(/O/O MB311/NN/B-NP/O und/CC/I-NP/O MB1174/NN/I-NP/O )/)/O/O und/CC/O/O den/DT/B-NP/O Familien/JJ/I-NP/O Methanosarcinaceae/NN/I-NP/O (/(/O/O Ms821/NN/B-NP/O )/)/O/O und/CC/O/O Methanosaetaceae/NN/B-NP/O (/(/O/O Mx825/NN/B-NP/O )/)/O/O verwendet/NN/B-NP/O ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O der/DT/B-NP/O Analysen/NN/I-NP/O zeigten/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O in/IN/B-PP/B-PNP neun/CD/B-NP/I-PNP der/DT/I-NP/I-PNP zehn/CD/I-NP/I-PNP untersuchten/NN/I-NP/I-PNP Biogasanlagen/NN/I-NP/I-PNP die/DT/B-NP/I-PNP hydroge-notrophen/NN/I-NP/I-PNP Methanogenen/NN/I-NP/I-PNP ,/,/O/O repr\xc3\xa4sentiert/VB/B-VP/O durch/IN/B-PP/B-PNP Vertreter/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Ordnungen/NN/I-NP/I-PNP Methanomicrobiales/NN/I-NP/I-PNP und/CC/O/O Methanobacteriales/NN/B-NP/O ,/,/O/O vorherrschend/JJ/B-ADJP/O waren/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP diesen/DT/B-NP/I-PNP Biogasreaktoren/NN/I-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O Gattung/JJ/I-NP/O Methanoculleus/NN/I-NP/O (/(/O/O Ordnung/NN/B-NP/O Methanomicrobiales/NN/I-NP/O )/)/O/O als/IN/B-PP/B-PNP dominierende/NN/B-NP/I-PNP Gattung/NN/I-NP/I-PNP nachgewiesen/RP/O/O ././O/O

Nennenswerte/JJ/B-NP/O Anteile/NN/I-NP/O an/IN/B-PP/B-PNP ace-toklastischen/JJ/B-NP/I-PNP Methanbildnern/NN/I-NP/I-PNP ,/,/O/O insbesondere/RB/B-ADVP/O der/DT/B-NP/O Gattung/NN/I-NP/O Methanosaeta/NN/I-NP/O ,/,/O/O konnten/VB/B-VP/O f\xc3\xbcr/IN/B-PP/B-PNP sechs/CD/B-NP/I-PNP der/DT/I-NP/I-PNP untersuchten/NN/I-NP/I-PNP zehn/CD/B-NP/I-PNP Anlagen/NN/I-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Jedoch/VBN/B-VP/O wurde/VB/I-VP/O nur/RB/B-ADVP/O in/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Biogasanlage/NN/I-NP/I-PNP diese/DT/B-NP/I-PNP Gattung/NN/I-NP/I-PNP als/IN/B-PP/B-PNP die/DT/B-NP/I-PNP dominierende/JJ/I-NP/I-PNP Gruppe/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Methanbildnern/NN/B-NP/I-PNP nachgewiesen/RP/O/O ././O/O

Diese/DT/B-NP/O Ergebnisse/NN/I-NP/O deuten/VB/B-VP/O darauf/RB/B-ADVP/O hin/IN/B-PP/O ,/,/O/O dass/IN/B-PP/B-PNP in/IN/I-PP/I-PNP 90/CD/B-NP/I-PNP %/NN/I-NP/I-PNP der/DT/B-NP/I-PNP untersuchten/NN/I-NP/I-PNP Biogasanlagen/NN/I-NP/I-PNP die/DT/B-NP/I-PNP hydrogenotrophe/NN/I-NP/I-PNP Methanogenese/NN/I-NP/I-PNP der/DT/B-NP/I-PNP vorrangige/JJ/I-NP/I-PNP Stoff-wechselweg/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Methanproduktion/NN/I-NP/I-PNP ist/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Studie/NN/I-NP/I-PNP konnte/VB/B-VP/O kein/JJ/B-NP/O Zusammenhang/NN/I-NP/O zwischen/IN/B-PP/O den/DT/O/O jeweils/RB/B-ADVP/O zur/IN/B-PP/B-PNP Biogasgewinnung/NN/B-NP/I-PNP eingesetzten/NN/I-NP/I-PNP Substraten/NN/I-NP/I-PNP und/CC/I-NP/I-PNP der/DT/I-NP/I-PNP Struktur/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Archaea-Bioz\xc3\xb6nose/NN/I-NP/I-PNP beobachtet/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Ebenso/RB/B-ADVP/O wenig/RB/B-NP/O scheinen/JJ/I-NP/O unter-schiedliche/JJ/I-NP/O Verweilzeiten/NN/I-NP/O der/DT/B-NP/O Substrate/NN/I-NP/O sowie/RB/B-ADVP/O die/DT/B-NP/O Raumbelastung/NN/I-NP/O der/DT/B-NP/O Reaktoren/NNS/I-NP/O einen/DT/B-NP/O Einfluss/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP methanogenen/NN/I-NP/I-PNP Archaea/NN/I-NP/I-PNP zu/TO/B-VP/O haben/VB/I-VP/O ././O/O

Jedoch/RB/B-VP/O lie\xc3\x9f/VB/I-VP/O sich/PRP/B-NP/O ein/DT/I-NP/O negativer/NN/I-NP/O Einfluss/NN/I-NP/O hoher/JJ/B-NP/O Ammonium/NN/I-NP/O -/-/O/O bzw./CC/O/O Am-moniakkonzentrationen/NN/B-NP/O auf/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Wachstum/NN/I-NP/I-PNP acetoklastischer/NN/I-NP/I-PNP Methanbildner/NN/I-NP/I-PNP ,/,/O/O insbesondere/IN/B-PP/B-PNP Methanosaeta/JJ/B-NP/I-PNP spp/NN/I-NP/I-PNP ././O/O

,/,/O/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP untersuchten/NN/I-NP/I-PNP landwirtschaftlichen/JJ/B-NP/I-PNP Biogasanlagen/NN/I-NP/I-PNP feststellen/VB/B-VP/O ././O/O

Die/DT/O/O aus/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Studie/NN/I-NP/I-PNP gewonnenen/NN/I-NP/I-PNP Erkenntnisse/NN/I-NP/I-PNP dienen/VB/B-VP/O dem/DT/B-NP/O grundlegenden/JJ/I-NP/O Verst\xc3\xa4ndnis/NN/I-NP/O der/DT/B-NP/O methanoge-nen/JJ/I-NP/O Lebensgemeinschaft/NN/I-NP/O in/IN/B-PP/B-PNP landwirtschaftlichen/JJ/B-NP/I-PNP Biogasanlagen/NN/I-NP/I-PNP ,/,/O/O und/CC/O/O sollen/MD/B-VP/O somit/RB/B-ADVP/O zur/IN/B-PP/B-PNP weiteren/JJ/B-NP/I-PNP Optimierung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Biogasgewinnung/NN/I-NP/I-PNP beitragen.Honigbienen/NN/I-NP/I-PNP werden/VB/B-VP/O im/IN/B-PP/B-PNP Freiland/NN/B-NP/I-PNP operant/NN/I-NP/I-PNP konditioniert/NN/I-NP/I-PNP ,/,/O/O wenn/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP spezifisches/JJ/I-NP/I-PNP Verhalten/NN/I-NP/I-PNP Belohnung/NN/I-NP/I-PNP erf\xc3\xa4hrt/NN/I-NP/I-PNP ,/,/O/O z.B./RB/B-ADVP/O das/DT/O/O erfolgreiche/JJ/B-ADJP/O Aufsuchen/JJ/I-ADJP/O einer/DT/B-NP/O Futterquelle/NN/I-NP/O oder/RB/B-ADVP/O die/DT/B-NP/O Heimkehr/NN/I-NP/O zum/IN/B-PP/B-PNP Stock/NN/B-NP/I-PNP ././O/O

Ziel/NN/B-NP/O der/DT/I-NP/O vorliegenden/JJ/I-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O es/PRP/B-NP/O ,/,/O/O ein/DT/B-NP/O operantes/JJ/I-NP/O Lernparadigma/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP Bienen/NN/B-NP/I-PNP unter/IN/B-PP/B-PNP Laborbedingungen/NN/B-NP/I-PNP zu/TO/B-VP/O entwickeln/VB/I-VP/O und/CC/O/O auf/IN/B-PP/B-PNP seine/PRP$/B-NP/I-PNP Charakteristika/NN/I-NP/I-PNP zu/TO/B-VP/O untersuchen/VB/I-VP/O ././O/O

Bienen/NN/B-NP/O k\xc3\xb6nnen/VB/B-VP/O unter/IN/B-PP/B-PNP Laborbedingungen/NN/B-NP/I-PNP lernen/VB/B-VP/O ,/,/O/O kleine/JJ/B-ADJP/O Pl\xc3\xa4ttchen/JJ/I-ADJP/O vermehrt/JJ/I-ADJP/O mit/IN/B-PP/B-PNP ihren/PRP$/B-NP/I-PNP Antennen/NN/I-NP/I-PNP abzutasten/VB/B-VP/O ,/,/O/O wenn/IN/B-PP/B-PNP die/DT/B-NP/I-PNP h\xc3\xa4ufige/NN/I-NP/I-PNP Ber\xc3\xbchrung/NN/I-NP/I-PNP belohnt/NN/I-NP/I-PNP wird/VB/B-VP/O ././O/O

ie/PRP/B-NP/O lernen/VB/B-VP/O in/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP differentiellen/NN/I-NP/I-PNP Lernsituation/NN/I-NP/I-PNP belohnte/NN/I-NP/I-PNP Pl\xc3\xa4ttchen/VB/B-VP/O von/IN/B-PP/B-PNP unbelohnten/NN/B-NP/I-PNP Pl\xc3\xa4ttchen/VB/B-VP/O zu/TO/I-VP/O unterscheiden/VB/I-VP/O und/CC/O/O tasten/VB/B-VP/O das/DT/B-NP/O konditionierte/NN/I-NP/O Pl\xc3\xa4ttchen/JJ/B-ADJP/O h\xc3\xa4ufiger/JJ/I-ADJP/O ab/RP/O/O ././O/O

Die/DT/B-NP/O Plastizit\xc3\xa4t/NN/I-NP/O des/DT/B-NP/O operanten/NN/I-NP/O Lernens/NN/I-NP/O konnte/VB/B-VP/O durch/IN/B-PP/B-PNP Umlernversuche/NN/B-NP/I-PNP zwischen/IN/B-PP/B-PNP dorsaler/NN/B-NP/I-PNP und/CC/I-NP/I-PNP ventraler/NN/I-NP/I-PNP Platte/NN/I-NP/I-PNP demonstriert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Die/DT/B-NP/O Akquisition/NN/I-NP/O operanten/NN/I-NP/O Lernens/NN/I-NP/O erreicht/VBN/B-VP/O schneller/JJ/B-NP/O ihre/PRP$/I-NP/O S\xc3\xa4ttigung/NN/I-NP/O als/IN/B-PP/B-PNP beim/IN/I-PP/I-PNP unbelohnten/NN/B-NP/I-PNP motorischen/JJ/I-NP/I-PNP Lernen/NN/I-NP/I-PNP und/CC/O/O langsamer/JJ/B-ADJP/O als/IN/B-PP/B-PNP beim/IN/I-PP/I-PNP taktilen/NN/B-NP/I-PNP oder/RB/I-NP/I-PNP olfaktorischen/JJ/I-NP/I-PNP Konditionieren/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Bienen/NN/B-NP/I-PNP ././O/O

Durch/IN/B-PP/B-PNP seitenspezifische/JJ/B-NP/I-PNP Konditionierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Antennenbewegungen/NN/B-NP/I-PNP konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP operantes/NN/B-NP/I-PNP Lernen/NN/I-NP/I-PNP spezifisch/JJ/B-ADJP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP konditionierte/NN/I-NP/I-PNP Antenne/NN/I-NP/I-PNP ist/VB/B-VP/O ././O/O

Die/DT/B-NP/O Hypothese/NN/I-NP/O ,/,/O/O dass/IN/B-PP/B-PNP operantes/JJ/B-NP/I-PNP Lernen/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Antennenbewegungen/NN/B-NP/I-PNP auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Dorsallobus/NN/I-NP/I-PNP begrenzt/VBN/B-VP/I-PNP ist/VB/I-VP/O ,/,/O/O bleibt/VBN/B-VP/O bestehen/VB/I-VP/O ././O/O

Operantes/JJ/B-NP/O Konditionieren/NN/I-NP/O l\xc3\xa4sst/VB/B-VP/O sich/PRP/B-NP/O an/IN/B-PP/O einem/DT/O/O im/IN/B-PP/B-PNP Abtasten/NN/B-NP/I-PNP sehr/IN/B-PP/B-PNP dominanten/JJ/B-NP/I-PNP Antennenmuskel/NN/I-NP/I-PNP (/(/O/O fast/NN/B-NP/O flagellum/NN/I-NP/O flexor/NN/I-NP/O )/)/O/O zeigen/VB/B-VP/O ,/,/O/O der/WDT/O/O von/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP einzelnen/JJ/I-NP/I-PNP identifizierten/NN/I-NP/I-PNP Motoneuron/NN/I-NP/I-PNP innerviert/NN/I-NP/I-PNP wird/VB/B-VP/O ././O/O

Der/DT/B-NP/O Effekt/NN/I-NP/O der/DT/B-NP/O Konditionierung/NN/I-NP/O liegt/VB/B-VP/O in/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Erh\xc3\xb6hung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP H\xc3\xa4ufigkeit/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Aktionspotentialen/NN/B-NP/I-PNP ././O/O

M\xc3\xb6gliche/JJ/B-NP/O Ursachen/NN/I-NP/O der/DT/O/O erh\xc3\xb6hten/VB/B-VP/O Feuerrate/NN/B-NP/O des/DT/I-NP/O Motoneurons/NN/I-NP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Konditionierung/NN/I-NP/I-PNP werden/VB/B-VP/O diskutiert/RP/I-VP/O ././O/O

Die/DT/B-NP/O Fixierung/NN/I-NP/O der/DT/B-NP/O antennalen/JJ/I-NP/O Gelenke/NN/I-NP/O reduziert/VBN/B-VP/O oder/CC/O/O verhindert/VB/B-VP/O operantes/NN/B-NP/O Lernen/NN/I-NP/O im/IN/B-PP/B-PNP elektrophysiologischen/JJ/B-NP/I-PNP Pr\xc3\xa4parat/NN/I-NP/I-PNP ././O/O

Daraus/RB/B-VP/O ergaben/VB/I-VP/O sich/PRP/B-NP/O Ausschaltexperimente/NN/I-NP/O ,/,/O/O die/DT/B-NP/O eine/DT/I-NP/O weitere/JJ/I-NP/O Eingrenzung/NN/I-NP/O der/DT/B-NP/O mechanosensorischen/JJ/I-NP/O R\xc3\xbcckkopplung/NN/I-NP/O auf/IN/B-PP/B-PNP das/DT/B-NP/I-PNP operante/NN/I-NP/I-PNP Lernen/NN/I-NP/I-PNP erm\xc3\xb6glichten/VB/B-VP/O ././O/O

Die/DT/B-NP/O Sinneshaarfelder/NN/I-NP/O am/IN/B-PP/B-PNP Kugelgelenk/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Antenne/NN/I-NP/I-PNP haben/VB/B-VP/O keinen/JJ/B-NP/O signifikanten/JJ/I-NP/O Einfluss/NN/I-NP/O auf/IN/B-PP/B-PNP das/DT/B-NP/I-PNP operante/JJ/I-NP/I-PNP Positionslernen/NN/I-NP/I-PNP ././O/O

Bienen/NN/B-NP/O ,/,/O/O die/WDT/B-NP/O sich/PRP/I-NP/O im/IN/B-PP/B-PNP Lernerfolg/NN/B-NP/I-PNP nach/IN/B-PP/B-PNP taktiler/NN/B-NP/I-PNP Oberfl\xc3\xa4chenkonditionierung/NN/I-NP/I-PNP unterschieden/VB/B-VP/O ,/,/O/O zeigten/RB/B-ADVP/O schon/RB/I-ADVP/O vorher/IN/B-PP/B-PNP Unterschiede/NN/B-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Abtastaktivit\xc3\xa4t/NN/I-NP/I-PNP ././O/O

M\xc3\xb6gliche/JJ/B-NP/O Zusammenh\xc3\xa4nge/NN/I-NP/O von/IN/B-PP/B-PNP Abtastaktivit\xc3\xa4t/NN/B-NP/I-PNP eines/DT/I-NP/I-PNP Tieres/NN/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O Modulation/NN/I-NP/O durch/IN/B-PP/B-PNP biogene/NN/B-NP/I-PNP Amine/NN/I-NP/I-PNP werden/VB/B-VP/O erl\xc3\xa4utert/VBN/I-VP/O ././O/O

Abtastverhalten/NN/B-NP/O und/CC/I-NP/O Antworteigenschaften/NN/I-NP/O auf/IN/B-PP/B-PNP Zuckerwasserreize/NN/B-NP/I-PNP wurden/RB/B-ADVP/O untersucht/RP/O/O ././O/O

Bienen/NN/B-NP/O ,/,/O/O die/WDT/O/O schon/RB/B-ADVP/O auf/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP Wasserstimulus/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP R\xc3\xbcsselreflex/NN/I-NP/I-PNP reagierten/NN/I-NP/I-PNP ,/,/O/O zeigten/VB/B-VP/O \xc3\xbcber/IN/B-PP/B-PNP kurze/JJ/B-NP/I-PNP Zeit/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP h\xc3\xb6here/JJ/I-NP/I-PNP ventrale/NN/I-NP/I-PNP Abtastaktivit\xc3\xa4t/NN/I-NP/I-PNP als/IN/B-PP/B-PNP Bienen/NN/B-NP/I-PNP ,/,/O/O die/WDT/O/O erst/RB/B-ADVP/O auf/IN/B-PP/B-PNP Zuckerwasser/JJ/B-NP/I-PNP reagierten/NN/I-NP/I-PNP ././O/O

Erkl\xc3\xa4rungsans\xc3\xa4tze/NN/B-NP/O zur/IN/B-PP/B-PNP unterschiedlichen/JJ/B-NP/I-PNP Abtastaktivit\xc3\xa4t/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Bienen/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP \xc2\x84Reaktionsschwellen\xc2\x93/NN/I-NP/I-PNP werden/VB/B-VP/O gesucht.Dipl.-Ing/NN/B-NP/O ././O/O

Peter/NNP/B-NP/O Witkowski/NNP/I-NP/O Abstract/NNP/I-NP/O zur/IN/B-PP/B-PNP Dissertation/NN/B-NP/I-PNP \xe2\x80\x9eExpression/NN/I-NP/I-PNP und/CC/I-NP/I-PNP Funktion/NN/I-NP/I-PNP Apoptose/NN/I-NP/I-PNP regulierender/JJ/B-NP/I-PNP Gene/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Orthopockenviren\xe2\x80\x9c/NN/B-NP/I-PNP Nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Eradikation/NN/I-NP/I-PNP des/DT/B-NP/I-PNP humanpathogenen/JJ/I-NP/I-PNP Variolavirus/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP das/DT/B-NP/I-PNP WHO-Impfprogramm/NN/I-NP/I-PNP im/IN/B-PP/O 20/CD/O/O ././O/O

Jahrhundert/NN/B-NP/O treten/VB/B-VP/O andere/JJ/B-NP/O Orthopockenviren/NN/I-NP/O (/(/O/O OPV/NNP/B-NP/O )/)/O/O geh\xc3\xa4uft/VB/B-VP/O als/IN/B-PP/B-PNP Erreger/NN/B-NP/I-PNP humaner/JJ/I-NP/I-PNP Infektionen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Erscheinung/NN/B-NP/I-PNP ././O/O

Weniger/RB/B-ADJP/O gef\xc3\xa4hrlich/JJ/I-ADJP/O als/IN/B-PP/B-PNP die/DT/B-NP/I-PNP humanen/NN/I-NP/I-PNP Pocken/NN/I-NP/I-PNP ,/,/O/O k\xc3\xb6nnen/PRP$/B-NP/O Kuhpocken/NN/I-NP/O -/-/O/O oder/CC/O/O Vacciniaviren/NN/B-NP/O dennoch/IN/B-PP/B-PNP Menschen/NN/B-NP/I-PNP infizieren/VB/B-VP/O und/CC/O/O zu/IN/B-PP/B-PNP schweren/JJ/B-NP/I-PNP Komplikationen/NN/I-NP/I-PNP f\xc3\xbchren/VB/B-VP/O ././O/O

OPV/NNP/B-NP/O besitzen/JJ/I-NP/O Erbinformationen/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Vielzahl/NN/I-NP/I-PNP sogenannter/JJ/B-NP/I-PNP Wirtsbereichsfaktoren/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O bis/IN/B-PP/O zu/TO/O/O 50%/CD/B-NP/O des/DT/I-NP/O gesamten/JJ/I-NP/O Pockengenoms/NN/I-NP/O ausmachen/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ././O/O

Das/DT/B-NP/O Arsenal/NN/I-NP/O dieser/DT/B-NP/O Gene/NN/I-NP/O ist/VB/B-VP/O abh\xc3\xa4ngig/JJ/B-ADJP/O von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Virusspezies/NNP/I-NP/I-PNP und/CC/O/O hat/VB/B-VP/O gro\xc3\x9fen/JJ/B-NP/O Einfluss/NN/I-NP/O auf/IN/B-PP/B-PNP deren/DT/B-NP/I-PNP Pathogenese/NN/I-NP/I-PNP ././O/O

Um/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Einfluss/NN/I-NP/I-PNP pockenviraler/JJ/B-NP/I-PNP Wirtsbereichsfaktoren/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Infektion/NN/I-NP/I-PNP zu/TO/B-VP/O untersuchen/VB/I-VP/O ,/,/O/O wurden/VB/B-VP/O Proteine/NN/B-NP/O ausgesucht/NN/I-NP/O ,/,/O/O die/WDT/O/O inhibitorisch/JJ/B-ADJP/O in/IN/B-PP/B-PNP apoptotische/JJ/B-NP/I-PNP Kaskaden/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Wirtszellen/NN/I-NP/I-PNP eingreifen/VB/B-VP/O ././O/O

Zu/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Zielen/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP geh\xc3\xb6rte/VB/B-VP/O die/DT/B-NP/O Etablierung/NN/I-NP/O von/IN/B-PP/B-PNP Nachweismethoden/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP apoptotische/JJ/B-NP/I-PNP Prozesse/NN/I-NP/I-PNP ,/,/O/O die/DT/B-NP/O Charakterisierung/NN/I-NP/O der/DT/B-NP/O Apoptose/NN/I-NP/O modulierenden/NN/I-NP/O Wirkung/NN/I-NP/O pockenviraler/NN/I-NP/O Proteine/NN/I-NP/O ,/,/O/O sowie/CC/O/O eine/DT/B-NP/O Untersuchung/NN/I-NP/O der/DT/B-NP/O Funktion/NN/I-NP/O der/DT/B-NP/O Modulatoren/NN/I-NP/O als/IN/B-PP/B-PNP tats\xc3\xa4chliche/JJ/B-NP/I-PNP Virulenzfaktoren/NN/I-NP/I-PNP in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP Fokus/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Projektes/NN/I-NP/I-PNP standen/VB/B-VP/O die/DT/B-NP/O Proteine/NN/I-NP/O CrmA/NNP/I-NP/O als/IN/B-PP/B-PNP Kaspase-Inhibitor/NN/B-NP/I-PNP ,/,/O/O F1L/NN/B-NP/O als/IN/B-PP/B-PNP Inhibitor/NN/B-NP/I-PNP der/DT/O/O intrinsisch/JJ/B-ADJP/O vermittelten/VB/B-VP/O Apoptose/NN/B-NP/O und/CC/O/O schlie\xc3\x9flich/IN/B-PP/B-PNP P28/NN/B-NP/I-PNP als/IN/B-PP/B-PNP RING-Finger-Protein/NNP/B-NP/I-PNP mit/IN/B-PP/B-PNP unbekanntem/JJ/B-NP/I-PNP Wirkmechanismus/NN/I-NP/I-PNP ././O/O

Homologe/NN/B-NP/O dieser/DT/I-NP/O Proteine/NN/I-NP/O aus/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Vaccinia/NN/I-NP/I-PNP -/-/O/O ,/,/O/O Kamel/NN/B-NP/O -/-/O/O und/CC/O/O Kuhpockenviren/NN/B-NP/O wurden/RB/B-ADVP/O untersucht/RP/O/O ././O/O

Mittels/IN/B-PP/B-PNP real-time/NN/B-NP/I-PNP PCR/NN/I-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O Expression/NN/I-NP/O der/DT/B-NP/O untersuchten/JJ/I-NP/O Genprodukte/NN/I-NP/O nach/IN/B-PP/B-PNP OPV/NNP/B-NP/I-PNP Infektion/JJ/I-NP/I-PNP quantifiziert/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O haben/RB/B-VP/O gezeigt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP spezifische/JJ/B-NP/I-PNP mRNA/NNP/I-NP/I-PNP bereits/RB/B-NP/I-PNP wenige/JJ/I-NP/I-PNP Minuten/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Infektion/NN/I-NP/I-PNP vorhanden/JJ/B-ADJP/O ist/VB/B-VP/O und/CC/O/O warfen/JJ/B-NP/O Fragen/NN/I-NP/O bez\xc3\xbcglich/IN/B-PP/B-PNP spezifischer/JJ/B-NP/I-PNP Transkripte/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Pockenvirionen/NN/B-NP/I-PNP auf/RP/O/O ,/,/O/O deren/WDT/B-NP/O Existenz/NN/I-NP/O im/IN/B-PP/B-PNP Laufe/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP gezeigt/VBN/B-VP/I-PNP werden/VB/I-VP/O konnte/VBN/I-VP/O ././O/O

Um/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Expression/NN/I-NP/I-PNP viraler/NN/I-NP/I-PNP Proteine/NN/I-NP/I-PNP untersuchen/JJ/B-ADJP/O zu/TO/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ,/,/O/O wurden/VB/B-VP/O spezifische/JJ/B-NP/O IgY/NN/I-NP/O Antik\xc3\xb6rper/JJ/B-NP/O generiert/NN/I-NP/O ././O/O

Dies/DT/B-NP/O geschah/NN/I-NP/O basierend/JJ/B-ADJP/O auf/IN/B-PP/B-PNP zirkul\xc3\xa4ren/NN/B-NP/I-PNP DNA/NN/I-NP/I-PNP Vakzinen/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Gene/JJ/I-NP/I-PNP Gun/NN/I-NP/I-PNP in/IN/B-PP/B-PNP H\xc3\xbchner/NNS/B-NP/I-PNP appliziert/VBN/B-VP/I-PNP wurden/VB/I-VP/O ././O/O

Ein/DT/B-NP/O neu/JJ/I-NP/O entwickelter/JJ/I-NP/O Antik\xc3\xb6rper-Neutralisationstest/NN/I-NP/O zur/IN/B-PP/B-PNP Charakterisierung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP generierten/NN/I-NP/I-PNP IgY/NN/I-NP/I-PNP wurde/VB/B-VP/O in/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP real-time/NN/I-NP/I-PNP Cell/FW/O/O Electronic/FW/O/O Sensing/FW/O/O System/FW/O/O angewendet/FW/O/O ././O/O

Im/IN/B-PP/B-PNP Laufe/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Projektes/NN/I-NP/I-PNP konnten/VB/B-VP/O Apoptose/JJ/B-NP/O Nachweismethoden/NN/I-NP/O auf/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Basis/NN/I-NP/I-PNP von/IN/B-PP/B-PNP markierten/NN/B-NP/I-PNP Kaspase-Inhibitoren/NN/I-NP/I-PNP etabliert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Hierbei/VBN/B-VP/O wurde/RB/I-VP/O gezeigt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP OPV/NNP/B-NP/I-PNP nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Infektion/NN/I-NP/I-PNP zum/IN/B-PP/B-PNP Teil/NN/B-NP/I-PNP Apoptose/NN/I-NP/I-PNP induzieren/NN/I-NP/I-PNP ,/,/O/O die/DT/B-NP/O Zellen/NNS/I-NP/O jedoch/RB/B-ADVP/O gegen\xc3\xbcber/IN/B-PP/B-PNP \xc3\xa4u\xc3\x9feren/NN/B-NP/I-PNP apoptotischen/JJ/I-NP/I-PNP Stimuli/NN/I-NP/I-PNP sch\xc3\xbctzen/VB/B-VP/O ././O/O

Eine/DT/B-NP/O heterologe/NN/I-NP/O Expression/NN/I-NP/O der/DT/B-NP/O viralen/JJ/I-NP/O Proteine/NN/I-NP/O in/IN/B-PP/B-PNP nicht-infizierten/NN/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP f\xc3\xbchrte/VB/B-VP/O ebenfalls/RB/B-ADVP/O zur/IN/B-PP/B-PNP Apoptose/JJ/B-NP/I-PNP Inhibition/NN/I-NP/I-PNP ././O/O

Weiterhin/IN/B-PP/B-PNP gelang/NN/B-NP/I-PNP es/PRP/I-NP/I-PNP mithilfe/IN/B-PP/B-PNP von/IN/I-PP/I-PNP shRNA/NNP/B-NP/I-PNP ,/,/O/O die/DT/B-NP/O Expression/NN/I-NP/O der/DT/B-NP/O drei/CD/I-NP/O Proteine/NN/I-NP/O in/IN/B-PP/B-PNP infizierten/NN/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP zu/TO/B-VP/O unterdr\xc3\xbccken/VB/I-VP/O ././O/O

Versuche/NN/B-NP/O in/IN/B-PP/B-PNP Zelllinien/NN/B-NP/I-PNP ,/,/O/O als/CC/O/O auch/RB/B-ADVP/O in/IN/B-PP/B-PNP prim\xc3\xa4ren/NN/B-NP/I-PNP H\xc3\xbchnerzellen/NN/I-NP/I-PNP haben/RB/B-VP/O jedoch/RB/I-VP/O gezeigt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Knock/NN/I-NP/I-PNP down/JJ/B-ADJP/O der/DT/B-NP/O Apoptose/NN/I-NP/O Inhibitoren/NN/I-NP/O keinen/JJ/B-NP/O Einfluss/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Virusvermehrung/JJ/I-NP/I-PNP hatte.NAC/NN/I-NP/I-PNP (/(/O/O Nascent/NN/B-NP/O Polypeptide-associated/NN/I-NP/O Complex/NN/I-NP/O )/)/O/O ist/VB/B-VP/O ein/DT/B-NP/O Proteinkomplex/NN/I-NP/O mit/IN/B-PP/B-PNP kontrovers/JJ/B-NP/I-PNP diskutierten/JJ/I-NP/I-PNP Funktionen/NN/I-NP/I-PNP ././O/O

\xc3\xa4uger-NAC/VBN/B-VP/O wurde/VB/I-VP/O als/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP Regulator/NN/I-NP/I-PNP des/DT/B-NP/I-PNP cotranslationalen/JJ/I-NP/I-PNP Transports/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Proteinen/NN/B-NP/I-PNP in/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Endoplasmatische/JJ/I-NP/I-PNP Retikulum/NN/I-NP/I-PNP (/(/O/O ER/PRP/B-NP/O )/)/O/O identifiziert/NN/B-NP/O ././O/O

Daneben/RB/B-VP/O existieren/VB/I-VP/O Arbeiten/NN/B-NP/O ,/,/O/O in/IN/B-PP/B-PNP denen/WDT/B-NP/I-PNP den/DT/I-NP/I-PNP Untereinheiten/NN/I-NP/I-PNP des/DT/B-NP/I-PNP NAC/NN/I-NP/I-PNP in/IN/B-PP/B-PNP S\xc3\xa4uger/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Hefe/JJ/I-NP/I-PNP Funktionen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Transkriptionskontrolle/NN/I-NP/I-PNP zugeschrieben/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Kombination/NN/I-NP/I-PNP von/IN/B-PP/B-PNP genetischen/JJ/B-NP/I-PNP und/CC/I-NP/I-PNP biochemischen/JJ/I-NP/I-PNP Methoden/NN/I-NP/I-PNP kann/VB/B-VP/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP gezeigt/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O da\xc3\x9f/IN/B-PP/B-PNP NAC/NN/B-NP/I-PNP in/IN/B-PP/O der/DT/O/O Hefe/FW/O/O Saccharomyces/FW/O/O cerevisiae/FW/O/O quantitativ/FW/O/O mit/IN/B-PP/B-PNP Ribosomen/JJ/B-NP/I-PNP assoziiert/NN/I-NP/I-PNP ././O/O

NAC/RB/B-VP/O verhindert/VB/I-VP/O in/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP homologen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP vitro-System/NN/B-NP/I-PNP die/DT/I-NP/I-PNP Bindung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Ribosomen/NN/B-NP/I-PNP ,/,/O/O die/DT/B-NP/O nicht-sekretorische/JJ/I-NP/O Proteine/NN/I-NP/O translatieren/NN/I-NP/O ,/,/O/O an/IN/B-PP/B-PNP Membranen/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Endoplasmatischen/JJ/I-NP/I-PNP Retikulums/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Abwesenheit/NN/I-NP/O von/IN/B-PP/B-PNP NAC/NN/B-NP/I-PNP f\xc3\xbchrt/VB/B-VP/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Fehlleitung/NN/I-NP/I-PNP dieser/DT/B-NP/I-PNP Substrate/NN/I-NP/I-PNP an/IN/B-PP/B-PNP die/DT/B-NP/I-PNP ER-Membran/NN/I-NP/I-PNP ././O/O

Es/PRP/B-NP/O wird/VB/B-VP/O demonstriert/NN/B-NP/O ,/,/O/O da\xc3\x9f/IN/B-PP/B-PNP NAC/NN/B-NP/I-PNP in/IN/B-PP/O S./VB/B-VP/O cerevisiae/NN/B-NP/O aus/IN/B-PP/O einem/DT/O/O festen/VB/B-VP/O ,/,/O/O heterodimeren/NN/B-NP/O oder/RB/I-NP/O trimeren/JJ/I-NP/O Komplex/NN/I-NP/O aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Proteinen/NN/I-NP/I-PNP Egd2p/NN/I-NP/I-PNP und/CC/O/O Egd1p/NN/B-NP/O sowie/RB/B-ADVP/O Egd2p/NN/B-NP/O und/CC/O/O Btt1p/NN/B-NP/O besteht/VB/B-VP/O ././O/O

Egd1p/RB/B-VP/O vermittelt/VB/I-VP/O die/DT/B-NP/O Ribosomenbindung/NN/I-NP/O des/DT/B-NP/O gesamten/JJ/I-NP/O Komplexes/NN/I-NP/O ././O/O

Die/DT/B-NP/O Untereinheiten/NN/I-NP/O Egd1p/NN/I-NP/O und/CC/O/O Egd2p/NN/B-NP/O k\xc3\xb6nnen/VB/B-VP/O mit/IN/B-PP/B-PNP kurzen/NN/B-NP/I-PNP naszierenden/NN/I-NP/I-PNP Peptidketten/NN/I-NP/I-PNP quervernetzt/NN/I-NP/I-PNP werden/VB/B-VP/O und/CC/O/O befinden/VB/B-VP/O sich/PRP/B-NP/O somit/RB/B-ADVP/O in/IN/B-PP/B-PNP ihrer/PRP$/B-NP/I-PNP unmittelbaren/JJ/I-NP/I-PNP N\xc3\xa4he/NN/I-NP/I-PNP ././O/O

In/IN/B-PP/B-PNP Wildtypzellen/NN/B-NP/I-PNP ist/VB/B-VP/O NAC/NN/B-NP/O ausschlie\xc3\x9flich/RB/I-NP/O cytosolisch/JJ/I-NP/O lokalisiert/NN/I-NP/O ././O/O

In/IN/B-PP/B-PNP vitro-Import-Versuche/NN/B-NP/I-PNP ergaben/VB/B-VP/O jedoch/RP/I-VP/O ,/,/O/O da\xc3\x9f/RB/B-ADVP/O die/DT/B-NP/O zwei/CD/I-NP/O untersuchten/NN/I-NP/O Untereinheiten/NN/I-NP/O Egd1p/NN/I-NP/O und/CC/O/O Egd2p/NN/B-NP/O f\xc3\xa4hig/JJ/B-ADJP/O sind/JJ/I-ADJP/O ,/,/I-ADJP/O abh\xc3\xa4ngig/JJ/I-ADJP/O von/IN/B-PP/B-PNP Energie/NN/B-NP/I-PNP und/CC/I-NP/I-PNP den/DT/I-NP/I-PNP klassischen/JJ/I-NP/I-PNP Importrezeptoren/NN/I-NP/I-PNP Importin/NN/I-NP/I-PNP a/PRP/I-NP/I-PNP und/CC/O/O b/NN/B-NP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Zellkern/NN/I-NP/I-PNP zu/TO/B-VP/O gelangen/VB/I-VP/O ././O/O

GFP-Fusionsproteine/NN/B-NP/O von/IN/B-PP/B-PNP Egd1p/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Egd2p/JJ/I-NP/I-PNP akkumulieren/NN/I-NP/I-PNP in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Kern/NN/B-NP/I-PNP ,/,/O/O wenn/IN/B-PP/B-PNP ihre/PRP$/B-NP/I-PNP Ribosomenbindung/NN/I-NP/I-PNP verhindert/VBN/B-VP/I-PNP wird/VB/I-VP/O ././O/O

Der/DT/B-NP/O Kernimport/NN/I-NP/O eines/DT/B-NP/O verk\xc3\xbcrzten/NN/I-NP/O ,/,/O/O im/IN/B-PP/B-PNP Kern/NN/B-NP/I-PNP lokalisierten/NN/I-NP/I-PNP Egd1p/NN/I-NP/I-PNP ist/VB/B-VP/O in/IN/B-PP/B-PNP KAP123/NN/B-NP/I-PNP und/CC/I-NP/I-PNP PSE1-Mutanten/NN/I-NP/I-PNP ,/,/O/O die/DT/B-NP/O Defekte/NN/I-NP/O im/IN/B-PP/B-PNP Kerntransport/NN/B-NP/I-PNP ribosomaler/NN/I-NP/I-PNP Proteine/NN/I-NP/I-PNP zeigen/VB/B-VP/O ,/,/O/O gest\xc3\xb6rt/RP/O/O ././O/O

Es/PRP/B-NP/O wurde/VB/B-VP/O eine/DT/B-NP/O Dom\xc3\xa4ne/NN/I-NP/O identifiziert/NN/I-NP/O ,/,/O/O die/WDT/O/O f\xc3\xbcr/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Kap123p&slash;Pse1p-vermittelten/NN/I-NP/I-PNP Kerntransport/NN/I-NP/I-PNP essentiell/NN/I-NP/I-PNP ist/VB/B-VP/O ././O/O

Die/DT/B-NP/O Hypothese/NN/I-NP/O wurde/VB/B-VP/O aufgestellt/NN/B-NP/O ,/,/O/O da\xc3\x9f/IN/B-PP/B-PNP neu/JJ/B-NP/I-PNP synthetisierte/JJ/I-NP/I-PNP NAC-Proteine/NN/I-NP/I-PNP in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Kern/NN/I-NP/I-PNP transportiert/NN/I-NP/I-PNP werden/VB/B-VP/O ,/,/O/O um/IN/B-PP/O dort/RB/B-ADVP/O an/IN/B-PP/B-PNP ribosomale/NN/B-NP/I-PNP Untereinheiten/NN/I-NP/I-PNP zu/TO/B-VP/O binden/VB/I-VP/O und/CC/O/O den/DT/B-NP/O Kern/NN/I-NP/O mit/IN/B-PP/B-PNP ihnen/PRP/B-NP/I-PNP zu/IN/B-PP/B-PNP verlassen.Der/NN/B-NP/I-PNP Schlaganfall/NN/I-NP/I-PNP ist/VB/B-VP/O eine/DT/O/O der/DT/O/O Haupttodesursachen/RB/B-ADVP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Industriel\xc3\xa4ndern/NN/I-NP/I-PNP und/CC/O/O f\xc3\xbchrt/VB/B-VP/O aufgrund/IN/B-PP/B-PNP resultierender/NN/B-NP/I-PNP k\xc3\xb6rperlicher/MD/B-VP/O Behinderungen/NN/B-NP/O j\xc3\xa4hrlich/RB/B-ADVP/O zu/IN/B-PP/B-PNP Kosten/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Millionenh\xc3\xb6he/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Gesundheitswesen/NN/B-NP/I-PNP ././O/O

Es/PRP/B-NP/O ist/VB/B-VP/O bereits/RB/I-VP/O bekannt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP entz\xc3\xbcndliche/JJ/B-NP/I-PNP Prozesse/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Verschlechterung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Gesundheitszustandes/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Schlaganfallpatienten/NN/I-NP/I-PNP f\xc3\xbchren/VB/B-VP/O ././O/O

Mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP globaler/NN/I-NP/I-PNP Genexpressionsanalysen/NN/I-NP/I-PNP wurde/VB/B-VP/O nicht/RB/B-ADVP/O nur/RB/I-ADVP/O die/DT/B-NP/O Hochregulierung/NN/I-NP/O der/DT/B-NP/O inflammatorischen/JJ/I-NP/O Proteine/JJ/I-NP/O TLR2/NN/I-NP/O (/(/O/O \xe2\x80\x9eToll-Like/NN/B-NP/O Receptor/NN/I-NP/O 2\xe2\x80\x9c/NN/I-NP/O )/)/O/O ,/,/O/O TLR4/NN/B-NP/O (/(/O/O \xe2\x80\x9eToll-Like/NN/B-NP/O Receptor/NN/I-NP/O 4\xe2\x80\x9c/NN/I-NP/O )/)/O/O und/CC/O/O MRP14/NN/B-NP/O (/(/O/O \xe2\x80\x9eMyeloid/NN/B-NP/O Related/NN/I-NP/O Protein/NN/I-NP/O 14\xe2\x80\x9c/NN/I-NP/O )/)/O/O ,/,/O/O sondern/CC/O/O auch/RB/B-ADVP/O die/DT/B-NP/O Hochregulierung/NN/I-NP/O TLR2/NN/I-NP/O -/-/O/O bzw./CC/O/O TLR4-Pathway/NNP/B-NP/O zugeh\xc3\xb6riger/NNP/I-NP/O Gene/JJ/B-NP/O detektiert/NN/I-NP/O ././O/O

Daher/RB/B-VP/O wurden/VB/I-VP/O im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Dissertationsarbeit/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Einfluss/NN/I-NP/I-PNP von/IN/B-PP/B-PNP TLR2/NN/B-NP/I-PNP und/CC/O/O das/DT/O/O mit/IN/B-PP/B-PNP TLR4/NN/B-NP/I-PNP interagierende/NN/I-NP/I-PNP Protein/JJ/I-NP/I-PNP MRP14/NN/I-NP/I-PNP in/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Mausmodell/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP Schlaganfall/NN/B-NP/I-PNP untersucht/RP/O/O ././O/O

Nach/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP einst\xc3\xbcndigen/NN/I-NP/I-PNP Verschluss/NN/I-NP/I-PNP der/DT/B-NP/I-PNP mittleren/JJ/I-NP/I-PNP Hirnarterie/NN/I-NP/I-PNP (/(/O/O \xe2\x80\x9emiddle/NN/B-NP/O cerebral/NN/I-NP/O artery/NNP/I-NP/O occlusion\xe2\x80\x9c/NNP/I-NP/O bzw./CC/I-NP/O MCAO/NNP/I-NP/O )/)/O/O in/IN/B-PP/B-PNP C57Bl&slash;6-Wildtyptieren/NN/B-NP/I-PNP wurde/VB/B-VP/O eine/DT/B-NP/O Hochregulierung/NN/I-NP/O der/DT/B-NP/O TLR2-mRNA/NNP/I-NP/O zwischen/IN/B-PP/O 3/CD/O/O bis/IN/B-PP/B-PNP 48/CD/B-NP/I-PNP Stunden/NN/I-NP/I-PNP Reperfusion/NN/I-NP/I-PNP sowie/RB/B-ADVP/O der/DT/B-NP/O MRP14-mRNA/NNP/I-NP/O zwischen/IN/B-PP/B-PNP 12/CD/B-NP/I-PNP und/CC/I-NP/I-PNP 48/CD/I-NP/I-PNP Stunden/NN/I-NP/I-PNP Reperfusion/NN/I-NP/I-PNP gezeigt/RP/O/O ././O/O

TLR2-Protein/NNP/B-NP/O ist/VB/B-VP/O fast/VB/I-VP/O ausschlie\xc3\x9flich/RB/B-ADVP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP ipsilateralen/JJ/I-NP/I-PNP Hemisph\xc3\xa4re/NN/I-NP/I-PNP ,/,/O/O insbesondere/RB/B-ADVP/O im/IN/B-PP/B-PNP Infarktkern/NN/B-NP/I-PNP ,/,/O/O zu/TO/B-VP/O finden/VB/I-VP/O ././O/O

Die/DT/B-NP/O meisten/DT/I-NP/O TLR2-positiven/NN/I-NP/O Zellen/NNS/I-NP/O lie\xc3\x9fen/VB/B-VP/O sich/PRP/B-NP/O als/IN/B-PP/B-PNP Mikroglia/NN/B-NP/I-PNP identifizieren/VB/B-VP/O ././O/O

Aber/CC/O/O auch/RB/B-ADVP/O einige/DT/B-NP/O ausgew\xc3\xa4hlte/JJ/I-NP/O Endothelien/NN/I-NP/O ,/,/O/O Neuronen/NN/B-NP/O und/CC/I-NP/O Astrozyten/NN/I-NP/O bilden/VB/B-VP/O TLR2-Protein/NNP/B-NP/O aus/RP/O/O ././O/O

Es/PRP/B-NP/O wurde/VB/B-VP/O ein/DT/B-NP/O isch\xc3\xa4mischer/JJ/I-NP/O Infarkt/NN/I-NP/O (/(/O/O 1/CD/B-NP/O h/NN/I-NP/O MCAO&slash;48/NN/I-NP/O h/NN/I-NP/O Reperfusion/NN/I-NP/O )/)/O/O in/IN/B-PP/B-PNP C57Bl&slash;6-Wildtypm\xc3\xa4usen/NN/B-NP/I-PNP sowie/RB/B-ADVP/O in/IN/B-PP/B-PNP TLR2-defizienten/NN/B-NP/I-PNP M\xc3\xa4usen/JJ/I-NP/I-PNP ausgel\xc3\xb6st/NN/I-NP/I-PNP ././O/O

Das/DT/B-NP/O Infarktvolumen/NN/I-NP/O ,/,/O/O sowie/CC/O/O die/DT/B-NP/O Anzahl/NN/I-NP/O an/IN/B-PP/B-PNP aktivierten/NN/B-NP/I-PNP Mikroglia/NN/I-NP/I-PNP bzw./RB/I-NP/I-PNP eingewanderten/NN/I-NP/I-PNP Makrophagen/NN/I-NP/I-PNP waren/VB/B-VP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP TLR2-defizienten/NN/I-NP/I-PNP Tieren/NN/I-NP/I-PNP geringer/JJ/B-ADJP/O als/IN/B-PP/B-PNP in/IN/I-PP/I-PNP den/DT/B-NP/I-PNP Wildtyptieren/NN/I-NP/I-PNP ././O/O

Dementgegen/RB/B-VP/O war/VB/I-VP/O die/DT/B-NP/O Neuronenzahl/NN/I-NP/O gr\xc3\xb6\xc3\x9fer/JJ/B-ADJP/O ././O/O

Dieses/DT/B-NP/O Ergebnis/NN/I-NP/O lie\xc3\x9f/VB/B-VP/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP wichtige/JJ/I-NP/I-PNP Rolle/NN/I-NP/I-PNP des/DT/B-NP/I-PNP TLR2/NN/I-NP/I-PNP hinsichtlich/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Ausweitung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Gewebeschadens/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Schlaganfall/NN/I-NP/I-PNP schlie\xc3\x9fen/VB/B-VP/O ././O/O

MRP14/RB/B-VP/O ist/VB/I-VP/O als/IN/B-PP/B-PNP endogener/NNP/B-NP/I-PNP TLR4-Agonist/NNP/I-NP/I-PNP bekannt/VBN/B-VP/I-PNP und/CC/O/O wurde/VB/B-VP/O hinsichtlich/IN/B-PP/B-PNP seiner/PRP$/B-NP/I-PNP Relevanz/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Ausweitung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Gewebeschadens/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Schlaganfall/NN/I-NP/I-PNP untersucht/RP/O/O ././O/O

MRP14/VBN/B-VP/O wurde/VB/I-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP ipsilateralen/JJ/I-NP/I-PNP Hemisph\xc3\xa4re/NN/I-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP und/CC/O/O zwar/RB/B-ADVP/O ausschlie\xc3\x9flich/RB/I-ADVP/O in/IN/B-PP/B-PNP aktivierten/NN/B-NP/I-PNP Mikroglia/NN/I-NP/I-PNP und/CC/I-NP/I-PNP einwandernden/JJ/I-NP/I-PNP Makrophagen/NN/I-NP/I-PNP ././O/O

MRP14-positive/NN/B-NP/O Zellen/NNS/I-NP/O lagern/VB/B-VP/O sich/PRP/B-NP/O an/IN/B-PP/B-PNP Endothelien/NN/B-NP/I-PNP an/RP/O/O ././O/O

MRP14-defiziente/JJ/B-NP/O M\xc3\xa4use/NN/I-NP/O (/(/O/O die/DT/O/O ebenfalls/RB/B-ADVP/O den/DT/B-NP/O Komplexpartner/NN/I-NP/O MRP8/NN/I-NP/O nicht/RB/B-VP/O bilden/VB/I-VP/O k\xc3\xb6nnen/VB/I-VP/O )/)/O/O zeigen/VB/B-VP/O nach/IN/B-PP/B-PNP 1/CD/B-NP/I-PNP h/NN/I-NP/I-PNP MCAO/NNP/I-NP/I-PNP und/CC/O/O 48/CD/B-NP/O h/NN/I-NP/O Reperfusion/NN/I-NP/O ein/DT/B-NP/O geringeres/NN/I-NP/O Infarktvolumen/NN/I-NP/O ,/,/O/O ein/DT/B-NP/O kleineres/NN/I-NP/O \xc3\x96dem/NN/I-NP/O sowie/RB/B-ADVP/O ein/DT/B-NP/O reduzierte/JJ/I-NP/O Anzahl/NN/I-NP/O an/IN/B-PP/B-PNP aktivierten/NN/B-NP/I-PNP Mikroglia/NN/I-NP/I-PNP und/CC/I-NP/I-PNP einwandernden/NN/I-NP/I-PNP Makrophagen/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP MRP14-Wurfgeschwister/NN/B-NP/I-PNP ././O/O

MRP14/RB/B-VP/O tr\xc3\xa4gt/VB/I-VP/O somit/RB/B-ADVP/O zum/IN/B-PP/B-PNP schlaganfallinduzierten/JJ/B-NP/I-PNP Gewebeschaden/NN/I-NP/I-PNP bei/RP/O/O ././O/O

Um/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP m\xc3\xb6gliche/JJ/I-NP/I-PNP Behandlung/NN/I-NP/I-PNP gegen/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Gewebeschadensausweitung/NN/I-NP/I-PNP zu/TO/B-VP/O entwickeln/VB/I-VP/O ,/,/O/O wurden/VB/B-VP/O in/IN/B-PP/B-PNP C57Bl&slash;6-M\xc3\xa4usen/NN/B-NP/I-PNP Schlaganf\xc3\xa4lle/JJ/I-NP/I-PNP ausgel\xc3\xb6st/NN/I-NP/I-PNP (/(/O/O 45/CD/B-NP/O min/NN/I-NP/O MCAO&slash;48/NN/I-NP/O h/NN/I-NP/O Reperfusion/NN/I-NP/O )/)/O/O ,/,/O/O die/WDT/O/O anschlie\xc3\x9fend/JJ/B-ADJP/O mit/IN/B-PP/B-PNP TLR2-blockierenden/NN/B-NP/I-PNP TLR2.5-Antik\xc3\xb6rper/NN/I-NP/I-PNP und/CC/I-NP/I-PNP nichtfunktionalen/JJ/I-NP/I-PNP \xe2\x80\x9eisotype/NN/I-NP/I-PNP control\xc3\xa2\xe2\x82\xac?-Antik\xc3\x83\xc2\xb6rper/NN/I-NP/I-PNP behandelt/VBN/B-VP/I-PNP wurden/VB/I-VP/O ././O/O

Es/PRP/B-NP/O wurde/VB/B-VP/O ein/DT/B-NP/O verringertes/NN/I-NP/O Schlaganfallvolumen/NN/I-NP/O ,/,/O/O eine/DT/B-NP/O hochsignifikante/NN/I-NP/O Reduzierung/NN/I-NP/O der/DT/B-NP/O Mikrogliaaktivierung/NN/I-NP/O bzw./RB/B-ADVP/O Makrophageninfiltration/NN/B-NP/O ,/,/O/O sowie/CC/O/O eine/DT/B-NP/O signifikante/NN/I-NP/O Erh\xc3\xb6hung/NN/I-NP/O des/DT/B-NP/O Neuronenerhalts/NN/I-NP/O festgestellt/RP/O/O ././O/O

Um/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP m\xc3\xb6gliche/JJ/I-NP/I-PNP Toxizit\xc3\xa4t/NN/I-NP/I-PNP einer/DT/B-NP/I-PNP Antik\xc3\xb6rperapplikation/NN/I-NP/I-PNP ins/IN/B-PP/B-PNP Gehirn/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP detektieren/NN/B-NP/I-PNP ,/,/O/O wurden/VB/B-VP/O Wildtypm\xc3\xa4use/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Schlaganfall/NN/I-NP/I-PNP ausgesetzt/VBN/B-VP/I-PNP und/CC/O/O mit/IN/B-PP/B-PNP \xe2\x80\x9eisotype/NN/B-NP/I-PNP control\xc3\xa2\xe2\x82\xac?-Antik\xc3\x83\xc2\xb6rper/NN/I-NP/I-PNP bzw./RB/I-NP/I-PNP PBS-Solvent/NN/I-NP/I-PNP behandelt/RP/O/O ././O/O

Der/DT/O/O so/IN/B-PP/B-PNP detektierte/NN/B-NP/I-PNP neurotoxische/JJ/I-NP/I-PNP Effekt/NN/I-NP/I-PNP einer/DT/B-NP/I-PNP Antik\xc3\xb6rperapplikation/NN/I-NP/I-PNP wurde/VB/B-VP/O durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Blockade/NN/I-NP/I-PNP des/DT/B-NP/I-PNP TLR2/NN/I-NP/I-PNP jedoch/RB/B-ADVP/O mehr/RB/I-ADVP/O als/IN/B-PP/O kompensiert/RP/O/O ././O/O

Zusammenfassend/JJ/B-ADJP/O tragen/VB/B-VP/O beide/JJ/B-NP/O Proteine/NN/I-NP/O (/(/O/O TLR2/NN/B-NP/O und/CC/I-NP/O MRP14/NN/I-NP/O )/)/O/O zum/IN/B-PP/B-PNP sekund\xc3\xa4ren/JJ/B-NP/I-PNP Schaden/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP isch\xc3\xa4mischen/JJ/I-NP/I-PNP Schlaganfall/NN/I-NP/I-PNP bei/RP/O/O ././O/O

Ich/PRP/B-NP/O vermute/NN/I-NP/O ,/,/O/O diese/WDT/B-NP/O Gewebe-schadensausweitung/NN/I-NP/O wird/VB/B-VP/O durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP erh\xc3\xb6hte/NN/I-NP/I-PNP Anzahl/NN/I-NP/I-PNP an/IN/B-PP/B-PNP Mikroglia/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Makrophagen/NN/I-NP/I-PNP und/CC/O/O damit/RB/B-ADVP/O durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Versch\xc3\xa4rfung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Inflammation/NN/I-NP/I-PNP verursacht/RP/O/O ././O/O

Des/JJ/B-NP/O Weiteren/NN/I-NP/O hat/VB/B-VP/O eine/DT/B-NP/O Blockade/NN/I-NP/O des/DT/B-NP/O TLR2-Signalweges/NN/I-NP/O einen/DT/B-NP/O positiven/JJ/I-NP/O Effekt/NN/I-NP/O auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Neuronenerhalt/NN/I-NP/I-PNP und/CC/O/O das/DT/B-NP/O klinische/JJ/I-NP/O Ergebnis/NN/I-NP/O ././O/O

Daraus/RB/B-VP/O ergibt/VB/I-VP/O sich/PRP/B-NP/O die/DT/I-NP/O M\xc3\xb6glichkeit/NN/I-NP/O zur/IN/B-PP/B-PNP Entwicklung/NN/B-NP/I-PNP medikament\xc3\xb6ser/NN/I-NP/I-PNP Anwendungen.In/NN/I-NP/I-PNP der/DT/I-NP/I-PNP regenerativen/NN/I-NP/I-PNP Medizin/NN/I-NP/I-PNP besteht/VB/B-VP/O die/DT/B-NP/O Hoffnung/NN/I-NP/O ,/,/O/O pluripotente/NN/B-NP/O embryonale/NNP/I-NP/O und/CC/I-NP/O multipotente/NNP/I-NP/O adulte/JJ/B-NP/O Stammzellen/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP zellbasierte/NN/B-NP/I-PNP Therapien/NN/I-NP/I-PNP zu/TO/B-VP/O verwenden/VB/I-VP/O ././O/O

ammzellen/NN/B-NP/O ,/,/O/O die/WDT/O/O in/IN/B-PP/B-PNP Hepatozyten/NN/B-NP/I-PNP differenzieren/VB/B-VP/O ,/,/O/O k\xc3\xb6nnen/VB/B-VP/O m\xc3\xb6glicherweise/RB/B-ADVP/O als/IN/B-PP/B-PNP \xc3\x9cberbr\xc3\xbcckungstherapie/NN/B-NP/I-PNP extrakorporal/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Bioreaktor/NN/B-NP/I-PNP oder/RB/B-ADVP/O durch/IN/B-PP/B-PNP intrahepatische/JJ/B-NP/I-PNP Transplantation/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Patienten/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP akutem/NN/B-NP/I-PNP Leberversagen/NN/I-NP/I-PNP eingesetzt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Das/DT/B-NP/O Ziel/NN/I-NP/O der/DT/B-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O der/DT/B-NP/O Vergleich/NN/I-NP/O des/DT/B-NP/O endodermal/NN/I-NP/O hepatischen/JJ/B-NP/O Differenzierungspotenzials/NN/I-NP/O von/IN/B-PP/B-PNP humanen/NN/B-NP/I-PNP pluripotenten/NN/I-NP/I-PNP ,/,/O/O embryonalen/JJ/B-NP/O Stammzellen/NN/I-NP/O und/CC/O/O multipotenten/NN/B-NP/O ,/,/O/O adulten/NN/B-NP/O CD34/NNP/I-NP/O +/JJ/I-NP/O Stammzellen/NN/I-NP/O aus/IN/B-PP/B-PNP Nabelschnurblut/NN/B-NP/I-PNP unter/IN/B-PP/B-PNP identischen/JJ/B-NP/I-PNP differenzierungsinduzierenden/JJ/I-NP/I-PNP Bedingungen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP ././O/O

Mittels/IN/B-PP/B-PNP Gen/NN/B-NP/I-PNP -/-/O/O und/CC/O/O Proteinexpression/NN/B-NP/O und/CC/O/O zellul\xc3\xa4rer/NN/B-NP/O Strukturanalyse/NN/I-NP/O sollten/NN/I-NP/O essentielle/NN/I-NP/O Schritte/NN/I-NP/O der/DT/O/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP Differenzierung/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Durch/IN/B-PP/B-PNP Zytokine/NN/B-NP/I-PNP ,/,/O/O hepatisch/JJ/B-NP/O konditioniertes/NN/I-NP/O AML12/NN/I-NP/O -/-/O/O und/CC/O/O HepG2-Medium/NN/B-NP/O und/CC/O/O Kokultur/NN/B-NP/O mit/IN/B-PP/B-PNP AML12-Hepatozyten/NN/B-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O hepatische/JJ/I-NP/O Differenzierung/NN/I-NP/O in/IN/B-PP/B-PNP CD34/NN/B-NP/I-PNP +/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP humanen/NN/B-NP/I-PNP embryonalen/JJ/I-NP/I-PNP Stammzellen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP gepr\xc3\xbcft/RP/O/O ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O der/DT/B-NP/O Experimente/NN/I-NP/O der/DT/B-NP/O endodermalen/JJ/I-NP/O hepatischen/JJ/I-NP/O Differenzierungsinduktion/NN/I-NP/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP zeigten/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O der/DT/B-NP/O direkte/JJ/I-NP/O Kontakt/NN/I-NP/O der/DT/B-NP/O adulten/NN/I-NP/O und/CC/O/O embryonalen/JJ/B-NP/O Stammzellen/NN/I-NP/O in/IN/B-PP/B-PNP Kokultur/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP Hepatozyten/NN/B-NP/I-PNP einen/DT/I-NP/I-PNP Vorteil/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Differenzierungsinduktion/NN/I-NP/I-PNP gegen\xc3\xbcber/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP konditionierten/NN/I-NP/I-PNP Medium/NN/I-NP/I-PNP bietet/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP den/DT/B-NP/I-PNP humanen/NN/I-NP/I-PNP embryonalen/JJ/B-NP/I-PNP Stammzellen/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Linie/NN/I-NP/I-PNP SA002/NN/I-NP/I-PNP konnte/VB/B-VP/O durch/IN/B-PP/O die/DT/O/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP Systeme/NN/I-NP/I-PNP eine/DT/I-NP/I-PNP endodermal/NN/I-NP/I-PNP hepatische/JJ/B-NP/I-PNP Differenzierung/NN/I-NP/I-PNP induziert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Neben/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Anstieg/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Expression/NN/I-NP/I-PNP von/IN/B-PP/B-PNP endodermalen/JJ/B-NP/I-PNP Genen/NN/I-NP/I-PNP \xc3\xa4nderte/VB/B-VP/O sich/PRP/B-NP/O auch/RB/B-ADVP/O die/DT/B-NP/O Morphologie/NN/I-NP/O der/DT/B-NP/O Zellen/NNS/I-NP/O ././O/O

Jedoch/VBN/B-VP/O wurde/VB/I-VP/O keine/JJ/B-NP/O eindeutige/JJ/I-NP/O Differenzierung/NN/I-NP/O in/IN/B-PP/B-PNP funktionelle/NN/B-NP/I-PNP Hepatozyten/NN/I-NP/I-PNP erreicht/RP/O/O ././O/O

Die/DT/O/O gew\xc3\xa4hlten/JJ/B-ADJP/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP differenzierungsinduzierenden/NN/I-NP/I-PNP Bedingungen/NN/I-NP/I-PNP der/DT/I-NP/I-PNP konditionierten/NN/I-NP/I-PNP Medien/NN/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O Kokultur/NN/I-NP/O erm\xc3\xb6glichten/VB/B-VP/O den/DT/B-NP/O CD34/NN/I-NP/O +/NN/I-NP/O Zellen/NNS/I-NP/O eine/DT/B-NP/O geringf\xc3\xbcgige/JJ/I-NP/O Differenzierung/NN/I-NP/O in/IN/B-PP/B-PNP hepatisch/JJ/B-NP/I-PNP endodermale/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP ././O/O

Die/DT/O/O gew\xc3\xa4hlten/JJ/B-ADJP/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP Bedingungen/NN/I-NP/I-PNP zeigten/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O der/DT/B-NP/O direkte/JJ/I-NP/O Kontakt/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Kokultur/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Differenzierung/NN/I-NP/I-PNP effizienter/JJ/B-ADJP/O als/IN/B-PP/B-PNP die/DT/B-NP/I-PNP konditionierten/JJ/I-NP/I-PNP Medien/NN/I-NP/I-PNP in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Stammzellen/NN/I-NP/I-PNP induzieren/NN/I-NP/I-PNP konnte/VB/B-VP/O ././O/O

Es/PRP/B-NP/O besteht/VB/B-VP/O jedoch/RB/B-ADVP/O der/DT/B-NP/O Bedarf/NN/I-NP/O ,/,/O/O die/DT/B-NP/O bestehenden/JJ/I-NP/O Differenzierungsprotokolle/NN/I-NP/O weiter/RB/B-VP/O zu/TO/I-VP/O verbessern/VB/I-VP/O ././O/O

In/IN/B-PP/B-PNP immundefizienten/NN/B-NP/I-PNP M\xc3\xa4usen/NN/I-NP/I-PNP wurden/VB/B-VP/O unterschiedliche/JJ/B-NP/O Leberschadensmodelle/NN/I-NP/O der/DT/B-NP/O Maus/NN/I-NP/O etabliert/NN/I-NP/O ,/,/O/O um/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Engraftment/NN/I-NP/I-PNP ,/,/O/O die/DT/B-NP/O Organverteilung/NN/I-NP/O und/CC/O/O das/DT/B-NP/O hepatische/JJ/I-NP/O Differenzierungs/NN/I-NP/O -/-/O/O und/CC/O/O Regenerationspotenzial/NN/B-NP/O von/IN/B-PP/B-PNP humanen/JJ/B-NP/I-PNP Stammzellen/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP in/IN/I-PP/I-PNP vivo/NN/B-NP/I-PNP Transplantation/NN/I-NP/I-PNP zu/TO/B-VP/O bestimmen/VB/I-VP/O ././O/O

Die/DT/O/O aus/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Klinik/NN/I-NP/I-PNP abgeleiteten/JJ/B-NP/I-PNP Leberschadensmodelle/NN/I-NP/I-PNP partielle/NN/I-NP/I-PNP Hepatektomie/NN/I-NP/I-PNP ,/,/O/O chronischer/JJ/B-NP/O Leberschaden/NN/I-NP/O durch/IN/B-PP/B-PNP Futterdi\xc3\xa4t/NN/B-NP/I-PNP und/CC/I-NP/I-PNP chemisch/JJ/I-NP/I-PNP induzierter/NN/I-NP/I-PNP Leberschaden/NN/I-NP/I-PNP wurden/VB/B-VP/O erfolgreich/JJ/B-ADJP/O in/IN/B-PP/B-PNP NOD&slash;SCID/NN/B-NP/I-PNP M\xc3\xa4usen/JJ/I-NP/I-PNP etabliert/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O erarbeiteten/NN/I-NP/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP Modelle/NNS/I-NP/I-PNP bildeten/VB/B-VP/O die/DT/B-NP/O Grundlage/NN/I-NP/O zur/IN/B-PP/B-PNP Pr\xc3\xbcfung/NN/B-NP/I-PNP des/DT/O/O Regenerations/FW/O/O -/-/O/O und/CC/O/O Differenzierungspotenzials/NN/B-NP/O von/IN/B-PP/B-PNP undifferenzierten/NN/B-NP/I-PNP Stammzellen/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP in/IN/I-PP/I-PNP vitro/NN/B-NP/I-PNP differenzierten/JJ/I-NP/I-PNP Stammzellen/NN/I-NP/I-PNP ././O/O

In/IN/B-PP/O Transplantationsversuchen/JJ/B-ADJP/O erwiesen/VBN/B-VP/O sich/PRP/B-NP/O die/DT/I-NP/O Modelle/NNS/I-NP/O von/IN/B-PP/B-PNP akuten/JJ/B-NP/I-PNP Lebersch\xc3\xa4den/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Verbindung/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP verst\xc3\xa4rkenden/NN/B-NP/I-PNP Zytokinen/NN/I-NP/I-PNP wie/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Hepatozytenwachstumsfaktor/NN/I-NP/I-PNP oder/RB/B-ADVP/O proliferationshemmenden/NN/B-NP/O Substanzen/NNS/I-NP/O wie/IN/B-PP/B-PNP Monocrotalin/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP erfolgreiche/JJ/I-NP/I-PNP Stammzelltransplantation/NN/I-NP/I-PNP als/IN/B-PP/O geeignet/JJ/B-ADJP/O ././O/O

Erst/RB/B-ADVP/O wenn/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Stammzell-abgeleiteten/JJ/I-NP/I-PNP Hepatozyten/NN/I-NP/I-PNP in/IN/B-PP/B-PNP pr\xc3\xa4klinischen/JJ/B-NP/I-PNP Modellen/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Leberschaden/NN/B-NP/I-PNP eine/DT/I-NP/I-PNP regenerative/NN/I-NP/I-PNP Wirkung/NN/I-NP/I-PNP zeigen/VB/B-VP/O und/CC/O/O keine/JJ/B-NP/O Nebenwirkungen/NN/I-NP/O hervorrufen/VB/B-VP/O ,/,/O/O ist/RB/B-ADVP/O ein/DT/B-NP/O Einsatz/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP regenerativen/NN/I-NP/I-PNP Medizin/NN/I-NP/I-PNP m\xc3\xb6glich/JJ/B-ADJP/O ././O/O

Vermutlich/VBN/B-VP/O hat/VB/I-VP/O der/DT/B-NP/O Einsatz/NN/I-NP/O von/IN/B-PP/B-PNP hepatisch/JJ/B-NP/I-PNP differenzierten/NN/I-NP/I-PNP Stammzellen/NN/I-NP/I-PNP als/IN/B-PP/B-PNP Leberersatztherapie/NN/B-NP/I-PNP noch/RB/B-ADVP/O einen/DT/B-NP/O l\xc3\xa4ngerfristigen/JJ/I-NP/O zeitlichen/JJ/I-NP/O Horizont.Kunststoffverpackungen/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Getr\xc3\xa4nkeindustrie/NN/I-NP/I-PNP sind/VB/B-VP/O weltweit/JJ/B-ADJP/O immer/IN/B-PP/B-PNP pr\xc3\xa4senter/NN/B-NP/I-PNP und/CC/O/O \xc3\xb6ffnen/VB/B-VP/O sich/PRP/B-NP/O hierbei/NN/I-NP/O auch/RB/I-NP/O qualitativ/JJ/I-NP/O sensitiven/NN/I-NP/O Produkten/NN/I-NP/O als/IN/B-PP/B-PNP Markterweiterung/NN/B-NP/I-PNP ././O/O

Um/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Barriereeigenschaften/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Polymermaterials/NN/I-NP/I-PNP zu/TO/B-VP/O verbessern/VB/I-VP/O ,/,/O/O laufen/VB/B-VP/O kontinuierlich/RB/B-ADJP/O Neu/JJ/I-ADJP/O -/-/O/O und/CC/O/O Weiterentwicklungen/NN/B-NP/O der/DT/B-NP/O bestehenden/JJ/I-NP/O Systeme/NN/I-NP/O (/(/O/O Multilayer/NN/B-NP/O ,/,/O/O Innenbeschichtungen/NN/B-NP/O ,/,/O/O Au\xc3\x9fenbeschichtungen/NN/B-NP/O und/CC/I-NP/O Blendings/NN/I-NP/O )/)/O/O ././O/O

Grundaufgabe/NN/B-NP/O der/DT/I-NP/O vorliegenden/JJ/I-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O es/PRP/B-NP/O ,/,/O/O analytische/JJ/B-NP/O Methodiken/NN/I-NP/O zu/TO/B-VP/O etablieren/VB/I-VP/O ,/,/O/O mit/IN/B-PP/B-PNP denen/WDT/B-NP/I-PNP sich/PRP/I-NP/I-PNP die/DT/B-NP/I-PNP notwendigen/JJ/I-NP/I-PNP Barrierel\xc3\xb6sungen/NN/I-NP/I-PNP bewerten/VB/B-VP/O lassen/VB/I-VP/O ././O/O

Es/PRP/B-NP/O werden/VB/B-VP/O realit\xc3\xa4tsnahe/JJ/B-NP/O Bedingungen/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP Echtzeit-Vergleich/JJ/I-NP/I-PNP nachgestellt/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O analytisch/JJ/I-NP/O erzielten/JJ/I-NP/O Werte/NN/I-NP/O werden/VB/B-VP/O durch/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP geschultes/NN/I-NP/I-PNP Verkosterpanel/NN/I-NP/I-PNP bewertet/NN/I-NP/I-PNP ,/,/O/O um/IN/B-PP/B-PNP den/DT/B-NP/I-PNP geschmacklichen/JJ/I-NP/I-PNP Alterungserscheinungen/JJ/I-NP/I-PNP Richtwerte/NN/I-NP/I-PNP \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Verpackungsqualit\xc3\xa4t/NN/I-NP/I-PNP zuschreiben/VB/B-VP/O zu/TO/I-VP/O k\xc3\xb6nnen/VB/I-VP/O ././O/O

Die/DT/B-NP/O Bedeutung/NN/I-NP/O der/DT/B-NP/O Arbeit/NN/I-NP/O liegt/VB/B-VP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP bisher/RB/I-NP/I-PNP nicht/RB/I-NP/I-PNP bekannten/JJ/I-NP/I-PNP Ergebnissen/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Kinetik/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Sauerstoffaufnahme/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Zusammenhang/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Permeation/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP Anwendung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP entwickelten/JJ/I-NP/I-PNP Referenzmethodik/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Ausblick/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Wirkungsoptimierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP O2-Scavengermaterialien/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Industrie/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Erkenntnis/NN/I-NP/O ,/,/O/O dass/IN/B-PP/B-PNP einzelne/JJ/B-NP/I-PNP Additive/NN/I-NP/I-PNP ,/,/O/O am/IN/B-PP/B-PNP Beispiel/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Farbzus\xc3\xa4tzen/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Sauerstofff\xc3\xa4ngern/NN/I-NP/I-PNP ,/,/O/O sich/PRP/B-NP/O gegenseitig/JJ/B-ADJP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Wirkung/NN/I-NP/I-PNP behindern/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O zeigt/VB/I-VP/O die/DT/B-NP/O Wichtigkeit/NN/I-NP/O der/DT/B-NP/O Validierung/NN/I-NP/O der/DT/B-NP/O finalen/JJ/I-NP/O Formulierung/NN/I-NP/O einer/DT/B-NP/O Verpackung/NN/I-NP/O ././O/O

Ein/DT/B-NP/O konsequentes/JJ/I-NP/O Umdenken/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Verwendung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Kunststoffmaterialien/NN/B-NP/I-PNP ergibt/VB/B-VP/O sich/PRP/B-NP/O aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP mikrobiologischen/JJ/I-NP/I-PNP Untersuchungen/NN/I-NP/I-PNP ././O/O

\xc3\x9cber/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Zusammenhang/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Sauerstoffeintrages/NN/I-NP/I-PNP und/CC/O/O des/DT/B-NP/O CO2-Verlustes/NN/I-NP/O wird/VB/B-VP/O deutlich/JJ/B-ADJP/O ,/,/O/O dass/RB/B-ADVP/O bei/IN/B-PP/B-PNP unzureichender/JJ/B-NP/I-PNP Barriere/NN/I-NP/I-PNP gegen/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Permeation/NN/I-NP/I-PNP von/IN/B-PP/B-PNP anorganischen/JJ/B-NP/I-PNP Gasen/NN/I-NP/I-PNP potentielle/NN/I-NP/I-PNP und/CC/O/O sogar/RB/B-ADVP/O nicht/RB/B-ADVP/O potenziell/NN/B-NP/O biersch\xc3\xa4dliche/JJ/B-NP/O Mikroogranismen/NN/I-NP/O zum/IN/B-PP/B-PNP Verderb/NN/B-NP/I-PNP des/DT/I-NP/I-PNP abgef\xc3\xbcllten/NN/I-NP/I-PNP Bieres/NN/I-NP/I-PNP f\xc3\xbchren/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ././O/O

Die/DT/B-NP/O Spanne/NN/I-NP/O der/DT/O/O m\xc3\xb6glichen/VB/B-VP/O Bierverderber/NN/B-NP/O ,/,/O/O die/WDT/O/O von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Qualit\xc3\xa4tskontrolle/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Praxis/NN/I-NP/I-PNP nicht/RB/B-VP/O erfasst/VBN/I-VP/O werden/VB/I-VP/O wird/VB/I-VP/O hierdurch/NN/B-NP/O nahezu/IN/B-PP/B-PNP un\xc3\xbcberschaulich.Eine/JJ/B-NP/I-PNP Vielzahl/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Protein-Protein-Wechselwirkungen/NN/B-NP/I-PNP ,/,/O/O die/DT/B-NP/O eine/DT/I-NP/O wichtige/JJ/I-NP/O Rolle/NN/I-NP/O in/IN/B-PP/B-PNP Signaltransduktionsprozessen/NN/B-NP/I-PNP spielen/VB/B-VP/O ,/,/O/O wird/VB/B-VP/O \xc3\xbcber/IN/B-PP/B-PNP Wechselwirkungen/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP relativ/IN/I-PP/I-PNP kurzen/NN/B-NP/I-PNP Peptidsequenzen/NN/I-NP/I-PNP vermittelt/VB/B-VP/O ,/,/O/O wobei/WRB/O/O vor/IN/B-PP/O allem/DT/O/O \xc3\xbcber/IN/B-PP/B-PNP posttranslational/NN/B-NP/I-PNP modifizierte/NN/I-NP/I-PNP Proteinsequenzen/NN/I-NP/I-PNP Bindungen/NN/I-NP/I-PNP ausgel\xc3\xb6st/NN/I-NP/I-PNP bzw./RB/B-VP/O unterbunden/VBN/I-VP/O werden/VB/I-VP/O k\xc3\xb6nnen/VB/I-VP/O ././O/O

o/RB/B-VP/O findet/VB/I-VP/O z.B./RB/B-ADVP/O eine/DT/B-NP/O exakte/JJ/I-NP/O Regulation/NN/I-NP/O wichtiger/JJ/B-NP/O zellul\xc3\xa4rer/JJ/I-NP/O Signalwege/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP reversible/NN/B-NP/I-PNP Proteinphosphorylierungen/NN/I-NP/I-PNP statt/RP/O/O ././O/O

In/IN/B-PP/B-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurden/VB/B-VP/O differentielle/JJ/B-NP/O Peptid-Protein-Interaktionsexperimente/NN/I-NP/O (/(/O/O Pulldown-Experimente/NN/B-NP/O )/)/O/O mit/IN/B-PP/B-PNP phosphorylierten/NN/B-NP/I-PNP und/CC/I-NP/I-PNP den/DT/I-NP/I-PNP korrespondierenden/NN/I-NP/I-PNP unphosphorylierten/NN/I-NP/I-PNP Peptiden/NN/I-NP/I-PNP durchgef\xc3\xbchrt/VBN/B-VP/I-PNP ,/,/O/O um/IN/B-PP/B-PNP phosphorylierungsspezifische/JJ/B-NP/I-PNP Interaktionspartner/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Adapterproteins/NNP/I-NP/I-PNP ADAP/NNP/I-NP/I-PNP ,/,/O/O welches/WDT/B-NP/O entscheidende/JJ/I-NP/O Funktionen/NN/I-NP/O im/IN/B-PP/B-PNP T-Zellsignalweg/NN/B-NP/I-PNP als/IN/B-PP/B-PNP Teil/NN/B-NP/I-PNP der/DT/I-NP/I-PNP adaptiven/NN/I-NP/I-PNP Immunantwort/NN/I-NP/I-PNP einnimmt/VB/B-VP/O ,/,/O/O zu/TO/B-VP/O bestimmen/VB/I-VP/O ././O/O

Dazu/RB/B-VP/O wurden/VB/I-VP/O Peptidsequenzen/NN/B-NP/O ,/,/O/O welche/WDT/B-NP/O die/DT/I-NP/O Tyrosine/NN/I-NP/O 595/CD/O/O ,/,/O/O 625/CD/B-NP/O sowie/CC/I-NP/O 771/CD/I-NP/O der/DT/I-NP/O ADAP-Sequenz/NN/I-NP/O abdeckten/NN/I-NP/O ,/,/O/O mittels/IN/B-PP/B-PNP Festphasenpeptidsynthese/NN/B-NP/I-PNP synthetisiert/NN/I-NP/I-PNP ,/,/O/O aufgereinigt/VB/B-VP/O und/CC/O/O kovalent/NN/B-NP/O an/IN/B-PP/B-PNP Agarose/NN/B-NP/I-PNP gebunden/RP/O/O ././O/O

Die/DT/B-NP/O Konjugate/NN/I-NP/O zeigten/JJ/B-NP/O vergleichbare/JJ/I-NP/O Beladungen/NN/I-NP/O mit/IN/B-PP/B-PNP phosphorylierten/NN/B-NP/I-PNP und/CC/I-NP/I-PNP unphosphorylierten/NN/I-NP/I-PNP Peptiden/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Bereich/NN/B-NP/I-PNP von/IN/B-PP/B-PNP 18-40/CD/B-NP/I-PNP nmol/NN/I-NP/I-PNP Peptid&slash;mg/NN/I-NP/I-PNP Agarose/NN/I-NP/I-PNP ,/,/O/O sowie/CC/O/O eine/DT/B-NP/O reproduzierbare/JJ/I-NP/O phosphorylierungsspezifische/JJ/I-NP/O Bindung/NN/I-NP/O der/DT/B-NP/O SH2-Dom\xc3\xa4ne/NN/I-NP/O der/DT/B-NP/O Tyrosin-Proteinkinase/JJ/I-NP/O Fyn/NN/I-NP/O ././O/O

Die/DT/B-NP/O Bestimmung/NN/I-NP/O der/DT/B-NP/O phosphorylierungsspezifisch/JJ/I-NP/O interagierenden/JJ/I-NP/O Proteine/NN/I-NP/O mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP ADAP-Peptiden/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP Jurkat-T-Zelllysat/NN/B-NP/I-PNP erfolgte/VB/B-VP/O \xc3\xbcber/IN/B-PP/B-PNP quantitative/JJ/B-NP/I-PNP Massenspektrometrie/NN/I-NP/I-PNP unter/IN/B-PP/B-PNP Verwendung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Markierungsverfahren/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP stabilen/JJ/B-NP/I-PNP Isotopen/NN/I-NP/I-PNP ././O/O

Daf\xc3\xbcr/RB/B-ADVP/O wurden/RB/I-ADVP/O zwei/CD/B-NP/O Methoden/NN/I-NP/O eingesetzt/VBN/B-VP/O :/:/O/O die/DT/B-NP/O Markierung/NN/I-NP/O von/IN/B-PP/B-PNP einzelnen/JJ/B-NP/I-PNP Aminos\xc3\xa4uren/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Zellkultur/NN/B-NP/I-PNP (/(/O/O stable/NN/B-NP/O isotope/NN/I-NP/O labeling/NN/I-NP/O by/NNP/I-NP/O amino/JJ/I-NP/O acids/NN/I-NP/O in/IN/B-PP/B-PNP cell/NN/B-NP/I-PNP culture/NN/I-NP/I-PNP [/NN/I-NP/I-PNP SILAC/NN/I-NP/I-PNP ]/NN/I-NP/I-PNP )/)/O/O und/CC/O/O die/DT/B-NP/O enzymatische/JJ/I-NP/O 18O-Markierung/NN/I-NP/O mit/IN/B-PP/B-PNP schwerem/JJ/B-NP/I-PNP Wasser/NN/I-NP/I-PNP ././O/O

An/IN/B-PP/B-PNP allen/JJ/B-NP/I-PNP untersuchten/NN/I-NP/I-PNP Peptidsequenzen/NN/I-NP/I-PNP konnten/VB/B-VP/O phosphorylierungsabh\xc3\xa4ngige/JJ/B-NP/O Wechselwirkungen/NN/I-NP/O von/IN/B-PP/O mehr/RB/B-ADVP/O als/IN/B-PP/B-PNP zehn/CD/B-NP/I-PNP Proteinen/NN/I-NP/I-PNP gezeigt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Dabei/RB/B-VP/O wurden/VB/I-VP/O die/DT/B-NP/O Proteine/NNP/I-NP/O CRK/NNP/I-NP/O ,/,/O/O NCK1&slash;2/NN/B-NP/O ,/,/O/O PIK3R1/NN/B-NP/O ,/,/O/O PLC\xce\xb31/NN/B-NP/O und/CC/I-NP/O SLP76/NN/I-NP/O von/IN/B-PP/B-PNP allen/DT/B-NP/I-PNP drei/CD/I-NP/I-PNP Phosphotyrosinpeptiden/NN/I-NP/I-PNP gleicherma\xc3\x9fen/IN/B-PP/B-PNP rekrutiert/NN/B-NP/I-PNP ././O/O

Andererseits/RB/B-VP/O zeigte/VB/I-VP/O sich/PRP/B-NP/O auch/RB/I-NP/O sequenzspezifisches/JJ/I-NP/O Bindungsverhalten/NN/I-NP/O ,/,/O/O da/IN/B-PP/O z.B./RB/B-ADVP/O das/DT/B-NP/O Ras/NN/I-NP/O GTPase/NN/I-NP/O aktivierende/NN/I-NP/O Protein/NN/I-NP/O RASA1/NN/I-NP/O nur/VB/B-VP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP ADAP-595-Sequenz/JJ/I-NP/I-PNP interagierte/NN/I-NP/I-PNP ././O/O

owohl/CC/O/O bekannte/VB/B-VP/O SH2-Dom\xc3\xa4nen-basierte/JJ/B-NP/O Wechselwirkungen/NN/I-NP/O von/IN/B-PP/B-PNP ADAP/NNP/B-NP/I-PNP mit/IN/B-PP/B-PNP SLP76/NN/B-NP/I-PNP ,/,/O/O als/CC/O/O auch/RB/B-NP/O neue/JJ/I-NP/O Interaktionspartner/NN/I-NP/O die/DT/O/O im/IN/B-PP/B-PNP Kontext/NN/B-NP/I-PNP des/DT/I-NP/I-PNP T-Zellrezeptor-Komplexes/NN/I-NP/I-PNP beschrieben/NN/I-NP/I-PNP werden/VB/B-VP/O ,/,/O/O wie/IN/B-PP/O z.B./RB/B-ADVP/O das/DT/B-NP/O Protein/NN/I-NP/O RASA1/NN/I-NP/O ,/,/O/O konnten/VB/B-VP/O identifiziert/NN/B-NP/O werden/VB/B-VP/O ././O/O

Der/DT/B-NP/O Vergleich/NN/I-NP/O beider/JJ/B-NP/O Quantifizierungsmethoden/NN/I-NP/O zeigte/VB/B-VP/O eine/DT/B-NP/O gute/JJ/I-NP/O \xc3\x9cbereinstimmung/NN/I-NP/O der/DT/B-NP/O Ergebnisse/NN/I-NP/O ././O/O

Alle/DT/O/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP SILAC-Methode/NN/I-NP/I-PNP identifizierten/NN/I-NP/I-PNP Proteine/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O mit/IN/B-PP/B-PNP ADAP-595/NN/B-NP/I-PNP und/CC/I-NP/I-PNP ADAP-771/NN/I-NP/I-PNP interagierten/NN/I-NP/I-PNP ,/,/O/O wurden/VB/B-VP/O auch/RB/B-ADVP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP 18O-Methode/JJ/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP ././O/O

Am/IN/B-PP/B-PNP Tyr/NN/B-NP/I-PNP 625/CD/O/O wurden/VB/B-VP/O zus\xc3\xa4tzlich/JJ/B-ADJP/O zu/IN/B-PP/B-PNP den/DT/B-NP/I-PNP neun/CD/I-NP/I-PNP phosphorylierungsspezifisch/JJ/I-NP/I-PNP bindenden/NN/I-NP/I-PNP Proteinen/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O mit/IN/B-PP/B-PNP beiden/DT/B-NP/I-PNP Methoden/NN/I-NP/I-PNP bestimmt/VBN/B-VP/I-PNP wurden/VB/I-VP/O ,/,/O/O zwei/CD/B-NP/O Bindungspartner/NN/I-NP/O ausschlie\xc3\x9flich/RB/B-ADVP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP SILAC-Methode/NN/I-NP/I-PNP und/CC/O/O vier/CD/B-NP/O Proteine/NN/I-NP/O ausschlie\xc3\x9flich/RB/B-ADVP/O \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP 18O-Markierung/JJ/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP ././O/O

Eines/DT/B-NP/O der/DT/I-NP/O interagierenden/NN/I-NP/O Proteine/NN/I-NP/O ,/,/O/O die/DT/O/O nicht/RB/B-ADVP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP SILAC-Methode/NN/I-NP/I-PNP best\xc3\xa4tigt/VBN/B-VP/I-PNP werden/VB/I-VP/O konnten/VBN/I-VP/O ,/,/O/O war/VB/B-VP/O beispielsweise/RB/B-ADVP/O die/DT/B-NP/O Tyrosin-Proteinkinase/JJ/I-NP/O Fyn/NN/I-NP/O ././O/O

Diese/DT/O/O ist/VB/B-VP/O bekannt/JJ/B-ADJP/O f\xc3\xbcr/IN/B-PP/B-PNP ihre/PRP$/B-NP/I-PNP Wechselwirkung/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP phosphorylierten/NN/I-NP/I-PNP Tyr/NN/I-NP/I-PNP 625/CD/O/O ././O/O

Die/DT/B-NP/O Interaktion/NN/I-NP/O konnte/VBN/B-VP/O jedoch/RB/B-ADVP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP 18O-Methode/NN/I-NP/I-PNP best\xc3\xa4tigt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Obwohl/IN/B-PP/B-PNP mit/IN/I-PP/I-PNP dieser/DT/B-NP/I-PNP Methode/NN/I-NP/I-PNP keine/JJ/B-NP/I-PNP Unterscheidung/NN/I-NP/I-PNP zwischen/IN/B-PP/O direkten/JJ/B-ADJP/O oder/CC/O/O indirekten/NN/B-NP/O Wechselwirkungen/NN/I-NP/O vorgenommen/VBN/B-VP/O werden/VB/I-VP/O kann/VBN/I-VP/O ,/,/O/O zeigt/VB/B-VP/O die/DT/B-NP/O Tatsache/NN/I-NP/O ,/,/O/O dass/IN/B-PP/O alle/DT/O/O \xc3\xbcber/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Peptid-Pulldown-Verfahren/NN/I-NP/I-PNP identifizierten/NN/I-NP/I-PNP potentiellen/JJ/B-NP/I-PNP Bindungspartner/NN/I-NP/I-PNP SH2-Dom\xc3\xa4nen/NN/I-NP/I-PNP enthalten/VBN/B-VP/I-PNP und/CC/O/O auch/RB/B-VP/O bekannte/VB/I-VP/O Adapterproteine/NN/B-NP/O und/CC/I-NP/O Kinasen/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP T-Zellrezeptor-Signalweiterleitung/NN/I-NP/I-PNP sind/VB/B-VP/O ,/,/O/O die/DT/B-NP/O Relevanz/NN/I-NP/O der/DT/B-NP/O detektierten/JJ/I-NP/O Wechselwirkungen/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP adaptive/JJ/I-NP/I-PNP Immunantwort/NN/I-NP/I-PNP ././O/O

Weiterhin/VBN/B-VP/O wurden/VB/I-VP/O Peptid-Pulldown-Experimente/NN/B-NP/O mit/IN/B-PP/B-PNP Phosphotyrosinanaloga/NN/B-NP/I-PNP durchgef\xc3\xbchrt/RP/O/O ././O/O

Daf\xc3\xbcr/RB/B-VP/O wurden/VB/I-VP/O Peptid-Phosphonate/NN/B-NP/O und/CC/I-NP/O \xe2\x80\x93Phosphoramidate/NN/I-NP/O der/DT/B-NP/O ADAP-595-Sequenz/NN/I-NP/O eingesetzt/RP/O/O ././O/O

Es/PRP/B-NP/O zeigte/VB/B-VP/O sich/PRP/B-NP/O ,/,/O/O dass/RB/B-NP/O beide/JJ/I-NP/O Analoga/NN/I-NP/O \xc3\xa4hnliche/JJ/B-NP/O Bindungseigenschaften/NN/I-NP/O wie/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Phosphotyrosin-Peptide/NN/I-NP/I-PNP aufweisen/VB/B-VP/O ,/,/O/O jedoch/RB/B-VP/O sind/VB/I-VP/O f\xc3\xbcr/IN/B-PP/B-PNP weiterf\xc3\xbchrende/NN/B-NP/I-PNP (/(/O/O biologische/JJ/B-ADJP/O )/)/O/O Experimente/NN/B-NP/O Optimierungsschritte/NN/I-NP/O der/DT/I-NP/O Interaktionsbedingungen/NN/I-NP/O und/CC/O/O die/DT/B-NP/O Charakterisierung/NN/I-NP/O der/DT/B-NP/O Bindungsparameter/NN/I-NP/O zwingend/JJ/B-NP/O notwendig.Im/NN/I-NP/O Rahmen/NN/I-NP/O dieser/DT/B-NP/O Arbeit/NN/I-NP/O wurde/VB/B-VP/O die/DT/B-NP/O Ladungsrekombination/NN/I-NP/O zwischen/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP oxidierten/NN/I-NP/I-PNP Elektronendonator/NN/I-NP/I-PNP ,/,/O/O P700/NN/B-NP/O +/NNP/I-NP/O ,/,/O/O und/CC/O/O den/DT/B-NP/O reduzierten/NN/I-NP/O Eisen-Schwefel-Zentren/NN/I-NP/O ,/,/O/O (/(/O/O FAFB/NN/B-NP/O )/)/O/O -/-/O/O bzw./CC/O/O (/(/O/O FA-FB/NN/B-NP/O -/-/O/O )/)/O/O ,/,/O/O untersucht/RP/O/O ././O/O

Als/IN/B-PP/B-PNP Methode/NN/B-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O blitzinduzierte/NN/I-NP/O Absorptionsdifferenzspektroskopie/NN/I-NP/O eingesetzt/RP/O/O ././O/O

Redoxtitrationen/VBN/B-VP/O wurden/VB/I-VP/O zus\xc3\xa4tzlich/JJ/B-ADJP/O mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP der/DT/I-NP/I-PNP EPR/NN/I-NP/I-PNP durchgef\xc3\xbchrt/RP/O/O ././O/O

Unterschiedliche/JJ/B-NP/O Ans\xc3\xa4tze/NNS/I-NP/O wurden/RB/B-VP/O ausgef\xc3\xbchrt/VBN/I-VP/O ,/,/O/O um/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Kinetik/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Ladungsrekombination/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP P700/NN/B-NP/I-PNP +/NN/I-NP/I-PNP und/CC/O/O (/(/O/O FAFB/NN/B-NP/O )/)/O/O -/-/O/O zu/TO/B-VP/O analysieren/VB/I-VP/O ././O/O

Die/DT/B-NP/O Untersuchungen/NN/I-NP/O wurden/VB/B-VP/O dadurch/RB/B-ADVP/O erschwert/NN/B-NP/O ,/,/O/O da\xc3\x9f/IN/B-PP/B-PNP in/IN/I-PP/I-PNP Konkurrenz/NN/B-NP/I-PNP zur/IN/B-PP/B-PNP Rekombination/NN/B-NP/I-PNP ein/DT/I-NP/I-PNP Vorw\xc3\xa4rtselektronentransfer/NN/I-NP/I-PNP von/IN/B-PP/B-PNP den/DT/B-NP/I-PNP reduzierten/NN/I-NP/I-PNP Eisen-Schwefel-Zentren/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP unbekannten/JJ/I-NP/I-PNP Akzeptor/NN/I-NP/I-PNP erfolgt/VB/B-VP/O ././O/O

Durch/IN/B-PP/B-PNP gezielte/JJ/B-NP/I-PNP Reduktion/NN/I-NP/I-PNP dieses/DT/B-NP/I-PNP Akzeptors/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Potential/NN/I-NP/I-PNP von/IN/B-PP/O -/-/O/O 250/CD/B-NP/O mV/NNP/I-NP/O und/CC/O/O durch/IN/B-PP/B-PNP Berechnung/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Zeitverlaufes/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Absorptions\xc3\xa4nderung/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP Blitzlichtanregung/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Gegenwart/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Akzeptoren/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Donatoren/NN/I-NP/I-PNP konnte/VB/B-VP/O eine/DT/B-NP/O Halbwertszeit/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Rekombination/NN/I-NP/I-PNP von/IN/B-PP/O (/(/O/O 95/CD/B-NP/O \xc2\xb1/NN/I-NP/O 10/CD/O/O )/)/O/O ms/NN/B-NP/O bestimmt/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Eine/DT/B-NP/O Verringerung/NN/I-NP/O des/DT/B-NP/O Redoxpotentials/NN/I-NP/O f\xc3\xbchrt/VB/B-VP/O zur/IN/B-PP/B-PNP einfachen/JJ/B-NP/I-PNP Reduktion/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Eisen-Schwefel-Zentren/NN/I-NP/I-PNP ,/,/O/O so/RB/B-ADVP/O da\xc3\x9f/IN/B-PP/B-PNP nach/IN/I-PP/I-PNP Blitzlichtanregung/NN/B-NP/I-PNP die/DT/I-NP/I-PNP Rekombination/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP P700/NN/B-NP/I-PNP +/NN/I-NP/I-PNP und/CC/O/O (/(/O/O FA-FB/NN/B-NP/O -/-/O/O )/)/O/O mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Halbwertszeit/NN/I-NP/I-PNP von/IN/B-PP/O (/(/O/O 10/CD/B-NP/O \xc2\xb1/NN/I-NP/O 3/CD/O/O )/)/O/O ms/NN/B-NP/O beobachtet/VBN/B-VP/O werden/VB/I-VP/O kann/VBN/I-VP/O ././O/O

Werden/VB/B-VP/O die/DT/B-NP/O Eisen-Schwefel-Zentren/NN/I-NP/O bei/IN/B-PP/B-PNP ca/NN/B-NP/I-PNP ././O/O

-/-/O/O 590/CD/B-NP/O mV/NNP/I-NP/O doppelt/JJ/B-ADJP/O reduziert/VB/B-VP/O ,/,/O/O erfolgt/RB/B-ADVP/O nach/IN/B-PP/B-PNP Blitzlichtanregung/NN/B-NP/I-PNP die/DT/I-NP/I-PNP Rekombination/NN/I-NP/I-PNP von/IN/B-PP/O P700+(A1FX)-(FA-FB/LS/O/O -/-/O/O )/)/O/O mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Halbwertszeit/NN/I-NP/I-PNP von/IN/B-PP/O (/(/O/O 275/CD/B-NP/O \xc2\xb1/NN/I-NP/O 25/CD/O/O )/)/O/O \xc2\xb5s/NN/B-NP/O ././O/O

Um/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Energetik/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Reaktion/NN/I-NP/I-PNP zu/TO/B-VP/O bestimmen/VB/I-VP/O ,/,/O/O wurden/VB/B-VP/O die/DT/O/O Halbstufenpotentiale/JJ/B-ADJP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Oxidation/NN/I-NP/I-PNP des/DT/B-NP/I-PNP prim\xc3\xa4ren/NN/I-NP/I-PNP Elektronendonators/NN/I-NP/I-PNP und/CC/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Reduktion/NN/I-NP/I-PNP der/DT/B-NP/I-PNP terminalen/JJ/I-NP/I-PNP Eisen-Schwefel-Zentren/NN/I-NP/I-PNP gemessen/RP/O/O ././O/O

Aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Messungen/NNS/I-NP/I-PNP an/IN/B-PP/B-PNP PS/NNP/B-NP/I-PNP I-Komplexen/NNP/I-NP/I-PNP aus/IN/B-PP/O Synechococcus/FW/O/O elongatus/FW/O/O und/CC/O/O Chlamydomonas/NN/B-NP/O reinhardtii/NN/I-NP/O folgt/VB/B-VP/O ein/DT/B-NP/O Halbstufenpotential/NN/I-NP/O von/IN/B-PP/O (/(/O/O 440/CD/B-NP/O \xc2\xb1/NN/I-NP/O 10/CD/O/O )/)/O/O mV/NNP/B-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Oxidation/NN/I-NP/I-PNP von/IN/B-PP/B-PNP P700/NN/B-NP/I-PNP ././O/O

Untersuchungen/NN/B-NP/O an/IN/B-PP/B-PNP PS/NNP/B-NP/I-PNP I-Mutanten/NNP/I-NP/I-PNP von/IN/B-PP/B-PNP Chlamydomonas/NN/B-NP/I-PNP reinhardtii/NN/I-NP/I-PNP ,/,/O/O bei/IN/B-PP/B-PNP denen/WDT/B-NP/I-PNP die/DT/I-NP/I-PNP axialen/JJ/I-NP/I-PNP Liganden/NN/I-NP/I-PNP Histidin/NN/I-NP/I-PNP A676/NN/I-NP/I-PNP und/CC/O/O Histidin/JJ/B-NP/O B656/NN/I-NP/O durch/IN/B-PP/B-PNP verschiedene/JJ/B-NP/I-PNP Aminos\xc3\xa4uren/NN/I-NP/I-PNP substituiert/NN/I-NP/I-PNP wurden/RB/B-ADVP/O ,/,/O/O haben/RB/B-VP/O gezeigt/VBN/I-VP/O ,/,/O/O da\xc3\x9f/IN/B-PP/O das/DT/O/O Halbstufenpotential/VB/B-VP/O sich/PRP/B-NP/O um/IN/B-PP/B-PNP bis/IN/I-PP/I-PNP zu/IN/I-PP/I-PNP +/NN/B-NP/I-PNP 140/CD/I-NP/I-PNP mV/NNP/I-NP/I-PNP verschiebt/NNP/I-NP/I-PNP ././O/O

Die/DT/O/O Halbstufenpotentiale/JJ/B-ADJP/O f\xc3\xbcr/IN/B-PP/O die/DT/O/O ein/DT/O/O -/-/O/O und/CC/O/O zweifache/NN/B-NP/O Reduktion/NN/I-NP/O der/DT/B-NP/O Eisen-Schwefel-Zentren/NN/I-NP/O ,/,/O/O (/(/O/O FAFB)&slash;(FAFB/LS/O/O )/)/O/O -/-/O/O und/CC/O/O (/(/O/O FAFB)-&slash;(FA-FB/LS/O/O -/-/O/O )/)/O/O ,/,/O/O werden/VB/B-VP/O mit/IN/B-PP/O (/(/O/O -/-/O/O 440/CD/B-NP/O \xc2\xb1/NN/I-NP/O 10/CD/O/O )/)/O/O mV/NNP/B-NP/O und/CC/O/O (/(/O/O -/-/O/O 465/CD/B-NP/O \xc2\xb1/NN/I-NP/O 10/CD/O/O )/)/O/O mV/NNP/B-NP/O bestimmt/RP/O/O ././O/O

Dazu/RB/B-VP/O wurden/VB/I-VP/O die/DT/B-NP/O Beitr\xc3\xa4ge/NN/I-NP/O der/DT/B-NP/O oben/RB/I-NP/O genannten/JJ/I-NP/O Ladungsrekombinationsreaktionen/NN/I-NP/O zu/IN/B-PP/B-PNP der/DT/B-NP/I-PNP blitzinduzierten/JJ/I-NP/I-PNP Absorptions\xc3\xa4nderung/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Abh\xc3\xa4ngigkeit/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Redoxpotentials/NN/I-NP/I-PNP analysiert/VB/B-VP/O ././O/O

Diese/DT/B-NP/O Ergebnisse/NN/I-NP/O werden/VB/B-VP/O qualitativ/JJ/B-ADJP/O mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP von/IN/B-PP/B-PNP EPR-Messungen/NN/B-NP/I-PNP \xc3\xbcberpr\xc3\xbcft/VBN/B-VP/I-PNP und/CC/O/O im/IN/B-PP/B-PNP Zusammenhang/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP untereinander/NN/I-NP/I-PNP stark/JJ/B-NP/I-PNP abweichenden/JJ/I-NP/I-PNP Daten/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Literatur/NN/I-NP/I-PNP diskutiert/RP/O/O ././O/O

Die/DT/B-NP/O Bestimmung/NN/I-NP/O der/DT/B-NP/O Aktivierungsenergie/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Rekombination/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP P700/NN/B-NP/I-PNP +/NN/I-NP/I-PNP und/CC/O/O (/(/O/O FAFB/NN/B-NP/O )/)/O/O -/-/O/O ergibt/VB/B-VP/O (/(/O/O 220/CD/B-NP/O \xc2\xb1/NN/I-NP/O 10/CD/O/O )/)/O/O meV/NNP/B-NP/O und/CC/I-NP/O eine/DT/I-NP/O maximale/JJ/I-NP/O Rate/NN/I-NP/O von/IN/B-PP/O (/(/O/O 44/CD/B-NP/O \xc2\xb1/NN/I-NP/O 10)\xc2\xb710\xc2\xb3s-1/LS/O/O ././O/O

Anhand/IN/B-PP/B-PNP der/DT/B-NP/I-PNP erhaltenen/NN/I-NP/I-PNP Ergebnisse/NN/I-NP/I-PNP erfolgt/VB/B-VP/O eine/DT/B-NP/O Zuordnung/NN/I-NP/O ,/,/O/O auf/IN/B-PP/O welchem/WP/O/O Wege/NN/B-NP/O der/DT/I-NP/O Zustand/NN/I-NP/O P700+(FAFB/NN/I-NP/O )/)/O/O -/-/O/O rekombiniert/NN/B-NP/O ././O/O

owohl/CC/O/O die/DT/B-NP/O direkte/JJ/I-NP/O Rekombination/NN/I-NP/O ,/,/O/O als/CC/O/O auch/RB/B-ADVP/O die/DT/B-NP/O Rekombination/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP das/DT/B-NP/I-PNP FX/NN/I-NP/I-PNP sind/VB/B-VP/O aufgrund/IN/B-PP/B-PNP des/DT/B-NP/I-PNP gro\xc3\x9fen/JJ/I-NP/I-PNP Abstandes/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Eisen-Schwefel-Zentren/NN/I-NP/I-PNP zum/IN/B-PP/B-PNP P700/NN/B-NP/I-PNP +/NN/I-NP/I-PNP und/CC/I-NP/I-PNP der/DT/I-NP/I-PNP daraus/RB/I-NP/I-PNP resultierenden/NN/I-NP/I-PNP sehr/RB/B-NP/I-PNP langsamen/JJ/I-NP/I-PNP Ratenkonstanten/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Rekombination/JJ/I-NP/I-PNP auszuschlie\xc3\x9fen/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Rekombination/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Zustand/NN/I-NP/I-PNP P700+A0/NN/I-NP/I-PNP -/-/O/O ist/VB/B-VP/O aufgrund/IN/B-PP/O der/DT/O/O zu/IN/B-PP/B-PNP geringen/JJ/B-NP/I-PNP Aktivierungsenergie/NN/I-NP/I-PNP nicht/RB/B-ADJP/O m\xc3\xb6glich/JJ/I-ADJP/O ././O/O

Nimmt/VB/B-VP/O man/DT/B-NP/O den/DT/I-NP/O Zustand/NN/I-NP/O P700+A1/NN/I-NP/O -/-/O/O als/IN/B-PP/B-PNP Zwischenstufe/NN/B-NP/I-PNP an/RP/O/O ,/,/O/O stimmen/VB/B-VP/O die/DT/B-NP/O ermittelte/RB/I-NP/O Energetik/NN/I-NP/O und/CC/O/O Kinetik/NN/B-NP/O der/DT/B-NP/O Rekombination/NN/I-NP/O zwischen/IN/B-PP/B-PNP P700/NN/B-NP/I-PNP +/NN/I-NP/I-PNP und/CC/O/O (/(/O/O FAFB/NN/B-NP/O )/)/O/O -/-/O/O gut/JJ/B-ADJP/O mit/IN/B-PP/O den/DT/O/O aus/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Literatur/NN/I-NP/I-PNP bekannten/JJ/B-NP/I-PNP Daten/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Zustand/NN/I-NP/I-PNP P700+A1/NN/I-NP/I-PNP -/-/O/O \xc3\xbcberein/RP/O/O ././O/O

Abschlie\xc3\x9fend/VBN/B-VP/O werden/VB/I-VP/O Untersuchungen/NN/B-NP/O zur/IN/B-PP/B-PNP Aktivit\xc3\xa4t/NN/B-NP/I-PNP von/IN/B-PP/O kristallisierten/VB/B-VP/O Photosystemen/JJ/B-NP/O beschrieben/NN/I-NP/O ././O/O

Diese/DT/O/O haben/RB/B-VP/O gezeigt/VBN/I-VP/O ,/,/O/O da\xc3\x9f/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP von/IN/B-PP/B-PNP kristallisiertem/NNP/B-NP/I-PNP PS/NNP/I-NP/I-PNP I/CD/I-NP/I-PNP und/CC/I-NP/I-PNP PS/NN/I-NP/I-PNP II/CD/O/O mindestens/RB/B-ADJP/O so/RB/I-ADJP/O hoch/JJ/I-ADJP/O ist/VB/B-VP/O wie/IN/B-PP/B-PNP bei/IN/I-PP/I-PNP gel\xc3\xb6sten/JJ/B-NP/I-PNP Komplexen/NN/I-NP/I-PNP ././O/O

Zus\xc3\xa4tzlich/VBN/B-VP/O wurde/VB/I-VP/O im/IN/B-PP/B-PNP PS/NNP/B-NP/I-PNP II/CD/I-NP/I-PNP die/DT/I-NP/I-PNP Sauerstoffentwicklung/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Abh\xc3\xa4ngigkeit/NN/B-NP/I-PNP von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Blitzzahl/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP bis/IN/I-PP/I-PNP zu/TO/O/O 10000/CD/B-NP/O Blitze/NNS/I-NP/O bestimmt/RP/O/O ././O/O

Daraus/RB/B-VP/O hat/VB/I-VP/O sich/PRP/B-NP/O ergeben/VBN/B-VP/O ,/,/O/O da\xc3\x9f/IN/B-PP/B-PNP kristallines/NN/B-NP/I-PNP PS/NNP/I-NP/I-PNP II/CD/O/O stabiler/JJ/B-ADJP/O ist/VB/B-VP/O als/IN/B-PP/B-PNP PS/NNP/B-NP/I-PNP II-Komplexe/NNP/I-NP/I-PNP in/IN/B-PP/B-PNP L\xc3\xb6sung.Das/NN/B-NP/I-PNP Hormon/NN/I-NP/I-PNP Angiotensin/NN/I-NP/I-PNP II/CD/O/O (/(/O/O Ang/NN/B-NP/O II/CD/O/O )/)/O/O ist/VB/B-VP/O das/DT/B-NP/O Haupteffektorpeptid/NN/I-NP/O des/DT/B-NP/O Renin-Angiotensin-Systems/NN/I-NP/O (/(/O/O RAS/NNP/B-NP/O )/)/O/O ././O/O

Es/PRP/B-NP/O ist/VB/B-VP/O neben/IN/B-PP/B-PNP physiologischen/JJ/B-NP/I-PNP Prozessen/NN/I-NP/I-PNP auch/RB/B-ADVP/O in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Pathogenese/NN/I-NP/I-PNP kardiovaskul\xc3\xa4rer/NN/I-NP/I-PNP Erkrankungen/NNS/I-NP/I-PNP involviert/NN/I-NP/I-PNP ././O/O

Ang/NN/B-NP/O II/CD/O/O vermittelt/VB/B-VP/O seine/PRP$/B-NP/O Wirkung/NN/I-NP/O haupts\xc3\xa4chlich/RB/B-ADVP/O \xc3\xbcber/IN/B-PP/B-PNP zwei/CD/B-NP/I-PNP membranst\xc3\xa4ndige/NN/I-NP/I-PNP Rezeptoren/NN/I-NP/I-PNP ,/,/O/O den/DT/B-NP/O Angiotensin-AT1-Rezeptor/NN/I-NP/O (/(/O/O AT1R/NN/B-NP/O )/)/O/O und/CC/O/O den/DT/B-NP/O Angiotensin-AT2-Rezeptor/NN/I-NP/O (/(/O/O AT2R/NN/B-NP/O )/)/O/O ,/,/O/O wobei/WRB/O/O die/DT/B-NP/O Stimulation/NN/I-NP/O beider/JJ/B-NP/O Rezeptoren/NN/I-NP/O gegens\xc3\xa4tzliche/JJ/B-NP/O zellul\xc3\xa4re/JJ/I-NP/O Effekte/NNS/I-NP/O vermittelt/VB/B-VP/O ././O/O

Die/DT/B-NP/O Rolle/NN/I-NP/O des/DT/B-NP/O AT2R/NN/I-NP/O innerhalb/IN/B-PP/B-PNP kardiovaskul\xc3\xa4rer/NN/B-NP/I-PNP Erkrankungen/NNS/I-NP/I-PNP wird/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Literatur/NN/I-NP/I-PNP kontrovers/JJ/B-ADJP/O diskutiert/RP/O/O ././O/O

Unsere/PRP$/B-NP/O Arbeitsgruppe/NN/I-NP/O identifizierte/NN/I-NP/O k\xc3\xbcrzlich/VB/B-VP/O ein/DT/B-NP/O neues/JJ/I-NP/O AT2R-Interaktionsprotein/NN/I-NP/O ,/,/O/O das/DT/B-NP/O AT2R-binding-Protein/NNP/I-NP/O (/(/O/O ATBP&slash;ATIP/NNP/B-NP/O )/)/O/O ,/,/O/O das/WDT/O/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP C-Terminus/NN/I-NP/I-PNP des/DT/B-NP/I-PNP AT2R/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Zytoplasma/JJ/B-NP/I-PNP wechselwirkt/NN/I-NP/I-PNP ././O/O

In/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurden/VB/B-VP/O neue/JJ/B-NP/O transkriptionelle/NN/I-NP/O Regulationsmechanismen/NN/I-NP/O des/DT/B-NP/O AT2R/NN/I-NP/O -/-/O/O und/CC/O/O des/DT/B-NP/O ATIP1-&slash;ATBP50-Gens/NN/I-NP/O identifiziert/NN/I-NP/O und/CC/O/O charakterisiert/NN/B-NP/O ././O/O

"Mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP der/DT/I-NP/I-PNP RLM-5'-RACE/NN/I-NP/I-PNP konnte/VB/B-VP/O f\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP humane/NN/I-NP/I-PNP AT2R-Gen/NN/I-NP/I-PNP ein/DT/B-NP/I-PNP transkriptioneller/NN/I-NP/I-PNP Startpunkt/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP werden/VB/B-VP/O ,/,/O/O der/WDT/B-NP/O sich/PRP/I-NP/O 29/CD/B-NP/O bp/NN/I-NP/O downstream/JJ/B-ADJP/O der/DT/B-NP/O TATA-box/NN/I-NP/O und/CC/O/O 1533/CD/B-NP/O bp/NN/I-NP/O upstream/JJ/B-ADJP/O vom/IN/B-PP/B-PNP Translationsstartpunkt/NN/B-NP/I-PNP befindet/VB/B-VP/O ././O/O"

F\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP TATA-box-lose/NN/I-NP/I-PNP ATIP1-Gen/NN/I-NP/I-PNP wurden/VB/B-VP/O zwei/CD/B-NP/O transkriptionelle/NN/I-NP/O Startpunkte/NN/I-NP/O ermittelt/VBN/B-VP/O ,/,/O/O die/DT/B-NP/O 293/CD/I-NP/O bp/NN/I-NP/O und/CC/O/O 304/CD/B-NP/O bp/NN/I-NP/O upstream/JJ/B-ADJP/O vom/IN/B-PP/B-PNP Translationsstartpunkt/NN/B-NP/I-PNP lokalisiert/NN/I-NP/I-PNP sind/VB/B-VP/O ././O/O

Promotoranalysen/NN/B-NP/O weisen/VB/B-VP/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP zentrale/JJ/I-NP/I-PNP Funktion/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Exon-1-&slash;Intron-1-Region/NN/I-NP/I-PNP des/DT/B-NP/I-PNP AT2R-Gens/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Transkription/NN/I-NP/I-PNP hin/IN/B-PP/O ././O/O

Unter/IN/B-PP/O anderem/DT/O/O mittels/IN/B-PP/B-PNP inverser/NN/B-NP/I-PNP Klonierungsexperimente/NN/I-NP/I-PNP konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP Sequenzen/NN/B-NP/I-PNP innerhalb/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Region/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Rekrutierung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Transkriptionsapparates/NN/I-NP/I-PNP vermitteln/VB/B-VP/O und/CC/O/O dabei/RB/B-ADVP/O einen/DT/B-NP/O weiteren/JJ/I-NP/O Transkriptionsstartpunkt/NN/I-NP/O generieren/VB/B-VP/O ././O/O

Der/DT/B-NP/O intronische/JJ/I-NP/O AT2R-Polymorphismus/NN/I-NP/O -/-/O/O G1332A/NNP/B-NP/O wird/VB/B-VP/O mit/IN/B-PP/B-PNP protektiven/JJ/B-NP/I-PNP Effekten/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP myokardialen/JJ/I-NP/I-PNP Hypertrophie/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Frauen/JJ/B-NP/I-PNP assoziiert/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Untersuchung/NN/I-NP/O dieses/DT/B-NP/O Polymorphismus/NN/I-NP/O hat/RB/B-VP/O gezeigt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP Promotoren/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP G-Allel/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP Promotoren/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP A-Allel/NN/I-NP/I-PNP generell/RB/B-ADVP/O eine/DT/B-NP/O st\xc3\xa4rkere/JJ/I-NP/O Promotoraktivit\xc3\xa4t/NN/I-NP/O aufweisen/VB/B-VP/O ././O/O

\xc3\x96strogene/RB/B-VP/O scheinen/VB/I-VP/O das/DT/B-NP/O Verh\xc3\xa4ltnis/NN/I-NP/O von/IN/B-PP/B-PNP AT1R&slash;AT2R/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP Gunsten/NN/B-NP/I-PNP des/DT/I-NP/I-PNP AT2R/NN/I-NP/I-PNP zu/TO/B-VP/O verschieben/VB/I-VP/O ././O/O

Der/DT/B-NP/O potenzielle/NN/I-NP/O Einfluss/NN/I-NP/O des/DT/B-NP/O Hormons/JJ/I-NP/O 17\xc3\xaf?\xc2\xa2-\xc3\x83\xe2\x80\x93stradiol/NN/I-NP/O (/(/O/O E2/NN/B-NP/O )/)/O/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Transkription/NN/I-NP/I-PNP des/DT/B-NP/I-PNP AT2R/NN/I-NP/I-PNP -/-/O/O und/CC/O/O des/DT/B-NP/O ATIP1-Gens/NN/I-NP/O wurde/VB/B-VP/O mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Promotoranalysen/NN/B-NP/I-PNP untersucht/RP/O/O ././O/O

Die/DT/B-NP/O durchgef\xc3\xbchrten/JJ/I-NP/O Experimente/NN/I-NP/O zeigten/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O E2/NN/B-NP/O keine/JJ/B-NP/O regulativen/NN/I-NP/O Effekte/NNS/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Transkription/NN/I-NP/I-PNP beider/JJ/B-NP/I-PNP Zielgene/NN/I-NP/I-PNP aus\xc3\xbcbt/VB/B-VP/O ././O/O

Das/DT/B-NP/O Protein/NN/I-NP/O Poly(ADP-Ribose)-Polymerase-1/LS/O/O (/(/O/O PARP-1/NN/B-NP/O )/)/O/O ist/NN/B-NP/O in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Ang/NN/I-NP/I-PNP II-vermittelten/NN/I-NP/I-PNP Effekte/NNS/I-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Pathogenese/NN/I-NP/I-PNP kardiovaskul\xc3\xa4rer/NN/I-NP/I-PNP Erkrankungen/NNS/I-NP/I-PNP involviert/NN/I-NP/I-PNP ././O/O

Promotorreportergenuntersuchungen/NN/B-NP/O der/DT/I-NP/O beiden/DT/I-NP/O Zielgene/NN/I-NP/O haben/RB/B-VP/O gezeigt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Promotoraktivit\xc3\xa4t/NN/I-NP/I-PNP des/DT/B-NP/I-PNP AT2R-Gens/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP \xc3\x9cberexpression/NN/I-NP/I-PNP von/IN/B-PP/B-PNP PARP-1/NN/B-NP/I-PNP reprimiert/NN/I-NP/I-PNP und/CC/O/O die/WDT/B-NP/O des/DT/I-NP/O ATIP1-Gens/NN/I-NP/O induziert/NN/I-NP/O wird/VB/B-VP/O ././O/O

Die/DT/B-NP/O Inhibierung/NN/I-NP/O der/DT/B-NP/O enzymatischen/JJ/I-NP/O PARP-Aktivit\xc3\xa4t/NN/I-NP/O oder/RB/B-ADVP/O der/DT/B-NP/O zellul\xc3\xa4re/JJ/I-NP/O knockout/NN/I-NP/O des/DT/B-NP/O PARP-1-Gens/NN/I-NP/O resultierten/VB/B-VP/O in/IN/B-PP/B-PNP Bezug/NN/B-NP/I-PNP auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Promotoraktivierung/NN/I-NP/I-PNP in/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Aktivierung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP AT2R/NN/I-NP/I-PNP -/-/O/O und/CC/O/O einer/DT/B-NP/O Hemmung/NN/I-NP/O des/DT/B-NP/O ATIP1-&slash;ATBP50-Gens/NN/I-NP/O ././O/O

Diese/DT/B-NP/O Ergebnisse/NN/I-NP/O wurden/VB/B-VP/O zus\xc3\xa4tzlich/JJ/B-ADJP/O durch/IN/B-PP/B-PNP Untersuchungen/NN/B-NP/I-PNP auf/IN/B-PP/B-PNP der/DT/B-NP/I-PNP entsprechenden/JJ/I-NP/I-PNP mRNA/NNP/I-NP/I-PNP -/-/O/O und/CC/O/O Chromatinebene/NN/B-NP/O best\xc3\xa4tigt/RP/O/O ././O/O

Es/PRP/B-NP/O konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP PARP-1/NN/B-NP/I-PNP die/DT/I-NP/I-PNP Transkription/NN/I-NP/I-PNP des/DT/B-NP/I-PNP ATIP1-&slash;ATBP50-Gens/NN/I-NP/I-PNP aktiviert/NN/I-NP/I-PNP und/CC/O/O als/IN/B-PP/B-PNP Repressor/NN/B-NP/I-PNP der/DT/I-NP/I-PNP AT2R-Transkription/NN/I-NP/I-PNP wirkt/VB/B-VP/O ././O/O

omit/RB/B-VP/O konnte/VB/I-VP/O innerhalb/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP das/DT/B-NP/I-PNP Protein/NN/I-NP/I-PNP PARP-1/NN/I-NP/I-PNP als/IN/B-PP/B-PNP neuer/JJ/B-NP/I-PNP transkriptioneller/NN/I-NP/I-PNP Modulator/NN/I-NP/I-PNP des/DT/B-NP/I-PNP AT2R/NN/I-NP/I-PNP -/-/O/O und/CC/O/O ATIP1-&slash;ATBP50-Gens/NN/B-NP/O identifiziert/NN/I-NP/O werden.Eine/NN/I-NP/O Vielzahl/NN/I-NP/O der/DT/B-NP/O heute/JJ/I-NP/O verwendeten/JJ/I-NP/O Immunsuppressiva/NN/I-NP/O ist/VB/B-VP/O nebenwirkungsreich/NNP/B-NP/O und/CC/O/O wirkt/VB/B-VP/O h\xc3\xa4ufig/JJ/B-NP/O unspezifisch/PRP$/I-NP/O ././O/O

Daher/RB/B-VP/O ist/VB/I-VP/O das/DT/B-NP/O Ziel/NN/I-NP/O neuer/JJ/B-NP/O Studien/NN/I-NP/O ,/,/O/O unter/IN/B-PP/B-PNP Ber\xc3\xbccksichtigung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP molekularen/JJ/I-NP/I-PNP Mechanismen/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Transplantatabsto\xc3\x9fung/NN/I-NP/I-PNP ,/,/O/O optimierte/JJ/B-NP/O Strategien/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP gezielte/JJ/I-NP/I-PNP Immunsuppression/NN/I-NP/I-PNP zu/TO/B-VP/O entwickeln/VB/I-VP/O ././O/O

In/IN/B-PP/B-PNP diesem/DT/B-NP/I-PNP Zusammenhang/NN/I-NP/I-PNP mehren/VB/B-VP/O sich/PRP/B-NP/O die/DT/I-NP/O Hinweise/NN/I-NP/O ,/,/O/O dass/IN/B-PP/B-PNP NK-Zellen/NN/B-NP/I-PNP durch/IN/B-PP/B-PNP Beeinflussung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP adaptiven/NN/I-NP/I-PNP Immunantwort/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP wichtige/JJ/I-NP/I-PNP Rolle/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Absto\xc3\x9fung/NN/I-NP/I-PNP \xc3\xbcbernehmen/VB/B-VP/O ././O/O

Bisherige/JJ/B-NP/O Analysen/NN/I-NP/O zur/IN/B-PP/B-PNP Funktion/NN/B-NP/I-PNP von/IN/B-PP/B-PNP NK-Zellen/NN/B-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP akuten/JJ/I-NP/I-PNP Absto\xc3\x9fung/NN/I-NP/I-PNP fokussierten/NN/I-NP/I-PNP jedoch/VB/B-VP/O auf/IN/B-PP/B-PNP Rezeptoren/NN/B-NP/I-PNP wie/IN/B-PP/B-PNP NK1.1/NN/B-NP/I-PNP und/CC/I-NP/I-PNP NKG2D/NN/I-NP/I-PNP ,/,/O/O welche/WDT/O/O u.a./VB/B-VP/O auch/RB/B-ADVP/O auf/IN/B-PP/B-PNP T/NN/B-NP/I-PNP -/-/O/O und/CC/O/O NKT-Zellen/NN/B-NP/O exprimiert/NN/I-NP/O werden/VB/B-VP/O ././O/O

Im/IN/B-PP/B-PNP Mittelpunkt/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Dissertationsarbeit/NN/I-NP/I-PNP stand/VB/B-VP/O daher/RB/B-ADVP/O die/DT/B-NP/O Identifikation/NN/I-NP/O der/DT/B-NP/O Rolle/NN/I-NP/O des/DT/B-NP/O aktivierenden/NN/I-NP/O Zytotoxizit\xc3\xa4tsrezeptor/JJ/B-NP/O NCR1/NN/I-NP/O (/(/O/O NKp46/NN/B-NP/O )/)/O/O ,/,/O/O welcher/WP/O/O spezifisch/JJ/B-ADJP/O auf/IN/B-PP/B-PNP NK-Zellen/NN/B-NP/I-PNP exprimiert/NN/I-NP/I-PNP wird/VB/B-VP/O ././O/O

Als/IN/B-PP/B-PNP Grundlage/NN/B-NP/I-PNP zur/IN/B-PP/B-PNP Untersuchung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Funktion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP NCR1/NN/B-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Transplantatabsto\xc3\x9fung/NN/I-NP/I-PNP diente/VB/B-VP/O das/DT/B-NP/O Modell/NN/I-NP/O der/DT/B-NP/O heterotopen/JJ/I-NP/O Herztransplantation/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Wildtyp/NN/I-NP/I-PNP bzw./RB/B-ADVP/O NCR1GFP&slash;GFP/NNP/B-NP/O Maus/NNP/I-NP/O ,/,/O/O welche/WDT/O/O anstelle/IN/B-PP/B-PNP von/IN/I-PP/I-PNP NCR1/NN/B-NP/I-PNP das/DT/I-NP/I-PNP GFP-Reportergen/JJ/I-NP/I-PNP exprimiert/NN/I-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP ersten/JJ/B-NP/I-PNP Teil/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O Infiltration/NN/I-NP/O von/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Lymphozytenpopulationen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Spenderorgan/NN/I-NP/I-PNP unter/IN/B-PP/B-PNP kinetischen/JJ/B-NP/I-PNP Gesichtspunkten/NN/I-NP/I-PNP untersucht/RP/O/O ././O/O

Es/PRP/B-NP/O konnte/VB/B-VP/O nachgewiesen/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP NK/NNP/B-NP/I-PNP -/-/O/O und/CC/O/O DC-Populationen/NN/B-NP/O bereits/RB/B-ADVP/O vor/IN/B-PP/B-PNP den/DT/B-NP/I-PNP T-Zellen/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Allotransplantat/JJ/B-NP/I-PNP akkumulieren/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O dazu/RB/I-NP/O reziprok/NN/I-NP/O verlaufenen/NN/I-NP/O Profile/NNS/I-NP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Milzen/NN/I-NP/I-PNP und/CC/O/O Lymphknoten/NN/B-NP/O lassen/VB/B-VP/O vermuten/VB/I-VP/O ,/,/O/O dass/RB/B-ADVP/O eine/DT/B-NP/O Migration/NN/I-NP/O der/DT/B-NP/O Zellen/NNS/I-NP/O aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP lymphatischen/JJ/I-NP/I-PNP Organen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Transplantat/NN/I-NP/I-PNP stattfindet/VB/B-VP/O ././O/O

Im/IN/B-PP/B-PNP zweiten/JJ/B-NP/I-PNP Teil/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Studie/NN/I-NP/I-PNP wurden/VB/B-VP/O zum/IN/B-PP/B-PNP Wildtyp/NN/B-NP/I-PNP vergleichende/JJ/I-NP/I-PNP Analysen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP NCR1GFP&slash;GFP/NNP/B-NP/I-PNP M\xc3\xa4usen/NNP/I-NP/I-PNP durchgef\xc3\xbchrt/RP/O/O ././O/O

Interessanterweise/RB/B-VP/O stie\xc3\x9fen/VB/I-VP/O NCR1-defiziente/NN/B-NP/O M\xc3\xa4use/NN/I-NP/O die/DT/I-NP/O Spenderherzen/NN/I-NP/O im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP zum/IN/B-PP/B-PNP Wildtyp/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP zwei/CD/B-NP/I-PNP Tagen/NN/I-NP/I-PNP Verz\xc3\xb6gerung/NN/I-NP/I-PNP ab/RP/O/O ././O/O

Obwohl/IN/B-PP/B-PNP naive/JJ/B-NP/I-PNP NK-Zellen/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP NCR1-defizienten/NN/B-NP/I-PNP M\xc3\xa4usen/NN/I-NP/I-PNP eine/DT/I-NP/I-PNP signifikant/JJ/I-NP/I-PNP geringere/NN/I-NP/I-PNP zytotoxische/JJ/B-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP besa\xc3\x9fen/NN/I-NP/I-PNP ,/,/O/O stieg/VB/B-VP/O die/DT/B-NP/O Zytotoxizit\xc3\xa4t/NN/I-NP/O nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Transplantation/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP zum/IN/I-PP/I-PNP Wildtyp/NN/B-NP/I-PNP vergleichbare/JJ/I-NP/I-PNP Werte/NN/I-NP/I-PNP an/RP/O/O ././O/O

Dank/IN/B-PP/B-PNP des/DT/B-NP/I-PNP GFP-Signals/NN/I-NP/I-PNP konnte/VB/B-VP/O bewiesen/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP im/IN/I-PP/I-PNP Transplantat/NN/B-NP/I-PNP detektierte/NN/I-NP/I-PNP NK-Zellen/NN/I-NP/I-PNP tats\xc3\xa4chlich/JJ/B-ADJP/O vom/IN/B-PP/B-PNP Empf\xc3\xa4nger/NN/B-NP/I-PNP stammen/VB/B-VP/O ././O/O

Ebenso/VBN/B-VP/O wurde/RB/I-VP/O gezeigt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP NK-Zellen/NN/B-NP/I-PNP nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Transplantation/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Milz/NN/I-NP/I-PNP auch/RB/B-ADVP/O in/IN/B-PP/B-PNP T-Zellzonen/NN/B-NP/I-PNP bzw./RB/B-ADVP/O in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Marginalzone/NN/I-NP/I-PNP migrieren/VB/B-VP/O ././O/O

Weiterhin/RB/B-VP/O f\xc3\xbchrte/VB/I-VP/O eine/DT/B-NP/O NCR1-Defizienz/NN/I-NP/O nach/IN/B-PP/B-PNP Transplantation/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP reduzierten/NN/I-NP/I-PNP NK-Zellinfiltration/NN/I-NP/I-PNP ,/,/O/O verminderten/JJ/B-NP/O Produktion/NN/I-NP/O von/IN/B-PP/B-PNP Zytokinen/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Effektormolek\xc3\xbclen/NN/I-NP/I-PNP (/(/O/O IFN-y/NNP/B-NP/O ,/,/O/O Granzyme/NN/B-NP/O B/NNP/I-NP/O ,/,/O/O Perforin/NN/B-NP/O )/)/O/O sowie/CC/O/O einer/DT/B-NP/O Verringerung/NN/I-NP/O von/IN/B-PP/B-PNP CD4/NN/B-NP/I-PNP +/JJ/I-NP/I-PNP T-Zellen/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP gleichzeitiger/JJ/B-NP/I-PNP Induktion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP CD8/NN/B-NP/I-PNP +/NN/I-NP/I-PNP T-Zellen/NN/I-NP/I-PNP und/CC/I-NP/I-PNP Tregs/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O sprechen/VB/B-VP/O f\xc3\xbcr/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP Beleg/NN/I-NP/I-PNP ,/,/O/O dass/IN/B-PP/B-PNP der/DT/B-NP/I-PNP NK-Zell-spezifische/JJ/I-NP/I-PNP Rezeptor/NN/I-NP/I-PNP NCR1/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Absto\xc3\x9fungsprozess/NN/B-NP/I-PNP immunregulatorisch/JJ/B-ADJP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP adaptive/NN/I-NP/I-PNP Immunantwort/NN/I-NP/I-PNP und/CC/O/O Toleranzinduktion/NN/B-NP/O wirkt/VB/B-VP/O ././O/O

Diese/DT/B-NP/O Ergebnisse/NN/I-NP/O sind/VB/B-VP/O insbesondere/RB/B-ADVP/O von/IN/B-PP/B-PNP klinischer/JJ/B-NP/I-PNP Relevanz/NN/I-NP/I-PNP ,/,/O/O da/IN/B-PP/B-PNP NK-Zellen/NN/B-NP/I-PNP in/IN/B-PP/B-PNP zeit/NN/B-NP/I-PNP -/-/O/O und/CC/O/O zielgerichteten/NN/B-NP/O immunmodulierenden/NN/I-NP/O Therapiestrategien/NN/I-NP/O zur/IN/B-PP/B-PNP Verl\xc3\xa4ngerung/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Transplantat\xc3\xbcberlebens/NN/I-NP/I-PNP nur/RB/B-ADJP/O unzureichend/JJ/I-ADJP/O als/IN/B-PP/B-PNP Gegenstand/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Untersuchungen/NN/B-NP/I-PNP dienten.Flora/NN/I-NP/I-PNP ,/,/O/O Vegetation/NN/B-NP/O und/CC/I-NP/O fossile/NN/I-NP/O Pollenf\xc3\xbchrung/NN/I-NP/O kleinfl\xc3\xa4chiger/NNP/I-NP/O Waldmoore/NNP/I-NP/O (/(/O/O 0,6\xe2\x80\x931,3/NN/B-NP/O ha/NN/I-NP/O )/)/O/O im/IN/B-PP/B-PNP Buntsandstein-Spessart/NNP/B-NP/I-PNP und/CC/I-NP/I-PNP Buntsandstein-Odenwald/NNP/I-NP/I-PNP (/(/O/O SW-Deutschland/NNP/B-NP/O )/)/O/O wurden/RB/B-ADVP/O untersucht/RP/O/O ././O/O

Die/DT/B-NP/O gegenw\xc3\xa4rtige/JJ/I-NP/O Artenzusammensetzung/NN/I-NP/O und/CC/O/O Vegetation/NN/B-NP/O der/DT/B-NP/O Moore/NN/I-NP/O \xc3\xbcberwiegend/JJ/B-ADJP/O aus/IN/B-PP/B-PNP naturnahen/NN/B-NP/I-PNP und/CC/I-NP/I-PNP geh\xc3\xb6lzfreien/JJ/I-NP/I-PNP Pflanzengesellschaften/NN/I-NP/I-PNP (/(/O/O v.a./JJ/B-NP/O Caricetum/NN/I-NP/O fuscae/NN/I-NP/O ,/,/O/O Caricetum/NN/B-NP/O rostratae/NNP/I-NP/O )/)/O/O weisen/VB/B-VP/O auf/IN/B-PP/B-PNP oligo-&slash;mesotroph-saure/NN/B-NP/I-PNP Standortbedingungen/NN/I-NP/I-PNP hin/IN/B-PP/O ././O/O

Einige/JJ/B-NP/O krautige/JJ/I-NP/O Arten/NN/I-NP/O (/(/O/O z.B./IN/B-PP/B-PNP Carex/NN/B-NP/I-PNP canescens/NN/I-NP/I-PNP ,/,/O/O Trientalis/NN/B-NP/O europaea/NNP/I-NP/O )/)/O/O und/CC/O/O Moose/NN/B-NP/O (/(/O/O z.B./IN/B-PP/B-PNP Sphagnum/NN/B-NP/I-PNP compactum/NN/I-NP/I-PNP ,/,/O/O S./VB/B-VP/O subnitens/NN/B-NP/O )/)/O/O sind/VB/B-VP/O in/IN/B-PP/B-PNP ihrem/PRP$/B-NP/I-PNP Bestand/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Region/NN/I-NP/I-PNP und&slash;oder/NN/I-NP/I-PNP Bayern/NNP/I-NP/I-PNP gef\xc3\xa4hrdet/VB/B-VP/O ././O/O

Nach/IN/B-PP/O pollenanalytischen/JJ/B-ADJP/O und/CC/O/O 14C-Datierungen/NN/B-NP/O entstanden/NN/I-NP/O die/DT/B-NP/O Moore/NN/I-NP/O vor/IN/B-PP/B-PNP 600\xe2\x80\x93700/NN/B-NP/I-PNP (/(/O/O Moor/NN/B-NP/O am/IN/B-PP/B-PNP Birkwasser/NN/B-NP/I-PNP ,/,/O/O s\xc3\xbcdlicher/NN/B-NP/O Hochspessart/NNP/I-NP/O )/)/O/O bzw./CC/O/O 300/CD/B-NP/O Jahren/NN/I-NP/O (/(/O/O Moor/NN/B-NP/O am/IN/B-PP/B-PNP \xc3\x96dborn/NN/B-NP/I-PNP ,/,/O/O n\xc3\xb6rdlicher/NN/B-NP/O Hochspessart/NNP/I-NP/O )/)/O/O ././O/O

Die/DT/B-NP/O Pollendiagramme/NN/I-NP/O erfassen/VB/B-VP/O die/DT/B-NP/O waldgeschichtlichen/JJ/I-NP/O Abschnitte/NN/I-NP/O Xa/NN/I-NP/O und/CC/O/O b/NN/B-NP/O nach/IN/B-PP/B-PNP FIRBAS/NNP/B-NP/I-PNP (/(/O/O 1949/CD/O/O )/)/O/O und/CC/O/O erg\xc3\xa4nzen/VB/B-VP/O die/DT/B-NP/O historischen/JJ/I-NP/O Quellen/NN/I-NP/O zur/IN/B-PP/B-PNP Wald/NN/B-NP/I-PNP -/-/O/O und/CC/O/O Forstgeschichte/NN/B-NP/O des/DT/B-NP/O Spessarts/NN/I-NP/O ././O/O

ie/PRP/B-NP/O belegen/VB/B-VP/O die/DT/B-NP/O Vorherrschaft/NN/I-NP/O von/IN/B-PP/O Quercus/FW/O/O und/CC/O/O Fagus/NN/B-NP/O mit/IN/B-PP/O einem/DT/O/O nat\xc3\xbcrlichen/IN/B-PP/B-PNP Eichenvorkommen/NN/B-NP/I-PNP (/(/O/O im/IN/B-PP/B-PNP Spessart/NNP/B-NP/I-PNP Quercus/FW/O/O petraea/FW/O/O )/)/O/O in/IN/B-PP/B-PNP unmittelbarer/JJ/B-NP/I-PNP Moorn\xc3\xa4he/NN/I-NP/I-PNP bis/IN/B-PP/B-PNP in/IN/I-PP/I-PNP das/DT/O/O 17.&slash;18/CD/O/O ././O/O

Jahrhundert/NN/B-NP/O und/CC/I-NP/O die/DT/I-NP/O anschlie\xc3\x9fenden/JJ/I-NP/O Nadelholzaufforstungen/NN/I-NP/O ././O/O

Trotz/IN/B-PP/B-PNP ihrer/PRP$/B-NP/I-PNP geringen/JJ/I-NP/I-PNP Gr\xc3\xb6\xc3\x9fe/NN/I-NP/I-PNP tragen/VB/B-VP/O die/DT/B-NP/O untersuchten/NN/I-NP/O Moore/NN/I-NP/O zur/IN/B-PP/B-PNP Arten/NN/B-NP/I-PNP -/-/O/O und/CC/O/O Biotopvielfalt/NN/B-NP/O der/DT/B-NP/O umgebenden/NN/I-NP/O W\xc3\xa4lder/NN/I-NP/O und/CC/O/O Forsten/NN/B-NP/O bei/RP/O/O ././O/O

Als/IN/B-PP/B-PNP Wasser/NN/B-NP/I-PNP -/-/O/O ,/,/O/O N\xc3\xa4hrstoff/NN/B-NP/O -/-/O/O und/CC/O/O Schadstoffspeicher/NN/B-NP/O \xc3\xbcbernehmen/VB/B-VP/O sie/PRP/B-NP/O wichtige/JJ/I-NP/O \xc3\xb6kologische/JJ/I-NP/O Funktionen/NN/I-NP/O im/IN/B-PP/B-PNP Naturhaushalt/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Waldes/NN/I-NP/I-PNP und/CC/O/O sind/VB/B-VP/O als/IN/B-PP/B-PNP Archive/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Landschaftsgeschichte/NN/I-NP/I-PNP unersetzbar/JJ/B-ADJP/O ././O/O

Um/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Sch\xc3\xa4digung/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP Eingriffe/NN/B-NP/I-PNP in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Wasserhaushalt/NN/I-NP/I-PNP zu/TO/B-VP/O verhindern/VB/I-VP/O (/(/O/O z.B./RB/B-ADVP/O durch/IN/B-PP/B-PNP Aufforstungen/NN/B-NP/I-PNP ,/,/O/O Rodungen/NN/B-NP/O )/)/O/O ,/,/O/O m\xc3\xbcssen/VB/B-VP/O sie/PRP/B-NP/O einem/DT/I-NP/O besonderen/JJ/I-NP/O Schutz/NN/I-NP/O unterstellt/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Vor/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Hintergrund/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Erhaltung/NN/B-NP/I-PNP ,/,/O/O Entwicklung/NN/B-NP/O ,/,/O/O Renaturierung/NN/B-NP/O und/CC/I-NP/O Naturschutz/NN/I-NP/O unterschiedlicher/JJ/B-NP/O Moortypen/NN/I-NP/O in/IN/B-PP/B-PNP Mitteleuropa/NN/B-NP/I-PNP sollten/NN/I-NP/I-PNP auch/IN/B-PP/B-PNP kleinfl\xc3\xa4chige/JJ/B-NP/I-PNP Waldmoore/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP ihren/PRP$/B-NP/I-PNP Sonderstrukturen/NN/I-NP/I-PNP st\xc3\xa4rker/JJ/I-NP/I-PNP beachtet/NN/I-NP/I-PNP und/CC/O/O untersucht/VB/B-VP/O werden.Die/NN/B-NP/O ISS/NNP/I-NP/O und/CC/I-NP/O Concordia/NNP/I-NP/O Forschungsstation/NNP/I-NP/O sind/VB/B-VP/O geschlossene/NN/B-NP/O und/CC/I-NP/O isolierte/JJ/I-NP/O Habitate/NN/I-NP/O inmitten/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP extremen/JJ/I-NP/I-PNP und/CC/I-NP/I-PNP lebensfeindlichen/JJ/I-NP/I-PNP Umgebung/NN/I-NP/I-PNP ././O/O

Aufgrund/IN/B-PP/B-PNP der/DT/B-NP/I-PNP extremen/JJ/I-NP/I-PNP Umweltbedingungen/NN/I-NP/I-PNP ver\xc3\xa4ndert/VBN/B-VP/I-PNP sich/PRP/B-NP/I-PNP die/DT/I-NP/I-PNP Mikroflora/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Menschen/NN/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O Station/NN/I-NP/O ,/,/O/O so/RB/B-ADVP/O dass/IN/B-PP/O es/JJ/B-ADJP/O zu/IN/B-PP/B-PNP mikrobiellen/JJ/B-NP/I-PNP Kontaminationen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP diesen/DT/B-NP/I-PNP \xe2\x80\x9eContainer\xe2\x80\x9c/NN/I-NP/I-PNP Systemen/NN/I-NP/I-PNP kommt/VB/B-VP/O ,/,/O/O die/WDT/B-NP/O die/DT/I-NP/O Gesundheit/NN/I-NP/O der/DT/B-NP/O Crew/NN/I-NP/O gef\xc3\xa4hrden/VB/B-VP/O ././O/O

Die/DT/O/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP untersuchten/NN/I-NP/I-PNP 113/CD/B-NP/I-PNP Isolate/NN/I-NP/I-PNP der/DT/B-NP/I-PNP ISS/NNP/I-NP/I-PNP und/CC/O/O Concordia/NNP/B-NP/O ,/,/O/O geh\xc3\xb6ren/VB/B-VP/O den/DT/B-NP/O Gattungen/NNS/I-NP/O Staphylococcus/FW/O/O ,/,/O/O Enterococcus/NN/B-NP/O ,/,/O/O Bacillus/NN/B-NP/O und/CC/I-NP/O Paenibacillus/NN/I-NP/O an/RP/O/O ././O/O

In/IN/B-PP/B-PNP 62%/CD/B-NP/I-PNP der/DT/I-NP/I-PNP St\xc3\xa4mme/NNS/I-NP/I-PNP konnten/JJ/B-NP/I-PNP Resistenzen/NN/I-NP/I-PNP gegen/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP oder/CC/I-NP/I-PNP mehrere/JJ/I-NP/I-PNP Antibiotika/NN/I-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

In/IN/B-PP/B-PNP 43%/CD/B-NP/I-PNP der/DT/I-NP/I-PNP St\xc3\xa4mme/NNS/I-NP/I-PNP wurden/VB/B-VP/O die/DT/B-NP/O entsprechenden/JJ/I-NP/O Resistenzgene/JJ/I-NP/O detektiert/NN/I-NP/O ././O/O

Dabei/RB/B-VP/O konnte/VB/I-VP/O das/DT/B-NP/O Methicillin-Resistenzgen/NN/I-NP/O mecA/NNP/I-NP/O in/IN/B-PP/O einem/DT/O/O Concordia/FW/O/O Staphylococcus/FW/O/O Isolat/FW/O/O neben/IN/B-PP/B-PNP zwei/CD/B-NP/I-PNP weiteren/JJ/I-NP/I-PNP Resistenzgenen/NN/I-NP/I-PNP detektiert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Plasmide/RB/B-VP/O konnten/VB/I-VP/O in/IN/B-PP/B-PNP 74%/CD/B-NP/I-PNP der/DT/I-NP/I-PNP St\xc3\xa4mme/NNS/I-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

In/IN/B-PP/B-PNP acht/CD/B-NP/I-PNP der/DT/I-NP/I-PNP E./JJ/I-NP/I-PNP faecalis/NN/I-NP/I-PNP St\xc3\xa4mme/NNS/I-NP/I-PNP wurden/VB/B-VP/O Plasmide/NN/B-NP/O detektiert/NN/I-NP/O ,/,/O/O die/DT/B-NP/O ca/NN/I-NP/O ././O/O

130/CD/B-NP/O kb/NN/I-NP/O gro\xc3\x9f/JJ/B-ADJP/O sind/VB/B-VP/O ././O/O

Relaxase/NN/B-NP/O -/-/O/O und/CC/O/O Transfergene/NN/B-NP/O aus/IN/B-PP/B-PNP Plasmiden/NN/B-NP/I-PNP Gram-positiver/NN/I-NP/I-PNP Bakterien/NN/I-NP/I-PNP ,/,/O/O wie/IN/B-PP/B-PNP pIP501/NN/B-NP/I-PNP ,/,/O/O pRE25/NN/B-NP/O ,/,/O/O pSK41/NN/B-NP/O und/CC/I-NP/O pGO1/NN/I-NP/O wurden/VB/B-VP/O in/IN/B-PP/B-PNP 58%/CD/B-NP/I-PNP der/DT/I-NP/I-PNP Isolate/JJ/I-NP/I-PNP detektiert/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O meisten/DT/I-NP/O pSK41/NN/I-NP/O homologen/NN/I-NP/O Transfergene/NN/I-NP/O wurden/VB/B-VP/O in/IN/B-PP/B-PNP Isolaten/NN/B-NP/I-PNP der/DT/I-NP/I-PNP ISS/NNP/I-NP/I-PNP ,/,/O/O die/WDT/O/O \xc3\xbcberwiegend/JJ/B-ADJP/O zu/IN/B-PP/O den/DT/O/O Koagulase-negativen/FW/O/O Staphylococcus/FW/O/O Spezies/FW/O/O geh\xc3\xb6ren/VB/B-VP/O ,/,/O/O nachgewiesen/RP/O/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP drei/CD/B-NP/I-PNP dieser/DT/I-NP/I-PNP St\xc3\xa4mme/NNS/I-NP/I-PNP wurden/VB/B-VP/O in/IN/B-PP/B-PNP Gentransferversuchen/JJ/B-NP/I-PNP konjugative/NN/I-NP/I-PNP Elemente/NN/I-NP/I-PNP best\xc3\xa4tigt/RP/O/O ././O/O

Auch/RB/B-ADVP/O aus/IN/B-PP/B-PNP zwei/CD/B-NP/I-PNP Concordia/NN/I-NP/I-PNP St\xc3\xa4mmen/NN/I-NP/I-PNP konnten/VB/B-VP/O Resistenzgene/NN/B-NP/O erfolgreich/JJ/B-ADJP/O \xc3\xbcbertragen/VBN/B-VP/O werden/VB/I-VP/O ,/,/O/O bei/IN/B-PP/O einem/DT/O/O davon/RB/B-ADVP/O durch/IN/B-PP/B-PNP Mobilisierung/NN/B-NP/I-PNP ././O/O

ieben/CD/B-NP/O der/DT/I-NP/O Isolate/NN/I-NP/O konnten/VB/B-VP/O in/IN/B-PP/B-PNP Monospezies/IN/I-PP/I-PNP Biofilmreaktoren/NN/B-NP/I-PNP Biofilme/NN/I-NP/I-PNP ausbilden/VB/B-VP/O und/CC/O/O im/IN/B-PP/B-PNP Multispezies/IN/I-PP/I-PNP Biofilmreaktor/NN/B-NP/I-PNP konnten/VB/B-VP/O f\xc3\xbcnf/CD/B-NP/O St\xc3\xa4mme/NNS/I-NP/O zusammen/RB/B-ADVP/O Biofilm/NNP/B-NP/O ausbilden/VB/B-VP/O ././O/O

Der/DT/B-NP/O Gentransfer/NN/I-NP/O in/IN/B-PP/B-PNP Biofilmen/NN/B-NP/I-PNP konnte/VBN/B-VP/I-PNP mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP eines/DT/I-NP/I-PNP klinischen/JJ/I-NP/I-PNP Isolats/NN/I-NP/I-PNP und/CC/O/O GFP-markierten/NN/B-NP/O mobilisierbaren/NN/I-NP/O Plasmiden/NN/I-NP/O best\xc3\xa4tigt/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Die/DT/B-NP/O Transfer/NN/I-NP/O -/-/O/O und/CC/O/O Resistenzgene/NN/B-NP/O wurden/VB/B-VP/O \xc3\xbcberwiegend/JJ/B-ADJP/O in/IN/B-PP/O den/DT/O/O Staphylococcus/FW/O/O und/CC/O/O E./JJ/B-NP/O facalis/NN/I-NP/O Isolaten/NN/I-NP/O ,/,/O/O die/DT/B-NP/O nosokomiale/JJ/I-NP/O Krankheitserreger/NN/I-NP/O sind/VB/B-VP/O ,/,/O/O detektiert/NN/B-NP/O ././O/O

Bei/IN/B-PP/B-PNP immungeschw\xc3\xa4chten/NN/B-NP/I-PNP Personen/NN/I-NP/I-PNP und/CC/I-NP/I-PNP Krankenhauspatienten/NN/I-NP/I-PNP kann/VB/B-VP/O durch/IN/B-PP/B-PNP diese/DT/B-NP/I-PNP ein/DT/I-NP/I-PNP Infektionsrisiko/NN/I-NP/I-PNP entstehen/VB/B-VP/O ././O/O

Die/DT/B-NP/O vorhandenen/JJ/I-NP/O Transfergene/NN/I-NP/O k\xc3\xb6nnen/VB/B-VP/O zur/IN/B-PP/B-PNP Entstehung/NN/B-NP/I-PNP multiresistenter/NN/I-NP/I-PNP Keime/NNS/I-NP/I-PNP beitragen/VB/B-VP/O ././O/O

Milchs\xc3\xa4urebakterien/NN/B-NP/O (/(/O/O LAB/NN/B-NP/O )/)/O/O finden/NN/B-NP/O ihre/PRP$/I-NP/O Verwendung/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Herstellung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP fermentierten/NN/B-NP/I-PNP Lebensmitteln/NN/I-NP/I-PNP und/CC/O/O als/IN/B-PP/B-PNP Probiotika/NN/B-NP/I-PNP ././O/O

ie/PRP/B-NP/O sind/VB/B-VP/O auch/IN/B-PP/B-PNP Bewohner/NN/B-NP/I-PNP des/DT/I-NP/I-PNP menschlichen/JJ/I-NP/I-PNP und/CC/I-NP/I-PNP tierischen/JJ/I-NP/I-PNP Magen-Darm/NN/I-NP/I-PNP -/-/O/O und/CC/O/O Urogenital-Traktes/NN/B-NP/O ././O/O

In/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurden/VB/B-VP/O 100/CD/B-NP/O Antibiotika/NN/I-NP/O resistente/NN/I-NP/O LAB/JJ/B-NP/O Isolate/NN/I-NP/O aus/IN/B-PP/B-PNP traditionell/JJ/B-NP/I-PNP hergestellten/NN/I-NP/I-PNP Milch/NN/I-NP/I-PNP -/-/O/O und/CC/O/O Fleischprodukten/NN/B-NP/O auf/IN/B-PP/B-PNP Resistenzgene/NN/B-NP/I-PNP ,/,/O/O Transfergene/NN/B-NP/O und/CC/I-NP/O Plasmide/NN/I-NP/O untersucht/RP/O/O ././O/O

Durch/IN/B-PP/B-PNP 16S/NNP/B-NP/I-PNP rDNA/NNP/I-NP/I-PNP Sequenzierung/NNP/I-NP/I-PNP konnten/VB/B-VP/O 33/CD/B-NP/O St\xc3\xa4mme/NNS/I-NP/O phylogenetisch/JJ/B-NP/O eingeordnet/NN/I-NP/O und/CC/O/O als/IN/B-PP/O Pediococcus/FW/O/O (/(/O/O 19/CD/O/O )/)/O/O ,/,/O/O Lactobacillus/NN/B-NP/O (/(/O/O 13/CD/O/O )/)/O/O und/CC/O/O als/IN/B-PP/O Enterococcus/FW/O/O durans/FW/O/O (/(/O/O 1/CD/O/O )/)/O/O identifiziert/NN/B-NP/O werden/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP 84%/CD/B-NP/I-PNP der/DT/I-NP/I-PNP LAB/NN/I-NP/I-PNP St\xc3\xa4mme/NNS/I-NP/I-PNP konnten/VB/B-VP/O Relaxasegene/NN/B-NP/O detektiert/NN/I-NP/O werden/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP 29%/CD/B-NP/I-PNP der/DT/I-NP/I-PNP St\xc3\xa4mme/NNS/I-NP/I-PNP konnten/VB/B-VP/O zwei/CD/O/O oder/CC/O/O mehr/RB/B-ADVP/O (/(/O/O bis/IN/B-PP/B-PNP zu/IN/I-PP/I-PNP acht/CD/O/O )/)/O/O Transfergene/NN/B-NP/O unterschiedlicher/JJ/I-NP/O Plasmide/NN/I-NP/O aus/IN/B-PP/B-PNP Gram-positiven/NN/B-NP/I-PNP Bakterien/NN/I-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Drei/CD/O/O Pediococcus/FW/O/O pentosaceus/FW/O/O Isolate/FW/O/O konnten/VB/B-VP/O das/DT/B-NP/O mobilisierbare/JJ/I-NP/O GFP-markierte/JJ/I-NP/O Plasmid/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP Gattungsgrenzen/NN/B-NP/I-PNP \xc3\xbcbertragen/RP/O/O ././O/O

Damit/RB/B-VP/O konnte/VB/I-VP/O bewiesen/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP diese/WDT/B-NP/I-PNP St\xc3\xa4mme/NNS/I-NP/I-PNP mindestens/RB/B-ADVP/O ein/DT/B-NP/O konjugatives/NN/I-NP/O Element/NN/I-NP/O besitzen/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP 23%/CD/B-NP/I-PNP der/DT/I-NP/I-PNP St\xc3\xa4mme/NNS/I-NP/I-PNP konnten/VB/B-VP/O bis/IN/B-PP/B-PNP zu/IN/I-PP/I-PNP f\xc3\xbcnf/CD/B-NP/I-PNP gro\xc3\x9fe/JJ/I-NP/I-PNP Plasmide/NN/I-NP/I-PNP detektiert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Diese/DT/B-NP/O Ergebnisse/NN/I-NP/O zeigten/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O Milchs\xc3\xa4urebakterien/NN/B-NP/O aus/IN/B-PP/B-PNP fermentierten/NN/B-NP/I-PNP Lebensmitteln/NN/I-NP/I-PNP konjugative/NN/I-NP/I-PNP Elemente/NN/I-NP/I-PNP unterschiedlicher/JJ/I-NP/I-PNP Gram-positiver/NN/I-NP/I-PNP Bakterien/NN/I-NP/I-PNP besitzen/VB/B-VP/O und/CC/O/O Resistenzgene/NN/B-NP/O weitergeben/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ././O/O

Die/DT/B-NP/O verwendeten/JJ/I-NP/O Starterkulturen/NN/I-NP/O sollten/NN/I-NP/O regelm\xc3\xa4\xc3\x9fig/JJ/B-ADJP/O kontrolliert/VBN/B-VP/O werden/VB/I-VP/O ,/,/O/O um/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Entwicklung/NN/I-NP/I-PNP multiresistenter/NN/I-NP/I-PNP Keime/NNS/I-NP/I-PNP in/IN/B-PP/B-PNP Lebensmitteln/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP unterbinden.Seit/NN/B-NP/I-PNP Beginn/NN/I-NP/I-PNP der/DT/I-NP/I-PNP kontinuierlichen/JJ/I-NP/I-PNP Messungen/NNS/I-NP/I-PNP der/DT/B-NP/I-PNP CO2-Konzentration/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Mauna-Loa/NN/I-NP/I-PNP 1958/CD/O/O ist/VB/B-VP/O die/DT/B-NP/O Konzentration/NN/I-NP/O bis/IN/B-PP/O 1997/CD/O/O von/IN/B-PP/B-PNP 315,83/CD/B-NP/I-PNP \xc2\xb5mol/JJ/I-NP/I-PNP mol-1/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP 363,82/CD/B-NP/I-PNP \xc2\xb5mol/NN/I-NP/I-PNP mol-1/NN/I-NP/I-PNP angestiegen/RP/O/O ././O/O

Mit/IN/B-PP/B-PNP gro\xc3\x9fer/JJ/B-NP/I-PNP Wahrscheinlichkeit/NN/I-NP/I-PNP ist/VB/B-VP/O die/DT/B-NP/O Erw\xc3\xa4rmung/NN/I-NP/O der/DT/B-NP/O Erde/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP anthropogene/NN/I-NP/I-PNP Erh\xc3\xb6hung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP atmosph\xc3\xa4rischen/JJ/I-NP/I-PNP CO2-Konzentration/NN/I-NP/I-PNP zur\xc3\xbcckzuf\xc3\xbchren/VB/B-VP/O ././O/O

Anhand/IN/B-PP/O eines/DT/O/O im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP entwickelten/VB/B-VP/O Modells/VBN/I-VP/O werden/VB/I-VP/O m\xc3\xb6gliche/JJ/B-NP/O Auswirkungen/NN/I-NP/O der/DT/B-NP/O Erh\xc3\xb6hung/NN/I-NP/O der/DT/B-NP/O atmosph\xc3\xa4rischen/JJ/I-NP/O CO2-Konzentration/NN/I-NP/O und/CC/O/O erwarteter/JJ/B-NP/O Temperaturerh\xc3\xb6hungen/NN/I-NP/O auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Wasserumsatz/NN/I-NP/I-PNP und/CC/O/O das/DT/B-NP/O Wachstum/NN/I-NP/O von/IN/B-PP/B-PNP Buchenbest\xc3\xa4nden/NN/B-NP/I-PNP untersucht/RP/O/O ././O/O

Die/DT/O/O im/IN/B-PP/B-PNP Modell/NN/B-NP/I-PNP verwendeten/JJ/I-NP/I-PNP Wetterdaten/NN/I-NP/I-PNP werden/VB/B-VP/O generiert/NN/B-NP/O ././O/O

Zwei/CD/B-NP/O Verfahren/NN/I-NP/O zur/IN/B-PP/B-PNP Generierung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Wetterdaten/NN/B-NP/I-PNP (/(/O/O Wettergenerator/NN/B-NP/O WGEN/NN/I-NP/O und/CC/I-NP/O FOURIER-Reihen/NN/I-NP/O )/)/O/O werden/VB/B-VP/O gegen\xc3\xbcbergestellt/NN/B-NP/O ././O/O

Die/DT/B-NP/O Biomassen/NN/I-NP/O werden/VB/B-VP/O basierend/JJ/B-ADJP/O auf/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Farquhar/JJ/I-NP/I-PNP Modell/NN/I-NP/I-PNP (/(/O/O der/DT/B-NP/O Stickstoffgehalt/NN/I-NP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Blattschichten/NN/I-NP/I-PNP beeinflu\xc3\x9ft/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP verwendeten/JJ/I-NP/I-PNP Variante/NN/I-NP/I-PNP VCmax/NN/I-NP/I-PNP und/CC/O/O Jmax/NN/B-NP/O )/)/O/O und/CC/O/O empirischen/JJ/B-NP/O Verteilungsfunktionen/JJ/I-NP/O berechnet/NN/I-NP/O ././O/O

Die/DT/B-NP/O Evapotranspiration/NN/I-NP/O wird/VB/B-VP/O auf/IN/B-PP/B-PNP Basis/NN/B-NP/I-PNP eines/DT/O/O von/IN/B-PP/B-PNP JARVIS/NN/B-NP/I-PNP modifizierten/NN/I-NP/I-PNP PENMAN-MONTEITH/NNP/I-NP/I-PNP Ansatz/NNP/I-NP/I-PNP berechnet/NNP/I-NP/I-PNP ,/,/O/O bei/IN/B-PP/B-PNP dem/WDT/B-NP/I-PNP der/DT/I-NP/I-PNP Einflu\xc3\x9f/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Bestandesrauhigkeit/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Grenzschichtwiderstand/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP Bestand/NN/B-NP/I-PNP und/CC/I-NP/I-PNP angrenzender/NN/I-NP/I-PNP Atmosph\xc3\xa4re/NN/I-NP/I-PNP ber\xc3\xbccksichtigt/VBN/B-VP/I-PNP wird/VB/I-VP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Darstellung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Bodenwasserhaushaltes/NN/I-NP/I-PNP wird/VB/B-VP/O ein/DT/B-NP/O Modell/NN/I-NP/O von/IN/B-PP/B-PNP VANDENBERG/NN/B-NP/I-PNP verwendet/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP einigen/JJ/B-NP/I-PNP Modell\xc3\xa4ufen/NN/I-NP/I-PNP wird/VB/B-VP/O zum/IN/B-PP/B-PNP Berechnen/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Beginns/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Vegetationsperiode/NN/I-NP/I-PNP ein/DT/B-NP/I-PNP Modell/NN/I-NP/I-PNP von/IN/B-PP/B-PNP KRAMER/NN/B-NP/I-PNP verwendet/VB/B-VP/O ././O/O

Das/DT/B-NP/O Modell/JJ/I-NP/O errechnet/NN/I-NP/O bei/IN/B-PP/B-PNP erh\xc3\xb6hter/JJ/B-NP/I-PNP CO2-Konzentration/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP deutlich/JJ/I-NP/I-PNP h\xc3\xb6here/JJ/I-NP/I-PNP Biomasse/NNP/I-NP/I-PNP und/CC/O/O einen/DT/B-NP/O h\xc3\xb6heren/JJ/I-NP/O LAI/NN/I-NP/O ././O/O

Die/DT/B-NP/O Transpiration/NN/I-NP/O sinkt/NN/I-NP/O bezogen/JJ/B-ADJP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Biomasse/NNP/I-NP/I-PNP um/IN/B-PP/O 14%/CD/O/O ././O/O

Bezogen/JJ/B-ADJP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Grundfl\xc3\xa4che/NN/I-NP/I-PNP gibt/VB/B-VP/O es/PRP/B-NP/O kaum/RB/B-ADVP/O eine/DT/B-NP/O \xc3\x84nderung/NN/I-NP/O ././O/O

Die/DT/B-NP/O Interzeption/NN/I-NP/O nimmt/VB/B-VP/O deutlich/JJ/B-ADJP/O (/(/O/O 36%/CD/O/O )/)/O/O ab/RP/O/O ././O/O

Die/DT/B-NP/O Evaporation/NN/I-NP/O von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Bodenoberfl\xc3\xa4che/NN/I-NP/I-PNP nimmt/VB/B-VP/O um/IN/B-PP/B-PNP 9%/CD/B-NP/I-PNP und/CC/I-NP/I-PNP die/DT/I-NP/I-PNP Versickerungsrate/NN/I-NP/I-PNP um/IN/B-PP/O 16%/CD/O/O zu/RP/O/O ././O/O

Eine/DT/B-NP/O konstante/JJ/I-NP/O Temperaturerh\xc3\xb6hung/NN/I-NP/O um/IN/B-PP/B-PNP 2/CD/B-NP/I-PNP \xc2\xb0C/NN/I-NP/I-PNP \xc3\xbcber/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Simulationszeitraum/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 150/CD/B-NP/I-PNP Jahren/NN/I-NP/I-PNP f\xc3\xbchrt/VB/B-VP/O bei/IN/B-PP/B-PNP Verwendung/NN/B-NP/I-PNP des/DT/O/O Modells/RB/B-ADVP/O von/IN/B-PP/B-PNP KRAMER/NN/B-NP/I-PNP nicht/RB/B-ADVP/O zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP verl\xc3\xa4ngerten/JJ/I-NP/I-PNP Vegetationsperiode/NN/I-NP/I-PNP ././O/O

Daher/RB/B-VP/O konnten/VB/I-VP/O Effekte/NNS/B-NP/O ,/,/O/O die/WDT/O/O durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP erh\xc3\xb6hten/NN/I-NP/I-PNP Temperatur/NN/I-NP/I-PNP erwarteten/NN/I-NP/I-PNP l\xc3\xa4ngeren/JJ/B-NP/I-PNP Vegetationsperiode/NN/I-NP/I-PNP auftreten/VB/B-VP/O ,/,/O/O im/IN/B-PP/B-PNP Modell/NN/B-NP/I-PNP nicht/RB/I-NP/I-PNP nachgebildet/NN/I-NP/I-PNP werden.Der/NN/I-NP/I-PNP Systemische/JJ/B-NP/I-PNP Lupus/JJ/I-NP/I-PNP Erythematodes/NN/I-NP/I-PNP (/(/O/O SLE/NN/B-NP/O )/)/O/O ist/NN/B-NP/O eine/DT/I-NP/O Autoimmunerkrankung/NN/I-NP/O ,/,/O/O die/WDT/O/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Entstehung/NN/I-NP/I-PNP autoreaktiver/NN/I-NP/I-PNP IgG-Autoantik\xc3\xb6rper/NN/I-NP/I-PNP und/CC/O/O eine/DT/B-NP/O chronische/JJ/I-NP/O Immunreaktion/NN/I-NP/O gegen/IN/B-PP/O k\xc3\xb6rpereigene/MD/B-VP/O Strukturen/NN/B-NP/O charakterisiert/NN/I-NP/O ist/VB/B-VP/O ././O/O

Die/DT/B-NP/O Selbstantigene/NN/I-NP/O sind/VB/B-VP/O dabei/RB/B-ADVP/O insbesondere/RB/B-NP/O nukle\xc3\xa4re/JJ/I-NP/O Strukturen/NN/I-NP/O ,/,/O/O welche/WDT/O/O \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Koaktivierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Toll-like/JJ/B-NP/I-PNP Rezeptoren/NN/I-NP/I-PNP (/(/O/O TLR/NN/B-NP/O )/)/O/O zur/IN/B-PP/B-PNP Autoantik\xc3\xb6rperbildung/NN/B-NP/I-PNP beitragen/VB/B-VP/O ././O/O

TLR9/JJ/B-NP/O bindet/NN/I-NP/O nicht-methylierte/NN/I-NP/O doppelstr\xc3\xa4ngige/NN/I-NP/O DNS/NNP/I-NP/O (/(/O/O dsDNS/NNP/B-NP/O )/)/O/O und/CC/O/O wurde/VB/B-VP/O daher/RB/B-ADVP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Bildung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP anti-dsDNS/NNP/B-NP/I-PNP Antik\xc3\xb6rpern/JJ/I-NP/I-PNP assoziiert/NN/I-NP/I-PNP ././O/O

Obwohl/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Defizienz/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP TLR9/NN/B-NP/I-PNP in/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP murinen/NN/I-NP/I-PNP Lupusmodellen/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP verringerten/NN/I-NP/I-PNP Produktion/NN/I-NP/I-PNP nukleosomenreaktiver/NN/I-NP/I-PNP Antik\xc3\xb6rper/NN/I-NP/I-PNP f\xc3\xbchrt/VB/B-VP/O ,/,/O/O kommt/RB/B-ADVP/O es/PRP/B-NP/O gleichzeitig/RB/B-ADVP/O zu/RB/I-ADVP/O einem/DT/B-NP/O deutlich/JJ/I-NP/O schwereren/JJ/I-NP/O Krankheitsverlauf/NN/I-NP/O ././O/O

Der/DT/B-NP/O zugrundeliegende/JJ/I-NP/O Toleranzmechanismus/NN/I-NP/O von/IN/B-PP/B-PNP TLR9/NN/B-NP/I-PNP war/VB/B-VP/O zu/IN/B-PP/B-PNP Beginn/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP noch/RB/B-ADVP/O unbekannt/RP/O/O ././O/O

In/IN/B-PP/B-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurde/VB/B-VP/O der/DT/B-NP/O TLR9-vermittelte/JJ/I-NP/O Toleranzmechanismus/NN/I-NP/O anhand/IN/B-PP/B-PNP des/DT/B-NP/I-PNP murinen/NN/I-NP/I-PNP Lupusmodells/IN/B-PP/B-PNP des/DT/B-NP/I-PNP Fc\xc3\xaf?\xc2\xa7/NN/I-NP/I-PNP Rezeptor/JJ/B-NP/I-PNP IIb/NN/I-NP/I-PNP (/(/O/O Fc\xc3\xaf?\xc2\xa7RIIB)-Knockouts/LS/O/O untersucht/RP/O/O ././O/O

Dieses/DT/O/O zeichnet/VB/B-VP/O sich/PRP/B-NP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP spontane/JJ/I-NP/I-PNP Bildung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP IgG-Autoantik\xc3\xb6rpern/NN/B-NP/I-PNP und/CC/I-NP/I-PNP der/DT/I-NP/I-PNP spontanen/JJ/I-NP/I-PNP Entwicklung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Lupusnephritis/NN/B-NP/I-PNP aus/RP/O/O ././O/O

Die/DT/B-NP/O Inaktivierung/NN/I-NP/O von/IN/B-PP/B-PNP TLR9/NN/B-NP/I-PNP f\xc3\xbchrte/VB/B-VP/O zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Reduktion/NN/I-NP/I-PNP nukleosomenreaktiver/NN/I-NP/I-PNP IgG-Antik\xc3\xb6rper/NN/I-NP/I-PNP und/CC/O/O gleichzeitig/RB/B-ADVP/O zu/RB/I-ADVP/O einem/DT/B-NP/O generell/RB/I-NP/O st\xc3\xa4rker/JJ/I-NP/O aktivierten/JJ/I-NP/O Immunstatus/NN/I-NP/O ././O/O

Dies/DT/O/O zeigte/VB/B-VP/O sich/PRP/B-NP/O anhand/IN/B-PP/B-PNP vergr\xc3\xb6\xc3\x9ferter/NN/B-NP/I-PNP sekund\xc3\xa4rer/NN/I-NP/I-PNP lymphatischer/JJ/I-NP/I-PNP Organe/NN/I-NP/I-PNP mit/IN/B-PP/O erh\xc3\xb6hten/VB/B-VP/O Plasmazellanteilen/NN/B-NP/O ,/,/O/O einer/DT/B-NP/O erh\xc3\xb6hten/NN/I-NP/O IgG-Autoantik\xc3\xb6rperproduktion/NN/I-NP/O ,/,/O/O der/DT/B-NP/O h\xc3\xa4ufigeren/JJ/I-NP/O Aktivierung/NN/I-NP/O von/IN/B-PP/B-PNP T-Helferzellen/NN/B-NP/I-PNP ,/,/O/O einer/DT/B-NP/O vermehrten/NN/I-NP/O Differenzierung/NN/I-NP/O von/IN/B-PP/B-PNP Th1/NN/B-NP/I-PNP -/-/O/O und/CC/O/O Th17-Zellen/NN/B-NP/O sowie/RB/B-ADVP/O der/DT/O/O verst\xc3\xa4rkten/VB/B-VP/O Bildung/NN/B-NP/O phagozytierender/NN/I-NP/O Zellen/NNS/I-NP/O ././O/O

Lupusm\xc3\xa4use/NN/B-NP/O ohne/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Signaltransduktionsmolek\xc3\xbcl/NN/I-NP/I-PNP MyD88/NN/I-NP/I-PNP ,/,/O/O welches/WDT/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Aktivierung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP meisten/DT/I-NP/I-PNP TLR/NN/I-NP/I-PNP ben\xc3\xb6tigt/VBN/B-VP/I-PNP wird/VB/I-VP/O ,/,/O/O entwickelten/VBN/B-VP/O keine/JJ/B-NP/O IgG-Autoantik\xc3\xb6rper/NN/I-NP/O und/CC/O/O keine/JJ/B-NP/O unkontrollierte/NN/I-NP/O Aktivierung/NN/I-NP/O des/DT/B-NP/O Immunsystems/NN/I-NP/O ././O/O

Anhand/IN/B-PP/B-PNP von/IN/I-PP/I-PNP Knochenmarkchim\xc3\xa4ren/NN/B-NP/I-PNP konnte/VB/B-VP/O der/DT/B-NP/O TLR9-abh\xc3\xa4ngige/JJ/I-NP/O Toleranzmechanismus/NN/I-NP/O auf/IN/B-PP/B-PNP knochenmarkst\xc3\xa4mmige/NN/B-NP/I-PNP B-Zellen/NN/I-NP/I-PNP zur\xc3\xbcckgef\xc3\xbchrt/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Lupusm\xc3\xa4use/NN/B-NP/O ,/,/O/O die/WDT/O/O nur/RB/B-ADVP/O in/IN/B-PP/B-PNP B-Zellen/NN/B-NP/I-PNP TLR9-defizient/NN/I-NP/I-PNP waren/VB/B-VP/O ,/,/O/O besa\xc3\x9fen/NN/B-NP/O demnach/RB/B-ADVP/O ebenso/RB/I-ADVP/O einen/DT/B-NP/O st\xc3\xa4rker/JJ/I-NP/O aktivierten/JJ/I-NP/O Immunstatus/NN/I-NP/O ././O/O

TLR9/RB/B-VP/O vermittelt/VB/I-VP/O in/IN/B-PP/B-PNP Fc\xc3\xaf?\xc2\xa7RIIB-defizienten/NN/B-NP/I-PNP M\xc3\xa4usen/NN/I-NP/I-PNP au\xc3\x9ferdem/VB/B-VP/O die/DT/B-NP/O Bildung/NN/I-NP/O von/IN/B-PP/B-PNP selbstreaktivem/NN/B-NP/I-PNP IgM/NN/I-NP/I-PNP ,/,/O/O welches/WDT/O/O allgemein/JJ/B-ADJP/O mit/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Schutz/NN/I-NP/I-PNP vor/IN/B-PP/B-PNP Infektionen/NN/B-NP/I-PNP aber/RB/B-ADVP/O auch/RB/I-ADVP/O einer/DT/B-NP/O geringeren/JJ/I-NP/O Auspr\xc3\xa4gung/NN/I-NP/O von/IN/B-PP/B-PNP SLE/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Verbindung/NN/B-NP/I-PNP gebracht/VBN/B-VP/I-PNP wird/VB/I-VP/O ././O/O

Beide/JJ/B-NP/O Merkmale/NN/I-NP/O werden/VB/B-VP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP F\xc3\xa4higkeit/NN/I-NP/I-PNP von/IN/B-PP/B-PNP selbstreaktivem/NN/B-NP/I-PNP IgM/NN/I-NP/I-PNP zur\xc3\xbcckgef\xc3\xbchrt/NN/I-NP/I-PNP ,/,/O/O die/DT/B-NP/O Clearance/NN/I-NP/O von/IN/B-PP/B-PNP Pathogenen/NN/B-NP/I-PNP und/CC/I-NP/I-PNP nekrotischem/NN/I-NP/I-PNP Material/NN/I-NP/I-PNP zu/TO/B-VP/O vermitteln/VB/I-VP/O ././O/O

Der/DT/B-NP/O Verlust/NN/I-NP/O von/IN/B-PP/B-PNP TLR9/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Fc\xc3\xaf?\xc2\xa7RIIB-defizienten/NN/B-NP/I-PNP M\xc3\xa4usen/NN/I-NP/I-PNP ging/VBN/B-VP/I-PNP mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP drastischen/JJ/I-NP/I-PNP Verminderung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP selbstreaktiven/NN/I-NP/I-PNP IgM-Titer/NN/I-NP/I-PNP einher/NN/I-NP/I-PNP und/CC/O/O war/VBN/B-VP/O mit/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP schwereren/JJ/I-NP/I-PNP Verlauf/NN/I-NP/I-PNP von/IN/B-PP/B-PNP SLE/JJ/B-NP/I-PNP assoziiert/NN/I-NP/I-PNP ././O/O

Es/PRP/B-NP/O konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP TLR9-abh\xc3\xa4ngige/NN/B-NP/I-PNP selbstreaktive/JJ/I-NP/I-PNP IgM-Antik\xc3\xb6rper/NN/I-NP/I-PNP von/IN/B-PP/B-PNP peritonealen/JJ/B-NP/I-PNP B1b-Zellen/NN/I-NP/I-PNP gebildet/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Die/DT/B-NP/O IgM-Titer/JJ/I-NP/O korrelierten/NN/I-NP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Lupusm\xc3\xa4usen/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP beobachteten/NN/I-NP/I-PNP Zellzahlen/NN/I-NP/I-PNP peritonealer/NN/I-NP/I-PNP B1b-Zellen/NN/I-NP/I-PNP ,/,/O/O w\xc3\xa4hrend/IN/B-PP/O dies/DT/O/O nicht/RB/B-ADVP/O auf/IN/B-PP/B-PNP andere/JJ/B-NP/I-PNP B-Zellpopulationen/JJ/I-NP/I-PNP zutraf/NN/I-NP/I-PNP ././O/O

Der/DT/B-NP/O Transfer/NN/I-NP/O von/IN/B-PP/B-PNP TLR9-exprimierenden/NN/B-NP/I-PNP peritonealen/JJ/I-NP/I-PNP B1b-Zellen/NN/I-NP/I-PNP resultierte/VB/B-VP/O in/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP reduzierten/JJ/I-NP/I-PNP Bildung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP IgG-Autoantik\xc3\xb6rpern/NN/B-NP/I-PNP und/CC/I-NP/I-PNP der/DT/I-NP/I-PNP verminderten/JJ/I-NP/I-PNP Entwicklung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Lupusnephritis/NN/B-NP/I-PNP ././O/O

Des/JJ/B-NP/O Weiteren/NN/I-NP/O konnten/VB/B-VP/O TLR9-exprimierende/NN/B-NP/O peritoneale/JJ/I-NP/O B1b-Zellen/NN/I-NP/O nach/IN/B-PP/B-PNP Transfer/NN/B-NP/I-PNP eine/DT/I-NP/I-PNP Reduktion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Th17-Zellen/NN/B-NP/I-PNP bereits/RB/B-ADVP/O binnen/IN/B-PP/B-PNP weniger/IN/I-PP/I-PNP Tage/NN/B-NP/I-PNP vermitteln/VB/B-VP/O ././O/O

Neben/IN/B-PP/B-PNP TLR9/NN/B-NP/I-PNP wird/VB/B-VP/O \xc3\xbcber/IN/B-PP/B-PNP TLR4/NN/B-NP/I-PNP durch/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP noch/RB/I-NP/I-PNP unbekannten/JJ/I-NP/I-PNP Mechanismus/NN/I-NP/I-PNP ebenfalls/RB/B-ADVP/O ein/DT/B-NP/O weiterer/JJ/I-NP/O sch\xc3\xbctzender/JJ/I-NP/O Effekt/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Krankheitsentwicklung/NN/I-NP/I-PNP des/DT/O/O verwendeten/VB/B-VP/O Lupusmodells/RB/B-ADVP/O vermittelt/RB/I-ADVP/O ././O/O

Die/DT/B-NP/O Beeinflussung/NN/I-NP/O von/IN/B-PP/B-PNP Toll-like/NN/B-NP/I-PNP Rezeptoren/NN/I-NP/I-PNP ,/,/O/O im/IN/B-PP/B-PNP Speziellen/NN/B-NP/I-PNP die/DT/I-NP/I-PNP TLR9-abh\xc3\xa4ngige/JJ/I-NP/I-PNP Aktivierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP peritonealen/JJ/B-NP/I-PNP B1b-Zellen/NN/I-NP/I-PNP und/CC/O/O die/DT/B-NP/O damit/RB/I-NP/O verbundene/JJ/I-NP/O Bildung/NN/I-NP/O von/IN/B-PP/B-PNP protektivem/NN/B-NP/I-PNP selbstreaktiven/NN/I-NP/I-PNP IgM/NN/I-NP/I-PNP ,/,/O/O muss/VB/B-VP/O bei/IN/B-PP/B-PNP TLR-blockierenden/NN/B-NP/I-PNP und/CC/I-NP/I-PNP B-Zell-depletierenden/JJ/I-NP/I-PNP Therapien/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP SLE-Patienten/NN/B-NP/I-PNP ber\xc3\xbccksichtigt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Zudem/RB/B-VP/O er\xc3\xb6ffnet/VB/I-VP/O sie/PRP/B-NP/O neue/JJ/I-NP/O M\xc3\xb6glichkeiten/NN/I-NP/O ,/,/O/O um/IN/B-PP/B-PNP gezieltere/NN/B-NP/I-PNP und/CC/I-NP/I-PNP schonendere/JJ/I-NP/I-PNP Therapien/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Behandlung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP SLE/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP entwickeln.In/NN/B-NP/I-PNP der/DT/I-NP/I-PNP h\xc3\xa4uslichen/JJ/I-NP/I-PNP Trinkwasserinstallation/NN/I-NP/I-PNP k\xc3\xb6nnen/VB/B-VP/O abh\xc3\xa4ngig/JJ/B-ADJP/O vom/IN/B-PP/B-PNP eingesetzten/NN/B-NP/I-PNP Material/NN/I-NP/I-PNP ,/,/O/O der/DT/B-NP/O Wassertemperatur/NN/I-NP/O und/CC/O/O des/DT/B-NP/O Trinkwassers/NN/I-NP/O unterschiedliche/JJ/B-NP/O Biofilmpopulationen/NN/I-NP/O entstehen/VB/B-VP/O ././O/O

Unter/IN/B-PP/B-PNP ung\xc3\xbcnstigen/JJ/B-NP/I-PNP Umweltbedingungen/NN/I-NP/I-PNP k\xc3\xb6nnen/VB/B-VP/O sich/PRP/B-NP/O auch/RB/I-NP/O hygienisch/JJ/I-NP/O relevante/NN/I-NP/O Mikroorganismen/NN/I-NP/O einnisten/NN/I-NP/O und/CC/O/O persistieren/NN/B-NP/O ././O/O

Im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurden/VB/B-VP/O verschiedene/JJ/B-NP/O Einflussfaktoren/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP bakterielle/NN/I-NP/I-PNP und/CC/O/O eukaryotische/JJ/B-NP/O Zusammensetzung/NN/I-NP/O von/IN/B-PP/B-PNP Trinkwasserbiofilmpopulationen/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP von/IN/B-PP/B-PNP 16S/NNP/B-NP/I-PNP und/CC/I-NP/I-PNP 18S/NNP/I-NP/I-PNP rDNA/NNP/I-NP/I-PNP Klonbibliotheken/NNP/I-NP/I-PNP und/CC/O/O genetischen/JJ/B-NP/O Fingerprints/NN/I-NP/O (/(/O/O DGGE/NN/B-NP/O )/)/O/O untersucht/RP/O/O ././O/O

Die/DT/B-NP/O Biofilme/NN/I-NP/O wurden/VB/B-VP/O auf/IN/B-PP/B-PNP mehreren/JJ/B-NP/I-PNP Trinkwassermaterialien/NN/I-NP/I-PNP (/(/O/O Kupfer/NN/B-NP/O ,/,/O/O PE-Xb/NN/B-NP/O ,/,/O/O PE-Xc/NN/B-NP/O ,/,/O/O EPDM/NN/B-NP/O mit&slash;ohne/NNP/I-NP/O Empfehlung/NNP/I-NP/O nach/IN/B-PP/B-PNP DVGW/NNP/B-NP/I-PNP W270/NNP/I-NP/I-PNP )/)/O/O ,/,/O/O in/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP deutschen/JJ/I-NP/I-PNP Trinkw\xc3\xa4ssern/NN/I-NP/I-PNP und/CC/O/O bei/IN/B-PP/B-PNP unterschiedlichen/JJ/B-NP/I-PNP Temperaturen/NNS/I-NP/I-PNP angezogen/NN/I-NP/I-PNP ,/,/O/O zum/IN/B-PP/B-PNP Teil/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP L./JJ/B-NP/I-PNP pneumophila/NN/I-NP/I-PNP und/CC/O/O P./JJ/B-NP/O aeruginosa/NN/I-NP/O kontaminiert/NN/I-NP/O und/CC/O/O desinfiziert/NN/B-NP/O ././O/O

Es/PRP/B-NP/O sollte/MD/B-VP/O u./IN/B-PP/B-PNP a./DT/B-NP/I-PNP der/DT/I-NP/I-PNP l\xc3\xa4ngerfristige/JJ/I-NP/I-PNP Einfluss/NN/I-NP/I-PNP von/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Desinfektionsmitteln/NN/I-NP/I-PNP und/CC/O/O Pr\xc3\xa4paraten/NN/B-NP/O (/(/O/O Cl2/NN/B-NP/O ClO2/NN/I-NP/O ,/,/O/O O3/NN/B-NP/O ,/,/O/O H2O2/NN/B-NP/O in/IN/B-PP/B-PNP Kombination/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP Fruchts\xc3\xa4ure/NN/B-NP/I-PNP ,/,/O/O Silber/NN/B-NP/O bzw./RB/I-NP/O Silber/NN/I-NP/O mit/IN/B-PP/B-PNP Peressigs\xc3\xa4ure/NN/B-NP/I-PNP )/)/O/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP mikrobielle/NN/I-NP/I-PNP Biofilmzusammensetzung/NN/I-NP/I-PNP ermittelt/VBN/B-VP/I-PNP und/CC/O/O die/DT/B-NP/O Anwendbarkeit/NN/I-NP/O der/DT/B-NP/O molekularbiologischen/JJ/I-NP/O Techniken/NN/I-NP/O (/(/O/O inkl./IN/B-PP/B-PNP qPCR/NN/B-NP/I-PNP )/)/O/O als/IN/B-PP/B-PNP Standardnachweismethoden/NN/B-NP/I-PNP evaluiert/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Die/DT/B-NP/O analysierten/NN/I-NP/O Einflussfaktoren/NN/I-NP/O konnten/VB/B-VP/O in/IN/B-PP/B-PNP drei/CD/B-NP/I-PNP \xc3\xbcbergeordnete/NN/I-NP/I-PNP Gruppen/NN/I-NP/I-PNP qualitativ/JJ/B-ADJP/O nach/IN/B-PP/B-PNP ihrer/PRP$/B-NP/I-PNP Einflussst\xc3\xa4rke/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Zusammensetzung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Biofilmpopulation/NN/I-NP/I-PNP eingeteilt/NN/I-NP/I-PNP werden/VB/B-VP/O (/(/O/O Trinkwasserbeschaffenheit/NN/B-NP/O &/NN/I-NP/O gt/VB/B-VP/O ;/:/O/O Trinkwasserinstallation/NN/B-NP/O &/NN/I-NP/O gt/VB/B-VP/O ;/:/O/O anthropogene/NN/B-NP/O Einfl\xc3\xbcsse/NN/I-NP/O )/)/O/O ././O/O

Neben/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Beschaffenheit/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Trinkwassers/NN/I-NP/I-PNP ,/,/O/O welches/WDT/O/O in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Installation/NN/I-NP/I-PNP eingespeist/NN/I-NP/I-PNP wird/VB/B-VP/O ,/,/O/O haben/VB/B-VP/O die/DT/B-NP/O Trinkwasserinstallation/NN/I-NP/O selbst/JJ/B-ADJP/O (/(/O/O Wassertemperatur/NN/B-NP/O ,/,/O/O eingesetzte/NN/B-NP/O Materialien/NNP/I-NP/O )/)/O/O und/CC/O/O anthropogene/JJ/B-NP/O Eingriffe/NN/I-NP/O (/(/O/O z.B./IN/B-PP/B-PNP Desinfektion/NN/B-NP/I-PNP )/)/O/O einen/DT/B-NP/O entscheidenden/JJ/I-NP/O Einfluss/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP mikrobielle/JJ/I-NP/I-PNP Biofilmzusammensetzung/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Biofilme/NN/I-NP/O setzten/VB/B-VP/O sich/PRP/B-NP/O haupts\xc3\xa4chlich/RB/B-ADVP/O aus/IN/B-PP/B-PNP Vertretern/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Alpha/NN/I-NP/I-PNP -/-/O/O ,/,/O/O Beta/NN/B-NP/O -/-/O/O und/CC/O/O teilweise/IN/B-PP/B-PNP Gammaproteobakterien/NN/B-NP/I-PNP in/IN/B-PP/B-PNP unterschiedlichen/JJ/B-NP/I-PNP Abundanzen/NN/I-NP/I-PNP zusammen/RP/O/O ././O/O

Der/DT/B-NP/O Einfluss/NN/I-NP/O der/DT/B-NP/O Trinkwasserbeschaffenheit/NN/I-NP/O \xc3\xa4u\xc3\x9ferte/VB/B-VP/O sich/PRP/B-NP/O durch/IN/B-PP/B-PNP das/DT/B-NP/I-PNP vermehrte/JJ/I-NP/I-PNP Auftreten/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Betaproteobakterien/NN/B-NP/I-PNP in/IN/B-PP/B-PNP grundwasserbeeinflussten/NN/B-NP/I-PNP und/CC/O/O von/IN/B-PP/B-PNP Alphaproteobakterien/NN/B-NP/I-PNP in/IN/B-PP/B-PNP oberfl\xc3\xa4chenbeeinflussten/NN/B-NP/I-PNP Trinkw\xc3\xa4ssern/NN/I-NP/I-PNP angezogenen/JJ/I-NP/I-PNP PE-Xc-Biofilmen/NN/I-NP/I-PNP ././O/O

Es/PRP/B-NP/O war/VB/B-VP/O auff\xc3\xa4llig/JJ/B-ADJP/O ,/,/O/O dass/RB/B-ADVP/O in/IN/B-PP/B-PNP PE-Xc-Biofilmen/NN/B-NP/I-PNP fast/VB/B-VP/O keine/JJ/B-NP/O Aquabakterien/NN/I-NP/O erfasst/VBN/B-VP/O wurden/VB/I-VP/O ,/,/O/O aber/CC/O/O zum/IN/B-PP/B-PNP Teil/NN/B-NP/I-PNP am/IN/B-PP/B-PNP gleichen/JJ/B-NP/I-PNP Standort/NN/I-NP/I-PNP in/IN/B-PP/B-PNP anderen/JJ/B-NP/I-PNP Biofilmen/NN/I-NP/I-PNP Aquabakterien/NN/I-NP/I-PNP dominant/JJ/B-ADJP/O waren/VB/B-VP/O ././O/O

Auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP EPDM-Materialien/NN/I-NP/I-PNP wurden/VB/B-VP/O vermehrt/JJ/B-NP/O Vertreter/NN/I-NP/O der/DT/B-NP/O Familie/NN/I-NP/O der/DT/B-NP/O Sphingomonadaceae/NN/I-NP/O und/CC/O/O Flavobakterien/NN/B-NP/O nachgewiesen/VBN/B-VP/O ,/,/O/O die/WDT/O/O f\xc3\xbcr/IN/B-PP/B-PNP ihr/PRP/B-NP/I-PNP breites/JJ/I-NP/I-PNP Abbaupotential/NN/I-NP/I-PNP bekannt/VBN/B-VP/I-PNP sind/VB/I-VP/O ././O/O

Desinfektionsma\xc3\x9fnahmen/VBN/B-VP/O haben/VB/I-VP/O einen/DT/B-NP/O materialabh\xc3\xa4ngigen/NN/I-NP/O ,/,/O/O l\xc3\xa4ngerfristigen/JJ/B-NP/O Einfluss/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP nachfolgende/JJ/I-NP/I-PNP Zusammensetzung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Biofilmpopulation/NN/I-NP/I-PNP ././O/O

Biofilmf\xc3\xb6rdernde/JJ/B-NP/O Materialien/NN/I-NP/O wurden/VB/B-VP/O relativ/RB/B-ADJP/O rasch/JJ/I-ADJP/O von/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP sehr/RB/I-NP/I-PNP \xc3\xa4hnlichen/JJ/I-NP/I-PNP Population/NN/I-NP/I-PNP erneut/VB/B-VP/O besiedelt/NN/B-NP/O ././O/O

Auf/IN/B-PP/B-PNP Materialien/NN/B-NP/I-PNP ,/,/O/O die/WDT/B-NP/O das/DT/I-NP/O Biofilmwachstum/NN/I-NP/O nicht/RB/B-VP/O f\xc3\xb6rdern/VB/I-VP/O ,/,/O/O k\xc3\xb6nnen/VB/B-VP/O durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Desinfektion/NN/I-NP/I-PNP m\xc3\xb6glicherweise/IN/B-PP/B-PNP Persister/NN/B-NP/I-PNP ,/,/O/O hygienisch/JJ/B-NP/O relevante/NN/I-NP/O Mikroorganismen/NN/I-NP/O und/CC/O/O Organismen/NN/B-NP/O selektiert/NN/I-NP/O werden/VB/B-VP/O ,/,/O/O die/WDT/B-NP/O sich/PRP/I-NP/O aufgrund/IN/B-PP/B-PNP toter/JJ/B-NP/I-PNP Biofilmzellen/NN/I-NP/I-PNP ansiedeln/NN/I-NP/I-PNP und/CC/O/O diese/DT/O/O als/IN/B-PP/B-PNP N\xc3\xa4hrstoffquelle/NN/B-NP/I-PNP nutzen/VB/B-VP/O ././O/O

Es/PRP/B-NP/O wurde/RB/B-VP/O gezeigt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP durch/IN/I-PP/I-PNP die/DT/B-NP/I-PNP Desinfektionsma\xc3\x9fnahme/NN/I-NP/I-PNP im/IN/B-PP/B-PNP PE-Xc-Biofilm/NNP/B-NP/I-PNP partiell/JJ/I-NP/I-PNP Mikroorganismen/NN/I-NP/I-PNP gef\xc3\xb6rdert/VBN/B-VP/I-PNP wurden/VB/I-VP/O ,/,/O/O die/DT/B-NP/O ein/DT/I-NP/O gro\xc3\x9fes/JJ/I-NP/O Substratspektrum/NN/I-NP/O besitzen/VB/B-VP/O und/CC/O/O die/DT/O/O teilweise/RB/B-ADVP/O bei/IN/B-PP/B-PNP immunkomprimierten/NN/B-NP/I-PNP Personen/NN/I-NP/I-PNP Infektionen/NN/I-NP/I-PNP ausl\xc3\xb6sen/VB/B-VP/O k\xc3\xb6nnten/VB/I-VP/O ././O/O

Die/DT/B-NP/O Trinkwasserbeschaffenheit/NN/I-NP/O und/CC/O/O eine/DT/B-NP/O Desinfektion/NN/I-NP/O mit/IN/B-PP/B-PNP Chlordioxid/NN/B-NP/I-PNP hatten/VB/B-VP/O auch/RB/B-ADVP/O eine/DT/B-NP/O \xc3\x84nderung/NN/I-NP/O der/DT/B-NP/O Eukaryotenpopulation/NN/I-NP/O zur/IN/B-PP/B-PNP Folge/NN/B-NP/I-PNP ././O/O

Es/PRP/B-NP/O wurden/VB/B-VP/O zum/IN/B-PP/B-PNP Teil/NN/B-NP/I-PNP unbekannte/JJ/I-NP/I-PNP Am\xc3\xb6benarten/NN/I-NP/I-PNP in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Trinkwasserbiofilmen/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP molekularbiologischen/JJ/I-NP/I-PNP Untersuchungen/NN/I-NP/I-PNP erfasst/RP/O/O ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O dieser/DT/B-NP/O Arbeit/NN/I-NP/O zeigen/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O die/DT/B-NP/O Populationszusammensetzung/NN/I-NP/O von/IN/B-PP/B-PNP Trinkwasserbiofilmen/NN/B-NP/I-PNP von/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Vielzahl/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Faktoren/NN/B-NP/I-PNP abh\xc3\xa4ngig/JJ/B-ADJP/O ist/VB/B-VP/O ././O/O

Ohne/IN/B-PP/B-PNP Beseitigung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Kontaminationsquelle/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Trinkwassers/NN/I-NP/I-PNP (/(/O/O z./IN/B-PP/B-PNP B./JJ/B-NP/I-PNP biofilmf\xc3\xb6rdernde/NN/I-NP/I-PNP Materialien/NN/I-NP/I-PNP )/)/O/O und/CC/O/O der/DT/B-NP/O f\xc3\xb6rdernden/JJ/I-NP/O Umweltbedingungen/NN/I-NP/O ,/,/O/O kann/VB/B-VP/O ein/DT/B-NP/O langfristiges/NN/I-NP/O ,/,/O/O nachhaltiges/JJ/B-NP/O Sanierungsziel/NN/I-NP/O durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP alleinige/JJ/I-NP/I-PNP Desinfektion/NN/I-NP/I-PNP ohne/IN/B-PP/B-PNP mechanische/JJ/B-NP/I-PNP Reinigung/NN/I-NP/I-PNP nicht/RB/B-VP/O erreicht/VB/I-VP/O werden.Aufgrund/NN/B-NP/O der/DT/I-NP/O unzureichenden/NN/I-NP/O regenerativen/NN/I-NP/O F\xc3\xa4higkeiten/NN/I-NP/O des/DT/B-NP/O Gelenkknorpels/NN/I-NP/O f\xc3\xbchren/VB/B-VP/O bereits/RB/B-NP/O kleine/JJ/I-NP/O L\xc3\xa4sionen/NN/I-NP/O zu/IN/B-PP/B-PNP progressiven/NN/B-NP/I-PNP Gelenkbeschwerden/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O in/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Arthrose/NN/I-NP/I-PNP und/CC/O/O nachfolgender/JJ/B-NP/O Invalidit\xc3\xa4t/NN/I-NP/O enden/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ././O/O

Bedingt/JJ/B-ADJP/O ist/VB/B-VP/O diese/DT/B-NP/O Problematik/NN/I-NP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP spezielle/JJ/I-NP/I-PNP Anatomie/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Knorpelgewebes/NN/I-NP/I-PNP ,/,/O/O insbesondere/RB/B-ADVP/O durch/IN/B-PP/B-PNP seine/PRP$/B-NP/I-PNP Avaskularit\xc3\xa4t/NN/I-NP/I-PNP ././O/O

Da/IN/B-PP/O die/DT/O/O bisher/IN/B-PP/B-PNP eingesetzten/NN/B-NP/I-PNP konventionellen/JJ/I-NP/I-PNP Behandlungsmethoden/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Regeneration/NN/I-NP/I-PNP von/IN/B-PP/B-PNP zonal/NN/B-NP/I-PNP aufgebautem/NN/I-NP/I-PNP ,/,/O/O hyalinem/NN/B-NP/O Knorpel/NNP/I-NP/O scheitern/VB/B-VP/O ,/,/O/O werden/VB/B-VP/O seit/IN/B-PP/O etwa/RB/B-ADVP/O 20/CD/B-NP/O Jahren/NN/I-NP/O neue/VB/B-VP/O ,/,/O/O regenerative/NN/B-NP/O Therapien/NNP/I-NP/O erforscht/NNP/I-NP/O ././O/O

Den/DT/B-NP/O Startpunkt/NN/I-NP/O dieser/DT/B-NP/O Methoden/NN/I-NP/O bildete/VB/B-VP/O 1994/CD/O/O die/DT/O/O von/IN/B-PP/B-PNP Brittberg/NNP/B-NP/I-PNP beschriebene/NNP/I-NP/I-PNP autologe/JJ/I-NP/I-PNP Chondrozyten-Transplantation/NN/I-NP/I-PNP (/(/O/O ACT/NNP/B-NP/O )/)/O/O ,/,/O/O bei/IN/B-PP/O der/DT/O/O k\xc3\xb6rpereigene/MD/B-VP/O Knorpelzellen/NN/B-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Reparatur/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Defekts/NN/I-NP/I-PNP genutzt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Aufgrund/IN/B-PP/B-PNP von/IN/I-PP/I-PNP operationstechnischen/JJ/B-NP/I-PNP und/CC/I-NP/I-PNP zellbiologischen/JJ/I-NP/I-PNP Problemen/NN/I-NP/I-PNP wurde/VB/B-VP/O diese/DT/B-NP/O Methode/NN/I-NP/O zu/IN/B-PP/B-PNP tr\xc3\xa4gerassoziierten/NN/B-NP/I-PNP Verfahren/NN/I-NP/I-PNP weiterentwickelt/NN/I-NP/I-PNP ,/,/O/O bei/IN/B-PP/B-PNP denen/WDT/B-NP/I-PNP resorbierbare/JJ/I-NP/I-PNP Zelltr\xc3\xa4ger/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP dreidimensionalen/JJ/I-NP/I-PNP Anordnung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Chondrozyten/NN/I-NP/I-PNP und/CC/O/O des/DT/B-NP/O sich/PRP/I-NP/O bildenden/NN/I-NP/O Gewebes/NN/I-NP/O sorgen/VB/B-VP/O ././O/O

Das/DT/B-NP/O Tr\xc3\xa4germaterial/NN/I-NP/O muss/VB/B-VP/O dabei/RB/B-NP/O verschiedene/JJ/I-NP/O Anforderungen/NN/I-NP/O bez\xc3\xbcglich/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Biokompatibilit\xc3\xa4t/NN/I-NP/I-PNP ,/,/O/O der/DT/B-NP/O Struktur/NN/I-NP/O ,/,/O/O der/DT/B-NP/O chemischen/JJ/I-NP/O und/CC/I-NP/O mechanischen/JJ/I-NP/O Stabilit\xc3\xa4t/NN/I-NP/O sowie/RB/B-ADVP/O der/DT/B-NP/O Oberfl\xc3\xa4cheneigenschaften/NN/I-NP/O erf\xc3\xbcllen/VB/B-VP/O ././O/O

Im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP sollte/MD/B-VP/O ein/DT/B-NP/O Zelltr\xc3\xa4germaterial/NN/I-NP/O ,/,/O/O basierend/JJ/B-ADJP/O auf/IN/B-PP/B-PNP Gelatine/NN/B-NP/I-PNP und/CC/I-NP/I-PNP dem/DT/I-NP/I-PNP synthetischen/JJ/I-NP/I-PNP Polymer/NNP/I-NP/I-PNP PLGA/NNP/I-NP/I-PNP ,/,/O/O hergestellt/VBN/B-VP/O werden/VB/I-VP/O ,/,/O/O das/WDT/B-NP/O die/DT/I-NP/O Anforderungen/NN/I-NP/O an/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP Tr\xc3\xa4germaterial/NN/I-NP/I-PNP m\xc3\xb6glichst/RB/B-ADJP/O weitgehend/JJ/I-ADJP/O erf\xc3\xbcllt/RP/O/O ././O/O

Durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP anf\xc3\xa4ngliche/JJ/I-NP/I-PNP Rezepturoptimierung/NN/I-NP/I-PNP gelang/NN/I-NP/I-PNP es/PRP/I-NP/I-PNP dabei/RB/B-ADVP/O ,/,/O/O das/DT/B-NP/O PLGA/NNP/I-NP/O l\xc3\xb6semittelfrei/NNP/I-NP/O und/CC/O/O homogen/JJ/B-ADJP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Gelatinebasis/NN/I-NP/I-PNP zu/TO/B-VP/O integrieren/VB/I-VP/O ././O/O

Anschlie\xc3\x9fend/RB/B-VP/O erfolgte/VB/I-VP/O die/DT/B-NP/O Herstellung/NN/I-NP/O der/DT/B-NP/O schwammf\xc3\xb6rmigen/JJ/I-NP/O Zelltr\xc3\xa4ger/NN/I-NP/O mittels/IN/B-PP/B-PNP gerichtetem/NN/B-NP/I-PNP Einfrieren/NN/I-NP/I-PNP und/CC/I-NP/I-PNP Gefriertrocknung/NN/I-NP/I-PNP ,/,/O/O wobei/WRB/O/O durch/IN/B-PP/B-PNP Anpassung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Herstellungsparameter/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP gleichm\xc3\xa4\xc3\x9fige/NN/I-NP/I-PNP und/CC/O/O parallel/JJ/B-ADJP/O angeordnete/VB/B-VP/O ,/,/O/O durchg\xc3\xa4ngige/NN/B-NP/O Porenstruktur/NNP/I-NP/O erzeugt/VBN/B-VP/O werden/VB/I-VP/O konnte/VBN/I-VP/O ././O/O

Die/DT/B-NP/O nachfolgende/JJ/I-NP/O Vernetzung/NN/I-NP/O und/CC/O/O Sterilisation/NN/B-NP/O des/DT/B-NP/O Materials/JJ/I-NP/O gelang/NN/I-NP/O in/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP einzigen/JJ/I-NP/I-PNP Prozessschritt/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP dehydrothermale/JJ/I-NP/I-PNP Behandlung/NN/I-NP/I-PNP ././O/O

Anhand/IN/B-PP/B-PNP der/DT/B-NP/I-PNP folgenden/JJ/I-NP/I-PNP physikochemischen/JJ/I-NP/I-PNP Charakterisierung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP entstandenen/NN/I-NP/I-PNP Gelatine-PLGA-Scaffolds/NN/I-NP/I-PNP konnte/VB/B-VP/O eine/DT/B-NP/O optimale/NN/I-NP/O Porosit\xc3\xa4t/NN/I-NP/O und/CC/O/O Porengr\xc3\xb6\xc3\x9fe/NN/B-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Besiedelung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Zelltr\xc3\xa4ger/NN/I-NP/I-PNP festgestellt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Weiterhin/RB/B-VP/O zeigte/VB/I-VP/O die/DT/B-NP/O Untersuchung/NN/I-NP/O zur/IN/B-PP/B-PNP in/IN/I-PP/I-PNP vitro/NN/B-NP/I-PNP Degradation/NN/I-NP/I-PNP des/DT/I-NP/I-PNP Materials/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP konstantem/NN/B-NP/I-PNP physiologischen/JJ/I-NP/I-PNP pH-Wert/NN/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O Abwesenheit/NN/I-NP/O von/IN/B-PP/B-PNP spezifischen/JJ/B-NP/I-PNP Enzymen/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP gute/JJ/I-NP/I-PNP chemische/JJ/I-NP/I-PNP Stabilit\xc3\xa4t/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Scaffolds/NN/I-NP/I-PNP ././O/O

Mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP von/IN/B-PP/B-PNP in/IN/I-PP/I-PNP vitro/NN/B-NP/I-PNP Zytotoxizit\xc3\xa4ts-Versuchen/VB/B-VP/O sowie/CC/O/O einer/DT/O/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP Studie/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP Gewebevertr\xc3\xa4glichkeit/NN/B-NP/I-PNP gem\xc3\xa4\xc3\x9f/IN/B-PP/B-PNP DIN/NN/B-NP/I-PNP EN/NN/I-NP/I-PNP ISO/NNP/I-NP/I-PNP 10993/CD/O/O wurde/VB/B-VP/O au\xc3\x9ferdem/RB/B-ADVP/O eine/DT/B-NP/O gute/JJ/I-NP/O Biokompatibilit\xc3\xa4t/NN/I-NP/O des/DT/B-NP/O Materials/NN/I-NP/O festgestellt/RP/O/O ././O/O

Zus\xc3\xa4tzlich/JJ/B-ADJP/O waren/VB/B-VP/O an/IN/B-PP/B-PNP den/DT/B-NP/I-PNP histologischen/JJ/I-NP/I-PNP Pr\xc3\xa4paraten/NN/I-NP/I-PNP der/DT/O/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP Studie/NN/I-NP/I-PNP eine/DT/I-NP/I-PNP bessere/NN/I-NP/I-PNP Gewebeintegration/NN/I-NP/I-PNP und/CC/O/O eine/DT/B-NP/O geringere/NN/I-NP/O Fremdk\xc3\xb6rperreaktion/NN/I-NP/O ,/,/O/O verglichen/JJ/B-ADJP/O mit/IN/B-PP/O dem/DT/O/O bereits/IN/B-PP/B-PNP zugelassenen/NN/B-NP/I-PNP Kontrollmaterial/NN/I-NP/I-PNP Ethisorb\xc2\xae/NN/I-NP/I-PNP ,/,/O/O feststellbar/JJ/B-ADJP/O ././O/O

Bei/IN/B-PP/B-PNP weiterf\xc3\xbchrenden/NN/B-NP/I-PNP in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP Versuchen/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP Besiedelbarkeit/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Zelltr\xc3\xa4ger/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP prim\xc3\xa4ren/NN/B-NP/I-PNP Chondrozyten/NN/I-NP/I-PNP konnte/VB/B-VP/O durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP dynamische/JJ/I-NP/I-PNP Besiedelungsmethode/NN/I-NP/I-PNP und/CC/O/O Optimierung/NN/B-NP/O der/DT/B-NP/O Zelldichte/NN/I-NP/O eine/DT/B-NP/O gleichm\xc3\xa4\xc3\x9fige/JJ/I-NP/O Zellverteilung/NN/I-NP/O auf/RP/O/O und/CC/O/O in/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Scaffold-Material/NN/I-NP/I-PNP erreicht/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Immunhistologische/JJ/B-NP/O Untersuchungen/NN/I-NP/O bez\xc3\xbcglich/IN/B-PP/B-PNP des/DT/B-NP/I-PNP Gehalts/NN/I-NP/I-PNP an/IN/B-PP/B-PNP Kollagen/NN/B-NP/I-PNP II/CD/O/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP synthetisierten/NN/I-NP/I-PNP Matrix/NN/I-NP/I-PNP zeigten/VB/B-VP/O dabei/RB/B-ADVP/O ,/,/O/O dass/RB/B-ADVP/O der/DT/B-NP/O differenzierte/NN/I-NP/O Status/NN/I-NP/O der/DT/B-NP/O Chondrozyten/NN/I-NP/O erhalten/VB/B-VP/O blieb/NN/B-NP/O ././O/O

Eine/DT/B-NP/O erste/JJ/I-NP/O Funktionalit\xc3\xa4tsstudie/NN/I-NP/O am/IN/B-PP/B-PNP Gelenkknorpeldefekt/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Ziegen/NN/B-NP/I-PNP deutete/NN/I-NP/I-PNP zudem/VB/B-VP/O im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP zur/IN/B-PP/B-PNP bisherigen/JJ/B-NP/I-PNP operativen/NN/I-NP/I-PNP Standardmethode/JJ/B-NP/I-PNP Mikrofrakturierung/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP bessere/NN/I-NP/I-PNP Geweberegeneration/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Defekts/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP Mikrofrakturierung/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP anschlie\xc3\x9fender/JJ/B-NP/I-PNP Applikation/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Tr\xc3\xa4germaterials/NN/I-NP/I-PNP (/(/O/O AMIC-Verfahren/NN/B-NP/O )/)/O/O hin/IN/B-PP/O ././O/O

Der/DT/B-NP/O entwickelte/JJ/I-NP/O Gelatine-PLGA-Scaffold/NN/I-NP/O stellt/VB/B-VP/O demnach/RB/B-ADVP/O aufgrund/IN/B-PP/B-PNP der/DT/B-NP/I-PNP untersuchten/NN/I-NP/I-PNP Eigenschaften/NNS/I-NP/I-PNP und/CC/O/O insbesondere/RB/B-ADVP/O seiner/PRP$/B-NP/O optimalen/JJ/B-NP/O Struktur/NN/I-NP/O einen/DT/B-NP/O geeigneten/JJ/I-NP/O Zelltr\xc3\xa4ger/NN/I-NP/O zur/IN/B-PP/B-PNP Unterst\xc3\xbctzung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Knorpelregeneration/NN/I-NP/I-PNP dar.ClC-7/VB/B-VP/O ist/RB/B-ADVP/O ein/DT/O/O nahezu/IN/B-PP/B-PNP ubiquit\xc3\xa4r/NN/B-NP/I-PNP exprimiertes/NN/I-NP/I-PNP ,/,/O/O sp\xc3\xa4t-endosomales&slash;lysosomales/NN/B-NP/O S\xc3\xa4uger-CLC-Protein/NNP/I-NP/O von/IN/B-PP/B-PNP tragender/JJ/B-NP/I-PNP Bedeutung/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP intra-lysosomale/NN/I-NP/I-PNP Cl--Akkumulation/NN/I-NP/I-PNP und/CC/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Ans\xc3\xa4uerung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Resorptionslakunen/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Osteoklasten/NN/B-NP/I-PNP ././O/O

Ostm1/RB/B-VP/O ist/VB/I-VP/O bekannt/VB/I-VP/O als/IN/B-PP/B-PNP seine/PRP$/B-NP/I-PNP Hilfsuntereinheit/NN/I-NP/I-PNP ././O/O

o/RB/B-ADVP/O f\xc3\xbchren/PRP$/B-NP/O Mutationen/NN/I-NP/O in/IN/B-PP/B-PNP beiden/DT/B-NP/I-PNP Proteinen/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP lysosomalen/JJ/B-NP/I-PNP Speicherkrankheiten/NN/I-NP/I-PNP und/CC/O/O Osteopetrose/NN/B-NP/O ././O/O

Die/DT/B-NP/O intrazellul\xc3\xa4re/JJ/I-NP/O Lokalisation/NN/I-NP/O dieses/DT/B-NP/O Cl-&slash;H+-Austauschers/NN/I-NP/O verwehrte/NN/I-NP/O seine/PRP$/I-NP/O biophysikalische/JJ/B-NP/O Untersuchung/NN/I-NP/O ././O/O

Durch/IN/B-PP/B-PNP Mutation/NN/B-NP/I-PNP einiger/JJ/I-NP/I-PNP Erkennungssequenzen/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP zellul\xc3\xa4re/JJ/I-NP/I-PNP Sortierungsmaschinerie/NN/I-NP/I-PNP ist/VB/B-VP/O eine/DT/B-NP/O partielle/NN/I-NP/O Umleitung/NN/I-NP/O des/DT/B-NP/O Proteins/NN/I-NP/O zur/IN/B-PP/B-PNP Plasmamembran/NN/B-NP/I-PNP gelungen/VBN/B-VP/I-PNP und/CC/O/O erm\xc3\xb6glichte/VB/B-VP/O den/DT/B-NP/O elektrischen/JJ/I-NP/O Zugang/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP elektrophysiologische/JJ/B-NP/I-PNP Standardmessmethoden/NN/I-NP/I-PNP ././O/O

o/RB/B-VP/O konnte/VB/I-VP/O im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP der/DT/I-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP ClC-7/NN/I-NP/I-PNP als/IN/B-PP/B-PNP letztes/JJ/B-NP/I-PNP Mitglied/NN/I-NP/I-PNP der/DT/B-NP/I-PNP S\xc3\xa4uger-CLCs/NN/I-NP/I-PNP einer/DT/B-NP/I-PNP biophysikalischen/JJ/I-NP/I-PNP Grundcharakterisierung/NN/I-NP/I-PNP unterzogen/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

ClC-7/NN/B-NP/O ,/,/O/O genauer/RB/B-VP/O gesagt/VB/I-VP/O seine/PRP$/B-NP/O Plasmamembran-lokalisierte/NN/I-NP/O Mutante/NN/I-NP/O ,/,/O/O ist/VB/B-VP/O ein/DT/B-NP/O langsam/JJ/I-NP/O gesteuerter/NN/I-NP/O ,/,/O/O ausw\xc3\xa4rts-gerichteter/NN/B-NP/O 2Cl-&slash;1H+-Austauscher/NNP/I-NP/O ,/,/O/O der/WDT/O/O nur/RB/B-ADVP/O unter/IN/B-PP/B-PNP Anwesenheit/NN/B-NP/I-PNP seiner/PRP$/I-NP/I-PNP Hilfsuntereinheit/NN/I-NP/I-PNP Ionen/NN/I-NP/I-PNP transportieren/PRP$/I-NP/I-PNP kann.Seine/NN/I-NP/I-PNP starke/JJ/I-NP/I-PNP Zeitabh\xc3\xa4ngigkeit/NN/I-NP/I-PNP unterscheidet/JJ/B-NP/I-PNP ClC-7/NN/I-NP/I-PNP von/IN/B-PP/B-PNP den/DT/B-NP/I-PNP restlichen/JJ/I-NP/I-PNP intrazellul\xc3\xa4ren/JJ/I-NP/I-PNP S\xc3\xa4uger-CLCs/NN/I-NP/I-PNP ././O/O

Der/DT/B-NP/O Aktivierungsprozess/NN/I-NP/O l\xc3\xa4uft/VB/B-VP/O ca/NN/B-NP/O ././O/O

zehn/CD/B-NP/O Mal/NN/I-NP/O langsamer/RB/B-ADVP/O ab/RB/I-ADVP/O als/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Deaktivierung/NN/I-NP/I-PNP und/CC/O/O ist/VB/B-VP/O auch/RB/B-ADVP/O fast/RB/I-ADVP/O zwei/CD/B-NP/O Mal/NN/I-NP/O st\xc3\xa4rker/JJ/B-ADJP/O Temperatur-abh\xc3\xa4ngig/JJ/I-ADJP/O ,/,/O/O was/WDT/O/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP gr\xc3\xb6\xc3\x9fere/JJ/I-NP/I-PNP Konformations\xc3\xa4nderung/NN/I-NP/I-PNP w\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Aktivierung/JJ/I-NP/I-PNP hinweist/NN/I-NP/I-PNP ././O/O

In/IN/B-PP/B-PNP den/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Experimenten/NN/I-NP/I-PNP konnte/VB/B-VP/O unter/IN/B-PP/B-PNP keinen/JJ/B-NP/I-PNP Bedingungen/NN/I-NP/I-PNP ein/DT/B-NP/I-PNP station\xc3\xa4rer/NN/I-NP/I-PNP Zustand/NN/I-NP/I-PNP des/DT/O/O Cl-&slash;H+-Austausches/JJ/B-ADJP/O erreicht/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Die/DT/B-NP/O starke/JJ/I-NP/O Spannungsabh\xc3\xa4ngigkeit/NN/I-NP/O ist/VB/B-VP/O allen/JJ/B-NP/O S\xc3\xa4uger-CLC-Antiportern/NN/I-NP/O gemein/JJ/B-ADJP/O ././O/O

Hier/RB/B-VP/O konnte/VB/I-VP/O am/IN/B-PP/B-PNP Beispiel/NN/B-NP/I-PNP von/IN/B-PP/B-PNP ClC-7/NN/B-NP/I-PNP zum/IN/B-PP/B-PNP ersten/JJ/B-NP/I-PNP Mal/NN/I-NP/I-PNP gezeigt/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Ionentranslokation/NN/I-NP/I-PNP durch/IN/B-PP/O den/DT/O/O offenen/JJ/B-ADJP/O Transporter/VB/B-VP/O nahezu/RB/B-ADJP/O linear/JJ/I-ADJP/O von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP elektrochemischen/JJ/I-NP/I-PNP Triebkraft/NN/I-NP/I-PNP abh\xc3\xa4ngig/JJ/B-ADJP/O ist/VB/B-VP/O und/CC/O/O dass/RB/B-ADVP/O somit/RB/I-ADVP/O die/DT/B-NP/O Rektifizierung/NN/I-NP/O dem/DT/B-NP/O Steuerungsverhalten/NN/I-NP/O des/DT/B-NP/O Proteins/NN/I-NP/O zu/IN/B-PP/B-PNP Grunde/NN/B-NP/I-PNP liegen/VB/B-VP/O muss/VB/I-VP/O ././O/O

Es/PRP/B-NP/O konnte/VB/B-VP/O ein/DT/B-NP/O V0,5/NN/I-NP/O von/IN/B-PP/B-PNP 82/CD/B-NP/I-PNP mV/NNP/I-NP/I-PNP und/CC/O/O eine/DT/B-NP/O Schaltladung/NN/I-NP/O von/IN/B-PP/O 1,32/CD/O/O bestimmt/VBN/B-VP/O werden/VB/I-VP/O ././O/O

owohl/CC/O/O die/DT/B-NP/O Zeit/NN/I-NP/O -/-/O/O als/CC/O/O auch/RB/B-ADVP/O die/DT/B-NP/O Spannungsabh\xc3\xa4ngigkeit/NN/I-NP/O konnte/VB/B-VP/O wie/IN/B-PP/B-PNP bei/IN/I-PP/I-PNP den/DT/B-NP/I-PNP anderen/JJ/I-NP/I-PNP CLCs/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP Mutieren/NN/B-NP/I-PNP des/DT/I-NP/I-PNP gating-Glutamats/NN/I-NP/I-PNP ,/,/O/O des/DT/B-NP/O molekularen/JJ/I-NP/O Korrelats/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP schnelle/NN/I-NP/I-PNP gate/NN/I-NP/I-PNP der/DT/B-NP/I-PNP CLCs/NN/I-NP/I-PNP ,/,/O/O aufgehoben/VB/B-VP/O werden/VB/I-VP/O \xe2\x80\x93/NN/B-NP/O es/PRP/I-NP/O entstand/VB/B-VP/O eine/DT/O/O pure/VB/B-VP/O ,/,/O/O nahezu/RB/B-NP/O ohm\xe2\x80\x98sche/JJ/I-NP/O Cl--Leitf\xc3\xa4higkeit/NN/I-NP/O ././O/O

Durch/IN/B-PP/B-PNP Mutation/NN/B-NP/I-PNP des/DT/I-NP/I-PNP intrazellul\xc3\xa4ren/JJ/I-NP/I-PNP H+-Akzeptors/NN/I-NP/I-PNP (/(/O/O Proton-Glutamat/NNP/B-NP/O )/)/O/O wurde/VB/B-VP/O ebenfalls/RB/B-ADVP/O wie/IN/B-PP/B-PNP bei/IN/I-PP/I-PNP den/DT/B-NP/I-PNP anderen/JJ/I-NP/I-PNP S\xc3\xa4uger-CLC-Antiportern/NN/I-NP/I-PNP nicht/RB/B-ADVP/O nur/RB/I-ADVP/O der/DT/B-NP/O H+-Transport/NN/I-NP/O sondern/RB/B-ADVP/O auch/RB/I-ADVP/O der/DT/B-NP/O Anionen-Transport/NN/I-NP/O g\xc3\xa4nzlich/JJ/B-ADJP/O unterbunden/RP/O/O ././O/O

Der/DT/B-NP/O Transport/NN/I-NP/O von/IN/B-PP/B-PNP extrazellul\xc3\xa4ren/NN/B-NP/I-PNP Anionen/NN/I-NP/I-PNP wurde/VB/B-VP/O in/IN/B-PP/B-PNP folgender/JJ/B-NP/I-PNP Reihenfolge/NN/I-NP/I-PNP pr\xc3\xa4feriert/NN/I-NP/I-PNP :/:/O/O Cl/NN/B-NP/O -/-/O/O &/NN/B-NP/O gt/VBN/B-VP/O ;/:/O/O Br/JJ/B-ADJP/O -/-/O/O &/NN/B-NP/O gt/VB/B-VP/O ;/:/O/O NO3/NN/B-NP/O -/-/O/O &/NN/B-NP/O gt/VBN/B-VP/O ;/:/O/O I/CD/O/O -/-/O/O ././O/O

Dabei/RB/B-VP/O konnte/VB/I-VP/O die/DT/B-NP/O Pr\xc3\xa4ferenz/NN/I-NP/O von/IN/B-PP/B-PNP Cl/NN/B-NP/I-PNP -/-/O/O \xc3\xbcber/IN/B-PP/B-PNP NO3/NN/B-NP/I-PNP -/-/O/O durch/IN/B-PP/B-PNP Substituieren/NN/B-NP/I-PNP des/DT/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Selektivit\xc3\xa4t/NN/I-NP/I-PNP verantwortlichen/JJ/B-NP/I-PNP Serins/NN/I-NP/I-PNP (/(/O/O Sercen/NN/B-NP/O )/)/O/O mit/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Prolin/NN/I-NP/I-PNP umgekehrt/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O was/WDT/O/O bereits/RB/B-ADVP/O vorher/RB/I-ADVP/O an/IN/B-PP/B-PNP mehreren/JJ/B-NP/I-PNP anderen/JJ/I-NP/I-PNP CLCs/NN/I-NP/I-PNP demonstriert/NN/I-NP/I-PNP wurde/VB/B-VP/O ././O/O

Die/DT/B-NP/O ClC-7-Transportaktivit\xc3\xa4t/NN/I-NP/O konnte/VB/B-VP/O auch/RB/B-ADVP/O durch/IN/B-PP/B-PNP extrazellul\xc3\xa4re/JJ/B-NP/I-PNP Protonen/NN/I-NP/I-PNP moduliert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

W\xc3\xa4hrend/IN/B-PP/B-PNP basische/JJ/B-NP/I-PNP pHa-Werte/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Stromamplitude/NN/I-NP/I-PNP erh\xc3\xb6hten/VB/B-VP/O und/CC/O/O die/DT/B-NP/O Aktivierungskinetik/NN/I-NP/O beschleunigten/NN/I-NP/O ,/,/O/O bewirkten/VB/B-VP/O saure/JJ/B-NP/O pHa-Werte/NN/I-NP/O das/DT/B-NP/O Gegenteil/NN/I-NP/O ././O/O

Im/IN/B-PP/B-PNP Gegensatz/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP einigen/JJ/B-NP/I-PNP anderen/JJ/I-NP/I-PNP CLCs/NN/I-NP/I-PNP konnte/VB/B-VP/O keine/JJ/B-NP/O Abh\xc3\xa4ngigkeit/NN/I-NP/O von/IN/B-PP/B-PNP ATP/NNP/B-NP/I-PNP festgestellt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Neben/IN/B-PP/B-PNP der/DT/B-NP/I-PNP biophysikalischen/JJ/I-NP/I-PNP Charakterisierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP ClC-7/NN/B-NP/I-PNP ,/,/O/O die/WDT/B-NP/O den/DT/I-NP/O Weg/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP weiterf\xc3\xbchrende/NN/B-NP/I-PNP Struktur-Funktions-Studien/NN/I-NP/I-PNP ebnet/RP/O/O ,/,/O/O konnte/VB/B-VP/O durch/IN/B-PP/B-PNP diese/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP auch/RB/B-ADVP/O das/DT/B-NP/O Konzept/NN/I-NP/O des/DT/B-NP/O Spannungs-abh\xc3\xa4ngigen/JJ/I-NP/O Schaltverhaltens/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP Kan\xc3\xa4le/NN/B-NP/I-PNP hinaus/IN/B-PP/B-PNP auf/IN/I-PP/I-PNP Transporter/JJ/B-ADJP/O erweitert/VB/B-VP/O werden.Der/NN/B-NP/O erstmals/RB/B-ADVP/O 1988/CD/B-NP/O beschriebene/NN/I-NP/O Actinomyceten-Stamm/NN/I-NP/O Actinomadura/NN/I-NP/O namibiensis/NN/I-NP/O produziert/JJ/B-ADJP/O in/IN/B-PP/B-PNP seinem/PRP$/B-NP/I-PNP Kultur\xc3\xbcberstand/NN/I-NP/I-PNP die/DT/I-NP/I-PNP drei/CD/I-NP/I-PNP Sekund\xc3\xa4rmetabolite/NN/I-NP/I-PNP LabA1/NN/I-NP/I-PNP ,/,/O/O A2/NN/B-NP/O und/CC/I-NP/O A3/NNP/I-NP/O ././O/O

Dabei/RB/B-VP/O handelt/VB/I-VP/O es/PRP/B-NP/O sich/PRP/I-NP/O um/IN/B-PP/B-PNP ribosomal/NN/B-NP/I-PNP synthetisierte/NN/I-NP/I-PNP Peptide/NN/I-NP/I-PNP ,/,/O/O welche/WDT/O/O aufgrund/IN/B-PP/B-PNP ihrer/PRP$/B-NP/I-PNP posttranslational/NN/I-NP/I-PNP eingef\xc3\xbchrten/JJ/I-NP/I-PNP Lanthionin-Verbr\xc3\xbcckungen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Gruppe/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Lantibiotika/NN/I-NP/I-PNP eingeordnet/NN/I-NP/I-PNP wurden/VB/B-VP/O ././O/O

Die/DT/B-NP/O Aufkl\xc3\xa4rung/NN/I-NP/O der/DT/B-NP/O R\xc3\xb6ntgenkristallstruktur/NN/I-NP/O von/IN/B-PP/B-PNP Labyrinthopeptin/NN/B-NP/I-PNP A2/NN/I-NP/I-PNP erbrachte/NN/I-NP/I-PNP weitere/JJ/I-NP/I-PNP detaillierte/JJ/I-NP/I-PNP Einblicke/NN/I-NP/I-PNP in/IN/B-PP/O die/DT/O/O bis/IN/B-PP/O dato/RB/B-ADVP/O noch/RB/I-ADVP/O relativ/IN/B-PP/B-PNP unbekannte/NN/B-NP/I-PNP Klasse/NN/I-NP/I-PNP III/CD/I-NP/I-PNP Lantibiotika/NN/I-NP/I-PNP ././O/O

Eine/DT/B-NP/O zentrale/JJ/I-NP/O Erkenntnis/NN/I-NP/O war/VB/B-VP/O vor/IN/B-PP/B-PNP allem/DT/B-NP/I-PNP die/DT/I-NP/I-PNP Entdeckung/NN/I-NP/I-PNP eines/DT/B-NP/I-PNP neuartigen/JJ/I-NP/I-PNP Labionin-Motives/NN/I-NP/I-PNP ././O/O

Mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Identifizierung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Genclusters/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Labyrinthopeptine/NN/I-NP/I-PNP wurde/VB/B-VP/O zudem/RB/B-ADVP/O der/DT/B-NP/O Grundstein/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP weitere/JJ/I-NP/I-PNP Untersuchung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Biosynthese/NN/I-NP/I-PNP gelegt/RP/O/O ././O/O

Neben/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Sequenzen/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Vorl\xc3\xa4uferpeptide/NN/I-NP/I-PNP von/IN/B-PP/B-PNP LabA1/NN/B-NP/I-PNP und/CC/I-NP/I-PNP LabA2/NN/I-NP/I-PNP codieren/NN/I-NP/I-PNP weiterhin/VB/B-VP/O zwei/CD/B-NP/O Gene/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Export/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Peptide/NN/I-NP/I-PNP ,/,/O/O sowie/CC/O/O ein/DT/B-NP/O Gen/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP Enzym/NN/I-NP/I-PNP LabKC/NN/I-NP/I-PNP ,/,/O/O welches/WDT/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Einf\xc3\xbchrung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Labionin-Verbr\xc3\xbcckungen/NN/I-NP/I-PNP verantwortlich/JJ/B-ADJP/O ist/VB/B-VP/O ././O/O

Durch/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP mit/IN/B-PP/O anderen/JJ/B-ADJP/O bekannten/VB/B-VP/O Enzymen/NN/B-NP/O konnten/RB/B-ADVP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Sequenz/NN/I-NP/I-PNP von/IN/B-PP/B-PNP LabKC/NN/B-NP/I-PNP eine/DT/I-NP/I-PNP N-terminale/NN/I-NP/I-PNP Lyase/NN/I-NP/I-PNP -/-/O/O und/CC/O/O eine/DT/B-NP/O zentrale/JJ/I-NP/O Ser&slash;Thr-Kinase-Dom\xc3\xa4ne/NN/I-NP/O sowie/RB/B-ADVP/O eine/DT/B-NP/O C-terminale/JJ/I-NP/O Dom\xc3\xa4ne/NN/I-NP/O mit/IN/B-PP/B-PNP \xc3\x84hnlichkeit/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP Lantibiotika-Zyklasen/NN/B-NP/I-PNP identifiziert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Der/DT/B-NP/O vorgeschlagene/JJ/I-NP/O Mechanismus/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Labionin-Bildung/NN/I-NP/I-PNP sieht/VB/B-VP/O zun\xc3\xa4chst/RB/B-ADVP/O die/DT/B-NP/O Phosphorylierung/NN/I-NP/O von/IN/B-PP/B-PNP zwei/CD/B-NP/I-PNP Serin-Resten/NN/I-NP/I-PNP im/IN/B-PP/B-PNP LabA2/JJ/B-NP/I-PNP Pr\xc3\xa4propeptid/NN/I-NP/I-PNP vor/RP/O/O ,/,/O/O gefolgt/JJ/B-ADJP/O von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP anschlie\xc3\x9fenden/JJ/I-NP/I-PNP Zyklisierung/NN/I-NP/I-PNP \xc3\xbcber/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP C-terminales/NN/I-NP/I-PNP Cystein/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP doppelte/JJ/I-NP/I-PNP Michael-Addition/NN/I-NP/I-PNP ././O/O

Ausgehend/JJ/B-ADJP/O von/IN/B-PP/B-PNP diesen/DT/B-NP/I-PNP Vorkenntnissen/NN/I-NP/I-PNP war/VB/B-VP/O das/DT/B-NP/O Hauptziel/NN/I-NP/O der/DT/B-NP/O vorliegenden/JJ/I-NP/O Arbeit/NN/I-NP/O zun\xc3\xa4chst/RB/B-ADVP/O die/DT/B-NP/O Etablierung/NN/I-NP/O eines/DT/O/O in/IN/B-PP/B-PNP vitro/JJ/B-NP/I-PNP Enzym-Assays/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Untersuchung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Labyrinthopeptin-Biosynthese/NN/I-NP/I-PNP ././O/O

Damit/RB/B-ADVP/O sollte/MD/B-VP/O eine/DT/B-NP/O detaillierte/NN/I-NP/O Charakterisierung/NN/I-NP/O der/DT/B-NP/O Funktionsweise/NN/I-NP/O des/DT/B-NP/O LabA2-prozessierenden/NN/I-NP/O Enzyms/NN/I-NP/O LabKC/NN/I-NP/O erm\xc3\xb6glicht/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Hierzu/VBN/B-VP/O wurde/VB/I-VP/O dieses/DT/B-NP/O zun\xc3\xa4chst/RB/I-NP/O erfolgreich/JJ/I-NP/O kloniert/NN/I-NP/O ,/,/O/O in/IN/B-PP/B-PNP E./JJ/B-NP/I-PNP coli/NN/I-NP/I-PNP exprimiert/NN/I-NP/I-PNP und/CC/O/O gereinigt/RP/O/O ././O/O

Die/DT/B-NP/O Bereitstellung/NN/I-NP/O geeigneter/JJ/B-NP/O Peptidsubstrate/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP enzymatische/JJ/I-NP/I-PNP Umsetzung/NN/I-NP/I-PNP erfolgte/VB/B-VP/O mittels/IN/B-PP/B-PNP chemischer/JJ/B-NP/I-PNP Peptidsynthese/NN/I-NP/I-PNP an/IN/B-PP/B-PNP fester/JJ/B-NP/I-PNP Phase/NN/I-NP/I-PNP ././O/O

Nach/IN/B-PP/B-PNP Optimierung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Assay-Bedingungen/NN/I-NP/I-PNP sowie/RB/B-ADVP/O unter/IN/B-PP/B-PNP Verwendung/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Nukleotids/NN/I-NP/I-PNP GTP/NNP/I-NP/I-PNP als/IN/B-PP/B-PNP Co-Substrat/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Phosphorylierungsreaktion/NN/I-NP/I-PNP konnte/VB/B-VP/O schlie\xc3\x9flich/RB/B-ADVP/O die/DT/B-NP/O komplette/JJ/I-NP/O Dehydratisierung/NN/I-NP/O und/CC/O/O Zyklisierung/NN/B-NP/O eines/DT/B-NP/O synthetischen/JJ/I-NP/O LabA2-Pr\xc3\xa4propeptids/NN/I-NP/O erreicht/VBN/B-VP/O werden/VB/I-VP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Analytik/NN/I-NP/I-PNP der/DT/B-NP/I-PNP enzymatischen/JJ/I-NP/I-PNP Umsetzungen/NN/I-NP/I-PNP wurden/VB/B-VP/O massenspektrometrische/JJ/B-NP/O Methoden/NN/I-NP/O angewandt/JJ/B-ADJP/O ././O/O

Nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Optimierung/NN/I-NP/I-PNP und/CC/O/O Charakterisierung/NN/B-NP/O wichtiger/JJ/B-NP/O Parameter/NN/I-NP/O f\xc3\xbcr/IN/B-PP/O die/DT/O/O in/IN/B-PP/B-PNP vitro/JJ/B-NP/I-PNP Umsetzung/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP LabKC/NN/B-NP/I-PNP stand/VB/B-VP/O die/DT/B-NP/O Untersuchung/NN/I-NP/O des/DT/B-NP/O katalytischen/JJ/I-NP/O Mechanismus/NN/I-NP/O im/IN/B-PP/B-PNP Mittelpunkt/NN/B-NP/I-PNP der/DT/I-NP/I-PNP weiteren/JJ/I-NP/I-PNP Arbeiten/NN/I-NP/I-PNP ././O/O

Unter/IN/B-PP/B-PNP Anwendung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Mutagenese-Methoden/NN/B-NP/I-PNP konnten/VB/B-VP/O katalytisch/JJ/B-NP/O wichtige/JJ/I-NP/O Aminos\xc3\xa4ureseitenketten/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Lyase/NN/I-NP/I-PNP -/-/O/O und/CC/O/O Ser&slash;Thr-Kinase/JJ/B-NP/O Dom\xc3\xa4ne/NN/I-NP/O von/IN/B-PP/B-PNP LabKC/NN/B-NP/I-PNP identifiziert/NN/I-NP/I-PNP und/CC/I-NP/I-PNP ein/DT/I-NP/I-PNP entsprechender/JJ/I-NP/I-PNP Mechanismus/NN/I-NP/I-PNP postuliert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Der/DT/B-NP/O Reaktionsablauf/NN/I-NP/O der/DT/B-NP/O Labyrinthopeptin-Biosynthese/NN/I-NP/O wurde/VB/B-VP/O zudem/RB/B-ADVP/O durch/IN/B-PP/B-PNP Umsetzungen/NN/B-NP/I-PNP synthetischer/JJ/I-NP/I-PNP Labyrinthopeptin-Derivate/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP LabKC/NN/B-NP/I-PNP untersucht/RP/O/O ././O/O

Ein/DT/B-NP/O weiteres/DT/I-NP/O Ziel/NN/I-NP/O war/VB/B-VP/O die/DT/B-NP/O detaillierte/NN/I-NP/O Untersuchung/NN/I-NP/O der/DT/B-NP/O Rolle/NN/I-NP/O des/DT/B-NP/O Leaderpeptids/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Biosynthese/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Labyrinthopeptine/NN/I-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP konnte/VB/B-VP/O durch/IN/B-PP/B-PNP Testierung/NN/B-NP/I-PNP zahlreicher/JJ/I-NP/I-PNP LabA2-Leaderpeptid-Varianten/NN/I-NP/I-PNP die/DT/B-NP/I-PNP absolute/JJ/I-NP/I-PNP Notwendigkeit/NN/I-NP/I-PNP dieser/DT/B-NP/I-PNP Aminos\xc3\xa4uresequenz/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP erfolgreiche/JJ/I-NP/I-PNP Prozessierung/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP LabKC/NN/B-NP/I-PNP gezeigt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Weiterhin/VBN/B-VP/O wurde/VB/I-VP/O ein/DT/B-NP/O Erkennungsmotiv/NN/I-NP/O identifiziert/NN/I-NP/O und/CC/O/O charakterisiert/NN/B-NP/O ././O/O

Im/IN/B-PP/B-PNP Fokus/NN/B-NP/I-PNP zuk\xc3\xbcnftiger/JJ/I-NP/I-PNP Arbeiten/NN/I-NP/I-PNP steht/VB/B-VP/O die/DT/B-NP/O Aufkl\xc3\xa4rung/NN/I-NP/O des/DT/B-NP/O Mechanismus/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Labionin-Zyklisierung/NN/I-NP/I-PNP sowie/RB/B-ADVP/O die/DT/B-NP/O Strukturaufkl\xc3\xa4rung/NN/I-NP/O von/IN/B-PP/B-PNP LabKC/NN/B-NP/I-PNP oder/RB/I-NP/I-PNP homologen/JJ/I-NP/I-PNP Enzymen/NN/I-NP/I-PNP mittels/IN/B-PP/B-PNP R\xc3\xb6ntgenkristallographie.Mit/NN/B-NP/I-PNP den/DT/I-NP/I-PNP Zelllinien/NN/I-NP/I-PNP D11/NN/I-NP/I-PNP ,/,/O/O RTG-2/NN/B-NP/O und/CC/I-NP/O PLHC-1/NN/I-NP/O wurde/VB/B-VP/O auf/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Basis/NN/I-NP/I-PNP der/DT/B-NP/I-PNP alkalischen/JJ/I-NP/I-PNP DNS-Aufwindung/NN/I-NP/I-PNP ein/DT/B-NP/I-PNP eukaryontisches/JJ/I-NP/I-PNP Testsystem/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP Gentoxizit\xc3\xa4tspr\xc3\xbcfung/NN/B-NP/I-PNP entwickelt/VB/B-VP/O ././O/O

Die/DT/B-NP/O RTG-2/NN/I-NP/O Zellen/NNS/I-NP/O erwiesen/VB/B-VP/O dabei/RB/B-ADVP/O als/IN/B-PP/B-PNP einfacher/NN/B-NP/I-PNP und/CC/O/O \xc3\xb6konomischer/JJ/B-ADJP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Vermehrung/NN/I-NP/I-PNP ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Pr\xc3\xbcfung/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP akute/NN/B-NP/I-PNP Gentoxizit\xc3\xa4t/NN/I-NP/I-PNP reichen/VB/B-VP/O kurze/JJ/B-NP/O Behandlungszeiten/NN/I-NP/O ././O/O

Lange/IN/B-PP/B-PNP Behandlungszeiten/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP hohen/JJ/B-NP/I-PNP Antibiotika-Konzentrationen/NN/I-NP/I-PNP k\xc3\xb6nnen/VB/B-VP/O dagegen/RB/B-ADVP/O das/DT/B-NP/O Ergebnis/NN/I-NP/O verf\xc3\xa4lschen/VB/B-VP/O ././O/O

Das/DT/B-NP/O langsame/JJ/I-NP/O Wachstum/NN/I-NP/O der/DT/B-NP/O Zelllinen/NN/I-NP/O erlaubt/VB/B-VP/O au\xc3\x9ferdem/RB/B-ADVP/O Untersuchungen/NN/B-NP/O zur/IN/B-PP/B-PNP DNS-Reparatur/NN/B-NP/I-PNP ohne/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Zusatz/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Wachstumshemmern/NN/B-NP/I-PNP ././O/O

Die/DT/B-NP/O Evaluierung/NN/I-NP/O des/DT/B-NP/O DNS-Aufwindungstests/NN/I-NP/O mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Zelllinien/NN/I-NP/I-PNP RTG-2/NN/I-NP/I-PNP und/CC/O/O PLHC-1/NN/B-NP/O erfolgte/VB/B-VP/O anhand/IN/B-PP/B-PNP von/IN/I-PP/I-PNP 5/CD/B-NP/I-PNP Referenzsubstanzen/NN/I-NP/I-PNP und/CC/O/O 16/CD/B-NP/O nativen/JJ/I-NP/O Abwasserproben/NN/I-NP/O ././O/O

Dabei/RB/B-VP/O erwies/VB/I-VP/O sich/PRP/B-NP/O die/DT/I-NP/O Zelllinie/NN/I-NP/O RTG-2/NN/I-NP/O ,/,/O/O trotz/IN/B-PP/B-PNP ihres/PRP$/B-NP/I-PNP niedrigeren/JJ/I-NP/I-PNP Temperaturoptimums/NN/I-NP/I-PNP ,/,/O/O als/IN/B-PP/O empfindlicher/VB/B-VP/O im/IN/B-PP/B-PNP Nachweis/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Gentoxizit\xc3\xa4t/NN/B-NP/I-PNP ,/,/O/O als/IN/B-PP/O die/DT/O/O ,/,/O/O bei/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP h\xc3\xb6heren/JJ/I-NP/I-PNP Temperaturoptimum/NN/I-NP/I-PNP erheblich/JJ/B-NP/I-PNP schneller/JJ/I-NP/I-PNP wachsende/JJ/I-NP/I-PNP Zelllinie/JJ/I-NP/I-PNP PLHC-1/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Aktivierung/NN/I-NP/O des/DT/O/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP PLHC-1/NN/I-NP/I-PNP Zelllinie/NN/I-NP/I-PNP vorhandenen/JJ/B-NP/I-PNP P450/NN/I-NP/I-PNP Systems/NN/I-NP/I-PNP bewirkte/NN/I-NP/I-PNP keine/JJ/B-NP/I-PNP \xc3\x84nderung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Ergebnisses/NN/I-NP/I-PNP ././O/O

Gegen\xc3\xbcber/NN/B-NP/O zytotoxischen/JJ/I-NP/O Einfl\xc3\xbcssen/NN/I-NP/O erwies/VB/B-VP/O sich/PRP/B-NP/O die/DT/I-NP/O PLHC-1/NN/I-NP/O Zelllinie/NN/I-NP/O als/IN/B-PP/B-PNP etwas/DT/B-NP/I-PNP empfindlicher/NN/I-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP umu-Test/NN/I-NP/I-PNP wurde/VB/B-VP/O mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Zelllinien/NN/I-NP/I-PNP RTG-2/NN/I-NP/I-PNP und/CC/O/O PLHC-1/NN/B-NP/O nach/IN/B-PP/B-PNP \xc3\x9cbereinstimmung/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Nachweis/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Zytotoxizit\xc3\xa4t/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Gentoxizit\xc3\xa4t/NN/I-NP/I-PNP gesucht/RP/O/O ././O/O

Bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP vergleichenden/JJ/I-NP/I-PNP Untersuchung/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP 5/CD/I-NP/I-PNP Referenzsubstanzen/NN/I-NP/I-PNP fiel/VB/B-VP/O die/DT/B-NP/O fehlende/JJ/I-NP/O Empfindlichkeit/NN/I-NP/O gegen\xc3\xbcber/IN/B-PP/O der/DT/O/O als/IN/B-PP/B-PNP mutagen/NN/B-NP/I-PNP bekannten/JJ/I-NP/I-PNP Substanz/JJ/I-NP/I-PNP 2-AAFauf/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O der/DT/B-NP/O Untersuchungen/NN/I-NP/O mit/IN/B-PP/B-PNP Elektroporation/NN/B-NP/I-PNP zeigen/VB/B-VP/O ,/,/O/O das/WDT/B-NP/O es/PRP/I-NP/O sich/PRP/I-NP/O hierbei/NN/I-NP/O nicht/RB/B-ADVP/O allein/RB/I-ADVP/O um/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP Problem/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Transports/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Zellmembran/NN/I-NP/I-PNP handeln/VB/B-VP/O kann/VB/I-VP/O ././O/O

Ebenso/RB/B-ADJP/O auff\xc3\xa4llig/JJ/I-ADJP/O waren/VB/B-VP/O die/DT/B-NP/O positiven/JJ/I-NP/O Ergebnisse/NN/I-NP/O der/DT/B-NP/O nicht-induzierten/NN/I-NP/O RTG-2/NN/I-NP/O Zellen/NNS/I-NP/O und/CC/O/O die/DT/B-NP/O fehlende/NN/I-NP/O Empfindlichkeit/NN/I-NP/O der/DT/B-NP/O induzierten/NN/I-NP/O PLHC-1/NN/I-NP/O Zellen/NNS/I-NP/O gegen\xc3\xbcber/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Substanzen/NNS/I-NP/I-PNP 2-AAF/NN/I-NP/I-PNP und/CC/O/O BaP/NNP/B-NP/O ././O/O

Die/DT/B-NP/O Substanz/NN/I-NP/O Nitrofurantoin/NN/I-NP/O sollte/MD/B-VP/O eigentlich/JJ/B-ADJP/O nur/RB/B-ADVP/O gegen/IN/B-PP/B-PNP Bakterien/NN/B-NP/I-PNP wirksam/JJ/B-ADJP/O sein/VB/B-VP/O ,/,/O/O aber/CC/O/O auch/RB/B-ADVP/O die/DT/B-NP/O RTG-2/NN/I-NP/O Zellen/NNS/I-NP/O reagierten/NN/I-NP/O darauf/VB/B-VP/O mit/IN/B-PP/B-PNP erh\xc3\xb6hter/JJ/B-NP/I-PNP DNS-Fragmentierung/NN/I-NP/I-PNP ././O/O

Der/DT/B-NP/O Vergleich/NN/I-NP/O mit/IN/B-PP/B-PNP Literaturwerten/NN/B-NP/I-PNP zeigt/VB/B-VP/O die/DT/B-NP/O N\xc3\xa4he/NN/I-NP/O der/DT/B-NP/O permanenten/JJ/I-NP/O Zelllinien/NN/I-NP/O zu/RB/B-NP/O prim\xc3\xa4r/JJ/I-NP/O gewonnenen/NN/I-NP/O Zellen/NNS/I-NP/O derselben/NN/I-NP/O Art/NN/I-NP/O und/CC/O/O zu/IN/B-PP/B-PNP verwandten/JJ/B-NP/I-PNP Arten/NN/I-NP/I-PNP ././O/O

Anhand/IN/B-PP/B-PNP von/IN/I-PP/I-PNP 91/CD/B-NP/I-PNP Abwasserproben/NN/I-NP/I-PNP wurde/VB/B-VP/O an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Zelllinie/NN/I-NP/I-PNP RTG-2/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Bedeutung/NN/I-NP/I-PNP und/CC/O/O Problematik/NN/B-NP/O der/DT/B-NP/O Pr\xc3\xbcfung/NN/I-NP/O nativer/NN/I-NP/O Abwasserproben/NN/I-NP/O untersucht/RP/O/O ././O/O

Zus\xc3\xa4tzlich/VBN/B-VP/O wurde/VB/I-VP/O der/DT/B-NP/O Einflu\xc3\x9f/NN/I-NP/O der/DT/B-NP/O EROD-Aktivit\xc3\xa4t/NN/I-NP/O und/CC/O/O deren/DT/B-NP/O Problematik/NN/I-NP/O anhand/IN/B-PP/B-PNP von/IN/I-PP/I-PNP 16/CD/B-NP/I-PNP Wasserproben/NN/I-NP/I-PNP an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Zelllinie/NN/I-NP/I-PNP PLHC-1/NN/I-NP/I-PNP untersucht/RP/O/O ././O/O

Mit/IN/B-PP/B-PNP Ausnahme/NN/B-NP/I-PNP einiger/RB/I-NP/I-PNP stark/JJ/I-NP/I-PNP f\xc3\xa4rbender/NN/I-NP/I-PNP Proben/NN/I-NP/I-PNP gab/VB/B-VP/O es/PRP/B-NP/O dabei/RB/I-NP/O keine/JJ/I-NP/O Schwierigkeiten/NN/I-NP/O ././O/O

Die/DT/B-NP/O Bedeutung/NN/I-NP/O der/DT/B-NP/O prim\xc3\xa4ren/NN/I-NP/O DNS-Sch\xc3\xa4den/NN/I-NP/O als/IN/B-PP/B-PNP Quelle/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP erh\xc3\xb6hte/NN/I-NP/I-PNP und/CC/O/O sich/PRP/B-NP/O negativ/JJ/B-NP/O auswirkende/JJ/I-NP/O Mutationsrate/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP Wildpopulationen/NN/B-NP/I-PNP wird/RB/B-ADJP/O international/JJ/I-ADJP/O anerkannt/RP/O/O ././O/O

Kein/JJ/B-NP/O Zweifel/NN/I-NP/O besteht/VB/B-VP/O auch/RB/B-ADVP/O hinsichtlich/IN/B-PP/O des/DT/O/O ,/,/O/O durch/IN/B-PP/B-PNP Schadstoffe/NN/B-NP/I-PNP entstehenden/NN/I-NP/I-PNP ,/,/O/O Selektionsdrucks/NN/B-NP/O ././O/O

Vor/IN/B-PP/B-PNP diesem/DT/B-NP/I-PNP Hintergrund/NN/I-NP/I-PNP ist/VB/B-VP/O die/DT/B-NP/O Menge/NN/I-NP/O gentoxischer/NN/I-NP/O Gemische/VB/B-VP/O in/IN/B-PP/B-PNP Abw\xc3\xa4ssern/NN/B-NP/I-PNP besorgniserregend/JJ/B-ADJP/O ././O/O

Anhand/IN/B-PP/B-PNP der/DT/B-NP/I-PNP eigenen/JJ/I-NP/I-PNP Ergebnisse/NN/I-NP/I-PNP und/CC/O/O von/IN/B-PP/B-PNP Literaturangaben/NN/B-NP/I-PNP wurden/VB/B-VP/O die/DT/B-NP/O Ergebnisse/NN/I-NP/O aus/IN/B-PP/B-PNP in/IN/I-PP/I-PNP Vitro/JJ/B-NP/I-PNP Tests/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Ergebnissen/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Feldstudien/NN/B-NP/I-PNP vergleichend/JJ/B-ADJP/O untersucht/RP/O/O ././O/O

Auch/RB/B-ADVP/O unter/IN/B-PP/B-PNP Laborbedingungen/NN/B-NP/I-PNP ist/VB/B-VP/O eine/DT/O/O durch/IN/B-PP/B-PNP Modellsubstanzen/NN/B-NP/I-PNP bedingte/JJ/I-NP/I-PNP Zunahme/NN/I-NP/I-PNP an/IN/B-PP/B-PNP DNS-Fragmentierung/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Fischen/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Muscheln/NN/I-NP/I-PNP gegen\xc3\xbcber/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Negativ-Kontrolle/NN/I-NP/I-PNP messbar/JJ/B-ADJP/O ././O/O

Die/DT/B-NP/O Untersuchung/NN/I-NP/O der/DT/B-NP/O vorliegenden/JJ/I-NP/O Ergebnisse/NN/I-NP/O aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Freilandbeobachtungen/NN/I-NP/I-PNP erlaubt/VB/B-VP/O aber/RB/B-NP/O keine/JJ/I-NP/O Herstellung/NN/I-NP/O einfacher/NN/I-NP/O kausaler/NN/I-NP/O Zusammenh\xc3\xa4nge/NN/I-NP/O ,/,/O/O da/IN/B-PP/B-PNP bei/IN/I-PP/I-PNP Wildf\xc3\xa4ngen/NN/B-NP/I-PNP eine/DT/I-NP/I-PNP ad\xc3\xa4quate/JJ/I-NP/I-PNP Negativkontrolle/NN/I-NP/I-PNP immer/JJ/B-ADJP/O fehlt/VB/B-VP/O ././O/O

Belastungen/NN/B-NP/O mit/IN/B-PP/B-PNP Giftstoffen/NNP/B-NP/I-PNP sowie/CC/I-NP/I-PNP die/DT/I-NP/I-PNP Umweltbedingungen/NN/I-NP/I-PNP k\xc3\xb6nnen/VB/B-VP/O sowohl/CC/O/O die/DT/B-NP/O F\xc3\xa4higkeit/NN/I-NP/O zur/IN/B-PP/B-PNP Metabolisierung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Giften/NN/B-NP/I-PNP als/CC/O/O auch/RB/B-ADVP/O die/DT/B-NP/O F\xc3\xa4higkeit/NN/I-NP/O zur/IN/B-PP/B-PNP DNS-Reparatur/NN/B-NP/I-PNP beeinflussen/VB/B-VP/O ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O zeigen/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O noch/RB/B-ADVP/O immer/RB/B-ADVP/O nicht/RB/B-NP/O gen\xc3\xbcgend/JJ/I-NP/O Informationen/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Bandbreite/NN/I-NP/I-PNP nat\xc3\xbcrlicher/IN/B-PP/B-PNP Variabilit\xc3\xa4t/NN/B-NP/I-PNP bei/IN/B-PP/B-PNP diesem/DT/B-NP/I-PNP Biomarker/NN/I-NP/I-PNP vorliegen.Bislang/NN/I-NP/I-PNP ist/VB/B-VP/O die/DT/B-NP/O Anzahl/NN/I-NP/O der/DT/B-NP/O gepr\xc3\xa4gten/NN/I-NP/O Gene/NN/I-NP/O nicht/RB/B-VP/O bekannt/VB/I-VP/O ,/,/O/O daher/RB/B-NP/O sind/JJ/I-NP/O systematische/JJ/I-NP/O Analysen/NN/I-NP/O zur/IN/B-PP/B-PNP genomweiten/NN/B-NP/I-PNP Identifizierung/NN/I-NP/I-PNP neuer/JJ/I-NP/I-PNP gepr\xc3\xa4gter/NN/I-NP/I-PNP Gene/NN/I-NP/I-PNP notwendig/JJ/B-ADJP/O ././O/O

In/IN/B-PP/B-PNP zwei/CD/B-NP/I-PNP aktuellen/JJ/I-NP/I-PNP Studien/NN/I-NP/I-PNP wurden/VB/B-VP/O mit/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP methodischen/JJ/I-NP/I-PNP Ans\xc3\xa4tzen/NN/I-NP/I-PNP 2101/CD/B-NP/I-PNP bzw./CC/I-NP/I-PNP 600/CD/I-NP/I-PNP neue/JJ/I-NP/I-PNP gepr\xc3\xa4gte/NN/I-NP/I-PNP Kandidatengene/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Mausgenom/NN/B-NP/I-PNP vorhergesagt/VBN/B-VP/I-PNP ,/,/O/O die/WDT/O/O noch/RB/B-ADVP/O durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP allelspezifische/JJ/I-NP/I-PNP Expressionsanalyse/NN/I-NP/I-PNP validiert/NN/I-NP/I-PNP werden/VB/B-VP/O mussten/VBN/I-VP/O ././O/O

Das/DT/B-NP/O prim\xc3\xa4re/JJ/I-NP/O Ziel/NN/I-NP/O der/DT/B-NP/O vorliegenden/JJ/I-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O die/DT/B-NP/O Identifizierung/NN/I-NP/O neuer/JJ/B-NP/O gepr\xc3\xa4gter/JJ/I-NP/O Gene/NN/I-NP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP systematische/JJ/I-NP/I-PNP Analyse/NN/I-NP/I-PNP vielversprechender/JJ/B-NP/I-PNP Kandidatengene/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP beiden/DT/B-NP/I-PNP Studien/NN/I-NP/I-PNP ././O/O

Zun\xc3\xa4chst/VBN/B-VP/O wurde/VB/I-VP/O mit/IN/B-PP/B-PNP QUASEP/NNP/B-NP/I-PNP eine/DT/I-NP/I-PNP neue/JJ/I-NP/I-PNP Methode/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP allelspezifischen/JJ/B-NP/I-PNP Expressionsanalyse/NN/I-NP/I-PNP etabliert/NN/I-NP/I-PNP ,/,/O/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP es/PRP$/I-NP/I-PNP m\xc3\xb6glich/JJ/B-NP/I-PNP ist/JJ/I-NP/I-PNP ,/,/I-NP/I-PNP selbst/JJ/I-NP/I-PNP geringe/JJ/I-NP/I-PNP allelische/JJ/I-NP/I-PNP Expressionsunterschiede/NN/I-NP/I-PNP genau/NNP/I-NP/I-PNP und/CC/O/O reproduzierbar/JJ/B-ADJP/O zu/TO/B-VP/O analysieren/VB/I-VP/O ././O/O

Damit/RB/B-VP/O stellt/VB/I-VP/O QUASEP/NNP/B-NP/O im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP anderen/JJ/B-NP/I-PNP Anwendungen/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Methode/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Wahl/NN/I-NP/I-PNP dar/RP/O/O ././O/O

Durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP systematische/JJ/I-NP/I-PNP QUASEP-Analyse/NN/I-NP/I-PNP von/IN/B-PP/O insgesamt/RB/B-ADVP/O 71/CD/B-NP/O ausgew\xc3\xa4hlten/JJ/I-NP/O Kandidatengenen/NN/I-NP/O wurde/VB/B-VP/O die/DT/B-NP/O gepr\xc3\xa4gte/JJ/I-NP/O Expression/NN/I-NP/O von/IN/B-PP/B-PNP zwei/CD/B-NP/I-PNP Genen/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP proximalen/JJ/I-NP/I-PNP Maus-Chromosom/NN/I-NP/I-PNP 7/CD/O/O bzw./CC/O/O auf/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP distalen/JJ/I-NP/I-PNP Maus-Chromosom/NN/I-NP/I-PNP 15/CD/B-NP/I-PNP identifiziert/NN/I-NP/I-PNP ././O/O

Da/IN/B-PP/B-PNP die/DT/B-NP/I-PNP gro\xc3\x9fe/JJ/I-NP/I-PNP Mehrzahl/NN/I-NP/I-PNP der/DT/B-NP/I-PNP untersuchten/NN/I-NP/I-PNP Gene/NN/I-NP/I-PNP jedoch/VB/B-VP/O biallelisch/JJ/B-NP/O exprimiert/NN/I-NP/O ist/VB/B-VP/O ,/,/O/O muss/RB/B-ADVP/O die/DT/B-NP/O Effizienz/NN/I-NP/O der/DT/B-NP/O methodischen/JJ/I-NP/O Ans\xc3\xa4tze/NNS/I-NP/O beider/JJ/B-NP/O Studien/NN/I-NP/O als/IN/B-PP/B-PNP gering/JJ/B-NP/I-PNP eingesch\xc3\xa4tzt/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Dies/DT/O/O sollte/MD/B-VP/O in/IN/B-PP/B-PNP zuk\xc3\xbcnftigen/JJ/B-NP/I-PNP Studien/NN/I-NP/I-PNP ber\xc3\xbccksichtigt/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O bei/IN/B-PP/O denen/WDT/O/O mit/IN/B-PP/B-PNP vergleichbarer/NN/B-NP/I-PNP Methodik/NN/I-NP/I-PNP neue/JJ/I-NP/I-PNP gepr\xc3\xa4gte/NN/I-NP/I-PNP Kandidatengene/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP werden/VB/B-VP/O sollen/MD/B-VP/O ././O/O

Neben/IN/B-PP/B-PNP der/DT/B-NP/I-PNP genomischen/JJ/I-NP/I-PNP Pr\xc3\xa4gung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP murinen/NN/I-NP/I-PNP Gene/NN/I-NP/I-PNP konnte/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP humanen/NN/I-NP/I-PNP orthologen/JJ/B-NP/I-PNP Region/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Chromosom/NN/I-NP/I-PNP 19q13.4/NN/I-NP/I-PNP ein/DT/O/O bisher/IN/B-PP/B-PNP unbekanntes/JJ/B-NP/I-PNP Transkript/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP ebenfalls/IN/I-PP/I-PNP monoallelischer/NN/B-NP/I-PNP Expression/NN/I-NP/I-PNP im/IN/B-PP/B-PNP humanen/NN/B-NP/I-PNP fetalen/JJ/I-NP/I-PNP Gehirn/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Auch/RB/B-ADVP/O das/DT/B-NP/O humane/NN/I-NP/O Ortholog/NN/I-NP/O des/DT/B-NP/O zweiten/JJ/I-NP/O murinen/NN/I-NP/O Gens/NN/I-NP/O zeigte/VB/B-VP/O bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP QUASEP-Analyse/NN/I-NP/I-PNP monoallelische/JJ/B-NP/I-PNP Expression/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Pr\xc3\xa4gung/NN/I-NP/O beider/JJ/B-NP/O Mausgene/NN/I-NP/O und/CC/O/O deren/DT/B-NP/O menschlichen/JJ/I-NP/O Orthologen/NN/I-NP/O lassen/VB/B-VP/O unterdessen/NN/B-NP/O zahlreiche/JJ/I-NP/O Fragen/NN/I-NP/O offen/JJ/B-ADJP/O ././O/O

Welche/WP/O/O Rolle/NN/B-NP/O die/DT/I-NP/O genomische/JJ/I-NP/O Pr\xc3\xa4gung/NN/I-NP/O beider/JJ/B-NP/O Gene/NN/I-NP/O hinsichtlich/IN/B-PP/B-PNP Imprinting-Regulation/NN/B-NP/I-PNP oder/RB/I-NP/I-PNP Entwicklung/NN/I-NP/I-PNP spielt/NN/I-NP/I-PNP ,/,/O/O muss/VB/B-VP/O in/IN/B-PP/B-PNP zuk\xc3\xbcnftigen/JJ/B-NP/I-PNP Studien/NN/I-NP/I-PNP gekl\xc3\xa4rt/VB/B-VP/O werden.F\xc3\xbcr/NN/B-NP/O die/DT/I-NP/O Transplantation/NN/I-NP/O von/IN/B-PP/B-PNP allogenem/NN/B-NP/I-PNP Gewebe/NN/I-NP/I-PNP als/IN/B-PP/B-PNP VKB\xe2\x80\x93Ersatz/NN/B-NP/I-PNP wird/VB/B-VP/O in/IN/B-PP/B-PNP Deutschland/NNP/B-NP/I-PNP eine/DT/I-NP/I-PNP sichere/NN/I-NP/I-PNP Keiminaktivierung/NN/I-NP/I-PNP verlangt/VBN/B-VP/I-PNP ,/,/O/O um/IN/B-PP/B-PNP Graft-versus-Host-Infektionen/NN/B-NP/I-PNP zu/TO/B-VP/O verhindern/VB/I-VP/O ././O/O

Insbesondere/RB/B-ADVP/O um/IN/B-PP/B-PNP klinisch/JJ/B-NP/I-PNP relevante/NN/I-NP/I-PNP Viren/NN/I-NP/I-PNP sicher/VB/B-VP/O zu/IN/B-PP/B-PNP inaktivieren/NN/B-NP/I-PNP ,/,/O/O sind/JJ/B-NP/O Bestrahlungsdosen/NN/I-NP/O von/IN/B-PP/O mehr/RB/B-ADVP/O als/IN/B-PP/B-PNP 30/CD/B-NP/I-PNP kGy/NNP/I-NP/I-PNP erforderlich/JJ/B-ADJP/O ././O/O

Diese/DT/O/O f\xc3\xbchren/VB/B-VP/O jedoch/RB/B-ADVP/O zu/IN/B-PP/B-PNP irreversiblen/NN/B-NP/I-PNP Sch\xc3\xa4digungen/NN/I-NP/I-PNP der/DT/I-NP/I-PNP allogenen/JJ/I-NP/I-PNP Sehnentransplantate/NN/I-NP/I-PNP ././O/O

Das/DT/B-NP/O Ziel/NN/I-NP/O der/DT/O/O vorliegenden/JJ/B-ADJP/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP Untersuchungen/NN/I-NP/I-PNP bestand/VB/B-VP/O daher/RB/B-ADVP/O darin/RB/I-ADVP/O ,/,/O/O dosisabh\xc3\xa4ngige/NN/B-NP/O Einfl\xc3\xbcsse/NNP/I-NP/O der/DT/O/O E-Beam/JJ/B-ADJP/O -/-/O/O und/CC/O/O Gamma/JJ/B-NP/O Sterilisation/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Biomechanik/NN/I-NP/I-PNP von/IN/B-PP/B-PNP allogenen/NN/B-NP/I-PNP und/CC/I-NP/I-PNP autologen/NN/I-NP/I-PNP Sehnen/NN/I-NP/I-PNP zu/TO/B-VP/O \xc3\xbcberpr\xc3\xbcfen/VB/I-VP/O ././O/O

Erstmals/VBN/B-VP/O wurde/VB/I-VP/O dabei/RB/B-ADVP/O eine/DT/B-NP/O fraktionierte/NN/I-NP/O E-Beam-Sterilisation/NN/I-NP/O untersucht/VBN/B-VP/O ,/,/O/O bei/IN/B-PP/B-PNP der/WDT/B-NP/I-PNP die/DT/I-NP/I-PNP erforderliche/JJ/I-NP/I-PNP minimale/JJ/I-NP/I-PNP Dosis/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 34/CD/B-NP/I-PNP kGy/NNP/I-NP/I-PNP in/IN/B-PP/B-PNP 10/CD/B-NP/I-PNP Bestrahlungszyklen/NN/I-NP/I-PNP zu/RB/B-ADVP/O je/RB/I-ADVP/O 3,4/CD/B-NP/O kGy/NNP/I-NP/O appliziert/VBN/B-VP/O wurde/VB/I-VP/O ././O/O

Das/DT/B-NP/O Studiendesign/NN/I-NP/O f\xc3\xbcr/IN/B-PP/O 4/CD/O/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP Untersuchungen/NN/I-NP/I-PNP waren/VB/B-VP/O kontrollierte/VB/I-VP/O ,/,/O/O randomisierte/NN/B-NP/O Laborstudien/NNP/I-NP/O ,/,/O/O in/IN/B-PP/O denen/WP/O/O bestrahlte/NN/B-NP/O und/CC/I-NP/O unbestrahlte/NN/I-NP/O ,/,/O/O tiefgefrorene/JJ/B-NP/O BPTB-Pr\xc3\xa4parate/NN/I-NP/O mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Breite/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 10/CD/B-NP/I-PNP mm/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP 10/CD/B-NP/I-PNP Tagen/JJ/I-NP/I-PNP Konservierung/NN/I-NP/I-PNP (/(/O/O -/-/O/O 70/CD/B-NP/O oC/NN/I-NP/O ;/:/O/O CO2/NN/B-NP/O )/)/O/O zyklischen/JJ/B-NP/O Dehnungstests/NN/I-NP/O unterzogen/VBN/B-VP/O wurden/VB/I-VP/O ././O/O

Anschlie\xc3\x9fend/VBN/B-VP/O wurden/VB/I-VP/O die/DT/B-NP/O biomechanischen/JJ/I-NP/O Eigenschaften/NNS/I-NP/O getestet/NN/I-NP/O ,/,/O/O wobei/WRB/O/O Steifigkeit/NN/B-NP/O ,/,/O/O maximale/NN/B-NP/O Versagenskraft/NNP/I-NP/O ,/,/O/O Dehnung/NN/B-NP/O L1\xe2\x80\x93L200/NNP/I-NP/O ,/,/O/O Dehnungsunterschiede/NN/B-NP/O und/CC/I-NP/O Zyklische/JJ/I-NP/O Elongation/NN/I-NP/O analysiert/VBN/B-VP/O wurden/VB/I-VP/O ././O/O

Die/DT/B-NP/O Gruppenzuteilung/NN/I-NP/O von/IN/B-PP/O insgesamt/RB/B-ADVP/O 142/CD/B-NP/O BPTBPr\xc3\xa4paraten/NN/I-NP/O erfolgte/VB/B-VP/O in/IN/B-PP/B-PNP 4/CD/B-NP/I-PNP Testreihen/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP computergest\xc3\xbctzten/NN/I-NP/I-PNP Randomschema/NN/I-NP/I-PNP :/:/O/O \xe2\x80\xa2/JJ/B-NP/O E-Beam-Bestrahlung/NN/I-NP/O von/IN/B-PP/O 0/CD/O/O ,/,/O/O 15/CD/O/O ,/,/O/O 25/CD/B-NP/O und/CC/I-NP/O 34/CD/I-NP/O kGy/NN/I-NP/O an/IN/B-PP/O je/RB/B-ADVP/O 8/CD/B-NP/O Pr\xc3\xa4paraten/NN/I-NP/O ,/,/O/O \xe2\x80\xa2/JJ/B-NP/O E-Beam-Bestrahlung/NN/I-NP/O von/IN/B-PP/O 0/CD/O/O ,/,/O/O 15/CD/O/O ,/,/O/O 25/CD/B-NP/O und/CC/I-NP/O Gamma/JJ/I-NP/O Bestrahlung/NN/I-NP/O mit/IN/B-PP/B-PNP 25/CD/B-NP/I-PNP kGy/NN/I-NP/I-PNP an/IN/B-PP/O je/RB/B-ADVP/O 10/CD/B-NP/O Pr\xc3\xa4paraten/NN/I-NP/O ,/,/O/O \xe2\x80\xa2/NN/B-NP/O Unbestrahlte/NNP/I-NP/O und/CC/I-NP/O 34/CD/I-NP/O kGy/NNP/I-NP/O E-Beam/JJ/B-ADJP/O -/-/O/O und/CC/O/O Gammabestrahlungan/NN/B-NP/O je/RB/B-ADVP/O 10/CD/B-NP/O Pr\xc3\xa4paraten/NN/I-NP/O ,/,/O/O \xe2\x80\xa2/NN/B-NP/O Unbestrahlte/NNP/I-NP/O ,/,/O/O 34/CD/B-NP/O kGy/NNP/I-NP/O Einzeldosis/NNP/I-NP/O E-Beam/JJ/B-ADJP/O -/-/O/O und/CC/O/O Gammabestrahlungund/NN/B-NP/O 34/CD/B-NP/O kGy/NNP/I-NP/O EBeam/JJ/B-ADJP/O -/-/O/O Bestrahlung/JJ/B-NP/O fraktioniert/NN/I-NP/O (/(/O/O 10/CD/B-NP/O x/NN/I-NP/O 3,4/CD/B-NP/O kGy/NNP/I-NP/O )/)/O/O an/IN/B-PP/O je/RB/B-ADVP/O 10/CD/B-NP/O Pr\xc3\xa4paraten/NN/I-NP/O ././O/O

Die/DT/O/O in/IN/B-PP/B-PNP vitro/JJ/B-NP/I-PNP Untersuchungen/NN/I-NP/I-PNP an/IN/B-PP/B-PNP humanen/NN/B-NP/I-PNP BPTB\xe2\x80\x93Transplantate/NN/I-NP/I-PNP zeigten/VB/B-VP/O in/IN/B-PP/B-PNP \xc3\x9cbereinstimmung/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Literatur/NN/I-NP/I-PNP signifikant/JJ/B-NP/I-PNP schlechtere/NN/I-NP/I-PNP biomechanische/JJ/B-NP/I-PNP Parameter/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Standard/JJ/I-NP/I-PNP EBeam-Bestrahlung/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP 34/CD/B-NP/I-PNP kGy/NNP/I-NP/I-PNP sowie/CC/O/O einer/DT/B-NP/O Gammabestrahlung/NN/I-NP/O mit/IN/B-PP/B-PNP 25/CD/B-NP/I-PNP und/CC/I-NP/I-PNP 34/CD/I-NP/I-PNP kGy/NNP/I-NP/I-PNP im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP nicht/RB/B-NP/I-PNP bestrahlten/JJ/I-NP/I-PNP Sehnenpr\xc3\xa4paraten/NN/I-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP Gegensatz/NN/B-NP/I-PNP dazu/VB/B-VP/O war/RB/B-ADVP/O die/DT/B-NP/O Biomechanik/NN/I-NP/O der/DT/B-NP/O fraktioniert/NN/I-NP/O mit/IN/B-PP/B-PNP 34/CD/B-NP/I-PNP kGy/NNP/I-NP/I-PNP E-Beam/JJ/B-NP/I-PNP bestrahlten/NN/I-NP/I-PNP BPTB\xe2\x80\x93Transplantate/NN/I-NP/I-PNP weitestgehend/JJ/B-ADJP/O identisch/JJ/I-ADJP/O mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP unbestrahlten/JJ/I-NP/I-PNP Vergleichskontrollen/NN/I-NP/I-PNP ././O/O

Eine/DT/B-NP/O m\xc3\xb6gliche/JJ/I-NP/O Erkl\xc3\xa4rung/NN/I-NP/O kann/VB/B-VP/O die/DT/O/O im/IN/B-PP/B-PNP fraktionierten/NN/B-NP/I-PNP Prozess/NN/I-NP/I-PNP erzeugte/NN/I-NP/I-PNP geringere/NN/I-NP/I-PNP Radikaldichte/NN/I-NP/I-PNP sein/VB/B-VP/O ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O der/DT/O/O in/IN/B-PP/B-PNP vitro/JJ/B-NP/I-PNP Untersuchungen/NN/I-NP/I-PNP an/IN/B-PP/B-PNP mit/IN/I-PP/I-PNP 34/CD/B-NP/I-PNP kGy/NNP/I-NP/I-PNP Einzeldosis/NNP/I-NP/I-PNP E-Beam/JJ/B-NP/I-PNP bestrahlten/NN/I-NP/I-PNP BPTB\xe2\x80\x93Transplantate/NN/I-NP/I-PNP konnten/VB/B-VP/O durch/IN/B-PP/B-PNP in/IN/I-PP/I-PNP vivo/JJ/B-NP/I-PNP Untersuchungen/NN/I-NP/I-PNP an/IN/B-PP/B-PNP implantierten/NN/B-NP/I-PNP Sehnen/NN/I-NP/I-PNP des/DT/I-NP/I-PNP M./NN/I-NP/I-PNP flexor/NN/I-NP/I-PNP digitorum/JJ/B-NP/I-PNP superficialis/NN/I-NP/I-PNP in/IN/B-PP/B-PNP 24/CD/B-NP/I-PNP Merinomix/NN/I-NP/I-PNP \xe2\x80\x93/NN/I-NP/I-PNP Schafen/NN/I-NP/I-PNP best\xc3\xa4tigt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

6/CD/B-NP/O Wochen/NN/I-NP/O und/CC/O/O 3/CD/B-NP/O Monate/NN/I-NP/O postoperativ/NN/I-NP/O wiesen/VB/B-VP/O die/DT/B-NP/O bestrahlten/NN/I-NP/O Ersatzplastiken/NN/I-NP/O des/DT/B-NP/O VKB/NN/I-NP/O signifikant/JJ/B-NP/O schlechtere/NN/I-NP/O biomechanische/JJ/B-NP/O Eigenschaften/NNS/I-NP/O gegen\xc3\xbcber/IN/B-PP/B-PNP nicht/RB/B-NP/I-PNP bestrahlten/JJ/I-NP/I-PNP Sehnen/NN/I-NP/I-PNP auf/RP/O/O ././O/O

Zusammenfassend/JJ/B-ADJP/O kann/VB/B-VP/O festgestellt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Standard/NN/I-NP/I-PNP E-Beam/JJ/B-NP/I-PNP Bestrahlung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP BPTB\xe2\x80\x93Transplantate/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP 15/CD/B-NP/I-PNP bzw./CC/I-NP/I-PNP 25/CD/I-NP/I-PNP kGy/NNP/I-NP/I-PNP zu/IN/B-PP/B-PNP geringeren/NN/B-NP/I-PNP Beeintr\xc3\xa4chtigungen/NN/I-NP/I-PNP des/DT/I-NP/I-PNP Sehnengewebes/NN/I-NP/I-PNP als/IN/B-PP/B-PNP die/DT/B-NP/I-PNP herk\xc3\xb6mmliche/JJ/I-NP/I-PNP Gammabestrahlung/NN/I-NP/I-PNP f\xc3\xbchrt/VB/B-VP/O ././O/O

F\xc3\xbcr/IN/B-PP/O die/DT/O/O in/IN/B-PP/B-PNP Deutschland/NNP/B-NP/I-PNP empfohlene/JJ/I-NP/I-PNP Bestrahlungsdosis/NN/I-NP/I-PNP von/IN/B-PP/B-PNP \xe2\x89\xa5/NN/B-NP/I-PNP 30/CD/I-NP/I-PNP kGy/NNP/I-NP/I-PNP sind/VB/B-VP/O nach/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Ergebnissen/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Literatur/NN/I-NP/I-PNP und/CC/O/O der/DT/O/O hier/IN/B-PP/B-PNP vorgelegten/NN/B-NP/I-PNP Untersuchungsergebnisse/NN/I-NP/I-PNP weder/RB/B-ADVP/O die/DT/B-NP/O Standard/NN/I-NP/O E-Beam/JJ/B-ADJP/O -/-/O/O noch/RB/B-ADVP/O die/DT/B-NP/O Gammabestrahlung/NN/I-NP/O einsetzbar/JJ/B-ADJP/O ././O/O

Dahingegen/RB/B-VP/O zeigten/VB/I-VP/O die/DT/B-NP/O fraktioniert/NN/I-NP/O mit/IN/B-PP/B-PNP 10/CD/B-NP/I-PNP x/NN/I-NP/I-PNP 3,4/CD/B-NP/I-PNP kGy/NNP/I-NP/I-PNP bestrahlten/NNP/I-NP/I-PNP Transplantate/NNP/I-NP/I-PNP keine/JJ/B-NP/I-PNP signifikante/NN/I-NP/I-PNP Beeintr\xc3\xa4chtigung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP biomechanischen/JJ/I-NP/I-PNP Parameter/NN/I-NP/I-PNP in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP ././O/O

In/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP Untersuchungen/NN/I-NP/I-PNP m\xc3\xbcssen/VB/B-VP/O zeigen/VB/I-VP/O ,/,/O/O wie/IN/B-PP/B-PNP sich/PRP/B-NP/I-PNP das/DT/I-NP/I-PNP Remodeling/NN/I-NP/I-PNP und/CC/O/O die/DT/B-NP/O biomechanischen/JJ/I-NP/O Eigenschaften/NNS/I-NP/O fraktioniert/NN/I-NP/O bestrahlter/NN/I-NP/O Sehnen/NN/I-NP/O darstellt/VB/B-VP/O und/CC/O/O ob/RB/B-ADVP/O sich/PRP/B-NP/O die/DT/O/O positiven/JJ/B-ADJP/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP Ergebnisse/NN/I-NP/I-PNP best\xc3\xa4tigen/VB/B-VP/O lassen/VB/I-VP/O ././O/O

Daraus/RB/B-VP/O k\xc3\xb6nnte/VB/I-VP/O sich/PRP/B-NP/O ein/DT/I-NP/O Anstieg/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Bereitstellung/NN/I-NP/I-PNP mikrobiologisch/JJ/B-NP/I-PNP sicherer/NN/I-NP/I-PNP und/CC/O/O klinisch/JJ/B-NP/O akzeptabler/NN/I-NP/O allogener/NNP/I-NP/O BPTBTransplantate/NNP/I-NP/O ergeben/VB/B-VP/O und/CC/O/O die/DT/B-NP/O klinische/JJ/I-NP/O Versorgung/NN/I-NP/O von/IN/B-PP/B-PNP Patienten/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP multiplen/NN/B-NP/I-PNP Bandverletzungen/NN/I-NP/I-PNP und/CC/I-NP/I-PNP Revisionseingriffen/NN/I-NP/I-PNP verbessert/VB/B-VP/O werden.Kontamination/NN/B-NP/O von/IN/B-PP/B-PNP Frischeprodukten/NN/B-NP/I-PNP durch/IN/B-PP/O human/JJ/B-ADJP/O -/-/O/O und/CC/O/O phytopathogene/NN/B-NP/O Bakterien/NN/I-NP/O stellt/VB/B-VP/O eine/DT/B-NP/O Gefahr/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP menschliche/JJ/I-NP/I-PNP Gesundheit/NN/I-NP/I-PNP dar/RP/O/O und/CC/O/O kann/VB/B-VP/O zu/IN/B-PP/B-PNP Verlusten/NN/B-NP/I-PNP w\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Lagerung/NN/I-NP/I-PNP f\xc3\xbchren/VB/B-VP/O ././O/O

Mikrobiologische/JJ/B-NP/O Untersuchungen/NN/I-NP/O von/IN/B-PP/B-PNP frischem/JJ/B-NP/I-PNP Gem\xc3\xbcse/NN/I-NP/I-PNP sind/VB/B-VP/O zu/IN/B-PP/B-PNP zeitintensiv/NN/B-NP/I-PNP ,/,/O/O um/IN/B-PP/O fortlaufend/JJ/B-ADJP/O w\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Produktion/NN/I-NP/I-PNP angewendet/NN/I-NP/I-PNP zu/TO/B-VP/O werden/VB/I-VP/O ././O/O

In/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Studie/NN/I-NP/I-PNP wurde/VB/B-VP/O mittels/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP 16S/NN/I-NP/I-PNP rRNA-Gen/NN/I-NP/I-PNP Klonbibliothek/NN/I-NP/I-PNP die/DT/B-NP/I-PNP mikrobiologische/JJ/I-NP/I-PNP Diversit\xc3\xa4t/NN/I-NP/I-PNP einer/DT/B-NP/I-PNP karottenverarbeitenden/NN/I-NP/I-PNP Anlage/NN/I-NP/I-PNP untersucht/VBN/B-VP/I-PNP ,/,/O/O sowohl/CC/O/O pathogene/NN/B-NP/O als/CC/O/O auch/RB/B-NP/O opportunistische/JJ/I-NP/O Gattungen/NNS/I-NP/O wurden/VB/B-VP/O entdeckt/NN/B-NP/O ././O/O

Die/DT/B-NP/O vierth\xc3\xa4ufigste/NN/I-NP/O Art/NN/I-NP/O geh\xc3\xb6rte/VB/B-VP/O zur/IN/B-PP/B-PNP Gattung/JJ/B-NP/I-PNP Arcobacter/NN/I-NP/I-PNP ././O/O

Arcobacter/RB/B-VP/O ist/VB/I-VP/O bekannt/VB/I-VP/O daf\xc3\xbcr/RB/B-ADVP/O Enteritis/NN/B-NP/O in/IN/B-PP/B-PNP Menschen/NN/B-NP/I-PNP zu/TO/B-VP/O verursachen/VB/I-VP/O ,/,/O/O konnte/VB/B-VP/O aber/RB/B-ADVP/O bisher/RB/I-ADVP/O in/IN/B-PP/B-PNP Verbindung/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP Frischeprodukten/NN/B-NP/I-PNP nicht/RB/I-NP/I-PNP isoliert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Zwei/CD/B-NP/O gattungsspezifische/JJ/I-NP/O PCR-Assays/NN/I-NP/O wurde/VB/B-VP/O entwickelt/VBN/I-VP/O :/:/O/O Eines/NN/B-NP/O spezifisch/JJ/B-ADJP/O f\xc3\xbcr/IN/B-PP/B-PNP Arcobacter/NN/B-NP/I-PNP und/CC/O/O eines/DT/O/O f\xc3\xbcr/IN/B-PP/B-PNP Pectobacterium/NN/B-NP/I-PNP ././O/O

Ziel/RB/B-VP/O war/VB/I-VP/O das/DT/B-NP/O Auftreten/NN/I-NP/O dieser/DT/B-NP/O beiden/DT/I-NP/O Gattungen/NNS/I-NP/O in/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP spinatverarbeitenden/NN/I-NP/I-PNP Anlage/NN/I-NP/I-PNP zu/TO/B-VP/O untersuchen/VB/I-VP/O ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O deuteten/NN/I-NP/O daraufhin/VB/B-VP/O ,/,/O/O dass/RB/B-NP/O beide/JJ/I-NP/O Pathogene/NN/I-NP/O wiederholt/VBN/B-VP/O auftreten/VB/I-VP/O ././O/O

Dies/DT/O/O wirft/VB/B-VP/O die/DT/B-NP/O Frage/NN/I-NP/O auf/RP/O/O ,/,/O/O ob/IN/B-PP/B-PNP pathogene/NN/B-NP/I-PNP und/CC/I-NP/I-PNP nicht-pathogene/NN/I-NP/I-PNP Arcobacter-Arten/NN/I-NP/I-PNP regelm\xc3\xa4\xc3\x9fig/JJ/B-ADJP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Anlage/NN/I-NP/I-PNP vorkommen/VB/B-VP/O ,/,/O/O deshalb/RB/B-ADVP/O und/CC/O/O um/IN/B-PP/B-PNP die/DT/B-NP/I-PNP weitere/JJ/I-NP/I-PNP Verbreitung/NN/I-NP/I-PNP zu/TO/B-VP/O untersuchen/VB/I-VP/O wurde/VB/I-VP/O die/DT/B-NP/O genetische/JJ/I-NP/O Diversit\xc3\xa4t/NN/I-NP/O von/IN/B-PP/B-PNP Arcobacter/NN/B-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP gesamten/JJ/I-NP/I-PNP Prozesslinie/NN/I-NP/I-PNP mittels/IN/B-PP/B-PNP 16S/NNP/B-NP/I-PNP rRNA-Gen/NNP/I-NP/I-PNP Klonbibliotheken/NNP/I-NP/I-PNP untersucht/RP/O/O ././O/O

Die/DT/B-NP/O gleiche/JJ/I-NP/O Arcobacter-Art/NN/I-NP/O wie/IN/B-PP/B-PNP in/IN/I-PP/I-PNP der/DT/B-NP/I-PNP karottenverarbeitenden/NN/I-NP/I-PNP Anlage/NN/I-NP/I-PNP wurde/VB/B-VP/O identifiziert/NN/B-NP/O ,/,/O/O sowie/CC/O/O einige/JJ/B-NP/O unbekannte/JJ/I-NP/O Arcobacter-Arten/NN/I-NP/O ././O/O

Zus\xc3\xa4tzlich/VBN/B-VP/O wurden/VB/I-VP/O auch/IN/B-PP/B-PNP pathogene/NN/B-NP/I-PNP Arten/NN/I-NP/I-PNP detektiert/NN/I-NP/I-PNP ,/,/O/O darunter/RB/B-ADVP/O A./NNP/B-NP/O butzleri/NNP/I-NP/O und/CC/O/O A./NNP/B-NP/O cryaerophilus/NNP/I-NP/O ././O/O

Drei/CD/B-NP/O Methoden/NN/I-NP/O zur/IN/B-PP/B-PNP Detektion/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Pathogenen/NN/B-NP/I-PNP wurden/VB/B-VP/O entwickelt/VBN/I-VP/O und/CC/O/O bewertet/NN/B-NP/O :/:/O/O 1/CD/O/O ././O/O

Eine/DT/B-NP/O Multiplex-PCR/NN/I-NP/O wurde/VB/B-VP/O konstruiert/NN/B-NP/O ,/,/O/O die/WDT/B-NP/O es/PRP/I-NP/O erm\xc3\xb6glicht/VB/B-VP/O neun/CD/B-NP/O Arcobacter-Arten/NN/I-NP/O simultan/JJ/B-ADJP/O zu/TO/B-VP/O unterscheiden/VB/I-VP/O ././O/O

2/CD/O/O ././O/O

Zwei/CD/B-NP/O qPCR-Assays/NN/I-NP/O wurden/VB/B-VP/O entwickelt/VBN/I-VP/O und/CC/O/O getestet/NN/B-NP/O ,/,/O/O die/DT/B-NP/O eine/DT/I-NP/O Quantifizierung/NN/I-NP/O der/DT/B-NP/O Bakterien/NN/I-NP/O erm\xc3\xb6glichen/VB/B-VP/O ././O/O

3/CD/O/O ././O/O

MALDI-TOF/NN/B-NP/O MS/NNP/I-NP/O erm\xc3\xb6glicht/VB/B-VP/O eine/DT/B-NP/O schnelle/NN/I-NP/O und/CC/O/O pr\xc3\xa4zise/JJ/B-NP/O Identifizierung/NN/I-NP/O von/IN/B-PP/B-PNP Bakterien/NN/B-NP/I-PNP ././O/O

Das/DT/B-NP/O Potential/NN/I-NP/O dieser/DT/B-NP/O Methode/NN/I-NP/O wurde/VB/B-VP/O getestet/NN/B-NP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Bestimmung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP mikrobiellen/NN/I-NP/I-PNP Diversit\xc3\xa4t/NN/I-NP/I-PNP der/DT/B-NP/I-PNP spinatverarbeitenden/NN/I-NP/I-PNP Anlage/NN/I-NP/I-PNP und/CC/O/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP spezifische/JJ/I-NP/I-PNP Detektion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Arcobacter.In/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Diagnostik/NN/I-NP/I-PNP und/CC/O/O Detektion/NN/B-NP/O von/IN/B-PP/B-PNP hochpathogenen/NN/B-NP/I-PNP Mikroorganismen/NN/I-NP/I-PNP bilden/JJ/B-ADJP/O molekularbiologische/VB/B-VP/O ,/,/O/O nukleins\xc3\xa4urebasierte/NN/B-NP/O Methoden/NNP/I-NP/O ,/,/O/O wie/IN/B-PP/O die/DT/O/O (/(/O/O real-time/NN/B-NP/O )/)/O/O PCR/NN/B-NP/O eine/DT/I-NP/O tragende/JJ/I-NP/O S\xc3\xa4ule/NN/I-NP/O ././O/O

In/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurden/VB/B-VP/O sowohl/CC/O/O die/DT/B-NP/O Aufbereitung/NN/I-NP/O von/IN/B-PP/B-PNP Erreger-Nukleins\xc3\xa4uren/NN/B-NP/I-PNP aus/IN/B-PP/B-PNP Umweltproben/NN/B-NP/I-PNP ,/,/O/O als/CC/O/O auch/RB/B-ADVP/O die/DT/B-NP/O eigentliche/JJ/I-NP/O Nukleins\xc3\xa4ure/NN/I-NP/O -/-/O/O Detektion/JJ/B-NP/O optimiert/NN/I-NP/O ././O/O

o/VBN/B-VP/O wurde/VB/I-VP/O ein/DT/B-NP/O Verfahren/NN/I-NP/O entwickelt/VBN/B-VP/O ,/,/O/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP m\xc3\xb6gliche/JJ/I-NP/I-PNP PCR-Inhibitoren/NN/I-NP/I-PNP vor/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Extraktion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP DNA/NN/B-NP/I-PNP und/CC/I-NP/I-PNP RNA/NNP/I-NP/I-PNP erfolgreich/JJ/B-ADJP/O aus/IN/B-PP/B-PNP diversen/JJ/B-NP/I-PNP Umweltsubstanzen/NN/I-NP/I-PNP entfernt/VBN/B-VP/I-PNP werden/VB/I-VP/O konnten/VBN/I-VP/O ././O/O

Die/DT/B-NP/O anschlie\xc3\x9fende/NN/I-NP/O Detektion/NN/I-NP/O der/DT/B-NP/O isolierten/NN/I-NP/O Erreger/NN/I-NP/O -/-/O/O Nukleins\xc3\xa4uren/NN/B-NP/O wurde/VB/B-VP/O vor/IN/B-PP/O allem/DT/O/O in/IN/B-PP/B-PNP Hinblick/NN/B-NP/I-PNP auf/IN/B-PP/B-PNP Schnelligkeit/NN/B-NP/I-PNP ,/,/O/O Zuverl\xc3\xa4ssigkeit/NN/B-NP/O und/CC/I-NP/O Spezifit\xc3\xa4t/JJ/I-NP/O optimiert/NN/I-NP/O ././O/O

Durch/IN/B-PP/O die/DT/O/O ,/,/O/O im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP erfolgte/VB/B-VP/O ,/,/O/O Entwicklung/NN/B-NP/O eines/DT/I-NP/O Screening/NN/I-NP/O Verfahrens/NN/I-NP/O ,/,/O/O welches/WDT/B-NP/O die/DT/I-NP/O real-time/JJ/I-NP/O PCR/NN/I-NP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Pyrosequenzierung/NN/I-NP/I-PNP (/(/O/O PSQ/NN/B-NP/O )/)/O/O kombiniert/JJ/B-ADJP/O ,/,/O/O k\xc3\xb6nnen/PRP$/B-NP/O Erreger-Nukleins\xc3\xa4uren/NN/I-NP/O schnell/JJ/B-ADJP/O und/CC/O/O sehr/RB/B-ADJP/O spezifisch/JJ/I-ADJP/O nachgewiesen/VBN/B-VP/O und/CC/O/O die/DT/B-NP/O detektierten/JJ/I-NP/O Pathogene/NN/I-NP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP anschlie\xc3\x9fende/NN/I-NP/I-PNP Sequenzierung/NN/I-NP/I-PNP typisiert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Um/IN/B-PP/B-PNP Probenmaterial/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Reagenzien/NN/I-NP/I-PNP ,/,/O/O sowie/CC/O/O Zeit/NN/B-NP/O und/CC/O/O Kosten/NN/B-NP/O zu/TO/B-VP/O sparen/VB/I-VP/O ,/,/O/O wurden/VB/B-VP/O verschiedene/JJ/B-NP/O multiplex/NN/I-NP/O real-time/NN/I-NP/O PCR/NN/I-NP/O Systeme/NN/I-NP/O entwickelt/VB/B-VP/O ././O/O

Zum/IN/B-PP/O einen/DT/O/O wurde/VB/B-VP/O eine/DT/B-NP/O 5-plex/NN/I-NP/O real-time/NN/I-NP/O PCR/NN/I-NP/O etabliert/NN/I-NP/O ,/,/O/O mit/IN/B-PP/O der/DT/O/O weniger/RB/B-ADVP/O als/IN/B-PP/B-PNP 40/CD/B-NP/I-PNP Genom\xc3\xa4quivalente/NN/I-NP/I-PNP von/IN/B-PP/B-PNP vier/CD/B-NP/I-PNP bioterroristisch/JJ/I-NP/I-PNP relevanten/NN/I-NP/I-PNP hochpathogenen/NN/I-NP/I-PNP Erregern/NN/I-NP/I-PNP detektiert/NN/I-NP/I-PNP werden/VB/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ././O/O

Zum/IN/B-PP/O anderen/VB/B-VP/O wurde/VB/I-VP/O die/DT/B-NP/O multicolour/NN/I-NP/O multiplex/NN/I-NP/O PCR/NN/I-NP/O am/IN/B-PP/B-PNP Beispiel/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Diagnostik/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Pockenvirusinfektionen/NN/B-NP/I-PNP entwickelt/VB/B-VP/O ././O/O

Diese/DT/O/O erm\xc3\xb6glicht/VB/B-VP/O die/DT/B-NP/O Differenzierung/NN/I-NP/O von/IN/B-PP/B-PNP Ortho/NN/B-NP/I-PNP -/-/O/O (/(/O/O OPV/NNP/B-NP/O )/)/O/O ,/,/O/O Para/NN/B-NP/O -/-/O/O und/CC/O/O Molluscipockenviren/NN/B-NP/O ,/,/O/O der/DT/B-NP/O drei/CD/I-NP/O wichtigsten/JJ/I-NP/O Genera/NN/I-NP/O ,/,/O/O die/DT/B-NP/O humanpathogene/NN/I-NP/O Vertreter/NN/I-NP/O der/DT/B-NP/O Pockenviren/NN/I-NP/O enthalten/RP/O/O ././O/O

Die/DT/B-NP/O weitere/JJ/I-NP/O Identifizierung/NN/I-NP/O und/CC/O/O Typisierung/NN/B-NP/O von/IN/B-PP/B-PNP OPV/NNP/B-NP/I-PNP wird/VB/B-VP/O durch/IN/B-PP/O die/DT/O/O ,/,/O/O in/IN/B-PP/B-PNP dieser/WDT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP ,/,/O/O etablierte/NN/B-NP/O multiplex/NNP/I-NP/O PSQ/NNP/I-NP/O erm\xc3\xb6glicht/RP/O/O ././O/O

Jede/DT/B-NP/O OPV/NNP/I-NP/O Spezies/RB/B-VP/O erzeugt/VB/I-VP/O dabei/RB/B-ADVP/O ein/DT/B-NP/O spezifisches/JJ/I-NP/O Sequenzmuster/NN/I-NP/O und/CC/O/O kann/VB/B-VP/O damit/RB/B-ADVP/O in/IN/B-PP/O weniger/RB/B-ADVP/O als/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Stunde/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP PCR/NN/I-NP/I-PNP Reaktion/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP ungerichtete/JJ/I-NP/I-PNP Suche/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP Infektionserregern/NN/B-NP/I-PNP in/IN/B-PP/B-PNP klinischen/JJ/B-NP/I-PNP Proben/NN/I-NP/I-PNP ,/,/O/O wurde/VB/B-VP/O ein/DT/B-NP/O Protokoll/NN/I-NP/O entwickelt/VBN/B-VP/O ,/,/O/O mit/IN/B-PP/B-PNP dem/WDT/B-NP/I-PNP die/DT/I-NP/I-PNP Aufbereitung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Nukleins\xc3\xa4uren/NN/B-NP/I-PNP aus/IN/B-PP/B-PNP humanem/JJ/B-NP/I-PNP Gewebe/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Vorbereitung/NN/B-NP/I-PNP auf/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Next/NN/I-NP/I-PNP Generation/FW/O/O Sequencing/FW/O/O erm\xc3\xb6glicht/VBN/B-VP/O wird/VB/I-VP/O ././O/O

Nach/IN/B-PP/B-PNP Entfernung/NN/B-NP/I-PNP humaner/NN/I-NP/I-PNP Hintergrund/NN/I-NP/I-PNP -/-/O/O rRNA/NNP/B-NP/O findet/VB/B-VP/O die/DT/B-NP/O Sequenzierung/NN/I-NP/O aller/JJ/B-NP/O Nukleins\xc3\xa4uren/NN/I-NP/O einer/DT/B-NP/O Probe/NN/I-NP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP 454-Technologie/NN/I-NP/I-PNP statt/RP/O/O ././O/O

Mit/IN/B-PP/B-PNP diesem/DT/B-NP/I-PNP Verfahren/NN/I-NP/I-PNP wurde/VB/B-VP/O nach/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP infekti\xc3\xb6sen/NN/I-NP/I-PNP Ursache/NN/I-NP/I-PNP des/DT/B-NP/I-PNP pl\xc3\xb6tzlichen/JJ/I-NP/I-PNP Kindstods/NN/I-NP/I-PNP gesucht/RP/O/O ././O/O

Zusammenfassend/VBN/B-VP/O wurden/VB/I-VP/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP verschiedene/JJ/B-NP/I-PNP innovative/JJ/I-NP/I-PNP Verfahren/NN/I-NP/I-PNP der/DT/B-NP/I-PNP nukleins\xc3\xa4urebasierten/JJ/I-NP/I-PNP Detektion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP hochpathogenen/NN/B-NP/I-PNP Erregern/NN/I-NP/I-PNP erfolgreich/JJ/I-NP/I-PNP etabliert/NN/I-NP/I-PNP und/CC/O/O optimiert/NN/B-NP/O ,/,/O/O die/WDT/B-NP/O das/DT/I-NP/O Methodenspektrum/NN/I-NP/O der/DT/B-NP/O bisherigen/JJ/I-NP/O molekularbiologischen/JJ/I-NP/O Diagnostik/NN/I-NP/O erweitern/VB/B-VP/O und/CC/O/O erg\xc3\xa4nzen/VB/B-VP/O k\xc3\xb6nnen.Die/MD/B-VP/O systematische/JJ/B-NP/O Analyse/NN/I-NP/O von/IN/B-PP/B-PNP Protein-Protein-Interaktionen/NN/B-NP/I-PNP ist/VB/B-VP/O eine/DT/B-NP/O wichtige/JJ/I-NP/O Voraussetzung/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Aufkl\xc3\xa4rung/NN/I-NP/I-PNP molekularer/NN/I-NP/I-PNP Zusammenh\xc3\xa4nge/NN/I-NP/I-PNP und/CC/O/O biologischer/JJ/B-NP/O Funktionen/NN/I-NP/O innerhalb/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Zelle/NN/I-NP/I-PNP ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP proteomweite/NN/I-NP/I-PNP Identifizierung/NN/I-NP/I-PNP interagierender/NN/I-NP/I-PNP Proteine/NN/I-NP/I-PNP haben/VB/B-VP/O sich/PRP/B-NP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP letzten/JJ/I-NP/I-PNP Jahren/NN/I-NP/I-PNP vermehrt/JJ/B-NP/I-PNP Methoden/NN/I-NP/I-PNP durchgesetzt/VBN/B-VP/I-PNP ,/,/O/O die/WDT/O/O auf/IN/B-PP/B-PNP Affinit\xc3\xa4ts-Pulldown-Experimenten/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Kombination/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP quantitativer/NN/B-NP/I-PNP Massenspektrometrie/NN/I-NP/I-PNP basieren/VB/B-VP/O (/(/O/O Affinit\xc3\xa4ts-MS-Experiment/NN/B-NP/O )/)/O/O ././O/O

In/IN/B-PP/B-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurde/VB/B-VP/O ein/DT/B-NP/O neuer/JJ/I-NP/O Ansatz/NN/I-NP/O ,/,/O/O bestehend/JJ/B-ADJP/O aus/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Kombination/NN/I-NP/I-PNP von/IN/B-PP/B-PNP mehrdimensionaler/JJ/B-NP/I-PNP Peptidauftrennung/NN/I-NP/I-PNP mittels/IN/B-PP/B-PNP Fl\xc3\xbcssigchromatographie/NN/B-NP/I-PNP und/CC/I-NP/I-PNP hochaufgel\xc3\xb6ster/NN/I-NP/I-PNP Tandem-Massenspektrometrie/NN/I-NP/I-PNP ,/,/O/O zur/IN/B-PP/B-PNP effektiven/JJ/B-NP/I-PNP Identifizierung/NN/I-NP/I-PNP und/CC/O/O Quantifizierung/NN/B-NP/O komplexer/JJ/B-ADJP/O Proteingemische/JJ/I-ADJP/O aus/IN/B-PP/B-PNP Affinit\xc3\xa4ts-Pulldown-Experimenten/NN/B-NP/I-PNP entwickelt/VB/B-VP/O ././O/O

Die/DT/B-NP/O Methode/NN/I-NP/O beruht/VB/B-VP/O auf/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Verwendung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Umkehrphasenchromatographie/NN/B-NP/I-PNP (/(/O/O RP/NNP/B-NP/O )/)/O/O mit/IN/B-PP/B-PNP pH-sauren/JJ/B-NP/I-PNP Elutionsbedingungen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP beiden/DT/B-NP/I-PNP chromatographischen/JJ/I-NP/I-PNP Dimensionen/NNS/I-NP/I-PNP und/CC/O/O f\xc3\xbchrt/VB/B-VP/O durch/IN/B-PP/B-PNP Anwendung/NN/B-NP/I-PNP eines/DT/I-NP/I-PNP spezifischen/JJ/I-NP/I-PNP Fraktionierungsschemas/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP ersten/JJ/I-NP/I-PNP Dimension/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP optimalen/JJ/I-NP/I-PNP Trenn/NN/I-NP/I-PNP -/-/O/O und/CC/O/O somit/IN/B-PP/B-PNP MS&slash;MS-Kapazit\xc3\xa4t/NN/B-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP zweiten/JJ/I-NP/I-PNP Dimension/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Entwicklung/NN/I-NP/O und/CC/O/O Validierung/NN/B-NP/O der/DT/B-NP/O Methodik/NN/I-NP/O erfolgte/VB/B-VP/O zun\xc3\xa4chst/RB/B-ADVP/O durch/IN/B-PP/B-PNP proteomweite/JJ/B-NP/I-PNP Interaktionsanalysen/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP gut/JJ/B-NP/I-PNP charakterisierten/NN/I-NP/I-PNP ,/,/O/O Tyrosin/NN/B-NP/O 595-phosphorylierten/NNP/I-NP/O ,/,/O/O Peptiden/NN/B-NP/O des/DT/I-NP/O T-Zelladapterproteins/NN/I-NP/O ADAP/NNP/I-NP/O ././O/O

In/IN/B-PP/B-PNP Kombination/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Isotopenmarkierungsverfahren/NN/I-NP/I-PNP (/(/O/O SILAC/NN/B-NP/O ,/,/O/O enzymatische/JJ/B-NP/O 18O-Markierung/NN/I-NP/O )/)/O/O konnten/VB/B-VP/O unter/IN/B-PP/B-PNP Anwendung/NN/B-NP/I-PNP der/DT/O/O entwickelten/VB/B-VP/O 2-D/NN/B-NP/O RP-RP/NNP/I-NP/O LC-MS&slash;MS/NNP/I-NP/O Methodik/NNP/I-NP/O phosphorylierungsspezifische/JJ/I-NP/O Interaktionspartner/NN/I-NP/O der/DT/B-NP/O ADAP-595-Peptidsequenz/NN/I-NP/O identifiziert/NN/I-NP/O werden/VB/B-VP/O ././O/O

Im/IN/B-PP/B-PNP weiteren/JJ/B-NP/I-PNP Verlauf/NN/I-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O 2-D/NN/I-NP/O RP-RP/NNP/I-NP/O LC-MS&slash;MS/NNP/I-NP/O Methodik/NNP/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP proteomweite/JJ/I-NP/I-PNP Analyse/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Interaktionspartnern/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Zellkernproteins/NN/I-NP/I-PNP Histon/NN/I-NP/I-PNP H4/NN/I-NP/I-PNP angewandt/JJ/B-ADJP/O ././O/O

Da/IN/B-PP/B-PNP Lysinacetylierungen/NN/B-NP/I-PNP generell/RB/B-ADVP/O mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Genaktivierung/NN/I-NP/I-PNP assoziiert/NN/I-NP/I-PNP sind/VB/B-VP/O ,/,/O/O sollte/MD/B-VP/O insbesondere/RB/B-ADVP/O die/DT/B-NP/O Rolle/NN/I-NP/O dieser/DT/B-NP/O Modifizierungen/NN/I-NP/O als/IN/B-PP/B-PNP potentielle/NN/B-NP/I-PNP Erkennungsmotive/NN/I-NP/I-PNP bzw./RB/B-ADVP/O als/IN/B-PP/B-PNP Werkzeug/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Ladungsneutralisierung/NN/I-NP/I-PNP untersucht/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Dazu/RB/B-VP/O wurden/VB/I-VP/O verschiedene/JJ/B-NP/O acetylierte/NN/I-NP/O Peptide/NN/I-NP/O der/DT/B-NP/O N-terminalen/JJ/I-NP/O Histon/NN/I-NP/O H4-Sequenz/NN/I-NP/O synthetisiert/NN/I-NP/O und/CC/O/O als/IN/B-PP/B-PNP Matrix-gebundene/JJ/B-NP/I-PNP K\xc3\xb6der/NN/I-NP/I-PNP in/IN/B-PP/B-PNP differenziellen/NN/B-NP/I-PNP ,/,/O/O SILAC-basierten/NN/B-NP/O Peptid-Pulldown-Experimenten/NNP/I-NP/O eingesetzt/RP/O/O ././O/O

Dabei/RB/B-VP/O konnten/VB/I-VP/O additive/NN/B-NP/O Effekte/NNS/I-NP/O der/DT/I-NP/O Histonacetylierung/NN/I-NP/O auf/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Bindungsverhalten/NN/I-NP/I-PNP beobachtet/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O d.h./CC/O/O mit/IN/B-PP/B-PNP zunehmender/JJ/B-NP/I-PNP Anzahl/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Lysinacetylierungen/NN/I-NP/I-PNP erh\xc3\xb6hte/VB/B-VP/O sich/PRP/B-NP/O auch/RB/B-ADVP/O die/DT/B-NP/O Anzahl/NN/I-NP/O der/DT/B-NP/O Proteine/NN/I-NP/O ,/,/O/O die/DT/O/O nicht/RB/B-ADVP/O mehr/RB/I-ADVP/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Peptid/JJ/I-NP/I-PNP interagierten/NN/I-NP/I-PNP ././O/O

Dar\xc3\xbcber/RB/B-ADVP/O hinaus/IN/B-PP/O wurden/VB/B-VP/O potentielle/NN/B-NP/O ,/,/O/O acetylierungsabh\xc3\xa4ngige/NN/B-NP/O Interaktionspartner/NNP/I-NP/O mehrfach/JJ/I-NP/O acetylierter/NN/I-NP/O H4-Peptide/NN/I-NP/O identifiziert/NN/I-NP/O ,/,/O/O wobei/WRB/O/O die/DT/B-NP/O Mehrzahl/NN/I-NP/O bekannte/VB/B-VP/O Chromatin/NN/B-NP/O -/-/O/O sowie/CC/O/O RNA-Polymerase/NN/B-NP/O II-Interaktoren/NN/I-NP/O darstellen/VB/B-VP/O ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O dieser/DT/B-NP/O Arbeit/NN/I-NP/O zeigen/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O Peptid-basierte/NN/B-NP/O Affinit\xc3\xa4ts-MS/NNP/I-NP/O Experimente/NNP/I-NP/O einen/DT/B-NP/O wertvollen/NN/I-NP/O Beitrag/NN/I-NP/O zum/IN/B-PP/B-PNP Verst\xc3\xa4ndnis/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Protein-Protein-Interaktionen/NN/B-NP/I-PNP leisten/VB/B-VP/O k\xc3\xb6nnen.Phosphatidylinositol-Phosphate/MD/B-VP/O (/(/O/O PIP/NNP/B-NP/O )/)/O/O sind/NN/B-NP/O an/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Vielzahl/NN/I-NP/I-PNP intrazellul\xc3\xa4rer/NN/I-NP/I-PNP Signalkaskaden/NN/I-NP/I-PNP beteiligt/RP/O/O ././O/O

Funktionseinschr\xc3\xa4nkungen/NN/B-NP/O von/IN/B-PP/B-PNP Proteinen/NN/B-NP/I-PNP ,/,/O/O die/WDT/O/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP PIP-Metabolismus/NN/I-NP/I-PNP eingreifen/VB/B-VP/O ,/,/O/O f\xc3\xbchren/VB/B-VP/O zu/IN/B-PP/B-PNP schweren/JJ/B-NP/I-PNP Krankheiten/NN/I-NP/I-PNP ,/,/O/O wie/IN/B-PP/B-PNP z.B./IN/I-PP/I-PNP Krebs/NN/B-NP/I-PNP ././O/O

Die/DT/B-NP/O spannungssensitive/NN/I-NP/O Phosphatase/NN/I-NP/O Ci-VSP/NNP/I-NP/O aus/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Seescheide/NN/I-NP/I-PNP Ciona/NN/I-NP/I-PNP intestinalis/NN/I-NP/I-PNP ist/VB/B-VP/O ein/DT/B-NP/O Modellprotein/NN/I-NP/O ,/,/O/O an/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP PIP-selektive/JJ/I-NP/I-PNP Katalysemechanismen/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP molekularer/NN/B-NP/I-PNP Ebene/NN/I-NP/I-PNP untersucht/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Ci-VSP/NNP/B-NP/O besteht/VB/B-VP/O aus/IN/B-PP/B-PNP zwei/CD/B-NP/I-PNP funktionellen/NN/I-NP/I-PNP Modulen/NN/I-NP/I-PNP :(/NN/I-NP/I-PNP 1/CD/O/O ././O/O )/)/O/O

iner/DT/B-NP/O transmembranen/NN/I-NP/O Spannungssensor/NN/I-NP/O -/-/O/O (/(/O/O VSD/NN/B-NP/O )/)/O/O und/CC/O/O (/(/O/O 2/CD/O/O ././O/O )/)/O/O

iner/DT/B-NP/O zytosolischen/JJ/I-NP/O katalytischen/JJ/I-NP/O Dom\xc3\xa4ne/NN/I-NP/O (/(/O/O CD/NN/B-NP/O )/)/O/O ,/,/O/O die/WDT/O/O nochmals/RB/B-ADVP/O in/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Phosphatase/NN/I-NP/I-PNP -/-/O/O (/(/O/O PD/NN/B-NP/O )/)/O/O und/CC/O/O eine/DT/B-NP/O C2-Dom\xc3\xa4ne/NN/I-NP/O unterteilt/NN/I-NP/O wird/VB/B-VP/O ././O/O

Beide/JJ/B-NP/O Module/NN/I-NP/O sind/VB/B-VP/O \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP mehrfach/JJ/I-NP/I-PNP positiv/JJ/I-NP/I-PNP geladene/NN/I-NP/I-PNP Linkersequenz/NN/I-NP/I-PNP M240-K257/NN/I-NP/I-PNP miteinander/VB/B-VP/O verbunden/RP/I-VP/O ././O/O

Bei/IN/B-PP/B-PNP depolarisierenden/NN/B-NP/I-PNP Membranpotentialen/JJ/B-ADJP/O laufen/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP VSD/NN/I-NP/I-PNP Konformations\xc3\xa4nderungen/NN/I-NP/I-PNP ab/RB/B-ADVP/O ,/,/O/O die/WDT/O/O zur/IN/B-PP/B-PNP Aktivierung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP PD/NN/I-NP/I-PNP f\xc3\xbchren/VB/B-VP/O ,/,/O/O wodurch/WRB/O/O sie/PRP/B-NP/O selektiv/NN/I-NP/O die/DT/I-NP/O Kopfgruppen/NN/I-NP/O von/IN/B-PP/B-PNP PIP-Membranlipiden/JJ/B-NP/I-PNP dephosphoryliert/NN/I-NP/I-PNP ././O/O

Im/IN/B-PP/B-PNP VSD-CD-Kopplungsprozess/NN/B-NP/I-PNP spielt/NN/I-NP/I-PNP der/DT/O/O Linker/JJ/B-ADJP/O eine/DT/B-NP/O essentielle/NN/I-NP/O Rolle/NN/I-NP/O ,/,/O/O da/IN/B-PP/O er/JJ/B-ADJP/O nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Aktivierung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP VSD/NN/I-NP/I-PNP \xc3\xbcber/IN/B-PP/B-PNP elektrostatische/JJ/B-NP/I-PNP Wechselwirkungen/NN/I-NP/I-PNP an/IN/B-PP/B-PNP die/DT/B-NP/I-PNP negativ/JJ/I-NP/I-PNP geladene/NN/I-NP/I-PNP Membranoberfl\xc3\xa4che/NN/I-NP/I-PNP bindet/NN/I-NP/I-PNP und/CC/O/O dabei/RB/B-ADVP/O die/DT/B-NP/O CD/NN/I-NP/O an/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Membran/NN/I-NP/I-PNP rekrutiert/NN/I-NP/I-PNP ,/,/O/O wodurch/RB/B-ADVP/O die/DT/B-NP/O enzymatische/JJ/I-NP/O Katalyse/NN/I-NP/O initiiert/NN/I-NP/O wird/VB/B-VP/O ././O/O

Um/IN/B-PP/B-PNP die/DT/B-NP/I-PNP funktionelle/NN/I-NP/I-PNP Rolle/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Linkers/NN/I-NP/I-PNP detaillierter/NN/I-NP/I-PNP aufzukl\xc3\xa4ren/NN/I-NP/I-PNP ,/,/O/O wurde/VB/B-VP/O im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP Cystein-Scanning-Mutagenese/NN/I-NP/I-PNP der/DT/B-NP/I-PNP gesamten/JJ/I-NP/I-PNP M240-K257-Sequenz/NN/I-NP/I-PNP durchgef\xc3\xbchrt/RP/O/O ././O/O

Die/DT/B-NP/O generierten/NN/I-NP/O Mutanten/NN/I-NP/O wurden/VB/B-VP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Oozyten/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Krallenfroschs/NN/I-NP/I-PNP Xenopus/NN/I-NP/I-PNP laevis/NN/I-NP/I-PNP heterolog/NN/I-NP/I-PNP exprimiert/NN/I-NP/I-PNP und/CC/O/O elektrophysiologisch/JJ/B-ADJP/O mittels/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Zwei-Elektroden-Spannungsklemme/JJ/I-NP/I-PNP charakterisiert/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Analyse/NN/I-NP/O der/DT/B-NP/O PD-Aktivit\xc3\xa4t/NN/I-NP/O erfolgte/VB/B-VP/O in/IN/B-PP/B-PNP Koexpressionsexperimenten/NN/B-NP/I-PNP mit/IN/B-PP/O den/DT/O/O PI(4,5)P2-sensitiven/LS/O/O Kaliumkan\xc3\xa4len/JJ/B-NP/O KCNQ2&slash;KCNQ3/NN/I-NP/O ././O/O

Zudem/RB/B-VP/O wurde/VB/I-VP/O die/DT/B-NP/O VSD-Dynamik/NN/I-NP/O aller/JJ/B-NP/O Ci-VSP-Mutanten/NN/I-NP/O untersucht/RP/O/O ././O/O

Hierbei/VBN/B-VP/O wurde/RB/I-VP/O festgestellt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP sich/PRP/B-NP/I-PNP N-terminale/JJ/I-NP/I-PNP Linkermutationen/NN/I-NP/I-PNP (/(/O/O M240C-K257C/NN/B-NP/O )/)/O/O weniger/RB/B-ADJP/O dramatisch/JJ/I-ADJP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP VSD-CD-Interaktion/NN/I-NP/I-PNP auswirken/VB/B-VP/O als/IN/B-PP/B-PNP C-terminale/NN/B-NP/I-PNP (/(/O/O Q250C-K257C/NN/B-NP/O )/)/O/O ././O/O

Mit/IN/B-PP/B-PNP A242C/NN/B-NP/I-PNP ,/,/O/O R245C/NN/B-NP/O ,/,/O/O K252C/NN/B-NP/O und/CC/I-NP/O Y255C/NN/I-NP/O wurden/VB/B-VP/O vier/CD/B-NP/O Konstrukte/NN/I-NP/O mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP vollst\xc3\xa4ndig/JJ/I-NP/I-PNP aufgehobenen/NN/I-NP/I-PNP PD-Aktivit\xc3\xa4t/JJ/B-NP/I-PNP identifiziert/NN/I-NP/I-PNP ././O/O

Aufgrund/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Periodizit\xc3\xa4t/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Mutationseffekts/NN/I-NP/I-PNP im/IN/B-PP/B-PNP N/NN/B-NP/I-PNP -/-/O/O und/CC/O/O C-terminalen/JJ/B-ADJP/O Linker/VB/B-VP/O wurden/VB/I-VP/O alpha-helikale/JJ/B-NP/O Strukturelemente/NN/I-NP/O in/IN/B-PP/B-PNP diesen/DT/B-NP/I-PNP Bereichen/JJ/I-NP/I-PNP vermutet/NN/I-NP/I-PNP ././O/O

Au\xc3\x9fer/IN/B-PP/B-PNP K252C/NN/B-NP/I-PNP wiesen/VB/B-VP/O alle/RB/B-NP/O katalytisch/JJ/I-NP/O inaktiven/NN/I-NP/O Mutanten/NN/I-NP/O zudem/VB/B-VP/O eine/DT/B-NP/O beschleunigtere/JJ/I-NP/O VSD-Kinetik/NN/I-NP/O auf/RB/B-ADVP/O als/IN/B-PP/B-PNP das/DT/B-NP/I-PNP unmutierte/JJ/I-NP/I-PNP Protein/NN/I-NP/I-PNP (/(/O/O Wildtyp/NN/B-NP/O )/)/O/O ././O/O

Durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP K257Stop-Mutante/NN/I-NP/I-PNP ,/,/O/O bei/IN/B-PP/B-PNP der/WDT/B-NP/I-PNP die/DT/I-NP/I-PNP CD/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Proteins/NN/I-NP/I-PNP deletiert/NN/I-NP/I-PNP war/VB/B-VP/O ,/,/O/O konnte/VBN/B-VP/O nachgewiesen/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Verlust/NN/I-NP/I-PNP der/DT/B-NP/I-PNP CD-Membranbindung/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Beschleunigung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP VSD-Kinetik/JJ/I-NP/I-PNP hervorrief/NN/I-NP/I-PNP ././O/O

Hieraus/VBN/B-VP/O wurde/VB/I-VP/O geschlussfolgert/NN/B-NP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Mutationen/NN/I-NP/I-PNP A242C/NN/I-NP/I-PNP ,/,/O/O R245C/NN/B-NP/O und/CC/I-NP/O Y255C/NN/I-NP/O die/DT/B-NP/O Proteinmodule/NN/I-NP/O voneinander/JJ/B-NP/O entkoppeln/NN/I-NP/O ././O/O

Im/IN/B-PP/B-PNP Gegensatz/NN/B-NP/I-PNP dazu/VB/B-VP/O wies/RB/B-ADVP/O die/DT/B-NP/O katalytisch/JJ/I-NP/O inaktive/NN/I-NP/O Mutante/NN/I-NP/O K252C/NN/I-NP/O eine/DT/B-NP/O dem/DT/I-NP/O Wildtyp/NN/I-NP/O \xc3\xa4hnliche/JJ/B-NP/O VSD-Kinetik/NN/I-NP/O auf/RP/O/O und/CC/O/O schien/VB/B-VP/O somit/RB/B-ADVP/O nicht/RB/I-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Membranbindung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP CD/NN/I-NP/I-PNP verantwortlich/JJ/B-ADJP/O zu/TO/B-VP/O sein/VB/I-VP/O ././O/O

Daher/RB/B-VP/O wurde/VB/I-VP/O vermutet/NN/B-NP/O ,/,/O/O dass/IN/B-PP/O der/DT/O/O Linker/VB/B-VP/O noch/RB/B-NP/O andere/JJ/I-NP/O Prozesse/NN/I-NP/O als/IN/B-PP/O nur/RB/B-ADVP/O die/DT/B-NP/O Membranbindung/NN/I-NP/O der/DT/B-NP/O CD/NN/I-NP/O vermitteln/VB/B-VP/O k\xc3\xb6nnte/VB/I-VP/O ././O/O

Um/IN/B-PP/B-PNP diese/DT/B-NP/I-PNP Frage/NN/I-NP/I-PNP zu/TO/B-VP/O kl\xc3\xa4ren/VB/I-VP/O ,/,/O/O wurde/VB/B-VP/O ein/DT/B-NP/O dreidimensionales/NN/I-NP/O Homologiemodell/NN/I-NP/O der/DT/B-NP/O Ci-VSP-Struktur/NN/I-NP/O konstruiert/NN/I-NP/O ,/,/O/O dessen/WDT/B-NP/O Dynamik/NN/I-NP/O simuliert/NN/I-NP/O wurde/VB/B-VP/O ././O/O

Anhand/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Simulationsergebnisse/NN/I-NP/I-PNP konnte/VB/B-VP/O bekr\xc3\xa4ftigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP sich/PRP/B-NP/I-PNP im/IN/B-PP/O gesamten/VB/B-VP/O ,/,/O/O \xc3\xbcberwiegend/JJ/B-NP/O alpha-helikal/NN/I-NP/O strukturierten/JJ/B-NP/O Linker/JJ/I-NP/O Aminos\xc3\xa4uren/NN/I-NP/O befinden/VB/B-VP/O ,/,/O/O die/WDT/O/O \xc3\xbcber/IN/B-PP/B-PNP Salzbr\xc3\xbccken/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP negativ/JJ/I-NP/I-PNP geladenen/JJ/I-NP/I-PNP Lipidkopfgruppen/NN/I-NP/I-PNP an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Membran/NN/I-NP/I-PNP interagieren/VB/B-VP/O ././O/O

Hierbei/JJ/B-NP/O spielt/NN/I-NP/O R245/NN/I-NP/O eine/DT/B-NP/O besondere/JJ/I-NP/O Rolle/NN/I-NP/O ,/,/O/O da/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Interaktionen/NN/I-NP/I-PNP dieser/DT/B-NP/I-PNP Seitenkette/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Membran/NN/I-NP/I-PNP einen/DT/B-NP/I-PNP strukturellen/JJ/I-NP/I-PNP Bruch/NN/I-NP/I-PNP im/IN/B-PP/O Linker/JJ/B-ADJP/O verursachen/VB/B-VP/O ,/,/O/O wodurch/VB/B-VP/O sich/PRP/B-NP/O der/DT/I-NP/O C-terminale/NN/I-NP/O Linkerbereich/NN/I-NP/O zur/IN/B-PP/B-PNP PD/NN/B-NP/I-PNP hin/IN/B-PP/B-PNP ausrichtet/NN/B-NP/I-PNP und/CC/I-NP/I-PNP sich/PRP/I-NP/I-PNP Salzbr\xc3\xbccken/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP K252/NN/B-NP/I-PNP ,/,/O/O R253/NN/B-NP/O im/IN/B-PP/O Linker/JJ/B-ADJP/O und/CC/O/O D400/NN/B-NP/O und/CC/O/O E402/NN/B-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP PD/NN/I-NP/I-PNP ausbilden/VB/B-VP/O ././O/O

D400/NN/B-NP/O und/CC/I-NP/O E402/NN/I-NP/O befinden/VB/B-VP/O sich/PRP/B-NP/O dabei/RB/B-ADVP/O in/IN/B-PP/O einem/DT/O/O von/IN/B-PP/B-PNP drei/CD/B-NP/I-PNP Loopregionen/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O die/DT/O/O katalytische/JJ/B-ADJP/O Bindungstasche/VB/B-VP/O der/DT/B-NP/O PD/NN/I-NP/O bilden/VB/B-VP/O und/CC/O/O stabilisieren/VB/B-VP/O ,/,/O/O dem/DT/B-NP/O TI-Loop/NN/I-NP/O ././O/O

Von/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Wechselwirkungen/NN/I-NP/I-PNP zwischen/IN/B-PP/O Linker/JJ/B-ADJP/O und/CC/O/O TI-Loop/NN/B-NP/O wurde/VB/B-VP/O die/DT/B-NP/O R253-D400-Salzbr\xc3\xbccke/NN/I-NP/O als/IN/B-PP/B-PNP die/DT/B-NP/I-PNP kritischste/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Ci-VSP-Funktionalit\xc3\xa4t/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP ,/,/O/O da/IN/B-PP/B-PNP Mutationen/NN/B-NP/I-PNP beider/JJ/I-NP/I-PNP Positionen/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Modulentkopplung/NN/I-NP/I-PNP f\xc3\xbchrten/VB/B-VP/O ,/,/O/O was/WDT/B-NP/O sich/PRP/I-NP/O in/IN/B-PP/O einer/DT/O/O nahezu/IN/B-PP/B-PNP aufgehobenen/NN/B-NP/I-PNP PD-Aktivit\xc3\xa4t/NN/I-NP/I-PNP und/CC/I-NP/I-PNP einer/DT/I-NP/I-PNP beschleunigten/NN/I-NP/I-PNP VSD-Kinetik/JJ/B-NP/I-PNP widerspiegelte/NN/I-NP/I-PNP ././O/O

Weitere/JJ/B-NP/O Untersuchungen/NN/I-NP/O zeigten/VB/B-VP/O auf/RP/I-VP/O ,/,/O/O dass/RB/B-ADVP/O der/DT/B-NP/O Kontakt/NN/I-NP/O zwischen/IN/B-PP/O Linker/JJ/B-ADJP/O und/CC/O/O TI-Loop/NN/B-NP/O neben/IN/B-PP/O den/DT/O/O elektrostatischen/VB/B-VP/O auch/RB/B-ADVP/O durch/IN/B-PP/B-PNP hydrophobe/NN/B-NP/I-PNP Interaktionen/NN/I-NP/I-PNP stabilisiert/NN/I-NP/I-PNP wird/VB/B-VP/O ,/,/O/O die/WDT/O/O insbesondere/RB/B-ADVP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Aminos\xc3\xa4uren/NN/I-NP/I-PNP Y255/NN/I-NP/I-PNP im/IN/B-PP/O Linker/JJ/B-ADJP/O und/CC/O/O F401/NN/B-NP/O im/IN/B-PP/B-PNP TI-Loop/NN/B-NP/I-PNP vermittelt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Zudem/RB/B-VP/O stabilisieren/VB/I-VP/O auch/RB/B-ADVP/O die/DT/B-NP/O negativ/JJ/I-NP/O geladenen/JJ/I-NP/O Kopfgruppen/NN/I-NP/O an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Membranoberfl\xc3\xa4che/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Interaktion/NN/I-NP/I-PNP zwischen/IN/B-PP/O Linker/JJ/B-ADJP/O und/CC/O/O TI-Loop/NN/B-NP/O ././O/O

Anhand/IN/B-PP/O der/DT/O/O hier/IN/B-PP/B-PNP erhaltenen/NN/B-NP/I-PNP Daten/NN/I-NP/I-PNP wurde/VB/B-VP/O eine/DT/B-NP/O Hypothese/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Ablauf/NN/I-NP/I-PNP des/DT/B-NP/I-PNP linkervermittelten/NN/I-NP/I-PNP VSD-CD-Kopplungsprozesses/NN/I-NP/I-PNP entwickelt/VB/B-VP/O ,/,/O/O bei/IN/B-PP/B-PNP dem/WDT/B-NP/I-PNP die/DT/I-NP/I-PNP Interaktionen/NN/I-NP/I-PNP zwischen/IN/B-PP/O Linker/JJ/B-ADJP/O und/CC/O/O TI-Loop/NN/B-NP/O entscheidend/JJ/B-ADJP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Formierung/NN/I-NP/I-PNP der/DT/O/O katalytischen/JJ/B-ADJP/O Bindungstasche/JJ/I-ADJP/O und/CC/O/O somit/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Aufrechterhaltung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP enzymatischen/JJ/I-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP der/DT/B-NP/I-PNP PD/NN/I-NP/I-PNP ist/VB/B-VP/O ././O/O

Mit/IN/B-PP/B-PNP diesen/DT/B-NP/I-PNP Ergebnissen/NN/I-NP/I-PNP wird/VB/B-VP/O das/DT/B-NP/O Wissen/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP den/DT/B-NP/I-PNP spannungsabh\xc3\xa4ngigen/NN/I-NP/I-PNP Aktivierungsmechanismus/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Ci-VSP-Proteins/NN/I-NP/I-PNP erweitert/VB/B-VP/O und/CC/O/O vertieft.Hypoxie/NN/B-NP/O und/CC/O/O Angiogenese/NN/B-NP/O stellen/VB/B-VP/O ein/DT/B-NP/O charakteristisches/JJ/I-NP/O Merkmal/NN/I-NP/O von/IN/B-PP/B-PNP chronisch/JJ/B-NP/I-PNP entz\xc3\xbcndeten/NN/I-NP/I-PNP ,/,/O/O verletzten/NN/B-NP/O oder/RB/I-NP/O tumor\xc3\xb6sen/NN/I-NP/O Geweben/NN/I-NP/O dar/RP/O/O ././O/O

Die/DT/B-NP/O Transkriptionsfaktoren/NN/I-NP/O Hypoxie/NN/I-NP/O induzierbarer/JJ/B-NP/O Faktor/NN/I-NP/O (/(/O/O HIF)-1/LS/O/O und/CC/O/O (/(/O/O HIF)-2/LS/O/O steuern/VB/B-VP/O die/DT/B-NP/O zellul\xc3\xa4re/JJ/I-NP/O und/CC/I-NP/O metabolische/JJ/I-NP/O Antwort/NN/I-NP/O auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP verminderten/JJ/I-NP/I-PNP Sauerstoffpartialdruck/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Induktion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Angiogenese/NN/B-NP/I-PNP sowie/RB/B-ADVP/O die/DT/B-NP/O Adaptation/NN/I-NP/O der/DT/B-NP/O Bioenergetik/NN/I-NP/O von/IN/B-PP/B-PNP Endothelzellen/NN/B-NP/I-PNP ,/,/O/O was/WDT/O/O wiederum/RB/B-ADVP/O einen/DT/B-NP/O Einfluss/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Auspr\xc3\xa4gung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Pathogenese/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Erkrankungen/NNS/B-NP/I-PNP mit/IN/B-PP/B-PNP hypoxischen/JJ/B-NP/I-PNP Erscheinungsbild/NN/I-NP/I-PNP hat/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurden/VB/B-VP/O die/DT/B-NP/O unterschiedlichen/JJ/I-NP/O Rollen/NN/I-NP/O von/IN/B-PP/B-PNP HIF-1/NN/B-NP/I-PNP und/CC/I-NP/I-PNP HIF-2/NN/I-NP/I-PNP bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Adaptation/NN/I-NP/I-PNP von/IN/B-PP/B-PNP humanen/NN/B-NP/I-PNP mikrovaskul\xc3\xa4ren/JJ/I-NP/I-PNP Endothelzellen/NN/I-NP/I-PNP (/(/O/O HMEC-1/NN/B-NP/O )/)/O/O an/IN/B-PP/B-PNP Hypoxie/NN/B-NP/I-PNP mittels/IN/B-PP/B-PNP eines/DT/B-NP/I-PNP Knockdowns/NN/I-NP/I-PNP von/IN/B-PP/B-PNP HIF-1\xce\xb1/NN/B-NP/I-PNP und/CC/I-NP/I-PNP HIF-2\xce\xb1/NN/I-NP/I-PNP untersucht/RP/O/O ././O/O

Der/DT/B-NP/O spezifische/JJ/I-NP/O Knockdown/NN/I-NP/O von/IN/B-PP/B-PNP HIF-1\xce\xb1/NN/B-NP/I-PNP und/CC/I-NP/I-PNP HIF-2\xce\xb1/NN/I-NP/I-PNP wurde/VB/B-VP/O mittels/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP lentiviral-basierten/NN/I-NP/I-PNP shRNA-Technologie/NN/I-NP/I-PNP durchgef\xc3\xbchrt/RP/O/O ././O/O

Die/DT/B-NP/O Angiogenese/NN/I-NP/O von/IN/B-PP/B-PNP HMEC-1/NN/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP wurde/VB/B-VP/O unter/IN/B-PP/B-PNP Normoxie/NN/B-NP/I-PNP (/(/O/O ~/NN/B-NP/O 18%/CD/I-NP/O O2/NN/I-NP/O )/)/O/O und/CC/O/O Hypoxie/NN/B-NP/O (/(/O/O &/NN/B-NP/O lt;1%/NN/I-NP/O O2/NN/I-NP/O )/)/O/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Ermittlung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP L\xc3\xa4nge/NN/I-NP/I-PNP der/DT/B-NP/I-PNP gebildeten/NN/I-NP/I-PNP Tubuli/NN/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O Anzahl/NN/I-NP/O der/DT/B-NP/O Verzweigungen/NN/I-NP/O funktionell/JJ/B-NP/O charakterisiert/NN/I-NP/O ././O/O

Des/JJ/B-NP/O Weiteren/NN/I-NP/O wurden/VB/B-VP/O zur/IN/B-PP/B-PNP Bestimmung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Funktionen/NN/I-NP/I-PNP von/IN/B-PP/B-PNP HIF-1/NN/B-NP/I-PNP und/CC/I-NP/I-PNP HIF-2/NN/I-NP/I-PNP im/IN/B-PP/B-PNP angiogenen/NN/B-NP/I-PNP Prozess/NN/I-NP/I-PNP das/DT/I-NP/I-PNP Transkriptom/NN/I-NP/I-PNP ,/,/O/O der/DT/B-NP/O bioenergetische/JJ/I-NP/O Status/NN/I-NP/O sowie/RB/B-ADVP/O die/DT/B-NP/O sekretierten/NN/I-NP/O Zytokine/NN/I-NP/O der/DT/B-NP/O Zellen/NNS/I-NP/O untersucht/RP/O/O ././O/O

Der/DT/B-NP/O Knockdown/NN/I-NP/O von/IN/B-PP/B-PNP HIF-1\xce\xb1/NN/B-NP/I-PNP bzw./RB/I-NP/I-PNP HIF-2\xce\xb1/NN/I-NP/I-PNP f\xc3\xbchrt/VB/B-VP/O zu/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Verlust/NN/I-NP/I-PNP der/DT/O/O unter/IN/B-PP/B-PNP Hypoxie/NN/B-NP/I-PNP induzierten/JJ/I-NP/I-PNP Angiogenese/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Form/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Sprossung/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Verzweigung/NN/I-NP/I-PNP ././O/O

Ferner/RB/B-VP/O \xc3\xa4ndert/VB/I-VP/O sich/PRP/B-NP/O das/DT/I-NP/O Transkriptom/NN/I-NP/O von/IN/B-PP/B-PNP HMEC-1/NN/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP mit/IN/B-PP/B-PNP Knockdown/NN/B-NP/I-PNP und/CC/O/O spiegelt/VB/B-VP/O sowohl/CC/O/O die/DT/B-NP/O \xc3\xbcberlappenden/NN/I-NP/O als/CC/O/O auch/RB/B-ADVP/O die/DT/B-NP/O distinkten/JJ/I-NP/O Funktionen/NN/I-NP/O von/IN/B-PP/B-PNP HIF-1/NN/B-NP/I-PNP und/CC/I-NP/I-PNP HIF-2/NN/I-NP/I-PNP wider/RP/O/O ././O/O

Dabei/RB/B-VP/O scheint/VB/I-VP/O HIF-1/NN/B-NP/O der/DT/I-NP/O Hauptregulator/NN/I-NP/O der/DT/B-NP/O bioenergetischen/JJ/I-NP/O Adaptation/NN/I-NP/O von/IN/B-PP/B-PNP HMEC-1/NN/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP zu/TO/B-VP/O sein/VB/I-VP/O ,/,/O/O da/IN/B-PP/B-PNP f\xc3\xbcr/IN/I-PP/I-PNP Zellen/NNS/B-NP/I-PNP mit/IN/B-PP/B-PNP HIF-1\xce\xb1/NN/B-NP/I-PNP Knockdown/NN/I-NP/I-PNP eine/DT/I-NP/I-PNP reduzierte/JJ/I-NP/I-PNP ATP/NN/I-NP/I-PNP Verf\xc3\xbcgbarkeit/NN/I-NP/I-PNP nachweisbar/JJ/B-ADJP/O war/VB/B-VP/O ././O/O

Der/DT/B-NP/O Knockdown/NN/I-NP/O von/IN/B-PP/B-PNP HIF-2\xce\xb1/NN/B-NP/I-PNP resultierte/VB/B-VP/O in/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP verminderten/JJ/I-NP/I-PNP Induktion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Angiogenese/NN/B-NP/I-PNP modulierenden/NN/I-NP/I-PNP Faktoren/NN/I-NP/I-PNP wie/IN/B-PP/B-PNP VEGF/NN/B-NP/I-PNP ,/,/O/O IL-8/NN/B-NP/O und/CC/I-NP/O IL-12/NN/I-NP/O ,/,/O/O was/WDT/B-NP/O die/DT/I-NP/O Hauptregulatorfunktion/NN/I-NP/O von/IN/B-PP/B-PNP HIF-2/NN/B-NP/I-PNP in/IN/B-PP/B-PNP diesem/DT/B-NP/I-PNP Prozess/NN/I-NP/I-PNP repr\xc3\xa4sentiert/VB/B-VP/O ././O/O

Zusammenfassend/JJ/B-ADJP/O fungieren/VB/B-VP/O sowohl/CC/O/O HIF-1\xce\xb1/NN/B-NP/O als/CC/O/O auch/IN/B-PP/B-PNP HIF-2\xce\xb1/NN/B-NP/I-PNP als/IN/B-PP/B-PNP wichtige/JJ/B-NP/I-PNP Regulatoren/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Angiogenese/NN/I-NP/I-PNP ././O/O

HIF-1/NN/B-NP/O und/CC/I-NP/O HIF-2/NN/I-NP/O unterscheiden/VB/B-VP/O sich/PRP/B-NP/O aber/IN/B-PP/B-PNP voneinander/NN/B-NP/I-PNP in/IN/B-PP/B-PNP ihrem/PRP$/B-NP/I-PNP Potential/NN/I-NP/I-PNP ,/,/O/O den/DT/B-NP/O zellul\xc3\xa4ren/NN/I-NP/O Energiemetabolismus/NN/I-NP/O bzw./RB/B-ADVP/O die/DT/B-NP/O Angiogenese/NN/I-NP/O zu/TO/B-VP/O regulieren/VB/I-VP/O ././O/O

Dabei/RB/B-VP/O beeinflusst/VB/I-VP/O HIF-2\xce\xb1/NN/B-NP/O die/DT/I-NP/O Angiogenese/NN/I-NP/O direkt/JJ/B-ADJP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Regulation/NN/I-NP/I-PNP proangiogener/NNP/I-NP/I-PNP Faktoren/NNP/I-NP/I-PNP ,/,/O/O wohingegen/IN/B-PP/B-PNP HIF-1\xce\xb1/NN/B-NP/I-PNP den/DT/I-NP/I-PNP zellul\xc3\xa4ren/NN/I-NP/I-PNP Energiemetabolismus/NN/I-NP/I-PNP regelt/VB/B-VP/O und/CC/O/O damit/RB/B-VP/O indirekt/VB/I-VP/O die/DT/B-NP/O Angiogenese/NN/I-NP/O beeinflusst/VB/B-VP/O ././O/O

Die/DT/O/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP gewonnenen/NN/I-NP/I-PNP neuen/JJ/B-NP/I-PNP Erkenntnisse/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP Rolle/NN/B-NP/I-PNP von/IN/B-PP/B-PNP HIF-1/NN/B-NP/I-PNP und/CC/I-NP/I-PNP HIF-2/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Prozess/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Angiogenese/NN/I-NP/I-PNP erm\xc3\xb6glichen/VB/B-VP/O neue/JJ/B-NP/O Ans\xc3\xa4tze/NNS/I-NP/O zur/IN/B-PP/B-PNP Behandlung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Erkrankungen/NNS/B-NP/I-PNP mit/IN/B-PP/B-PNP hypoxischem/NN/B-NP/I-PNP Erscheinungsbild/NN/I-NP/I-PNP und/CC/O/O sind/VB/B-VP/O daher/RB/B-ADVP/O von/IN/B-PP/B-PNP klinischer/JJ/B-NP/I-PNP Relevanz.Die/NN/I-NP/I-PNP vorliegende/JJ/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP besch\xc3\xa4ftigte/VBN/B-VP/I-PNP sich/PRP/B-NP/I-PNP mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Identifizierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP assoziierten/JJ/B-NP/I-PNP Bakterien/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP marinen/JJ/I-NP/I-PNP Kaltwasserschw\xc3\xa4mmen/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Untersuchung/NN/I-NP/O der/DT/B-NP/O schwammassoziierten/NN/I-NP/O Bakterien/NN/I-NP/O erfolgte/VBN/B-VP/O mit/IN/B-PP/B-PNP kultivierungsabh\xc3\xa4ngigen/NN/B-NP/I-PNP und/CC/I-NP/I-PNP kultivierungsunabh\xc3\xa4ngigen/JJ/I-NP/I-PNP Methoden/NN/I-NP/I-PNP ././O/O

o/VBN/B-VP/O wurden/VB/I-VP/O aerobe/NN/B-NP/O und/CC/I-NP/O anaerobe/JJ/I-NP/O Bakterien/NN/I-NP/O durch/IN/B-PP/B-PNP Batch-Kultivierung/NN/B-NP/I-PNP und&slash;oder/NN/I-NP/I-PNP kontinuierliche/JJ/I-NP/I-PNP Kultivierung/NN/I-NP/I-PNP untersucht/RP/O/O ././O/O

Von/IN/B-PP/B-PNP ausgew\xc3\xa4hlten/JJ/B-NP/I-PNP Isolaten/NN/I-NP/I-PNP erfolgte/VB/B-VP/O die/DT/B-NP/O \xc3\x9cberpr\xc3\xbcfung/NN/I-NP/O ihrer/PRP$/I-NP/O biologischen/JJ/B-NP/O Aktivit\xc3\xa4t/NN/I-NP/O ././O/O

Als/IN/B-PP/B-PNP kultivierungsunabh\xc3\xa4ngige/NN/B-NP/I-PNP Methode/NN/I-NP/I-PNP wurde/VB/B-VP/O eine/DT/B-NP/O 16S/NN/I-NP/O rDNA-Klonierung/NN/I-NP/O durchgef\xc3\xbchrt/RP/O/O ././O/O

Aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP untersuchten/NN/I-NP/I-PNP Kaltwasserschw\xc3\xa4mmen/NN/I-NP/I-PNP wurden/VB/B-VP/O rund/RB/B-ADVP/O 400/CD/B-NP/O Bakterien/NN/I-NP/O isoliert/NN/I-NP/O und/CC/O/O identifiziert/NN/B-NP/O ././O/O

Der/DT/B-NP/O Einsatz/NN/I-NP/O unterschiedlicher/JJ/B-NP/O Kultivierungstechniken/NN/I-NP/O und/CC/O/O Medien/NN/B-NP/O f\xc3\xbchrte/VB/B-VP/O zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP hohen/JJ/I-NP/I-PNP Diversit\xc3\xa4t/NN/I-NP/I-PNP an/IN/B-PP/B-PNP bakteriellen/NN/B-NP/I-PNP Gattungen/NNS/I-NP/I-PNP und/CC/I-NP/I-PNP Arten/NN/I-NP/I-PNP ././O/O

Es/PRP/B-NP/O konnten/VB/B-VP/O insgesamt/RB/B-ADVP/O 30/CD/B-NP/O Gattungen/NNS/I-NP/O aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Klassen/NN/I-NP/I-PNP Gammaproteobacteria/NN/I-NP/I-PNP ,/,/O/O Alphaproteobacteria/NN/B-NP/O ,/,/O/O Deltaproteobacteria/NN/B-NP/O ,/,/O/O Actinobacteria/NN/B-NP/O ,/,/O/O Bacilli/NN/B-NP/O und/CC/I-NP/O Flavobacteria/NN/I-NP/O identifiziert/NN/I-NP/O werden/VB/B-VP/O ././O/O

Bei/IN/B-PP/B-PNP den/DT/B-NP/I-PNP aeroben/NN/I-NP/I-PNP Isolaten/NN/I-NP/I-PNP war/VB/B-VP/O der/DT/B-NP/O Anteil/NN/I-NP/O der/DT/B-NP/O Gammaproteobacteria/NN/I-NP/O am/IN/B-PP/O h\xc3\xb6chsten/VB/B-VP/O ,/,/O/O wogegen/WRB/O/O aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP anaeroben/NN/I-NP/I-PNP Kultivierungen/NN/I-NP/I-PNP haupts\xc3\xa4chlich/IN/B-PP/B-PNP Bakterien/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Klasse/NN/I-NP/I-PNP Deltaproteobacteria/NN/I-NP/I-PNP isoliert/NN/I-NP/I-PNP wurden/VB/B-VP/O ././O/O

Der/DT/B-NP/O Vergleich/NN/I-NP/O der/DT/B-NP/O aeroben/NN/I-NP/O Batch-Kultivierung/NN/I-NP/O zur/IN/B-PP/B-PNP kontinuierlichen/JJ/B-NP/I-PNP Kultivierung/NN/I-NP/I-PNP zeigte/VB/B-VP/O eine/DT/B-NP/O Verschiebung/NN/I-NP/O der/DT/B-NP/O Gattungen/NNS/I-NP/O innerhalb/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Gammaproteobacteria/NN/I-NP/I-PNP und/CC/O/O Flavobacteria/NN/B-NP/O ././O/O

Zwei/CD/B-NP/O Drittel/NN/I-NP/O der/DT/B-NP/O isolierten/NN/I-NP/O bakteriellen/NN/I-NP/O Gattungen/NNS/I-NP/O wurden/VB/B-VP/O als/IN/B-PP/B-PNP bedeutend/JJ/B-NP/I-PNP schwammassoziiert/JJ/I-NP/I-PNP bewertet/NN/I-NP/I-PNP ././O/O

Zus\xc3\xa4tzlich/JJ/B-ADJP/O konnten/VB/B-VP/O Bakterien/NN/B-NP/O der/DT/O/O als/IN/B-PP/B-PNP schwammspezifisch/JJ/B-NP/I-PNP eingestuften/NN/I-NP/I-PNP Gattung/JJ/B-NP/I-PNP Pseudovibrio/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Klasse/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Gammaproteobacteria/NN/I-NP/I-PNP isoliert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Die/DT/B-NP/O Gattung/NN/I-NP/O und/CC/O/O Art/NN/B-NP/O Spongiispira/NN/I-NP/O norvegica/NN/I-NP/O wurde/VB/B-VP/O im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP neu/JJ/B-NP/I-PNP beschrieben/NN/I-NP/I-PNP ././O/O

Es/PRP/B-NP/O wurden/VB/B-VP/O insgesamt/RB/B-ADVP/O 56/CD/B-NP/O Isolate/NN/I-NP/O mit/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Testsystemen/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP ihre/PRP$/B-NP/I-PNP biologische/JJ/I-NP/I-PNP Wirksamkeit/NN/I-NP/I-PNP untersucht/RP/O/O ././O/O

Davon/RB/B-VP/O waren/VB/I-VP/O 41/CD/B-NP/O Isolate/NN/I-NP/O nachweislich/JJ/B-ADJP/O biologisch/JJ/I-ADJP/O aktiv/JJ/I-ADJP/O ././O/O

Die/DT/B-NP/O untersuchten/JJ/I-NP/O Isolate/NN/I-NP/O aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP kontinuierlichen/JJ/I-NP/I-PNP Kultivierungsans\xc3\xa4tzen/NN/I-NP/I-PNP zeigten/VB/B-VP/O die/DT/B-NP/O umfangreichsten/NN/I-NP/O nachweisbaren/NN/I-NP/O Aktivit\xc3\xa4ten/NN/I-NP/O ,/,/O/O wobei/WRB/O/O die/DT/B-NP/O Arten/NN/I-NP/O Pseudoalteromonas/NN/I-NP/O agarivorans/NN/I-NP/O und/CC/O/O Glaciecola/JJ/B-NP/O mesophila/NN/I-NP/O (/(/O/O Klasse/NN/B-NP/O Gammaproteobacteria/NN/I-NP/O )/)/O/O am/RB/B-NP/O biologisch/JJ/I-NP/O wirksamsten/NN/I-NP/O waren/VB/B-VP/O ././O/O

Die/DT/B-NP/O Analyse/NN/I-NP/O von/IN/B-PP/O rund/RB/B-ADVP/O 100/CD/B-NP/O Klonen/NN/I-NP/O aus/IN/B-PP/B-PNP der/DT/B-NP/I-PNP 16S/NNP/I-NP/I-PNP rDNA-Klonierung/NNP/I-NP/I-PNP ergab/VB/B-VP/O die/DT/B-NP/O phylogenetische/JJ/I-NP/O Einordnung/NN/I-NP/O in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Phyla/JJ/I-NP/I-PNP Proteobacteria/NN/I-NP/I-PNP (/(/O/O Klassen/NN/B-NP/O Alphaproteobacteria/NN/I-NP/O und/CC/I-NP/O Deltaproteobacteria/NN/I-NP/O )/)/O/O ,/,/O/O Chloroflexi/NN/B-NP/O ,/,/O/O Acidobacteria/NN/B-NP/O ,/,/O/O Gemmatimonadetes/NN/B-NP/O ,/,/O/O Deferribacteres/NN/B-NP/O ,/,/O/O Nitrospira/NN/B-NP/O und/CC/I-NP/O Thaumarchaeota/NN/I-NP/O ././O/O

Von/IN/B-PP/B-PNP den/DT/B-NP/I-PNP erhaltenen/NN/I-NP/I-PNP 30/CD/B-NP/I-PNP phylogenetischen/JJ/I-NP/I-PNP Klongruppen/NN/I-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O H\xc3\xa4lfte/NN/I-NP/O als/IN/B-PP/B-PNP schwammspezifisch/JJ/B-NP/I-PNP und/CC/I-NP/I-PNP bedeutend/JJ/I-NP/I-PNP schwammassoziiert/JJ/I-NP/I-PNP bewertet/NN/I-NP/I-PNP ././O/O

Der/DT/B-NP/O Vergleich/NN/I-NP/O der/DT/B-NP/O erhaltenen/JJ/I-NP/O Daten/NN/I-NP/O aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP kultivierungsabh\xc3\xa4ngigen/NN/I-NP/I-PNP und/CC/O/O kultivierungsunabh\xc3\xa4ngigen/NN/B-NP/O Ans\xc3\xa4tzen/NN/I-NP/O ergab/VB/B-VP/O eine/DT/B-NP/O \xc3\x9cberschneidung/NN/I-NP/O der/DT/B-NP/O Daten/NN/I-NP/O bez\xc3\xbcglich/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Klassen/NN/I-NP/I-PNP Alphaproteobacteria/NN/I-NP/I-PNP und/CC/O/O Deltaproteobacteria/NN/B-NP/O ././O/O

In/IN/B-PP/B-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP konnte/VBN/B-VP/I-PNP mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP gew\xc3\xa4hlten/JJ/I-NP/I-PNP Methoden/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP hohe/JJ/I-NP/I-PNP Anzahl/NN/I-NP/I-PNP von/IN/B-PP/B-PNP schwammassoziierten/JJ/B-NP/I-PNP Bakterien/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP Kaltwassergebieten/NN/B-NP/I-PNP charakterisiert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Diese/DT/B-NP/O Ergebnisse/NN/I-NP/O tragen/VB/B-VP/O zur/IN/B-PP/B-PNP Erh\xc3\xb6hung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP begrenzten/JJ/I-NP/I-PNP mikrobiologischen/JJ/I-NP/I-PNP Datenlage/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Kaltwasserschw\xc3\xa4mmen/NN/B-NP/I-PNP bei/RP/O/O ././O/O

Jede/DT/B-NP/O der/DT/I-NP/O eingesetzten/NN/I-NP/O Methoden/NN/I-NP/O war/VB/B-VP/O erfolgreich/JJ/B-ADJP/O und/CC/O/O f\xc3\xbchrte/VB/B-VP/O zum/IN/B-PP/B-PNP Erhalt/NN/B-NP/I-PNP bedeutend/JJ/I-NP/I-PNP schwammassoziierter/NN/I-NP/I-PNP und&slash;oder/NN/I-NP/I-PNP schwammspezifischer/JJ/B-NP/I-PNP Bakterien/NN/I-NP/I-PNP ././O/O

Die/DT/O/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP angewendeten/NN/I-NP/I-PNP Methoden/NN/I-NP/I-PNP der/DT/O/O kontinuierlichen/JJ/B-ADJP/O und/CC/O/O der/DT/B-NP/O anaeroben/NN/I-NP/O Kultivierung/NN/I-NP/O wurden/VB/B-VP/O erstmals/RB/B-ADVP/O zur/IN/B-PP/B-PNP Isolierung/NN/B-NP/I-PNP schwammassoziierter/NN/I-NP/I-PNP Bakterien/NN/I-NP/I-PNP eingesetzt/RP/O/O ././O/O

Die/DT/B-NP/O angelegte/NN/I-NP/O Stammsammlung/NN/I-NP/O enth\xc3\xa4lt/JJ/B-NP/O weitere/JJ/I-NP/O Isolate/NN/I-NP/O ,/,/O/O die/WDT/O/O f\xc3\xbcr/IN/B-PP/B-PNP neue/JJ/B-NP/I-PNP Artbeschreibungen/NN/I-NP/I-PNP geeignete/JJ/B-ADJP/O w\xc3\xa4ren/VB/B-VP/O ././O/O

Das/DT/B-NP/O Ziel/NN/I-NP/O des/DT/B-NP/O Nachweises/NN/I-NP/O von/IN/B-PP/B-PNP marinen/JJ/B-NP/I-PNP Naturstoffen/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP schwammassoziierten/NN/B-NP/I-PNP Bakterien/NN/I-NP/I-PNP konnte/VBN/B-VP/I-PNP mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP gew\xc3\xa4hlten/JJ/I-NP/I-PNP unterschiedlichen/JJ/I-NP/I-PNP Kultivierungsans\xc3\xa4tzen/NN/I-NP/I-PNP erreicht/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Insbesondere/RB/B-ADVP/O die/DT/B-NP/O Isolate/NN/I-NP/O aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP kontinuierlichen/JJ/I-NP/I-PNP Kulturen/NN/I-NP/I-PNP zeigten/VB/B-VP/O eine/DT/B-NP/O hohe/JJ/I-NP/O biologische/JJ/I-NP/O Aktivit\xc3\xa4t.Die/NN/I-NP/O Actinomycine/NN/I-NP/O ,/,/O/O eine/DT/B-NP/O Gruppe/NN/I-NP/O cytostatisch/JJ/B-NP/O wirksamer/JJ/I-NP/O Chromopeptide/NN/I-NP/O ,/,/O/O werden/VB/B-VP/O von/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Streptomyces/NN/I-NP/I-PNP St\xc3\xa4mmen/NN/I-NP/I-PNP gebildet/RP/O/O ././O/O

Ihre/PRP$/B-NP/O Struktur/NN/I-NP/O ist/VB/B-VP/O gepr\xc3\xa4gt/JJ/B-ADJP/O durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Dimethyl-Phenoxazinon-Dicarbons\xc3\xa4ure/NN/I-NP/I-PNP ,/,/O/O welche/WDT/O/O in/IN/B-PP/B-PNP Amidbindungen/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP zwei/CD/B-NP/I-PNP Pentapeptidlactonringen/NN/I-NP/I-PNP verkn\xc3\xbcpft/NN/I-NP/I-PNP ist/VB/B-VP/O ././O/O

Die/DT/B-NP/O Bildung/NN/I-NP/O des/DT/B-NP/O Phenoxazinon-Chromophors/NN/I-NP/O findet/VB/B-VP/O im/IN/B-PP/B-PNP letzten/JJ/B-NP/I-PNP Schritt/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Actinomycin-Biosynthese/NN/I-NP/I-PNP statt/RP/O/O ,/,/O/O wenn/IN/B-PP/O zwei/CD/O/O 3-Hydroxy-4-methylanthraniloyl-(4-MHA)-Pentapeptidlacton-Zwischenstufen/LS/O/O oxidativ/NN/B-NP/O miteinander/IN/B-PP/B-PNP kondensiert/NN/B-NP/I-PNP werden/VB/B-VP/O ././O/O

Enzymatische/JJ/B-NP/O und/CC/I-NP/O genetische/JJ/I-NP/O Arbeiten/NN/I-NP/O in/IN/B-PP/O Streptomyces/FW/O/O chrysomallus/FW/O/O haben/VB/B-VP/O die/DT/B-NP/O Schritte/NN/I-NP/O des/DT/B-NP/O Aufbaus/NN/I-NP/O der/DT/B-NP/O 4-MHA/NNP/I-NP/O Pentapeptidlactone/NNP/I-NP/O an/IN/B-PP/B-PNP den/DT/B-NP/I-PNP multifunktionellen/NN/I-NP/I-PNP Actinomycin/JJ/B-NP/I-PNP Synthetasen/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Pentapeptidlactonring-Aminos\xc3\xa4uren/NN/I-NP/I-PNP und/CC/O/O 4-MHA/NNP/B-NP/O gekl\xc3\xa4rt/RP/O/O ././O/O

Dagegen/RB/B-VP/O waren/VB/I-VP/O die/DT/B-NP/O Schritte/NN/I-NP/O der/DT/B-NP/O Biosynthese/NN/I-NP/O der/DT/B-NP/O 4-MHA/NN/I-NP/O nur/RB/B-ADVP/O teilweise/RB/I-ADVP/O auf/IN/B-PP/B-PNP enzymatischer/NN/B-NP/I-PNP Ebene/NN/I-NP/I-PNP charakterisiert/NN/I-NP/I-PNP und/CC/I-NP/I-PNP die/DT/I-NP/I-PNP verantwortlichen/JJ/I-NP/I-PNP Gene/NN/I-NP/I-PNP unbekannt/RP/O/O ././O/O

Die/DT/B-NP/O Sequenzanalyse/NN/I-NP/O des/DT/B-NP/O Actinomycin-Biosynthese-Genclusters/NN/I-NP/O von/IN/B-PP/O S./VB/B-VP/O chrysomallus/NN/B-NP/O f\xc3\xbchrte/VB/B-VP/O zur/IN/B-PP/B-PNP Auffindung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP 4-MHA/NNP/B-NP/I-PNP Biosynthese/NNP/I-NP/I-PNP Genen/NNP/I-NP/I-PNP wie/IN/B-PP/B-PNP f\xc3\xbcr/IN/I-PP/I-PNP Tryptophandioxygenase/NN/B-NP/I-PNP (/(/O/O acmG/NN/B-NP/O )/)/O/O ,/,/O/O Kynureninformamidase/NN/B-NP/O (/(/O/O acmF/NN/B-NP/O )/)/O/O und/CC/O/O Hydroxykynureninase/NN/B-NP/O (/(/O/O acmH/NNP/B-NP/O )/)/O/O ././O/O

Die/DT/B-NP/O betreffenden/JJ/I-NP/O Enzymaktivit\xc3\xa4ten/NN/I-NP/O konnten/VB/B-VP/O durch/IN/B-PP/B-PNP vergleichende/NN/B-NP/I-PNP enzymatische/JJ/I-NP/I-PNP Analysen/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Zellextrakten/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Actinomycin-produzierenden/NN/I-NP/I-PNP Wildtyp-Stamms/NN/I-NP/I-PNP und/CC/O/O einer/DT/B-NP/O Actinomycin-negativen/NN/I-NP/O Mutante/NN/I-NP/O ,/,/O/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP diese/DT/I-NP/I-PNP Gene/NN/I-NP/I-PNP deletiert/NN/I-NP/I-PNP waren/VB/B-VP/O ,/,/O/O identifiziert/NN/B-NP/O und/CC/O/O von/IN/B-PP/B-PNP den/DT/B-NP/I-PNP entsprechenden/JJ/I-NP/I-PNP katabolischen/JJ/I-NP/I-PNP Enzymen/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Prim\xc3\xa4rstoffwechsels/NN/I-NP/I-PNP funktionell/JJ/B-ADJP/O unterschieden/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Weitere/DT/O/O als/IN/B-PP/B-PNP Methyltransferase/NN/B-NP/I-PNP Gene/NN/I-NP/I-PNP annotierte/JJ/I-NP/I-PNP Gene/NN/I-NP/I-PNP (/(/O/O acmI/NNP/B-NP/O und/CC/I-NP/O acmL/NNP/I-NP/O )/)/O/O wurden/VB/B-VP/O heterolog/NN/B-NP/O in/IN/B-PP/B-PNP E./JJ/B-NP/I-PNP coli/JJ/I-NP/I-PNP exprimiert/NN/I-NP/I-PNP ././O/O

Testung/NN/B-NP/O von/IN/B-PP/B-PNP AcmI/NNP/B-NP/I-PNP und/CC/I-NP/I-PNP AcmL/NNP/I-NP/I-PNP ergab/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O sie/PRP/B-NP/O 3-Hydroxykynurenin/NN/I-NP/O (/(/O/O 3-HK/NNP/B-NP/O )/)/O/O zu/IN/B-PP/B-PNP 3-Hydroxy-4-methylkynurenin/NN/B-NP/I-PNP (/(/O/O 4-MHK/NN/B-NP/O )/)/O/O aber/RB/B-ADVP/O nicht/RB/I-ADVP/O die/DT/B-NP/O 3-Hydroxyanthranils\xc3\xa4ure/NN/I-NP/O (/(/O/O 3-HA/NNP/B-NP/O )/)/O/O zu/TO/O/O 4-MHA/NNP/B-NP/O -/-/O/O wie/IN/B-PP/B-PNP Daten/NN/B-NP/I-PNP fr\xc3\xbcherer/JJ/I-NP/I-PNP Arbeiten/NN/I-NP/I-PNP eigentlich/JJ/B-NP/I-PNP voraussagten/NN/I-NP/I-PNP -/-/O/O methylieren/NN/B-NP/O ././O/O

Demgem\xc3\xa4\xc3\x9f/RB/B-NP/O resultierte/JJ/I-NP/O Zugabe/NN/I-NP/O von/IN/B-PP/B-PNP \xc3\xbcbersch\xc3\xbcssiger/NNP/B-NP/I-PNP 3-HA/NNP/I-NP/I-PNP zu/IN/B-PP/O S./VB/B-VP/O chrysomallus/NN/B-NP/O und/CC/O/O Streptomyces/FW/O/O parvulus/FW/O/O als/CC/O/O auch/FW/O/O zu/TO/O/O Streptomyces/FW/O/O antibioticus/FW/O/O keine/JJ/B-NP/O Stimulierung/NN/I-NP/O der/DT/B-NP/O Actinomycinsynthese/NN/I-NP/O ././O/O

attdessen/VBN/B-VP/O wurde/VB/I-VP/O die/DT/O/O im/IN/B-PP/B-PNP \xc3\x9cberschuss/NN/B-NP/I-PNP vorliegende/JJ/I-NP/I-PNP 3-HA/NNP/I-NP/I-PNP aufgrund/IN/B-PP/B-PNP ihrer/PRP$/B-NP/I-PNP strukturellen/JJ/I-NP/I-PNP Homologie/NN/I-NP/I-PNP anstelle/IN/B-PP/B-PNP der/DT/B-NP/I-PNP intrazellul\xc3\xa4ren/NN/I-NP/I-PNP 4-MHA/NNP/I-NP/I-PNP in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Phenoxazinon-Chromophor/NN/I-NP/I-PNP neuer/JJ/B-NP/I-PNP Actinomycine/NN/I-NP/I-PNP ,/,/O/O der/DT/B-NP/O C-Demethylactinomycine/NN/I-NP/O ,/,/O/O eingebaut/NN/B-NP/O ././O/O

Dar\xc3\xbcber/RB/B-ADVP/O hinaus/IN/B-PP/B-PNP induzierte/NN/B-NP/I-PNP die/DT/I-NP/I-PNP 3-HA/NNP/I-NP/I-PNP in/IN/B-PP/O S./VB/B-VP/O antibioticus/FW/O/O zus\xc3\xa4tzlich/FW/O/O die/DT/B-NP/O Bildung/NN/I-NP/O von/IN/B-PP/B-PNP neuen/JJ/B-NP/I-PNP C-Demethyl-hemi-Actinomycinen/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O nur/RB/B-ADVP/O einen/DT/O/O statt/RP/O/O zwei/CD/B-NP/O Pentapeptidlactonringen/NN/I-NP/O am/IN/B-PP/B-PNP Phenoxazinonchromophor/NN/B-NP/I-PNP tragen/VB/B-VP/O ././O/O

Entsprechend/RB/B-VP/O resultierte/VB/I-VP/O die/DT/B-NP/O F\xc3\xbctterung/NN/I-NP/O von/IN/B-PP/O S./VB/B-VP/O antibioticus/FW/O/O mit/IN/B-PP/B-PNP \xc3\xbcbersch\xc3\xbcssiger/NNP/B-NP/I-PNP 4-MHA/NNP/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Bildung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Hemiactinomycinen/NN/B-NP/I-PNP ././O/O

Letztere/NN/B-NP/O und/CC/I-NP/O die/DT/I-NP/O Demethyl-hemi-Actinomycine/NN/I-NP/O entstehen/VB/B-VP/O durch/IN/B-PP/B-PNP oxidative/NN/B-NP/I-PNP Kondensation/NN/I-NP/I-PNP im/IN/B-PP/B-PNP \xc3\x9cberschuss/NN/B-NP/I-PNP pr\xc3\xa4senter/NN/I-NP/I-PNP 3-HA/NNP/I-NP/I-PNP oder/CC/I-NP/I-PNP 4-MHA/NNP/I-NP/I-PNP mit/IN/B-PP/B-PNP vorgebildeten/JJ/B-NP/I-PNP Actinomycinh\xc3\xa4lften/NN/I-NP/I-PNP ././O/O

Diese/DT/B-NP/O Reaktionen/NN/I-NP/O werden/VB/B-VP/O offensichtlich/JJ/B-ADJP/O von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Phenoxazinon/JJ/I-NP/I-PNP Synthase/NN/I-NP/I-PNP (/(/O/O PHS/NNP/B-NP/O )/)/O/O in/IN/B-PP/O S./VB/B-VP/O antibioticus/FW/O/O katalysiert/FW/O/O ,/,/O/O die/WDT/O/O in/IN/B-PP/O S./VB/B-VP/O chrysomallus/NN/B-NP/O oder/RB/B-VP/O S./VB/I-VP/O parvulus/NN/B-NP/O nicht/RB/I-NP/O vorkommt/NN/I-NP/O ././O/O

Weitere/DT/B-NP/O enzymatische/JJ/I-NP/O und/CC/I-NP/O kinetische/JJ/I-NP/O Charakterisierungen/NN/I-NP/O von/IN/B-PP/B-PNP AcmI/NNP/B-NP/I-PNP und/CC/I-NP/I-PNP AcmL/NNP/I-NP/I-PNP zeigten/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O sie/PRP/B-NP/O neben/IN/B-PP/B-PNP ihrem/PRP$/B-NP/I-PNP eigentlichen/JJ/I-NP/I-PNP Substrat/NN/I-NP/I-PNP ,/,/O/O 3-Hydroxy-D-Kynurenin/NN/B-NP/O ,/,/O/O auch/RB/B-NP/O andere/JJ/I-NP/O phenolische/JJ/I-NP/O Aminos\xc3\xa4uren/NN/I-NP/O mit/IN/B-PP/B-PNP neuartiger/NNP/B-NP/I-PNP antipodaler/NNP/I-NP/I-PNP Stereospezifit\xc3\xa4t/NNP/I-NP/I-PNP am/IN/B-PP/B-PNP aromatischen/JJ/B-NP/I-PNP Kern/JJ/I-NP/I-PNP methylieren/NN/I-NP/I-PNP ././O/O

Diese/DT/O/O wird/RB/B-ADJP/O bestimmt/JJ/I-ADJP/O von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP optischen/JJ/I-NP/I-PNP Konfiguration/NN/I-NP/I-PNP am/IN/B-PP/B-PNP alpha-C/NN/B-NP/I-PNP und/CC/O/O gleichzeitig/RB/B-ADVP/O der/DT/B-NP/O unterschiedlichen/JJ/I-NP/O L\xc3\xa4nge/NN/I-NP/O der/DT/B-NP/O aliphatischen/JJ/I-NP/O Aminos\xc3\xa4ureseitenkette/NN/I-NP/O ././O/O

Wildtyp/JJ/B-NP/O AcmI&slash;AcmL/NN/I-NP/O wurden/VB/B-VP/O auch/RB/B-ADVP/O in/IN/B-PP/B-PNP Zellextrakten/NN/B-NP/I-PNP von/IN/B-PP/O S./VB/B-VP/O chrysomallus/NN/B-NP/O nachgewiesen/VBN/B-VP/O ,/,/O/O in/IN/B-PP/O welchen/WP/O/O sie/PRP/B-NP/O zusammen/RB/B-ADVP/O mit/IN/B-PP/B-PNP Hydroxykynureninase/NN/B-NP/I-PNP die/DT/I-NP/I-PNP Konversion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 3-HK/NNP/B-NP/I-PNP (/(/O/O \xc3\xbcber/IN/B-PP/B-PNP 4-MHK/NNP/B-NP/I-PNP )/)/O/O in/IN/B-PP/B-PNP 4-MHA/NNP/B-NP/I-PNP katalysierten/NNP/I-NP/I-PNP ././O/O

Die/DT/O/O in/IN/B-PP/B-PNP geringem/JJ/B-NP/I-PNP Ausma\xc3\x9f/NN/I-NP/I-PNP stattfindende/NN/I-NP/I-PNP vorzeitige/JJ/B-NP/I-PNP Spaltung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 3-HK/NNP/B-NP/I-PNP in/IN/B-PP/B-PNP 3-HA/NNP/B-NP/I-PNP durch/IN/B-PP/B-PNP Hydroxykynureninase/NN/B-NP/I-PNP ist/JJ/I-NP/I-PNP Grund/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Vorkommen/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Spuren/NNS/B-NP/I-PNP von/IN/B-PP/B-PNP C-Demethylactinomycinen/NN/B-NP/I-PNP in/IN/B-PP/B-PNP nat\xc3\xbcrlichen/IN/I-PP/I-PNP Actinomycingemischen.Untersuchungen/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Bildung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Alkaloidpeptide/NN/I-NP/I-PNP vom/IN/B-PP/B-PNP Cyclol-Typ/NN/B-NP/I-PNP (/(/O/O Ergopeptine/NN/B-NP/O )/)/O/O in/IN/B-PP/B-PNP Claviceps/NN/B-NP/I-PNP purpurea/NN/I-NP/I-PNP zeigten/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O deren/WDT/B-NP/O Peptidgrundger\xc3\xbcst/NN/I-NP/O von/IN/B-PP/B-PNP den/DT/B-NP/I-PNP nichtribosomalen/JJ/I-NP/I-PNP Peptidsynthetasen/NN/I-NP/I-PNP (/(/O/O NPRS/NNP/B-NP/O )/)/O/O ,/,/O/O LPS1/NN/B-NP/O und/CC/I-NP/O LPS2/NN/I-NP/O ,/,/O/O aufgebaut/VBN/B-VP/O wird/VB/I-VP/O ././O/O

Diese/DT/B-NP/O verkn\xc3\xbcpfen/NN/I-NP/O die/DT/B-NP/O D/JJ/I-NP/O Lysergs\xc3\xa4ure/NN/I-NP/O mit/IN/B-PP/B-PNP drei/CD/B-NP/I-PNP Aminos\xc3\xa4uren/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP thioestergebundenen/NN/I-NP/I-PNP D-Lysergyltripepid/NN/I-NP/I-PNP ,/,/O/O welches/WDT/O/O in/IN/B-PP/B-PNP in-vitro-Bedingungen/NN/B-NP/I-PNP als/IN/B-PP/O D-Lysergyltripeptidlactam/JJ/B-ADJP/O (/(/O/O z.B./RB/B-ADVP/O im/IN/B-PP/B-PNP Falle/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Ergotamins/NN/I-NP/I-PNP als/IN/B-PP/B-PNP N-(D-Lysergyl-Alanyl)-Phenylalanyl-Prolin-Lactam/IN/I-PP/I-PNP )/)/O/O von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP LPS1/NN/I-NP/I-PNP freigesetzt/VBN/B-VP/I-PNP wird/VB/I-VP/O ././O/O

Die/DT/B-NP/O Bildung/NN/I-NP/O des/DT/B-NP/O Cyclol-Endprodukts/NN/I-NP/O (/(/O/O Ergopeptin/NN/B-NP/O )/)/O/O bzw./CC/O/O die/DT/B-NP/O Cyclolisierung/NN/I-NP/O von/IN/B-PP/B-PNP D/NN/B-NP/I-PNP Lysergyltripeptidlactamen/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP Ergopeptinen/NN/B-NP/I-PNP konnte/VB/B-VP/O bisher/RB/I-VP/O nicht/RB/I-VP/O erreicht/VBN/I-VP/O werden/VB/I-VP/O ././O/O

Dagegen/RB/B-VP/O wird/VB/I-VP/O hier/RB/B-ADVP/O ein/DT/B-NP/O enzymatisches/JJ/I-NP/O in-vitro-Totalsynthesesystem/NN/I-NP/O f\xc3\xbcr/IN/B-PP/O alle/DT/O/O drei/CD/O/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Natur/NN/I-NP/I-PNP vorkommenden/NN/I-NP/I-PNP Ergopeptinklassen/NN/I-NP/I-PNP vorgestellt/RP/O/O ././O/O

Es/PRP/B-NP/O fu\xc3\x9ft/NN/I-NP/O auf/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP schonend/JJ/I-NP/I-PNP hergestellten/NN/I-NP/I-PNP Zellextrakt/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Alkaloid-Hochproduzenten/NN/I-NP/I-PNP C./NNP/I-NP/I-PNP purpurea/NNP/I-NP/I-PNP D11/NNP/I-NP/I-PNP ,/,/O/O welcher/WP/O/O sowohl/CC/O/O unfraktioniert/NN/B-NP/O als/CC/O/O auch/RB/B-ADVP/O nach/IN/B-PP/B-PNP Anreicherung/NN/B-NP/I-PNP durch/IN/B-PP/B-PNP schnelle/NN/B-NP/I-PNP Fraktionierungsschritte/NN/I-NP/I-PNP die/DT/I-NP/I-PNP Bildung/NN/I-NP/I-PNP von/IN/B-PP/O z.B./RB/B-ADVP/O von/IN/B-PP/B-PNP Ergotamin/NN/B-NP/I-PNP aus/IN/B-PP/B-PNP D-Lysergs\xc3\xa4ure/NN/B-NP/I-PNP ,/,/O/O Alanin/NN/B-NP/O ,/,/O/O Phenylalanin/NN/B-NP/O und/CC/I-NP/O Prolin/NN/I-NP/O in/IN/B-PP/B-PNP ATP/NNP/B-NP/I-PNP -/-/O/O ,/,/O/O Fe(II/NNP/B-NP/O )/)/O/O -/-/O/O und/CC/O/O \xce\xb1-Ketoglutarat-abh\xc3\xa4ngiger/NNP/B-NP/O Weise/JJ/B-NP/O katalysiert/NN/I-NP/O ././O/O

Dissektion/NN/B-NP/O des/DT/I-NP/O Systems/NN/I-NP/O in/IN/B-PP/B-PNP seine/PRP$/B-NP/I-PNP enzymatischen/JJ/I-NP/I-PNP Einzelkomponenten/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP Gelfiltration/NN/B-NP/I-PNP erm\xc3\xb6glichte/VB/B-VP/O die/DT/B-NP/O Identifikation/NN/I-NP/O der/DT/B-NP/O Cyclolisierungsaktivit\xc3\xa4t/NN/I-NP/O gegen\xc3\xbcber/IN/B-PP/B-PNP den/DT/B-NP/I-PNP ausschlie\xc3\x9flich/RB/I-NP/I-PNP D-Lysergyltripeptidlactam/JJ/I-NP/I-PNP synthetisierenden/NN/I-NP/I-PNP Peptidsynthetasen/NN/I-NP/I-PNP LPS1&slash;LPS2/NN/I-NP/I-PNP als/IN/B-PP/O eigenst\xc3\xa4ndige/JJ/B-ADJP/O Fe(II)&slash;\xce\xb1-KG/LS/O/O abh\xc3\xa4ngige/JJ/B-NP/O Dioxygenase/NN/I-NP/O (/(/O/O Cyclol-Synthase/NN/B-NP/O )/)/O/O ././O/O

Homologievergleiche/VB/B-VP/O der/DT/B-NP/O Gene/NN/I-NP/O des/DT/B-NP/O Ergotalkaloid-Biosynthese-Genclusters/NN/I-NP/O aus/IN/B-PP/B-PNP C./NNP/B-NP/I-PNP purpurea/NNP/I-NP/I-PNP f\xc3\xbchrten/VB/B-VP/O schlie\xc3\x9flich/RB/B-ADVP/O zur/IN/B-PP/B-PNP Auffindung/NN/B-NP/I-PNP eines/DT/I-NP/I-PNP Gens/NN/I-NP/I-PNP easH1/NN/I-NP/I-PNP als/IN/B-PP/B-PNP Kandidatengen/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP cycloliserende/NN/I-NP/I-PNP Fe(II)&slash;\xce\xb1/LS/O/O KG-abh\xc3\xa4ngige/JJ/B-NP/O Dioxygenase/NN/I-NP/O ././O/O

Die/DT/B-NP/O Expression/NN/I-NP/O dieses/DT/B-NP/O Gens/NN/I-NP/O als/IN/B-PP/B-PNP His6-Fusionsprotein/NNP/B-NP/I-PNP EasH/NNP/I-NP/I-PNP lieferte/VB/B-VP/O ein/DT/B-NP/O Protein/NN/I-NP/O des/DT/O/O Mr/RB/B-ADVP/O 36.500/CD/O/O ,/,/O/O das/DT/O/O als/IN/B-PP/B-PNP Dimer/NN/B-NP/I-PNP einer/DT/I-NP/I-PNP Molek\xc3\xbclmasse/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 71,4/CD/B-NP/I-PNP kDa/NN/I-NP/I-PNP rein/JJ/B-ADJP/O erhalten/VBN/B-VP/O wurde/VB/I-VP/O ././O/O

Koinkubation/NN/B-NP/O von/IN/B-PP/B-PNP rekombinantem/NNP/B-NP/I-PNP EasH/NNP/I-NP/I-PNP mit/IN/B-PP/B-PNP Wildtyp-Dioxygenase-freien/NN/B-NP/I-PNP Peptidsynthetasen/NN/I-NP/I-PNP LPS1&slash;LPS2/NN/I-NP/I-PNP und/CC/I-NP/I-PNP allen/DT/I-NP/I-PNP notwendigen/JJ/I-NP/I-PNP Substraten/NN/I-NP/I-PNP einschlie\xc3\x9flich/JJ/B-NP/I-PNP Fe(II/NNP/I-NP/I-PNP )/)/O/O und/CC/O/O \xce\xb1/NN/B-NP/O KG/NN/I-NP/O resultierte/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Vollsynthese/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Ergotamin/NN/B-NP/I-PNP ././O/O

Dies/DT/O/O beweist/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O EasH/NNP/B-NP/O das/DT/B-NP/O cyclolisierende/NN/I-NP/O Enzym/NN/I-NP/O ist/VB/B-VP/O ././O/O

Untersuchungen/NN/B-NP/O zum/IN/B-PP/B-PNP Schritt/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Cyclolbildung/NN/I-NP/I-PNP ergaben/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O EasH/NNP/B-NP/O alle/DT/O/O drei/CD/O/O nat\xc3\xbcrlichen/IN/B-PP/B-PNP Klassen/NN/B-NP/I-PNP von/IN/B-PP/B-PNP D-Lysergyltripeptidlactamen/NN/B-NP/I-PNP direkt/JJ/B-ADJP/O in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP entsprechenden/JJ/I-NP/I-PNP Ergopeptine/NN/I-NP/I-PNP konvertieren/VB/B-VP/O kann/VB/I-VP/O ././O/O

Ausl\xc3\xb6sender/JJ/B-NP/O Schritt/NN/I-NP/O ist/VB/B-VP/O die/DT/B-NP/O Hydroxylierung/NN/I-NP/O der/DT/B-NP/O ersten/JJ/I-NP/O Aminos\xc3\xa4ure/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Tripeptidlactam-Kette/NN/I-NP/I-PNP ././O/O

Anschlie\xc3\x9fende/JJ/B-NP/O spontane/NN/I-NP/O Kondensation/NN/I-NP/O der/DT/B-NP/O Hydroxylgruppe/NN/I-NP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP carboxyterminalen/JJ/I-NP/I-PNP Prolyl-Lactam-Carbonylgruppe/NN/I-NP/I-PNP generiert/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Esterbindung/NN/I-NP/I-PNP und/CC/O/O die/DT/B-NP/O terti\xc3\xa4re/JJ/I-NP/O Hydroxylgruppe/NN/I-NP/O der/DT/B-NP/O Cyclolgruppierung/NN/I-NP/O ././O/O

Die/DT/B-NP/O Analyse/NN/I-NP/O thioestergebundener/NNP/I-NP/O D/NNP/I-NP/O Lysergylmonopeptid/NNP/I-NP/O -/-/O/O und/CC/O/O D/JJ/B-NP/O Lysergyldipeptid-Zwischenstufen/NN/I-NP/O auf/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Peptidsynthetase/NN/I-NP/I-PNP LPS1/NN/I-NP/I-PNP ergab/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O sie/PRP/B-NP/O durch/IN/B-PP/B-PNP EasH/NNP/B-NP/I-PNP nicht/RB/I-NP/I-PNP hydroxyliert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Jedoch/RB/B-VP/O konnte/VB/I-VP/O die/DT/B-NP/O Hydroxylierung/NN/I-NP/O der/DT/B-NP/O thioestergebundenen/NN/I-NP/O D/NN/I-NP/O Lysergyltripeptid-Zwischenstufe/NN/I-NP/O nicht/RB/B-VP/O ausgeschlossen/VBN/I-VP/O werden/VB/I-VP/O ././O/O

Umsetzung/NN/B-NP/O von/IN/B-PP/B-PNP EasH/NNP/B-NP/I-PNP mit/IN/B-PP/B-PNP synthetischen/JJ/B-NP/I-PNP Dihydrolysergyl-Alanyl-Phenylalanyl-Prolyl-Coenzym/NN/I-NP/I-PNP A/NN/I-NP/I-PNP ,/,/O/O -/-/O/O Pantethein/NN/B-NP/O oder/RB/B-ADVP/O -/-/O/O N/JJ/B-NP/O Acetylcysteamin/NN/I-NP/O (/(/O/O SNAC/NN/B-NP/O )/)/O/O Thioestern/NN/B-NP/O resultierte/VB/B-VP/O in/IN/B-PP/B-PNP deren/DT/B-NP/I-PNP Hydroxylierung/NN/I-NP/I-PNP ././O/O

Jedoch/IN/B-PP/B-PNP reagierten/NN/B-NP/I-PNP die/DT/I-NP/I-PNP hydroxylierten/NN/I-NP/I-PNP Peptidthioester/NN/I-NP/I-PNP spontan/JJ/B-ADJP/O zum/RB/I-ADJP/O Dihdrolysergyltripeptidlactam/JJ/I-ADJP/O und/CC/O/O weiter/RB/B-ADVP/O zum/IN/B-PP/B-PNP Cyclol/NN/B-NP/I-PNP ././O/O

Dies/DT/O/O weist/VB/B-VP/O auf/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP konzertierten/NN/I-NP/I-PNP Ablauf/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Schritte/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Hydroxylierung/NN/I-NP/I-PNP und/CC/O/O Lactamring-Bildung/NN/B-NP/O hin/IN/B-PP/O ,/,/O/O der/WDT/O/O m\xc3\xb6glicherweise/RB/B-ADVP/O auch/RB/I-ADVP/O eine/DT/B-NP/O Bedeutung/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Cycloliserungsreaktion/NN/I-NP/I-PNP in/IN/B-PP/B-PNP vivo/JJ/B-NP/I-PNP hat.Grundlage/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP vorliegende/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP war/VB/B-VP/O der/DT/O/O 1988/CD/O/O als/IN/B-PP/B-PNP Actinomadura/NN/B-NP/I-PNP namibiensis/NN/I-NP/I-PNP taxonomisch/JJ/I-NP/I-PNP eingeordnete/NN/I-NP/I-PNP Mikroorganismus/NN/I-NP/I-PNP ,/,/O/O der/WDT/B-NP/O die/DT/I-NP/O drei/CD/I-NP/O peptidischen/JJ/I-NP/O Sekund\xc3\xa4rmetabolite/NN/I-NP/O A1/NN/I-NP/O ,/,/O/O A2/NN/B-NP/O und/CC/I-NP/O A3/NNP/I-NP/O produziert/RP/O/O ././O/O

Die/DT/B-NP/O Struktur/NN/I-NP/O von/IN/B-PP/B-PNP A2/NN/B-NP/I-PNP konnte/VBN/B-VP/I-PNP mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP einer/DT/I-NP/I-PNP R\xc3\xb6ntgenkristall-strukturanalyse/NN/I-NP/I-PNP aufgekl\xc3\xa4rt/NN/I-NP/I-PNP werden/VB/B-VP/O ,/,/O/O was/WDT/B-NP/O die/DT/I-NP/O Einordnung/NN/I-NP/O in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Klasse/NN/I-NP/I-PNP der/DT/B-NP/I-PNP ribosomal/NN/I-NP/I-PNP synthetisierten/NN/I-NP/I-PNP Lantibiotika/NN/I-NP/I-PNP erm\xc3\xb6glichte/VB/B-VP/O ././O/O

Die/DT/O/O im/IN/B-PP/B-PNP Folgenden/NN/B-NP/I-PNP als/IN/B-PP/B-PNP Labyrinthopeptin/NN/B-NP/I-PNP A2/NN/I-NP/I-PNP bezeichnete/VB/B-VP/O Verbindung/NN/B-NP/O weist/RB/B-ADVP/O neben/IN/B-PP/B-PNP den/DT/B-NP/I-PNP typischerweise/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Lantibiotika/NN/B-NP/I-PNP vorkommenden/NN/I-NP/I-PNP Lanthioninbr\xc3\xbccken/NN/I-NP/I-PNP sowie/RB/B-ADVP/O einer/DT/B-NP/O Disulfidbr\xc3\xbccke/NN/I-NP/O eine/DT/B-NP/O strukturelle/JJ/I-NP/O Besonderheit/NN/I-NP/O auf/RP/O/O ,/,/O/O die/WDT/B-NP/O bisher/RB/I-NP/O nicht/RB/I-NP/O literaturbekannt/NN/I-NP/O ist/VB/B-VP/O und/CC/O/O als/IN/B-PP/B-PNP Labionin/NN/B-NP/I-PNP bezeichnet/VBN/B-VP/I-PNP wurde/VB/I-VP/O ././O/O

Dabei/RB/B-VP/O handelt/VB/I-VP/O es/PRP/B-NP/O sich/PRP/I-NP/O um/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Verbr\xc3\xbcckung/NN/I-NP/I-PNP ,/,/O/O die/DT/O/O zu/IN/B-PP/B-PNP quart\xc3\xa4r/NN/B-NP/I-PNP substituierten/NN/I-NP/I-PNP \xc3\xaf?\xc2\xa1C-Atomen/NN/I-NP/I-PNP f\xc3\xbchrt/VB/B-VP/O und/CC/O/O somit/RB/B-ADVP/O eine/DT/B-NP/O ungew\xc3\xb6hnliche/JJ/I-NP/O C-C-Bindungskn\xc3\xbcpfung/NN/I-NP/O w\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Biosynthese/NN/I-NP/I-PNP erfordert/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP sollten/NN/I-NP/I-PNP diese/DT/B-NP/I-PNP Vorkenntnisse/NN/I-NP/I-PNP genutzt/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O um/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Biosynthese/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Labyrinthopeptin/JJ/B-NP/I-PNP A2/NN/I-NP/I-PNP (/(/O/O LabA2/NN/B-NP/O )/)/O/O und/CC/O/O dabei/RB/B-ADVP/O insbesondere/RB/I-ADVP/O der/DT/B-NP/O Labionin-Verbr\xc3\xbcckung/JJ/I-NP/O aufzukl\xc3\xa4ren/NN/I-NP/O ././O/O

Um/IN/B-PP/B-PNP dieses/DT/B-NP/I-PNP Ziel/NN/I-NP/I-PNP zu/TO/B-VP/O erreichen/VB/I-VP/O ,/,/O/O sollte/MD/B-VP/O zun\xc3\xa4chst/RB/B-ADVP/O das/DT/B-NP/O entsprechende/JJ/I-NP/O Biosynthese-Gencluster/NN/I-NP/O gesucht/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Nachdem/IN/B-PP/B-PNP Bedingungen/NN/B-NP/I-PNP optimiert/NN/I-NP/I-PNP werden/VB/B-VP/O konnten/VBN/I-VP/O ,/,/O/O die/WDT/B-NP/O die/DT/I-NP/O Isolierung/NN/I-NP/O hochmolekularer/NN/I-NP/O genomischer/JJ/B-NP/O DNA/NN/I-NP/O aus/IN/B-PP/B-PNP A./NNP/B-NP/I-PNP namibiensis/NNP/I-NP/I-PNP erm\xc3\xb6glichten/VB/B-VP/O ,/,/O/O wurde/VB/B-VP/O in/IN/B-PP/B-PNP Zusammenarbeit/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Firma/NN/I-NP/I-PNP Agowa/NNP/I-NP/I-PNP GmbH/NNP/I-NP/I-PNP ,/,/O/O Berlin/NNP/B-NP/O ,/,/O/O eine/DT/B-NP/O Cosmidbank/NN/I-NP/O erstellt/RP/O/O ././O/O

Die/DT/B-NP/O gr\xc3\xb6\xc3\x9fte/JJ/I-NP/O Herausforderung/NN/I-NP/O bestand/VB/B-VP/O nun/RB/B-ADVP/O darin/RB/I-ADVP/O ,/,/O/O ausgehend/JJ/B-ADJP/O von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP 18/CD/I-NP/I-PNP Aminos\xc3\xa4uren/NN/I-NP/I-PNP lange/IN/B-PP/B-PNP Struktur/NN/B-NP/I-PNP von/IN/B-PP/B-PNP LabA2/NN/B-NP/I-PNP ,/,/O/O von/IN/B-PP/O der/DT/O/O nur/RB/B-ADVP/O zw\xc3\xb6lf/CD/O/O als/IN/B-PP/B-PNP proteinogene/NN/B-NP/I-PNP Aminos\xc3\xa4uren/NN/I-NP/I-PNP definiert/VBN/B-VP/I-PNP waren/VB/I-VP/O ,/,/O/O eine/DT/B-NP/O Sonde/NN/I-NP/O f\xc3\xbcr/IN/B-PP/O ein/DT/O/O Screening/FW/O/O der/DT/B-NP/O Cosmidbank/NN/I-NP/O abzuleiten/VB/B-VP/O ././O/O

Durch/IN/B-PP/B-PNP Kombination/NN/B-NP/I-PNP verschiedener/JJ/I-NP/I-PNP PCR-Methoden/NN/I-NP/I-PNP gelang/NN/I-NP/I-PNP es/PRP/I-NP/I-PNP schlie\xc3\x9flich/RP/O/O ,/,/O/O eine/DT/B-NP/O Sonde/NN/I-NP/O zu/TO/B-VP/O generieren/VB/I-VP/O ,/,/O/O die/WDT/O/O im/IN/B-PP/B-PNP Cosmidbankscreening/NN/B-NP/I-PNP eingesetzt/VBN/B-VP/I-PNP werden/VB/I-VP/O konnte/VBN/I-VP/O ././O/O

Nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Sequenzierung/NN/I-NP/I-PNP eines/DT/B-NP/I-PNP positiv-getesteten/NN/I-NP/I-PNP Cosmids/NN/I-NP/I-PNP konnte/VBN/B-VP/I-PNP mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP von/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Softwaretools/NN/I-NP/I-PNP das/DT/B-NP/I-PNP Biosynthese-Gencluster/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP und/CC/O/O annotiert/NN/B-NP/O werden/VB/B-VP/O ././O/O

Darin/RB/B-ADJP/O konnte/JJ/I-ADJP/O u.a./JJ/I-ADJP/O ein/DT/B-NP/O Strukturgen/NN/I-NP/O identifiziert/NN/I-NP/O werden/VB/B-VP/O ,/,/O/O das/WDT/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Pr\xc3\xa4propeptide/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Labyrinthopeptine/NN/I-NP/I-PNP A1/NN/I-NP/I-PNP und/CC/O/O A3/NNP/B-NP/O kodiert/NNP/I-NP/O ././O/O

Basierend/JJ/B-ADJP/O auf/IN/B-PP/B-PNP der/DT/B-NP/I-PNP hohen/JJ/I-NP/I-PNP Homologie/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Labyrinthopeptine/NN/I-NP/I-PNP untereinander/NN/I-NP/I-PNP konnte/VB/B-VP/O damit/RB/B-ADVP/O ein/DT/B-NP/O Strukturvorschlag/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP LabA1/NN/B-NP/I-PNP und/CC/I-NP/I-PNP LabA3/NN/I-NP/I-PNP erstellt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Die/DT/B-NP/O weitere/JJ/I-NP/O Auswertung/NN/I-NP/O des/DT/B-NP/O Biosynthese-Genclusters/NN/I-NP/O zeigte/VB/B-VP/O neben/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Strukturgenen/NN/I-NP/I-PNP noch/RB/B-ADVP/O zwei/CD/B-NP/O Gene/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP ABC-Transporter/NN/I-NP/I-PNP sowie/RB/B-ADVP/O ein/DT/B-NP/O Gen/NN/I-NP/O ,/,/O/O das/DT/B-NP/O C-terminal/NN/I-NP/O eine/DT/B-NP/O Ser&slash;Thr-Kinase/NN/I-NP/O -/-/O/O und/CC/O/O N-terminal/NN/B-NP/O eine/DT/B-NP/O LanC-Dom\xc3\xa4ne/JJ/I-NP/O kodiert/NN/I-NP/O ././O/O

Dabei/RB/B-VP/O handelt/VB/I-VP/O es/PRP/B-NP/O sich/PRP/I-NP/O vermutlich/JJ/B-ADJP/O um/IN/B-PP/O das/DT/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Labionin-Biosynthese/NN/I-NP/I-PNP zust\xc3\xa4ndige/JJ/B-NP/I-PNP Gen/NN/I-NP/I-PNP ././O/O

Um/IN/B-PP/B-PNP diese/DT/B-NP/I-PNP Hypothese/NN/I-NP/I-PNP experimentell/JJ/B-ADJP/O zu/TO/B-VP/O beweisen/VB/I-VP/O ,/,/O/O wurden/VB/B-VP/O zwei/CD/B-NP/O unterschiedliche/JJ/I-NP/O Strategien/NN/I-NP/O verfolgt/VB/B-VP/O ././O/O

Die/DT/B-NP/O erste/JJ/I-NP/O Strategie/NN/I-NP/O sah/VB/B-VP/O einen/DT/O/O in/IN/B-PP/B-PNP vitro-Assay/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP entsprechenden/JJ/I-NP/I-PNP \xc3\xbcberexprimierten/NN/I-NP/I-PNP Protein/NN/I-NP/I-PNP und/CC/O/O hypothetischen/JJ/B-NP/O Substraten/NN/I-NP/O vor/RP/O/O ,/,/O/O w\xc3\xa4hrend/IN/B-PP/B-PNP die/DT/B-NP/I-PNP zweite/JJ/I-NP/I-PNP Strategie/NN/I-NP/I-PNP die/DT/B-NP/I-PNP heterologe/NN/I-NP/I-PNP Expression/NN/I-NP/I-PNP des/DT/B-NP/I-PNP gefundenen/JJ/I-NP/I-PNP Biosynthese-Genclusters/NN/I-NP/I-PNP in/IN/B-PP/O S./VB/B-VP/O lividans/NN/B-NP/O umfasste/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP beiden/DT/B-NP/I-PNP Strategien/NN/I-NP/I-PNP konnten/VB/B-VP/O bedeutende/JJ/B-NP/O Zwischenziele/NN/I-NP/O erreicht/VBN/B-VP/O werden/VB/I-VP/O ,/,/O/O die/WDT/O/O in/IN/B-PP/B-PNP zuk\xc3\xbcnftigen/JJ/B-NP/I-PNP Arbeiten/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Best\xc3\xa4tigung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Hypothese/NN/I-NP/I-PNP erm\xc3\xb6glichen/PRP$/I-NP/I-PNP sollten.F\xc3\xbcr/NN/I-NP/I-PNP das/DT/B-NP/I-PNP detaillierte/NN/I-NP/I-PNP molekulare/NN/I-NP/I-PNP Verst\xc3\xa4ndnis/NN/I-NP/I-PNP neuronaler/NN/I-NP/I-PNP Erregungskreise/NN/I-NP/I-PNP ist/VB/B-VP/O es/PRP/B-NP/O notwendig/JJ/I-NP/O ankommende/NN/I-NP/O Axone/NN/I-NP/O ,/,/O/O die/DT/B-NP/O Targetneurone/NN/I-NP/O und/CC/O/O weitere/JJ/B-ADJP/O beteiligte/VB/B-VP/O Molek\xc3\xbcle/NN/B-NP/O der/DT/I-NP/O Signaltransduktion/NN/I-NP/O auf/IN/B-PP/B-PNP ultrastruktureller/NN/B-NP/I-PNP Ebene/NN/I-NP/I-PNP zu/TO/B-VP/O untersuchen/VB/I-VP/O ././O/O

Dies/DT/O/O erfordert/VB/B-VP/O sehr/IN/B-PP/B-PNP anspruchsvolle/JJ/B-NP/I-PNP Mehrfachmarkierungstechniken/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP elektronenmikroskopischem/JJ/B-NP/I-PNP Niveau/NN/I-NP/I-PNP ././O/O

Eine/DT/O/O zus\xc3\xa4tzliche/JJ/B-ADJP/O von/IN/B-PP/B-PNP \xc3\xbcblichen/JJ/B-NP/I-PNP Doppelmarkierungsmethoden/NN/I-NP/I-PNP -/-/O/O z.B./IN/B-PP/B-PNP Kombination/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Immunogold/NN/B-NP/I-PNP -/-/O/O und/CC/O/O Peroxidase-Techniken/NN/B-NP/O -/-/O/O unabh\xc3\xa4ngigen/NN/B-NP/O Markierungsprozedur/NN/I-NP/O w\xc3\xbcrde/VB/B-VP/O einen/DT/B-NP/O erheblichen/JJ/I-NP/O Nutzen/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP solche/DT/B-NP/I-PNP Untersuchungen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP sich/PRP/B-NP/I-PNP bergen/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP sollte/MD/B-VP/O hierf\xc3\xbcr/RB/B-ADVP/O eine/DT/B-NP/O immunenzymatische/JJ/I-NP/O Markierungstechnik/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP alkalische/JJ/B-NP/I-PNP Phosphatase/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP elektronenmikroskopischer/JJ/B-NP/I-PNP Ebene/NN/I-NP/I-PNP \xc3\xbcber/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP Cer-Phosphat-Niederschlag/NN/I-NP/I-PNP entwickelt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Erstaunlicherweise/RB/B-VP/O waren/VB/I-VP/O etablierte/JJ/B-NP/O Techniken/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP endogene/NN/B-NP/I-PNP alkalische/JJ/I-NP/I-PNP Phosphatasen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP verschiedensten/JJ/B-NP/I-PNP Geweben/NN/I-NP/I-PNP nicht/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Anwendung/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Immunzytochemie/NN/I-NP/I-PNP geeignet/JJ/B-ADJP/O ././O/O

Durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP sorgf\xc3\xa4ltige/JJ/I-NP/I-PNP Charakterisierung/NN/I-NP/I-PNP und/CC/O/O Optimierung/NN/B-NP/O der/DT/B-NP/O einzelnen/JJ/I-NP/O Reaktionsbedingungen/NN/I-NP/O konnte/VB/B-VP/O eine/DT/B-NP/O entscheidende/JJ/I-NP/O Steigerung/NN/I-NP/O der/DT/B-NP/O Sensitivit\xc3\xa4t/NN/I-NP/O der/DT/B-NP/O Cer-Phosphat-H2O2-Methode/NN/I-NP/O erreicht/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Das/DT/O/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP neue/JJ/I-NP/I-PNP Technik/NN/I-NP/I-PNP niedergeschlagene/NN/I-NP/I-PNP Cer-Pr\xc3\xa4ziptat/NN/I-NP/I-PNP erlaubt/VB/B-VP/O nun/RB/B-ADVP/O eine/DT/B-NP/O Detektion/NN/I-NP/O des/DT/B-NP/O immunenzymatischen/JJ/I-NP/O Reaktionsproduktes/NN/I-NP/O im/IN/B-PP/B-PNP Elektronenmikroskop/NN/B-NP/I-PNP ././O/O

Am/IN/B-PP/B-PNP Modellsystem/NN/B-NP/I-PNP Bulbus/NN/I-NP/I-PNP olfactorius/NN/I-NP/I-PNP der/DT/I-NP/I-PNP Ratte/NN/I-NP/I-PNP wurde/RB/B-ADJP/O anschlie\xc3\x9fend/JJ/I-ADJP/O gezeigt/VBN/B-VP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Kombination/NN/I-NP/I-PNP der/DT/B-NP/I-PNP neuen/JJ/I-NP/I-PNP Technik/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP \xc3\xbcblichen/JJ/I-NP/I-PNP Peroxidase&slash;Diaminobenzidin-Methode/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP simultane/JJ/I-NP/I-PNP Doppelmarkierung/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP ultrastruktureller/NN/B-NP/I-PNP Ebene/NN/I-NP/I-PNP erlaubt/RP/O/O ././O/O

Das/DT/B-NP/O Cer-Pr\xc3\xa4zipitat/NN/I-NP/O der/DT/B-NP/O alkalischen/JJ/I-NP/O Phosphatase/NN/I-NP/O wurde/VB/B-VP/O mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Energiefilter-Transmissons-Elektronenmikroskopie/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP und/CC/O/O konnte/VB/B-VP/O somit/RB/B-ADVP/O vom/IN/B-PP/B-PNP Cer-freien/NN/B-NP/I-PNP Niederschlag/NN/I-NP/I-PNP der/DT/I-NP/I-PNP Peroxidase/NN/I-NP/I-PNP eindeutig/JJ/B-ADJP/O unterschieden/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Auf/IN/B-PP/B-PNP diese/DT/B-NP/I-PNP Weise/NN/I-NP/I-PNP konnte/VB/B-VP/O festgestellt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP ankommende/NN/B-NP/I-PNP serotininerge/JJ/I-NP/I-PNP Axone/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Raphe/NN/I-NP/I-PNP nuklei/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Mittelhirns/NN/I-NP/I-PNP keine/DT/B-NP/I-PNP synaptischen/JJ/I-NP/I-PNP Kontakte/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP dopaminergen/NN/B-NP/I-PNP periglomerul\xc3\xa4ren/NN/I-NP/I-PNP Neuronen/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Bulbus/NN/B-NP/I-PNP olfaktorius/NN/I-NP/I-PNP der/DT/I-NP/I-PNP Ratte/NN/I-NP/I-PNP etablieren.In/NN/I-NP/I-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Studie/NN/I-NP/I-PNP wurde/VB/B-VP/O ein/DT/B-NP/O zweistufiger/NN/I-NP/O Anaerobreaktor/NN/I-NP/O zur/IN/B-PP/B-PNP Behandlung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP R\xc3\xbcbenmelasseschlempe/NN/B-NP/I-PNP mikrobiologisch/JJ/I-NP/I-PNP charakterisiert/NN/I-NP/I-PNP ././O/O

Es/PRP/B-NP/O wurden/VB/B-VP/O unterschiedliche/JJ/B-NP/O Verfahren/NN/I-NP/O zur/IN/B-PP/B-PNP Beschreibung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP mikrobiellen/NN/I-NP/I-PNP Reaktorbioz\xc3\xb6nose/NN/I-NP/I-PNP eingesetzt/VBN/B-VP/I-PNP ,/,/O/O da/IN/B-PP/B-PNP einzelne/JJ/B-NP/I-PNP Methoden/NN/I-NP/I-PNP in/IN/B-PP/B-PNP ihrer/PRP$/B-NP/I-PNP Aussagekraft/NN/I-NP/I-PNP limitiert/NN/I-NP/I-PNP sind/VB/B-VP/O ././O/O

Durch/IN/B-PP/B-PNP Fluoreszenz/NN/B-NP/I-PNP in/IN/B-PP/B-PNP situ/JJ/B-NP/I-PNP Hybridisierungen/NN/I-NP/I-PNP (/(/O/O FISH/NNP/B-NP/O )/)/O/O wurde/VB/B-VP/O die/DT/B-NP/O r\xc3\xa4umliche/JJ/I-NP/O Verteilung/NN/I-NP/O verschiedener/JJ/B-NP/O phylogenetischer/NN/I-NP/O Gruppen/NN/I-NP/O im/IN/B-PP/B-PNP Reaktor/NN/B-NP/I-PNP untersucht/RP/O/O ././O/O

Bis/IN/B-PP/B-PNP zu/IN/I-PP/I-PNP 70/CD/B-NP/I-PNP %/NN/I-NP/I-PNP der/DT/O/O mit/IN/B-PP/B-PNP DAPI/NNP/B-NP/I-PNP nachweisbaren/NNP/I-NP/I-PNP Gesamtzellzahl/NNP/I-NP/I-PNP lie\xc3\x9fen/VB/B-VP/O sich/PRP/B-NP/O mit/IN/B-PP/O der/DT/O/O in/IN/B-PP/B-PNP situ/NN/B-NP/I-PNP Hybridisierung/NN/I-NP/I-PNP erfassen/VB/B-VP/O und/CC/O/O durch/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Einsatz/NN/I-NP/I-PNP spezifischer/JJ/B-NP/I-PNP Oligonukleotidsonden/NN/I-NP/I-PNP konnte/VB/B-VP/O die/DT/B-NP/O r\xc3\xa4umliche/JJ/I-NP/O Verteilung/NN/I-NP/O verschiedener/JJ/B-NP/O phylogenetischer/NN/I-NP/O Gruppen/NN/I-NP/O im/IN/B-PP/B-PNP Reaktor/NN/B-NP/I-PNP untersucht/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Most/JJ/B-NP/O Probable/JJ/I-NP/O Number/NN/I-NP/O (/(/O/O MPN/NN/B-NP/O )/)/O/O Experimente/NN/B-NP/O wurden/VB/B-VP/O zur/IN/B-PP/B-PNP Absch\xc3\xa4tzung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Kultivierungseffizienz/NN/I-NP/I-PNP beim/IN/B-PP/B-PNP Einsatz/NN/B-NP/I-PNP unterschiedlicher/JJ/I-NP/I-PNP Substrate/NN/I-NP/I-PNP sowie/RB/B-ADVP/O zur/IN/B-PP/B-PNP Untersuchung/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Auftretens/NN/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O Verteilung/NN/I-NP/O physiologischer/NN/I-NP/O Gruppen/NN/I-NP/O im/IN/B-PP/B-PNP Reaktor/NN/B-NP/I-PNP eingesetzt/RP/O/O ././O/O

Mehr/NN/B-NP/O als/IN/B-PP/B-PNP 10/CD/B-NP/I-PNP %/NN/I-NP/I-PNP der/DT/O/O mit/IN/B-PP/B-PNP DAPI/NNP/B-NP/I-PNP nachweisbaren/NNP/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP lie\xc3\x9fen/VB/B-VP/O sich/PRP/B-NP/O mit/IN/B-PP/B-PNP Melasseschlempe/NN/B-NP/I-PNP als/IN/B-PP/B-PNP Substrat/NN/B-NP/I-PNP kultivieren/VB/B-VP/O ././O/O

Durch/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Einsatz/NN/I-NP/I-PNP spezifischer/JJ/B-NP/I-PNP Substrate/NN/I-NP/I-PNP und/CC/O/O Elektronenakzeptoren/NN/B-NP/O f\xc3\xbcr/IN/B-PP/B-PNP sulfatreduzierende/NN/B-NP/I-PNP Bakterien/NN/I-NP/I-PNP ,/,/O/O homoacetogene/NN/B-NP/O Bakterien/NNP/I-NP/O und/CC/I-NP/O methanogene/NNP/I-NP/O Archeen/NNP/I-NP/O konnten/JJ/B-NP/O deutliche/JJ/I-NP/O Profile/NNS/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Verteilung/NN/I-NP/I-PNP dieser/DT/B-NP/I-PNP physiologischen/JJ/I-NP/I-PNP Gruppen/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Reaktor/NN/B-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Die/DT/B-NP/O MPN-Experimente/NN/I-NP/O dienten/VB/B-VP/O als/IN/B-PP/B-PNP Ausgangspunkt/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Isolierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Reinkulturen/NN/B-NP/I-PNP ././O/O

Insgesamt/VBN/B-VP/O wurden/VB/I-VP/O 182/CD/B-NP/O St\xc3\xa4mme/NNS/I-NP/O isoliert/NN/I-NP/O ,/,/O/O die/WDT/O/O \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Analyse/NN/I-NP/I-PNP der/DT/B-NP/I-PNP 16S/NNP/I-NP/I-PNP rDNA/NNP/I-NP/I-PNP 58/CD/B-NP/I-PNP Arten/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP 18/CD/B-NP/I-PNP verschiedenen/JJ/I-NP/I-PNP Gattungen/NNS/I-NP/I-PNP zugeordnet/NN/I-NP/I-PNP werden/VB/B-VP/O konnten/VBN/I-VP/O ././O/O

Dominierend/JJ/B-ADJP/O waren/VB/B-VP/O Vertreter/NN/B-NP/O der/DT/I-NP/O Gattungen/NNS/I-NP/O Clostridium/NN/I-NP/O ,/,/O/O Ruminococcus/NN/B-NP/O ,/,/O/O Eubacterium/NN/B-NP/O und/CC/I-NP/O Bacteroides/NN/I-NP/O ././O/O

Aus/IN/B-PP/B-PNP anderen/JJ/B-NP/I-PNP Gattungen/NNS/I-NP/I-PNP wurden/VB/B-VP/O jeweils/RB/B-ADVP/O nur/RB/B-NP/O wenige/JJ/I-NP/O Arten/JJ/I-NP/O isoliert/NN/I-NP/O ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O der/DT/B-NP/O phylogenetischen/JJ/I-NP/O Einordnung/NN/I-NP/O der/DT/B-NP/O Isolate/NN/I-NP/O wurde/VB/B-VP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Absch\xc3\xa4tzung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Artenzahl/NN/I-NP/I-PNP (/(/O/O S/NN/B-NP/O )/)/O/O im/IN/B-PP/B-PNP Reaktor/NN/B-NP/I-PNP genutzt/RP/O/O ././O/O

Durch/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Einsatz/NN/I-NP/I-PNP unterschiedlicher/JJ/B-NP/I-PNP Verfahren/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP Absch\xc3\xa4tzung/NN/B-NP/I-PNP dieses/DT/I-NP/I-PNP Diversit\xc3\xa4tsindex/NN/I-NP/I-PNP konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP zwischen/IN/I-PP/I-PNP 30/CD/B-NP/I-PNP %/NN/I-NP/I-PNP und/CC/O/O 70/CD/B-NP/O %/NN/I-NP/O der/DT/O/O mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP eingesetzten/NN/I-NP/I-PNP Methoden/NN/I-NP/I-PNP kultivierbaren/NN/I-NP/I-PNP Arten/NN/I-NP/I-PNP isoliert/NN/I-NP/I-PNP wurden/VB/B-VP/O und/CC/O/O damit/RB/B-ADVP/O ein/DT/B-NP/O erheblicher/JJ/I-NP/O Teil/NN/I-NP/O der/DT/B-NP/O mikrobiellen/JJ/I-NP/O Population/NN/I-NP/O mit/IN/B-PP/B-PNP kultivierungsbasierenden/NN/B-NP/I-PNP Methoden/NN/I-NP/I-PNP erfasst/VBN/B-VP/I-PNP werden/VB/I-VP/O konnte/VBN/I-VP/O ././O/O

Die/DT/B-NP/O taxonomische/JJ/I-NP/O Einordnung/NN/I-NP/O der/DT/B-NP/O Isolate/NN/I-NP/O erm\xc3\xb6glichte/VB/B-VP/O eine/DT/B-NP/O erste/JJ/I-NP/O funktionale/JJ/I-NP/O Einordnung/NN/I-NP/O anhand/IN/B-PP/B-PNP der/DT/B-NP/I-PNP physiologischen/JJ/I-NP/I-PNP Kapazit\xc3\xa4ten/NN/I-NP/I-PNP der/DT/B-NP/I-PNP n\xc3\xa4chsten/JJ/I-NP/I-PNP Verwandten/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Isolats/NN/I-NP/I-PNP ././O/O

Physiologische/JJ/B-NP/O Experimente/NN/I-NP/O an/IN/B-PP/B-PNP ausgew\xc3\xa4hlten/JJ/B-NP/I-PNP Reinkulturen/NN/I-NP/I-PNP erlaubten/VB/B-VP/O die/DT/B-NP/O qualitative/JJ/I-NP/O Absch\xc3\xa4tzung/NN/I-NP/O der/DT/B-NP/O Stofffl\xc3\xbcsse/NN/I-NP/O im/IN/B-PP/B-PNP Reaktor/NN/B-NP/I-PNP ././O/O

Verschiedene/JJ/B-NP/O Experimente/NN/I-NP/O wurden/VB/B-VP/O direkt/JJ/B-ADJP/O am/IN/B-PP/B-PNP untersuchten/NN/B-NP/I-PNP Reaktor/NN/I-NP/I-PNP durchgef\xc3\xbchrt/RP/O/O ././O/O

Anhand/IN/B-PP/B-PNP von/IN/I-PP/I-PNP Fallbeispielen/VBN/B-VP/I-PNP wurden/VB/I-VP/O die/DT/B-NP/O M\xc3\xb6glichkeiten/NN/I-NP/O zum/IN/B-PP/B-PNP Einsatz/NN/B-NP/I-PNP mikrobiologischer/JJ/I-NP/I-PNP Parameter/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Prozesssteuerung/NN/I-NP/I-PNP dargelegt/RP/O/O ././O/O

Dabei/RB/B-VP/O zeigte/VB/I-VP/O sich/PRP/B-NP/O ,/,/O/O dass/RB/B-ADVP/O besonders/RB/I-ADVP/O in/IN/B-PP/B-PNP kritischen/JJ/B-NP/I-PNP Phasen/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Reaktorbetriebs/NN/I-NP/I-PNP (/(/O/O z.B./IN/B-PP/B-PNP Inbetriebnahme/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Reaktors/NN/I-NP/I-PNP )/)/O/O die/DT/B-NP/O Ergebnisse/NN/I-NP/O der/DT/B-NP/O mikrobiologischen/JJ/I-NP/O Untersuchungen/NN/I-NP/O n\xc3\xbctzliche/JJ/B-NP/O Informationen/NN/I-NP/O liefern/VB/B-VP/O ,/,/O/O die/WDT/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Prozesssteuerung/NN/I-NP/I-PNP herangezogen/NN/I-NP/I-PNP werden/VB/B-VP/O k\xc3\xb6nnen.Apoptose/MD/I-VP/O ist/VB/I-VP/O eine/DT/B-NP/O physiologische/JJ/I-NP/O Form/NN/I-NP/O des/DT/B-NP/O Zelltods/NN/I-NP/O ,/,/O/O bei/IN/B-PP/O dem/DT/O/O durch/IN/B-PP/B-PNP Signaltransduktion/NN/B-NP/I-PNP in/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP intrazellul\xc3\xa4ren/NN/I-NP/I-PNP Weg/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Tod/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Zelle/NN/I-NP/I-PNP aktiv/JJ/B-ADJP/O infolge/IN/B-PP/B-PNP der/DT/B-NP/I-PNP proteolytischen/JJ/I-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP spezialisierter/NN/I-NP/I-PNP Enzyme/NN/I-NP/I-PNP ,/,/O/O der/DT/B-NP/O sog/NN/I-NP/O ././O/O

Caspasen/NN/B-NP/O ,/,/O/O herbeigef\xc3\xbchrt/NN/B-NP/O wird/VB/B-VP/O ././O/O

Der/DT/B-NP/O Schwerpunkt/NN/I-NP/O dieser/DT/B-NP/O Arbeit/NN/I-NP/O bestand/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Suche/NN/I-NP/I-PNP nach/RP/O/O und/CC/O/O Charakterisierung/NN/B-NP/O von/IN/B-PP/B-PNP Interaktionspartnern/NN/B-NP/I-PNP zweier/DT/I-NP/I-PNP wichtiger/JJ/I-NP/I-PNP Regulatoren/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Apoptose/NN/I-NP/I-PNP :/:/O/O 1/CD/O/O ././O/O

des/DT/B-NP/O Proteins/JJ/I-NP/O P35/NN/I-NP/O aus/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Baculovirus/NN/I-NP/I-PNP Autographa/NN/I-NP/I-PNP californica/NN/I-NP/I-PNP Nuclear/NN/I-NP/I-PNP Polyhe-drosis/JJ/B-NP/I-PNP Virus/NN/I-NP/I-PNP (/(/O/O Ac-P35-Protein/NNP/B-NP/O )/)/O/O und/CC/O/O 2/CD/O/O ././O/O

des/DT/B-NP/O Caspasenadaptermolek\xc3\xbcls/JJ/I-NP/O Apaf-1/NN/I-NP/O ././O/O

Ac-P35/RB/B-VP/O ist/VB/I-VP/O ein/DT/B-NP/O effektiver/JJ/I-NP/O Apoptoseinhibitor/NN/I-NP/O in/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Organismen/NN/I-NP/I-PNP wie/IN/B-PP/B-PNP z./IN/I-PP/I-PNP B./RB/B-ADVP/O in/IN/B-PP/B-PNP Nematoden/NN/B-NP/I-PNP ,/,/O/O Insekten/NN/B-NP/O und/CC/O/O im/IN/B-PP/B-PNP Menschen/NN/B-NP/I-PNP ././O/O

ine/PRP$/B-NP/O antiapoptiotische/JJ/I-NP/O Eigenschaft/NN/I-NP/O ist/VB/B-VP/O aller/JJ/B-NP/O Wahrscheinlichkeit/NN/I-NP/O nach/IN/B-PP/B-PNP auf/IN/I-PP/I-PNP die/DT/B-NP/I-PNP Inhibi-tion/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Caspasen/NN/I-NP/I-PNP zur\xc3\xbcckzuf\xc3\xbchren/VB/B-VP/O ././O/O

1/CD/O/O ././O/O

Experimente/NN/B-NP/O an/IN/B-PP/B-PNP Vertebratenzellen/NN/B-NP/I-PNP ,/,/O/O die/DT/B-NP/O deutliche/JJ/I-NP/O Hinweise/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Existenz/NN/I-NP/I-PNP eines/DT/B-NP/I-PNP zellul\xc3\xa4ren/NN/I-NP/I-PNP P35-Homologs/NN/I-NP/I-PNP ,/,/O/O das/WDT/O/O mit/IN/B-PP/B-PNP viralem/NN/B-NP/I-PNP P35/NN/I-NP/I-PNP interagiert/NN/I-NP/I-PNP und/CC/O/O m\xc3\xb6glicherweise/RB/B-ADVP/O eine/DT/B-NP/O Funktion/NN/I-NP/O w\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Apoptose/NN/I-NP/I-PNP besitzt/NN/I-NP/I-PNP ,/,/O/O aufzeigten/NN/B-NP/O ,/,/O/O waren/VB/B-VP/O der/DT/B-NP/O Ausgangspunkt/NN/I-NP/O dieser/DT/B-NP/O Aufgabenstellung/NN/I-NP/O ././O/O

Das/DT/B-NP/O Ziel/NN/I-NP/O war/VB/B-VP/O es/PRP/B-NP/O ,/,/O/O das/DT/B-NP/O vermutete/NN/I-NP/O zellul\xc3\xa4re/JJ/B-NP/O P35-Homolog/NN/I-NP/O zu/IN/B-PP/B-PNP klonieren/NN/B-NP/I-PNP und/CC/O/O funktionell/JJ/B-ADJP/O und/CC/I-ADJP/O strukturell/JJ/I-ADJP/O zu/TO/B-VP/O charakterisieren/VB/I-VP/O ././O/O

Interaktionspartner/VBN/B-VP/O wurden/VB/I-VP/O mit/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP System/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP Darstellung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Protein-Protein-Interaktion/NN/B-NP/I-PNP (/(/O/O sog/NN/B-NP/O ././O/O

Yeast/JJ/B-NP/O Two-Hybrid/NN/I-NP/O System/NN/I-NP/O )/)/O/O in/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Genbank/NN/I-NP/I-PNP gesucht/RP/O/O ././O/O

Im/IN/B-PP/B-PNP gleichen/JJ/B-NP/I-PNP System/NN/I-NP/I-PNP wurden/VB/B-VP/O spezifisch/JJ/B-NP/O Interaktionen/NN/I-NP/O von/IN/B-PP/B-PNP Proteinen/NN/B-NP/I-PNP \xc3\xbcberpr\xc3\xbcft/RP/O/O ././O/O

Das/DT/B-NP/O Ziel/NN/I-NP/O ,/,/O/O ein/DT/B-NP/O zellul\xc3\xa4res/JJ/I-NP/O Homolog/NN/I-NP/O von/IN/B-PP/B-PNP Ac-P35/NN/B-NP/I-PNP zu/TO/B-VP/O finden/VB/I-VP/O und/CC/O/O zu/TO/B-VP/O charakterisieren/VB/I-VP/O ,/,/O/O konnte/VB/B-VP/O nicht/RB/I-VP/O erreicht/VBN/I-VP/O werden/VB/I-VP/O ././O/O

att/IN/B-PP/O dessen/DT/O/O wurde/VB/B-VP/O eine/DT/B-NP/O Untereinheit/NN/I-NP/O der/DT/B-NP/O humanen/NN/I-NP/O RNA-Polymerase/NN/I-NP/O II/CD/O/O ,/,/O/O hRPB11/NN/B-NP/O ,/,/O/O als/IN/B-PP/B-PNP spezifischer/JJ/B-NP/I-PNP Interaktionspartner/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Ac-P35/JJ/B-NP/I-PNP identifiziert/NN/I-NP/I-PNP ././O/O

In/IN/B-PP/B-PNP weiteren/JJ/B-NP/I-PNP Untersu-chungen/NN/I-NP/I-PNP wurde/RB/B-VP/O dargestellt/VBN/I-VP/O ,/,/O/O da\xc3\x9f/IN/B-PP/B-PNP Ac-P35/NN/B-NP/I-PNP nach/IN/B-PP/B-PNP Expression/NN/B-NP/I-PNP in/IN/B-PP/B-PNP menschlichen/JJ/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP auch/RB/B-ADVP/O im/IN/B-PP/B-PNP Kern/NN/B-NP/I-PNP lokalisiert/NN/I-NP/I-PNP ist/VB/B-VP/O ././O/O

Die/DT/B-NP/O Interaktion/NN/I-NP/O mit/IN/B-PP/B-PNP hRPB11/NN/B-NP/I-PNP und/CC/I-NP/I-PNP die/DT/I-NP/I-PNP nukle\xc3\xa4re/JJ/I-NP/I-PNP Lokalisation/NN/I-NP/I-PNP lie\xc3\x9fen/NN/I-NP/I-PNP darauf/VB/B-VP/O schlie\xc3\x9fen/RB/B-ADVP/O ,/,/O/O dass/RB/B-ADVP/O Ac-P35/NN/B-NP/O an/IN/B-PP/B-PNP Transkrip-ti-onsvorg\xc3\xa4ngen/NN/B-NP/I-PNP in/IN/B-PP/B-PNP infizierten/NN/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP beteiligt/VBN/B-VP/I-PNP sein/VB/I-VP/O k\xc3\xb6nnte/VB/I-VP/O ././O/O

Mittels/IN/B-PP/B-PNP Promoterstudien/NN/B-NP/I-PNP in/IN/B-PP/B-PNP menschlichen/JJ/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP wurde/RB/B-VP/O gezeigt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP Ac-P35/NN/B-NP/I-PNP und/CC/I-NP/I-PNP sein/PRP$/I-NP/I-PNP Interaktionspartner/NN/I-NP/I-PNP hRPB11/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP humaner/NN/I-NP/I-PNP Promotoren/NN/I-NP/I-PNP stimulieren/VB/B-VP/O konn-ten/NN/B-NP/O ././O/O

Dieses/DT/B-NP/O Ergebnis/NN/I-NP/O legt/VB/B-VP/O den/DT/B-NP/O Schlu\xc3\x9f/NN/I-NP/O nahe/RP/O/O ,/,/O/O dass/IN/B-PP/B-PNP Ac-P35/NN/B-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Lage/NN/I-NP/I-PNP ist/VB/B-VP/O ,/,/O/O ein/DT/O/O bereits/RB/B-ADVP/O seit/IN/B-PP/B-PNP einiger/JJ/B-NP/I-PNP Zeit/NN/I-NP/I-PNP bekanntes/NN/I-NP/I-PNP Ph\xc3\xa4nomen/NN/I-NP/I-PNP ,/,/O/O das/DT/B-NP/O Abschalten/NN/I-NP/O der/DT/B-NP/O Proteinsynthese/NN/I-NP/O in/IN/B-PP/B-PNP Ac-P35-infizierten/NN/B-NP/I-PNP Insektenzellen/NN/I-NP/I-PNP ,/,/O/O durch/IN/B-PP/B-PNP Beeinflussung/NN/B-NP/I-PNP des/DT/I-NP/I-PNP zellul\xc3\xa4ren/NN/I-NP/I-PNP Transkriptionsapparates/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP induzieren/NN/B-NP/I-PNP ././O/O

Eine/DT/B-NP/O Homodimerisierung/NN/I-NP/O von/IN/B-PP/B-PNP Ac-P35/NN/B-NP/I-PNP wurde/RB/B-VP/O weiterhin/RB/I-VP/O nachgewiesen/VBN/I-VP/O ;/:/O/O die/DT/B-NP/O m\xc3\xb6gliche/JJ/I-NP/O Relevanz/NN/I-NP/O dieser/DT/B-NP/O Eigenschaft/NN/I-NP/O wird/RB/B-ADVP/O diskutiert/RP/O/O ././O/O

hRPB11/JJ/B-NP/O interagiert/NN/I-NP/O im/IN/B-PP/B-PNP Holoenzym/NN/B-NP/I-PNP der/DT/I-NP/I-PNP RNA/NNP/I-NP/I-PNP Polymerase/NNP/I-NP/I-PNP mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP weiteren/JJ/I-NP/I-PNP Untereinheit/NN/I-NP/I-PNP der/DT/B-NP/I-PNP humanen/NN/I-NP/I-PNP RNA-Polymerase/NN/I-NP/I-PNP II/CD/O/O ,/,/O/O der/DT/B-NP/O Untereinheit/JJ/I-NP/O hRPB3/NN/I-NP/O ././O/O

Der/DT/B-NP/O Befund/NN/I-NP/O ,/,/O/O dass/IN/B-PP/B-PNP hRPB11/NN/B-NP/I-PNP auch/RB/B-ADVP/O mit/IN/B-PP/B-PNP Ac-P35/NN/B-NP/I-PNP interagiert/NN/I-NP/I-PNP ,/,/O/O machte/VB/B-VP/O die/DT/B-NP/O Frage/NN/I-NP/O interessant/JJ/B-ADJP/O ,/,/O/O ob/IN/B-PP/B-PNP hRPB3/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Ac-P35/NN/I-NP/I-PNP strukturelle/JJ/B-NP/I-PNP Gemeinsamkeiten/NNS/I-NP/I-PNP besitzen/VB/B-VP/O ././O/O

Ein/DT/B-NP/O Vergleich/NN/I-NP/O der/DT/B-NP/O Aminos\xc3\xa4uresequenzen/NN/I-NP/O von/IN/B-PP/B-PNP P35/NN/B-NP/I-PNP -/-/O/O und/CC/O/O RPB3-Proteinen/NN/B-NP/O aus/IN/B-PP/O verschiedenen/VB/B-VP/O Spezies/RB/B-NP/O lie\xc3\x9f/JJ/I-NP/O klare/JJ/I-NP/O Anh\xc3\xa4ufungen/NN/I-NP/O von/IN/B-PP/B-PNP identischen/JJ/B-NP/I-PNP und/CC/I-NP/I-PNP \xc3\xa4hnlichen/JJ/I-NP/I-PNP Aminos\xc3\xa4uren/NN/I-NP/I-PNP erkennen/VB/B-VP/O ,/,/O/O so/RB/B-ADVP/O dass/RB/I-ADVP/O diese/DT/B-NP/O Proteine/NN/I-NP/O als/IN/B-PP/B-PNP einander/PRP/B-NP/I-PNP \xc3\xa4hnlich/JJ/I-NP/I-PNP eingestuft/NN/I-NP/I-PNP wurden/VB/B-VP/O ././O/O

Dies/DT/O/O hat/VB/B-VP/O m\xc3\xb6glicherweise/IN/B-PP/B-PNP Konsequenzen/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Regulation/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Transkription/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP Ac-P35/NN/B-NP/I-PNP ././O/O

2/CD/O/O ././O/O

Der/DT/B-NP/O zweite/JJ/I-NP/O Teil/NN/I-NP/O der/DT/B-NP/O Aufgabenstellung/NN/I-NP/O umfasste/VB/B-VP/O die/DT/B-NP/O Suche/NN/I-NP/O und/CC/O/O Charakterisierung/NN/B-NP/O von/IN/B-PP/B-PNP Interaktionspartnern/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Caspasenadaptormolek\xc3\xbcls/NN/I-NP/I-PNP Apaf-1/NN/I-NP/I-PNP ,/,/O/O dessen/WDT/B-NP/O zentrale/JJ/I-NP/O Bedeutung/NN/I-NP/O in/IN/B-PP/O manchen/DT/O/O Wegen/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Apoptose/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP feine/JJ/I-NP/I-PNP Regulation/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP interagierende/NN/B-NP/I-PNP Proteine/JJ/I-NP/I-PNP nahelegte/NN/I-NP/I-PNP ././O/O

Die/DT/O/O zwei/CD/O/O bekannten/VB/B-VP/O funktionellen/JJ/B-NP/O Dom\xc3\xa4nen/NN/I-NP/O von/IN/B-PP/B-PNP Apaf-1/NN/B-NP/I-PNP ,/,/O/O CARD/NN/B-NP/O und/CC/I-NP/O WD-40/NN/I-NP/O wurden/VB/B-VP/O im/IN/B-PP/B-PNP Interaction/NN/B-NP/I-PNP Trap-System/NN/I-NP/I-PNP eingesetzt/RP/O/O ././O/O

Es/PRP/B-NP/O konnte/VB/B-VP/O kein/JJ/B-NP/O Interaktionspartner/NN/I-NP/O der/DT/B-NP/O WD-40-Dom\xc3\xa4ne/NN/I-NP/O gefunden/VBN/B-VP/O werden/VB/I-VP/O ,/,/O/O jedoch/IN/B-PP/B-PNP interagierte/NN/B-NP/I-PNP die/DT/I-NP/I-PNP CARD-Dom\xc3\xa4ne/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP C-terminalen/JJ/I-NP/I-PNP Teil/NN/I-NP/I-PNP des/DT/B-NP/I-PNP humanen/NN/I-NP/I-PNP Proteins/JJ/B-NP/I-PNP hVPS41/NN/I-NP/I-PNP ././O/O

\xc3\x9cber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Funktion/NN/I-NP/I-PNP dieses/DT/B-NP/I-PNP Proteins/NN/I-NP/I-PNP ist/VB/B-VP/O nicht/RB/B-ADVP/O viel/RB/I-ADVP/O bekannt/RP/O/O ././O/O

Es/PRP/B-NP/O wird/VB/B-VP/O vermutet/NN/B-NP/O ,/,/O/O dass/IN/B-PP/O es/JJ/B-ADJP/O eine/DT/B-NP/O Rolle/NN/I-NP/O beim/IN/B-PP/B-PNP intrazellul\xc3\xa4ren/NN/B-NP/I-PNP Proteintransport/NN/I-NP/I-PNP spielt/NN/I-NP/I-PNP ,/,/O/O in/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP es/PRP$/I-NP/I-PNP an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Bildung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Transportvesi-keln/NN/B-NP/I-PNP am/IN/B-PP/B-PNP Golgi-Apparat/NN/B-NP/I-PNP beteiligt/VBN/B-VP/I-PNP ist/VB/I-VP/O ././O/O

In/IN/B-PP/B-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP wird/VB/B-VP/O die/DT/B-NP/O Hypothese/NN/I-NP/O aufgestellt/NN/I-NP/O ,/,/O/O dass/IN/B-PP/B-PNP hVPS41/NN/B-NP/I-PNP direkt/JJ/B-ADJP/O mit/IN/B-PP/B-PNP Apaf-1/NN/B-NP/I-PNP am/IN/B-PP/B-PNP Golgi-Apparat/NN/B-NP/I-PNP interagiert/NN/I-NP/I-PNP und/CC/O/O f\xc3\xbcr/IN/B-PP/B-PNP den/DT/B-NP/I-PNP intrazellul\xc3\xa4ren/JJ/I-NP/I-PNP Transport/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Apaf-1/NN/B-NP/I-PNP verantwortlich/JJ/B-ADJP/O ist/VB/B-VP/O ././O/O

M\xc3\xb6gliche/JJ/B-ADJP/O pro/IN/B-PP/O -/-/O/O oder/CC/O/O anti-apoptotische/JJ/B-NP/O Funktionen/NN/I-NP/O von/IN/B-PP/B-PNP hVPS41/NN/B-NP/I-PNP ,/,/O/O die/WDT/O/O aufgrund/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Transporteigenschaften/NN/I-NP/I-PNP von/IN/B-PP/B-PNP hVPS41/NN/B-NP/I-PNP und/CC/I-NP/I-PNP der/DT/I-NP/I-PNP vermuteten/JJ/I-NP/I-PNP Interaktion/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP vollst\xc3\xa4ndigem/NN/B-NP/I-PNP hVPS41/NN/I-NP/I-PNP -/-/O/O und/CC/O/O Apaf-1-Protein/NNP/B-NP/O resultieren/VB/B-VP/O ,/,/O/O werden/VB/B-VP/O diskutiert.Wald\xc3\xb6kosysteme/NN/B-NP/O bilden/VBN/B-VP/O die/DT/B-NP/O Hauptkomponente/NN/I-NP/O der/DT/B-NP/O terrestrischen/JJ/I-NP/O Biomasse/NNP/I-NP/O und/CC/O/O ihre/PRP$/B-NP/O Reaktion/NN/I-NP/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP ansteigende/NN/I-NP/I-PNP atmosph\xc3\xa4rische/JJ/B-NP/I-PNP CO2-Konzentration/NN/I-NP/I-PNP hat/VB/B-VP/O einen/DT/B-NP/O wesentlichen/JJ/I-NP/O Einfluss/NN/I-NP/O auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP globalen/JJ/I-NP/I-PNP Kohlenstoffkreislauf/NN/I-NP/I-PNP ././O/O

Daher/RB/B-VP/O wurden/VB/I-VP/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP juvenile/JJ/B-NP/I-PNP Eichenbest\xc3\xa4nde/NN/I-NP/I-PNP (/(/O/O Quercus/FW/O/O robur/FW/O/O L./FW/O/O )/)/O/O langfristig/FW/O/O normaler/FW/O/O (/(/O/O 350/CD/B-NP/O \xc2\xb5mol/NN/I-NP/O mol-1/NN/I-NP/O )/)/O/O und/CC/O/O erh\xc3\xb6hter/JJ/B-NP/O CO2-Konzentration/NN/I-NP/O (/(/O/O 700/CD/B-NP/O \xc2\xb5mol/NN/I-NP/O mol-1/NN/I-NP/O )/)/O/O ausgesetzt/RP/O/O ././O/O

Mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Mikrokosmos-Technik/NN/I-NP/I-PNP wurden/VB/B-VP/O der/DT/B-NP/O Gaswechsel/NN/I-NP/O (/(/O/O CO2&slash;H2O/NNP/B-NP/O )/)/O/O und/CC/O/O das/DT/B-NP/O Wachstum/NN/I-NP/O dieser/DT/B-NP/O Modellbest\xc3\xa4nde/NN/I-NP/O unter/IN/B-PP/O nahezu/RB/B-ADVP/O nat\xc3\xbcrlichen/IN/B-PP/B-PNP Umweltbedingungen/NN/B-NP/I-PNP untersucht/RP/O/O ././O/O

Die/DT/B-NP/O Abh\xc3\xa4ngigkeiten/NN/I-NP/O einzelner/JJ/B-NP/O Teilprozesse/NN/I-NP/O im/IN/B-PP/B-PNP Kronen/NNS/B-NP/I-PNP -/-/O/O und/CC/O/O Bodenraum/NN/B-NP/O (/(/O/O Nettophotosynthese/NN/B-NP/O ,/,/O/O stomat\xc3\xa4re/JJ/B-NP/O Leitf\xc3\xa4higkeit/NN/I-NP/O ,/,/O/O Pflanzen/NN/B-NP/O -/-/O/O und/CC/O/O Bodenatmung/NN/B-NP/O )/)/O/O von/IN/B-PP/B-PNP verschiedenen/JJ/B-NP/I-PNP Umweltfaktoren/NN/I-NP/I-PNP (/(/O/O Strahlung/NN/B-NP/O ,/,/O/O Temperatur/NN/B-NP/O ,/,/O/O Stickstoffverf\xc3\xbcgbarkeit/NNP/B-NP/O )/)/O/O wurden/RB/B-ADVP/O ermittelt/RP/O/O ././O/O

Einzelblattmessungen/RB/B-VP/O konnten/VB/I-VP/O direkt/JJ/B-ADJP/O integriert/VBN/B-VP/O und/CC/O/O mit/IN/B-PP/B-PNP Gaswechselmessungen/NN/B-NP/I-PNP des/DT/I-NP/I-PNP gesamten/JJ/I-NP/I-PNP Modellbestandes/NN/I-NP/I-PNP verglichen/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

In/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Vegetationsperioden/NN/I-NP/I-PNP war/VB/B-VP/O die/DT/B-NP/O Nettophotosyntheserate/NN/I-NP/O (/(/O/O An/IN/B-PP/O )/)/O/O unter/IN/B-PP/B-PNP erh\xc3\xb6hter/JJ/B-NP/I-PNP CO2-Konzentration/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Mittel/NN/B-NP/I-PNP um/IN/B-PP/O 11%-50%/CD/O/O gr\xc3\xb6\xc3\x9fer/JJ/B-ADJP/O ././O/O

Die/DT/B-NP/O CO2-bedingte/JJ/I-NP/O Steigerung/NN/I-NP/O von/IN/B-PP/B-PNP An&lt/NN/B-NP/I-PNP ;/:/O/O nahm/VBN/B-VP/O mit/IN/B-PP/B-PNP zunehmender/JJ/B-NP/I-PNP Versuchsdauer/NN/I-NP/I-PNP ab/RP/O/O ././O/O

ie/PRP/B-NP/O war/VBN/B-VP/O mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Reduktion/NN/I-NP/I-PNP (/(/O/O 10-38%/CD/O/O )/)/O/O der/DT/B-NP/O maximalen/JJ/I-NP/O Carboxylierungsrate/NN/I-NP/O (/(/O/O Vcmax/NN/B-NP/O )/)/O/O und/CC/O/O der/DT/B-NP/O maximalen/JJ/I-NP/O Elektronentransportrate/NN/I-NP/O (/(/O/O Jmax/NN/B-NP/O )/)/O/O unter/IN/B-PP/B-PNP erh\xc3\xb6htem/NN/B-NP/I-PNP CO2-Angebot/NN/I-NP/I-PNP gekoppelt/RP/O/O ././O/O

Diese/DT/B-NP/O Akklimatisation/NN/I-NP/O der/DT/B-NP/O Nettophotosynthese/JJ/I-NP/O basierte/NN/I-NP/O auf/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP R\xc3\xbcckkoppelung/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Stickstofflimitierung/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Boden/NN/B-NP/I-PNP ././O/O

Die/DT/B-NP/O hohe/JJ/I-NP/O Variabilit\xc3\xa4t/NN/I-NP/O von/IN/B-PP/B-PNP An/IN/I-PP/I-PNP war/VB/B-VP/O auf/IN/B-PP/B-PNP Unterschiede/NN/B-NP/I-PNP in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Stickstoffgehalten/NN/I-NP/I-PNP (/(/O/O Na/NN/B-NP/O )/)/O/O der/DT/B-NP/O Bl\xc3\xa4tter/NN/I-NP/O zur\xc3\xbcckzuf\xc3\xbchren/VB/B-VP/O und/CC/O/O konnte/VBN/B-VP/O mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP generischen/JJ/I-NP/I-PNP Vcmax&slash;Na/NN/I-NP/I-PNP -/-/O/O bzw./CC/O/O Jmax&slash;Na-Beziehung/NN/B-NP/O erkl\xc3\xa4rt/VBN/B-VP/O werden/VB/I-VP/O ././O/O

owohl/CC/O/O die/DT/B-NP/O Variabilit\xc3\xa4t/NN/I-NP/O der/DT/B-NP/O Photosyntheseparameter/NN/I-NP/O aufgrund/IN/B-PP/B-PNP verschiedener/JJ/B-NP/I-PNP Blatttypen/NN/I-NP/I-PNP ,/,/O/O als/CC/O/O auch/RB/B-ADVP/O die/DT/B-NP/O Variabilit\xc3\xa4t/NN/I-NP/O zwischen/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Best\xc3\xa4nden/NN/I-NP/I-PNP und/CC/O/O Vegetationsperioden/NN/B-NP/O wurden/VB/B-VP/O mit/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Beziehung/NN/I-NP/I-PNP aufgel\xc3\xb6st/RP/O/O ././O/O

Die/DT/B-NP/O Temperaturabh\xc3\xa4ngigkeiten/NN/I-NP/O von/IN/B-PP/B-PNP Vcmax/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Jmax/NN/I-NP/I-PNP wurden/VB/B-VP/O durch/IN/B-PP/B-PNP Messungen/NNS/B-NP/I-PNP von/IN/B-PP/B-PNP An&lt;&slash;sub&gt;&slash;ci-Kurven/NN/B-NP/I-PNP bei/IN/B-PP/O 12/CD/O/O ,/,/O/O 20/CD/O/O ,/,/O/O 25/CD/O/O ,/,/O/O 30/CD/B-NP/O und/CC/I-NP/O 36\xc2\xb0C/NN/I-NP/O bestimmt/RP/O/O ././O/O

Eine/DT/B-NP/O CO2-Erh\xc3\xb6hung/NN/I-NP/O beeinflusste/NN/I-NP/O die/DT/B-NP/O Temperaturabh\xc3\xa4ngigkeit/NN/I-NP/O nicht/RB/B-ADVP/O ././O/O

Es/PRP/B-NP/O wurden/VB/B-VP/O niedrigere/JJ/B-NP/O Temperaturoptima/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP Jmax/NN/B-NP/I-PNP (/(/O/O 32.8\xc2\xb0C/NN/B-NP/O )/)/O/O als/IN/B-PP/B-PNP f\xc3\xbcr/IN/I-PP/I-PNP Vcmax/NN/B-NP/I-PNP (/(/O/O 35.0\xc2\xb0C/NN/B-NP/O )/)/O/O ermittelt/RP/O/O ././O/O

Die/DT/B-NP/O stomat\xc3\xa4re/JJ/I-NP/O Leitf\xc3\xa4higkeit/NN/I-NP/O (/(/O/O gs/NN/B-NP/O )/)/O/O war/NN/B-NP/O nach/IN/B-PP/B-PNP Verdoppelung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP CO2-Konzentration/NN/I-NP/I-PNP signifikant/JJ/B-ADJP/O um/IN/B-PP/O 36%/CD/O/O reduziert/RP/O/O ././O/O

Die/DT/B-NP/O gemessenen/NN/I-NP/O gs-Werte/NN/I-NP/O wurden/VB/B-VP/O entsprechend/JJ/B-ADJP/O den/DT/B-NP/O Modellans\xc3\xa4tzen/NN/I-NP/O von/IN/B-PP/B-PNP Ball/NN/B-NP/I-PNP et/NN/I-NP/I-PNP al./JJ/B-ADJP/O (/(/O/O 1987/CD/O/O )/)/O/O und/CC/O/O Jarvis/NN/B-NP/O (/(/O/O 1976/CD/O/O )/)/O/O ausgewertet/RP/O/O ././O/O

Neben/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP CO2/NN/I-NP/I-PNP -/-/O/O ,/,/O/O Strahlungs/NN/B-NP/O -/-/O/O ,/,/O/O und/CC/O/O Temperaturabh\xc3\xa4ngigkeit/NN/B-NP/O wurde/VB/B-VP/O auch/RB/B-ADVP/O eine/DT/B-NP/O lineare/NN/I-NP/O Na-Abh\xc3\xa4ngigkeit/NN/I-NP/O der/DT/B-NP/O stomat\xc3\xa4ren/NN/I-NP/O Leitf\xc3\xa4higkeit/NN/I-NP/O ermittelt/VBN/B-VP/O und/CC/O/O in/IN/B-PP/B-PNP beide/DT/B-NP/I-PNP Modelle/NNS/I-NP/I-PNP integriert/RP/O/O ././O/O

Vertikale/JJ/B-NP/O Kronenraumprofile/NN/I-NP/O wurden/VB/B-VP/O f\xc3\xbcr/IN/B-PP/B-PNP LMA/NNP/B-NP/I-PNP und/CC/I-NP/I-PNP Na/NNP/I-NP/I-PNP bestimmt/RP/O/O ././O/O

Die/DT/B-NP/O LMA/NNP/I-NP/O -/-/O/O und/CC/O/O Na-Werte/NN/B-NP/O der/DT/B-NP/O einzelnen/JJ/I-NP/O Kronenschichten/NN/I-NP/O korrlierten/NN/I-NP/O gut/JJ/B-ADJP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP relativen/NN/I-NP/I-PNP Einstrahlung/NN/I-NP/I-PNP und/CC/O/O dem/DT/B-NP/O kumulativen/NN/I-NP/O LAI/NNP/I-NP/O ././O/O

Diese/DT/B-NP/O Beziehungen/NN/I-NP/O wurden/VB/B-VP/O in/IN/B-PP/B-PNP Verbindung/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Na/NN/I-NP/I-PNP und/CC/O/O LMA-Abh\xc3\xa4ngigkeit/NN/B-NP/O der/DT/B-NP/O Modellparameter/NN/I-NP/O angewandt/JJ/B-ADJP/O ,/,/O/O um/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Verteilung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP physiologischen/JJ/I-NP/I-PNP Parameter/NN/I-NP/I-PNP innerhalb/IN/B-PP/B-PNP des/DT/B-NP/I-PNP Kronenraumes/NN/I-NP/I-PNP abzusch\xc3\xa4tzen.Der/VB/B-VP/O CO2-Bestandesgaswechsel/NN/B-NP/O war/VB/B-VP/O nach/IN/B-PP/B-PNP langfristigem/JJ/B-NP/I-PNP Wachstum/NN/I-NP/I-PNP unter/IN/B-PP/B-PNP erh\xc3\xb6hter/JJ/B-NP/I-PNP CO2-Konzentration/NN/I-NP/I-PNP um/IN/B-PP/O 44%/CD/O/O reduziert/RP/O/O ././O/O

In/IN/B-PP/O 1997/CD/O/O betrug/VB/B-VP/O der/DT/B-NP/O NEF/NN/I-NP/O unter/IN/B-PP/B-PNP normaler/JJ/B-NP/I-PNP CO2-Konzentration/NN/I-NP/I-PNP 61.48/CD/B-NP/I-PNP mol/NN/I-NP/I-PNP m-\xc2\xb2a-1/NN/I-NP/I-PNP und/CC/O/O unter/IN/B-PP/O erh\xc3\xb6hter/JJ/B-ADJP/O 34.39/CD/B-NP/O mol/JJ/I-NP/O m-\xc2\xb2a-1/NN/I-NP/O ././O/O

Die/DT/B-NP/O G\xc3\xbcte/NN/I-NP/O der/DT/B-NP/O Bestandesgaswechselmessungen/NN/I-NP/O wurde/VB/B-VP/O im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Biomasseernten/NN/I-NP/I-PNP belegt/RP/O/O ././O/O

Die/DT/O/O aus/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP NEF/NN/I-NP/I-PNP berechneten/NN/I-NP/I-PNP und/CC/O/O die/DT/O/O bei/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Ernten/NNS/I-NP/I-PNP bestimmten/JJ/B-NP/I-PNP Biomassezunahmen/NN/I-NP/I-PNP stimmten/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Bestand/NN/B-NP/I-PNP juv350/NN/I-NP/I-PNP zu/TO/O/O 98%/CD/O/O und/CC/O/O im/IN/B-PP/B-PNP Bestand/NN/B-NP/I-PNP juv700/NN/I-NP/I-PNP zu/TO/O/O 83%/CD/O/O \xc3\xbcberein/RP/O/O ././O/O

Die/DT/B-NP/O beobachtete/NN/I-NP/O Reduktion/NN/I-NP/O des/DT/B-NP/O NEF/NN/I-NP/O beruhte/VB/B-VP/O \xc3\xbcberwiegend/JJ/B-ADJP/O auf/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Erh\xc3\xb6hung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Bodenatmungsraten/NN/I-NP/I-PNP aufgrund/IN/B-PP/O der/DT/O/O signifikant/JJ/B-ADJP/O erh\xc3\xb6hten/VB/B-VP/O Feinwurzelmasse/NNP/B-NP/O ././O/O

Anhand/IN/B-PP/B-PNP von/IN/I-PP/I-PNP Simulationsl\xc3\xa4ufen/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Bestandesgaswechselmodell/NN/I-NP/I-PNP FORSTFLUX/NN/I-NP/I-PNP wurde/VB/B-VP/O eine/DT/B-NP/O Zunahme/NN/I-NP/O der/DT/B-NP/O Bodenatmung/NN/I-NP/O um/IN/B-PP/B-PNP 29%/CD/B-NP/I-PNP berechnet/NN/I-NP/I-PNP ././O/O

In/IN/B-PP/B-PNP weiteren/JJ/B-NP/I-PNP Simulationsl\xc3\xa4ufen/NN/I-NP/I-PNP wurde/VB/B-VP/O der/DT/B-NP/O erhebliche/JJ/I-NP/O Einfluss/NN/I-NP/O der/DT/B-NP/O Bestandesstruktur/NN/I-NP/O auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Bestandesgaswechsel/JJ/I-NP/I-PNP quantifiziert/NN/I-NP/I-PNP ././O/O

Dabei/RB/B-VP/O waren/VB/I-VP/O die/DT/B-NP/O Auswirkungen/NN/I-NP/O einer/DT/B-NP/O Akklimatisation/NN/I-NP/O der/DT/B-NP/O Nettophotosynthese/NN/I-NP/O auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP NEF/NN/I-NP/I-PNP deutlich/JJ/B-ADJP/O geringer/JJ/I-ADJP/O als/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Auswirkungen/NN/I-NP/I-PNP einer/DT/B-NP/I-PNP ver\xc3\xa4nderten/NN/I-NP/I-PNP Bestandesstruktur/NN/I-NP/I-PNP ././O/O

imulationsl\xc3\xa4ufe/NN/B-NP/O mit/IN/B-PP/B-PNP erh\xc3\xb6hter/JJ/B-NP/I-PNP Temperatur/NN/I-NP/I-PNP (/(/O/O +/NN/B-NP/O 1/CD/O/O ,/,/O/O +/NN/B-NP/O 2/CD/I-NP/O und/CC/I-NP/O +/NN/I-NP/O 4\xc2\xb0C/NN/I-NP/O )/)/O/O ergaben/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Jahresbilanz/NN/I-NP/I-PNP einen/DT/B-NP/I-PNP verringerten/JJ/I-NP/I-PNP NEF/NN/I-NP/I-PNP (/(/O/O -/-/O/O 12%/CD/O/O ,/,/O/O -/-/O/O 27%/CD/O/O und/CC/O/O -/-/O/O 63%/CD/O/O )/)/O/O und/CC/O/O eine/DT/B-NP/O gesteigerte/NN/I-NP/O ET/NN/I-NP/O (/(/O/O 7%/CD/O/O ,/,/O/O 16%/CD/O/O und/CC/O/O 33%/CD/O/O )/)/O/O ././O/O

Diese/DT/B-NP/O Ergebnisse/NN/I-NP/O unterst\xc3\xbctzen/VB/B-VP/O die/DT/B-NP/O Hypothese/NN/I-NP/O ,/,/O/O dass/IN/B-PP/B-PNP sich/PRP/B-NP/I-PNP aufgrund/IN/B-PP/B-PNP des/DT/B-NP/I-PNP exponentiellen/NN/I-NP/I-PNP Anstiegs/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Respiration/NN/I-NP/I-PNP und/CC/O/O Dekomposition/NN/B-NP/O mit/IN/B-PP/B-PNP ansteigender/NN/B-NP/I-PNP Temperatur/NN/I-NP/I-PNP die/DT/I-NP/I-PNP terrestrische/JJ/I-NP/I-PNP Biosph\xc3\xa4re/NN/I-NP/I-PNP von/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Kohlenstoffsenke/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Kohlenstoffquelle/NN/I-NP/I-PNP wandelt.Die/NN/I-NP/I-PNP Famile/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Orthopockenviren/JJ/I-NP/I-PNP umschlie\xc3\x9ft/NN/I-NP/I-PNP neben/IN/B-PP/O den/DT/O/O zwar/IN/B-PP/B-PNP ausgerotteten/NN/B-NP/I-PNP ,/,/O/O im/IN/B-PP/B-PNP Falle&#13;einer/NN/B-NP/I-PNP nicht/RB/I-NP/I-PNP auszuschlie\xc3\x9fenden/NN/I-NP/I-PNP bioterroristischen/JJ/B-NP/I-PNP Ausbringung/NN/I-NP/I-PNP aber/IN/B-PP/B-PNP hochgef\xc3\xa4hrlichen&#13;Variolaviren/NN/B-NP/I-PNP weitere/JJ/I-NP/I-PNP humanpathogene/NN/I-NP/I-PNP Viren/NN/I-NP/I-PNP wie/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Affenpocken/NN/I-NP/I-PNP -/-/O/O ,/,/O/O das/DT/B-NP/O Kuhpockensowie&#13;das/JJ/I-NP/O Vacciniavirus/NN/I-NP/O ././O/O

Als/IN/B-PP/B-PNP zoonotische/JJ/B-NP/I-PNP Erreger/NN/I-NP/I-PNP endemisch/JJ/B-ADJP/O in/IN/B-PP/B-PNP Zentral/NN/B-NP/I-PNP -/-/O/O und/CC/O/O Westafrika,&#13;Europa/NN/B-NP/O sowie/RB/B-ADVP/O S\xc3\xbcdamerika/NNP/B-NP/O ,/,/O/O verursachen/VB/B-VP/O Sie/PRP/B-NP/O lokal/JJ/B-ADJP/O begrenzt/JJ/I-ADJP/O bis/IN/B-PP/B-PNP systemisch/JJ/B-NP/I-PNP verlaufende&#13;pustul\xc3\xa4re/JJ/I-NP/I-PNP Erkrankungen/NNS/I-NP/I-PNP ,/,/O/O welche/WDT/O/O in/IN/B-PP/B-PNP Einzelf\xc3\xa4llen/NN/B-NP/I-PNP bis/IN/B-PP/B-PNP zum/IN/I-PP/I-PNP Tod/NN/B-NP/I-PNP f\xc3\xbchren/VB/B-VP/O k\xc3\xb6nnen.&#13;Aufgrund/MD/B-VP/O des/DT/B-NP/O seltenen/NN/I-NP/O Auftretens/NN/I-NP/O sind/VB/B-VP/O deutschlandweit/NN/B-NP/O nur/RB/I-NP/O wenige/JJ/I-NP/O Speziallabore/NN/I-NP/O wie&#13;das/NN/I-NP/O Robert/NNP/I-NP/O Koch-Institut/NNP/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Lage/NN/I-NP/I-PNP ,/,/O/O den/DT/B-NP/O Nachweis/NN/I-NP/O einer/DT/B-NP/O Orthopockenvirusinfektion&#13;anhand/NN/I-NP/O serologischer/NN/I-NP/O ,/,/O/O Nukleins\xc3\xa4ure/NN/B-NP/O -/-/O/O oder/CC/O/O Partikel-basierter/NN/B-NP/O Nachweisverfahren/JJ/B-NP/O zu&#13;erbringen/NN/I-NP/O ././O/O

Ein/DT/O/O im/IN/B-PP/B-PNP Falle/NN/B-NP/I-PNP einer/DT/I-NP/I-PNP bioterroristischen/JJ/I-NP/I-PNP Freisetzung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Variolaviren/NN/B-NP/I-PNP notwendiges&#13;schnelles/NN/I-NP/I-PNP ,/,/O/O sensitives/NN/B-NP/O und/CC/O/O einfach/IN/B-PP/B-PNP durchzuf\xc3\xbchrendes/NN/B-NP/I-PNP Detektionssystem/NN/I-NP/I-PNP existiert&#13;bis/VB/B-VP/O heute/VB/I-VP/O jedoch/IN/B-PP/B-PNP nicht.&#13;Um/NN/B-NP/I-PNP diese/DT/I-NP/I-PNP L\xc3\xbccke/NN/I-NP/I-PNP zu/TO/B-VP/O schlie\xc3\x9fen/VB/I-VP/O ,/,/O/O war/VB/B-VP/O das/DT/B-NP/O Ziel/NN/I-NP/O dieser/DT/B-NP/O Arbeit/NN/I-NP/O die/DT/B-NP/O Entwicklung/NN/I-NP/O eines&#13;Antik\xc3\xb6rper-basierten/NN/I-NP/O Schnelldetektionssystems/NNP/I-NP/O zum/IN/B-PP/B-PNP Nachweis/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Orthopockenviren.&#13;Durch/NN/B-NP/I-PNP Testung/NN/I-NP/I-PNP Oberfl\xc3\xa4chenprotein-spezifischer/NN/I-NP/I-PNP polyklonaler/NN/I-NP/I-PNP Antik\xc3\xb6rper/NN/I-NP/I-PNP konnte&#13;gezeigt/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Attachment-Protein/NNP/I-NP/I-PNP A27/NNP/I-NP/I-PNP am/IN/B-PP/B-PNP geeignetsten/NN/B-NP/I-PNP zur/IN/B-PP/B-PNP Induktion/NN/B-NP/I-PNP Detektions-&#13;optimierter/NN/I-NP/I-PNP Antik\xc3\xb6rper/NN/I-NP/I-PNP ist/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP mehrstufigen/NN/I-NP/I-PNP Screeningverfahren/NN/I-NP/I-PNP wurden&#13;daher/NN/I-NP/I-PNP monoklonale/JJ/B-NP/I-PNP Antik\xc3\xb6rper/NN/I-NP/I-PNP gegen/IN/B-PP/B-PNP A27/NN/B-NP/I-PNP generiert/NN/I-NP/I-PNP ,/,/O/O deren/WDT/B-NP/O Bindungsepitope/JJ/I-NP/O und&#13;Bindungskinetik/NN/I-NP/O mittels/IN/B-PP/O Peptid-Epitopmapping/FW/O/O und/CC/O/O Oberfl\xc3\xa4chenplasmonresonanz-&#13;Messung/NN/B-NP/O bestimmt/VBN/B-VP/O wurden/VB/I-VP/O ././O/O

Hierbei/RB/B-VP/O zeigte/VB/I-VP/O sich/PRP/B-NP/O ,/,/O/O dass/RB/B-NP/O gute/JJ/I-NP/O Zug\xc3\xa4nglichkeit/NN/I-NP/O der/DT/B-NP/O Bindungsepitope&#13;sowie/NN/I-NP/O schnelle/NN/I-NP/O und/CC/O/O multivalente/NN/B-NP/O Bindung/NN/I-NP/O entscheidend/JJ/B-ADJP/O f\xc3\xbcr/IN/B-PP/B-PNP Detektionsoptimierte&#13;Antik\xc3\xb6rper/NN/B-NP/I-PNP waren/VB/B-VP/O ././O/O

Die/DT/B-NP/O beiden/DT/I-NP/O besten/JJ/I-NP/O Antik\xc3\xb6rper/NN/I-NP/O wurden/VB/B-VP/O schlie\xc3\x9flich/IN/B-PP/B-PNP auf&#13;der/NN/B-NP/I-PNP Abicap/NN/I-NP/I-PNP Vor-Ort-Detektionsplattform/NN/I-NP/I-PNP implementiert/NN/I-NP/I-PNP und/CC/O/O bez\xc3\xbcglich/IN/B-PP/B-PNP Sensitivit\xc3\xa4t&#13;und/NN/B-NP/I-PNP Spezifit\xc3\xa4t/NN/I-NP/I-PNP beim/IN/B-PP/B-PNP Orthopockenvirusnachweis/JJ/B-NP/I-PNP charakterisiert/NN/I-NP/I-PNP ././O/O

Als/IN/B-PP/B-PNP Ansatzpunkt/NN/B-NP/I-PNP f\xc3\xbcr&#13;potenzielle/NN/I-NP/I-PNP Weiterentwicklungen/NN/I-NP/I-PNP wurden/VB/B-VP/O diese/DT/O/O zus\xc3\xa4tzlich/JJ/B-ADJP/O in/IN/B-PP/B-PNP Form/NN/B-NP/I-PNP rekombinanter/NN/I-NP/I-PNP single&#13;chain/NN/I-NP/I-PNP fragment/NN/I-NP/I-PNP variable/NN/I-NP/I-PNP Antik\xc3\xb6rper/NN/I-NP/I-PNP exprimiert/NN/I-NP/I-PNP und/CC/I-NP/I-PNP getestet.&#13;Das/NN/I-NP/I-PNP etablierte/NN/I-NP/I-PNP Detektionssystem/NN/I-NP/I-PNP war/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Lage/NN/I-NP/I-PNP ,/,/O/O alle/JJ/B-NP/O getesteten/JJ/I-NP/O humanpathogenen&#13;Orthopockenviren/NN/I-NP/O mit/IN/B-PP/B-PNP hoher/JJ/B-NP/I-PNP Sensitivit\xc3\xa4t/NN/I-NP/I-PNP von/IN/B-PP/B-PNP bis/IN/I-PP/I-PNP zu/IN/I-PP/I-PNP 1,75\xc3\x9710^2/JJ/B-NP/I-PNP PFU&slash;ml/NN/I-NP/I-PNP in/IN/B-PP/B-PNP 45/CD/B-NP/I-PNP Minuten&#13;zu/NN/I-NP/I-PNP detektieren/NN/I-NP/I-PNP ,/,/O/O wobei/WRB/O/O der/DT/B-NP/O Nachweis/NN/I-NP/O aus/IN/B-PP/B-PNP klinischem/NN/B-NP/I-PNP Material/NN/I-NP/I-PNP sowie/RB/B-ADVP/O einem/DT/B-NP/O verblindetem&#13;Probenpanel/NN/I-NP/O ohne/IN/B-PP/B-PNP Kreuzreaktivit\xc3\xa4ten/NN/B-NP/I-PNP m\xc3\xb6glich/JJ/B-ADJP/O war/VB/B-VP/O ././O/O

Durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP schnelle/NN/I-NP/I-PNP und/CC/O/O einfache&#13;Durchf\xc3\xbchrbarkeit/NN/B-NP/O bei/IN/B-PP/B-PNP gleichzeitig/RB/B-NP/I-PNP hoher/JJ/I-NP/I-PNP Sensitivit\xc3\xa4t/NN/I-NP/I-PNP eignet/VB/B-VP/O sich/PRP/B-NP/O das/DT/I-NP/O Abicap-System&#13;sehr/NN/I-NP/O gut/JJ/B-ADJP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Vor-Ort-Testung/NN/I-NP/I-PNP sowohl/RB/B-ADVP/O bioterroristischer/NN/B-NP/O als/CC/O/O auch/RB/B-NP/O klinischer/JJ/I-NP/O Proben.&#13;Dar\xc3\xbcber/NN/I-NP/O hinaus/IN/B-PP/O k\xc3\xb6nnen/VB/B-VP/O die/DT/O/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP gewonnenen/NN/I-NP/I-PNP Erkenntnisse/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP Generierung&#13;Detektions-optimierter/JJ/B-NP/I-PNP Antik\xc3\xb6rper/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP anderer/JJ/B-NP/I-PNP Erreger/NN/I-NP/I-PNP \xc3\xbcbertragen/VB/B-VP/O werden.Es/NN/B-NP/O war/RB/B-ADVP/O einmal/RB/I-ADVP/O ein/DT/B-NP/O toxisches/JJ/I-NP/O Element/NN/I-NP/O \xe2\x80\xa6,&#13;ein/NN/I-NP/O karzinogenes/NN/I-NP/O Element/NN/I-NP/O \xe2\x80\xa6,&#13;ein/NN/I-NP/O essentielles/NN/I-NP/O Spurenelement/NN/I-NP/O \xe2\x80\xa6,&#13;und/NN/I-NP/O alle/DT/O/O trugen/VB/B-VP/O die/DT/O/O gleiche/JJ/B-ADJP/O Bezeichnung:&#13;Selen/VB/B-VP/O (/(/O/O Se).&#13;Se/LS/O/O \xc3\xbcbt/NN/B-NP/O seine/PRP$/I-NP/O Effekte/NNS/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP menschliche/JJ/I-NP/I-PNP Gesundheit/NN/I-NP/I-PNP haupts\xc3\xa4chlich/RB/B-ADVP/O in/IN/B-PP/B-PNP Form/NN/B-NP/I-PNP der/DT/O/O 21/CD/O/O ././O/O

proteinogenen/JJ/B-NP/O Aminos\xc3\xa4ure/NN/I-NP/O Selenocystein/NNP/I-NP/O (/(/O/O Sec/FW/O/O )/)/O/O aus/RP/O/O ././O/O

Die/DT/B-NP/O Sec-enthaltenden/NN/I-NP/O Selenoproteine/NN/I-NP/O werden/VB/B-VP/O im/IN/B-PP/B-PNP Menschen/NN/B-NP/I-PNP von/IN/B-PP/B-PNP 25/CD/B-NP/I-PNP Genen/NN/I-NP/I-PNP kodiert/NN/I-NP/I-PNP und/CC/O/O kontrollieren/VB/B-VP/O zentrale/JJ/B-NP/O Prozesse/NN/I-NP/O der/DT/B-NP/O Entwicklung/NN/I-NP/O ,/,/O/O des/DT/B-NP/O Metabolismus/NN/I-NP/O und/CC/O/O der/DT/B-NP/O Alterung/NN/I-NP/O ././O/O

Diese/DT/B-NP/O essentielle/NN/I-NP/O Bedeutung/NN/I-NP/O des/DT/B-NP/O Se/NN/I-NP/O und/CC/O/O der/DT/B-NP/O Selenoproteine/NN/I-NP/O wird/VB/B-VP/O zunehmend/JJ/B-ADJP/O durch/IN/B-PP/B-PNP tierexperimentelle/NN/B-NP/I-PNP und/CC/I-NP/I-PNP humane/NN/I-NP/I-PNP Studien/NN/I-NP/I-PNP belegt/RP/O/O ././O/O

o/VBN/B-VP/O werden/VB/I-VP/O Se-Mangel/NN/B-NP/O bzw./RB/I-NP/O Se-Supplementation/NN/I-NP/O mit/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP ver\xc3\xa4nderten/NN/I-NP/I-PNP Krebsrisiko/NN/I-NP/I-PNP ,/,/O/O der/DT/B-NP/O Reaktionsf\xc3\xa4higkeit/NN/I-NP/O des/DT/B-NP/O Immunsystems/NN/I-NP/O und/CC/O/O sogar/RB/B-ADVP/O der/DT/B-NP/O Mortalit\xc3\xa4tsrate/NN/I-NP/O bei/IN/B-PP/B-PNP Krebs/NN/B-NP/I-PNP oder/RB/I-NP/I-PNP Sepsis/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Verbindung/NN/B-NP/I-PNP gebracht.&#13;Der/JJ/I-NP/I-PNP Einfluss/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Se/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Knochengesundheit/NN/I-NP/I-PNP ist/VB/B-VP/O dagegen/RB/B-ADVP/O bis/IN/B-PP/O dato/RB/B-ADVP/O nur/RB/I-ADVP/O wenig/IN/B-PP/B-PNP charakterisiert/NN/B-NP/I-PNP ,/,/O/O obwohl/CC/O/O eine/DT/B-NP/O wichtige/JJ/I-NP/O Rolle/NN/I-NP/O von/IN/B-PP/B-PNP Se/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Kashin/NN/I-NP/I-PNP Beck/NN/I-NP/I-PNP Erkrankung/NN/I-NP/I-PNP ,/,/O/O einer/DT/B-NP/O endemischen/JJ/I-NP/O Osteoarthritis/NN/I-NP/O ,/,/O/O seit/IN/B-PP/B-PNP Jahrzehnten/NN/B-NP/I-PNP bekannt/VBN/B-VP/I-PNP ist/VB/I-VP/O ././O/O

Daneben/RB/B-VP/O konnte/VB/I-VP/O eine/DT/B-NP/O Verbindung/NN/I-NP/O zwischen/IN/B-PP/B-PNP verz\xc3\xb6gerter/JJ/B-NP/I-PNP Knochenentwicklung/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Kindern/NN/B-NP/I-PNP und/CC/I-NP/I-PNP einer/DT/I-NP/I-PNP vererbten/NN/I-NP/I-PNP Mutation/NN/I-NP/I-PNP im/IN/B-PP/B-PNP SECIS/NNP/B-NP/I-PNP Binding/FW/O/O Protein/FW/O/O 2/CD/O/O (/(/O/O SBP2/NN/B-NP/O )/)/O/O ,/,/O/O einem/DT/B-NP/O essentiellen/NN/I-NP/O Faktor/NN/I-NP/O der/DT/B-NP/O Selenoproteinbiosynthese/NN/I-NP/O ,/,/O/O beobachtet/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Zus\xc3\xa4tzlich/VBN/B-VP/O wurde/VB/I-VP/O k\xc3\xbcrzlich/RB/B-ADVP/O eine/DT/B-NP/O positive/JJ/I-NP/O Assoziation/NN/I-NP/O zwischen/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Se-Status/NN/I-NP/I-PNP und/CC/O/O dem/DT/B-NP/O Se-transportierenden/JJ/I-NP/O Protein/NN/I-NP/O (/(/O/O SePP/NNP/B-NP/O )/)/O/O im/IN/B-PP/B-PNP Serum/NN/B-NP/I-PNP und/CC/I-NP/I-PNP dem/DT/I-NP/I-PNP Knochenumbau/NN/I-NP/I-PNP (/(/O/O bone/NN/B-NP/O turnover/NN/I-NP/O )/)/O/O bei/TO/B-VP/O gesunden/VB/I-VP/O postmenopausalen/JJ/B-NP/O Frauen/NN/I-NP/O gezeigt/VBN/B-VP/O (/(/O/O OPUS-Studie).&#13;Diese/LS/O/O Arbeit/NN/B-NP/O beschreibt/NN/I-NP/O experimentelle/JJ/I-NP/O Studien/NN/I-NP/O zur/IN/B-PP/B-PNP Rolle/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Se/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Knochenentwicklung/NN/I-NP/I-PNP und/CC/O/O \xe2\x80\x93Hom\xc3\xb6ostase/NN/B-NP/O ././O/O

Hierzu/VBN/B-VP/O wurden/VB/I-VP/O Zellkultursysteme/NN/B-NP/O und/CC/I-NP/O die/DT/I-NP/O langen/JJ/I-NP/O R\xc3\xb6hrenknochen/JJ/I-NP/O Femur/NN/I-NP/O und/CC/O/O Tibia/NN/B-NP/O im/IN/B-PP/B-PNP Sepp-Mausmodell/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP unterschiedlichem/NN/B-NP/I-PNP Se-Status/NN/I-NP/I-PNP untersucht/RP/O/O ././O/O

Es/PRP/B-NP/O zeigte/VB/B-VP/O sich/PRP/B-NP/O ,/,/O/O dass/RB/B-ADVP/O die/DT/B-NP/O Mehrheit/NN/I-NP/O der/DT/O/O bekannten/VB/B-VP/O Selenoproteingene/NN/B-NP/O im/IN/B-PP/B-PNP Knochen/NN/B-NP/I-PNP exprimiert/NN/I-NP/I-PNP wird/VB/B-VP/O (/(/O/O mit/IN/B-PP/B-PNP Ausnahme/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Dejodase/NN/I-NP/I-PNP Typ/NN/I-NP/I-PNP 1/CD/B-NP/I-PNP und/CC/I-NP/I-PNP des/DT/I-NP/I-PNP Selenoprotein/NNP/I-NP/I-PNP V/NNP/I-NP/I-PNP )/)/O/O ,/,/O/O ebenso/RB/B-ADVP/O wie/IN/B-PP/B-PNP alle/DT/B-NP/I-PNP wichtigen/JJ/I-NP/I-PNP Faktoren/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Se-Metabolismus/NN/I-NP/I-PNP ,/,/O/O wobei/WRB/O/O geschlechtsspezifische/JJ/B-NP/O Expressionsunterschiede/NN/I-NP/O identifiziert/NN/I-NP/O wurden/VB/B-VP/O ././O/O

Biomechanische/JJ/B-NP/O Untersuchungen/NN/I-NP/O deuten/PRP$/I-NP/O Genotypen/NN/I-NP/O -/-/O/O und/CC/O/O geschlechtsspezifische/JJ/B-NP/O Unterschiede/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Knochenqualit\xc3\xa4t/NN/I-NP/I-PNP an/RP/O/O ,/,/O/O w\xc3\xa4hrend/IN/B-PP/B-PNP histologische/JJ/B-NP/I-PNP Arbeiten/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP verz\xc3\xb6gerte/JJ/I-NP/I-PNP Knochenentwicklung/NN/I-NP/I-PNP in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Sepp-KO-Tieren/NN/I-NP/I-PNP schlie\xc3\x9fen/VB/B-VP/O lassen/VB/I-VP/O ././O/O

Eine/DT/B-NP/O neue/JJ/I-NP/O Methodik/NN/I-NP/O zur/IN/B-PP/B-PNP Ermittlung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Se-Konzentration/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP murinen/NN/B-NP/I-PNP Knochenproben/NN/I-NP/I-PNP wurde/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP etabliert/NN/I-NP/I-PNP ;/:/O/O hierdurch/NN/B-NP/O konnte/VB/B-VP/O das/DT/B-NP/O gesamte/JJ/I-NP/O Se/NN/I-NP/O des/DT/B-NP/O Knochens/NN/I-NP/O exklusiv/JJ/B-ADJP/O der/DT/B-NP/O organischen/JJ/I-NP/O Knochenmatrix/NN/I-NP/O zugeordnet/NN/I-NP/O werden/VB/B-VP/O ././O/O

Ein/DT/B-NP/O starker/JJ/I-NP/O Se-Mangel/NN/I-NP/O im/IN/B-PP/B-PNP Serum/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Sepp-KO-M\xc3\xa4usen/NN/B-NP/I-PNP (/(/O/O 25-fach/NN/B-NP/O im/IN/B-PP/B-PNP Vergleich/NN/B-NP/I-PNP zum/IN/B-PP/B-PNP WT/NNP/B-NP/I-PNP )/)/O/O wurde/VB/B-VP/O nur/RB/B-ADJP/O minimal/JJ/I-ADJP/O im/IN/B-PP/B-PNP Knochen/JJ/B-NP/I-PNP reflektiert/NN/I-NP/I-PNP (/(/O/O 2,5-fach/NN/B-NP/O )/)/O/O ,/,/O/O was/WDT/O/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP pr\xc3\xa4ferentielle/NN/I-NP/I-PNP Versorgung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Knochens/JJ/I-NP/I-PNP hindeutet/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Hepatozyten-spezifische/JJ/I-NP/O Expression/NN/I-NP/O eines/DT/B-NP/O SePP-Transgens/NN/I-NP/O konnte/VB/B-VP/O den/DT/B-NP/O Knochen/JJ/I-NP/O Se-Status/NN/I-NP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP KO-M\xc3\xa4usen/NN/I-NP/I-PNP wieder/RB/B-VP/O herstellen/VB/I-VP/O ,/,/O/O wodurch/RB/B-ADVP/O ein/DT/B-NP/O physiologischer/JJ/I-NP/O Transportweg/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP Se/NN/B-NP/I-PNP in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Knochen/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP werden/VB/B-VP/O konnte/VBN/I-VP/O ././O/O

Hierzu/NN/B-NP/O passend/JJ/B-ADJP/O wurde/VB/B-VP/O von/IN/B-PP/O den/DT/O/O zwei/CD/O/O bekannten/VB/B-VP/O Sepp-Rezeptoren/JJ/B-NP/O Apoer2/NN/I-NP/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Knochenzellen/NN/B-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP ,/,/O/O wobei/WRB/O/O dessen/WDT/B-NP/O Expression/NN/I-NP/O in/IN/B-PP/B-PNP m\xc3\xa4nnlichen/JJ/B-NP/I-PNP Sepp-KO-Tieren/NN/I-NP/I-PNP stark/JJ/B-NP/I-PNP hochreguliert/NN/I-NP/I-PNP wird/VB/B-VP/O ././O/O

Dies/DT/O/O konnte/VB/B-VP/O auch/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP zwei/CD/I-NP/I-PNP intrazellul\xc3\xa4r/NN/I-NP/I-PNP Se-bindenden/NN/I-NP/I-PNP Proteine/FW/O/O Selenium-Binding/FW/O/O Protein/FW/O/O 1/CD/O/O (/(/O/O Sebp1/NN/B-NP/O )/)/O/O und/CC/O/O Fatty/FW/O/O Acid/FW/O/O Binding/FW/O/O Protein/FW/O/O 1/CD/O/O (/(/O/O Fabp1/NN/B-NP/O )/)/O/O beobachtet/VBN/B-VP/O werden/VB/I-VP/O und/CC/O/O beschreibt/NN/B-NP/O damit/VB/B-VP/O einen/DT/B-NP/O neuen/JJ/I-NP/O physiologischen/JJ/I-NP/O Feedbackmechanismus/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP verbesserte/JJ/I-NP/I-PNP Se-Aufnahme/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Mangelzeiten/NN/B-NP/I-PNP in/IN/B-PP/B-PNP das/DT/B-NP/I-PNP essentielle/NN/I-NP/I-PNP Knochengewebe.&#13;Die/JJ/B-NP/I-PNP Wirkungen/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Se/NN/B-NP/I-PNP auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Knochen/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Menschen/NN/B-NP/I-PNP sind/VB/B-VP/O elementspezifisch/JJ/B-ADJP/O ,/,/O/O denn/RB/B-ADVP/O unsere/PRP$/B-NP/O begleitenden/JJ/B-NP/O Studien/NN/I-NP/O zur/IN/B-PP/B-PNP Assoziation/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Kupfer/NN/I-NP/I-PNP -/-/O/O und/CC/O/O Zink-Konzentrationen/NN/B-NP/O mit/IN/B-PP/B-PNP Knochenbeschaffenheit/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Knochenumsatz/NN/I-NP/I-PNP in/TO/B-VP/O gesunden/VB/I-VP/O postmenopausalen/JJ/B-NP/O Frauen/NN/I-NP/O lieferten/NN/I-NP/O grunds\xc3\xa4tzlich/VB/B-VP/O andere/JJ/B-NP/O Zusammenh\xc3\xa4nge/NN/I-NP/O ,/,/O/O z.B./RB/B-ADVP/O eine/DT/B-NP/O g\xc3\xa4nzlich/JJ/I-NP/O fehlende/NN/I-NP/O Bedeutung/NN/I-NP/O der/DT/B-NP/O Serumzinkkonzentration/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP knochenspezifischen/JJ/I-NP/I-PNP Parameter.&#13;Die/NN/I-NP/I-PNP Ergebnisse/NN/I-NP/I-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP bef\xc3\xb6rdern/VB/B-VP/O den/DT/B-NP/O Knochen/NN/I-NP/O ,/,/O/O neben/IN/B-PP/B-PNP Gehirn/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Hoden/NN/I-NP/I-PNP ,/,/O/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Blickpunkt/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Se-Forschung/NN/I-NP/I-PNP ,/,/O/O da/IN/B-PP/B-PNP Knochen/NN/B-NP/I-PNP als/IN/B-PP/B-PNP bevorzugtes/NN/B-NP/I-PNP Se-Zielgewebe/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Menschen/NN/B-NP/I-PNP identifiziert/NN/I-NP/I-PNP wurde/VB/B-VP/O ././O/O

Knochen/RB/B-VP/O ist/VB/I-VP/O relativ/IN/B-PP/B-PNP resistent/NN/B-NP/I-PNP gegen\xc3\xbcber/IN/B-PP/B-PNP Se-Mangel/NN/B-NP/I-PNP ././O/O

Die/DT/B-NP/O Leber/JJ/I-NP/O transportiert/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP SePP/NNP/B-NP/I-PNP das/DT/I-NP/I-PNP Se/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Nahrung/NN/I-NP/I-PNP gezielt/JJ/B-ADJP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Knochen/NN/I-NP/I-PNP ,/,/O/O wo/WRB/O/O es/PRP/B-NP/O \xc3\xbcber/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP dynamische/JJ/I-NP/I-PNP Regulation/NN/I-NP/I-PNP des/DT/B-NP/I-PNP SePP-Rezeptors/NN/I-NP/I-PNP ApoER2/NN/I-NP/I-PNP bedarfsgerecht/NN/I-NP/I-PNP aufgenommen/VBN/B-VP/I-PNP wird/VB/I-VP/O ././O/O

\xc3\xb6rungen/NN/B-NP/O der/DT/I-NP/O SePP-ApoER2-SeBP1-Interaktion/NN/I-NP/O ,/,/O/O die/DT/O/O zu/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Se-Mangel/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Knochen/NN/B-NP/I-PNP f\xc3\xbchren/VB/B-VP/O ,/,/O/O sind/VBN/B-VP/O von/IN/B-PP/B-PNP medizinischer/JJ/B-NP/I-PNP Relevanz/NN/I-NP/I-PNP und/CC/O/O sollten/NN/B-NP/O bei/IN/B-PP/B-PNP Knochenfehlentwicklungen/NN/B-NP/I-PNP ,/,/O/O \xe2\x80\x93Erkrankungen/NN/B-NP/O und/CC/I-NP/O \xe2\x80\x93Alterung/NN/I-NP/O ber\xc3\xbccksichtigt/VB/B-VP/O werden.&#13;In/NN/B-NP/O der/DT/I-NP/O vorliegenden/JJ/I-NP/O Arbeit/NN/I-NP/O wurde/VB/B-VP/O die/DT/B-NP/O Frequenz/NN/I-NP/O der/DT/B-NP/O Tumor-spezifischen/JJ/I-NP/O T-Zellen/NN/I-NP/O bei/IN/B-PP/B-PNP Melanompatienten/NN/B-NP/I-PNP unter/IN/B-PP/B-PNP Immuntherapie/NN/B-NP/I-PNP untersucht/VBN/B-VP/I-PNP sowie/CC/O/O der/DT/B-NP/O Ph\xc3\xa4notyp/NN/I-NP/O und/CC/O/O die/DT/B-NP/O Funktionalit\xc3\xa4t/NN/I-NP/O dieser/DT/B-NP/O Zellen/NNS/I-NP/O analysiert/VB/B-VP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Induktion/NN/I-NP/I-PNP einer/DT/B-NP/I-PNP spezifischen/JJ/I-NP/I-PNP Immunantwort/NN/I-NP/I-PNP wurden/VB/B-VP/O zwei/CD/B-NP/O unterschiedliche/JJ/I-NP/O Vakzinationsans\xc3\xa4tze/NN/I-NP/O konzipiert/VBN/B-VP/O :/:/O/O eine/DT/B-NP/O nicht-zellul\xc3\xa4re/JJ/I-NP/O Vakzine/NN/I-NP/O aus/IN/B-PP/B-PNP Melanom-assoziierten/JJ/B-NP/I-PNP Peptiden/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Kombination/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP ubiquit\xc3\xa4ren/NN/B-NP/I-PNP Recall-Antigenen/NN/I-NP/I-PNP sowie/RB/B-ADVP/O eine/DT/B-NP/O zellul\xc3\xa4re/JJ/I-NP/O Vakzine/NN/I-NP/O aus/IN/B-PP/B-PNP Hybridzellen/NN/B-NP/I-PNP ,/,/O/O die/WDT/O/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Fusion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP autologen/JJ/B-NP/I-PNP Tumorzellen/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP allogenen/NN/B-NP/I-PNP dendritischen/JJ/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP generiert/NN/I-NP/I-PNP wurden/VB/B-VP/O ././O/O

Die/DT/B-NP/O Evaluation/NN/I-NP/O der/DT/B-NP/O Therapien/NN/I-NP/O erfolgte/VB/B-VP/O sowohl/CC/O/O \xc3\xbcber/IN/B-PP/B-PNP klinische/JJ/B-NP/I-PNP Parameter/NN/I-NP/I-PNP als/CC/O/O auch/RB/B-ADVP/O \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Untersuchung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP spezifischen/JJ/I-NP/I-PNP Immunreaktion/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Patienten/NN/I-NP/I-PNP ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP letztere/NN/B-NP/I-PNP wurden/VB/B-VP/O die/DT/B-NP/O Frequenzen/NN/I-NP/O der/DT/B-NP/O Peptid-spezifischen/JJ/I-NP/O CTLs/NN/I-NP/O und/CC/O/O der/DT/B-NP/O Helfer-Antigen-spezifischen/JJ/I-NP/O CD4/NN/I-NP/O +/NN/I-NP/O T-Zellen/NN/I-NP/O im/IN/B-PP/B-PNP peripheren/NN/B-NP/I-PNP Blut/NN/I-NP/I-PNP der/DT/O/O behandelten/VB/B-VP/O Patienten/NN/B-NP/O bestimmt/RP/O/O ././O/O

Der/DT/B-NP/O Nachweis/NN/I-NP/O erfolgte/VB/B-VP/O mittels/IN/B-PP/B-PNP intrazellul\xc3\xa4rer/NN/B-NP/I-PNP IFN/NN/I-NP/I-PNP -/-/O/O F\xc3\xa4rbung/NN/B-NP/O nach/IN/B-PP/B-PNP Restimulation/NN/B-NP/I-PNP der/DT/I-NP/I-PNP PBMCs/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP entsprechenden/JJ/I-NP/I-PNP Peptiden/NN/I-NP/I-PNP bzw./RB/B-ADVP/O Antigenen/NN/B-NP/O und/CC/O/O anschlie\xc3\x9fender/JJ/B-NP/O FACS-Analyse/NN/I-NP/O ././O/O

Vor/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Vakzination/NN/I-NP/I-PNP wurde/VB/B-VP/O das/DT/B-NP/O Tumormaterial/NN/I-NP/O der/DT/B-NP/O Patienten/NN/I-NP/O immunhistologisch/JJ/B-ADJP/O auf/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Vorkommen/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Tumor-Antigene/NN/I-NP/I-PNP untersucht/RP/O/O ././O/O

Bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Peptid-Vakzinationsstudie/NN/I-NP/I-PNP wurden/VB/B-VP/O vier/CD/B-NP/O Melanompatienten/NN/I-NP/O im/IN/B-PP/B-PNP Krankheitsstadium/NN/B-NP/I-PNP IV/CD/O/O mit/IN/B-PP/B-PNP Melanom-assoziierten/JJ/B-NP/I-PNP Peptiden/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Kombination/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP Helfer-Antigenen/JJ/B-NP/I-PNP vakziniert/NN/I-NP/I-PNP ././O/O

Ein/DT/B-NP/O Patient/NN/I-NP/O hatte/VB/B-VP/O eine/DT/B-NP/O stabile/JJ/I-NP/O Erkrankung/NN/I-NP/O ,/,/O/O drei/CD/B-NP/O Patienten/NN/I-NP/O waren/JJ/B-NP/O progredient/NN/I-NP/O unter/IN/B-PP/B-PNP Therapie/NN/B-NP/I-PNP ././O/O

Bei/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP der/DT/I-NP/I-PNP vier/CD/I-NP/I-PNP Patienten/NN/I-NP/I-PNP wurde/VB/B-VP/O ein/DT/B-NP/O 7-facher/NN/I-NP/O Anstieg/NN/I-NP/O der/DT/B-NP/O Frequenz/NN/I-NP/O der/DT/B-NP/O Proteus-spezifischen/JJ/I-NP/O T-Zellen/NN/I-NP/O im/IN/B-PP/B-PNP peripheren/JJ/B-NP/I-PNP Blut/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP Vakzination/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP diesem/DT/B-NP/I-PNP Antigen/NN/I-NP/I-PNP festgestellt/RP/O/O ././O/O

Die/DT/B-NP/O Frequenz/NN/I-NP/O der/DT/B-NP/O Peptid-spezifischen/JJ/I-NP/O CD3+&slash;CD8/NN/I-NP/O +/NN/I-NP/O IFN/NN/I-NP/O -/-/O/O produzierenden/NN/B-NP/O T-Zellen/NN/I-NP/O lag/VB/B-VP/O im/IN/B-PP/B-PNP peripheren/JJ/B-NP/I-PNP Blut/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP Vakzination/NN/B-NP/I-PNP zwischen/IN/B-PP/O 0,01/CD/O/O und/CC/O/O 1,25%/CD/O/O bezogen/JJ/B-ADJP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP gesamte/JJ/I-NP/I-PNP CD3+&slash;CD8+-Population/NN/I-NP/I-PNP ././O/O

Mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Hybridzell-Vakzine/NN/I-NP/I-PNP wurden/VB/B-VP/O sechs/CD/B-NP/O Melanompatienten/NN/I-NP/O im/IN/B-PP/B-PNP Krankheitsstadium/NN/B-NP/I-PNP III/CD/O/O und/CC/O/O IV/CD/O/O behandelt/RP/O/O ././O/O

Durch/IN/B-PP/B-PNP diese/DT/B-NP/I-PNP Therapie/NN/I-NP/I-PNP konnte/VB/B-VP/O bei/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Patienten/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP komplette/JJ/I-NP/I-PNP Remission/NN/I-NP/I-PNP erzielt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Drei/CD/B-NP/O Patienten/NN/I-NP/O zeigten/VB/B-VP/O eine/DT/B-NP/O Stabilisierung/NN/I-NP/O der/DT/B-NP/O Krankheit/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP mehrere/JJ/B-NP/I-PNP Monate/NN/I-NP/I-PNP und/CC/O/O zwei/CD/B-NP/O Patienten/NN/I-NP/O waren/VB/B-VP/O progredient/NN/B-NP/O ././O/O

Die/DT/B-NP/O Frequenzwerte/NN/I-NP/O der/DT/B-NP/O reaktiven/NN/I-NP/O Peptid-spezifischen/JJ/B-NP/O T-Zellen/NN/I-NP/O im/IN/B-PP/B-PNP peripheren/NN/B-NP/I-PNP Blut/NN/I-NP/I-PNP lagen/VB/B-VP/O bei/IN/B-PP/B-PNP diesen/DT/B-NP/I-PNP Patienten/NN/I-NP/I-PNP nach/IN/B-PP/B-PNP Vakzination/NN/B-NP/I-PNP zwischen/IN/B-PP/O 0,01%/CD/O/O und/CC/O/O 6,5%/CD/O/O bezogen/JJ/B-ADJP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP gesamten/JJ/I-NP/I-PNP CD3+&slash;CD8/NN/I-NP/I-PNP +/JJ/B-NP/I-PNP T-Zellen/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Charakterisierung/NN/I-NP/O zirkulierender/NN/I-NP/O Peptid-spezifischer/NN/I-NP/O T-Zellen/NN/I-NP/O erfolgte/VBN/B-VP/O mit/IN/B-PP/B-PNP tetramerisierten/NN/B-NP/I-PNP ,/,/O/O Peptid-beladenen/NN/B-NP/O MHC-I-Molek\xc3\xbclen/NNP/I-NP/O und/CC/I-NP/O funktionellen/NNP/I-NP/O Analysen/NNP/I-NP/O ././O/O

Hiermit/VBN/B-VP/O wurde/RB/I-VP/O gezeigt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/O nicht/RB/B-ADVP/O alle/DT/B-NP/O Tumor-spezifischen/JJ/I-NP/O T-Zellen/NN/I-NP/O aktivierbar/JJ/B-ADJP/O waren/VB/B-VP/O ././O/O

Die/DT/B-NP/O reaktiven/NN/I-NP/O Peptid-spezifischen/JJ/B-NP/O T-Zellen/NN/I-NP/O zeigten/VB/B-VP/O jedoch/RB/B-ADVP/O eine/DT/B-NP/O hohe/JJ/I-NP/O lytische/JJ/I-NP/O Kapazit\xc3\xa4t/NN/I-NP/O im/IN/B-PP/B-PNP 51Cr-Freisetzungsversuch/NN/B-NP/I-PNP ././O/O

Diese/DT/B-NP/O Zellen/NNS/I-NP/O konnten/VB/B-VP/O nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Ph\xc3\xa4notypisierung/NN/I-NP/I-PNP einem/DT/B-NP/I-PNP enddifferenzierten/JJ/I-NP/I-PNP Zelltyp/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Effektorfunktion/NN/B-NP/I-PNP zugeordnet/NN/I-NP/I-PNP werden.Proteine/NN/I-NP/I-PNP der/DT/I-NP/I-PNP VirB4/NN/I-NP/I-PNP Familie/NN/I-NP/I-PNP werden/VB/B-VP/O von/IN/B-PP/O mating/FW/O/O pair/FW/O/O formation/FW/O/O (/(/O/O Mpf/NN/B-NP/O -/-/O/O )/)/O/O Systemen/NN/B-NP/O konjugativer/NN/I-NP/O Plasmide/NN/I-NP/O und/CC/O/O von/IN/B-PP/B-PNP Typ/NN/B-NP/I-PNP IV/CD/I-NP/I-PNP Sekretionssystemen/JJ/I-NP/I-PNP kodiert/NN/I-NP/I-PNP ././O/O

Mpf/NN/B-NP/O -/-/O/O und/CC/O/O Typ/NN/B-NP/O IV/CD/B-NP/O Sekretionssysteme/NN/I-NP/O haben/VB/B-VP/O sich/PRP/B-NP/O vermutlich/JJ/B-ADJP/O aus/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP gemeinsamen/JJ/I-NP/I-PNP Vorl\xc3\xa4ufer/NN/I-NP/I-PNP entwickelt/VB/B-VP/O ././O/O

Eine/DT/B-NP/O Aufgabe/NN/I-NP/O von/IN/B-PP/B-PNP Mpf-Systemen/NN/B-NP/I-PNP ist/VB/B-VP/O die/DT/B-NP/O Biogenese/NN/I-NP/O von/IN/B-PP/B-PNP Pili/NN/B-NP/I-PNP ././O/O

Diese/DT/B-NP/O extrazellul\xc3\xa4ren/NN/I-NP/O Filamente/NN/I-NP/O sind/VB/B-VP/O f\xc3\xbcr/IN/B-PP/B-PNP konjugativen/NN/B-NP/I-PNP DNA-Transfer/JJ/I-NP/I-PNP essentiell/NN/I-NP/I-PNP ././O/O

Typ/NN/B-NP/O IV/CD/I-NP/O Sekretionssysteme/NN/I-NP/O stehen/VB/B-VP/O meist/RB/B-ADVP/O im/IN/B-PP/B-PNP Zusammenhang/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Pathogenit\xc3\xa4t/NN/I-NP/I-PNP Gram-negativer/NN/I-NP/I-PNP Bakterien/NN/I-NP/I-PNP ,/,/O/O eine/DT/B-NP/O Eigenschaft/NN/I-NP/O scheint/VB/B-VP/O die/DT/B-NP/O Sekretion/NN/I-NP/O von/IN/B-PP/B-PNP Virulenzfaktoren/NN/B-NP/I-PNP zu/TO/B-VP/O sein/VB/I-VP/O ././O/O

VirB4-\xc3\xa4hnliche/JJ/B-NP/O Proteine/NN/I-NP/O sind/JJ/B-NP/O essentiell/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP diese/DT/B-NP/I-PNP Sekretionssysteme/NN/I-NP/I-PNP und/CC/O/O sind/VB/B-VP/O deren/DT/B-NP/O gr\xc3\xb6\xc3\x9fte/JJ/I-NP/O Bestandteile/NN/I-NP/O ;/:/O/O ihr/PRP/B-NP/O wesentliches/JJ/I-NP/O Merkmal/NN/I-NP/O ist/VB/B-VP/O eine/DT/B-NP/O Nukleotidbindungsstelle/NN/I-NP/O (/(/O/O Walker/NN/B-NP/O A/NN/I-NP/O box/NN/I-NP/O ,/,/O/O NBS/NNP/B-NP/O )/)/O/O ././O/O

VirB4/JJ/B-NP/O Proteine/NN/I-NP/O sind/VB/B-VP/O daher/RB/B-ADVP/O potentielle/NN/B-NP/O NTPasen/NN/I-NP/O oder/RB/B-ADVP/O Nukleotidbindungsproteine/NN/B-NP/O ././O/O

In/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Multisequenzvergleich/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP 19/CD/B-NP/I-PNP Vertretern/NN/I-NP/I-PNP der/DT/B-NP/I-PNP VirB4/NN/I-NP/I-PNP Proteinfamilie/NN/I-NP/I-PNP wurden/RB/B-NP/I-PNP hohe/JJ/I-NP/I-PNP Sequenz\xc3\xa4hnlichkeiten/NN/I-NP/I-PNP gefunden/RP/O/O ././O/O

Neben/IN/B-PP/B-PNP der/DT/B-NP/I-PNP NBS/NNP/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O Walker/NN/I-NP/O B/NN/I-NP/O box/NN/I-NP/O wurden/VB/B-VP/O zwei/CD/B-NP/O weitere/JJ/I-NP/O konservierte/NN/I-NP/O Motive/NNS/I-NP/O gefunden/VBN/B-VP/O und/CC/O/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP erstmals/IN/B-PP/B-PNP beschrieben/NN/B-NP/I-PNP ././O/O

Das/DT/B-NP/O konjugative/JJ/I-NP/O Modellsystem/NN/I-NP/O von/IN/B-PP/B-PNP RP4/NN/B-NP/I-PNP (/(/O/O IncPalpha/NNP/B-NP/O )/)/O/O wurde/VB/B-VP/O verwendet/VBN/I-VP/O ,/,/O/O um/IN/B-PP/B-PNP das/DT/B-NP/I-PNP VirB4/NN/I-NP/I-PNP homologe/NN/I-NP/I-PNP Protein/NN/I-NP/I-PNP TrbE/NN/I-NP/I-PNP genetisch/JJ/B-ADJP/O zu/TO/B-VP/O charakterisieren/VB/I-VP/O ././O/O

Dazu/RB/B-VP/O wurden/VB/I-VP/O die/DT/B-NP/O Ph\xc3\xa4notypen/NN/I-NP/O Pilusproduktion/NN/I-NP/O ,/,/O/O Vermehrung/NN/B-NP/O IncP-spezifischer/NNP/I-NP/O Phagen/NNP/I-NP/O und/CC/I-NP/O DNA-Transfer/NNP/I-NP/O in/IN/B-PP/B-PNP Escherichia/NN/B-NP/I-PNP coli/NN/I-NP/I-PNP untersucht/RP/O/O ././O/O

Die/DT/B-NP/O Motive/NNS/I-NP/O Walker/NN/I-NP/O A/NN/I-NP/O und/CC/O/O B/NN/B-NP/O sind/JJ/B-NP/O essentiell/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP von/IN/B-PP/B-PNP RP4/NN/B-NP/I-PNP TrbE/NN/I-NP/I-PNP ,/,/O/O das/DT/B-NP/O Protein/NN/I-NP/O d\xc3\xbcrfte/VB/B-VP/O daher/RB/B-ADVP/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP Nukleotide/NN/I-NP/I-PNP binden/VB/B-VP/O oder/CC/O/O hydrolysieren/NN/B-NP/O ././O/O

Die/DT/B-NP/O zwei/CD/I-NP/O weiteren/JJ/I-NP/O konservierten/NN/I-NP/O Motive/NNS/I-NP/O sind/VB/B-VP/O ebenfalls/IN/B-PP/B-PNP essentiell/NN/B-NP/I-PNP bzw./RB/B-ADJP/O wichtig/JJ/I-ADJP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Proteinaktivit\xc3\xa4t/NN/I-NP/I-PNP ././O/O

Nahezu/RB/B-ADVP/O das/DT/B-NP/O gesamte/JJ/I-NP/O Polypeptid/NN/I-NP/O von/IN/B-PP/B-PNP 852/CD/B-NP/I-PNP Aminos\xc3\xa4uren/NN/I-NP/I-PNP ist/VB/B-VP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP erforderlich/JJ/B-ADJP/O ././O/O

Die/DT/B-NP/O vorhergesagte/NN/I-NP/O transmembranale/NN/I-NP/O Helix/NN/I-NP/O am/IN/B-PP/B-PNP N-Terminus/NN/B-NP/I-PNP ist/VB/B-VP/O jedoch/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Proteins/NN/I-NP/I-PNP in/IN/B-PP/B-PNP E./JJ/B-NP/I-PNP coli/NN/I-NP/I-PNP entbehrlich/JJ/B-ADJP/O ././O/O

Zwei/CD/B-NP/O Vertreter/NN/I-NP/O der/DT/B-NP/O VirB4/NN/I-NP/O Proteinfamilie/NN/I-NP/O wurden/RB/B-ADJP/O biochemisch/JJ/I-ADJP/O untersucht/RP/O/O ././O/O

Das/DT/O/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP uneingeschr\xc3\xa4nkt/JJ/I-NP/I-PNP aktive/JJ/I-NP/I-PNP Deletionsderivat/NN/I-NP/I-PNP RP4/NN/I-NP/I-PNP TrbEHNdelta2/NN/I-NP/I-PNP und/CC/O/O das/DT/B-NP/O Wildtyp/NN/I-NP/O Protein/NN/I-NP/O TrwK/NNP/I-NP/O des/DT/B-NP/O konjugativen/NN/I-NP/O Plasmids/JJ/B-NP/O R388/NN/I-NP/O (/(/O/O IncW/NNP/B-NP/O )/)/O/O wurden/RB/B-ADVP/O gereinigt/RP/O/O ././O/O

Obwohl/IN/B-PP/B-PNP beide/JJ/B-NP/I-PNP VirB4/NN/I-NP/I-PNP Homologe/NN/I-NP/I-PNP fluoreszierende/NN/I-NP/I-PNP Nukleotidanaloga/NN/I-NP/I-PNP binden/VB/B-VP/O ,/,/O/O wurden/VB/B-VP/O weder/CC/O/O ATP/NNP/B-NP/O noch/RB/B-ADVP/O GTP/NNP/B-NP/O hydrolysiert/NNP/I-NP/O ././O/O

RP4/JJ/B-NP/O TrbEHNdelta2/NN/I-NP/O und/CC/O/O R388/NN/B-NP/O TrwK/NNP/I-NP/O verhielten/VB/B-VP/O sich/PRP/B-NP/O in/IN/B-PP/B-PNP L\xc3\xb6sung/NN/B-NP/I-PNP wie/IN/B-PP/B-PNP Monomere/NN/B-NP/I-PNP ././O/O

Die/DT/B-NP/O Proteine/NN/I-NP/O bildeten/VBN/B-VP/O mit/IN/B-PP/B-PNP Einzelstrang&slash;Doppelstrang/NN/B-NP/I-PNP DNA/NN/I-NP/I-PNP keine/DT/I-NP/I-PNP stabilen/JJ/I-NP/I-PNP Komplexe/NN/I-NP/I-PNP ,/,/O/O scheinen/VB/B-VP/O also/RB/B-ADJP/O nicht/RB/I-ADJP/O direkt/JJ/I-ADJP/O am/IN/B-PP/B-PNP DNA-Transport/NN/B-NP/I-PNP beteiligt/VBN/B-VP/I-PNP zu/TO/I-VP/O sein/VB/I-VP/O ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O deuten/VB/B-VP/O an/RP/I-VP/O ,/,/O/O da\xc3\x9f/RB/B-ADVP/O RP4/NN/B-NP/O TrbEHNdelta2/NN/I-NP/O und/CC/O/O R388/NN/B-NP/O TrwK/NNP/I-NP/O ihre/PRP$/I-NP/O Aktivit\xc3\xa4ten/NN/I-NP/O nur/RB/B-ADVP/O im/IN/B-PP/B-PNP Verband/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP weiteren/JJ/B-NP/I-PNP Komponenten/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Sekretionssystemen/NN/I-NP/I-PNP entfalten.Die/NN/I-NP/I-PNP Antennen/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Honigbiene/NN/I-NP/I-PNP dienen/VB/B-VP/O der/DT/B-NP/O Wahrnehmung/NN/I-NP/O multimodaler/NN/I-NP/O Sinneseindr\xc3\xbccke/NN/I-NP/O und/CC/O/O zur/IN/B-PP/B-PNP Kommunikation/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP Nestgenossinnen/NN/B-NP/I-PNP ././O/O

Bewegungen/NNS/B-NP/O der/DT/I-NP/O Antennen/NN/I-NP/O sind/VB/B-VP/O f\xc3\xbcr/IN/B-PP/B-PNP Kommunikation/NN/B-NP/I-PNP wie/IN/B-PP/B-PNP Sinneswahrnehmung/NN/B-NP/I-PNP unabdingbar/JJ/B-ADJP/O ././O/O

Ziel/NN/B-NP/O der/DT/I-NP/O vorliegenden/JJ/I-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O es/PRP/B-NP/O ,/,/O/O L\xc3\xbccken/NN/B-NP/O der/DT/I-NP/O Erkenntnis/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Bewegungsapparat/NN/I-NP/I-PNP zu/TO/B-VP/O schlie\xc3\x9fen/VB/I-VP/O ././O/O

Die/DT/B-NP/O Antennen/NN/I-NP/O werden/VB/B-VP/O bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Biene/NN/I-NP/I-PNP nahezu/RB/B-ADJP/O ununterbrochen/JJ/I-ADJP/O in/IN/B-PP/O einem/DT/O/O scheinbar/JJ/B-ADJP/O "/"/O/O chaotischen/JJ/B-ADJP/O "/"/O/O Rhythmus/NN/B-NP/O bewegt/VB/B-VP/O ././O/O

Durch/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Einsatz/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Frequenzanalysen/NN/B-NP/I-PNP wurde/VB/B-VP/O erstmalig/JJ/B-ADJP/O die/DT/B-NP/O Dynamik/NN/I-NP/O der/DT/B-NP/O Antennenbewegung/NN/I-NP/O quantitativ/JJ/B-ADJP/O untersucht/RP/O/O ././O/O

Dabei/RB/B-VP/O konnte/VB/I-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O da\xc3\x9f/IN/B-PP/B-PNP keine/DT/B-NP/I-PNP prominenten/JJ/I-NP/I-PNP Spitzen/NN/I-NP/I-PNP in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Spektren/NN/I-NP/I-PNP auftreten/VB/B-VP/O ././O/O

attdessen/RB/B-VP/O liegt/VB/I-VP/O ein/DT/B-NP/O breitbandiges/JJ/I-NP/O Rauschen/NN/I-NP/O vor/IN/B-PP/B-PNP mit/IN/I-PP/I-PNP einem/DT/B-NP/I-PNP Frequenzgang/NN/I-NP/I-PNP ,/,/O/O der/WDT/B-NP/O dem/DT/I-NP/O eines/DT/I-NP/O Tiefpa\xc3\x9ffilters/NN/I-NP/O erster/JJ/B-NP/O Ordnung/JJ/I-NP/O \xc3\xa4hnelt/NN/I-NP/O (/(/O/O Rauschen/NN/B-NP/O gleichbleibender/JJ/I-NP/O Amplitude/NN/I-NP/O bis/IN/B-PP/B-PNP zu/IN/I-PP/I-PNP einer/DT/B-NP/I-PNP Eckfrequenz/NN/I-NP/I-PNP f(index/FW/O/O c/FW/O/O )/)/O/O ,/,/O/O dann/IN/B-PP/B-PNP Abfall/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP deutlicher/JJ/B-NP/I-PNP 1&slash;f-Charakteristik/NN/I-NP/I-PNP ././O/O

Hochgeschwindigkeitsaufnahmen/NN/B-NP/O der/DT/I-NP/O Antennenbewegung/NN/I-NP/O zeigen/VB/B-VP/O ,/,/O/O da\xc3\x9f/RB/B-ADVP/O auch/RB/I-ADVP/O im/IN/B-PP/B-PNP Bereich/NN/B-NP/I-PNP zwischen/IN/B-PP/B-PNP 10/CD/B-NP/I-PNP und/CC/I-NP/I-PNP 100/CD/I-NP/I-PNP Hz/NN/I-NP/I-PNP keine/JJ/B-NP/I-PNP dominanten/NN/I-NP/I-PNP Frequenzen/NN/I-NP/I-PNP auftreten/VB/B-VP/O ././O/O

Die/DT/B-NP/O Reizung/NN/I-NP/O eines/DT/B-NP/O Tieres/NN/I-NP/O mit/IN/B-PP/B-PNP Saccharosel\xc3\xb6sung/NN/B-NP/I-PNP f\xc3\xbchrt/VB/B-VP/O zu/IN/B-PP/B-PNP antennalen/JJ/B-NP/I-PNP Reaktionen/NN/I-NP/I-PNP ././O/O

Diese/DT/O/O \xc3\xa4u\xc3\x9fern/VB/B-VP/O sich/PRP/B-NP/O im/IN/B-PP/B-PNP Frequenzspektrum/NN/B-NP/I-PNP durch/IN/B-PP/B-PNP Reduktion/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Amplitude/NN/I-NP/I-PNP im/IN/B-PP/B-PNP niederfrequenten/NN/B-NP/I-PNP Bereich/NN/I-NP/I-PNP und/CC/I-NP/I-PNP relative/JJ/I-NP/I-PNP Betonung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Frequenzen/NN/B-NP/I-PNP zwischen/IN/B-PP/O etwa/RB/B-ADVP/O 5/CD/O/O und/CC/O/O 10/CD/O/O Hz./JJ/B-ADJP/O Dies/DT/O/O k\xc3\xb6nnte/VB/B-VP/O einer/DT/B-NP/O Optimierung/NN/I-NP/O der/DT/B-NP/O Duftwahrnehmung/NN/I-NP/O dienen/VB/B-VP/O ././O/O

Die/DT/B-NP/O Vermutung/NN/I-NP/O ,/,/O/O der/DT/B-NP/O Saccharoseeffekt/NN/I-NP/O w\xc3\xbcrde/VB/B-VP/O durch/IN/B-PP/B-PNP biogene/NN/B-NP/I-PNP Amine/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Erregungszustand/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Biene/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Zusammenhang/NN/B-NP/I-PNP gebracht/VBN/B-VP/I-PNP werden/VB/I-VP/O (/(/O/O Serotonin/NN/B-NP/O und/CC/I-NP/O Octopamin/NN/I-NP/O )/)/O/O ,/,/O/O vermittelt/VB/B-VP/O ,/,/O/O wurde/VB/B-VP/O durch/IN/B-PP/B-PNP lokale/JJ/B-NP/I-PNP Injektionen/NN/I-NP/I-PNP dieser/DT/B-NP/I-PNP Substanzen/NNS/I-NP/I-PNP in/IN/B-PP/B-PNP das/DT/B-NP/I-PNP antennomotorische/JJ/I-NP/I-PNP Zentrum/NN/I-NP/I-PNP (/(/O/O Dorsallobus/NN/B-NP/O )/)/O/O untersucht/RP/O/O ././O/O

Es/PRP/B-NP/O konnten/VB/B-VP/O jedoch/RB/B-ADVP/O keine/DT/B-NP/O Effekte/NNS/I-NP/O auf/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Frequenzspektrum/NN/I-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

M\xc3\xb6gliche/JJ/B-ADJP/O Ursachen/JJ/I-ADJP/O werden/VB/B-VP/O diskutiert/RP/I-VP/O ././O/O

Durch/IN/B-PP/B-PNP simultane/NN/B-NP/I-PNP Elektromyogramme/NN/I-NP/I-PNP der/DT/I-NP/I-PNP Antennenmuskulatur/NN/I-NP/I-PNP und/CC/O/O Aufzeichnung/NN/B-NP/O der/DT/B-NP/O Antennenbewegung/NN/I-NP/O konnten/VB/B-VP/O die/DT/B-NP/O Zusammenh\xc3\xa4nge/NN/I-NP/O zwischen/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP der/DT/B-NP/I-PNP sechs/CD/I-NP/I-PNP Muskeln/NNS/I-NP/I-PNP des/DT/B-NP/I-PNP Bewegungsapparates/NN/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O Bewegung/NN/I-NP/O quantifiziert/NN/I-NP/O werden/VB/B-VP/O ././O/O

Es/PRP/B-NP/O wurden/VB/B-VP/O N\xc3\xa4herungsfunktionen/NN/B-NP/O zur/IN/B-PP/B-PNP Berechnung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP resultierenden/JJ/I-NP/I-PNP Bewegungsgeschwindigkeit/NN/I-NP/I-PNP durch/IN/B-PP/O einzelne/JJ/B-ADJP/O Muskelpotentiale/JJ/I-ADJP/O ermittelt/RP/O/O ././O/O

Die/DT/B-NP/O Antennen/NN/I-NP/O lassen/VB/B-VP/O sich/PRP/B-NP/O operant/JJ/I-NP/O konditionieren/NN/I-NP/O ././O/O

Durch/IN/B-PP/B-PNP Belohnung/NN/B-NP/I-PNP einer/DT/I-NP/I-PNP hohen/JJ/I-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Motoneurons/NN/I-NP/I-PNP ,/,/O/O das/WDT/B-NP/O den/DT/I-NP/O schnellen/PRP$/I-NP/O Teil/NN/I-NP/O des/DT/B-NP/O Flexors/NN/I-NP/O innerviert/NN/I-NP/O ,/,/O/O steigt/VB/B-VP/O die/DT/B-NP/O mittlere/JJ/I-NP/O Aktionspotentialfrequenz/NN/I-NP/O dieses/DT/B-NP/O Neurons/NN/I-NP/O signifikant/JJ/B-ADJP/O an/RP/O/O ././O/O

Im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurden/VB/B-VP/O die/DT/B-NP/O Muster/NN/I-NP/O der/DT/B-NP/O Aktionspotentialfolgen/NN/I-NP/O und/CC/O/O der/DT/B-NP/O Einflu\xc3\x9f/NN/I-NP/O der/DT/B-NP/O Konditionierung/NN/I-NP/O auf/IN/B-PP/O diese/DT/O/O untersucht/RP/O/O ././O/O

Die/DT/B-NP/O Ergebnisse/NN/I-NP/O weisen/VB/B-VP/O darauf/RB/B-ADVP/O hin/IN/B-PP/O ,/,/O/O da\xc3\x9f/IN/B-PP/B-PNP die/DT/B-NP/I-PNP motoneurale/NN/I-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP stochastisch/JJ/B-NP/I-PNP generiert/NN/I-NP/I-PNP wird/VB/B-VP/O ././O/O

Auch/RB/B-ADVP/O nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Konditionierung/NN/I-NP/I-PNP sind/VB/B-VP/O keine/JJ/B-NP/O Regelm\xc3\xa4\xc3\x9figkeiten/NN/I-NP/O zu/TO/B-VP/O beobachten/VB/I-VP/O ././O/O

Der/DT/B-NP/O Effekt/NN/I-NP/O der/DT/B-NP/O Konditionierung/NN/I-NP/O liegt/VB/B-VP/O demnach/RB/B-ADVP/O in/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP generellen/NN/I-NP/I-PNP Erh\xc3\xb6hung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP H\xc3\xa4ufigkeit/NN/I-NP/I-PNP von/IN/B-PP/O Aktionspotentialen/VB/B-VP/O ,/,/O/O ohne/IN/B-PP/O da\xc3\x9f/RB/B-ADVP/O das/DT/B-NP/O motorische/JJ/I-NP/O Muster/NN/I-NP/O beeinflu\xc3\x9ft/VB/B-VP/O wird/VB/I-VP/O ././O/O

Aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP experimentellen/JJ/I-NP/I-PNP Ergebnissen/NN/I-NP/I-PNP wurde/VB/B-VP/O ein/DT/B-NP/O Modell/NN/I-NP/O des/DT/B-NP/O Bewegungsapparates/NN/I-NP/O der/DT/B-NP/O Honigbiene/NN/I-NP/O gebildet/VBN/B-VP/O und/CC/O/O in/IN/B-PP/B-PNP Simulationsmodellen/NN/B-NP/I-PNP auf/IN/B-PP/B-PNP seine/PRP$/B-NP/I-PNP Validit\xc3\xa4t/NN/I-NP/I-PNP gepr\xc3\xbcft.Proteinasen/NN/I-NP/I-PNP verschiedener/JJ/I-NP/I-PNP Proteinasefamilien/NN/I-NP/I-PNP zeigen/VB/B-VP/O eine/DT/B-NP/O negative/JJ/I-NP/O Korrelation/NN/I-NP/O von/IN/B-PP/B-PNP Proteinaseaktivit\xc3\xa4t/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Abnahme/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Schaumstabilit\xc3\xa4t/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Bier/NN/B-NP/I-PNP ././O/O

Ein/DT/B-NP/O eindeutig/JJ/I-NP/O negativer/JJ/I-NP/O Einflu\xc3\x9f/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Schaumstabilit\xc3\xa4t/NN/I-NP/I-PNP wurde/VB/B-VP/O sowohl/CC/O/O f\xc3\xbcr/IN/B-PP/B-PNP Proteinasen/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Carboxylproteinasefamilie/NN/I-NP/I-PNP (/(/O/O Proteinase/NN/B-NP/O A/NN/I-NP/O und/CC/I-NP/O Pepsin/NN/I-NP/O )/)/O/O ,/,/O/O als/CC/O/O auch/RB/B-ADVP/O der/DT/B-NP/O Serinproteinasefamilie/NN/I-NP/O (/(/O/O Carboxypeptidase/NN/B-NP/O Y/NN/I-NP/O )/)/O/O nachgewiesen/RP/O/O ././O/O

Die/DT/B-NP/O schaumnegativen/NN/I-NP/O Konzentrationen/NN/I-NP/O der/DT/B-NP/O Hefeproteinasen/NN/I-NP/O Proteinase/JJ/B-NP/O A/NN/I-NP/O (/(/O/O PrA/NNP/B-NP/O )/)/O/O und/CC/O/O Carboxypeptidase/JJ/B-NP/O Y/NN/I-NP/O (/(/O/O CPY/NN/B-NP/O )/)/O/O waren/NN/B-NP/O so/RB/B-ADJP/O gering/JJ/I-ADJP/O ,/,/O/O da\xc3\x9f/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP Nachweis/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP herk\xc3\xb6mmlichen/JJ/B-NP/I-PNP Methoden/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP Konzentrationsbestimmung/NN/B-NP/I-PNP nicht/RB/B-ADJP/O m\xc3\xb6glich/JJ/I-ADJP/O war/VB/B-VP/O ././O/O

Von/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Proteinhauptkomponenten/NN/I-NP/I-PNP im/IN/B-PP/B-PNP Bier/NN/B-NP/I-PNP unterliegt/VB/B-VP/O das/DT/B-NP/O schaumpositive/NN/I-NP/O Lipidtransferprotein/NNP/I-NP/O 1/CD/O/O (/(/O/O LTP1/NN/B-NP/O )/)/O/O im/IN/B-PP/B-PNP Gegensatz/NN/B-NP/I-PNP zum/IN/B-PP/B-PNP Protein/NN/B-NP/I-PNP Z/NN/I-NP/I-PNP einem/DT/I-NP/I-PNP Abbau/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP PrA/NNP/B-NP/I-PNP ././O/O

Damit/RB/B-VP/O wurde/VB/I-VP/O LTP1/NN/B-NP/O eindeutig/JJ/B-ADJP/O als/IN/B-PP/B-PNP spezifisches/JJ/B-NP/I-PNP Substrat/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP PrA/NNP/B-NP/I-PNP identifiziert/NNP/I-NP/I-PNP ././O/O

Verschiedene/JJ/B-NP/O LTP1-Formen/NN/I-NP/O besitzen/VB/B-VP/O gegen\xc3\xbcber/IN/B-PP/B-PNP PrA/NNP/B-NP/I-PNP unterschiedliche/JJ/I-NP/I-PNP Sensitivit\xc3\xa4ten/NN/I-NP/I-PNP ././O/O

W\xc3\xa4hrend/IN/B-PP/B-PNP PrA/NNP/B-NP/I-PNP ein/DT/O/O in/IN/B-PP/B-PNP E./JJ/B-NP/I-PNP coli/NN/I-NP/I-PNP exprimiertes/NN/I-NP/I-PNP rekombinantes/NN/I-NP/I-PNP LTP1/NN/I-NP/I-PNP abbaute/NN/I-NP/I-PNP ,/,/O/O wurde/VB/B-VP/O der/DT/B-NP/O Abbau/NN/I-NP/O eines/DT/B-NP/O rekombinanten/NN/I-NP/O Histag-LTP1-Fusionsproteins/NN/I-NP/O und/CC/O/O des/DT/B-NP/O nativen/NN/I-NP/O Gersten-LTP1/NN/I-NP/O vermutlich/JJ/B-ADJP/O konformationsbedingt/VBN/B-VP/O behindert/VB/I-VP/O ././O/O

Die/DT/B-NP/O proteinasesensitive/JJ/I-NP/O LTP1-Form/NN/I-NP/O in/IN/B-PP/B-PNP Bier/NN/B-NP/I-PNP entsteht/VB/B-VP/O vermutlich/JJ/B-ADJP/O durch/IN/B-PP/B-PNP Modifikationen/NN/B-NP/I-PNP w\xc3\xa4hrend/IN/B-PP/B-PNP des/DT/B-NP/I-PNP M\xc3\xa4lz/NN/I-NP/I-PNP -/-/O/O und/CC/O/O Brauprozesses/NN/B-NP/O ././O/O

Als/IN/B-PP/B-PNP Grundlage/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Entwicklung/NN/I-NP/I-PNP eines/DT/B-NP/I-PNP sensitiven/JJ/I-NP/I-PNP Nachweises/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP PrA-Konzentrationen/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Bier/NN/B-NP/I-PNP wurden/VB/B-VP/O potentielle/NN/B-NP/O PrA-Spaltsequenzen/NN/I-NP/O im/IN/B-PP/B-PNP LTP1-Molek\xc3\xbcl/JJ/B-NP/I-PNP identifiziert/NN/I-NP/I-PNP ././O/O

Massenspektrometrische/JJ/B-NP/O Untersuchungen/NN/I-NP/O potentieller/NN/I-NP/O LTP1-Abbauprodukte/NN/I-NP/O ergaben/VB/B-VP/O ,/,/O/O da\xc3\x9f/RB/B-ADVP/O PrA/NNP/B-NP/O in/IN/B-PP/B-PNP LTP1/NN/B-NP/I-PNP sowohl/RB/I-NP/I-PNP Peptidbindungen/NN/I-NP/I-PNP C-terminal/JJ/B-NP/I-PNP hydrophober/NN/I-NP/I-PNP (/(/O/O Ala/NN/B-NP/O ,/,/O/O Ile/NN/B-NP/O ,/,/O/O Leu/NN/B-NP/O )/)/O/O als/CC/O/O auch/IN/B-PP/B-PNP polarer/JJ/B-NP/I-PNP Aminos\xc3\xa4uren/NN/I-NP/I-PNP (/(/O/O Gln/NN/B-NP/O ,/,/O/O Tyr/NN/B-NP/O ,/,/O/O Asp/NN/B-NP/O ,/,/O/O Cys/NN/B-NP/O )/)/O/O hydrolysiert.Gruppe/NN/B-NP/O II/CD/I-NP/O Ribozyme/NN/I-NP/O stellen/VB/B-VP/O eine/DT/B-NP/O Gruppe/NN/I-NP/O von/IN/B-PP/B-PNP Introns/NN/B-NP/I-PNP dar/RB/B-ADVP/O ,/,/O/O die/WDT/O/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Organellen/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Pilzen/NN/B-NP/I-PNP ,/,/O/O Algen/NN/B-NP/O und/CC/I-NP/O Pflanzen/NN/I-NP/O und/CC/O/O k\xc3\xbcrzlich/RB/B-ADVP/O auch/RB/I-ADVP/O in/IN/B-PP/B-PNP Bakterien/NN/B-NP/I-PNP gefunden/VBN/B-VP/I-PNP wurden/VB/I-VP/O ././O/O

In/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP sind/VB/B-VP/O einige/DT/B-NP/O dieser/DT/I-NP/O Introns/NN/I-NP/O selbstsplei\xc3\x9fend/JJ/B-ADJP/O ,/,/O/O wie/IN/B-PP/O z.B./RB/B-ADVP/O das/DT/B-NP/O Gruppe/NN/I-NP/O II/CD/B-NP/O Intron/NN/I-NP/O aI5g/NN/I-NP/O ,/,/O/O das/WDT/O/O in/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP mitochondrialen/JJ/I-NP/I-PNP Gen/JJ/I-NP/I-PNP COX1/NN/I-NP/I-PNP von/IN/B-PP/O Saccharomyces/FW/O/O cerevisiae/FW/O/O lokalisiert/FW/O/O ist/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP werden/VB/B-VP/O allerdings/IN/B-PP/B-PNP Proteine/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Splei\xc3\x9fvorgang/NN/I-NP/I-PNP ben\xc3\xb6tigt/VBN/B-VP/I-PNP ,/,/O/O die/DT/O/O entweder/CC/O/O von/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Introns/NN/I-NP/I-PNP selbst/JJ/B-ADJP/O oder/CC/O/O vom/IN/B-PP/B-PNP Wirtsorganismus/NN/B-NP/I-PNP kodiert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Das/DT/B-NP/O nukle\xc3\xa4r/NN/I-NP/O kodierte/NN/I-NP/O Mrs2/NN/I-NP/O Protein/NN/I-NP/O ist/VB/B-VP/O eines/DT/B-NP/O dieser/DT/I-NP/O Proteine/NN/I-NP/O ././O/O

Es/PRP/B-NP/O ist/VB/B-VP/O am/IN/B-PP/B-PNP Splei\xc3\x9fvorgang/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Gruppe/NN/B-NP/I-PNP II/CD/I-NP/I-PNP Introns/NN/I-NP/I-PNP beteiligt/VB/B-VP/O und/CC/O/O besitzt/NN/B-NP/O eine/DT/B-NP/O wichtige/JJ/I-NP/O Funktion/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Biogenese/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Mitochondrien/NN/I-NP/I-PNP ././O/O

Das/DT/B-NP/O Protein/NN/I-NP/O ist/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP inneren/JJ/I-NP/I-PNP Mitochondrien/NN/I-NP/I-PNP Membran/NN/I-NP/I-PNP lokalisiert/NN/I-NP/I-PNP ,/,/O/O mit/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP l\xc3\xa4ngeren/JJ/I-NP/I-PNP N-terminalen/JJ/I-NP/I-PNP Teil/NN/I-NP/I-PNP und/CC/O/O einem/DT/B-NP/O k\xc3\xbcrzeren/NN/I-NP/O C-terminalen/JJ/B-NP/O Teil/NN/I-NP/O ,/,/O/O die/WDT/O/O beide/DT/O/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Matrix/NN/I-NP/I-PNP Raum/NN/I-NP/I-PNP ragen/VB/B-VP/O ././O/O

K\xc3\xbcrzlich/RB/B-VP/O konnte/VB/I-VP/O zus\xc3\xa4tzlich/JJ/B-ADJP/O auch/RB/B-ADVP/O eine/DT/B-NP/O Mg2+Transportfunktion/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Mrs2p/NN/I-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Da/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Mg2/NN/I-NP/I-PNP +/NN/I-NP/I-PNP Konzentration/NN/I-NP/I-PNP beim/IN/B-PP/B-PNP Selbstsplei\xc3\x9fen/NN/B-NP/I-PNP in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP eine/DT/I-NP/I-PNP wichtige/JJ/I-NP/I-PNP Rolle/NN/I-NP/I-PNP spielt/NN/I-NP/I-PNP ,/,/O/O war/VB/B-VP/O bisher/RB/B-NP/O unklar/JJ/I-NP/O ob/RB/I-NP/O es/PRP/I-NP/O sich/PRP/I-NP/O bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Splei\xc3\x9ffunktion/NN/I-NP/I-PNP um/IN/B-PP/O einen/DT/O/O direkten/JJ/B-ADJP/O oder/CC/O/O einen/DT/B-NP/O indirekten/NN/I-NP/O Vorgang/NN/I-NP/O handelt/VB/B-VP/O ././O/O

Es/PRP/B-NP/O konnten/VB/B-VP/O trotzdem/RB/B-ADVP/O zwei/CD/B-NP/O Regionen/NNS/I-NP/O in/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Protein/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP werden/VB/B-VP/O ,/,/O/O die/WDT/O/O f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP direkte/JJ/I-NP/I-PNP Protein-RNA-Interaktion/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Frage/NN/B-NP/I-PNP kommen/VB/B-VP/O :/:/O/O Zum/IN/B-PP/B-PNP einen/DT/B-NP/I-PNP ein/DT/I-NP/I-PNP \xc2\x84hot/NN/I-NP/I-PNP spot\xc2\x93/NN/I-NP/I-PNP im/IN/B-PP/B-PNP N-terminalen/JJ/B-NP/I-PNP Teil/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Proteins/NN/I-NP/I-PNP (/(/O/O Suppressor-Dom\xc3\xa4ne/NN/B-NP/O )/)/O/O und/CC/O/O zum/IN/B-PP/O anderen/JJ/B-ADJP/O ein/DT/B-NP/O putatives/NN/I-NP/O Argenin-reiches-Motiv/NN/I-NP/O im/IN/B-PP/B-PNP C-terminalen/JJ/B-NP/I-PNP Teil/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Proteins/NN/I-NP/I-PNP (/(/O/O hydrophile/NN/B-NP/O Dom\xc3\xa4ne/NN/I-NP/O )/)/O/O ././O/O

In/IN/B-PP/B-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurden/VB/B-VP/O die/DT/B-NP/O m\xc3\xb6glichen/JJ/I-NP/O Protein-RNA-Bindestellen/NN/I-NP/O des/DT/B-NP/O Mrs2p/NN/I-NP/O durch/IN/B-PP/B-PNP Deletionen/NN/B-NP/I-PNP und/CC/O/O gezielte/JJ/B-ADJP/O Aminos\xc3\xa4ureaustausche/JJ/I-ADJP/O eingehend/JJ/I-ADJP/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP analysiert/VB/B-VP/O ././O/O

Zur/IN/B-PP/B-PNP Identifikation/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Mg2/NN/B-NP/I-PNP +/NN/I-NP/I-PNP unabh\xc3\xa4ngigen/NN/I-NP/I-PNP Effekten/NN/I-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O Mg2+-Konzentration/NN/I-NP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Mitochondrien/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Mutanten/NN/I-NP/I-PNP bestimmt/RP/O/O ././O/O

Die/DT/B-NP/O Daten/NN/I-NP/O zeigen/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O sowohl/CC/O/O der/DT/B-NP/O N/NN/I-NP/O -/-/O/O als/CC/O/O auch/RB/B-ADVP/O der/DT/B-NP/O C-terminale/NN/I-NP/O Teil/NN/I-NP/O des/DT/B-NP/O Mrs2p/NN/I-NP/O den/DT/B-NP/O Splei\xc3\x9fph\xc3\xa4notyp/NN/I-NP/O beeinflussen/VB/B-VP/O und/CC/O/O unabh\xc3\xa4ngig/RB/B-ADVP/O und/CC/O/O spezifisch/JJ/B-ADJP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Lage/NN/I-NP/I-PNP sind/VB/B-VP/O die/DT/B-NP/O Intron/NN/I-NP/O RNA/NNP/I-NP/O zu/TO/B-VP/O binden/VB/I-VP/O ././O/O

Dabei/RB/B-VP/O konnte/VB/I-VP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP hydrophile/NN/I-NP/I-PNP Dom\xc3\xa4ne/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Funktionalit\xc3\xa4t/NN/I-NP/I-PNP des/DT/B-NP/I-PNP vermuteten/NN/I-NP/I-PNP Argenin-reichen-Motivs/NN/I-NP/I-PNP nicht/RB/B-VP/O best\xc3\xa4tigt/VBN/I-VP/O werden/VB/I-VP/O ././O/O

F\xc3\xbcr/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP Suppressor-Protein/NN/I-NP/I-PNP konnte/VB/B-VP/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP jedoch/RB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/O eine/DT/O/O ver\xc3\xa4nderte/VB/B-VP/O Proteinstruktur/NN/B-NP/O vorliegt/VBN/B-VP/O ,/,/O/O die/WDT/O/O in/IN/B-PP/O den/DT/O/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP Bindungsstudien/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP st\xc3\xa4rkeren/JJ/I-NP/I-PNP Bindung/NN/I-NP/I-PNP an/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Intron-RNA/NNP/I-NP/I-PNP f\xc3\xbchrt/VB/B-VP/O als/IN/B-PP/B-PNP beim/IN/I-PP/I-PNP wt/NN/B-NP/I-PNP Protein.Das/NN/I-NP/I-PNP konjugative/NN/I-NP/I-PNP Resistenzplasmid/NN/I-NP/I-PNP pIP501/NN/I-NP/I-PNP geh\xc3\xb6rt/VB/B-VP/O zur/IN/B-PP/B-PNP Inkompatibilit\xc3\xa4tsgruppe/NN/B-NP/I-PNP Inc18/NN/I-NP/I-PNP und/CC/O/O weist/VB/B-VP/O einen/DT/B-NP/O breiten/JJ/I-NP/O Wirtsbereich/NN/I-NP/O in/IN/B-PP/B-PNP Gram-positiven/JJ/B-NP/I-PNP Bakterien/NN/I-NP/I-PNP auf/RP/O/O ,/,/O/O zu/IN/B-PP/O denen/WP/O/O humanpathogene/NN/B-NP/O Keime/NNS/I-NP/O sowie/CC/I-NP/O biotechnologisch/JJ/I-NP/O relevante/NN/I-NP/O Spezies/RB/B-VP/O geh\xc3\xb6ren/VB/I-VP/O ././O/O

ine/PRP$/B-NP/O Gr\xc3\xb6\xc3\x9fe/NN/I-NP/O betr\xc3\xa4gt/VB/B-VP/O 30.599/CD/B-NP/O bp/NN/I-NP/O ,/,/O/O und/CC/O/O es/PRP/B-NP/O enth\xc3\xa4lt/VB/B-VP/O 32/CD/B-NP/O offene/JJ/I-NP/O Leserahmen/NN/I-NP/O mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Gr\xc3\xb6\xc3\x9fe/NN/I-NP/I-PNP von/IN/B-PP/O mehr/RB/B-ADVP/O als/IN/B-PP/B-PNP 90/CD/B-NP/I-PNP AS/NNP/I-NP/I-PNP ././O/O

Mittels/IN/B-PP/O Kreuzungsversuchen/JJ/B-ADJP/O auf/IN/B-PP/B-PNP halbfesten/NN/B-NP/I-PNP Oberfl\xc3\xa4chen/JJ/B-ADJP/O konnte/VB/B-VP/O konjugativer/JJ/B-NP/O Transfer/NN/I-NP/O von/IN/B-PP/B-PNP pIP501/NN/B-NP/I-PNP von/IN/B-PP/O Enterococcus/FW/O/O faecalis/FW/O/O sowohl/CC/O/O nach/IN/B-PP/O Streptomyces/FW/O/O lividans/FW/O/O als/CC/O/O auch/FW/O/O nach/IN/B-PP/B-PNP Escherichia/NN/B-NP/I-PNP coli/NN/I-NP/I-PNP gezeigt/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Replikations/FW/O/O -/-/O/O ,/,/O/O Resistenz/NN/B-NP/O -/-/O/O und/CC/O/O Transferfaktoren/NN/B-NP/O sind/VB/B-VP/O in/IN/B-PP/B-PNP beiden/DT/B-NP/I-PNP neuen/JJ/I-NP/I-PNP Wirten/NN/I-NP/I-PNP funktionell/JJ/B-ADJP/O ././O/O

Dies/DT/O/O ist/VB/B-VP/O der/DT/B-NP/O erste/JJ/I-NP/O Nachweis/NN/I-NP/O konjugativen/NN/I-NP/O Transfers/NN/I-NP/O eines/DT/O/O nat\xc3\xbcrlich/IN/B-PP/B-PNP vorkommenden/JJ/B-NP/I-PNP Plasmids/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP diesen/DT/B-NP/I-PNP Organismen/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Sequenzierung/NN/I-NP/O des/DT/B-NP/O bisher/RB/I-NP/O unbekannten/JJ/I-NP/O Abschnitts/NN/I-NP/O von/IN/B-PP/B-PNP pIP501/JJ/B-NP/I-PNP stromabw\xc3\xa4rts/NN/I-NP/I-PNP von/IN/B-PP/B-PNP orf6/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Transfer/NN/I-NP/I-PNP (/(/O/O tra)-Region/LS/O/O zeigte/NN/B-NP/O das/DT/I-NP/O Vorhandensein/NN/I-NP/O von/IN/B-PP/B-PNP neun/CD/B-NP/I-PNP weiteren/JJ/I-NP/I-PNP offenen/JJ/I-NP/I-PNP Leserahmen/NN/I-NP/I-PNP (/(/O/O orf7-orf15/NN/B-NP/O )/)/O/O ././O/O

Die/DT/B-NP/O Genprodukte/NN/I-NP/O Orf5/NN/I-NP/O ,/,/O/O Orf7/NN/B-NP/O und/CC/I-NP/O Orf10/NN/I-NP/O zeigen/JJ/B-NP/O \xc3\x84hnlichkeiten/NN/I-NP/O mit/IN/B-PP/B-PNP Komponenten/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Typ/NNP/B-NP/I-PNP VI/NNP/I-NP/I-PNP Sekretionssystemen/NNP/I-NP/I-PNP ././O/O

Das/DT/B-NP/O sich/PRP/I-NP/O orf15/NN/I-NP/O anschlie\xc3\x9fende/NN/I-NP/O Gen/NN/I-NP/O ist/VB/B-VP/O der/DT/B-NP/O \xc2\x84Copy-Number\xc2\x93/NN/I-NP/O Repressor/JJ/B-NP/O copR/NN/I-NP/O ././O/O

Mit/IN/B-PP/B-PNP 15,07/CD/B-NP/I-PNP kb/NN/I-NP/I-PNP umfasst/VB/B-VP/O die/DT/B-NP/O tra-Region/NN/I-NP/O fast/VB/B-VP/O die/DT/B-NP/O H\xc3\xa4lfte/NN/I-NP/O des/DT/B-NP/O gesamten/JJ/I-NP/O Plasmids/NN/I-NP/O ,/,/O/O dessen/WDT/B-NP/O Gesamtsequenz/NN/I-NP/O mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP der/DT/I-NP/I-PNP neuen/JJ/I-NP/I-PNP Daten/NN/I-NP/I-PNP assembliert/NN/I-NP/I-PNP werden/VB/B-VP/O konnte/VBN/I-VP/O ././O/O

Mittels/IN/B-PP/B-PNP RT-PCR/NN/B-NP/I-PNP konnte/VB/B-VP/O gezeigt/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP tra-Region/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP transkriptionelle/NN/I-NP/I-PNP Einheit/NN/I-NP/I-PNP darstellt/VB/B-VP/O ././O/O

Ein/DT/B-NP/O putativer/NN/I-NP/O rho-unabh\xc3\xa4ngiger/NN/I-NP/O Terminator/JJ/B-NP/O stromabw\xc3\xa4rts/NN/I-NP/O von/IN/B-PP/B-PNP orf15/NN/B-NP/I-PNP wurde/VB/B-VP/O postuliert/NN/B-NP/O ,/,/O/O die/DT/B-NP/O Transkription/NN/I-NP/O endet/VBN/B-VP/O mit/IN/B-PP/B-PNP orf15/NN/B-NP/I-PNP ././O/O

Der/DT/B-NP/O Transkriptionsstartpunkt/NN/I-NP/O der/DT/B-NP/O tra-Region/NN/I-NP/O liegt/VB/B-VP/O etwa/RB/B-ADVP/O 120/CD/B-NP/O bp/NN/I-NP/O stromaufw\xc3\xa4rts/NN/I-NP/O des/DT/B-NP/O putativen/JJ/I-NP/O Startcodons/NN/I-NP/O von/IN/B-PP/B-PNP orf1/NN/B-NP/I-PNP innerhalb/IN/B-PP/B-PNP des/DT/B-NP/I-PNP oriT/NNP/I-NP/I-PNP ././O/O

Der/DT/B-NP/O abgeleitete/NN/I-NP/O Promotor/NN/I-NP/O Ptra/NN/I-NP/O \xc3\xbcberlappt/NN/I-NP/O teilweise/VB/B-VP/O mit/IN/B-PP/B-PNP benachbarten/JJ/B-NP/I-PNP inverted/NN/I-NP/I-PNP repeat/JJ/B-NP/I-PNP Strukturen/NN/I-NP/I-PNP ././O/O

Zusammengenommen/RB/B-VP/O ergeben/VB/I-VP/O diese/DT/B-NP/O Daten/NN/I-NP/O einen/DT/B-NP/O extrem/JJ/I-NP/O kompakten/JJ/I-NP/O Aufbau/NN/I-NP/O von/IN/B-PP/B-PNP oriT&slash;Ptra/NN/B-NP/I-PNP ,/,/O/O welcher/WP/O/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP negative/NN/I-NP/I-PNP Autoregulierung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Region/NN/I-NP/I-PNP durch/IN/B-PP/O die/DT/O/O von/IN/B-PP/B-PNP orf1/NN/B-NP/I-PNP codierte/NN/I-NP/I-PNP TraA/NNP/I-NP/I-PNP DNA-Relaxase/NNP/I-NP/I-PNP hinweisen/VB/B-VP/O k\xc3\xb6nnte/VB/I-VP/O ././O/O

mi-quantitative/JJ/B-NP/O RT-PCR/NN/I-NP/O wurden/RB/B-VP/O durchgef\xc3\xbchrt/VBN/I-VP/O ,/,/O/O um/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Einfluss/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Zelldichte/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Regulation/NN/I-NP/I-PNP des/DT/B-NP/I-PNP tra-Operons/NN/I-NP/I-PNP zu/TO/B-VP/O untersuchen/VB/I-VP/O ././O/O

Unter/IN/B-PP/B-PNP den/DT/B-NP/I-PNP untersuchten/NN/I-NP/I-PNP Bedingungen/NN/I-NP/I-PNP ist/VB/B-VP/O die/DT/B-NP/O Regulation/NN/I-NP/O wachstumsphasenunabh\xc3\xa4ngig/JJ/B-ADJP/O ././O/O

Die/DT/B-NP/O postulierte/JJ/I-NP/O Relaxase-Funktion/NN/I-NP/O von/IN/B-PP/B-PNP TraA/NNP/B-NP/I-PNP wurde/RB/B-ADVP/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP bewiesen/RP/O/O ././O/O

TraA/NNP/B-NP/O (/(/O/O 662/CD/B-NP/O AS/NNP/I-NP/O )/)/O/O und/CC/O/O ein/DT/B-NP/O verk\xc3\xbcrztes/NN/I-NP/O Protein/NN/I-NP/O TraA293/NN/I-NP/O ,/,/O/O das/WDT/O/O die/DT/O/O N-terminalen/RB/B-ADVP/O 293/CD/B-NP/O AS/NNP/I-NP/O von/IN/B-PP/B-PNP TraA/NNP/B-NP/I-PNP umfasst/VB/B-VP/O ,/,/O/O wurden/VB/B-VP/O in/IN/B-PP/B-PNP in/IN/I-PP/I-PNP vitro/NN/B-NP/I-PNP Cleavage/NN/I-NP/I-PNP Assays/NN/I-NP/I-PNP eingesetzt/VBN/B-VP/I-PNP und/CC/O/O bez\xc3\xbcglich/IN/B-PP/B-PNP ihres/PRP$/B-NP/I-PNP Temperaturoptimums/NN/I-NP/I-PNP sowie/RB/B-ADVP/O der/DT/B-NP/O Abh\xc3\xa4ngigkeit/NN/I-NP/O von/IN/B-PP/B-PNP zweiwertigen/NN/B-NP/I-PNP Kationen/JJ/I-NP/I-PNP charakterisiert/NN/I-NP/I-PNP ././O/O

TraA/NNP/B-NP/O ist/VB/B-VP/O das/DT/B-NP/O einzige/JJ/I-NP/O Protein/NN/I-NP/O ,/,/O/O das/WDT/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Nicking-Aktivit\xc3\xa4t/NN/I-NP/I-PNP an/IN/B-PP/B-PNP oriT/NNP/B-NP/I-PNP in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP notwendig/JJ/I-NP/I-PNP ist.Hyphenpilze/NN/I-NP/I-PNP sind/VB/B-VP/O wirtschaftlich/JJ/B-NP/O bedeutende/JJ/I-NP/O Produzenten/NNS/I-NP/O von/IN/B-PP/B-PNP prim\xc3\xa4ren/NN/B-NP/I-PNP und/CC/I-NP/I-PNP sekund\xc3\xa4ren/JJ/I-NP/I-PNP Metaboliten/NN/I-NP/I-PNP ././O/O

Durch/IN/B-PP/B-PNP gerichtete/JJ/B-NP/I-PNP Beeinflussung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Stoffwechselfl\xc3\xbcssen/NN/B-NP/I-PNP (/(/O/O Metabolic/FW/O/O Engineering/FW/O/O )/)/O/O kann/VB/B-VP/O die/DT/B-NP/O Produktbildung/NN/I-NP/O in/IN/B-PP/B-PNP industriell/JJ/B-NP/I-PNP genutzten/NN/I-NP/I-PNP Pilzst\xc3\xa4mmen/NN/I-NP/I-PNP verbessert/VBN/B-VP/I-PNP bzw./CC/O/O die/DT/B-NP/O Produktion/NN/I-NP/O von/IN/B-PP/B-PNP unerw\xc3\xbcnschten/NN/B-NP/I-PNP Nebenprodukten/NN/I-NP/I-PNP vermindert/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

H\xc3\xa4ufig/JJ/B-ADJP/O sind/VB/B-VP/O Produktbildungs/NN/B-NP/O -/-/O/O und/CC/O/O Wachstumsphase/NN/B-NP/O zeitlich/RB/B-ADVP/O getrennt/RP/O/O ././O/O

Es/PRP/B-NP/O ist/VB/B-VP/O daher/RB/B-ADJP/O oftmals/RB/I-ADJP/O notwendig/JJ/I-ADJP/O ,/,/O/O die/DT/B-NP/O n\xc3\xb6tigen/PRP$/I-NP/O Eingriffe/NN/I-NP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Pilzstoffwechsel/NN/I-NP/I-PNP zeitlich/RB/B-ADJP/O steuerbar/JJ/I-ADJP/O zu/TO/B-VP/O gestalten/VB/I-VP/O ././O/O

Ein/DT/O/O viel/IN/B-PP/B-PNP versprechendes/JJ/B-NP/I-PNP Werkzeug/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP diesen/DT/B-NP/I-PNP Zweck/NN/I-NP/I-PNP k\xc3\xb6nnte/VB/B-VP/O die/DT/B-NP/O posttranskriptionale/NN/I-NP/O Regulation/NN/I-NP/O der/DT/B-NP/O Genexpression/NN/I-NP/O mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Ribozymtechnologie/NN/I-NP/I-PNP darstellen/VB/B-VP/O ././O/O

Da/IN/B-PP/B-PNP es/JJ/B-NP/I-PNP bisher/RB/I-NP/I-PNP keine/JJ/I-NP/I-PNP Beispiele/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Verwendung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Ribozymen/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Hyphenpilzen/NN/B-NP/I-PNP gibt/VB/B-VP/O ,/,/O/O wurde/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP vorliegenden/JJ/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP ein/DT/B-NP/I-PNP Modellsystem/NN/I-NP/I-PNP (/(/O/O GUS-Reportersystems/NN/B-NP/O aus/IN/B-PP/B-PNP E./JJ/B-NP/I-PNP coli/NN/I-NP/I-PNP ,/,/O/O uidA/NNP/B-NP/O Gen/NNP/I-NP/O unter/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Kontrolle/NN/I-NP/I-PNP des/DT/B-NP/I-PNP pah4-Promoter/NN/I-NP/I-PNP )/)/O/O etabliert/NN/B-NP/O ,/,/O/O mit/IN/B-PP/B-PNP dessen/WDT/B-NP/I-PNP Hilfe/NN/I-NP/I-PNP die/DT/O/O in/IN/B-PP/B-PNP vivo/JJ/B-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Ribozymen/NN/B-NP/I-PNP in/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Hyphenpilz/NN/I-NP/I-PNP Aspergillus/NN/I-NP/I-PNP giganteus/NN/I-NP/I-PNP untersucht/VBN/B-VP/I-PNP werden/VB/I-VP/O konnte/VBN/I-VP/O ././O/O

Basierend/JJ/B-ADJP/O auf/IN/B-PP/O einer/DT/O/O in/IN/B-PP/B-PNP silico/NN/B-NP/I-PNP Strukturvorhersage/NN/I-NP/I-PNP der/DT/I-NP/I-PNP uidA/NNP/I-NP/I-PNP RNA/NNP/I-NP/I-PNP wurden/VB/B-VP/O sieben/CD/B-NP/O Ribozym/JJ/I-NP/O Zielsequenzen/NN/I-NP/O (/(/O/O \xc2\x84GUC\xc2\x93/NN/B-NP/O )/)/O/O identifiziert/NN/B-NP/O ././O/O

Von/IN/B-PP/O den/DT/O/O anschlie\xc3\x9fend/JJ/B-ADJP/O entwickelten/VB/B-VP/O ,/,/O/O im/IN/B-PP/B-PNP Bereich/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Zielsequenzen/NN/I-NP/I-PNP bindenden/NN/I-NP/I-PNP Ribozyme/NN/I-NP/I-PNP wurden/VB/B-VP/O unterschiedliche/JJ/B-NP/O Versionen/NN/I-NP/O generiert/NN/I-NP/O ,/,/O/O um/IN/B-PP/O u.a./VB/B-VP/O den/DT/B-NP/O Einfluss/NN/I-NP/O der/DT/B-NP/O L\xc3\xa4nge/NN/I-NP/O der/DT/B-NP/O bindenden/NN/I-NP/O Arme/NNS/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Ribozymaktivit\xc3\xa4t/NN/I-NP/I-PNP zu/TO/B-VP/O testen/VB/I-VP/O ././O/O

Die/DT/B-NP/O Aktivit\xc3\xa4t/NN/I-NP/O der/DT/B-NP/O unterschiedlichen/JJ/I-NP/O Ribozyme/NN/I-NP/O und/CC/O/O der/DT/B-NP/O Einfluss/NN/I-NP/O der/DT/B-NP/O Gr\xc3\xb6\xc3\x9fe/NN/I-NP/O des/DT/B-NP/O Substrats/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Ribozym-katalysierte/NN/I-NP/I-PNP Spaltung/NN/I-NP/I-PNP wurde/VB/B-VP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Verwendung/NN/I-NP/I-PNP unterschiedlich/JJ/B-NP/I-PNP gro\xc3\x9fer/JJ/I-NP/I-PNP 5\xc2\x92-Fragmente/NN/I-NP/I-PNP der/DT/B-NP/I-PNP uidA/NNP/I-NP/I-PNP mRNA/NNP/I-NP/I-PNP in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP untersucht/RP/O/O ././O/O

Anschlie\xc3\x9fend/VBN/B-VP/O wurden/VB/I-VP/O Ribozym-kodierende/JJ/B-NP/O Plasmide/NN/I-NP/O nach/IN/B-PP/B-PNP A./NNP/B-NP/I-PNP giganteus/NNP/I-NP/I-PNP transferiert/NNP/I-NP/I-PNP und/CC/O/O \xc3\xbcber/IN/B-PP/B-PNP das/DT/B-NP/I-PNP Reportersystem/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP RNA/NNP/B-NP/I-PNP und/CC/I-NP/I-PNP Proteinlevel/NNP/I-NP/I-PNP deren/DT/B-NP/I-PNP Funtkionalit\xc3\xa4t/NN/I-NP/I-PNP gezeigt/RP/O/O ././O/O

Alle/DT/O/O in/IN/B-PP/B-PNP silico/NN/B-NP/I-PNP entwickelten/VB/B-VP/O Ribozyme/NN/B-NP/O reduzierten/NN/I-NP/O die/DT/I-NP/O Reporteraktivit\xc3\xa4t/NN/I-NP/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP ././O/O

Eine/DT/B-NP/O vollst\xc3\xa4ndige/NN/I-NP/O Repression/NN/I-NP/O der/DT/B-NP/O GUS-Aktivit\xc3\xa4t/NN/I-NP/O erreichten/JJ/B-NP/O Ribozyme/NN/I-NP/O mit/IN/B-PP/B-PNP Zielsequenzen/NN/B-NP/I-PNP im/IN/B-PP/B-PNP 5\xc2\x92-Bereich/NN/B-NP/I-PNP der/DT/I-NP/I-PNP uidA/NNP/I-NP/I-PNP mRNA/NNP/I-NP/I-PNP ,/,/O/O was/WDT/O/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP besonders/RB/I-NP/I-PNP gute/JJ/I-NP/I-PNP Zug\xc3\xa4nglichkeit/NN/I-NP/I-PNP dieser/DT/B-NP/I-PNP Region/JJ/I-NP/I-PNP hinweist/NN/I-NP/I-PNP ././O/O

Ribozyme/NN/B-NP/O mit/IN/B-PP/B-PNP symmetrischen/JJ/B-NP/I-PNP Bindungsarmen/NN/I-NP/I-PNP zeigten/VB/B-VP/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP eine/DT/I-NP/I-PNP h\xc3\xb6here/JJ/I-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP als/IN/B-PP/B-PNP Ribozyme/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP asymmetrischen/JJ/B-NP/I-PNP Bindungsarmen/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Untersuchung/NN/I-NP/O der/DT/O/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP Spaltprodukte/NN/I-NP/I-PNP zeigte/VB/B-VP/O neben/IN/B-PP/B-PNP den/DT/B-NP/I-PNP erwarteten/NN/I-NP/I-PNP auch/RB/B-NP/I-PNP unerwartete/JJ/I-NP/I-PNP Abbauprodukte/NN/I-NP/I-PNP ,/,/O/O welche/WDT/O/O in/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP DotPlot/JJ/I-NP/I-PNP Analyse/NN/I-NP/I-PNP auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Restriktion/NN/I-NP/I-PNP alternativer/NN/I-NP/I-PNP Zielsequenzen/NN/I-NP/I-PNP zur\xc3\xbcckgef\xc3\xbchrt/NN/I-NP/I-PNP werden/VB/B-VP/O konnten/VBN/I-VP/O ././O/O

Die/DT/B-NP/O vorliegende/JJ/I-NP/O Arbeit/NN/I-NP/O ist/VB/B-VP/O die/DT/B-NP/O erfolgreiche/JJ/I-NP/O Anwendung/NN/I-NP/O von/IN/B-PP/B-PNP Ribozymen/NN/B-NP/I-PNP zur/IN/B-PP/B-PNP Genregulation/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Hyphenpilzen/NN/B-NP/I-PNP ././O/O

Die/DT/B-NP/O Ribozymtechnologie/NN/I-NP/O ist/VB/B-VP/O deshalb/RB/B-ADVP/O als/IN/B-PP/B-PNP Werkzeug/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/O das/DT/O/O Metabolic/FW/O/O Engineering/FW/O/O in/IN/B-PP/O industriell/FW/O/O und/CC/O/O auch/FW/O/O wissenschaftlich/FW/O/O interessanten/FW/O/O Hyphenpilzen/FW/O/O denkbar/FW/O/O ,/,/O/O und/CC/O/O eine/DT/B-NP/O interessante/JJ/I-NP/O Alternative/NN/I-NP/O zu/IN/B-PP/B-PNP den/DT/B-NP/I-PNP konventionellen/JJ/I-NP/I-PNP Methoden.Subzellul\xc3\xa4re/JJ/I-NP/I-PNP Ca2/NN/I-NP/I-PNP +/NN/I-NP/I-PNP Signale/NNS/I-NP/I-PNP werden/VB/B-VP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Ca2/NN/I-NP/I-PNP +/JJ/B-NP/I-PNP Freisetzung/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP intrazellul\xc3\xa4ren/NN/B-NP/I-PNP Speichern/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Second-Messenger/NN/I-NP/I-PNP IP3/NN/I-NP/I-PNP ,/,/O/O cADPR/NN/B-NP/O und/CC/I-NP/O NAADP/NNP/I-NP/O aktiviert/NNP/I-NP/O werden/VB/B-VP/O ,/,/O/O erzeugt/RP/O/O ././O/O

W\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Pacemaker-Phase/NN/I-NP/I-PNP werden/VB/B-VP/O diese/DT/B-NP/O subzellul\xc3\xa4ren/NN/I-NP/O Ca2/NN/I-NP/O +/NN/I-NP/O Signale/NNS/I-NP/O amplifiziert/NN/I-NP/O ,/,/O/O \xc3\xbcberschreiten/VB/B-VP/O dann/RB/B-ADVP/O einen/DT/B-NP/O Ca2/NN/I-NP/O +/NN/I-NP/O Schwellenwert/NN/I-NP/O und/CC/O/O f\xc3\xbchren/VB/B-VP/O zur/IN/B-PP/B-PNP Entwicklung/NN/B-NP/I-PNP eines/DT/I-NP/I-PNP globalen/JJ/I-NP/I-PNP Ca2/NN/I-NP/I-PNP +/JJ/B-NP/I-PNP Signals/NN/I-NP/I-PNP ././O/O

owohl/CC/O/O subzellul\xc3\xa4re/JJ/B-ADJP/O als/CC/O/O auch/IN/B-PP/B-PNP globale/NN/B-NP/I-PNP Ca2/NN/I-NP/I-PNP +/NN/I-NP/I-PNP Signale/NNS/I-NP/I-PNP sind/VB/B-VP/O je/RB/B-ADVP/O nach/IN/B-PP/B-PNP Zelltyp/NN/B-NP/I-PNP und/CC/I-NP/I-PNP physiologischer/JJ/I-NP/I-PNP Antwort/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP weitere/JJ/I-NP/I-PNP Signaltransduktion/NN/I-NP/I-PNP unerl\xc3\xa4sslich/JJ/B-ADJP/O ././O/O

Im/IN/B-PP/B-PNP Rahmen/NN/B-NP/I-PNP dieser/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP wurde/VB/B-VP/O zun\xc3\xa4chst/RB/B-ADVP/O die/DT/B-NP/O Auswertung/NN/I-NP/O zur/IN/B-PP/B-PNP Analyse/NN/B-NP/I-PNP der/DT/I-NP/I-PNP subzellul\xc3\xa4ren/NN/I-NP/I-PNP Ca2/NN/I-NP/I-PNP +/NN/I-NP/I-PNP Signale/NNS/I-NP/I-PNP so/IN/B-PP/B-PNP optimiert/NN/B-NP/I-PNP ,/,/O/O dass/IN/B-PP/B-PNP diese/WDT/B-NP/I-PNP Signale/NNS/I-NP/I-PNP \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Parameter/NN/I-NP/I-PNP Durchmesser/NN/I-NP/I-PNP ,/,/O/O Amplitude/NN/B-NP/O und/CC/I-NP/O Frequenz/NN/I-NP/O charakterisiert/NN/I-NP/O werden/VB/B-VP/O konnten/VBN/I-VP/O ././O/O

Die/DT/B-NP/O subzellul\xc3\xa4ren/NN/I-NP/O Ca2/NN/I-NP/O +/NN/I-NP/O Signale/NNS/I-NP/O w\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Pacemaker-Phase/NN/I-NP/I-PNP wurden/VB/B-VP/O in/IN/B-PP/B-PNP Jurkat/NN/B-NP/I-PNP und/CC/I-NP/I-PNP peripheren/NN/I-NP/I-PNP T-Lymphozyten/NN/I-NP/I-PNP analysiert/VB/B-VP/O und/CC/O/O lokalisiert/NN/B-NP/O ././O/O

Dabei/RB/B-VP/O hat/VB/I-VP/O der/DT/B-NP/O Einstrom/NN/I-NP/O von/IN/B-PP/B-PNP Ca2/JJ/B-NP/I-PNP +/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP extrazellul\xc3\xa4ren/NN/I-NP/I-PNP Raum/NN/I-NP/I-PNP kaum/IN/B-PP/B-PNP Einfluss/NN/B-NP/I-PNP auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP subzellul\xc3\xa4ren/NN/I-NP/I-PNP Signale/NNS/I-NP/I-PNP ,/,/O/O allein/RB/B-ADVP/O die/DT/B-NP/O Entstehung/NN/I-NP/O des/DT/B-NP/O globalen/JJ/I-NP/O Ca2/NN/I-NP/O +/NN/I-NP/O Signals/NN/I-NP/O wird/VB/B-VP/O deutlich/JJ/B-NP/O verz\xc3\xb6gert/NN/I-NP/O ././O/O

Protein-Lokalisationsstudien/NN/B-NP/O deuten/VB/B-VP/O darauf/RB/B-ADVP/O hin/IN/B-PP/O ,/,/O/O dass/IN/B-PP/O die/DT/O/O am/IN/B-PP/B-PNP Zellrand/NN/B-NP/I-PNP und/CC/O/O im/IN/B-PP/B-PNP Cytosol/NN/B-NP/I-PNP analysierten/JJ/I-NP/I-PNP Pacemaker-Signale/NN/I-NP/I-PNP von/IN/B-PP/B-PNP IP3R/NN/B-NP/I-PNP und/CC/I-NP/I-PNP RyR/NN/I-NP/I-PNP stammen/VB/B-VP/O ././O/O

Um/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Rezeptoren/NN/I-NP/I-PNP (/(/O/O IP3R&slash;RyR/NN/B-NP/O )/)/O/O ,/,/O/O die/WDT/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP subzellul\xc3\xa4ren/NN/I-NP/I-PNP Ca2/NN/I-NP/I-PNP +/NN/I-NP/I-PNP Signale/NNS/I-NP/I-PNP verantwortlich/JJ/B-ADJP/O sind/VB/B-VP/O ,/,/O/O genauer/RB/B-VP/O zu/TO/I-VP/O definieren/VB/I-VP/O ,/,/O/O wurde/VB/B-VP/O einerseits/RB/B-ADVP/O mit/IN/B-PP/B-PNP Inhibitoren/NN/B-NP/I-PNP gearbeitet/VBN/B-VP/I-PNP ,/,/O/O andererseits/RB/B-ADVP/O die/DT/B-NP/O Rolle/NN/I-NP/O des/DT/B-NP/O Typ/NN/I-NP/O 3/CD/B-NP/O RyR/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Amplifikation/NN/I-NP/I-PNP der/DT/B-NP/I-PNP subzellul\xc3\xa4ren/NN/I-NP/I-PNP Ca2/NN/I-NP/I-PNP +/NN/I-NP/I-PNP Signale/NNS/I-NP/I-PNP vergleichend/JJ/B-ADJP/O in/IN/B-PP/B-PNP Typ/NN/B-NP/I-PNP 3/CD/I-NP/I-PNP RyR/NN/I-NP/I-PNP knock-down/NN/I-NP/I-PNP T-Zellen/NN/I-NP/I-PNP und/CC/O/O entsprechenden/JJ/B-NP/O Kontrollzellen/NN/I-NP/O analysiert/VB/B-VP/O ././O/O

owohl/CC/O/O nach/IN/B-PP/B-PNP physiologischer/JJ/B-NP/I-PNP Stimulation/NN/I-NP/I-PNP (/(/O/O anti-CD3/NN/B-NP/O )/)/O/O als/CC/O/O auch/RB/B-ADVP/O nach/IN/B-PP/B-PNP spezifischer/JJ/B-NP/I-PNP Stimulation/NN/I-NP/I-PNP des/DT/B-NP/I-PNP RyR/NN/I-NP/I-PNP (/(/O/O cADPR/NN/B-NP/O ,/,/O/O cADPR/NN/B-NP/O Analogon/NNP/I-NP/O )/)/O/O war/VB/B-VP/O die/DT/B-NP/O Signalfrequenz/NN/I-NP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP knock-down/NN/I-NP/I-PNP T-Zellen/NN/I-NP/I-PNP insbesondere/VB/B-VP/O im/IN/B-PP/B-PNP Cytosol/NN/B-NP/I-PNP erniedrigt/RP/O/O ././O/O

Eine/DT/B-NP/O \xc3\xa4hnlich/JJ/I-NP/O signifikante/NN/I-NP/O Frequenzverringerung/NN/I-NP/O im/IN/B-PP/B-PNP Cytosol/NN/B-NP/I-PNP wurde/VB/B-VP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Kontrollzellen/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Hemmung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP cADPR&slash;RyR-Signalwegs/JJ/I-NP/I-PNP hervorgerufen/NN/I-NP/I-PNP ././O/O

Eine/DT/B-NP/O signifikante/NN/I-NP/O Abnahme/NN/I-NP/O der/DT/B-NP/O Frequenz/NN/I-NP/O der/DT/B-NP/O subzellul\xc3\xa4ren/NN/I-NP/O Ca2/NN/I-NP/O +/NN/I-NP/O Signale/NNS/I-NP/O wurde/VB/B-VP/O au\xc3\x9ferdem/RB/B-ADVP/O nach/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Blockierung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP IP3R/NN/I-NP/I-PNP beobachtet/RP/O/O ././O/O

Eine/DT/B-NP/O Reduktion/NN/I-NP/O der/DT/B-NP/O Frequenz/NN/I-NP/O und/CC/O/O Amplitude/NN/B-NP/O der/DT/B-NP/O subzellul\xc3\xa4ren/NN/I-NP/O Ca2/NN/I-NP/O +/NN/I-NP/O Signale/NNS/I-NP/O wurde/VB/B-VP/O auch/RB/B-ADVP/O w\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP langanhaltenden/JJ/I-NP/I-PNP Plateau-Phase/NN/I-NP/I-PNP in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Typ/NN/I-NP/I-PNP 3/CD/B-NP/I-PNP RyR/NN/I-NP/I-PNP knock-down/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP nach/IN/B-PP/B-PNP physiologischer/NN/B-NP/I-PNP Stimulation/NN/I-NP/I-PNP gefunden/RP/O/O ././O/O

Alternativ/NN/B-NP/O zu/IN/B-PP/B-PNP den/DT/B-NP/I-PNP T-Lymphozyten/NN/I-NP/I-PNP wurde/VB/B-VP/O in/IN/B-PP/B-PNP 3T3/NN/B-NP/I-PNP Fibroblasten/NN/I-NP/I-PNP der/DT/I-NP/I-PNP Maus/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Rolle/NN/I-NP/I-PNP von/IN/B-PP/B-PNP cADPR/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Bezug/NN/B-NP/I-PNP auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP subzellul\xc3\xa4ren/NN/I-NP/I-PNP Ca2/NN/I-NP/I-PNP +/NN/I-NP/I-PNP Signale/NNS/I-NP/I-PNP w\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Pacemaker-Phase/NN/I-NP/I-PNP und/CC/O/O die/DT/B-NP/O Entwicklung/NN/I-NP/O der/DT/B-NP/O globalen/JJ/I-NP/O Ca2/NN/I-NP/O +/NN/I-NP/O Welle/JJ/B-NP/O charakterisiert/NN/I-NP/O ././O/O

Bei/IN/B-PP/B-PNP Anwesenheit/NN/B-NP/I-PNP von/IN/B-PP/B-PNP intrazellul\xc3\xa4rem/NN/B-NP/I-PNP cADPR/NN/I-NP/I-PNP entwickelten/VB/B-VP/O die/DT/B-NP/O subzellul\xc3\xa4ren/NN/I-NP/O Ca2/NN/I-NP/O +/NN/I-NP/O Signale/NNS/I-NP/O w\xc3\xa4hrend/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Pacemaker-Phase/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP signifikant/JJ/I-NP/I-PNP h\xc3\xb6here/JJ/I-NP/I-PNP Amplitude/NN/I-NP/I-PNP und/CC/O/O Frequenz/NN/B-NP/O und/CC/O/O trugen/VB/B-VP/O ma\xc3\x9fgeblich/JJ/B-ADJP/O zur/IN/B-PP/B-PNP globalen/JJ/B-NP/I-PNP Ca2/NN/I-NP/I-PNP +/JJ/B-NP/I-PNP Welle/NN/I-NP/I-PNP bei/RP/O/O ././O/O

Zum/IN/B-PP/B-PNP ersten/JJ/B-NP/I-PNP Mal/NN/I-NP/I-PNP wurden/VB/B-VP/O innerhalb/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP subzellul\xc3\xa4re/JJ/B-NP/I-PNP Ca2/NN/I-NP/I-PNP +/NN/I-NP/I-PNP Signale/NNS/I-NP/I-PNP in/IN/B-PP/B-PNP T-Lymphozyten/NN/B-NP/I-PNP und/CC/I-NP/I-PNP 3T3/NN/I-NP/I-PNP Fibroblasten/NN/I-NP/I-PNP analysiert/VB/B-VP/O ,/,/O/O charakterisiert/NN/B-NP/O und/CC/I-NP/O subzellul\xc3\xa4r/JJ/I-NP/O lokalisiert/NN/I-NP/O ././O/O

In/IN/B-PP/B-PNP T-Lymphozyten/NN/B-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O Bedeutung/NN/I-NP/O des/DT/B-NP/O Typ/NN/I-NP/O 3/CD/B-NP/O RyR/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Entwicklung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP lokalen/JJ/I-NP/I-PNP Ca2/NN/I-NP/I-PNP +/NN/I-NP/I-PNP Signale/NNS/I-NP/I-PNP im/IN/B-PP/B-PNP Cytosol/NN/B-NP/I-PNP aufgekl\xc3\xa4rt/NN/I-NP/I-PNP :/:/O/O der/DT/B-NP/O Typ/NN/I-NP/O 3/CD/B-NP/O RyR/NN/I-NP/O ist/VB/B-VP/O im/IN/B-PP/B-PNP inneren/JJ/B-NP/I-PNP Cytosol/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Amplifikation/NN/I-NP/I-PNP der/DT/B-NP/I-PNP lokalen/JJ/I-NP/I-PNP subzellul\xc3\xa4ren/NN/I-NP/I-PNP Ca2/NN/I-NP/I-PNP +/NN/I-NP/I-PNP Signale/NNS/I-NP/I-PNP ,/,/O/O die/WDT/O/O am/IN/B-PP/B-PNP Zellrand/NN/B-NP/I-PNP gebildet/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O verantwortlich/JJ/B-ADJP/O und/CC/O/O bewirkt/VB/B-VP/O somit/RB/B-ADVP/O das/DT/B-NP/O Entstehen/NN/I-NP/O der/DT/B-NP/O globalen/JJ/I-NP/O Ca2/NN/I-NP/O +/JJ/B-NP/O Welle/NN/I-NP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Kern/NN/I-NP/I-PNP ././O/O

Diese/DT/B-NP/O Aussagen/NN/I-NP/O wurden/VB/B-VP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Ergebnisse/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP 3T3/NN/I-NP/I-PNP Fibroblasten/NN/I-NP/I-PNP best\xc3\xa4tigt/VBN/B-VP/I-PNP ,/,/O/O denn/RB/B-ADVP/O nur/RB/I-ADVP/O in/IN/B-PP/B-PNP Anwesenheit/NN/B-NP/I-PNP von/IN/B-PP/B-PNP cADPR/NN/B-NP/I-PNP ,/,/O/O das/WDT/B-NP/O die/DT/I-NP/O Ca2/NN/I-NP/O +/JJ/B-NP/O Freisetzung/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP den/DT/B-NP/I-PNP RyR/NN/I-NP/I-PNP stimuliert/NN/I-NP/I-PNP ,/,/O/O k\xc3\xb6nnen/VB/B-VP/O subzellul\xc3\xa4re/JJ/B-NP/O Ca2/NN/I-NP/O +/NN/I-NP/O Signale/NNS/I-NP/O von/IN/B-PP/B-PNP ausreichender/JJ/B-NP/I-PNP Amplitude/NN/I-NP/I-PNP und/CC/O/O Frequenz/NN/B-NP/O generiert/NN/I-NP/O werden/VB/B-VP/O ,/,/O/O sodass/CC/O/O sich/PRP/B-NP/O eine/DT/B-NP/O globale/NN/I-NP/O Ca2/NN/I-NP/O +/JJ/B-NP/O Welle/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP ausbreiten/VB/B-VP/O kann/VB/I-VP/O ././O/O

Die/DT/B-NP/O Pacemaker-Signale/NN/I-NP/O in/IN/B-PP/B-PNP 3T3/NN/B-NP/I-PNP Zellen/NNS/I-NP/I-PNP stimmen/VB/B-VP/O bez\xc3\xbcglich/IN/B-PP/B-PNP Amplitude/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Durchmesser/NN/I-NP/I-PNP in/IN/B-PP/O etwa/RB/B-ADVP/O mit/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Ca2+-Quarks/NN/I-NP/I-PNP \xc3\xbcberein/RB/B-ADVP/O ,/,/O/O die/DT/B-NP/O subzellul\xc3\xa4re/JJ/I-NP/O Ca2/NN/I-NP/O +/NN/I-NP/O Signale/NNS/I-NP/O aufgrund/IN/B-PP/B-PNP der/DT/B-NP/I-PNP \xc3\x96ffnung/NN/I-NP/I-PNP eines/DT/O/O oder/CC/O/O weniger/IN/B-PP/B-PNP RyR/NN/B-NP/I-PNP darstellen/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP T-Lymphozyten/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Fibroblasten/NN/I-NP/I-PNP ist/VBN/B-VP/I-PNP mit/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP die/DT/B-NP/I-PNP entscheidende/JJ/I-NP/I-PNP Rolle/NN/I-NP/I-PNP der/DT/B-NP/I-PNP subzellul\xc3\xa4ren/NN/I-NP/I-PNP Ca2/NN/I-NP/I-PNP +/NN/I-NP/I-PNP Signale/NNS/I-NP/I-PNP im/IN/B-PP/B-PNP cADPR&slash;RyR/NN/B-NP/I-PNP Signalweg/NN/I-NP/I-PNP aufgekl\xc3\xa4rt/VBN/B-VP/I-PNP worden/VBN/I-VP/I-PNP ././O/O

o/RB/B-VP/O bietet/VB/I-VP/O es/PRP/B-NP/O sich/PRP/I-NP/O an/RP/O/O ,/,/O/O modulierende/NN/B-NP/O Pharmaka/NNP/I-NP/O schon/RB/B-ADVP/O auf/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Ebene/NN/I-NP/I-PNP der/DT/B-NP/I-PNP subzellul\xc3\xa4ren/NN/I-NP/I-PNP Signale/NNS/I-NP/I-PNP einzusetzen/NN/I-NP/I-PNP ,/,/O/O da/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Verlauf/NN/I-NP/I-PNP des/DT/B-NP/I-PNP globalen/JJ/I-NP/I-PNP Signals/NN/I-NP/I-PNP von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Amplifikation/NN/I-NP/I-PNP der/DT/B-NP/I-PNP subzellul\xc3\xa4ren/NN/I-NP/I-PNP Pacemaker-Signale/NN/I-NP/I-PNP abh\xc3\xa4ngt.Innerhalb/NN/I-NP/I-PNP der/DT/B-NP/I-PNP angeborenen/JJ/I-NP/I-PNP Immunabwehr/NN/I-NP/I-PNP gegen/IN/B-PP/B-PNP intrazellul\xc3\xa4r/NN/B-NP/I-PNP replizierende/NN/I-NP/I-PNP Erreger/NN/I-NP/I-PNP induzieren/JJ/I-NP/I-PNP Interferone/NN/I-NP/I-PNP in/IN/B-PP/B-PNP nahezu/RB/B-NP/I-PNP jeder/JJ/I-NP/I-PNP K\xc3\xb6rperzelle/NN/I-NP/I-PNP spezifische/JJ/B-NP/I-PNP Resistenzprogramme/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O unabh\xc3\xa4ngig/JJ/B-ADJP/O von/IN/B-PP/B-PNP extrazellul\xc3\xa4ren/NN/B-NP/I-PNP Komponenten/NN/I-NP/I-PNP des/DT/I-NP/I-PNP Immunsystems/NN/I-NP/I-PNP agieren/VB/B-VP/O ,/,/O/O sozusagen/IN/B-PP/B-PNP \xc2\x84zellautonom\xc2\x93/NN/B-NP/I-PNP erfolgen/VB/B-VP/O ././O/O

Es/PRP/B-NP/O gibt/VB/B-VP/O inzwischen/IN/B-PP/B-PNP signifikante/NN/B-NP/I-PNP Belege/NN/I-NP/I-PNP daf\xc3\xbcr/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O die/DT/B-NP/O Mitglieder/NN/I-NP/O der/DT/O/O vorrangig/JJ/B-ADJP/O durch/IN/B-PP/B-PNP Interferon/NN/B-NP/I-PNP -/-/O/O ?/./O/O

induzierten/NN/B-NP/O 47/CD/I-NP/O kDa/NN/I-NP/O GTPase/NN/I-NP/O Familie/NN/I-NP/O wesentliche/JJ/B-NP/O Komponenten/NN/I-NP/O dieser/DT/B-NP/O zellautonomen/NN/I-NP/O Abwehrprogramme/NN/I-NP/O darstellen/VB/B-VP/O und/CC/O/O essentiell/NN/B-NP/O zur/IN/B-PP/B-PNP Resistenz/NN/B-NP/I-PNP des/DT/I-NP/I-PNP Wirtsorganismus/NN/I-NP/I-PNP gegen/IN/B-PP/B-PNP intrazellul\xc3\xa4re/JJ/B-NP/I-PNP bakterielle/NN/I-NP/I-PNP und/CC/O/O parasit\xc3\xa4re/JJ/B-NP/O Erreger/NN/I-NP/O beitragen/VB/B-VP/O ././O/O

Die/DT/B-NP/O molekularen/JJ/I-NP/O Mechanismen/NN/I-NP/O ,/,/O/O die/WDT/B-NP/O der/DT/I-NP/O antimikrobiellen/NN/I-NP/O Wirkung/NN/I-NP/O der/DT/B-NP/O 47/CD/I-NP/O kDa/NN/I-NP/O GTPasen/NN/I-NP/O zugrunde/NN/I-NP/O liegen/VB/B-VP/O ,/,/O/O sind/VB/B-VP/O bislang/RB/B-ADVP/O unbekannt/RP/O/O ././O/O

Die/DT/B-NP/O Zielsetzung/NN/I-NP/O dieser/DT/B-NP/O Arbeit/NN/I-NP/O bestand/VB/B-VP/O deshalb/RB/B-ADVP/O darin/RB/I-ADVP/O ,/,/O/O mit/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP molekularen/JJ/I-NP/I-PNP Charakterisierung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP 47/CD/I-NP/I-PNP kDa/NN/I-NP/I-PNP GTPasen/JJ/B-NP/I-PNP Einblicke/NN/I-NP/I-PNP in/IN/B-PP/B-PNP ihre/PRP$/B-NP/I-PNP Wirkungsweise/NN/I-NP/I-PNP und/CC/I-NP/I-PNP diejenigen/DT/I-NP/I-PNP Prozesse/NN/I-NP/I-PNP zu/TO/B-VP/O erlangen/VB/I-VP/O ,/,/O/O innerhalb/IN/B-PP/B-PNP der/DT/B-NP/I-PNP sie/PRP$/I-NP/I-PNP ihre/PRP$/I-NP/I-PNP Funktion/NN/I-NP/I-PNP aus\xc3\xbcben/VB/B-VP/O ././O/O

Ausgehend/JJ/B-ADJP/O von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Annahme/NN/I-NP/I-PNP ,/,/O/O dass/IN/B-PP/B-PNP 47/CD/B-NP/I-PNP kDa/NN/I-NP/I-PNP GTPasen/NN/I-NP/I-PNP analog/JJ/B-ADJP/O zu/IN/B-PP/B-PNP klassischen/JJ/B-NP/I-PNP GTPasen/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP anderen/JJ/B-NP/I-PNP Proteinen/NN/I-NP/I-PNP interagieren/VB/B-VP/O ,/,/O/O wurden/VB/B-VP/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP Hefe-Interaktionssystem/NN/I-NP/I-PNP erstmals/IN/B-PP/B-PNP Protein-Interaktionspartner/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP einzelne/JJ/B-NP/I-PNP Mitglieder/NN/I-NP/I-PNP der/DT/B-NP/I-PNP 47/CD/I-NP/I-PNP kDa/NN/I-NP/I-PNP GTPasen/JJ/B-NP/I-PNP identifiziert/NN/I-NP/I-PNP ././O/O

Exemplarisch/VBN/B-VP/O wurde/VB/I-VP/O die/DT/B-NP/O Interaktion/NN/I-NP/O des/DT/O/O in/IN/B-PP/B-PNP unserem/PRP$/B-NP/I-PNP Labor/NN/I-NP/I-PNP klonierten/NN/I-NP/I-PNP Familienmitglieds/NN/I-NP/I-PNP IIGP/NNP/I-NP/I-PNP und/CC/O/O dem/DT/O/O erst/RB/B-ADVP/O vor/IN/B-PP/B-PNP kurzem/JJ/B-NP/I-PNP identifizierten/NN/I-NP/I-PNP hook3/JJ/B-NP/I-PNP Protein/NN/I-NP/I-PNP (/(/O/O mHk3/NN/B-NP/O )/)/O/O detailliert/JJ/B-ADJP/O untersucht/RP/O/O ././O/O

Mit/IN/B-PP/B-PNP unterschiedlichen/JJ/B-NP/I-PNP biochemischen/JJ/I-NP/I-PNP Methoden/NN/I-NP/I-PNP konnte/VB/B-VP/O die/DT/B-NP/O physikalische/JJ/I-NP/O Interaktion/NN/I-NP/O zwischen/IN/B-PP/B-PNP IIGP/NNP/B-NP/I-PNP und/CC/I-NP/I-PNP mHk3/NNP/I-NP/I-PNP best\xc3\xa4tigt/VBN/B-VP/I-PNP werden/VB/I-VP/O und/CC/O/O die/DT/O/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Interaktion/NN/I-NP/I-PNP relevanten/NN/I-NP/I-PNP Bereiche/NN/I-NP/I-PNP beider/JJ/B-NP/I-PNP Proteine/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Es/PRP/B-NP/O zeigte/VB/B-VP/O sich/PRP/B-NP/O ,/,/O/O dass/RB/B-ADVP/O mHk3/NN/B-NP/O spezifisch/JJ/B-ADJP/O mit/IN/B-PP/B-PNP IIGP/NNP/B-NP/I-PNP und/CC/I-NP/I-PNP keinem/DT/I-NP/I-PNP anderen/JJ/I-NP/I-PNP Mitglied/NN/I-NP/I-PNP der/DT/B-NP/I-PNP 47/CD/I-NP/I-PNP kDa/NN/I-NP/I-PNP GTPase/NN/I-NP/I-PNP Familie/NN/I-NP/I-PNP interagiert/NN/I-NP/I-PNP und/CC/O/O die/DT/B-NP/O Interaktion/NN/I-NP/O in/IN/B-PP/B-PNP Abh\xc3\xa4ngigkeit/NN/B-NP/I-PNP des/DT/I-NP/I-PNP GTP/NNP/I-NP/I-PNP gebundenen/VB/B-VP/O ,/,/O/O aktiven/JJ/B-NP/O Zustands/NN/I-NP/O von/IN/B-PP/B-PNP IIGP/NNP/B-NP/I-PNP erfolgt/VB/B-VP/O ././O/O

Hook3/RB/B-VP/O vermittelt/VB/I-VP/O eine/DT/B-NP/O Assoziation/NN/I-NP/O von/IN/B-PP/B-PNP Organellmembranen/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP Mikrotubuli/NN/B-NP/I-PNP und/CC/O/O wird/VB/B-VP/O als/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP Faktor/NN/I-NP/I-PNP diskutiert/VBN/B-VP/I-PNP ,/,/O/O der/DT/B-NP/O membranabh\xc3\xa4ngige/NN/I-NP/O Transportprozesse/NN/I-NP/O steuert/NN/I-NP/O und/CC/O/O offensichtlich/JJ/B-ADJP/O in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP gerichteten/NN/I-NP/I-PNP intrazellul\xc3\xa4ren/NN/I-NP/I-PNP Vesikeltransport/NN/I-NP/I-PNP involviert/NN/I-NP/I-PNP ist/VB/B-VP/O ././O/O

Die/DT/B-NP/O Befunde/NNS/I-NP/O der/DT/B-NP/O konfokal-mikroskopischen/JJ/I-NP/O Analysen/NN/I-NP/O deuten/VB/B-VP/O darauf/RB/B-ADVP/O hin/IN/B-PP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Interaktion/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP IIGP/NNP/B-NP/I-PNP und/CC/I-NP/I-PNP mHk3/NNP/I-NP/I-PNP an/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Strukturen/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Golgi-Apparats/NN/I-NP/I-PNP bzw./RB/B-ADVP/O an/IN/B-PP/O noch/RB/B-ADVP/O nicht/RB/B-NP/O n\xc3\xa4her/JJ/I-NP/O charakterisierten/NN/I-NP/O vesikul\xc3\xa4ren/JJ/B-NP/O Strukturen/NN/I-NP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Zellperipherie/NN/I-NP/I-PNP stattfindet/VB/B-VP/O ././O/O

Diese/DT/B-NP/O Befunde/NNS/I-NP/O legen/VB/B-VP/O nahe/RP/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP 47/CD/I-NP/I-PNP kDa/NN/I-NP/I-PNP GTPasen/NN/I-NP/I-PNP generell/VB/B-VP/O am/IN/B-PP/B-PNP Transport/NN/B-NP/I-PNP oder/RB/B-ADVP/O der/DT/B-NP/O Modifikation/NN/I-NP/O von/IN/B-PP/B-PNP Membranen/NN/B-NP/I-PNP beteiligt/VBN/B-VP/I-PNP sein/VB/I-VP/O k\xc3\xb6nnten/VB/I-VP/O ././O/O

Damit/RB/B-VP/O h\xc3\xa4tten/VB/I-VP/O sie/PRP/B-NP/O das/DT/I-NP/O Potential/NN/I-NP/O ,/,/O/O gegen/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Erreger/NN/I-NP/I-PNP gerichtete/VB/B-VP/O ,/,/O/O immunrelevante/JJ/B-NP/O Abwehrmechanismen/NN/I-NP/O an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Vakuolenmembran/NN/I-NP/I-PNP zu/TO/B-VP/O vermitteln/VB/I-VP/O ,/,/O/O die/WDT/B-NP/O die/DT/I-NP/O Schnittstelle/NNP/I-NP/O zwischen/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP internalisiertem/NN/I-NP/I-PNP Erreger/NN/I-NP/I-PNP und/CC/O/O der/DT/B-NP/O Wirtszelle/NN/I-NP/O darstellt/VB/B-VP/O ././O/O

Im/IN/B-PP/B-PNP Einklang/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP diesem/DT/B-NP/I-PNP Konzept/NN/I-NP/I-PNP konnte/VB/B-VP/O nach/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP in-vitro/JJ/I-NP/I-PNP Infektion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Mausfibroblasten/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Erreger/NN/I-NP/I-PNP Toxoplasma/JJ/B-NP/I-PNP gondii/NN/I-NP/I-PNP an/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Pathogenvakuolen/NN/I-NP/I-PNP die/DT/B-NP/I-PNP GTPase/NN/I-NP/I-PNP IIGP/NNP/I-NP/I-PNP detektiert/NNP/I-NP/I-PNP werden/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP Mausfibroblasten/NN/B-NP/I-PNP ,/,/O/O die/DT/B-NP/O IIGP/NNP/I-NP/O ektopisch/JJ/B-NP/O exprimieren/NN/I-NP/O ,/,/O/O bildet/VB/B-VP/O IIGP/NNP/B-NP/O in/IN/B-PP/B-PNP Abh\xc3\xa4ngigkeit/NN/B-NP/I-PNP der/DT/I-NP/I-PNP GTPase-Aktivit\xc3\xa4t/NN/I-NP/I-PNP gro\xc3\x9fe/JJ/B-NP/I-PNP perinukle\xc3\xa4re/JJ/I-NP/I-PNP Proteinaggregate/NN/I-NP/I-PNP aus/RP/O/O ,/,/O/O bei/IN/B-PP/B-PNP denen/WDT/B-NP/I-PNP es/PRP/I-NP/I-PNP sich/PRP/I-NP/I-PNP offensichtlich/JJ/B-ADJP/O nicht/RB/B-ADVP/O um/IN/B-PP/B-PNP typische/JJ/B-NP/I-PNP Aggresomen/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP aberrant/JJ/B-NP/I-PNP gefaltetem/NN/I-NP/I-PNP Protein/NN/I-NP/I-PNP handelt/VB/B-VP/O ././O/O

Interessanterweise/RB/B-VP/O l\xc3\xb6st/VB/I-VP/O eine/DT/B-NP/O Stimulation/NN/I-NP/O dieser/DT/B-NP/O Zellen/NNS/I-NP/O mit/IN/B-PP/B-PNP Interferon/NN/B-NP/I-PNP -/-/O/O ?/./O/O

die/DT/B-NP/O IIGP-Aggregate/NN/I-NP/O auf/RP/O/O ,/,/O/O was/WDT/O/O nahe/IN/B-PP/O legt/VB/B-VP/O ,/,/O/O dass/IN/B-PP/B-PNP f\xc3\xbcr/IN/I-PP/I-PNP die/DT/B-NP/I-PNP Rekrutierung/NN/I-NP/I-PNP oder/RB/B-ADVP/O Bindung/NN/B-NP/O von/IN/B-PP/B-PNP IIGP/NNP/B-NP/I-PNP an/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Membranen/NN/I-NP/I-PNP des/DT/B-NP/I-PNP ER/PRP$/I-NP/I-PNP und/CC/O/O des/DT/B-NP/O Golgi-Apparats/NN/I-NP/O weitere/JJ/B-NP/O IFN-abh\xc3\xa4ngige/NN/I-NP/O Faktoren/NN/I-NP/O ben\xc3\xb6tigt/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Elektronenmikroskopische/JJ/B-NP/O Analysen/NN/I-NP/O zeigten/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O die/DT/B-NP/O ektopische/JJ/I-NP/O Expression/NN/I-NP/O von/IN/B-PP/B-PNP IIGP/NNP/B-NP/I-PNP zu/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Deformation/NN/I-NP/I-PNP bzw./RB/B-ADVP/O Kompartimentalisierung/NN/B-NP/O des/DT/B-NP/O ER/PRP$/I-NP/O f\xc3\xbchrt/VB/B-VP/O ././O/O

In/IN/B-PP/B-PNP IFN/NN/B-NP/I-PNP -/-/O/O ?/./O/O

stimulierten/JJ/B-NP/O Fibroblasten/NN/I-NP/O ,/,/O/O die/WDT/O/O mit/IN/B-PP/B-PNP Toxoplasma/NN/B-NP/I-PNP gondii/NN/I-NP/I-PNP Erregern/NN/I-NP/I-PNP infiziert/JJ/B-ADJP/O wurden/VB/B-VP/O ,/,/O/O konnte/VBN/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP fr\xc3\xbchen/JJ/I-NP/I-PNP Infektionsphase/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP \xc3\xa4hnliche/JJ/I-NP/I-PNP Aggregatbildung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP endogenem/NNP/B-NP/I-PNP IIGP/NNP/I-NP/I-PNP beobachtet/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Die/DT/B-NP/O Ausbildung/NN/I-NP/O dieser/DT/B-NP/O makromolekularen/NN/I-NP/O Strukturen/NN/I-NP/O steht/VB/B-VP/O im/IN/B-PP/B-PNP Einklang/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP Oligomerisierungspotential/NN/I-NP/I-PNP von/IN/B-PP/B-PNP IIGP/NNP/B-NP/I-PNP ././O/O

Zum/IN/B-PP/B-PNP jetzigen/JJ/B-NP/I-PNP Zeitpunkt/NN/I-NP/I-PNP ist/VB/B-VP/O jedoch/RB/B-ADJP/O ungekl\xc3\xa4rt/JJ/I-ADJP/O ,/,/O/O inwieweit/NN/B-NP/O die/DT/I-NP/O F\xc3\xa4higkeit/NN/I-NP/O von/IN/B-PP/B-PNP IIGP/NNP/B-NP/I-PNP zur/IN/B-PP/B-PNP Oligomerisierung/NN/B-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Vermittlung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Resistenzmechanismen/NN/B-NP/I-PNP gegen/IN/B-PP/B-PNP intrazellul\xc3\xa4re/JJ/B-NP/I-PNP Erreger/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Relevanz/NN/B-NP/I-PNP sein/VB/B-VP/O k\xc3\xb6nnte/VB/I-VP/O ././O/O

Die/DT/B-NP/O Befunde/NNS/I-NP/O der/DT/B-NP/O Hefe-Interaktionsanalysen/NN/I-NP/O deuten/VB/B-VP/O darauf/RB/B-ADVP/O hin/IN/B-PP/O ,/,/O/O dass/IN/B-PP/B-PNP neben/IN/I-PP/I-PNP IIGP/NNP/B-NP/I-PNP auch/RB/I-NP/I-PNP andere/JJ/I-NP/I-PNP Familienmitglieder/NN/I-NP/I-PNP der/DT/B-NP/I-PNP 47/CD/I-NP/I-PNP kDa/NN/I-NP/I-PNP GTPasen/NN/I-NP/I-PNP oligomerisieren/NN/I-NP/I-PNP k\xc3\xb6nnen/VB/B-VP/O und/CC/O/O offensichtlich/RB/B-ADVP/O auch/RB/I-ADVP/O zu/IN/B-PP/B-PNP interfamili\xc3\xa4ren/NN/B-NP/I-PNP Protein-Interaktionen/NN/I-NP/I-PNP bef\xc3\xa4higt/VBN/B-VP/I-PNP sind/VB/I-VP/O ././O/O

M\xc3\xb6glicherweise/RB/B-VP/O existiert/VB/I-VP/O zwischen/IN/B-PP/B-PNP den/DT/B-NP/I-PNP 47/CD/I-NP/I-PNP kDa/NN/I-NP/I-PNP GTPasen/NN/I-NP/I-PNP ein/DT/B-NP/I-PNP komplexes/JJ/I-NP/I-PNP Interaktionsnetzwerk/NN/I-NP/I-PNP ,/,/O/O das/DT/B-NP/O ihre/PRP$/I-NP/O immunrelevanten/NN/I-NP/O Funktionen/NN/I-NP/O bestimmt/RP/O/O ././O/O

Neben/IN/B-PP/B-PNP der/DT/B-NP/I-PNP detailliert/JJ/I-NP/I-PNP untersuchten/JJ/I-NP/I-PNP Interaktion/NN/I-NP/I-PNP zwischen/IN/B-PP/B-PNP IIGP/NNP/B-NP/I-PNP und/CC/I-NP/I-PNP mHk3/NNP/I-NP/I-PNP lassen/VB/B-VP/O sich/PRP/B-NP/O von/IN/B-PP/O den/DT/O/O weiterhin/IN/B-PP/B-PNP identifizierten/NN/B-NP/I-PNP Protein-Interaktionspartnern/JJ/I-NP/I-PNP Funktionsmodelle/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP 47/CD/I-NP/I-PNP kDa/NN/I-NP/I-PNP GTPasen/NN/I-NP/I-PNP ableiten/VB/B-VP/O ,/,/O/O die/WDT/O/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP eingehend/JJ/B-ADJP/O diskutiert/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Diese/DT/B-NP/O Molek\xc3\xbcle/NN/I-NP/O k\xc3\xb6nnten/VB/B-VP/O den/DT/B-NP/O Ausgangspunkt/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP zuk\xc3\xbcnftige/JJ/B-NP/I-PNP Forschungsarbeiten/NN/I-NP/I-PNP zum/IN/B-PP/B-PNP molekularen/JJ/B-NP/I-PNP Wirkungsmechanismus/NN/I-NP/I-PNP der/DT/B-NP/I-PNP 47/CD/I-NP/I-PNP kDa/NN/I-NP/I-PNP GTPasen/NN/I-NP/I-PNP darstellen.DNA-Microarrays/VB/B-VP/O sind/RB/B-ADVP/O ein/DT/B-NP/O unverzichtbares/JJ/I-NP/O Werkzeug/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Analyse/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Nukleins\xc3\xa4uren/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Hochdurchsatz/NN/B-NP/I-PNP geworden/RP/O/O ././O/O

Heutzutage/VBN/B-VP/O werden/VB/I-VP/O Hybridisierungsexperimente/NN/B-NP/O f\xc3\xbcr/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Vielzahl/NN/I-NP/I-PNP biotechnologischer/NN/I-NP/I-PNP Fragestellungen/NN/I-NP/I-PNP ,/,/O/O zumeist/NN/B-NP/O in/IN/B-PP/B-PNP Kombination/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP Fluoreszenzdetektion/NN/B-NP/I-PNP ,/,/O/O routinem\xc3\xa4\xc3\x9fig/JJ/B-ADJP/O durchgef\xc3\xbchrt/RP/O/O ././O/O

Die/DT/B-NP/O M\xc3\xb6glichkeiten/NN/I-NP/O der/DT/B-NP/O Analyse/NN/I-NP/O von/IN/B-PP/B-PNP Microarrays/NN/B-NP/I-PNP sind/VB/B-VP/O jedoch/RB/B-ADVP/O noch/RB/I-ADVP/O lange/RB/I-ADVP/O nicht/RB/I-ADVP/O ausgesch\xc3\xb6pft/RP/O/O ././O/O

Potential/RB/B-VP/O liegt/VB/I-VP/O hier/RB/B-ADVP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Vereinfachung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Prozesses/NN/I-NP/I-PNP (/(/O/O z.B./RB/B-ADVP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP markierungsfreie/NN/I-NP/I-PNP Analyse/NN/I-NP/I-PNP )/)/O/O oder/CC/O/O dem/DT/B-NP/O Steigern/NN/I-NP/O der/DT/B-NP/O Sensitivit\xc3\xa4t/NN/I-NP/O ././O/O

In/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP werden/VB/B-VP/O einige/JJ/B-NP/O Strategien/NN/I-NP/O zur/IN/B-PP/O schnellen/VB/B-VP/O und/CC/O/O g\xc3\xbcnstigen/JJ/B-NP/O Produktion/NN/I-NP/O von/IN/B-PP/B-PNP PNA-Microarrays/JJ/B-NP/I-PNP beschrieben/NN/I-NP/I-PNP ././O/O

PNAs/NN/B-NP/O (/(/O/O peptide/FW/O/O nucleic/FW/O/O acids/FW/O/O )/)/O/O wurden/VB/B-VP/O in/IN/B-PP/B-PNP einem/DT/B-NP/I-PNP automatisierten/JJ/I-NP/I-PNP Prozess/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Mikrotiterplatten/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP integrierten/NN/B-NP/I-PNP Fritten/JJ/I-NP/I-PNP synthetisiert/NN/I-NP/I-PNP ././O/O

Die/DT/O/O so/IN/B-PP/B-PNP erhaltenen/NN/B-NP/I-PNP PNA-Molek\xc3\xbcle/NN/I-NP/I-PNP wurden/VB/B-VP/O anschlie\xc3\x9fend/JJ/B-ADJP/O vom/IN/B-PP/B-PNP Syntheseharz/NN/B-NP/I-PNP abgespalten/NN/I-NP/I-PNP und/CC/O/O ohne/IN/B-PP/B-PNP weitere/JJ/B-NP/I-PNP Aufreinigung/NN/I-NP/I-PNP \xc3\xbcber/IN/B-PP/B-PNP ihre/PRP$/B-NP/I-PNP N-terminale/NN/I-NP/I-PNP Aminogruppe/NN/I-NP/I-PNP oder/RB/I-NP/I-PNP andere/JJ/I-NP/I-PNP N-terminale/JJ/I-NP/I-PNP Modifikationen/NN/I-NP/I-PNP an/IN/B-PP/O die/DT/O/O Microarray-Oberfl\xc3\xa4chen/JJ/B-ADJP/O gebunden/RP/O/O ././O/O

Durch/IN/B-PP/B-PNP dieses/DT/B-NP/I-PNP selektive/NN/I-NP/I-PNP Anbinden/NN/I-NP/I-PNP wurden/VB/B-VP/O die/DT/B-NP/O PNA-Endprodukte/NN/I-NP/O der/DT/B-NP/O Synthese/NN/I-NP/O direkt/JJ/B-ADJP/O beim/IN/B-PP/B-PNP Spotten/NN/B-NP/I-PNP auf/IN/B-PP/O die/DT/O/O Oberfl\xc3\xa4chen/JJ/B-ADJP/O aufgereinigt/RP/O/O ././O/O

Die/DT/O/O so/IN/B-PP/B-PNP hergestellten/NN/B-NP/I-PNP PNA-Microarrays/NN/I-NP/I-PNP wurden/VB/B-VP/O anschlie\xc3\x9fend/JJ/B-ADJP/O f\xc3\xbcr/IN/B-PP/B-PNP Hybridisierungen/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP unmarkierten/NN/B-NP/I-PNP DNA-Proben/NN/I-NP/I-PNP und/CC/I-NP/I-PNP deren/DT/I-NP/I-PNP Detektion/NN/I-NP/I-PNP mittels/IN/B-PP/B-PNP TOF-SIMS/NNP/B-NP/I-PNP (/(/O/O time-of-flight/NN/B-NP/O secondary/NNP/I-NP/O ion/NNP/I-NP/O mass/NNP/I-NP/O spectrometry/NNP/I-NP/O )/)/O/O verwendet/VB/B-VP/O ././O/O

Dabei/RB/B-VP/O kann/VB/I-VP/O die/DT/B-NP/O Hybridisierungen/NN/I-NP/O der/DT/B-NP/O DNA-Molek\xc3\xbcle/NN/I-NP/O auf/IN/B-PP/B-PNP den/DT/B-NP/I-PNP PNA-Spots/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Microarrays/NN/I-NP/I-PNP anhand/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Phosphate/NN/I-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O die/DT/B-NP/O Bestandteil/NN/I-NP/O der/DT/B-NP/O Nukleins\xc3\xa4uren/NN/I-NP/O sind/VB/B-VP/O ,/,/O/O in/IN/B-PP/B-PNP PNA-Molek\xc3\xbclen/NN/B-NP/I-PNP aber/RB/B-VP/O nicht/RB/I-VP/O vorkommen/VB/I-VP/O ././O/O

Zus\xc3\xa4tzlich/VBN/B-VP/O wurde/RB/I-VP/O gezeigt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP sich/PRP/B-NP/I-PNP PNA-Microarrays/NN/I-NP/I-PNP auch/RB/B-ADVP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Detektion/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Einzelbasenmutationen/NN/B-NP/I-PNP eignen.Die/NN/I-NP/I-PNP Nucleosidanaloga/JJ/I-NP/I-PNP Fludarabin/NN/I-NP/I-PNP (/(/O/O F-Ara-A/NNP/B-NP/O )/)/O/O und/CC/O/O Cladribin/NN/B-NP/O (/(/O/O 2-CdA/NNP/B-NP/O )/)/O/O werden/VB/B-VP/O zur/IN/B-PP/B-PNP Therapie/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Leuk\xc3\xa4mie-Erkrankungen/NN/B-NP/I-PNP eingesetzt/RP/O/O ././O/O

Die/DT/B-NP/O Substanzen/NNS/I-NP/O wirken/VB/B-VP/O DNA-sch\xc3\xa4digend/RP/I-VP/O ,/,/O/O hemmen/VB/B-VP/O die/DT/B-NP/O DNA-Reparatur/NN/I-NP/O und/CC/O/O induzieren/JJ/B-NP/O Apoptose/NN/I-NP/O ././O/O

Obwohl/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Substanzen/NNS/I-NP/I-PNP bereits/RB/B-ADVP/O zur/IN/B-PP/B-PNP Therapie/NN/B-NP/I-PNP verwendet/VBN/B-VP/I-PNP werden/VB/I-VP/O ,/,/O/O war/VBN/B-VP/O \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP ausgel\xc3\xb6sten/JJ/I-NP/I-PNP Apoptosesignalwege/NN/I-NP/I-PNP bisher/RB/B-ADVP/O wenig/RB/I-ADVP/O bekannt/RP/O/O ././O/O

Mitochondrialer/NN/B-NP/O -/-/O/O und/CC/O/O Todesrezeptorsignalweg/NN/B-NP/O stellen/VB/B-VP/O die/DT/B-NP/O beiden/DT/I-NP/O Hauptapoptosesignalwege/NN/I-NP/O dar/RP/O/O ././O/O

Um/IN/B-PP/O diese/DT/O/O detailliert/JJ/B-ADJP/O untersuchen/JJ/I-ADJP/O zu/TO/B-VP/O k\xc3\xb6nnen/VB/I-VP/O ,/,/O/O wurden/VB/B-VP/O FADD/NN/B-NP/O -/-/O/O und/CC/O/O Caspase-8-defiziente/NN/B-NP/O ,/,/O/O Bcl-2/NN/B-NP/O \xc3\xbcberexprimierende/NNP/I-NP/O bzw./CC/I-NP/O Caspase-9/NNP/I-NP/O dn/NNP/I-NP/O (/(/O/O dominant-negative/NN/B-NP/O )/)/O/O Zellen/NNS/B-NP/O verwendet/VB/B-VP/O ././O/O

Die/DT/B-NP/O Apoptoseinduktion/NN/I-NP/O durch/IN/B-PP/B-PNP Nucleosidanaloga/NN/B-NP/I-PNP wurde/VB/B-VP/O weder/CC/O/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Abwesenheit/NN/I-NP/I-PNP von/IN/B-PP/B-PNP FADD/NN/B-NP/I-PNP oder/RB/I-NP/I-PNP Caspase-8/NN/I-NP/I-PNP ,/,/O/O noch/RB/B-ADVP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Blockierung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP CD95&slash;/NN/I-NP/I-PNP Fas-Rezeptors/NN/I-NP/I-PNP beeinflusst/VB/B-VP/O ././O/O

Jedoch/RB/B-VP/O war/VB/I-VP/O der/DT/B-NP/O Zelltod/NN/I-NP/O in/IN/B-PP/B-PNP Jurkat/NN/B-NP/I-PNP Bcl-2/NN/I-NP/I-PNP \xc3\xbcberexprimierenden/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP sowie/CC/I-NP/I-PNP Caspase-9/NN/I-NP/I-PNP dn/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP blockiert/NN/I-NP/I-PNP ././O/O

Aus/IN/B-PP/B-PNP diesen/DT/B-NP/I-PNP Ergebnissen/NN/I-NP/I-PNP kann/VB/B-VP/O geschlussfolgert/NN/B-NP/O werden/VB/B-VP/O ,/,/O/O dass/IN/B-PP/B-PNP Nucleosidanaloga-induzierte/NN/B-NP/I-PNP Apoptose/NN/I-NP/I-PNP unabh\xc3\xa4ngig/JJ/B-ADJP/O vom/IN/B-PP/B-PNP Todesrezeptorsignalweg/NN/B-NP/I-PNP \xc3\xbcber/IN/B-PP/B-PNP den/DT/B-NP/I-PNP mitochondrialen/JJ/I-NP/I-PNP Signalweg/JJ/I-NP/I-PNP verl\xc3\xa4uft/NN/I-NP/I-PNP ././O/O

Dabei/RB/B-VP/O kommt/VB/I-VP/O es/PRP/B-NP/O zur/IN/B-PP/B-PNP Freisetzung/NN/B-NP/I-PNP von/IN/B-PP/O Cytochrom/FW/O/O c/FW/O/O aus/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Mitochondrien/NN/I-NP/I-PNP und/CC/O/O zur/IN/B-PP/B-PNP Aktivierung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Caspase-9/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Caspase-3/NN/I-NP/I-PNP ././O/O

Bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Untersuchung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP mitochondrialen/JJ/I-NP/I-PNP Signalweges/NN/I-NP/I-PNP konnte/VB/B-VP/O interessanterweise/NN/B-NP/O festgestellt/VBN/B-VP/O werden/VB/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Zusammenbruch/NN/I-NP/I-PNP des/DT/B-NP/I-PNP mitochondrialen/JJ/I-NP/I-PNP Membranpotentials/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Jurkat/NN/B-NP/I-PNP Caspase-9/NN/I-NP/I-PNP dn/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP und/CC/O/O in/IN/B-PP/B-PNP 3T9/NN/B-NP/I-PNP Caspase-9/NN/I-NP/I-PNP -/-/O/O &slash;/CC/O/O -/-/O/O Mausfibroblasten/NN/B-NP/O inhibiert/NN/I-NP/O war/VB/B-VP/O ././O/O

Daten/NN/B-NP/O aus/IN/B-PP/B-PNP Experimenten/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP 3T9/NN/B-NP/I-PNP APAF-1/NN/I-NP/I-PNP -/-/O/O &slash;/CC/O/O -/-/O/O Mausfibroblasten/NN/B-NP/O haben/RB/B-VP/O gezeigt/VBN/I-VP/O ,/,/O/O dass/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Bildung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Apoptosom-Komplexes/NN/I-NP/I-PNP f\xc3\xbcr/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Zusammenbruch/NN/I-NP/I-PNP des/DT/B-NP/I-PNP mitochondrialen/JJ/I-NP/I-PNP Membranpotentials/NN/I-NP/I-PNP und/CC/O/O die/DT/B-NP/O Freisetzung/NN/I-NP/O von/IN/B-PP/O Cytochrom/FW/O/O c/FW/O/O essentiell/FW/O/O ist/VB/B-VP/O ././O/O

Diese/DT/B-NP/O Ergebnisse/NN/I-NP/O verdeutlichen/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O Caspase-9/NN/B-NP/O an/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP Amplifikationsschleife/NN/I-NP/I-PNP beteiligt/VBN/B-VP/I-PNP ist/VB/I-VP/O ,/,/O/O die/WDT/O/O \xc3\xbcber/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Bildung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Apoptosom-Komplexes/NN/I-NP/I-PNP den/DT/B-NP/I-PNP Zusammenbruch/NN/I-NP/I-PNP des/DT/B-NP/I-PNP mitochondrialen/JJ/I-NP/I-PNP Membranpotentials/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP Folge/NN/B-NP/I-PNP hat/VB/B-VP/O ././O/O

Weiterhin/VBN/B-VP/O wurde/VB/I-VP/O die/DT/B-NP/O Position/NN/I-NP/O von/IN/B-PP/B-PNP Caspase-2/NN/B-NP/I-PNP im/IN/B-PP/B-PNP mitochondrialen/JJ/B-NP/I-PNP Signalweg/NN/I-NP/I-PNP durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Verwendung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 3T9/NN/B-NP/I-PNP Caspase-2/NN/I-NP/I-PNP -/-/O/O &slash;/CC/O/O -/-/O/O Mausfibroblasten/NN/B-NP/O untersucht/RP/O/O ././O/O

Die/DT/B-NP/O Analyse/NN/I-NP/O der/DT/B-NP/O Caspaseaktivierung/NN/I-NP/O in/IN/B-PP/B-PNP 3T9/NN/B-NP/I-PNP wt/NN/I-NP/I-PNP ,/,/O/O APAF-1/NN/B-NP/O -/-/O/O &slash;/CC/O/O -/-/O/O ,/,/O/O Caspase-2/NN/B-NP/O -/-/O/O &slash;/CC/O/O -/-/O/O ,/,/O/O Caspase-9/NN/B-NP/O -/-/O/O &slash;/CC/O/O -/-/O/O Mausfibroblasten/NN/B-NP/O zeigte/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O Caspase-2/NN/B-NP/O Aktivierung/NN/I-NP/O abh\xc3\xa4ngig/JJ/B-ADJP/O von/IN/B-PP/B-PNP APAF-1&slash;/NN/B-NP/I-PNP Caspase-9/NN/I-NP/I-PNP erfolgt/VB/B-VP/O und/CC/O/O umgekehrt/RP/O/O ././O/O

Daher/RB/B-VP/O ist/VB/I-VP/O Caspase-2/RB/B-ADJP/O offensichtlich/JJ/I-ADJP/O in/IN/B-PP/O die/DT/O/O in/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP vorgestellte/NN/I-NP/I-PNP Amplifikationsschleife/NN/I-NP/I-PNP integriert/VBN/B-VP/I-PNP und/CC/O/O beeinflusst/VB/B-VP/O m\xc3\xb6glicherweise/RB/B-ADVP/O die/DT/B-NP/O Aktivierung/NN/I-NP/O von/IN/B-PP/B-PNP Caspase-9.Bei/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Entfernung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Sarkomen/NN/B-NP/I-PNP werden/VB/B-VP/O ausgedehnte/NN/B-NP/O Weichgewebsdefekte/NN/I-NP/O geschaffen/VBN/B-VP/O ,/,/O/O die/WDT/O/O wegen/IN/B-PP/B-PNP ihrer/PRP$/B-NP/I-PNP Gr\xc3\xb6\xc3\x9fe/NN/I-NP/I-PNP und/CC/O/O aufgrund/IN/B-PP/B-PNP einer/DT/B-NP/I-PNP pr\xc3\xa4operativen/NN/I-NP/I-PNP Bestrahlung/NN/I-NP/I-PNP eine/DT/B-NP/I-PNP niedrige/NN/I-NP/I-PNP Reparaturtendenz/NN/I-NP/I-PNP aufweisen/VB/B-VP/O und/CC/O/O schwere/NN/B-NP/O Heilungsst\xc3\xb6rungen/NN/I-NP/O verursachen/VB/B-VP/O ././O/O

Aufgrund/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Wundprobleme/NN/I-NP/I-PNP kann/VB/B-VP/O eine/DT/B-NP/O Nachbehandlung/NN/I-NP/O ,/,/O/O wie/IN/B-PP/O z.B./RB/B-ADVP/O Strahlen/NNS/B-NP/O -/-/O/O oder/CC/O/O Chemotherapie/NN/B-NP/O ,/,/O/O nur/IN/B-PP/B-PNP verz\xc3\xb6gert/NN/B-NP/I-PNP ,/,/O/O m\xc3\xb6glicherweise/RB/B-VP/O \xc3\xbcberhaupt/RB/I-VP/O nicht/RB/I-VP/O vorgenommen/VBN/I-VP/O werden/VB/I-VP/O ,/,/O/O was/WDT/B-NP/O die/DT/I-NP/O \xc3\x9cberlebenschancen/NN/I-NP/O der/DT/B-NP/O Patienten/NN/I-NP/O reduziert/RP/O/O ././O/O

Da/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Behandlung/NN/I-NP/I-PNP dieser/DT/B-NP/I-PNP Weichgewebssch\xc3\xa4den/NN/I-NP/I-PNP gegenw\xc3\xa4rtig/RB/B-ADJP/O nur/RB/I-ADJP/O unbefriedigend/JJ/I-ADJP/O gel\xc3\xb6st/VBN/B-VP/O ist/VB/I-VP/O ,/,/O/O war/VBN/B-VP/O es/PRP/B-NP/O Ziel/NN/I-NP/O ,/,/O/O einen/DT/B-NP/O Weichgewebsersatz/NN/I-NP/O herzustellen/NN/I-NP/O ,/,/O/O der/DT/B-NP/O eine/DT/I-NP/O l\xc3\xa4ngerfristige/NN/I-NP/O Defektf\xc3\xbcllung/NN/I-NP/O gestattet/NN/I-NP/O ,/,/O/O durch/IN/B-PP/B-PNP Transfer/NN/B-NP/I-PNP aktiver/JJ/I-NP/I-PNP autologer/NN/I-NP/I-PNP Zellen/NNS/I-NP/I-PNP die/DT/B-NP/I-PNP Heilungsprobleme/NN/I-NP/I-PNP ausgleicht/NN/I-NP/I-PNP sowie/RB/B-ADVP/O die/DT/B-NP/O rechtlichen/JJ/I-NP/O Anforderungen/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP den/DT/B-NP/I-PNP klinischen/JJ/I-NP/I-PNP Einsatz/NN/I-NP/I-PNP in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Bundesrepublik/NN/I-NP/I-PNP Deutschland/NNP/I-NP/I-PNP erf\xc3\xbcllt/RP/O/O ././O/O

Mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP eines/DT/I-NP/I-PNP eigens/RB/I-NP/I-PNP entwickelten/JJ/I-NP/I-PNP Tr\xc3\xa4germaterials/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Form/NN/B-NP/I-PNP einer/DT/I-NP/I-PNP humanen/NN/I-NP/I-PNP ,/,/O/O sterilisierten/NN/B-NP/O azellul\xc3\xa4ren/NNP/I-NP/O Dermis/NNP/I-NP/O sowie/CC/I-NP/O humaner/NNP/I-NP/O dermaler/NNP/I-NP/O Fibroblasten/NNP/I-NP/O konnte/VB/B-VP/O ein/DT/B-NP/O komplexer/JJ/I-NP/O Weichgewebsersatz/NN/I-NP/O geschaffen/VBN/B-VP/O werden/VB/I-VP/O ././O/O

Das/DT/B-NP/O Vorliegen/NN/I-NP/O typischer/JJ/B-NP/O dermaler/NN/I-NP/O Strukturen/NN/I-NP/O ,/,/O/O einer/DT/B-NP/O gro\xc3\x9fen/JJ/I-NP/O Durchl\xc3\xa4ssigkeit/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP Modellsubstanzen/NN/B-NP/I-PNP ,/,/O/O einer/DT/B-NP/O hohen/JJ/I-NP/O Biokompatibilit\xc3\xa4t/NN/I-NP/O sowie/RB/B-ADVP/O Materialstabilit\xc3\xa4t/NN/B-NP/O zeigte/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O die/DT/B-NP/O hergestellte/NN/I-NP/O azellul\xc3\xa4re/JJ/B-NP/O Dermis/NN/I-NP/O gute/JJ/B-NP/O Voraussetzungen/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Zellbesiedelung/NN/I-NP/I-PNP bietet/VB/B-VP/O ././O/O

Durch/IN/B-PP/B-PNP Anwendung/NN/B-NP/I-PNP eines/DT/I-NP/I-PNP validierten/NN/I-NP/I-PNP Virusinaktivierungsverfahrens/NN/I-NP/I-PNP erf\xc3\xbcllt/VB/B-VP/O diese/DT/B-NP/O Matrix/NN/I-NP/O die/DT/B-NP/O Anforderungen/NN/I-NP/O an/IN/B-PP/B-PNP Arzneimittel/NN/B-NP/I-PNP humanen/JJ/I-NP/I-PNP Ursprungs/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O azellul\xc3\xa4re/JJ/I-NP/O Dermis/NN/I-NP/O wurde/VB/B-VP/O unter/IN/B-PP/B-PNP Nutzung/NN/B-NP/I-PNP der/DT/I-NP/I-PNP Methoden/NN/I-NP/I-PNP des/DT/O/O Tissue/FW/O/O Engineering/FW/O/O mit/IN/B-PP/O den/DT/O/O zuvor/FW/O/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP vermehrten/VB/B-VP/O Fibroblasten/NN/B-NP/O kombiniert/JJ/B-ADJP/O ././O/O

Dabei/RB/B-VP/O war/VB/I-VP/O das/DT/B-NP/O Einsaatverfahren/NN/I-NP/O entscheidend/JJ/B-ADJP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Zelleinwanderung/NN/I-NP/I-PNP in/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Matrix/NN/I-NP/I-PNP ,/,/O/O am/IN/B-PP/O besten/VB/B-VP/O eignete/VB/I-VP/O sich/PRP/B-NP/O eine/DT/I-NP/O dynamische/JJ/I-NP/O Zelleinsaat/NN/I-NP/O ././O/O

Um/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP Ersatzgewebe/NN/I-NP/I-PNP zu/TO/B-VP/O erzeugen/VB/I-VP/O ,/,/O/O wurden/VB/B-VP/O die/DT/B-NP/O besiedelten/JJ/I-NP/O Pr\xc3\xa4parate/NN/I-NP/O in/IN/B-PP/B-PNP Kultursystemen/NN/B-NP/I-PNP gef\xc3\xbchrt/RP/O/O ././O/O

Neben/IN/B-PP/B-PNP statischen/JJ/B-NP/I-PNP Ans\xc3\xa4tzen/NN/I-NP/I-PNP fand/VB/B-VP/O daf\xc3\xbcr/RB/B-ADVP/O auch/RB/I-ADVP/O ein/DT/B-NP/O Bioreaktor/NN/I-NP/O Anwendung/NN/I-NP/O ,/,/O/O in/IN/B-PP/B-PNP dem/WDT/B-NP/I-PNP die/DT/I-NP/I-PNP Pr\xc3\xa4parate/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Medium/NN/B-NP/I-PNP durchstr\xc3\xb6mt/NN/I-NP/I-PNP wurden/VB/B-VP/O ././O/O

Die/DT/B-NP/O Tr\xc3\xa4ger-basierten/NN/I-NP/O Fibroblasten/NN/I-NP/O zeichneten/VB/B-VP/O sich/PRP/B-NP/O durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP gute/JJ/I-NP/I-PNP Proliferation/NN/I-NP/I-PNP und/CC/O/O Stoffwechselaktivit\xc3\xa4t/NN/B-NP/O aus/RP/O/O ././O/O

Aufgrund/IN/B-PP/B-PNP nur/RB/B-NP/I-PNP geringer/JJ/I-NP/I-PNP Kollagenasefreisetzung/NN/I-NP/I-PNP und/CC/O/O Kontraktion/NN/B-NP/O besiedelter/NN/I-NP/O Pr\xc3\xa4parate/NN/I-NP/O wurde/VB/B-VP/O ein/DT/B-NP/O hoher/JJ/I-NP/O Struktur/NN/I-NP/O -/-/O/O und/CC/O/O Volumenerhalt/NN/B-NP/O des/DT/B-NP/O Gewebsersatzes/NN/I-NP/O sichergestellt/RP/O/O ././O/O

Mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP eines/DT/O/O Hypoxiemodells/RB/B-VP/O konnten/VB/I-VP/O in/IN/B-PP/B-PNP vitro/NN/B-NP/I-PNP Aussagen/NN/I-NP/I-PNP zu/IN/B-PP/B-PNP den/DT/B-NP/I-PNP guten/JJ/I-NP/I-PNP Transplantateigenschaften/NN/I-NP/I-PNP getroffen/VBN/B-VP/I-PNP und/CC/O/O nachfolgend/JJ/B-ADJP/O in/IN/B-PP/B-PNP vivo/NN/B-NP/I-PNP durch/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP Rattenmodell/NN/I-NP/I-PNP verifiziert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Nach/IN/B-PP/B-PNP sechsw\xc3\xb6chiger/NNP/B-NP/I-PNP subkutaner/NNP/I-NP/I-PNP Transplantation/NNP/I-NP/I-PNP war/VB/B-VP/O dabei/RB/B-ADVP/O eine/DT/B-NP/O hohe/JJ/I-NP/O Akzeptanz/NN/I-NP/O und/CC/O/O Stabilit\xc3\xa4t/NN/B-NP/O der/DT/O/O mit/IN/B-PP/B-PNP autologen/NN/B-NP/I-PNP (/(/O/O Ratten)Fibroblasten/LS/O/O besiedelten/NN/B-NP/O humanen/NN/I-NP/O azellul\xc3\xa4ren/NN/I-NP/O Dermis/NN/I-NP/O beobachtbar/JJ/B-ADJP/O ././O/O

Die/DT/B-NP/O Fibroblastenbesiedelung/NN/I-NP/O stimulierte/NN/I-NP/O das/DT/B-NP/O Einwachsen/NN/I-NP/O von/IN/B-PP/B-PNP Blutgef\xc3\xa4\xc3\x9fen/NN/B-NP/I-PNP erheblich/JJ/B-ADJP/O ././O/O

Die/DT/B-NP/O Transplantation/NN/I-NP/O dieses/DT/B-NP/O aktiven/JJ/I-NP/O und/CC/I-NP/O stabilen/JJ/I-NP/O Ersatzgewebes/NN/I-NP/O kann/VB/B-VP/O einen/DT/B-NP/O wichtigen/JJ/I-NP/O Beitrag/NN/I-NP/O zur/IN/B-PP/B-PNP verbesserten/JJ/B-NP/I-PNP Therapie/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Patienten/NN/B-NP/I-PNP mit/IN/B-PP/B-PNP postoperativen/NN/B-NP/I-PNP Weichgewebsdefekten/NN/I-NP/I-PNP darstellen/VB/B-VP/O und/CC/O/O er\xc3\xb6ffnet/RB/B-ADVP/O die/DT/B-NP/O M\xc3\xb6glichkeit/NN/I-NP/O ,/,/O/O Heilungsst\xc3\xb6rungen/NN/B-NP/O entgegenzuwirken/VB/B-VP/O und/CC/O/O die/DT/B-NP/O Gewebsstabilit\xc3\xa4t/NN/I-NP/O und/CC/O/O -/-/O/O funktionalit\xc3\xa4t/NN/B-NP/O wiederherzustellen.Der/NN/I-NP/O benthische/JJ/I-NP/O Biofilm/NNP/I-NP/O nimmt/VB/B-VP/O eine/DT/B-NP/O Schl\xc3\xbcsselposition/NN/I-NP/O bei/IN/B-PP/B-PNP den/DT/B-NP/I-PNP Selbstreinigungsprozessen/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Flie\xc3\x9fgew\xc3\xa4ssern/NN/B-NP/I-PNP ein/RP/O/O ././O/O

\xc3\x9cber/IN/B-PP/B-PNP seine/PRP$/B-NP/I-PNP Entwicklung/NN/I-NP/I-PNP und/CC/I-NP/I-PNP Zusammensetzung/NN/I-NP/I-PNP liegen/VB/B-VP/O jedoch/RB/B-ADVP/O nur/RB/B-NP/O wenige/JJ/I-NP/O Daten/NN/I-NP/O vor/RP/O/O ././O/O

Aus/IN/B-PP/B-PNP diesem/DT/B-NP/I-PNP Grund/NN/I-NP/I-PNP wird/VB/B-VP/O der/DT/B-NP/O benthische/JJ/I-NP/O Biofilm/NNP/I-NP/O bei/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Modellierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Stoffumwandlungsprozessen/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Flie\xc3\x9fgew\xc3\xa4ssern/NN/B-NP/I-PNP oft/RB/B-VP/O nicht/RB/I-VP/O ber\xc3\xbccksichtigt/VBN/I-VP/O ,/,/O/O obwohl/CC/O/O ihm/PRP/B-NP/O hierbei/NN/I-NP/O vor/IN/B-PP/O allem/DT/O/O in/IN/B-PP/B-PNP kleinen/JJ/B-NP/I-PNP Flie\xc3\x9fgew\xc3\xa4ssern/NN/I-NP/I-PNP die/DT/B-NP/I-PNP gr\xc3\xb6\xc3\x9fte/JJ/I-NP/I-PNP Bedeutung/NN/I-NP/I-PNP zukommt/VB/B-VP/O ././O/O

Das/DT/B-NP/O Ziel/NN/I-NP/O der/DT/B-NP/O Arbeit/NN/I-NP/O war/VB/B-VP/O es/PRP/B-NP/O deshalb/RB/B-ADVP/O ,/,/O/O die/DT/B-NP/O Entwicklung/NN/I-NP/O des/DT/B-NP/O benthischen/JJ/I-NP/O Biofilms/NN/I-NP/O in/IN/B-PP/B-PNP Flie\xc3\x9fgew\xc3\xa4ssern/NN/B-NP/I-PNP im/IN/B-PP/B-PNP Verlauf/NN/B-NP/I-PNP eines/DT/I-NP/I-PNP Jahres/NN/I-NP/I-PNP zu/TO/B-VP/O untersuchen/VB/I-VP/O sowie/CC/O/O den/DT/B-NP/O Einfluss/NN/I-NP/O verschiedener/JJ/B-NP/O Umweltfaktoren/NN/I-NP/O zu/TO/B-VP/O erfassen/VB/I-VP/O ././O/O

Die/DT/B-NP/O Untersuchungen/NN/I-NP/O wurden/VB/B-VP/O in/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Ehle/NN/I-NP/I-PNP ,/,/O/O einem/DT/B-NP/O kleinen/JJ/I-NP/O Flie\xc3\x9fgew\xc3\xa4sser/NN/I-NP/O in/IN/B-PP/B-PNP Sachsen-Anhalt/NNP/B-NP/I-PNP (/(/O/O Deutschland/NNP/B-NP/O )/)/O/O ,/,/O/O im/IN/B-PP/B-PNP South-Saskatchewan-River/NN/B-NP/I-PNP in/IN/B-PP/B-PNP Saskatoon/NN/B-NP/I-PNP (/(/O/O Kanada/NNP/B-NP/O )/)/O/O sowie/CC/O/O in/IN/B-PP/B-PNP Biofilmreaktoren/NN/B-NP/I-PNP durchgef\xc3\xbchrt/RP/O/O ././O/O

Mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP der/DT/O/O konfokalen/JJ/B-ADJP/O Laser/FW/O/O Scanning/FW/O/O Mikroskopie/FW/O/O (/(/O/O CLSM/NN/B-NP/O )/)/O/O und/CC/O/O der/DT/B-NP/O Verwendung/NN/I-NP/O von/IN/B-PP/B-PNP Fluoreszenzfarbstoffen/NN/B-NP/I-PNP wurde/VB/B-VP/O die/DT/B-NP/O Struktur/NN/I-NP/O und/CC/O/O Zusammensetzung/NN/B-NP/O des/DT/B-NP/O benthischen/JJ/I-NP/O Biofilms/NN/I-NP/O untersucht/RP/O/O ././O/O

Besonders/RB/B-VP/O ber\xc3\xbccksichtigt/VB/I-VP/O wurden/VB/I-VP/O dabei/RB/B-ADVP/O die/DT/B-NP/O Bakterien/NN/I-NP/O ,/,/O/O die/DT/B-NP/O Algen/NN/I-NP/O ,/,/O/O die/DT/B-NP/O Cyanobakterien/NN/I-NP/O und/CC/O/O die/DT/B-NP/O extrazellul\xc3\xa4ren/JJ/I-NP/O Glykokonjugate/NN/I-NP/O ././O/O

Die/DT/B-NP/O digitalen/JJ/I-NP/O Bilddaten/NN/I-NP/O erm\xc3\xb6glichten/VB/B-VP/O eine/DT/B-NP/O drei-dimensionale/NN/I-NP/O Rekonstruktion/NN/I-NP/O des/DT/B-NP/O Biofilms/NN/I-NP/O sowie/RB/B-ADVP/O eine/DT/O/O qualitative/JJ/B-ADJP/O und/CC/O/O quantitative/NN/B-NP/O Auswertung/NN/I-NP/O der/DT/B-NP/O Struktur/NN/I-NP/O und/CC/O/O Zusammensetzung/NN/B-NP/O ././O/O

Hierf\xc3\xbcr/RB/B-VP/O wurden/VB/I-VP/O verschiedene/JJ/B-NP/O Bildanalyseprogramme/NN/I-NP/O auf/IN/B-PP/B-PNP ihre/PRP$/B-NP/I-PNP Eignung/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP Analyse/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Flie\xc3\x9fgew\xc3\xa4sserbiofilmen/JJ/B-NP/I-PNP getestet/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O Untersuchungen/NN/I-NP/O zeigten/VB/B-VP/O eine/DT/B-NP/O starke/JJ/I-NP/O jahreszeitliche/JJ/I-NP/O Abh\xc3\xa4ngigkeit/NN/I-NP/O der/DT/B-NP/O Biofilmdicke/NN/I-NP/O sowie/RB/B-ADVP/O der/DT/B-NP/O Zusammensetzung/NN/I-NP/O ././O/O

Diese/DT/O/O wurde/VB/B-VP/O vor/IN/B-PP/O allem/DT/O/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Populationsdynamik/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Makrozoobenthos/JJ/I-NP/I-PNP hervorgerufen/NN/I-NP/I-PNP ././O/O

Weiterhin/VBN/B-VP/O wurde/VB/I-VP/O der/DT/B-NP/O Einfluss/NN/I-NP/O der/DT/B-NP/O Aufwuchsoberfl\xc3\xa4che/NN/I-NP/O ,/,/O/O der/DT/B-NP/O hydrodynamischen/JJ/I-NP/O Bedingungen/NN/I-NP/O sowie/RB/B-ADVP/O der/DT/B-NP/O Ammoniumkonzentration/NN/I-NP/O auf/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Entwicklung/NN/I-NP/I-PNP ,/,/O/O die/DT/B-NP/O Struktur/NN/I-NP/O und/CC/O/O den/DT/B-NP/O Sauerstoffhaushalt/NN/I-NP/O des/DT/B-NP/O Biofilms/NN/I-NP/O untersucht/RP/O/O ././O/O

Zur/IN/B-PP/B-PNP Messung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Sauerstoffkonzentrationsprofilen/NN/B-NP/I-PNP und/CC/I-NP/I-PNP der/DT/I-NP/I-PNP photosynthetischen/JJ/I-NP/I-PNP Aktivit\xc3\xa4t/NN/I-NP/I-PNP wurden/RB/B-ADVP/O Sauerstoff-Mikroelektroden/NN/B-NP/O eingesetzt/RP/O/O ././O/O

Die/DT/B-NP/O gewonnenen/NN/I-NP/O Ergebnisse/NN/I-NP/O wurden/VB/B-VP/O in/IN/B-PP/B-PNP ein/DT/B-NP/I-PNP Biofilmmodell/NN/I-NP/I-PNP integriert/VBN/B-VP/I-PNP ,/,/O/O um/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Entwicklung/NN/I-NP/I-PNP des/DT/B-NP/I-PNP benthischen/JJ/I-NP/I-PNP Biofilms/NN/I-NP/I-PNP in/IN/B-PP/B-PNP Flie\xc3\x9fgew\xc3\xa4ssern/NN/B-NP/I-PNP zu/IN/B-PP/B-PNP simulieren/NN/B-NP/I-PNP ././O/O

Daf\xc3\xbcr/RB/B-VP/O wurde/VB/I-VP/O das/DT/B-NP/O Simulationsprogramm/NN/I-NP/O AQUASIM/NN/I-NP/O genutzt/VBN/B-VP/O ,/,/O/O sowie/CC/O/O die/DT/B-NP/O Prozesse/NN/I-NP/O in/IN/B-PP/B-PNP Anlehnung/NN/B-NP/I-PNP an/IN/B-PP/B-PNP das/DT/B-NP/I-PNP IWA/NNP/I-NP/I-PNP River/NNP/I-NP/I-PNP Water/FW/O/O Quality/FW/O/O Model/FW/O/O No.1/FW/O/O formuliert/RP/O/O ././O/O

Das/DT/B-NP/O Model/NN/I-NP/O wurde/VB/B-VP/O durch/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Abtragsfunktion/NN/I-NP/I-PNP erweitert/VBN/B-VP/I-PNP ,/,/O/O welche/WDT/B-NP/O das/DT/I-NP/O Grazing/NN/I-NP/O des/DT/B-NP/O Makrozoobenthos/NN/I-NP/O in/IN/B-PP/B-PNP Abh\xc3\xa4ngigkeit/NN/B-NP/I-PNP von/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Temperatur/NN/I-NP/I-PNP und/CC/O/O einem/DT/B-NP/O gew\xc3\xa4sserspezifischen/JJ/I-NP/O Faktor/NN/I-NP/O ber\xc3\xbccksichtigt/RP/O/O ././O/O

Damit/RB/B-VP/O konnte/VB/I-VP/O die/DT/B-NP/O \xc3\x84nderung/NN/I-NP/O der/DT/B-NP/O Biofilmdicke/NN/I-NP/O w\xc3\xa4hrend/IN/B-PP/B-PNP des/DT/B-NP/I-PNP Jahres/NN/I-NP/I-PNP sehr/RB/B-NP/I-PNP gut/JJ/I-NP/I-PNP simuliert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

Ein/DT/B-NP/O zweites/JJ/I-NP/O Biofilmmodell/NN/I-NP/O integriert/VB/B-VP/O die/DT/B-NP/O gewonnenen/NN/I-NP/O CLSM-Daten/NN/I-NP/O zur/IN/B-PP/B-PNP vertikalen/JJ/B-NP/I-PNP Verteilung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP Biofilmkomponenten/NN/I-NP/I-PNP und/CC/O/O simuliert/NN/B-NP/O auf/IN/B-PP/B-PNP dieser/DT/B-NP/I-PNP Grundlage/NN/I-NP/I-PNP die/DT/B-NP/I-PNP Sauerstoffkonzentrationen/NN/I-NP/I-PNP sowie/RB/B-ADVP/O die/DT/B-NP/O photosynthetische/JJ/I-NP/O Aktivit\xc3\xa4t/NN/I-NP/O in/IN/B-PP/B-PNP jeder/JJ/B-NP/I-PNP Schicht/NN/I-NP/I-PNP des/DT/B-NP/I-PNP Biofilms/NN/I-NP/I-PNP ././O/O

Die/DT/B-NP/O simulierten/NN/I-NP/O Werte/NN/I-NP/O konnten/VB/B-VP/O durch/IN/B-PP/B-PNP die/DT/B-NP/I-PNP experimentell/JJ/I-NP/I-PNP ermittelten/JJ/I-NP/I-PNP Daten/NN/I-NP/I-PNP aus/IN/B-PP/O den/DT/O/O Sauerstoff-Mikroelektroden-Versuchen/JJ/B-ADJP/O best\xc3\xa4tigt/VBN/B-VP/O werden/VB/I-VP/O ././O/O

omit/IN/B-PP/B-PNP liefert/NN/B-NP/I-PNP diese/DT/I-NP/I-PNP Arbeit/NN/I-NP/I-PNP 2/CD/B-NP/I-PNP Biofilmmodelle/NN/I-NP/I-PNP zum/IN/B-PP/B-PNP besseren/JJ/B-NP/I-PNP Verst\xc3\xa4ndnis/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Flie\xc3\x9fgew\xc3\xa4sserbiofilmen/NN/B-NP/I-PNP sowie/RB/B-ADVP/O zur/IN/B-PP/B-PNP Verbesserung/NN/B-NP/I-PNP von/IN/B-PP/B-PNP bestehenden/JJ/B-NP/I-PNP Flie\xc3\x9fgew\xc3\xa4ssermodellen.Die/NN/I-NP/I-PNP vorliegende/JJ/B-NP/I-PNP Arbeit/NN/I-NP/I-PNP beschreibt/NN/I-NP/I-PNP Eigenschaften/NNS/I-NP/I-PNP der/DT/B-NP/I-PNP reduktiven/JJ/I-NP/I-PNP Chlorbenzol-Dehalogenase/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP Dehalococcoides/JJ/B-NP/I-PNP sp/NN/I-NP/I-PNP ././O/O

amm/JJ/B-NP/O CBDB1/NN/I-NP/O ,/,/O/O einem/DT/B-NP/O strikt/JJ/I-NP/O anaeroben/NN/I-NP/O Bakterium/NN/I-NP/O ,/,/O/O das/DT/B-NP/O Chlorbenzole/NN/I-NP/O als/IN/B-PP/B-PNP terminale/NN/B-NP/I-PNP Elektronenakzeptoren/NN/I-NP/I-PNP zur/IN/B-PP/B-PNP Energiegewinnung/JJ/B-NP/I-PNP nutzt/NN/I-NP/I-PNP ././O/O

1,2,3-Trichlorbenzol/NN/B-NP/O (/(/O/O TCB/NN/B-NP/O )/)/O/O ,/,/O/O 1,2,4-TCB/NN/B-NP/O ,/,/O/O alle/JJ/B-NP/O Tetrachlorbenzol-Isomere/NN/I-NP/O ,/,/O/O Pentachlorbenzol/NN/B-NP/O und/CC/I-NP/O Hexachlorbenzol/NN/I-NP/O wurden/VB/B-VP/O durch/IN/B-PP/B-PNP Rohextrakt/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Stamm/NN/B-NP/I-PNP CBDB1/NN/I-NP/I-PNP reduktiv/JJ/I-NP/I-PNP dechloriert/NN/I-NP/I-PNP ././O/O

Besonders/RB/B-NP/O hohe/JJ/I-NP/O spezifische/JJ/I-NP/O Aktivit\xc3\xa4ten/NN/I-NP/O konnten/VB/B-VP/O f\xc3\xbcr/IN/B-PP/B-PNP 1,2,3,4-Tetrachlorbenzol/NN/B-NP/I-PNP und/CC/I-NP/I-PNP Pentachlorbenzol/NN/I-NP/I-PNP mit/IN/B-PP/B-PNP Methylviologen/NN/B-NP/I-PNP als/IN/B-PP/B-PNP Elektronendonor/NN/B-NP/I-PNP nachgewiesen/VBN/B-VP/I-PNP werden/VB/I-VP/O ././O/O

Die/DT/B-NP/O lichtreversible/JJ/I-NP/O Hemmung/NN/I-NP/O durch/IN/B-PP/B-PNP Alkyliodide/NN/B-NP/I-PNP lie\xc3\x9f/VB/B-VP/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP Beteiligung/NN/I-NP/I-PNP von/IN/B-PP/O Cob(I)alamin/LS/O/O an/IN/B-PP/B-PNP der/DT/B-NP/I-PNP reduktiven/JJ/I-NP/I-PNP Dechlorierung/NN/I-NP/I-PNP von/IN/B-PP/B-PNP 1,2,3-TCB/NN/B-NP/I-PNP schlie\xc3\x9fen/VB/B-VP/O ././O/O

Die/DT/B-NP/O 1,2,3-TCB-Dehalogenase-Aktivit\xc3\xa4t/NN/I-NP/O war/VBN/B-VP/O mit/IN/B-PP/B-PNP der/DT/B-NP/I-PNP Membranfraktion/JJ/I-NP/I-PNP assoziiert/NN/I-NP/I-PNP ././O/O

Hohe/JJ/B-NP/O Dechlorierungsaktivit\xc3\xa4ten/NN/I-NP/O intakter/NN/I-NP/O Zellen/NNS/I-NP/O mit/IN/B-PP/B-PNP dem/DT/B-NP/I-PNP hydrophilen/NN/I-NP/I-PNP Elektronendonor/NN/I-NP/I-PNP Methylviologen/NN/I-NP/I-PNP wiesen/VB/B-VP/O auf/IN/B-PP/B-PNP eine/DT/B-NP/I-PNP extrazellul\xc3\xa4re/JJ/I-NP/I-PNP Orientierung/NN/I-NP/I-PNP der/DT/B-NP/I-PNP TCB-Dehalogenase/NN/I-NP/I-PNP hin/IN/B-PP/O ././O/O

Aufgrund/IN/B-PP/B-PNP der/DT/B-NP/I-PNP geringen/JJ/I-NP/I-PNP Proteinertr\xc3\xa4ge/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP CBDB1-Kulturen/NN/B-NP/I-PNP (/(/O/O &/NN/B-NP/O lt;1/NN/I-NP/O \xc2\xb5g/NN/I-NP/O Protein&slash;ml/NNP/I-NP/O )/)/O/O wurden/VB/B-VP/O gelelektrophoretische/JJ/B-NP/O Methoden/NN/I-NP/O f\xc3\xbcr/IN/B-PP/B-PNP die/DT/B-NP/I-PNP Proteinaufreinigung/NN/I-NP/I-PNP eingesetzt/RP/O/O ././O/O

Mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP von/IN/B-PP/B-PNP nativen/NN/B-NP/I-PNP ,/,/O/O Taurodesoxycholat/NN/B-NP/O enthaltenden/NNP/I-NP/O Polyacrylamidgelen/VBN/B-VP/O wurden/VB/I-VP/O solubilisierte/NN/B-NP/O Membranproteine/NN/I-NP/O aufgetrennt/NN/I-NP/O ,/,/O/O und/CC/O/O einer/DT/B-NP/O einzelnen/JJ/I-NP/O Proteinbande/NN/I-NP/O konnte/VB/B-VP/O Dehalogenase-Aktivit\xc3\xa4t/NN/B-NP/O zugeordnet/NN/I-NP/O werden/VB/B-VP/O ././O/O

Eine/DT/B-NP/O Analyse/NN/I-NP/O \xc3\xbcber/IN/B-PP/B-PNP Tandem-Massenspektrometrie/NN/B-NP/I-PNP lieferte/VB/B-VP/O aufgrund/IN/B-PP/B-PNP der/DT/B-NP/I-PNP geringen/JJ/I-NP/I-PNP Proteinmenge/NN/I-NP/I-PNP keine/DT/B-NP/I-PNP verwertbare/JJ/I-NP/I-PNP Aminos\xc3\xa4ure-Sequenz/JJ/I-NP/I-PNP formation/NN/I-NP/I-PNP ././O/O

Bindungsversuche/NN/B-NP/O mit/IN/B-PP/B-PNP immobilisierten/NN/B-NP/I-PNP rekombinanten/JJ/I-NP/I-PNP B-Proteinen/NN/I-NP/I-PNP aus/IN/B-PP/B-PNP Stamm/NN/B-NP/I-PNP CBDB1/NN/I-NP/I-PNP gaben/VB/B-VP/O Hinweise/NN/B-NP/O darauf/VB/B-VP/O ,/,/O/O dass/RB/B-ADVP/O Dehalogenasen/NN/B-NP/O spezifisch/JJ/B-ADJP/O mit/IN/B-PP/B-PNP Membranankerproteinen/NN/B-NP/I-PNP interagieren/VB/B-VP/O und/CC/O/O eine/DT/B-NP/O Aufreinigung/NN/I-NP/O von/IN/B-PP/B-PNP Dehalogenasen/NN/B-NP/I-PNP \xc3\xbcber/IN/B-PP/B-PNP diese/DT/B-NP/I-PNP Interaktion/NN/I-NP/I-PNP m\xc3\xb6glich/JJ/B-ADJP/O ist/VB/B-VP/O ././O/O

Aus/IN/B-PP/B-PNP genomischer/JJ/B-NP/I-PNP DNA/NN/I-NP/I-PNP von/IN/B-PP/B-PNP Stamm/NN/B-NP/I-PNP CBDB1/NN/I-NP/I-PNP und/CC/I-NP/I-PNP dem/DT/I-NP/I-PNP Trichlorethen/NN/I-NP/I-PNP (/(/O/O TCE/NN/B-NP/O )/)/O/O dechlorierenden/NN/B-NP/O Bakterium/NN/I-NP/O Dehalococcoides/JJ/I-NP/O sp/NN/I-NP/O ././O/O

amm/JJ/B-NP/O FL2/NN/I-NP/O wurden/VB/B-VP/O jeweils/RB/B-ADVP/O 14/CD/B-NP/O verschiedene/JJ/I-NP/O reduktive/JJ/I-NP/O Dehalogenase-homologe/NN/I-NP/O (/(/O/O RDH)-Gene/LS/O/O \xc3\xbcber/IN/B-PP/B-PNP PCR/NN/B-NP/I-PNP amplifiziert/NN/I-NP/I-PNP ,/,/O/O die/WDT/O/O mit/IN/B-PP/B-PNP RDH-Genen/NN/B-NP/I-PNP von/IN/B-PP/B-PNP Dehalococcoides/NN/B-NP/I-PNP ethenogenes/NN/I-NP/I-PNP Stamm/NN/I-NP/I-PNP 195/CD/I-NP/I-PNP und/CC/I-NP/I-PNP Dehalococcoides/JJ/I-NP/I-PNP sp/NN/I-NP/I-PNP ././O/O

amm/JJ/B-NP/O BAV1/NN/I-NP/O sowie/RB/B-ADVP/O dem/DT/B-NP/O TCE-Dehalogenase/NN/I-NP/O kodierenden/JJ/B-NP/O tceA-Gen/NN/I-NP/O von/IN/B-PP/B-PNP Stamm/NN/B-NP/I-PNP 195/CD/I-NP/I-PNP einen/DT/I-NP/I-PNP Gencluster/NN/I-NP/I-PNP bildeten/VB/B-VP/O ././O/O

Die/DT/B-NP/O Sequenzbeziehungen/NN/I-NP/O der/DT/B-NP/O RDH-Gene/NN/I-NP/O lassen/VB/B-VP/O eine/DT/B-NP/O fr\xc3\xbche/NN/I-NP/O Evolution/NN/I-NP/O der/DT/B-NP/O reduktiven/NN/I-NP/O Dehalogenasen/NN/I-NP/O vermuten/VB/B-VP/O ././O/O

Mit/IN/B-PP/B-PNP Hilfe/NN/B-NP/I-PNP von/IN/B-PP/B-PNP vergleichenden/NN/B-NP/I-PNP Sequenzanalysen/NN/I-NP/I-PNP konnten/VB/B-VP/O Consensussequenzen/NN/B-NP/O zur/IN/B-PP/B-PNP Cobalaminbindung/NN/B-NP/I-PNP in/IN/B-PP/B-PNP den/DT/B-NP/I-PNP abgeleiteten/JJ/I-NP/I-PNP Aminos\xc3\xa4uresequenzen/NN/I-NP/I-PNP von/IN/B-PP/B-PNP sieben/CD/B-NP/I-PNP RDH-Genen/NN/I-NP/I-PNP identifiziert/NN/I-NP/I-PNP werden/VB/B-VP/O ././O/O

